10-Q

Accounting Standard Update

Description

Date of Adoption

Effect on the Financial Statements or Other Significant Matters

Simplifying the Accounting for Measurement-Period Adjustments

The updated guidance eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. The guidance is effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted.

September 26, 2015

Provisional amounts that occur on or after the adoption date will be recognized in the period in which they are determined. The adoption of this accounting guidance did not materially impact the financial statements for the quarter ended September 26, 2015.

0001585364-15-000156.txt : 20151102 0001585364-15-000156.hdr.sgml : 20151102 20151102164049 ACCESSION NUMBER: 0001585364-15-000156 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20150926 FILED AS OF DATE: 20151102 DATE AS OF CHANGE: 20151102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO Co plc CENTRAL INDEX KEY: 0001585364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0627 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36353 FILM NUMBER: 151191117 BUSINESS ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 269-673-8451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 FORMER COMPANY: FORMER CONFORMED NAME: PERRIGO Co Ltd DATE OF NAME CHANGE: 20130828 10-Q 1 a2016q110q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________________________________

FORM 10-Q

_______________________________________________



[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 26, 2015



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-36353

_______________________________________________

Perrigo Company plc

(Exact name of registrant as specified in its charter)

_______________________________________________



Ireland		Not Applicable
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland		-
(Address of principal executive offices)		(Zip Code)

+353 1 7094000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [X] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer [X]		Accelerated filer [ ]
Non-accelerated filer [ ]		Smaller reporting company [ ]
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] YES [X] NO

As of October 30, 2015, there were 146,402,066 ordinary shares outstanding.

PERRIGO COMPANY PLC

FORM 10-Q

INDEX



		PAGE NUMBER
Cautionary Note Regarding Forward-Looking Statements		1

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements (Unaudited)

Condensed Consolidated Statements of Operations for the Three Months Ended September 26, 2015 and September 27, 2014		2

Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended September 26, 2015 and September 27, 2014		3

Condensed Consolidated Balance Sheets as of September 26, 2015 and June 27, 2015		4

Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 26, 2015 and September 27, 2014		5

Notes to the Condensed Consolidated Financial Statements

1	Summary of Significant Accounting Policies	6

2	Acquisitions	7

3	Goodwill and Other Intangible Assets	12

4	Inventories	13

5	Fair Value Measurements	14

6	Investments	15

7	Derivative Instruments and Hedging Activities	15

8	Indebtedness	18

9	Earning per Share and Shareholders' Equity	20

10	Accumulated Other Comprehensive Income	21

11	Income Taxes	21

12	Commitments and Contingencies	22

13	Segment Information	23

14	Subsequent Events	24

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		24

Item 3. Quantitative and Qualitative Disclosures About Market Risk		34

Item 4. Controls and Procedures		34

PART II. OTHER INFORMATION

Item 1. Legal Proceedings		35

Item 1A. Risk Factors		35

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		36

Item 6. Exhibits		37

SIGNATURES		38

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this report are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or our industry's, actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this report, including certain statements contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or the negative of those terms or other comparable terminology.

Please see Item 1A of our Form 10-K for the fiscal year ended June 27, 2015 and Part II, Item 1A of this Form 10-Q for a discussion of certain important risk factors that relate to forward-looking statements contained in this report. We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. Risks and uncertainties include future actions that may be taken by Mylan N.V. ("Mylan") in furtherance of its unsolicited offer for all of our outstanding ordinary shares; the timing, amount and cost of share repurchases; and the ability to execute and achieve the desired benefits of announced initiatives. These and other important factors may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this report are made only as of the date hereof, and unless otherwise required by applicable securities laws, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Our directors accept responsibility for the information contained in this report. To the best of the knowledge and belief of our directors (who have taken all reasonable care to ensure such is the case), the information contained in this report is in accordance with the facts and does not omit anything likely to affect the import of such information.

A person interested in 1% or more of any class of our relevant securities or Mylan's may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2013.

This report contains trademarks, trade names and service marks that are our property, as well as, for informational purposes, trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, certain trademarks and trade names referred to in this report appear without the ^® and ™ symbols, but those references are not intended to indicate that we or the applicable owner, as the case may be, will not assert, to the fullest extent under applicable law, our or their rights to such trademarks, trade names, and service marks.

Perrigo Company plc - Item 1

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

PERRIGO COMPANY PLC

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share amounts)

(unaudited)



	Three Months Ended
	September 26, 2015		September 27, 2014
Net sales	$	1,344.7	$	951.5
Cost of sales	795.9		629.7
Gross profit	548.8		321.8

Operating expenses
Distribution	24.9		14.4
Research and development	41.6		36.6
Selling	167.9		50.4
Administration	123.6		81.5
Restructuring	2.2		1.7
Total operating expenses	360.2		184.6

Operating income	188.6		137.2

Interest expense, net	43.4		25.9
Other expense, net	13.0		2.7
Income before income taxes	132.2		108.6
Income tax expense	19.6		12.3
Net income	$	112.6	$	96.3

Earnings per share
Basic earnings per share	$	0.77	$	0.72
Diluted earnings per share	$	0.77	$	0.72

Weighted-average shares outstanding
Basic	146.3		133.9
Diluted	146.9		134.4

Dividends declared per share	$	0.125	$	0.105

See accompanying Notes to the Condensed Consolidated Financial Statements

Perrigo Company plc - Item 1

PERRIGO COMPANY PLC

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

(unaudited)



	Three Months Ended
	September 26, 2015			September 27, 2014
Net income	$	112.6		$	96.3
Other comprehensive income (loss):
Foreign currency translation adjustments	(39.8		)	(63.8		)
Change in fair value of derivative financial instruments, net of tax	0.1			(2.1		)
Change in fair value of investment securities, net of tax	2.5			0.6
Other comprehensive (loss), net of tax	(37.2		)	(65.3		)
Comprehensive income	$	75.4		$	31.0

See accompanying Notes to the Condensed Consolidated Financial Statements

Perrigo Company plc - Item 1

PERRIGO COMPANY PLC

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions)

(unaudited)



	September 26, 2015		June 27, 2015
Assets
Cash and cash equivalents	$	506.5	$	785.6
Investment securities	16.5		12.7
Accounts receivable, net of allowance for doubtful accounts of $2.1 million and $2.4 million, respectively	1,232.2		1,282.1
Inventories	888.0		838.9
Current deferred income taxes	69.0		122.3
Prepaid expenses and other current assets	168.6		141.3
Total current assets	2,880.8		3,182.9
Property and equipment, net	924.1		932.4
Goodwill and other indefinite-lived intangible assets	7,355.2		7,235.0
Other intangible assets, net	8,290.2		8,105.6
Non-current deferred income taxes	27.8		39.6
Other non-current assets	225.0		225.1
Total non-current assets	16,822.3		16,537.7
Total assets	$	19,703.1	$	19,720.6
Liabilities and Shareholders’ Equity
Accounts payable	$	541.2	$	747.5
Short-term debt	86.9		6.4
Payroll and related taxes	112.2		133.9
Accrued customer programs	367.1		368.1
Accrued liabilities	308.8		246.4
Accrued income taxes	82.3		52.6
Current deferred income taxes	104.5		80.6
Current portion of long-term debt	58.2		58.2
Total current liabilities	1,661.2		1,693.7
Long-term debt, less current portion	5,229.9		5,246.9
Non-current deferred income taxes	1,705.1		1,745.1
Other non-current liabilities	374.9		372.1
Total non-current liabilities	7,309.9		7,364.1
Total liabilities	8,971.1		9,057.8
Commitments and contingencies - Note 12
Preferred shares, $0.0001 par value, 10 million shares authorized	—		—
Ordinary shares, €0.001 par value, 10 billion shares authorized	8,632.8		8,621.9
Accumulated other comprehensive income	65.2		102.4
Retained earnings	2,034.0		1,938.3
Total controlling interest	10,732.0		10,662.6
Noncontrolling interest	—		0.2
Total shareholders’ equity	10,732.0		10,662.8
Total liabilities and shareholders' equity	$	19,703.1	$	19,720.6

Supplemental Disclosures of Balance Sheet Information
Preferred shares, issued and outstanding	—		—
Ordinary shares, issued and outstanding	146.4		146.3

See accompanying Notes to the Condensed Consolidated Financial Statements

Perrigo Company plc - Item 1

PERRIGO COMPANY PLC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)



	Three Months Ended
	September 26, 2015			September 27, 2014
Cash Flows From (For) Operating Activities
Net income	$	112.6		$	96.3
Adjustments to derive cash flows
Depreciation and amortization	175.4			126.6
Share-based compensation	14.3			8.8
Non-cash restructuring charges	2.2			1.7
Deferred income taxes	(14.2		)	(20.1		)
Other non-cash adjustments	3.2			0.3
Subtotal	293.5			213.6
Increase (decrease) in cash due to:
Accounts receivable	46.2			57.3
Inventories	(57.0		)	(29.7		)
Accounts payable	(194.0		)	(32.5		)
Payroll and related taxes	(22.8		)	(34.9		)
Accrued customer programs	(0.4		)	18.1
Accrued liabilities	61.5			0.6
Accrued income taxes	15.2			14.6
Other	(6.2		)	(12.0		)
Subtotal	(157.5		)	(18.5		)
Net cash from (for) operating activities	136.0			195.1
Cash Flows From (For) Investing Activities
Acquisitions of businesses, net of cash acquired	(405.1		)	—
Additions to property and equipment	(38.6		)	(31.7		)
Other investing	(5.0		)	1.0
Net cash from (for) investing activities	(448.7		)	(30.7		)
Cash Flows From (For) Financing Activities
Repayments of long-term debt	(14.3		)	(39.5		)
Borrowings (repayments) of short-term debt, net	79.0			(2.1		)
Issuance of ordinary shares	2.2			2.6
Shares withheld for payment of employees' withholding tax liability	(9.0		)	(7.5		)
Cash dividends	(18.3		)	(14.1		)
Other financing	4.1			(0.7		)
Net cash from (for) financing activities	43.7			(61.3		)
Effect of exchange rate changes on cash	(10.1		)	(11.1		)
Net increase (decrease) in cash and cash equivalents	(279.1		)	92.0
Cash and cash equivalents, beginning of period	785.6			799.5
Cash and cash equivalents, end of period	$	506.5		$	891.5

Supplemental Disclosures of Cash Flow Information
Cash paid/received during the year for:
Interest paid	$	6.2		$	5.2
Interest received	$	0.3		$	0.2
Income taxes paid	$	19.8		$	10.9
Income taxes refunded	$	1.0		$	0.5

See accompanying Notes to the Condensed Consolidated Financial Statements

Perrigo Company plc - Item 1

Note 1

NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a. General Information

The Company

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013. We became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo", the "Company", "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries. We are a leading over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high-quality products at affordable prices. From our beginning in 1887 as a packager of generic home remedies, we have grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri^®. We provide “Quality Affordable Healthcare Products^®” across a wide variety of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the fiscal year ended June 27, 2015. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included.

In fiscal year 2015, we announced that our fiscal year-end will begin on January 1 and end on December 31 of each year, starting on January 1, 2016. Fiscal year 2015, which ended on June 27, 2015, will be followed by a transition period from June 28, 2015 to December 31, 2015. We plan to disclose the results of the transition period on a Form 10-KT transition report.

We will continue to close our books on the Saturday closest to end of the quarter, with the last quarter ending on December 31. This practice will only affect the quarterly reporting periods and not the annual reporting periods.

Sales of OTC pharmaceutical products in the Consumer Healthcare ("CHC") segment are typically subject to seasonal demands for cough/cold/flu products from September through March and allergy products from April through September. Our Branded Consumer Healthcare ("BCH") sales are also impacted by seasonality and tend to peak in April through June due to increased demand for seasonal health and wellness products. In addition, our animal health products are subject to seasonal demand for flea and tick products that peaks during the warmer weather months, typically from March through June. Our Prescription Pharmaceuticals ("Rx"), Specialty Sciences, and Other segments' sales are not generally impacted by seasonal conditions. Accordingly, operating results for the three months ended September 26, 2015 are not necessarily indicative of the results that may be expected for a full year.

Principles of Consolidation

The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Perrigo Company plc - Item 1

Note 1

Accounts Receivable Factoring

As a result of our acquisition of Omega Pharma Invest N.V. ("Omega"), we assumed multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was $159.3 million at September 26, 2015, a $12.3 million decrease since June 27, 2015.

b. Recent Accounting Standard Pronouncements

NOTE 2 – ACQUISITIONS

All of the below acquisitions have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date.

Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets and liabilities assumed, as well as asset lives, can materially impact our results of operations. For those acquisitions for which the purchase price allocation is preliminary, we will continue to refine the allocation during the measurement period. As we obtain the information to finalize our purchase accounting assessments, it is reasonably possible that there will be changes in the valuation of assets acquired and liabilities assumed that may have a material impact on our results of operations and financial position.

The effects of all of the acquisitions described below were included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense.

Current Period Acquisitions

Naturwohl Pharma GmbH

On September 15, 2015, we completed our acquisition of 100% of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe. The acquisition builds on our BCH segment's leading OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at €133.5 million ($150.4 million). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired

Perrigo Company plc - Item 1

Note 2

included a trademark with a 15-year useful life, customer relationships with a 15-year useful life, non-compete agreements with a three-year useful life, and a licensing agreement with a three-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, the lost income method for valuing the non-compete agreements, and the with or without approach for the licensing agreement. The with or without approach estimates the fair value of an asset by comparing the value of the business, inclusive of the asset, to the hypothetical value of the same business excluding the asset. The goodwill acquired is not deductible for tax purposes.

ScarAway^®

On August 28, 2015, we acquired ScarAway^®, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for $27.0 million in cash. This acquisition serves as our entry into the branded OTC business in the U.S. Operating results attributable to ScarAway^®are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life, non-compete agreements with a four-year useful life and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.

GlaxoSmithKline Consumer Healthcare

On August 28, 2015, we completed the acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK”). This acquisition further leverages our European market share and expands our product offerings. The assets were purchased through an all-cash transaction valued at €200.0 million ($223.6 million). Operating results attributable to GSK are included in the BCH segment. The intangible assets acquired included trademarks with 25-year useful lives and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes.

Other Product Acquisitions

We also acquired two OTC product portfolios totaling €7.9 million ($8.7 million) during the three months ended September 26, 2015, which are included in the BCH segment.

Purchase Price Allocation of Current Period Acquisitions

The Naturwohl, ScarAway^®, and GSK opening balance sheets are still preliminary and are based on valuation information, estimates, and assumptions available at September 26, 2015. As we finalize the fair value estimates of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period. Tax accounts as well as certain tangible and intangible assets have not yet been finalized.

Perrigo Company plc - Item 1

Note 2

The below table indicates the purchase price allocation for our current period acquisitions (in millions):



	Naturwohl*		ScarAway^®*		GSK*
Total purchase consideration	$	150.4	$	27.0	$	223.6
Assets acquired:
Cash and cash equivalents	$	4.6	$	—	$	—
Accounts receivable	3.3		0.9		—
Inventories	1.7		—		—
Prepaid expenses and other current assets	—		0.1		—
Goodwill	63.5		4.9		48.7
Intangible assets:
Trademarks, trade names, and brands	51.8		11.6		132.4
Customer relationships and distribution networks	33.8		9.0		42.5
Non-competition agreements	0.3		0.5		—
Distribution and license agreements	21.4		—		—
Other intangible assets	107.3		21.1		174.9
Total assets	180.4		27.0		223.6
Liabilities assumed:
Accounts payable	2.8		—		—
Accrued liabilities	0.9		—		—
Current net deferred income tax liabilities	0.9		—		—
Non-current net deferred income tax liabilities	25.4		—		—
Total liabilities	30.0		—		—
Net assets acquired	$	150.4	$	27.0	$	223.6


*	Opening balance sheets are preliminary.

Prior Period Acquisitions

Gelcaps Exportadora de Mexico, S.A. de C.V.

On May 12, 2015, we acquired 100% of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for $36.4 million in cash. The purchase price was adjusted during the three months ended September 26, 2015 to account for a working capital adjustment with the seller. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life and customer relationships with a 20-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $0.6 million was recorded in the opening balance sheet, which was charged to cost of goods sold during the three months ended September 26, 2015. In addition, property, plant and equipment were written up by $0.9 million to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.

Omega Pharma Invest N.V.

On March 30, 2015, we completed our acquisition of Omega, a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company, and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with

Perrigo Company plc - Item 1

Note 2

critical mass in key European countries, establishing commercial infrastructure in the high-barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, enhancing our financial profile, and expanding our international management capabilities.

We purchased 95.77% of the issued and outstanding share capital of Omega (685,348,257 shares) from Alychlo N.V. (“Alychlo”) and Holdco I BE N.V. (“Holdco” and, together with Alychlo, the “Sellers”), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining 30,243,983 shares as treasury shares.

The acquisition was a cash and stock transaction made up of the following consideration (in millions, except per share data):



Perrigo ordinary shares issued	5.4
Perrigo share price at transaction close on March 30, 2015	$	167.64
Total value of Perrigo ordinary shares issued	$	904.9
Cash consideration	2,078.3
Total consideration	$	2,983.2

The cash consideration shown in the above table was financed by a combination of debt and equity. We issued $1.6 billion of debt and 6.8 million ordinary shares, which raised $999.3 million net of issuance costs.

The Sellers agreed to indemnify us for certain potential future losses. The Sellers’ indemnification and other obligations to us under the Share Purchase Agreement are secured up to €248.0 million ($277.0 million). Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a three-year non-compete in Europe, and the Sellers are subject to a two-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto.

The operating results attributable to Omega are included in the BCH segment. We incurred costs in connection with the Omega acquisition related to general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded in the fiscal year ended June 27, 2015 (in millions):



Line item	June 27, 2015
Administration	$	29.7
Interest expense, net	23.7
Other expense, net	324.0
Loss on extinguishment of debt	9.6
Total acquisition-related costs	$	387.0

The $324.0 million loss recorded in Other expense, net, consisted of losses from hedging Omega's euro-denominated purchase price due to changes in the euro-to-U.S. dollar exchange rates. These losses were economically offset at closing in the final settlement of the euro-denominated purchase price.

We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an eight-year useful life, definite-lived brands with a 19-year useful life, a distribution network with a 21-year useful life, and developed product technology with useful lives ranging from four to 13 years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above. We utilized the multi-period excess earnings method for the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method for the developed product technology and definite-lived trade name.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $15.1 million was recorded in the opening balance sheet and was charged to cost of goods sold during the three

Perrigo Company plc - Item 1

Note 2

months ended June 27, 2015. In addition, property, plant and equipment were written up $41.5 million to their estimated fair market value based on a valuation method that included both the cost and market approaches during the three months ended June 27, 2015. This step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed on the date of acquisition exceeded par value by $101.9 million, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see Note 8.

Lumara Health, Inc.

On October 31, 2014, we acquired a portfolio of women's healthcare products from Lumara Health, Inc., ("Lumara") a privately-held, Chesterfield, Missouri-based specialty pharmaceutical company, for cash consideration of $83.0 million. The acquisition of this portfolio further expanded our women's healthcare product offerings. Operating results attributable to the acquired Lumara products are included in the Rx segment. The intangible assets acquired consisted of three product formulations with useful lives ranging from eight to 12 years. The assets were valued utilizing the multi-period excess earnings method.

Purchase Price Allocation of Prior Period Acquisitions

The Lumara opening balance sheet is final. The Omega and Gelcaps opening balance sheets are still preliminary and are based on valuation information, estimates, and assumptions available at September 26, 2015.

Since the initial valuation, revisions to the Omega allocation have included: a $98.0 million increase in indefinite-lived brands and an $18.4 million increase in definite-lived intangible assets (trade names, brands, and distribution networks) due to refinements in underlying valuation assumptions; a $7.4 million reduction in inventory due to additional analysis related to the fair value of inventory and obsolescence reserves; a $9.6 million increase in property, plant, and equipment due to the completion of additional tangible asset valuations; and an increase in the net deferred tax liabilities of $31.6 million due to the valuation update. These revisions resulted in an $87.0 million reduction in goodwill. The purchase price allocation is still open for verification of the intangible assets valuation, related deferred taxes, and the resulting effects on the value of goodwill.

The Gelcaps purchase price allocation is open for verification of the intangible assets valuation, tax accounts, and any resulting effects on the value of goodwill.

Perrigo Company plc - Item 1

Note 2

The below table indicates the purchase price allocation for our prior year acquisitions (in millions):



	Gelcaps*		Omega*		Lumara
Total purchase consideration	$	36.4	$	2,983.2	$	83.0
Assets acquired:
Cash and cash equivalents	$	4.6	$	14.7	$	—
Accounts receivable	8.5		264.7		2.9
Inventories	7.2		207.1		1.5
Current net deferred tax assets	0.6		7.6		—
Prepaid expenses and other current assets	2.3		39.2		0.4
Property and equipment	6.0		130.8		0.1
Goodwill	4.6		1,426.1		—
Intangible assets:
Trademarks, trade names and brands	4.4		2,492.6		—
Customer relationships and distribution networks	6.6		1,393.9		—
Formulations	—		—		82.0
Developed product technology	—		32.6		—
Other intangible assets	11.0		3,919.1		82.0
Other non-current assets	0.4		2.4		—
Total assets	45.2		6,011.7		86.9
Liabilities assumed:
Accounts payable	3.4		243.1		—
Short-term debt	—		24.6		—
Accrued liabilities	1.6		44.5		3.9
Payroll and related taxes	—		51.3		—
Accrued customer programs	—		39.8		—
Long-term debt	—		1,471.0		—
Non-current net deferred income tax liabilities	3.7		1,071.7		—
Other non-current liabilities	0.1		82.5		—
Total liabilities	8.8		3,028.5		3.9
Net assets acquired	$	36.4	$	2,983.2	$	83.0


*	Opening balance sheets are preliminary.

NOTE 3 – GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):



Reporting Segments:	Balance at June 27, 2015		Business Acquisitions		Purchase Accounting Adjustments			Currency Translation Adjustment			Balance at September 26, 2015
CHC	$	1,897.5	$	4.9	$	(0.2	)	$	(3.8	)	$	1,898.4
BCH	1,551.9		112.2		(87.0		)	0.4			1,577.5
Rx	1,233.6		—		—			(8.1		)	1,225.5
Specialty Sciences	200.7		—		—			—			200.7
Other	88.2		—		—			(3.2		)	85.0
Total goodwill	$	4,971.9	$	117.1	$	(87.2	)	$	(14.7	)	$	4,987.1

Perrigo Company plc - Item 1

Note 3

Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):



	September 26, 2015				June 27, 2015
	Gross		Accumulated Amortization		Gross		Accumulated Amortization
Definite-lived intangibles:
Distribution and license agreements	$	6,064.2	$	582.6	$	6,029.9	$	502.3
Developed product technology/formulation and product rights	1,015.4		402.5		1,025.3		383.1
Customer relationships and distribution networks	1,888.2		181.5		1,749.9		146.2
Trademarks, trade names, and brands	502.8		16.7		340.8		11.5
Non-compete agreements	15.2		12.3		14.7		11.9
Total definite-lived intangibles	$	9,485.8	$	1,195.6	$	9,160.6	$	1,055.0
Indefinite-lived intangibles:
Trademarks, trade names, and brands	$	2,362.5	$	—	$	2,257.3	$	—
In-process research and development	5.6		—		5.8		—
Total indefinite-lived intangibles	2,368.1		—		2,263.1		—
Total other intangible assets	$	11,853.9	$	1,195.6	$	11,423.7	$	1,055.0

Certain intangible assets are denominated in currencies other than the U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.

We recorded amortization expense of $147.6 million and $106.5 million for the three months ended September 26, 2015 and September 27, 2014, respectively. The increase in amortization expense was due primarily to the incremental amortization expense incurred on the definite-lived intangible assets acquired from Omega.

NOTE 4 – INVENTORIES

Major components of inventory at September 26, 2015 and June 27, 2015, were as follows (in millions):



	September 26, 2015		June 27, 2015
Finished goods	$	504.7	$	468.9
Work in process	163.2		158.2
Raw materials	220.1		211.8
Total inventories	$	888.0	$	838.9

Perrigo Company plc - Item 1

Note 5

NOTE 5 – FAIR VALUE MEASUREMENTS

Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable.


Level 1:	Quoted prices for identical instruments in active markets.


Level 2:	Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.


Level 3:	Valuations derived from valuation techniques in which one or more significant inputs are not observable.

The following tables summarize the valuation of our financial instruments carried at fair value by the above pricing categories at September 26, 2015 and June 27, 2015 (in millions):



	September 26, 2015
	Level 1		Level 2		Level 3		Total
Assets:
Investment securities	$	16.5	$	—	$	—	$	16.5
Foreign currency forward contracts	—		4.8		—		4.8
Funds associated with Israeli post-employment benefits	—		16.5		—		16.5
Total assets	$	16.5	$	21.3	$	—	$	37.8
Liabilities:
Foreign currency forward contracts	—		5.9		—		5.9
Total liabilities	$	—	$	5.9	$	—	$	5.9



	June 27, 2015
	Level 1		Level 2		Level 3		Total
Assets:
Investment securities	$	12.7	$	—	$	—	$	12.7
Foreign currency forward contracts	—		12.4		—		12.4
Funds associated with Israeli post-employment benefits	—		17.3		—		17.3
Total assets	$	12.7	$	29.7	$	—	$	42.4
Liabilities:
Foreign currency forward contracts	—		4.6		—		4.6
Total liabilities	$	—	$	4.6	$	—	$	4.6

There were no transfers between Levels 1, 2, and 3 during the three months ended September 26, 2015. Our policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period. See Note 6 for information on our investment securities. See Note 7 for a discussion of derivatives.

Israeli post-employment benefits represent amounts we have deposited in funds managed by financial institutions designated by management to cover post-employment benefits for its Israeli employees as required by Israeli law. The funds are recorded in Other non-current assets and values are determined using prices for recently traded financial instruments with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves, that are observable at commonly quoted intervals.

As of September 26, 2015 and June 27, 2015, our fixed rate long-term debt consisted of public bonds, retail bonds, and private placement notes. The fair value of the public bonds was determined by quoted market prices (Level 1). As of September 26, 2015, the public bonds had a carrying value of $3.9 billion and a fair value of $3.8 billion. As of June 27, 2015, the public bonds had a carrying value and a fair value of $3.9 billion. The fair value of the retail bonds and private placement notes was determined by discounting the future cash flows of the financial

Perrigo Company plc - Item 1

Note 5

instruments to their present value, using interest rates offered for borrowings of a similar nature and remaining maturities (Level 2). As of September 26, 2015 and June 27, 2015, the retail bonds and private placement notes had a carrying value of $822.7 million and $820.9 million, respectively, and a fair value of $890.9 million and $902.4 million, respectively.

The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.

NOTE 6 – INVESTMENTS

Available for Sale Securities

Our available for sale securities are reported in Investment securities. Unrealized investment gains (losses) on available for sale securities were as follows (in millions):



	September 26, 2015			June 27, 2015
Equity securities, at cost less impairments	$	17.1		$	17.1
Gross unrealized gains	10.6			5.7
Gross unrealized losses	(11.2		)	(10.1		)
Estimated fair value of equity securities	$	16.5		$	12.7

The factors affecting the assessment of impairments include both general financial market conditions and factors specific to a particular company. The equity securities in a gross unrealized loss position at September 26, 2015 were in that position for less than 12 months. We have evaluated the near-term prospects of the equity securities in relation to the severity and duration of the unrealized impairments, and based on that evaluation, we have the ability and intent to hold the investments until a recovery of fair value.

Cost Method Investments

Our cost method investments totaled $6.9 million and $6.8 million at September 26, 2015 and June 27, 2015, respectively, and are included in Other non-current assets.

Equity Method Investments

Our equity method investments totaled $48.5 million and $48.9 million at September 26, 2015 and June 27, 2015, respectively, and are included in Other non-current assets. We recorded net losses of $4.1 million and $3.1 million during the three months ended September 26, 2015 and September 27, 2014, respectively, for our proportionate share of the equity method investment earnings or losses. The losses were recorded in Other expense, net.

NOTE 7 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as

Perrigo Company plc - Item 1

Note 7

foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of September 26, 2015 and June 27, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of Other Comprehensive Income ("OCI"), net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.

Interest Rate Swaps and Treasury Locks

Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. All of our interest rate swaps qualify for hedge accounting treatment.

Foreign Currency Derivatives

We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of 15 months. The total notional amount for these contracts was $562.3 million and $452.3 million as of September 26, 2015 and June 27, 2015, respectively.

Effects of Derivatives on the Financial Statements

The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements at September 26, 2015 and June 27, 2015. All amounts exclude income tax effects and are presented in millions.

Perrigo Company plc - Item 1

Note 7

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:



	Asset Derivatives
	Balance Sheet Location	Fair Value
		September 26, 2015		June 27, 2015
Designated derivatives:
Foreign currency forward contracts	Other current assets	$	2.3	$	3.3
Total designated derivatives		$	2.3	$	3.3
Non-designated derivatives:
Foreign currency forward contracts	Other current assets	$	2.5	$	9.1
Total non-designated derivatives		$	2.5	$	9.1



	Liability Derivatives
	Balance Sheet Location	Fair Value
		September 26, 2015		June 27, 2015
Designated derivatives:
Foreign currency forward contracts	Accrued liabilities	$	2.5	$	2.0
Total designated derivatives		$	2.5	$	2.0
Non-designated derivatives:
Foreign currency forward contracts	Accrued liabilities	$	3.4	$	2.6
Total non-designated derivatives		$	3.4	$	2.6

The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:



	Amount of Gain/(Loss) Recorded in OCI (Effective Portion)
	Three Months Ended
Designated Cash Flow Hedges	September 26, 2015			September 27, 2014
Interest rate swap agreements	—			2.7
Foreign currency forward contracts	(0.5		)	(5.2		)
	$	(0.5	)	$	(2.5	)

The gains (losses) reclassified from Accumulated Other Comprehensive Income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:



Designated Cash Flow Hedges	Income Statement Location	Amount of Gain/(Loss) Reclassified from AOCI to Income (Effective Portion)
		Three Months Ended
		September 26, 2015			September 27, 2014
Interest rate swap agreements	Interest expense, net	(0.4		)	(0.9		)
Foreign currency forward contracts	Net sales	(0.1		)	0.6
	Cost of sales	0.2			0.4
	Other expense, net	(0.1		)	(0.8		)
		$	(0.4	)	$	(0.7	)

The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a$1.8 million loss.

Perrigo Company plc - Item 1

Note 7

The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:



Non-Designated Derivatives	Income Statement Location	Amount of Gain/(Loss) Recognized in Income
		Three Months Ended
		September 26, 2015			September 27, 2014
Foreign currency forward contracts	Other expense, net	$	(8.9	)	$	(1.8	)
	Interest expense, net	0.1			(1.5		)
Total		$	(8.8	)	$	(3.3	)

NOTE 8 – INDEBTEDNESS

Total borrowings outstanding at September 26, 2015 and June 27, 2015 are summarized as follows (in millions):



				September 26, 2015			June 27, 2015
Short-term debt				$	86.9		$	6.4
Term loans
*	2014 Term loan due December 5, 2019			517.7			530.5
Public bonds
	Coupon	Due
	1.300%	November 8, 2016	⁽³⁾	500.0			500.0
*	4.500%	May 23, 2017	⁽²⁾	201.5			201.0
*	5.125%	December 12, 2017	⁽²⁾	335.8			335.0
	2.300%	November 8, 2018	⁽³⁾	600.0			600.0
*	5.000%	May 23, 2019	⁽²⁾	134.3			134.1
	3.500%	December 15, 2021	⁽¹⁾	500.0			500.0
*	5.105%	July 19, 2023	⁽²⁾	151.1			150.8
	4.000%	November 15, 2023	⁽³⁾	800.0			800.0
	3.900%	December 15, 2024	⁽¹⁾	700.0			700.0
	5.300%	November 15, 2043	⁽³⁾	400.0			400.0
	4.900%	December 15, 2044	⁽¹⁾	400.0			400.0
	Total public bonds			4,722.7			4,720.9
Other financing				6.3			6.6
Unamortized premium (discount), net				80.4			87.5
Deferred financing fees				(39.0		)	(40.5		)
Total borrowings outstanding				5,375.0			5,311.4
	Less short-term debt and current portion of long-term debt			(145.1		)	(64.6		)
Total long-term debt less current portion				$	5,229.9		$	5,246.8


⁽¹⁾	Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds."


⁽²⁾	Debt assumed from Omega.


⁽³⁾	Discussed below collectively as the "2013 Bonds."


*	Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.

We were in compliance with all covenants under our various debt agreements as of September 26, 2015 and June 27, 2015.

Our term loan and revolving credit facility each have an event of default for changes of control that would be triggered upon a 35% change of control. Also, if there is a change of control under our $3.9 billion of public senior notes (the 2014 Bonds and 2013 Bonds), and they are downgraded below investment grade by both Moody's

Perrigo Company plc - Item 1

Note 8

Investor Services, Inc. and Standard & Poor's Rating Service, we would be obligated to offer to repurchase all of the 2014 Bonds and 2013 Bonds at 101% of par.

Omega Financing

Debt Issuance

On December 2, 2014, Perrigo Finance plc, our 100% owned finance subsidiary ("Perrigo Finance"), issued $500.0 million in aggregate principal amount of 3.50% senior notes due 2021 (the "2021 Notes”), $700.0 million in aggregate principal amount of 3.90% senior notes due 2024 (the “2024 Notes”), and $400.0 million in aggregate principal amount of 4.90% senior notes due 2044 (the “2044 Notes” and, together with the 2021 Notes and the 2024 Notes, the “2014 Bonds”). Interest on the 2014 Bonds is payable semiannually in arrears in June and December of each year, beginning in June 2015. The 2014 Bonds are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Bonds are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo Company plc, and no other subsidiary of Perrigo Company plc guarantees the 2014 Bonds. There are no restrictions under the 2014 Bonds on our ability to obtain funds from our subsidiaries. Perrigo Finance received net proceeds of approximately $1.6 billion from issuance of the 2014 Bonds after fees and market discount. Perrigo Finance may redeem the 2014 Bonds in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture.

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, with the ability to draw an additional €300.0 million ($368.6 million) tranche, maturing December 5, 2019, and a $600.0 million revolving credit agreement, which stepped up to $1.0 billion upon the closing of the Omega acquisition (the "2014 Revolver") (together, the "2014 Credit Agreements"). On the same date, Perrigo Company plc entered into a $300.0 million term loan tranche maturing December 18, 2015, which we repaid on June 14, 2015. There were no borrowings outstanding under the 2014 Revolver as of September 26, 2015. Subsequent to September 26, 2015, we allowed the undrawn €300.0 million term loan tranche to expire.

Assumed Debt and Repayment

In connection with the Omega acquisition, we assumed $20.0 million in aggregate principal amount of 6.19% senior notes due 2016 ("2016 Notes"), €135.0 million ($147.0 million) in aggregate principal amount of 5.1045% senior notes due 2023 ("2023 Notes"), €300.0 million ($326.7 million) in aggregate principal amount of 5.125% retail bonds due 2017, €180.0 million ($196.0 million) in aggregate principal amount of 4.500% retail bonds due 2017, €120.0 million ($130.7 million) in aggregate principal amount of 5.000% retail bonds due 2019 (collectively, the "Retail Bonds"), a revolving credit facility with €500.0 million ($544.5 million) outstanding, and certain overdraft facilities totaling €51.4 million ($56.0 million). The fair value of the 2023 Notes and Retail Bonds exceeded par value by €93.6 million ($101.9 million) on the date of the acquisition. As a result, a fair value adjustment was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. The adjustment does not affect cash interest payments.

On April 8, 2015, we repaid the €500.0 million ($539.1 million) outstanding under the assumed Omega revolving credit facility and terminated the facility. On May 29, 2015, we repaid the $20.0 million outstanding on the 2016 Notes.

Omega regularly utilizes overdraft facilities to meet its short-term liquidity needs and its balances fluctuate on a day-to-day basis. While the assumed overdraft facilities balance noted above was repaid as of June 27, 2015, additional borrowings were made as of September 26, 2015 and make up the majority of the short-term debt balance in the above table.

Elan Financing

Debt Issuance

On November 8, 2013, Perrigo Company issued $500.0 million aggregate principal amount of its 1.300% senior notes due 2016 (the "2016 Notes"), $600.0 million aggregate principal amount of its 2.300% senior notes due

Perrigo Company plc - Item 1

Note 8

2018 (the "2018 Notes"), $800.0 million aggregate principal amount of its 4.000% senior notes due 2023 (the "2023 Notes") and $400.0 million aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 2016 Notes, the 2018 Notes and the 2023 Notes, the "2013 Bonds") in a private placement with registration rights. Interest on the 2013 Bonds is payable semiannually in arrears in May and November of each year, beginning in May 2014. The 2013 Bonds are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Bonds are the Company's unsecured and unsubordinated obligations, ranking equally in right of payment to all of Perrigo Company's existing and future unsecured and unsubordinated indebtedness. Perrigo Company received net proceeds of $2.3 billion from the issuance of the 2013 Bonds after fees and market discount. The 2013 Bonds are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Bonds in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Bonds were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our 2013 credit agreements until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors.

On September 2, 2014, we offered to exchange our private placement senior notes with public bonds. The offer was open until October 1, 2014, at which time substantially all of the private placement notes had been exchanged for bonds registered with the Securities and Exchange Commission. As a result of the changes in the guarantor structure noted above, we are no longer required to present guarantor financial statements.

NOTE 9 – EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):



	Three Months Ended
	September 26, 2015		September 27, 2014
Numerator:
Net income	$	112.6	$	96.3

Denominator:
Weighted average shares outstanding for basic EPS	146.3		133.9
Dilutive effect of share-based awards	0.6		0.5
Weighted average shares outstanding for diluted EPS	146.9		134.4

Anti-dilutive share-based awards excluded from computation of diluted EPS	0.1		0.1

Shareholders' Equity

On and prior to December 18, 2013, our common stock consisted of common stock of Perrigo Company, a Michigan Corporation, and since December 19, 2013, our common stock has consisted of ordinary shares of Perrigo Company plc, incorporated under the laws of Ireland.

Prior to June 6, 2013, our common stock traded on the NASDAQ Global Select Market under the symbol PRGO. Since June 6, 2013, our ordinary shares have traded on the New York Stock Exchange under the symbol PRGO. In association with the acquisition of Agis Industries (1983) Ltd., our ordinary shares have been trading on the Tel Aviv Stock Exchange since March 16, 2005.

We issued 154 thousand and 186 thousand shares related to the exercise and vesting of share-based compensation during the three months ended September 26, 2015 and September 27, 2014, respectively.

Perrigo Company plc - Item 1

Note 9

As of September 26, 2015, we did not have an ordinary share repurchase program. On October 22, 2015, we announced a $2.0 billion share repurchase plan over three years, including $500.0 million expected to be repurchased during the fourth quarter of calendar year 2015.

NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in our AOCI balances, net of tax, for the three months ended September 26, 2015 were as follows (in millions):



	Foreign currency translation adjustments			Fair value of derivative financial instruments, net of tax			Fair value of investment securities, net of tax			Post-retirement and pension liability adjustments, net of tax			Total AOCI
Balance at June 27, 2015	$	130.9		$	(16.3	)	$	(3.0	)	$	(9.2	)	$	102.4
OCI before reclassifications	(39.8		)	(0.3		)	2.5			—			(37.6		)
Amounts reclassified from AOCI	—			0.4			—			—			0.4
Other comprehensive income	(39.8		)	0.1			2.5			—			(37.2		)
Balance at September 26, 2015	$	91.1		$	(16.2	)	$	(0.5	)	$	(9.2	)	$	65.2

NOTE 11 - INCOME TAXES

The effective tax rate was 14.8% and 11.4% for the three months ended September 26, 2015 and September 27, 2014, respectively.

Our tax rate is subject to adjustment over the balance of the prior fiscal year ended due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments to our interpretation of transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes.

The total liability for uncertain tax positions was $399.0 million and $384.3 million as of September 26, 2015 and June 27, 2015, respectively, before considering the federal tax benefit of certain state and local items.

We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $69.0 million and $65.7 million as of September 26, 2015 and June 27, 2015, respectively.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the U.S., Israel, Belgium, France, and the United Kingdom (U.K.).

Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit, and any related litigation, could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, or interest assessments.

Perrigo Company plc - Item 1

Note 11

incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the notice of deficiency. In January 2015, we paid this amount, a prerequisite to being able to contest the IRS’s positions in U.S. Federal court, and in June 2015, we filed a request for a refund. As the IRS has denied our request for a refund, we intend to contest the IRS’s asserted positions in U.S. Federal court. The payment was recorded as a deferred charge on the balance sheet given our anticipated action to recover this amount. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods. There are numerous other income tax jurisdictions for which tax returns are not yet settled, none of which are individually significant. At this time, we cannot predict the outcome of any audit or related litigation.

NOTE 12 – COMMITMENTS AND CONTINGENCIES

In addition to the discussions below, we have pending certain other legal actions and claims incurred in the normal course of business. We record accruals for such contingencies when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. As of September 26, 2015, we have determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. We have accrued for these matters and will continue to monitor each related legal issue and adjust accruals for new information and further development. Other than what is disclosed below, we consider the litigation matters to be immaterial individually and in the aggregate.

Texas Medicaid

In June 2013, we received notices from the Office of the Attorney General for the State of Texas, of civil investigative demands to two of our affiliates, Perrigo Pharmaceuticals Company and Paddock Laboratories, LLC, for information under the Texas Medicaid Fraud Prevention Act relating to the submission of prices to Texas Medicaid in claims for reimbursement for drugs. We have cooperated with requests for information and are in the process of evaluating this and other information. While we do not know the full extent of our potential liability at this time and intend to vigorously defend against any claims, we could be subject to material penalties and damages. We initially established a contingency loss accrual of $15.0 million to cover potential settlement or other outcomes. Due to changes in circumstances, during the three months ended March 28, 2015, we accrued an additional $9.0 million. In addition, we recorded a receivable of $7.0 million representing the amount we expect to collect from the previous owners of Paddock Laboratories, LLC. We cannot predict whether we will obtain a settlement on terms we deem acceptable, or whether a settlement or potential liability for these claims will be materially higher than the amount recorded.

Eltroxin

During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by Perrigo Israel Agencies Ltd. The respondents include Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel.

One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.

Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd.

Perrigo Company plc - Item 1

Note 12

On June 16, 2015, Perrigo submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. Other than requiring Perrigo to file its statement of defense to the underlying proceedings, the underlying proceedings have been stayed pending a decision on the motion to appeal.

At this stage, we cannot reasonably predict the outcome or the liability, if any, associated with these claims.

Tysabri^® Product Liability Lawsuits

Perrigo Company plc and collaborator Biogen Idec are co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy, a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri^®. Perrigo Company plc and Biogen Idec will each be responsible for 50% of losses and expenses arising out of any Tysabri^® product liability claims. While these lawsuits will be vigorously defended, management cannot predict how these cases will be resolved. Adverse results in one or more of these lawsuits could result in substantial judgments against us.

NOTE 13 – SEGMENT INFORMATION

Our reporting segments are as follows:


•	CHC is focused primarily on the global sale of OTC store brand products including cough, cold, and allergy products, gastrointestinal products, analgesics, nicotine-replacement therapy ("NRT"), Vitamins, Minerals and Supplements ("VMS"), animal health products, infant formula and foods, and diagnostic products.


•	BCH develops, manufactures, markets and distributes some of Europe's most well-known OTC brands in the natural health and VMS, cough, cold and allergy, NRT, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.


•	Rx develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and U.K. markets.


•	Specialty Sciences is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri^®).

We also have an "Other" segment comprised of our active pharmaceutical ingredient ("API") business, which develops, manufactures, and markets active API used worldwide by both generic and branded pharmaceutical companies.

The below tables show select financial measures by reporting segment (in millions):



	Three Months Ended							Balance at September 26, 2015
	September 26, 2015							Balance at September 26, 2015
	Net Sales		Operating Income (Loss)			Amortization of Intangibles		Total Assets
CHC	$	675.2	$	117.3		$	19.4	$	4,211.2
BCH	302.2		4.4			36.3		6,728.0
Rx	260.3		91.0			18.6		2,597.6
Specialty Sciences	84.5		9.0			72.8		5,920.8
Other	22.5		6.2			0.5		245.5
Unallocated expenses	—		(39.3		)	—		—
Total	$	1,344.7	$	188.6		$	147.6	$	19,703.1

Perrigo Company plc - Item 1

Note 13



	Three Months Ended							Balance at June 27, 2015
	September 27, 2014							Balance at June 27, 2015
	Net Sales		Operating Income (Loss)			Amortization of Intangibles		Total Assets
CHC	$	640.3	$	74.8		$	16.2	$	4,381.6
BCH	—		—			—		6,441.1
Rx	194.5		64.7			17.0		2,667.9
Specialty Sciences	91.9		14.9			72.8		5,979.0
Other	24.8		7.1			0.5		251.0
Unallocated expenses	—		(24.3		)	—		—
Total	$	951.5	$	137.2		$	106.5	$	19,720.6

NOTE 14 – SUBSEQUENT EVENTS

On October 22, 2015, we announced that we intend to undertake certain initiatives designed to increase operational efficiency and improve our return on invested capital by globalizing our supply chain through global shared service arrangements, streamlining our organizational structure, and disposing of certain assets.


ITEM 2.	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EXECUTIVE OVERVIEW

We are a leading global over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high-quality products at affordable prices. From our beginning in 1887 as a packager of generic home remedies, we have grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri^®. We provide “Quality Affordable Healthcare Products^®” across a wide variety of product categories and geographies, primarily in North America, Europe, and Australia, as well as in other markets, including Israel and China.

Our reporting segments are as follows:


•	Consumer Healthcare ("CHC") is focused primarily on the global sale of OTC store brand products including cough, cold, and allergy products, gastrointestinal products, analgesics, nicotine-replacement therapy ("NRT"), Vitamins, Minerals and Supplements ("VMS"), animal health products, infant formula and foods, and diagnostic products.


•	Branded Consumer Healthcare ("BCH") develops, manufactures, markets and distributes some of Europe's most well-known OTC brands in the natural health and VMS, cough, cold and allergy, NRT, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.


•	Prescription Pharmaceuticals ("Rx") develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and United Kingdom markets.


•	Specialty Sciences is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri^®).

Perrigo Company plc - Item 2

Executive Overview

We also have an "Other" segment comprised of our active pharmaceutical ingredients ("API") business, which develops, manufactures, and markets active API used worldwide by both generic and branded pharmaceutical companies. For results by segment, see "Segment Results" below and Item 1. Note 13.

Seasonality

Sales of OTC pharmaceutical products in the CHC segment are typically subject to seasonal demands for cough/cold/flu products from September through March and allergy products from April through September. Our BCH sales are also impacted by seasonality and tend to peak in April through June due to increased demand for seasonal health and wellness products. In addition, our animal health products are subject to seasonal demand for flea and tick products that peaks during the warmer weather months, typically from March through June. Our Rx, Specialty Sciences, and Other segments' sales are not generally impacted by seasonal conditions. Accordingly, operating results for the three months ended September 26, 2015 are not necessarily indicative of the results that may be expected for a full year.

Unsolicited Offer from Mylan N.V. ("Mylan")

In April 2015, Mylan made several unsolicited proposals to purchase all of our outstanding ordinary shares. On September 14, 2015, Mylan commenced an exchange offer (the "Exchange Offer") to acquire all of our outstanding ordinary shares, which will expire on November 13, 2015, unless it is extended with the consent of the Irish Takeover Panel. The Exchange Offer and certain of its potential consequences are explained in further detail in Part II, Item 1A. Risk Factors.

We have rejected each of Mylan’s unsolicited proposals, and on September 17, 2015, we filed a solicitation/recommendation statement unanimously recommending that shareholders do not tender into the Exchange Offer.

Defending against Mylan's proposals and the Exchange Offer has required, and will continue to require, us to incur fees. During the three months ended September 26, 2015, we incurred $15.6 million in consulting and legal fees related to our defense against Mylan's unsolicited offer. See "Cautionary Note Regarding Forward-Looking Statements" and Part II, Item 1A. Risk Factors for more information on risks relating to the Exchange Offer.

We have $517.7 million of outstanding term loans and a $1.0 billion revolving credit facility (no borrowings outstanding) as of September 26, 2015, that each have an event of default for changes of control that would be triggered upon Mylan’s acquisition of more than 35% of our ordinary shares in the Exchange Offer. The occurrence of this event of default would give our term lenders the right to immediately accelerate and declare due and payable all of such outstanding term loans and our revolving lenders the right to declare any amounts then outstanding immediately due and payable and all commitments immediately terminated.

In addition, an aggregate principal amount of approximately $3.9 billion (as of September 26, 2015) of our outstanding public bonds contain change of control provisions that would be triggered if (1) a change of control were to occur and (2) our public bonds were to suffer a rating downgrade to a level below investment grade from both Moody’s and Standard & Poor’s Rating Services. If these provisions were triggered, we would be required to commence a change of control offer to repurchase the public bonds at 101% of the aggregate principal amount, plus accrued and unpaid interest. Any of our future debt agreements could contain similar restrictions and provisions. We might not have sufficient funds to repay the amounts due in relation to our debt instruments following a change of control.

The consummation of the Exchange Offer also presents additional risks, as discussed in Item 4, “The Solicitation or Recommendation-Reasons for Recommendation” of our Solicitation/Recommendation Statement filed in response to the Exchange Offer on Schedule 14D-9, on September 17, 2015.

Perrigo Company plc - Item 2

Consolidated

RESULTS OF OPERATIONS

CONSOLIDATED

Significant Trends and Developments

Consolidated Results



	Three Months Ended						% Change
($ in millions)	September 27, 2014			September 26, 2015			% Change
Net sales	$	951.5		$	1,344.7		41	%
Gross profit	$	321.8		$	548.8		71	%
Gross profit %	33.8		%	40.8		%
Operating expenses	$	184.6		$	360.2		95	%
Operating expenses %	19.4		%	26.8		%
Operating income	$	137.2		$	188.6		37	%
Operating income %	14.4		%	14.0		%
Interest and other, net	$	28.6		$	56.4		97	%
Income tax expense	$	12.3		$	19.6		58	%
Net income	$	96.3		$	112.6		17	%

Further details and analysis of our financial results for the three months ended September 26, 2015 are described below by reporting segment and line item.

Perrigo Company plc - Item 2

CHC

CONSUMER HEALTHCARE

Significant Trends and Developments


•	On August 28, 2015, we acquired ScarAway^®, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC for $27.0 million in cash. This acquisition serves as our entry into the branded OTC business in the U.S. We plan to continue to pursue niche branded opportunities for products for which there is not a store brand market.

Segment Results



	Three Months Ended
($ in millions)	September 27, 2014			September 26, 2015
Net sales	$	640.3		$	675.2
Gross profit	$	193.0		$	231.0
Gross profit %	30.1		%	34.2		%
Operating income	$	74.8		$	117.3
Operating income %	11.7		%	17.4		%

Three Months Ended September 26, 2015 vs Three Months Ended September 27, 2014

Segment operating income increased $42.5 million, or 57%, as a result of:


•	An increase in net sales of $34.9 million, or 5%, due primarily to:


•	New product sales of $65.3 million related primarily to certain new infant formula products;


•	Incremental net sales of $14.0 million from acquisitions, primarily the acquisition of Gelcaps Exportadora de Mexico, S.A. de C.V.; and


•	Increased sales volumes totaling $48.6 million, primarily in the cough/cold, infant formula, and gastrointestinal categories, due in part to an expected stronger cough/cold season in the current year;


•	Offset partially by a decline of $26.5 million in volumes of net sales in the animal health, diabetes, and analgesics categories;


•	Discontinued products of $52.5 million primarily in the infant formula and animal health categories; and


•	Unfavorable foreign currency movement of $14.0 million.


•	An increase of $38.0 million in gross profit due to:


•	Increased new product sales and favorable product mix;


•	Improved efficiencies in manufacturing facilities; and


•	Favorable commodities pricing.


•	A decrease of $4.5 million in operating expenses due to:


•	Proactive cost controls, including decreased selling expense; and


•	Decreased R&D spending due to the timing of spending for certain projects.

Perrigo Company plc - Item 2

BCH

BRANDED CONSUMER HEALTHCARE

Significant Trends and Developments


•	On September 15, 2015, we completed our acquisition of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe.


•	On August 28, 2015, we completed the acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK”).


•	Both of these acquisitions build upon the global platform we established through the Omega Pharma Invest N.V. ("Omega") acquisition, leveraging our European market share and expanding our product offerings.

Segment Results



	Three Months Ended
($ in millions)	September 26, 2015
Net sales	$	302.2
Gross profit	$	164.3
Gross profit %	54.4		%
Operating income	$	4.4
Operating income %	1.4		%

BCH sales were impacted positively by sales growth in our Top 20 brands, $30.7 million of net sales from new branded products, and $10.7 million of sales attributable to the Naturwohl and GSK acquisitions, offset partially by low distribution sales.

In the three months ended September 26, 2015, operating expenses included selling, general, and administrative expenses of $143.1 million (of which $36.3 million related to amortization expense on acquired intangible assets), research and development expenses of $6.5 million, and distribution expenses of $10.0 million. Selling expense as a percent of net sales of the BCH segment was significantly higher for the BCH segment than it was for our other business segments due to advertising and promotional expenses that are unique to the BCH segment.

PRESCRIPTION PHARMACEUTICALS

Segment Results



	Three Months Ended
($ in millions)	September 27, 2014			September 26, 2015
Net sales	$	194.5		$	260.3
Gross profit	$	96.4		$	130.4
Gross profit %	49.6		%	50.1		%
Operating income	$	64.7		$	91.0
Operating income %	33.3		%	34.9		%

Perrigo Company plc - Item 2

Three Months Ended September 26, 2015 vs Three Months Ended September 27, 2014

Segment operating income increased $26.3 million, or 40%, as a result of:


•	An increase in net sales of $65.8 million, or 34%, due primarily to:


•	New product sales of $18.4 million related primarily to the launches of clobetasol propionate 0.05% spray and tacrolimus 0.1% ointment;


•	Increased sales of existing products of $46.7 million; and


•	Absence of planned contractual wholesaler chargeback and stock adjustments associated with pricing programs completed in the prior year; offset partially by


•	Unfavorable foreign exchange movement of $1.2 million.


•	An increase of $34.0 million in gross profit due primarily to:


•	Higher net sales and an improved gross profit percentage; and


•	Favorable product mix and absence of pricing initiatives completed in the prior year.


•	Partially offset by a $7.7 million increase in operating expenses due to:


•	Higher research and development expenses resulting from planned higher spending on new product development; and


•	Increased selling and administrative expenses related to the specialty pharmaceuticals sales force.

SPECIALTY SCIENCES

Segment Results



	Three Months Ended
($ in millions)	September 27, 2014			September 26, 2015
Net sales	$	91.9		$	84.5
Gross profit	$	19.4		$	12.0
Gross profit %	21.1		%	14.2		%
Operating income	$	14.9		$	9.0
Operating income %	16.2		%	10.7		%

Three Months Ended September 26, 2015 vs Three Months Ended September 27, 2014

Segment operating income decreased $5.9 million, or 39%, as a result of:


•	A decrease in net sales and gross profit of $7.4 million due primarily to unfavorable changes in foreign currency exchange rates and the current period reflecting 13 shipping weeks of product compared to 14 weeks in the prior year; and


•	A decrease of $1.5 million in operating expenses due to a reduction in administrative expenses, primarily related to legal expenses.

Perrigo Company plc - Item 2

Other

OTHER

Segment Results



	Three Months Ended
($ in millions)	September 27, 2014			September 26, 2015
Net sales	$	24.8		$	22.5
Gross profit	$	13.0		$	11.1
Gross profit %	52.3		%	49.5		%
Operating income	$	7.1		$	6.2
Operating income %	28.3		%	27.5		%

Three Months Ended September 26, 2015 vs Three Months Ended September 27, 2014

Operating income decreased $0.9 million, or 12%, as a result of:


•	A decrease in net sales of $2.3 million, or 9%, due primarily to competition on certain products and unfavorable changes in foreign currency exchange rates; and


•	A decrease of $1.9 million in gross profit due primarily to a decrease in sales of existing products; partially offset by


•	A $1.0 million decrease in operating expenses due to proactive cost controls and decreases in certain R&D spending.

Unallocated Expenses

Unallocated expenses are comprised of certain corporate services not allocated to the segments and are recorded above Operating income. Unallocated expenses increased from $24.3 million for the three months ended September 27, 2014 to $39.3 million for the three months ended September 26, 2015 due primarily to $15.6 million in fees incurred in our defense against Mylan's unsolicited offer.

Interest and Other (Consolidated)

Interest expense, net for the three months ended September 26, 2015 was $43.7 million, compared to $26.1 million for the three months ended September 27, 2014. The increase was due to the interest expense incurred on the incremental debt we issued to finance the Omega acquisition and the additional debt we assumed from Omega.

Other expense, net, was $13.0 million during the three months ended September 26, 2015, compared to $2.7 million during the three months ended September 27, 2014. The increase was due mainly to changes in cash balances held in foreign currencies, the largest portion consisting of a $4.6 million foreign exchange loss resulting from the impact of holding €200.0 million ($223.6 million) in cash associated with the euro-denominated purchase price of the GSK acquisition. The increase in Other expense, net, was also due to a $1.3 million increase in losses from equity method investments in the three months ended September 26, 2015, compared to the prior year period, and the absence of a $1.2 million cash distribution received from an investment in the prior year.

Income Taxes (Consolidated)

The effective tax rate was 14.8% and 11.4% for the three months ended September 26, 2015 and September 27, 2014, respectively.

Perrigo Company plc - Item 2

Unallocated, Interest, Other, and Taxes

Although we believe that our tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit, and any related litigation, could be materially different from our estimates or from our historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on operating results or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, or interest assessments.

We are under audit by the Israel Tax Authority and the Internal Revenue Service ("IRS") for the fiscal year ended June 25, 2011 and June 30, 2012. The IRS audit of the fiscal year ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of $8.0 million, inclusive of interest, in November 2014, the statutory notice of deficiency asserted various additional positions, including transfer pricing, relative to the same fiscal year ended June 27, 2009 and June 26, 2010 audit. The statutory notice asserted an incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the notice of deficiency. In January 2015, we paid this amount, a prerequisite to being able to contest the IRS’s positions in U.S. Federal court, and in June 2015, we filed a request for a refund. As the IRS has denied our request for a refund, we intend to contest the IRS’s asserted positions in U.S. Federal court. The payment was recorded as a deferred charge on the balance sheet given our anticipated action to recover this amount. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods. There are numerous other income tax jurisdictions for which tax returns are not yet settled, none of which are individually significant. At this time, we cannot predict the outcome of any audit or related litigation.

FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES

Cash and Cash Equivalents

* Working capital represents current assets less current liabilities.

Cash, cash equivalents, cash flows from operations and borrowings available under our credit facilities are expected to be sufficient to finance our known and/or foreseeable liquidity, capital expenditures, dividends, and, to the extent authorized, our share repurchases. Although our lenders have made commitments to make funds available to us in a timely fashion under our revolving credit agreements and overdraft facilities, if economic conditions worsen or new information becomes publicly available impacting the institutions’ credit rating or capital ratios, these lenders may be unable or unwilling to lend money pursuant to our existing credit facilities.

Perrigo Company plc - Item 2

Financial Condition, Liquidity and Capital Resources

Cash Flows

Operating

We generated $136.0 million from operating activities during the three months ended September 26, 2015, a $59.1 million decrease over the comparable prior year period as a result of changes in working capital due primarily to the Omega acquisition. The primary driver of the decrease was payments on accounts payable, which used $194.0 million of cash compared to $32.5 million in the prior year period. The change is largely attributable to Omega as its payments to suppliers are higher in the quarters ended in March and September due primarily to inventory purchases in these periods. Omega has historically experienced favorable operating cash flow in the second and fourth calendar quarters consistent with the sales seasonality of the business. Operating cash flow was also impacted by the use of $57.0 million to increase inventory compared to $29.7 million in the prior year period, which was due primarily to the inclusion of Omega.

These decreases were offset partially by increased accrued liabilities of $61.5 million, compared to $0.6 million in the prior year period, due primarily to timing of accrued interest on the debt we assumed in the Omega acquisition, other accruals attributable to Omega, and accrued fees related to our defense against Mylan's unsolicited offer. Additionally, operating cash flow was impacted positively by increased net earnings after adjusting for non-cash items such as depreciation and amortization, which resulted in an increase in operating cash of $79.9 million over the prior year period.

Investing

Cash used for investing activities totaled $448.7 million for the three months ended September 26, 2015, an increase of $418.0 million over the comparable prior period. The increase in cash used was due primarily to the acquisitions we completed in the current year, which used $405.1 million in cash. There were no acquisitions during the three months ended September 27, 2014.

Perrigo Company plc - Item 2

Financial Condition, Liquidity and Capital Resources

Financing

Cash generated from financing activities totaled $43.7 million for the three months ended September 26, 2015, compared to cash used for financing activities of $61.3 million for the comparable prior year period. The primary contributor to the cash generation in the current year period was the borrowing of $79.0 million of short-term debt in the current year versus net payments of short-term debt of $2.1 million in the prior year period. The increase in borrowings was due to Omega's use of overdraft facilities in its day-to-day operations. In addition, we used $25.2 million less in the current year period for payments on long-term debt than in the prior year period.

The declaration and payment of dividends, if any, is subject to the discretion of our Board of Directors and will depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements, and other factors our Board of Directors may consider relevant.

Capital Resources

Accounts Receivable Factoring

We have multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”) that we assumed in the Omega acquisition. Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable on the Condensed Consolidated Balance Sheets was $159.3 million at September 26, 2015, a $12.3 million decrease since June 27, 2015.

Revolving Credit Agreements

There were no borrowings outstanding under our $1.0 billion revolving credit agreement at September 26, 2015 or June 27, 2015.

Long-Term Debt

We had $4.7 billion of public bonds and a $517.7 million term loan outstanding at September 26, 2015, as well as the ability to draw on a €300.0 million term loan. At June 27, 2015, we had $4.7 billion of public bonds and a $530.5 million term loan outstanding. Subsequent to September 26, 2015, we allowed the undrawn €300.0 million term loan tranche to expire.

We were in compliance with all covenants under our various debt agreements as of September 26, 2015. See Item 1. Note 8 for more information on all of the above debt facilities.

Perrigo Company plc - Item 2

Financial Condition, Liquidity and Capital Resources

Share Repurchases

On October 22, 2015, we announced a $2.0 billion share repurchase plan over three years, including $500.0 million expected to be repurchased during the fourth quarter of calendar year 2015. We plan to fund these share repurchases through our available liquidity.

Credit Ratings

Our credit ratings on September 26, 2015 were Baa3 (stable) and BBB (watch negative) by Moody's Investors Service and Standard and Poor's ("S&P") Rating Services, respectively. On April 9, 2015, after the announcement of Mylan’s unsolicited proposal to acquire all of our outstanding ordinary shares, S&P placed our BBB credit rating on CreditWatch with negative implications.

Credit rating agencies review their ratings periodically and, therefore, the credit rating assigned to us by each agency may be subject to revision at any time. Accordingly, we are not able to predict whether current credit ratings will remain as disclosed above. Factors that can affect our credit ratings include changes in operating performance, the economic environment, our financial position, and changes in business strategy. If changes in our credit ratings were to occur, they could impact, among other things, future borrowing costs, access to capital markets, and vendor financing terms.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our quantitative or qualitative disclosures found in Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," of our Annual Report on Form 10-K for the fiscal year ended June 27, 2015.

ITEM 4. CONTROLS AND PROCEDURES

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

As of September 26, 2015, our management, including our Chief Executive Officer and our Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures are effective in ensuring that all material information relating to us and our consolidated subsidiaries required to be included in our periodic SEC filings would be made known to them by others within those entities in a timely manner and that no changes are required at this time.

Management’s Annual Report on Internal Control over Financial Reporting

In connection with the evaluation by our management, including our Chief Executive Officer and Chief Financial Officer, of our internal control over financial reporting pursuant to Rule 13a-15(d) of the Securities Exchange Act of 1934, no changes during the quarter ended September 26, 2015, were identified that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting except as noted below.

Perrigo Company plc - Item 4

Controls and Procedures

Changes in Internal Control over Financial Reporting

We acquired Omega Pharma Invest N.V. ("Omega") and Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps") during the three months ended June 27, 2015 and we acquired Naturwohl Pharma GmbH ("Naturwohl") during the three months ended September 26, 2015 (see Item 1. Note 2 for additional information). As permitted by Securities and Exchange Commission Staff interpretive guidance for newly acquired businesses, management excluded Omega, Gelcaps, and Naturwohl from its evaluation of internal control over financial reporting as of September 26, 2015, other than goodwill and intangible asset controls that have been incorporated into our existing control environment. We are in the process of documenting and testing Omega's, Gelcaps', and Naturwohl's internal controls over financial reporting. We will incorporate the acquired entities into our transition report on internal control over financial reporting for our six-month transition period ending December 31, 2015. As of September 26, 2015, assets excluded from management's assessment totaled $920.8 million and contributed $310.2 million of net sales and $2.9 million of operating income to our Condensed Consolidated Financial Statements for the three months ended September 26, 2015.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Refer to Part I, Item 1. Note 12 to the Condensed Consolidated Financial Statements.

ITEM 1A. RISK FACTORS

Our Annual Report on Form 10-K for the fiscal year ended June 27, 2015 includes a detailed discussion of our risk factors. At the time of this filing, there have been no material changes to the risk factors that were included in the Form 10-K, other than those noted below.

We have been the subject of unsolicited interest from Mylan N.V. ("Mylan"), which has been, and may continue to be, a distraction to our management and employees and could have a material adverse impact on our business and operations.

The pharmaceutical industry has been intensely acquisitive over the past several years. Mylan has made an exchange offer to purchase all of our outstanding ordinary shares (the "Exchange Offer"). The uncertainty regarding the Exchange Offer may be disruptive to our business, which could have a negative effect on our operations, financial condition, or results of operations.

As discussed in our Annual Report on Form 10-K for the fiscal year ended June 27, 2015, in April 2015, Mylan made a series of proposals to acquire all our outstanding ordinary shares (the “Proposals”). Our Board of Directors unanimously rejected each of the Proposals, concluding that they substantially undervalued us and our future growth prospects and were not in the best interests of our shareholders. Subsequent to the filing of our Annual Report on Form 10-K, there have been further developments in Mylan's unsolicited interest in acquiring our shares, including:


•	On August 28, 2015, Mylan held an extraordinary meeting of its shareholders in which Mylan received the necessary Mylan shareholder approval to move forward with the Exchange Offer.

•

On September 14, 2015, Mylan commenced the Exchange Offer, which will expire on November 13, 2015, unless it is extended with the consent of the Irish Takeover Panel. The Exchange Offer provides that if all conditions to the Exchange Offer are satisfied or waived, Mylan will exchange $75.00 in cash and 2.3 Mylan ordinary shares for each of our outstanding ordinary shares that is validly tendered. The Exchange Offer is subject to various conditions, including that Mylan receive valid acceptances of holders greater than 50% of Perrigo ordinary shares.


•	On September 17, 2015, we issued a solicitation/recommendation statement unanimously recommending that our shareholders do not tender into the Exchange Offer.

Responding to and defending against the Proposals and the Exchange Offer has been, and may continue to be, a distraction for our management and employees, and has required, and may continue to require, us to incur

Perrigo Company plc - Item 1A

Risk Factors

additional expenses and costs. Since the announcement of the initial Proposal, we have incurred $29.0 million in consulting and legal fees related to our defense. Management and employee distraction related to Mylan's unsolicited interest also may adversely impact our ability to optimally conduct our business and pursue our strategic objectives. Further, we are deemed to be in an "offer period" for purposes of the Irish Takeover Rules, which may restrict our ability to execute our strategy on a timely basis.

There can be no assurance that our strategic initiatives will achieve their intended effects.

We are in the process of implementing certain initiatives designed to increase operational efficiency and improve our return on invested capital by globalizing our supply chain through global shared service arrangements, streamlining our organizational structure, and disposing of certain assets. We believe these initiatives will enhance our revenue, operating margins and earnings. There can be no assurance that these initiatives will produce the anticipated benefits. Any delay or failure to achieve the anticipated benefits could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

We cannot guarantee that we will buy back our ordinary shares pursuant to our recently announced share repurchase plan or that our share repurchase plan will enhance long-term shareholder value.

Our board of directors recently authorized a $2.0 billion share repurchase plan, consisting of $500.0 million of initial share repurchases that are expected be completed by the end of 2015, and an additional $1.5 billion in repurchases that may extend through the year ended December 31, 2018. Though we anticipate that we will complete the initial $500.0 million of share repurchases before the end of 2015 and the remaining $1.5 billion in accordance with the announced timeline, the specific timing and amount of buybacks, if any, will depend upon several factors, including market and business conditions, the trading price of our ordinary shares, and, with respect to the expected repurchases in 2016 and beyond, the nature of other investment opportunities. Buybacks of our ordinary shares pursuant to our share repurchase plan could affect the market price of our ordinary shares or increase its volatility. Additionally, our share repurchase plan could diminish our cash reserves, which may impact our ability to finance future growth and to pursue possible future strategic opportunities and acquisitions. Although our share repurchase plan is intended to enhance long-term shareholder value, there is no assurance that it will do so, and short-term share price fluctuations could reduce the plan’s effectiveness.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Perrigo Company plc - Part II - Item 6

Exhibits

ITEM 6. EXHIBITS



Exhibit Number		Description

3.1		Certificate of Incorporation of Perrigo Company plc (formerly known as Perrigo Company Limited) (incorporated by reference to Exhibit 4.1 of our Registration Statement on Form S-8 filed December 19, 2013).

3.2		Amended and Restated Memorandum and Articles of Association of Perrigo Company plc (formerly known as Perrigo Company Limited) (incorporated by reference to Exhibit 4.2 of our Registration Statement on Form S-8 filed December 19, 2013).

10.1		Form of Performance-Based Restricted Stock Unit Award Agreement for Non-U.S. Participants under the Perrigo Company plc 2013 Long-Term Incentive Plan (filed herewith).

10.2		Amendment Five to the Nonqualified Deferred Compensation Plan, dated as of August 17, 2015 (filed herewith).

31.1		Rule 13a-14(a) Certification by Joseph C. Papa, Chairman and Chief Executive Officer.

31.2		Rule 13a-14(a) Certification by Judy L. Brown, Executive Vice President and Chief Financial Officer.

32		Certification Pursuant to 18 United States Code 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934.

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema Document.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		XBRL Taxonomy Extension Label Linkbase Document.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		PERRIGO COMPANY PLC
		(Registrant)

Date:	November 2, 2015	By: /s/ Joseph C. Papa
		Joseph C. Papa
		Chairman and Chief Executive Officer
		(Principal Executive Officer)

Date:	November 2, 2015	By: /s/ Judy L. Brown
		Judy L. Brown
		Executive Vice President and Chief Financial Officer
		(Principal Accounting and Financial Officer)

EX-10.1 2 a2016q1ex101.htm EXHIBIT 10.1 Exhibit

EXHIBIT 10.1

PERRIGO COMPANY PLC

RESTRICTED STOCK UNIT AWARD AGREEMENT FOR NON-U.S. PARTICIPANTS

(PERFORMANCE-BASED)

(Under the Perrigo Company plc 2013 Long-Term Incentive Plan)

TO:

RE: Notice of Restricted Stock Unit Award (Performance-Based)

This is to notify you that Perrigo Company plc (the “Company”) has granted you an Award for non-U.S. participants under the Perrigo Company plc 2013 Long-Term Incentive Plan (the “Plan”), effective as of ______________________ (the “Grant Date”). This Award consists of performance-based restricted stock units. The terms and conditions of this incentive are set forth in the remainder of this agreement (including any special terms and conditions set forth in any appendix for your country (“Appendix”)) (collectively, the “Agreement”). The capitalized terms that are not otherwise defined in this Agreement shall have the meanings ascribed to such terms under the Plan.

SECTION 1

Restricted Stock Units - Performance-Based Vesting

1.1 Grant. As of the Grant Date, the Company grants to you «Target_Number_of_Performance_Based_Restr» restricted stock units (“Performance Restricted Stock Units” or “PRSUs”), subject to the terms and conditions set forth in this Agreement. The number of Performance Restricted Stock Units awarded in this Section 1.1 is referred to as the “Target Award.” The Target Award may be increased or decreased depending on the level of attainment of Performance Goals for designated Performance Measures as described in Section 1.2. Each Performance Restricted Stock Unit shall entitle you to one share of common stock of the Company (“Common Stock”) on the PRSU Vesting Date set forth in Section 1.2, provided the applicable Performance Goals for each Performance Measure are satisfied.

1.2 Calculation of PRSUs Payable. The number of PRSUs awarded in Section 1.1 payable to you, if any, shall be determined as of the PRSU Vesting Date. That number will be determined based on the average level of attainment of the Performance Measure(s) for each Measurement Period in the Performance Period, in accordance with the schedule determined by the Committee at the time the Performance Measures and applicable Performance Goals are established by the Committee.

The Committee shall establish one or more Performance Measures and the Performance Goals with respect to each Performance Measure that must be attained for Threshold, Target and Maximum performance for each Measurement Period. The Performance Measure and Performance Goals for each Measurement Period will be provided to you.

Following the end of each Measurement Period in the Performance Period, the Committee will determine the percentage of Target Award PRSUs that would be payable for such Measurement Period, based on the attainment of the Performance Goals for each Performance Measure(s) established by the Committee for that Measurement Period. The percentage of the Target Award that would be payable under the schedule shall be adjusted, pro rata, to reflect attained performance between Threshold and Target, and Target and Maximum.

At the end of the Performance Period, the percentage payout for each Measurement Period in the Performance Period will be averaged to determine the actual percentage of Target Award PRSUs that may become payable to you under this Agreement. In no event will the calculation of a positive payout percentage for any Measurement Period be construed to guarantee that any PRSUs will be paid to you under this Agreement. Payout percentages for the each Measurement Period are determined solely for purposes of determining the average Measurement Period payout percentage for the Performance Period.

Except as provided in Section 1.4, the PRSUs will be permanently forfeited if your Termination Date occurs on or prior to the PRSU Vesting Date. If the average Measurement Period performance payout for the Performance Period is less than the Threshold performance level established by the Committee, all PRSUs that have not

previously been forfeited shall be forfeited as of the PRSU Vesting Date. If the average Measurement Period performance payout for the Performance Period exceeds the Maximum performance level established by the Committee, in no event will the number of PRSUs vesting exceed 200% of the Target Award.

1.3 Definitions. The following terms shall have the following meanings under this Section 1.

(a) “Performance Goal” means the level of performance that must be attained with respect to a Performance Measure for a Measurement Period for Minimum, Target and Maximum payout.

(b) “Performance Measure” for any Measurement Period means one or more financial measures, as determined by the Committee. The Committee shall provide how the Performance Measure will be adjusted, if at all, as a result of extraordinary events or circumstances, as determined by the Committee, or to exclude the effects of extraordinary, unusual, or non-recurring items; changes in applicable laws, regulations, or accounting principles; currency fluctuations; discontinued operations; non-cash items, such as amortization, depreciation, or reserves; asset impairment; or any recapitalization, restructuring, reorganization, merger, acquisition, divestiture, consolidation, spin-off, split-up, combination, liquidation, dissolution, sale of assets, or other similar corporation transaction.

(c) “Performance Period” means the period beginning on June 28, 2015 and ending on December 31, 2017. The Performance Period consists of three “Measurement Periods.” The first Measurement Period begins on June 28, 2015 and ends on December 31, 2015. The second and third Measurement Periods are the calendar years 2016 and 2017, respectively.

(d) “PRSU Vesting Date” means June 29, 2018.

1.4 Special Vesting Rules. Notwithstanding Section 1.2 above, in the event of a Change in Control (as defined in the Plan and as such definition may be amended hereafter) while you are employed by or otherwise providing service to the Company, all of the PRSUs awarded under Section 1.1 that have not previously been forfeited shall become fully vested as if Target performance had been obtained for the Performance Period effective as of the date of any such event. If your Termination Date occurs because of death, Disability, or Retirement, the PRSUs shall vest or be forfeited as of the PRSU Vesting Date based on the attainment of the performance goals. If your Termination Date occurs because of an Involuntary Termination for Economic Reasons, the Company’s Chief Executive Officer (or the Committee, if you are subject to Section 16 of the Exchange Act), in his or her sole and absolute discretion, may permit all or part of the PRSUs awarded hereunder to remain outstanding and vest or be forfeited as of the PRSU Vesting Date, depending on the attainment of Performance Goals. To the extent that the Chief Executive Officer (or Committee, if applicable) does not exercise discretionary authority to allow PRSUs to remain outstanding on the date of your Involuntary Termination for Economic Reasons, such PRSUs shall be permanently forfeited.

1.5 Settlement of PRSUs. Provided the Committee has certified the average payout for each of the three Measurement Periods in the Performance Period and provided your Termination Date has not occurred on or prior to the PRSU Vesting Date, on or as soon as practicable following the PRSU Vesting Date and in no event later than the date set forth in Section 2.8, the Company shall transfer to you one share of Common Stock for each PRSU, if any, as determined pursuant to Section 1.2 or 1.4 of this Agreement (the date of any such transfer shall be the “settlement date” for purposes of this Agreement); provided, however, the Company may settle PRSUs in cash, based on the fair market value of the shares on the settlement date, to the extent necessary to satisfy tax withholding pursuant to Section 2.7. No fractional shares shall be transferred. Any fractional share shall be rounded to the nearest whole share. The income attributable to the vesting of PRSUs and the amount of any required tax withholding will be determined based on the value of the shares on the settlement date. PRSUs are not eligible for dividend equivalents.

SECTION 2

General Terms and Conditions

2.1 Nontransferability. The Award under this Agreement shall not be transferable other than by will or by the laws of descent and distribution.

2.2 No Rights as a Stockholder. You shall not have any rights as a stockholder with respect to any shares of Common Stock subject to the PRSUs awarded under this Agreement prior to the date of issuance to you of a certificate or certificates for such shares.

2.3 Cause Termination. If your Termination Date occurs for reasons of Cause, all of your rights under this Agreement, whether or not vested, shall terminate immediately.

2.4 Award Subject to Plan. The granting of the Award under this Agreement is being made pursuant to the Plan and the Award shall be payable only in accordance with the applicable terms of the Plan. The Plan contains certain definitions, restrictions, limitations and other terms and conditions all of which shall be applicable to this Agreement. ALL THE PROVISIONS OF THE PLAN ARE INCORPORATED HEREIN BY REFERENCE AND ARE MADE A PART OF THIS AGREEMENT IN THE SAME MANNER AS IF EACH AND EVERY SUCH PROVISION WERE FULLY WRITTEN INTO THIS AGREEMENT. Should the Plan become void or unenforceable by operation of law or judicial decision, this Agreement shall have no force or effect. Nothing set forth in this Agreement is intended, nor shall any of its provisions be construed, to limit or exclude any definition, restriction, limitation or other term or condition of the Plan as is relevant to this Agreement and as may be specifically applied to it by the Committee. In the event of a conflict in the provisions of this Agreement and the Plan, as a rule of construction the terms of the Plan shall be deemed superior and apply.

2.5 Adjustments in Event of Change in Common Stock. In the event of a stock split, stock dividend, recapitalization, reclassification or combination of shares, merger, sale of assets or similar event, the number and kind of shares subject to Award under this Agreement will be appropriately adjusted in an equitable manner to prevent dilution or enlargement of the rights granted to or available for you.

2.6 Acknowledgement. The Company and you agree that the PRSUs are granted under and governed by the Notice of Grant, this Agreement (including the Appendix) and by the provisions of the Plan (incorporated herein by reference). You: (i) acknowledge receipt of a copy of each of the foregoing documents, (ii) represent that you have carefully read and are familiar with their provisions, and (iii) hereby accept the PRSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice of Grant.

2.7 Responsibility for Taxes. Regardless of any action the Company or, if different, the Affiliate employing or retaining you takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (“Tax-Related Items”), you acknowledge that the ultimate liability for all Tax-Related Items is and remains your responsibility and may exceed the amount actually withheld by the Company or the Affiliate employing or retaining you. You further acknowledge that the Company and/or the Affiliate employing or retaining you (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PRSUs, including, but not limited to, the grant, vesting or settlement of the PRSUs, the subsequent sale of shares of Common Stock acquired pursuant to such settlement and the receipt of any dividends; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the PRSUs to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you have become subject to tax in more than one jurisdiction between the PRSU Grant Date and the date of any relevant taxable event, as applicable, you acknowledge that the Company and/or the Affiliate employing or retaining you (or formerly employing or retaining you, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(a) Prior to any relevant taxable or tax withholding event, as applicable, you will pay or make adequate arrangements satisfactory to the Company and/or the Affiliate employing or retaining you to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Affiliate employing or retaining you, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following:

(1) withholding from your wages or other cash compensation paid to you by the Company and/or the Affiliate employing or retaining you; or

(2) withholding from proceeds of the sale of shares of Common Stock acquired upon settlement of the PRSUs either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization); or

(3) withholding in shares of Common Stock to be issued upon settlement of the PRSUs.

(b) To avoid negative accounting treatment, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, you are deemed to have been issued the full number of shares of Common Stock subject to the vested PRSUs, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.

(c) Finally, you shall pay to the Company or the Affiliate employing or retaining you any amount of Tax-Related Items that the Company or the Affiliate employing or retaining you may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the shares of Common Stock or the proceeds of the sale of shares of Common Stock, if you fail to comply with your obligations in connection with the Tax-Related Items.

2.8 Compliance with Applicable Law. The issuance of Common Stock will be subject to and conditioned upon compliance by the Company and you, including any written representations, warranties and agreements as the Administrator may request of you for compliance with all (i) applicable U.S. state and federal laws and regulations, (ii) applicable laws of the country where you reside pertaining to the issuance or sale of shares of Common Stock, and (iii) applicable requirements of any stock exchange or automated quotation system on which the Company’s Common Stock may be listed or quoted at the time of such issuance or transfer.

2.9 Short Term Deferral. PRSUs payable under this Agreement are intended to be exempt from Code Section 409A under the exemption for short-term deferrals. Accordingly, PRSUs will be settled no later than the 15^th day of the third month following the later of (i) the end of the PRSU recipient’s tax year in which the PRSU Vesting Date occurs, or (ii) the end of the tax year of the Company in which the PRSU Vesting Date occurs.

2.10 Data Privacy.

(a) By entering into this Agreement and accepting this Award, you hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Agreement and any other PRSU grant materials by and among, as applicable, the Affiliate employing or retaining you, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing your participation in the Plan.

(b) You understand that the Company and the Affiliate employing or retaining you may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all PRSUs or any other entitlement to shares of Stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the exclusive purpose of implementing, administering and managing the Plan (“Data”).

(c) You understand that Data will be transferred to legal counsel or a broker or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of the Data may be located in the United States or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than your country. You understand that if you reside outside the United States, you may request a list with the names and addresses of any potential recipients of the Data by contacting your local or Company human resources representative. You authorize the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the Plan. You understand that Data will be held only as long as is necessary

to implement, administer and manage your participation in the Plan. You understand that if you reside outside the United States, you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local or Company human resources representative. You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local or Company human resources representative.

2.11 Nature of Grant. In accepting the grant, you acknowledge, understand and agree that:

(a) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, except as otherwise provided in the Plan;

(b) the grant of the PRSUs is voluntary and occasional and does not create any contractual or other right to receive future grants of PRSUs, or benefits in lieu of PRSUs, even if PRSUs have been granted repeatedly in the past;

(d) you are voluntarily participating in the Plan;

(e) the PRSUs and the shares of Common Stock subject to the PRSUs are an extraordinary item which is outside the scope of your employment or service contract, if any;

(f) the PRSUs and the shares of Common Stock subject to the PRSUs are not intended to replace any pension rights or compensation;

(g) the PRSUs and the shares of Common Stock subject to the PRSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Affiliate employing or retaining you or any other Affiliate;

(h) the grant and your participation in the Plan will not be interpreted to form an employment or service contract with the Company or any Affiliate;

(i) the future value of the underlying shares of Common Stock is unknown, indeterminable and cannot be predicted with certainty;

(j) no claim or entitlement to compensation or damages shall arise from forfeiture of the PRSUs resulting from your Termination Date (for any reason whatsoever, whether or not later found to be invalid and whether or not in breach of employment laws in the jurisdiction where you are employed or rendering services, or the terms of your employment agreement, if any), and in consideration of the grant of the PRSUs to which you are otherwise not entitled, you irrevocably agree never to institute any claim against the Company or the Affiliate employing or retaining you, waive your ability, if any, to bring any such claim, and release the Company and the Affiliate employing or retaining you from any such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, you shall be deemed irrevocably to have agreed not to pursue such claim and agree to execute any and all documents necessary to request dismissal or withdrawal of such claim; and

(k) you acknowledge and agree that neither the Company, the Affiliate employing or retaining you nor any other Affiliate shall be liable for any foreign exchange rate fluctuation between your local currency and the United States Dollar that may affect the value of the PRSUs or of any

amounts due to you pursuant to the settlement of the PRSUs or the subsequent sale of any shares of Common Stock acquired upon settlement.

2.12 Successors and Assigns. This Agreement shall be binding upon any or all successors and assigns of the Company.

2.13 Applicable Law. This Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Michigan, U.S.A., without regard to principles of conflict of laws. Any proceeding related to or arising out of this Agreement shall be commenced, prosecuted or continued in the Circuit Court in Kent County, Michigan located in Grand Rapids, Michigan or in the United Stated District Court for the Western District of Michigan, and in any appellate court thereof.

2.14 Forfeiture of PRSUs. If the Company, as a result of misconduct, is required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws, then (a) if your incentive or equity-based compensation is subject to automatic forfeiture due to such misconduct and restatement under Section 304 of the Sarbanes-Oxley Act of 2002, or (b) the Committee determines you either knowingly engaged in or failed to prevent the misconduct, or your actions or inactions with respect to the misconduct and restatement constituted gross negligence, you shall (i) be required to reimburse the Company the amount of any payment relating to any PRSUs earned or accrued during the twelve month period following the first public issuance or filing with the SEC (whichever first occurred) of the financial document embodying such financial reporting requirement, and (ii) all outstanding PRSUs (including related dividend equivalents, if any) that have not yet been settled shall be immediately forfeited. In addition, Common Stock acquired under this Agreement, and any gains or profits on the sale of such Common Stock, shall be subject to any “clawback” or recoupment policy later adopted by the Company.

2.15 Appendix. Notwithstanding any provisions in this Agreement, the PRSU grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for your country. Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country will apply to you, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan. The Appendix constitutes part of this Agreement.

2.16 Imposition of Other Requirements. The Company reserves the right to impose other requirements on your participation in the Plan, on the PRSUs and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with laws of the country where you reside or to facilitate the administration of the Plan, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

****

We look forward to your continuing contribution to the growth of the Company. Please acknowledge your receipt of the Plan and this Award.

Very truly yours,

Judy L. Brown

Executive Vice President & Chief Financial Officer

EX-10.2 3 a2016q1ex102.htm EXHIBIT 10.2 Exhibit

EXHIBIT 10.2

AMENDMENT FIVE

TO THE

PERRIGO COMPANY

NONQUALIFIED DEFERRED COMPENSATION PLAN

WHEREAS, Perrigo Company, a Michigan corporation (the “Company”), maintains the Perrigo Company Nonqualified Deferred Compensation Plan, as amended and restated effective January 1, 2007 (the “Plan”), and as subsequently amended; and

WHEREAS, the Company deems it desirable to amend the Plan to streamline its administration;

NOW, THEREFORE, pursuant to the amendment authority reserved to the Company and delegated to the Perrigo Company Retirement Plan Committee, subsections 3.3(b) and (c) of the Plan are amended to read as follows effective for deferral elections made on or after September 1, 2015:

“(b)

Subsequent Plan Years. A Participant’s deferral election shall apply to all subsequent Plan Years until revoked or altered in accordance with the terms of the Plan (an “evergreen election”); provided, however, that the Participant’s election shall become irrevocable as of each December 31 for Base Annual Salary, Annual Bonus or Directors Fees payable for services to be rendered in the Plan Year immediately following such December 31.

(c)

Special Election for Section 409A Performance Based Annual Bonuses. Notwithstanding subsection (b) above, if the Committee determines that an Annual Bonus eligible for deferral satisfies the requirements of “performance based compensation” within the meaning of Code Section 409A, any election to defer such Annual Bonus must be made no later than the date which is six months prior to the end of the performance period, and a Participant’s evergreen election to defer such Annual Bonus shall become irrevocable on the date which is six months prior to the end of the performance period (i.e., the election shall become irrevocable on June 30 of the calendar year performance period in which such June 30 occurs). Any deferral of an Annual Bonus shall be made in accordance with the rules and procedures established by the Committee.”

IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly authorized officer this 17th day of August, 2015.



	PERRIGO COMPANY

By	/s/ Michael Kelly
	Its: Chairman, Retirement Committee

EX-31.1 4 a2016q1ex311.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

CERTIFICATION

I, Joseph C. Papa, certify that:


1.	I have reviewed this report on Form 10-Q of Perrigo Company plc;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:


a.	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 2, 2015

/s/ Joseph C. Papa

Joseph C. Papa

Chairman and Chief Executive Officer

EX-31.2 5 a2016q1ex312.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

CERTIFICATION

I, Judy L. Brown, certify that:


1.	I have reviewed this report on Form 10-Q of Perrigo Company plc;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:


a.	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 2, 2015

/s/ Judy L. Brown

Judy L. Brown

Executive Vice President and Chief Financial Officer

EX-32 6 a2016q1ex32.htm EXHIBIT 32 Exhibit

Exhibit 32

The following statement is being made to the Securities and Exchange Commission solely for the purposes of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation.

Securities and Exchange Commission

450 Fifth Street NW

Washington, D.C. 20549



	Re:	Perrigo Company plc

Ladies and Gentlemen:

In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that:


(i)	this Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and


(ii)	the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Perrigo Company plc.

Dated: November 2, 2015



/s/ Joseph C. Papa		/s/ Judy L. Brown
Joseph C. Papa		Judy L. Brown
Chairman and Chief Executive Officer		Executive Vice President and Chief Financial Officer

EX-101.INS 7 prgo-20150926.xml XBRL INSTANCE DOCUMENT 0001585364 2015-06-28 2015-09-26 0001585364 prgo:OmegaGelcapsLumaraMember 2015-06-28 2015-09-26 0001585364 prgo:NaturwohlGSKScarawayMember 2015-06-28 2015-09-26 0001585364 2015-10-30 0001585364 2014-06-29 2014-09-27 0001585364 2015-06-27 0001585364 2015-09-26 0001585364 2014-09-27 0001585364 2014-06-28 0001585364 us-gaap:MaximumMember 2015-09-26 0001585364 us-gaap:MinimumMember 2015-09-26 0001585364 prgo:OmegaMember 2015-03-30 0001585364 prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:GelcapsMember 2015-05-12 0001585364 prgo:LumaraMember 2014-10-31 0001585364 prgo:OmegaMember us-gaap:CustomerRelationshipsMember 2015-03-30 0001585364 prgo:LumaraMember us-gaap:TrademarksAndTradeNamesMember 2014-10-31 0001585364 prgo:OmegaMember us-gaap:DevelopedTechnologyRightsMember 2015-03-30 0001585364 prgo:GelcapsMember prgo:ProductFormulationsMember 2015-05-12 0001585364 prgo:GelcapsMember us-gaap:TrademarksAndTradeNamesMember 2015-05-12 0001585364 prgo:OmegaMember us-gaap:TrademarksAndTradeNamesMember 2015-03-30 0001585364 prgo:LumaraMember us-gaap:CustomerRelationshipsMember 2014-10-31 0001585364 prgo:OmegaMember prgo:ProductFormulationsMember 2015-03-30 0001585364 prgo:LumaraMember us-gaap:DevelopedTechnologyRightsMember 2014-10-31 0001585364 prgo:LumaraMember prgo:ProductFormulationsMember 2014-10-31 0001585364 prgo:GelcapsMember 2015-05-12 2015-05-12 0001585364 prgo:LumaraMember 2014-10-31 2014-10-31 0001585364 prgo:GelcapsMember us-gaap:CustomerRelationshipsMember 2015-05-12 0001585364 prgo:GelcapsMember us-gaap:DevelopedTechnologyRightsMember 2015-05-12 0001585364 prgo:GSKMember 2015-08-28 0001585364 prgo:ScarAwayMember 2015-08-28 0001585364 prgo:NaturwohlPharmaMember 2015-09-15 0001585364 prgo:NaturwohlPharmaMember us-gaap:CustomerRelationshipsMember 2015-09-15 0001585364 prgo:GSKMember 2015-08-28 2015-08-28 0001585364 prgo:NaturwohlPharmaMember us-gaap:LicensingAgreementsMember 2015-09-15 0001585364 prgo:GSKMember us-gaap:LicensingAgreementsMember 2015-08-28 0001585364 prgo:NaturwohlPharmaMember 2015-09-15 2015-09-15 0001585364 prgo:GSKMember us-gaap:TrademarksAndTradeNamesMember 2015-08-28 0001585364 prgo:ScarAwayMember us-gaap:CustomerRelationshipsMember 2015-08-28 0001585364 prgo:NaturwohlPharmaMember us-gaap:NoncompeteAgreementsMember 2015-09-15 0001585364 prgo:ScarAwayMember us-gaap:LicensingAgreementsMember 2015-08-28 0001585364 prgo:ScarAwayMember us-gaap:TrademarksAndTradeNamesMember 2015-08-28 0001585364 prgo:ScarAwayMember us-gaap:NoncompeteAgreementsMember 2015-08-28 0001585364 prgo:ScarAwayMember 2015-08-28 2015-08-28 0001585364 prgo:GSKMember us-gaap:NoncompeteAgreementsMember 2015-08-28 0001585364 prgo:GSKMember us-gaap:CustomerRelationshipsMember 2015-08-28 0001585364 prgo:NaturwohlPharmaMember us-gaap:TrademarksAndTradeNamesMember 2015-09-15 0001585364 prgo:OmegaMember prgo:NonsolicitagreementMember 2015-03-30 2015-03-30 0001585364 us-gaap:LongTermDebtMember prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:ScarAwayMember us-gaap:NoncompeteAgreementsMember 2015-08-28 2015-08-28 0001585364 prgo:GSKMember us-gaap:TrademarksMember 2015-08-28 2015-08-28 0001585364 prgo:OmegaMember 2015-06-28 2015-09-26 0001585364 prgo:NaturwohlPharmaMember currency:EUR 2015-09-15 2015-09-15 0001585364 prgo:OtherMemberMember 2015-06-28 2015-09-26 0001585364 prgo:OmegaMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MinimumMember 2015-03-30 2015-03-30 0001585364 prgo:NaturwohlPharmaMember us-gaap:CustomerRelationshipsMember 2015-09-15 2015-09-15 0001585364 us-gaap:InventoriesMember prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:GSKMember us-gaap:CustomerRelationshipsMember 2015-08-28 2015-08-28 0001585364 prgo:OmegaMember currency:EUR us-gaap:MaximumMember 2015-03-30 2015-03-30 0001585364 prgo:LumaraMember prgo:ProductFormulationsMember us-gaap:MinimumMember 2014-10-31 2014-10-31 0001585364 us-gaap:PropertyPlantAndEquipmentMember prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 us-gaap:IndefinitelivedIntangibleAssetsMember prgo:OmegaMember 2015-06-28 2015-09-26 0001585364 prgo:NaturwohlPharmaMember us-gaap:TrademarksMember 2015-09-15 2015-09-15 0001585364 prgo:NaturwohlPharmaMember us-gaap:NoncompeteAgreementsMember 2015-09-15 2015-09-15 0001585364 us-gaap:PropertyPlantAndEquipmentMember prgo:GelcapsMember 2015-05-12 2015-05-12 0001585364 prgo:OmegaMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MaximumMember 2015-03-30 2015-03-30 0001585364 prgo:A2014bondsMember 2015-06-27 0001585364 prgo:OmegaMember us-gaap:TrademarksAndTradeNamesMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember us-gaap:CustomerRelationshipsMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember us-gaap:NoncompeteAgreementsMember 2015-03-30 2015-03-30 0001585364 prgo:GSKMember currency:EUR 2015-08-28 2015-08-28 0001585364 2014-06-29 2015-06-27 0001585364 prgo:OmegaMember us-gaap:MaximumMember 2015-03-30 2015-03-30 0001585364 prgo:ScarAwayMember us-gaap:TrademarksMember 2015-08-28 2015-08-28 0001585364 prgo:LumaraMember prgo:ProductFormulationsMember us-gaap:MaximumMember 2014-10-31 2014-10-31 0001585364 us-gaap:InventoriesMember prgo:GelcapsMember 2015-05-12 2015-05-12 0001585364 prgo:GelcapsMember us-gaap:TrademarksMember 2015-05-12 2015-05-12 0001585364 prgo:NaturwohlPharmaMember us-gaap:LicensingAgreementsMember 2015-09-15 2015-09-15 0001585364 prgo:ScarAwayMember us-gaap:CustomerRelationshipsMember 2015-08-28 2015-08-28 0001585364 prgo:OmegaMember us-gaap:OtherExpenseMember 2014-06-29 2015-06-27 0001585364 us-gaap:FiniteLivedIntangibleAssetsMember prgo:OmegaMember 2015-06-28 2015-09-26 0001585364 prgo:GelcapsMember us-gaap:CustomerRelationshipsMember 2015-05-12 2015-05-12 0001585364 us-gaap:CommonStockMember 2014-06-29 2015-06-27 0001585364 prgo:OmegaMember prgo:BrandsMember 2015-03-30 2015-03-30 0001585364 prgo:OtherMemberMember currency:EUR 2015-06-28 2015-09-26 0001585364 prgo:OmegaMember us-gaap:DischargeOfDebtMember 2014-06-29 2015-06-27 0001585364 prgo:OmegaMember prgo:InterestNetMember 2014-06-29 2015-06-27 0001585364 prgo:OmegaMember 2014-06-29 2015-06-27 0001585364 prgo:OmegaMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-06-29 2015-06-27 0001585364 prgo:SpecialtySciencesMember 2015-06-28 2015-09-26 0001585364 prgo:RxPharmaceuticalsMember 2015-09-26 0001585364 prgo:ConsumerHealthcareMember 2015-06-28 2015-09-26 0001585364 prgo:RxPharmaceuticalsMember 2015-06-28 2015-09-26 0001585364 prgo:BrandedCHCMember 2015-06-28 2015-09-26 0001585364 prgo:OtherMember 2015-09-26 0001585364 prgo:ConsumerHealthcareMember 2015-06-27 0001585364 prgo:SpecialtySciencesMember 2015-06-27 0001585364 prgo:OtherMember 2015-06-28 2015-09-26 0001585364 prgo:ConsumerHealthcareMember 2015-09-26 0001585364 prgo:SpecialtySciencesMember 2015-09-26 0001585364 prgo:BrandedCHCMember 2015-06-27 0001585364 prgo:BrandedCHCMember 2015-09-26 0001585364 prgo:OtherMember 2015-06-27 0001585364 prgo:RxPharmaceuticalsMember 2015-06-27 0001585364 us-gaap:NoncompeteAgreementsMember 2015-09-26 0001585364 us-gaap:TrademarksMember 2015-09-26 0001585364 us-gaap:InProcessResearchAndDevelopmentMember 2015-09-26 0001585364 us-gaap:CustomerRelationshipsMember 2015-06-27 0001585364 us-gaap:DevelopedTechnologyRightsMember 2015-09-26 0001585364 us-gaap:NoncompeteAgreementsMember 2015-06-27 0001585364 us-gaap:InProcessResearchAndDevelopmentMember 2015-06-27 0001585364 us-gaap:TrademarksMember 2015-09-26 0001585364 us-gaap:TrademarksMember 2015-06-27 0001585364 us-gaap:CustomerRelationshipsMember 2015-09-26 0001585364 us-gaap:DevelopedTechnologyRightsMember 2015-06-27 0001585364 prgo:DistributionAndLicenseAgreementsMember 2015-06-27 0001585364 prgo:DistributionAndLicenseAgreementsMember 2015-09-26 0001585364 us-gaap:TrademarksMember 2015-06-27 0001585364 us-gaap:FairValueInputsLevel1Member 2015-09-26 0001585364 us-gaap:FairValueInputsLevel1Member 2015-06-27 0001585364 us-gaap:FairValueInputsLevel3Member 2015-09-26 0001585364 us-gaap:FairValueInputsLevel2Member 2015-09-26 0001585364 us-gaap:FairValueInputsLevel3Member 2015-06-27 0001585364 us-gaap:FairValueInputsLevel2Member 2015-06-27 0001585364 us-gaap:OtherNoncurrentAssetsMember 2015-09-26 0001585364 us-gaap:OtherNoncurrentAssetsMember 2015-06-27 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-28 2015-09-26 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2014-06-29 2014-09-27 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:NondesignatedMember 2014-06-29 2014-09-27 0001585364 us-gaap:NondesignatedMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2014-06-29 2014-09-27 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:NondesignatedMember 2015-06-27 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2015-09-26 0001585364 us-gaap:NondesignatedMember 2015-09-26 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-09-26 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2015-06-27 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-27 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2015-09-26 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-27 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2015-09-26 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2015-09-26 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2015-06-27 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2015-06-27 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-27 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeContractMember 2015-09-26 0001585364 us-gaap:ForeignExchangeContractMember 2015-06-27 0001585364 prgo:PerrigoCoPLCMember 2015-06-27 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2015-09-26 0001585364 prgo:A3.5Seniornotedue2021Member 2015-09-26 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2015-06-27 0001585364 prgo:A3.9seniornotedue2024Member 2015-09-26 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2015-09-26 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2015-09-26 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2015-09-26 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2015-06-27 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2015-06-27 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2015-06-28 2015-09-26 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2015-06-28 2015-09-26 0001585364 prgo:A3.5Seniornotedue2021Member 2015-09-26 0001585364 prgo:A4.9SeniorLoandue2044Member 2015-09-26 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2015-06-28 2015-09-26 0001585364 prgo:A3.9seniornotedue2024Member 2015-06-27 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2015-09-26 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2015-06-28 2015-09-26 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2015-06-28 2015-09-26 0001585364 prgo:A3.9seniornotedue2024Member 2015-09-26 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2015-09-26 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2015-09-26 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2015-09-26 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2015-06-27 0001585364 prgo:PerrigoCoPLCMember 2015-09-26 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2015-09-26 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2015-09-26 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2015-06-27 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2015-09-26 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2015-09-26 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2015-06-28 2015-09-26 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2015-06-27 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2015-06-27 0001585364 prgo:A3.5Seniornotedue2021Member 2015-06-28 2015-09-26 0001585364 prgo:A4.9SeniorLoandue2044Member 2015-09-26 0001585364 prgo:A4.9SeniorLoandue2044Member 2015-06-27 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2015-06-27 0001585364 prgo:A3.9seniornotedue2024Member 2015-06-28 2015-09-26 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2015-06-28 2015-09-26 0001585364 prgo:A3.5Seniornotedue2021Member 2015-06-27 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2015-09-26 0001585364 prgo:A4.9SeniorLoandue2044Member 2015-06-28 2015-09-26 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2015-06-27 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2015-06-28 2015-09-26 0001585364 prgo:A4.9SeniorLoandue2044Member 2014-12-02 0001585364 prgo:OmegaMember prgo:A5.125RetailBondMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember currency:EUR prgo:A5.1045SeniorNoteMember 2015-03-30 0001585364 prgo:OmegaMember prgo:OmegaMember prgo:A6.19SeniorNoteMember 2015-03-30 0001585364 prgo:OmegaMember prgo:A4.5RetailBondMember 2015-03-30 0001585364 prgo:OmegaMember prgo:A5.125RetailBondMember 2015-03-30 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2013-11-08 0001585364 prgo:OmegaMember prgo:A5.1045SeniorNoteMember 2015-03-30 0001585364 prgo:A3.5Seniornotedue2021Member 2014-12-02 2014-12-02 0001585364 prgo:OmegaMember currency:EUR 2015-04-08 2015-04-08 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2013-11-08 0001585364 prgo:OmegaMember currency:EUR 2015-03-30 2015-03-30 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2013-11-08 0001585364 prgo:A2014termloandieDecember182015Member 2014-12-05 0001585364 prgo:A3.5Seniornotedue2021Member 2014-12-02 0001585364 prgo:OmegaMember prgo:A6.19SeniorNoteMember 2015-03-30 0001585364 us-gaap:RevolvingCreditFacilityMember 2014-12-05 0001585364 prgo:A3.9seniornotedue2024Member 2014-12-02 0001585364 prgo:OmegaMember currency:EUR prgo:CreditfacilityindebtednessMember 2015-03-30 0001585364 prgo:OmegaMember 2015-04-08 2015-04-08 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2014-12-05 0001585364 2013-11-08 0001585364 prgo:OmegaMember prgo:A5.0RetailBondMember 2015-03-30 0001585364 prgo:OmegaMember prgo:OverDraftMember 2015-03-30 0001585364 prgo:OmegaMember prgo:A5.0RetailBondMember 2015-03-30 2015-03-30 0001585364 2014-12-05 2014-12-05 0001585364 prgo:OmegaMember prgo:A4.5RetailBondMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember prgo:A5.1045SeniorNoteMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember currency:EUR prgo:A4.5RetailBondMember 2015-03-30 0001585364 prgo:OmegaMember currency:EUR prgo:A5.125RetailBondMember 2015-03-30 0001585364 currency:EUR prgo:A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain 2014-12-05 0001585364 prgo:PublicMember 2015-06-27 0001585364 2014-12-05 0001585364 prgo:OmegaMember currency:EUR prgo:A5.0RetailBondMember 2015-03-30 0001585364 prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain 2014-12-05 0001585364 prgo:OmegaMember prgo:CreditfacilityindebtednessMember 2015-03-30 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2013-11-08 0001585364 currency:EUR prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2014-12-05 0001585364 prgo:TermLoansMember 2015-09-26 0001585364 prgo:OmegaMember currency:EUR prgo:OverDraftMember 2015-03-30 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2015-06-28 2015-09-26 0001585364 us-gaap:RevolvingCreditFacilityMember 2015-09-26 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2014-06-29 2014-09-27 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2015-06-27 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2014-06-29 2014-09-27 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2015-06-27 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2014-06-29 2014-09-27 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2014-06-29 2014-09-27 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2015-06-27 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2015-06-27 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2014-06-29 2014-09-27 0001585364 us-gaap:SubsequentEventMember 2015-10-22 0001585364 us-gaap:SubsequentEventMember 2015-10-22 2015-10-22 0001585364 prgo:PerrigoCoPLCMember us-gaap:SubsequentEventMember 2015-10-22 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-06-28 2015-09-26 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-06-28 2015-09-26 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2015-09-26 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2015-06-28 2015-09-26 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2015-06-27 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-06-28 2015-09-26 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-09-26 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-06-27 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-06-27 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-09-26 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-09-26 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-06-27 0001585364 prgo:TexasMedicaidMember 2015-03-28 0001585364 prgo:TexasMedicaidMember 2015-09-26 0001585364 prgo:BrandedCHCMember 2014-06-29 2014-09-27 0001585364 prgo:ConsumerHealthcareMember 2014-06-29 2014-09-27 0001585364 prgo:SpecialtySciencesMember 2014-06-29 2014-09-27 0001585364 us-gaap:AllOtherSegmentsMember 2014-06-29 2014-09-27 0001585364 us-gaap:MaterialReconcilingItemsMember 2014-06-29 2014-09-27 0001585364 prgo:RxPharmaceuticalsMember 2014-06-29 2014-09-27 0001585364 us-gaap:MaterialReconcilingItemsMember 2015-06-27 0001585364 us-gaap:MaterialReconcilingItemsMember 2015-06-28 2015-09-26 0001585364 us-gaap:AllOtherSegmentsMember 2015-06-27 0001585364 us-gaap:AllOtherSegmentsMember 2015-06-28 2015-09-26 0001585364 us-gaap:MaterialReconcilingItemsMember 2015-09-26 0001585364 us-gaap:AllOtherSegmentsMember 2015-09-26 xbrli:shares iso4217:USD xbrli:shares xbrli:pure prgo:products iso4217:EUR xbrli:shares iso4217:USD iso4217:EUR false --06-25 Q1 2016 2015-09-26 10-Q 0001585364 146402066 Large Accelerated Filer PERRIGO CO PLC 452300000 562300000 368100000 367100000 101900000 93600000 159300000 2078300000 0 0 39800000 0 0 51300000 0 0 24600000 2 101900000 0.35 35000000.00 64600000 145100000 0 0 0.0015 0.0014 17300000 0 17300000 0 16500000 0 16500000 0 7235000000 7355200000 18100000 -400000 68900000 248000000 277000000 12300000 3 1.01 384300000 399000000

747500000

541200000

1282100000

1232200000

52600000

82300000

246400000

308800000

102400000

-9200000

-16300000

-3000000

130900000

65200000

-9200000

-16200000

-500000

91100000

P2Y

P3Y

213600000

293500000

2400000

2100000

106500000

16200000

17000000

72800000

500000

147600000

36300000

19400000

18600000

72800000

500000

100000

19720600000

6441100000

4381600000

2667900000

5979000000

251000000

19703100000

6728000000

4211200000

2597600000

5920800000

245500000

3182900000

2880800000

42400000

12700000

29700000

37800000

16500000

21300000

16537700000

16822300000

5700000

10600000

10100000

11200000

17100000

12700000

16500000

12700000

16500000

2014-10-31

2015-03-30

2015-05-12

2015-09-15

2015-08-28

904900000

0.9577

167.64

387000000

29700000

324000000

31600000

18400000

98000000

15100000

600000

-7400000

41500000

900000

9600000

223600000

27000000

86900000

45200000

6011700000

180400000

4600000

14700000

4600000

100000

400000

2300000

39200000

900000

2900000

8500000

264700000

3300000

3900000

1600000

44500000

900000

3400000

243100000

2800000

20000000

180000000

120000000

300000000

500000000

51400000

196000000

130700000

326700000

544500000

56000000

600000

7600000

900000

3700000

1071700000

25400000

174900000

42500000

132400000

21100000

9000000

500000

11600000

82000000

11000000

6600000

4400000

3919100000

1393900000

32600000

2492600000

107300000

33800000

21400000

300000

51800000

1500000

7200000

207100000

1700000

3900000

8800000

3028500000

30000000

223600000

27000000

83000000

36400000

2983200000

150400000

400000

2400000

100000

82500000

1471000000

135000000

147000000

100000

6000000

130800000

799500000

891500000

785600000

506500000

92000000

-279100000

0.105

0.125

0.001

10000000000

146300000

146400000

146300000

146400000

8621900000

8632800000

31000000

75400000

6800000

6900000

629700000

795900000

500000000

600000000

800000000

400000000

500000000

300000000

614300000

368600000

300000000

600000000

500000000

700000000

400000000

902400000

3850700000

890900000

3811500000

40500000

39000000

0.013

0.023

0.04

0.053

0.01300

0.02300

0.03500

0.03900

0.04000

0.04900

0.05300

0.04500

0.05000

0.05105

0.05125

0.0350

0.0390

0.0490

0.04500

0.05000

0.051045

0.05125

0.0619

2014-12-05

2014-12-02

2016-01-01

2017-01-01

2019-01-01

2023-01-01

2017-01-01

2016-11-08

2018-11-08

2023-11-15

2043-11-15

2019-12-05

2016-11-08

2018-11-08

2021-12-15

2024-12-15

2023-11-15

2044-12-15

2043-11-15

2017-05-23

2019-05-23

2023-07-19

2017-12-12

-87500000

-80400000

5311400000

5375000000

-20100000

-14200000

39600000

27800000

122300000

69000000

80600000

104500000

1745100000

1705100000

126600000

175400000

3300000

9100000

3300000

2300000

2500000

2300000

2000000

2600000

2000000

2600000

2500000

3400000

2500000

3400000

-1500000

-1800000

-3300000

100000

-8900000

-8800000

400000

-800000

600000

-900000

-700000

200000

-100000

-400000

-5200000

2700000

-2500000

-500000

0.72

0.77

0.72

0.77

-11100000

-10100000

0.114

0.148

133900000

112200000

48900000

48500000

539100000

500000000

P12Y

P8Y

P19Y

P21Y

P13Y

P4Y

P8Y

P20Y

P25Y

P15Y

P3Y

P15Y

P25Y

P15Y

P4Y

P25Y

1055000000

502300000

146200000

383100000

11900000

11500000

1195600000

582600000

181500000

402500000

12300000

16700000

9160600000

6029900000

1749900000

1025300000

14700000

340800000

9485800000

6064200000

1888200000

1015400000

15200000

502800000

8105600000

8290200000

1800000

4600000

5900000

12400000

4800000

-4100000

9600000

81500000

123600000

4971900000

1551900000

1897500000

88200000

1233600000

200700000

4987100000

1577500000

1898400000

85000000

1225500000

200700000

48700000

4900000

4600000

1426100000

63500000

117100000

112200000

4900000

-87200000

-87000000

-200000

-14700000

400000

-3800000

-3200000

-8100000

321800000

548800000

108600000

132200000

-3100000

8000000

12300000

19600000

10900000

19800000

-32500000

-194000000

-57300000

-46200000

14600000

15200000

600000

61500000

-34900000

-22800000

29700000

57000000

18500000

157500000

12000000

6200000

500000

600000

2263100000

5800000

2257300000

2368100000

5600000

2362500000

11423700000

11853900000

-25900000

-23700000

-43400000

5200000

6200000

468900000

504700000

838900000

888000000

211800000

220100000

158200000

163200000

12700000

16500000

9057800000

8971100000

19720600000

19703100000

1693700000

1661200000

4600000

5900000

7364100000

7309900000

1000000000

530500000

517700000

820900000

822700000

58200000

5246900000

5246800000

5229900000

9000000

15000000

7000000

P15M

200000

-61300000

43700000

-30700000

-448700000

195100000

136000000

96300000

112600000

184600000

360200000

137200000

74800000

64700000

14900000

7100000

-24300000

188600000

4400000

117300000

91000000

9000000

6200000

-39300000

225100000

225000000

600000

2500000

-2100000

100000

-63800000

-39800000

-37600000

-300000

2500000

-39800000

-65300000

-37200000

100000

2500000

-39800000

372100000

374900000

6600000

6300000

-2700000

-13000000

300000

3200000

-1000000

5000000

7500000

9000000

14100000

18300000

83000000

2983200000

36400000

150400000

133500000

223600000

200000000

27000000

8700000

7900000

405100000

31700000

38600000

0.0001

10000000

141300000

168600000

500000

1000000

200000

300000

2600000

2200000

999300000

-700000

4100000

-2100000

79000000

14400000

24900000

932400000

924100000

-400000

39500000

14300000

P3Y

36600000

41600000

1700000

2200000

1700000

2200000

1938300000

2034000000

951500000

640300000

194500000

91900000

24800000

1344700000

302200000

675200000

260300000

84500000

22500000

50400000

167900000

4720900000

1600000000

3900000000

500000000

600000000

500000000

700000000

800000000

201000000

400000000

134100000

150800000

335000000

400000000

3900000000

4722700000

3900000000

500000000

600000000

500000000

700000000

800000000

201500000

400000000

134300000

151100000

335800000

400000000

2300000000

8800000

14300000

5400000

685348257

6400000

86900000

6800000

186000

154000

2000000000

500000000

10662600000

10732000000

10662800000

10732000000

30243983

65700000

69000000

134400000

146900000

133900000

146300000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The acquisition was a cash and stock transaction made up of the following consideration (in millions, except per share data):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.21383647798741%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo share price at transaction close on March 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">167.64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total value of Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">904.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,078.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other intangible assets and related accumulated amortization consisted of the following (in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="39%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,064.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">582.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,029.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">502.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology/formulation and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,015.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">402.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,025.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">383.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,888.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">181.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,749.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">502.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">340.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9,485.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,195.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9,160.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,055.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,362.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,257.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,368.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,263.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,853.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,195.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,423.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,055.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded in the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;"> (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:51.36268343815513%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="70%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Line item</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Administration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">23.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">324.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Loss on extinguishment of debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total acquisition-related costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">387.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In fiscal year 2015, we announced that our fiscal year-end will begin on January 1 and end on December 31 of each year, starting on January 1, 2016. Fiscal year 2015, which ended on June 27, 2015, will be followed by a transition period from June 28, 2015 to December 31, 2015. We plan to disclose the results of the transition period on a Form 10-KT transition report.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We will continue to close our books on the Saturday closest to end of the quarter, with the last quarter ending on December 31. This practice will only affect the quarterly reporting periods and not the annual reporting periods. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Sales of OTC pharmaceutical products in the Consumer Healthcare ("CHC") segment are typically subject to seasonal demands for cough/cold/flu products from September through March and allergy products from April through September. Our Branded Consumer Healthcare ("BCH") sales are also impacted by seasonality and tend to peak in April through June due to increased demand for seasonal health and wellness products. In addition, our animal health products are subject to seasonal demand for flea and tick products that peaks during the warmer weather months, typically from March through June. Our Prescription Pharmaceuticals </font><font style="font-family:inherit;font-size:10pt;">(</font><font style="font-family:Arial;font-size:10pt;">"Rx"), Specialty Sciences, and Other segments' sales are not generally impacted by seasonal conditions. Accordingly, operating results for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> are not necessarily indicative of the results that may be expected for a full year.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ACQUISITIONS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All of the below acquisitions have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets and liabilities assumed, as well as asset lives, can materially impact our results of operations. For those acquisitions for which the purchase price allocation is preliminary, we will continue to refine the allocation during the measurement period. As we obtain the information to finalize our purchase accounting assessments, it is reasonably possible that there will be changes in the valuation of assets acquired and liabilities assumed that may have a material impact on our results of operations and financial position. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of all of the acquisitions described below were included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Current Period Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Naturwohl Pharma GmbH</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">September 15, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of </font><font style="font-family:Arial;font-size:10pt;">100%</font><font style="font-family:Arial;font-size:10pt;"> of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe. The acquisition builds on our BCH segment's leading OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at </font><font style="font-family:Arial;font-size:10pt;">€133.5 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$150.4 million</font><font style="font-family:Arial;font-size:10pt;">). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired included a trademark with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life, customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life, non-compete agreements with a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year useful life, and a licensing agreement with a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, the lost income method for valuing the non-compete agreements, and the with or without approach for the licensing agreement. The with or without approach estimates the fair value of an asset by comparing the value of the business, inclusive of the asset, to the hypothetical value of the same business excluding the asset. The goodwill acquired is not deductible for tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">ScarAway</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">®</sup> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">August 28, 2015</font><font style="font-family:Arial;font-size:10pt;">, we acquired ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">®</sup></font><font style="font-family:Arial;font-size:10pt;">, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for </font><font style="font-family:Arial;font-size:10pt;">$27.0 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. This acquisition serves as our entry into the branded OTC business in the U.S. Operating results attributable to ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">® </sup></font><font style="font-family:Arial;font-size:10pt;">are included in the CHC segment. The intangible assets acquired included a trademark with a </font><font style="font-family:Arial;font-size:10pt;">25</font><font style="font-family:Arial;font-size:10pt;">-year useful life, non-compete agreements with a </font><font style="font-family:Arial;font-size:10pt;">four</font><font style="font-family:Arial;font-size:10pt;">-year useful life and customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">GlaxoSmithKline</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Consumer Healthcare</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">August 28, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed the acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK”). This acquisition further leverages our European market share and expands our product offerings. The assets were purchased through an all-cash transaction valued at </font><font style="font-family:Arial;font-size:10pt;">€200.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$223.6 million</font><font style="font-family:Arial;font-size:10pt;">). Operating results attributable to GSK are included in the BCH segment. The intangible assets acquired included trademarks with </font><font style="font-family:Arial;font-size:10pt;">25</font><font style="font-family:Arial;font-size:10pt;">-year useful lives and customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Other Product Acquisitions</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also acquired </font><font style="font-family:Arial;font-size:10pt;">two</font><font style="font-family:Arial;font-size:10pt;"> OTC product portfolios totaling </font><font style="font-family:Arial;font-size:10pt;font-style:normal;">€7.9 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$8.7 million</font><font style="font-family:Arial;font-size:10pt;">) during the </font><font style="font-family:Arial;font-size:10pt;font-style:normal;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;font-style:normal;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">, which are included in the BCH segment. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Purchase Price Allocation of Current Period Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The Naturwohl, </font><font style="font-family:Arial;font-size:10pt;">ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">®</sup></font><font style="font-family:Arial;font-size:10pt;">,</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">and GSK opening balance sheets are still preliminary and are</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">based on valuation information, estimates, and assumptions available at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">. As we finalize the fair value estimates of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period. Tax accounts as well as certain tangible and intangible assets have not yet been finalized. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The below table indicates the purchase price allocation for our current period acquisitions (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:586px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="338px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="67px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="67px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="67px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Naturwohl*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">ScarAway</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">®</sup></font><font style="font-family:Arial;font-size:9pt;font-weight:bold;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">GSK*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">63.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">132.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">42.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-competition agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">107.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">174.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">180.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-current net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Opening balance sheets are preliminary. </font></div></td></tr></table><div style="line-height:120%;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Prior Period Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Gelcaps Exportadora de Mexico, S.A. de C.V. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">May 12, 2015</font><font style="font-family:Arial;font-size:10pt;">, we acquired </font><font style="font-family:Arial;font-size:10pt;">100%</font><font style="font-family:Arial;font-size:10pt;"> of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for </font><font style="font-family:Arial;font-size:10pt;">$36.4 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. The purchase price was adjusted during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> to account for a working capital adjustment with the seller. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a </font><font style="font-family:Arial;font-size:10pt;">25</font><font style="font-family:Arial;font-size:10pt;">-year useful life and customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of </font><font style="font-family:Arial;font-size:10pt;">$0.6 million</font><font style="font-family:Arial;font-size:10pt;"> was recorded in the opening balance sheet, which was charged to cost of goods sold during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">. In addition, property, plant and equipment were written up by </font><font style="font-family:Arial;font-size:10pt;">$0.9 million</font><font style="font-family:Arial;font-size:10pt;"> to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Omega Pharma Invest N.V.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March 30, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of Omega, a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company, and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with critical mass in key European countries, establishing commercial infrastructure in the high-barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, enhancing our financial profile, and expanding our international management capabilities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We purchased</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">95.77%</font><font style="font-family:Arial;font-size:10pt;"> of the issued and outstanding share capital of Omega (</font><font style="font-family:Arial;font-size:10pt;">685,348,257</font><font style="font-family:Arial;font-size:10pt;"> shares) from Alychlo N.V. (“Alychlo”) and Holdco I BE N.V. (“Holdco” and, together with Alychlo, the “Sellers”), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining </font><font style="font-family:Arial;font-size:10pt;">30,243,983</font><font style="font-family:Arial;font-size:10pt;"> shares as treasury shares. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The acquisition was a cash and stock transaction made up of the following consideration (in millions, except per share data):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.21383647798741%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="22%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo share price at transaction close on March 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">167.64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total value of Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">904.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,078.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The cash consideration shown in the above table was financed by a combination of debt and equity. We issued </font><font style="font-family:Arial;font-size:10pt;">$1.6 billion</font><font style="font-family:Arial;font-size:10pt;"> of debt and </font><font style="font-family:Arial;font-size:10pt;">6.8 million</font><font style="font-family:Arial;font-size:10pt;"> ordinary shares, which raised </font><font style="font-family:Arial;font-size:10pt;">$999.3 million</font><font style="font-family:Arial;font-size:10pt;"> net of issuance costs. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Sellers agreed to indemnify us for certain potential future losses. The Sellers’ indemnification and other obligations to us under the Share Purchase Agreement are secured up to </font><font style="font-family:Arial;font-size:10pt;">€248.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$277.0 million</font><font style="font-family:Arial;font-size:10pt;">). Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year non-compete in Europe, and the Sellers are subject to a </font><font style="font-family:Arial;font-size:10pt;">two</font><font style="font-family:Arial;font-size:10pt;">-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The operating results attributable to Omega are included in the BCH segment. We incurred costs in connection with the Omega acquisition related to general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded in the fiscal year ended </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;"> (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:51.36268343815513%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="70%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Line item</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Administration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">23.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">324.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Loss on extinguishment of debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total acquisition-related costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">387.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The </font><font style="font-family:Arial;font-size:10pt;">$324.0 million</font><font style="font-family:Arial;font-size:10pt;"> loss recorded in Other expense, net, consisted of losses from hedging Omega's euro-denominated purchase price due to changes in the euro-to-U.S. dollar exchange rates. These losses were economically offset at closing in the final settlement of the euro-denominated purchase price. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an </font><font style="font-family:Arial;font-size:10pt;">eight</font><font style="font-family:Arial;font-size:10pt;">-year useful life, definite-lived brands with a </font><font style="font-family:Arial;font-size:10pt;">19</font><font style="font-family:Arial;font-size:10pt;">-year useful life, a distribution network with a </font><font style="font-family:Arial;font-size:10pt;">21</font><font style="font-family:Arial;font-size:10pt;">-year useful life, and developed product technology with useful lives ranging from </font><font style="font-family:Arial;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">to </font><font style="font-family:Arial;font-size:10pt;">13</font><font style="font-family:Arial;font-size:10pt;"> years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above. We utilized the multi-period excess earnings method for the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method for the developed product technology and definite-lived trade name.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of </font><font style="font-family:Arial;font-size:10pt;">$15.1 million</font><font style="font-family:Arial;font-size:10pt;"> was recorded in the opening balance sheet and was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment were written up </font><font style="font-family:Arial;font-size:10pt;">$41.5 million</font><font style="font-family:Arial;font-size:10pt;"> to their estimated fair market value based on a valuation method that included both the cost and market approaches during the three months ended June 27, 2015. This step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">on the date of acquisition exceeded par value by </font><font style="font-family:Arial;font-size:10pt;">$101.9 million</font><font style="font-family:Arial;font-size:10pt;">, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see </font><a style="font-family:Arial;font-size:10pt;" href="#s6665DA99BD2F54B9AFB9BE5F1E6924BB"><font style="font-family:Arial;font-size:10pt;">Note 8</font></a><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Lumara Health, Inc.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">October 31, 2014</font><font style="font-family:Arial;font-size:10pt;">, we acquired a portfolio of women's healthcare products from Lumara Health, Inc., ("Lumara") a privately-held, Chesterfield, Missouri-based specialty pharmaceutical company, for cash consideration of </font><font style="font-family:Arial;font-size:10pt;">$83.0 million</font><font style="font-family:Arial;font-size:10pt;">. The acquisition of this portfolio further expanded our women's healthcare product offerings. Operating results attributable to the acquired Lumara products are included in the Rx segment. The intangible assets acquired consisted of </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;"> product formulations with useful lives ranging from </font><font style="font-family:Arial;font-size:10pt;">eight</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">12</font><font style="font-family:Arial;font-size:10pt;"> years. The assets were valued utilizing the multi-period excess earnings method.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Purchase Price Allocation of Prior Period Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The Lumara opening balance sheet is final. The Omega and Gelcaps opening balance sheets are still preliminary and are </font><font style="font-family:Arial;font-size:10pt;">based on valuation information, estimates, and assumptions available at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Since the initial valuation, revisions to the Omega allocation have included: a </font><font style="font-family:Arial;font-size:10pt;">$98.0 million</font><font style="font-family:Arial;font-size:10pt;"> increase in indefinite-lived brands and an </font><font style="font-family:Arial;font-size:10pt;">$18.4 million</font><font style="font-family:Arial;font-size:10pt;"> increase in definite-lived intangible assets (trade names, brands, and distribution networks) due to refinements in underlying valuation assumptions; a </font><font style="font-family:Arial;font-size:10pt;">$7.4 million</font><font style="font-family:Arial;font-size:10pt;"> reduction in inventory due </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">to additional analysis related to the fair value of inventory and obsolescence reserves;</font><font style="font-family:Arial;font-size:10pt;"> a </font><font style="font-family:Arial;font-size:10pt;">$9.6 million</font><font style="font-family:Arial;font-size:10pt;"> increase in property, plant, and equipment due to the completion of additional tangible asset valuations; and an increase in the net deferred tax liabilities of </font><font style="font-family:Arial;font-size:10pt;">$31.6 million</font><font style="font-family:Arial;font-size:10pt;"> due to the valuation update. These revisions resulted in an </font><font style="font-family:Arial;font-size:10pt;">$87.0 million</font><font style="font-family:Arial;font-size:10pt;"> reduction in goodwill. The purchase price allocation is still open for verification of the intangible assets valuation, related deferred taxes, and the resulting effects on the value of goodwill. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Gelcaps purchase price allocation is open for verification of the intangible assets valuation, tax accounts, and any resulting effects on the value of goodwill.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The below table indicates the purchase price allocation for our prior year acquisitions (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:608px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="350px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="70px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="71px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="71px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gelcaps*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Omega*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Lumara</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">83.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">264.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">207.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current net deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">130.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,426.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,492.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,393.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Formulations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">82.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">32.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,919.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">82.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">45.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,011.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">243.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Short-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payroll and related taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued customer programs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,471.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-current net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,071.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">82.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,028.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">83.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:0px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;text-indent:-24px;"><font style="font-family:Arial;font-size:8pt;">Opening balance sheets are preliminary.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The below table indicates the purchase price allocation for our current period acquisitions (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:586px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="338px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="67px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="67px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="67px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Naturwohl*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">ScarAway</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">®</sup></font><font style="font-family:Arial;font-size:9pt;font-weight:bold;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">GSK*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">63.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">132.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">33.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">42.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-competition agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">107.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">174.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">180.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-current net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Opening balance sheets are preliminary. </font></div></td></tr></table><div style="line-height:120%;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Principles of Consolidation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEBTEDNESS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total borrowings outstanding at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;"> are summarized as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.0335429769392%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="3%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="23%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, <br clear="none"/>2015</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Short-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Term loans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Term loan due December 5, 2019</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">517.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">530.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Public bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Coupon</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Due</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 8, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May 23, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">201.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">201.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.125%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 12, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">335.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">335.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.300%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 8, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.000%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May 23, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 15, 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.105%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">July 19, 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 15, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 15, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.300%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 15, 2043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 15, 2044</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total public bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,722.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,720.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Other financing</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Unamortized premium (discount), net</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">80.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">87.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Deferred financing fees</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(40.5</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total borrowings outstanding</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,375.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,311.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Less short-term debt and current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(145.1</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(64.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total long-term debt less current portion</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,229.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,246.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds." </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt assumed from Omega.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2013 Bonds."</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We were in compliance with all covenants under our various debt agreements as of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our term loan and revolving credit facility</font><font style="font-family:Arial;font-size:10pt;color:#1f497d;"> </font><font style="font-family:Arial;font-size:10pt;">each have an event of default for changes of control that would be triggered upon a </font><font style="font-family:Arial;font-size:10pt;">35%</font><font style="font-family:Arial;font-size:10pt;"> change of control. Also, if there is a change of control under our </font><font style="font-family:Arial;font-size:10pt;">$3.9 billion</font><font style="font-family:Arial;font-size:10pt;"> of public senior notes (the 2014 Bonds and 2013 Bonds), and they are downgraded below investment grade by both Moody's Investor Services, Inc. and Standard & Poor's Rating Service, we would be obligated to offer to repurchase all of the 2014 Bonds and 2013 Bonds at </font><font style="font-family:Arial;font-size:10pt;">101%</font><font style="font-family:Arial;font-size:10pt;"> of par. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Omega Financing </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Debt Issuance</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December 2, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance plc, our 100% owned finance subsidiary ("Perrigo Finance"), issued </font><font style="font-family:Arial;font-size:10pt;">$500.0 million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">3.50%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2021</font><font style="font-family:Arial;font-size:10pt;"> (the "2021 Notes”), </font><font style="font-family:Arial;font-size:10pt;">$700.0 million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">3.90%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2024</font><font style="font-family:Arial;font-size:10pt;"> (the “2024 Notes”), and </font><font style="font-family:Arial;font-size:10pt;">$400.0 million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">4.90%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2044</font><font style="font-family:Arial;font-size:10pt;"> (the “2044 Notes” and, together with the 2021 Notes and the 2024 Notes, the “2014 Bonds”). Interest on the 2014 Bonds is payable semiannually in arrears in June and December of each year, beginning in June 2015. The 2014 Bonds are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Bonds are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo Company plc, and no other subsidiary of Perrigo Company plc guarantees the 2014 Bonds. There are no restrictions under the 2014 Bonds on our ability to obtain funds from our subsidiaries. Perrigo Finance received net proceeds of approximately </font><font style="font-family:Arial;font-size:10pt;">$1.6 billion</font><font style="font-family:Arial;font-size:10pt;"> from issuance of the 2014 Bonds after fees and market discount. Perrigo Finance may redeem the 2014 Bonds in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December 5, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance entered into a term loan agreement consisting of a </font><font style="font-family:Arial;font-size:10pt;">€500.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$614.3 million</font><font style="font-family:Arial;font-size:10pt;">) tranche, with the ability to draw an additional </font><font style="font-family:Arial;font-size:10pt;">€300.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$368.6 million</font><font style="font-family:Arial;font-size:10pt;">) tranche, maturing December 5, 2019, and a </font><font style="font-family:Arial;font-size:10pt;">$600.0 million</font><font style="font-family:Arial;font-size:10pt;"> revolving credit agreement, which stepped up to </font><font style="font-family:Arial;font-size:10pt;">$1.0 billion</font><font style="font-family:Arial;font-size:10pt;"> upon the closing of the Omega acquisition (the "2014 Revolver") (together, the "2014 Credit Agreements"). On the same date, Perrigo Company plc entered into a </font><font style="font-family:Arial;font-size:10pt;">$300.0 million</font><font style="font-family:Arial;font-size:10pt;"> term loan tranche maturing December 18, 2015, which we repaid on June 14, 2015. There were no borrowings outstanding under the 2014 Revolver as of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">. Subsequent to </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">, we allowed the undrawn </font><font style="font-family:Arial;font-size:10pt;">€300.0 million</font><font style="font-family:Arial;font-size:10pt;"> term loan tranche to expire.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Assumed Debt and Repayment</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the Omega acquisition, we assumed </font><font style="font-family:Arial;font-size:10pt;">$20.0 million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">6.19%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2016</font><font style="font-family:Arial;font-size:10pt;"> ("2016 Notes"), </font><font style="font-family:Arial;font-size:10pt;">€135.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$147.0 million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">5.1045%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2023</font><font style="font-family:Arial;font-size:10pt;"> ("2023 Notes"), </font><font style="font-family:Arial;font-size:10pt;">€300.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$326.7 million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">5.125%</font><font style="font-family:Arial;font-size:10pt;"> retail bonds due </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">€180.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$196.0 million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">4.500%</font><font style="font-family:Arial;font-size:10pt;"> retail bonds due </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, </font><font style="font-family:Arial;font-size:10pt;">€120.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$130.7 million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">5.000%</font><font style="font-family:Arial;font-size:10pt;"> retail bonds due </font><font style="font-family:Arial;font-size:10pt;">2019</font><font style="font-family:Arial;font-size:10pt;"> (collectively, the "Retail Bonds"), a revolving credit facility with </font><font style="font-family:Arial;font-size:10pt;">€500.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$544.5 million</font><font style="font-family:Arial;font-size:10pt;">) outstanding, and certain overdraft facilities totaling </font><font style="font-family:Arial;font-size:10pt;">€51.4 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$56.0 million</font><font style="font-family:Arial;font-size:10pt;">). The fair value of the 2023 Notes and Retail Bonds</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">exceeded par value by </font><font style="font-family:Arial;font-size:10pt;">€93.6 million</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">(</font><font style="font-family:Arial;font-size:10pt;">$101.9 million</font><font style="font-family:Arial;font-size:10pt;">) on the date of the acquisition. As a result, a fair value adjustment was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. The adjustment does not affect cash interest payments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">April 8, 2015</font><font style="font-family:Arial;font-size:10pt;">, we repaid the </font><font style="font-family:Arial;font-size:10pt;">€500.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$539.1 million</font><font style="font-family:Arial;font-size:10pt;">) outstanding under the assumed Omega revolving credit facility and terminated the facility. On May 29, 2015, we repaid the </font><font style="font-family:Arial;font-size:10pt;">$20.0 million</font><font style="font-family:Arial;font-size:10pt;"> outstanding on the 2016 Notes. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Omega regularly utilizes overdraft facilities to meet its short-term liquidity needs and its balances fluctuate on a day-to-day basis. While the assumed overdraft facilities balance noted above was repaid as of </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">, additional borrowings were made as of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and make up the majority of the short-term debt balance in the above table. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Elan Financing</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Debt Issuance</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On November 8, 2013, Perrigo Company issued </font><font style="font-family:Arial;font-size:10pt;">$500.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:Arial;font-size:10pt;">1.300%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due 2016 (the "2016 Notes"), </font><font style="font-family:Arial;font-size:10pt;">$600.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:Arial;font-size:10pt;">2.300%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due 2018 (the "2018 Notes"), </font><font style="font-family:Arial;font-size:10pt;">$800.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:Arial;font-size:10pt;">4.000%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due 2023 (the "2023 Notes") and </font><font style="font-family:Arial;font-size:10pt;">$400.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:Arial;font-size:10pt;">5.300%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due 2043 (the "2043 Notes" and, together with the 2016 Notes, the 2018 Notes and the 2023 Notes, the "2013 Bonds") in a private placement with registration rights. Interest on the 2013 Bonds is payable semiannually in arrears in May and November of each year, beginning in May 2014. The 2013 Bonds are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Bonds are the Company's unsecured and unsubordinated obligations, ranking equally in right of payment to all of Perrigo Company's existing and future unsecured and unsubordinated indebtedness. Perrigo Company received net proceeds of </font><font style="font-family:Arial;font-size:10pt;">$2.3 billion</font><font style="font-family:Arial;font-size:10pt;"> from the issuance of the 2013 Bonds after fees and market discount. The 2013 Bonds are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Bonds in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Bonds were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our 2013 credit agreements until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On September 2, 2014, we offered to exchange our private placement senior notes with public bonds. The offer was open until October 1, 2014, at which time substantially all of the private placement notes had been exchanged for bonds registered with the Securities and Exchange Commission. As a result of the changes in the guarantor structure noted above, we are no longer required to present guarantor financial statements.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Interest rate risk management - </font><font style="font-family:Arial;font-size:10pt;">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Foreign currency exchange risk management - </font><font style="font-family:Arial;font-size:10pt;">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> All of our designated derivatives were classified as cash flow hedges as of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of Other Comprehensive Income ("OCI"), net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.     </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Swaps and Treasury Locks </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:Arial;font-size:10pt;">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. All of our interest rate swaps qualify for hedge accounting treatment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Derivatives</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;"></font><font style="font-family:Arial;font-size:10pt;">We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;"> months. The total notional amount for these contracts was </font><font style="font-family:Arial;font-size:10pt;">$562.3 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$452.3 million</font><font style="font-family:Arial;font-size:10pt;"> as of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Effects of Derivatives on the Financial Statements</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">. All amounts exclude income tax effects and are presented in millions.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:86.37316561844864%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="39%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.63102725366876%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="40%" rowspan="1" colspan="1"></td><td width="27%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:432px;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI<br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) reclassified from Accumulated Other Comprehensive Income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:561px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="124px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI to Income <br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a</font><font style="font-family:Arial;font-size:10pt;">$1.8 million</font><font style="font-family:Arial;font-size:10pt;"> loss. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.56603773584906%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Interest rate risk management - </font><font style="font-family:Arial;font-size:10pt;">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Foreign currency exchange risk management - </font><font style="font-family:Arial;font-size:10pt;">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> All of our designated derivatives were classified as cash flow hedges as of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of Other Comprehensive Income ("OCI"), net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item. </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:150px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:Arial;font-size:10pt;">Level 1:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Quoted prices for identical instruments in active markets.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:150px;text-indent:-90px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:150px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:Arial;font-size:10pt;">Level 2:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:150px;text-indent:-90px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:150px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:Arial;font-size:10pt;">Level 3:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Valuations derived from valuation techniques in which one or more significant inputs are not observable.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following tables summarize the valuation of our financial instruments carried at fair value by the above pricing categories at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;"> (in millions):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Funds associated with Israeli post-employment benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Funds associated with Israeli post-employment benefits</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">42.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">There were no transfers between Levels 1, 2, and 3 during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">. Our policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period. See </font><a style="font-family:Arial;font-size:10pt;" href="#s672DA3BBF30A55DA9E384D978C17A54D"><font style="font-family:Arial;font-size:10pt;">Note 6</font></a><font style="font-family:Arial;font-size:10pt;"> for information on our investment securities. See </font><a style="font-family:Arial;font-size:10pt;" href="#sF79178AC36CA58AE8BF42A2C102B2ED4"><font style="font-family:Arial;font-size:10pt;">Note 7</font></a><font style="font-family:Arial;font-size:10pt;"> for a discussion of derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Israeli post-employment benefits represent amounts we have deposited in funds managed by financial institutions designated by management to cover post-employment benefits for its Israeli employees as required by Israeli law. The funds are recorded in Other non-current assets and values are determined using prices for recently traded financial instruments with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves, that are observable at commonly quoted intervals.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">, our fixed rate long-term debt consisted of public bonds, retail bonds, and private placement notes. The fair value of the public bonds was determined by quoted market prices (Level 1). As of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;">, the public bonds had a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$3.9 billion</font><font style="font-family:Arial;font-size:10pt;"> and a fair value of </font><font style="font-family:Arial;font-size:10pt;">$3.8 billion</font><font style="font-family:Arial;font-size:10pt;">. As of </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">, the public bonds had a carrying value and a fair value of </font><font style="font-family:Arial;font-size:10pt;">$3.9 billion</font><font style="font-family:Arial;font-size:10pt;">. The fair value of the retail bonds and private placement notes was determined by discounting the future cash flows of the financial instruments to their present value, using interest rates offered for borrowings of a similar nature and remaining maturities (Level 2). As of </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">, the retail bonds and private placement notes had a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$822.7 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$820.9 million</font><font style="font-family:Arial;font-size:10pt;">, respectively, and a fair value of </font><font style="font-family:Arial;font-size:10pt;">$890.9 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$902.4 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">GOODWILL AND OTHER INTANGIBLE ASSETS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">    </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.08176100628931%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="23%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Reporting Segments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance at June 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:center;">Business Acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase Accounting Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency Translation Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance at September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,897.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,898.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,551.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(87.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,577.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Rx</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,233.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,225.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Specialty Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">88.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">85.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Total goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,971.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(14.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,987.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Intangible Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other intangible assets and related accumulated amortization consisted of the following (in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="39%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,064.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">582.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,029.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">502.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology/formulation and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,015.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">402.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,025.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">383.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,888.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">181.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,749.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">502.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">340.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9,485.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,195.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9,160.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,055.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,362.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,257.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,368.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,263.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,853.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,195.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,423.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,055.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certain intangible assets are denominated in currencies other than the U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recorded amortization expense of </font><font style="font-family:Arial;font-size:10pt;">$147.6 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$106.5 million</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">September 27, 2014</font><font style="font-family:Arial;font-size:10pt;">, respectively. The increase in amortization expense was due primarily to the incremental amortization expense incurred on the definite-lived intangible assets acquired from Omega.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="37%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="24%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Accounting Standard Update</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Date of Adoption</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Simplifying the Accounting for Measurement-Period Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The updated guidance eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. The guidance is effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Provisional amounts that occur on or after the adoption date will be recognized in the period in which they are determined. The adoption of this accounting guidance did not materially impact the financial statements for the quarter ended September 26, 2015.</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) reclassified from Accumulated Other Comprehensive Income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:561px;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="124px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI to Income <br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total borrowings outstanding at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;"> are summarized as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.0335429769392%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="3%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="23%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, <br clear="none"/>2015</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Short-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Term loans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Term loan due December 5, 2019</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">517.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">530.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Public bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Coupon</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Due</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 8, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May 23, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">201.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">201.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.125%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 12, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">335.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">335.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.300%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 8, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.000%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May 23, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 15, 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.105%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">July 19, 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 15, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 15, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.300%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November 15, 2043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:left;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December 15, 2044</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total public bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,722.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,720.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Other financing</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Unamortized premium (discount), net</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">80.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">87.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Deferred financing fees</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.0</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(40.5</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total borrowings outstanding</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,375.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,311.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Less short-term debt and current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(145.1</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(64.6</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total long-term debt less current portion</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,229.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,246.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds." </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt assumed from Omega.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup> </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2013 Bonds."</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</font></div></td></tr></table></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:432px;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="240px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="79px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI<br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(5.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:86.37316561844864%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="39%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.63102725366876%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="40%" rowspan="1" colspan="1"></td><td width="27%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.14884696016772%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="63%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, <br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">96.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">133.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following tables summarize the valuation of our financial instruments carried at fair value by the above pricing categories at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;"> (in millions):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Funds associated with Israeli post-employment benefits</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Funds associated with Israeli post-employment benefits</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">42.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.08176100628931%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td width="23%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Reporting Segments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance at June 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-align:center;">Business Acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase Accounting Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency Translation Adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance at September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,897.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,898.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,551.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(87.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,577.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Rx</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,233.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,225.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Specialty Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">88.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">85.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Total goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,971.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(87.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(14.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,987.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Major components of inventory at </font><font style="font-family:Arial;font-size:10pt;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;">, were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.312368972746334%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">504.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">468.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">163.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">158.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Raw materials</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">220.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">211.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">888.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">838.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.56603773584906%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td width="42%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables show select financial measures by reporting segment (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.08176100628931%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance at September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization of Intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:18px;text-indent:-18px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">675.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,211.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">BCH</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">302.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,728.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Rx</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">91.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,597.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">84.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,920.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">245.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,344.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">188.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">147.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19,703.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.08176100628931%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="29%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance at </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 27, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amortization of Intangibles</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;padding-left:18px;text-indent:-18px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">640.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">74.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,381.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">BCH</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,441.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-align:left;">Rx</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">194.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">64.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,667.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">91.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,979.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">251.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(24.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">951.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">137.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">106.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19,720.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Accounts Receivable Factoring</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#252525;">As a result of our acquisition of Omega Pharma Invest N.V. ("Omega"), we assumed multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from </font><font style="font-family:Arial;font-size:10pt;color:#252525;">0.14%</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> to </font><font style="font-family:Arial;font-size:10pt;color:#252525;">0.15%</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was </font><font style="font-family:Arial;font-size:10pt;color:#252525;">$159.3 million</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> at </font><font style="font-family:Arial;font-size:10pt;color:#252525;">September 26, 2015</font><font style="font-family:Arial;font-size:10pt;color:#252525;">, a </font><font style="font-family:Arial;font-size:10pt;color:#252525;">$12.3 million</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> decrease since </font><font style="font-family:Arial;font-size:10pt;color:#252525;">June 27, 2015</font><font style="font-family:Arial;font-size:10pt;color:#252525;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Unrealized investment gains (losses) on available for sale securities were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:461px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="276px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="82px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td><td width="5px" rowspan="1" colspan="1"></td><td width="6px" rowspan="1" colspan="1"></td><td width="74px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">June 27, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity securities, at cost less impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross unrealized losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(11.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(10.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Estimated fair value of equity securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">16.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate. (1) Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds." (3) Discussed below collectively as the "2013 Bonds." (2) Debt assumed from Omega. Opening balance sheets are preliminary. EX-101.SCH 8 prgo-20150926.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2110100 - Schedule - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 2410402 - Schedule - Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Schedule - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Business Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Business Acquisitions (Notes) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Business Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Collaboration Arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Collaboration Arrangements (Notes) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Collaboration Arrangements (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Derivative Instruments and Hedging Activities - balance sheet location (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities -Fair value hedges (Details) link:presentationLink link:calculationLink link:definitionLink 2407406 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Derivative Instruments and Hedging Activities (Note) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Fair value measurements - assets and liabilities on a recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Fair Value Measurements Fair value measurements - items not carried at fair value (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Fair value measurements - level 3 roll (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Fair value measurements (Note) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Fair value measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Goodwill and Other Intangible Assets - Intangible categories (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2411401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Indebtedness (Debt arrangements) (details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Indebtedness (note) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Indebtedness (Tables) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Inventories (Notes) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Investments (Notes) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Subsequent events (Details) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Subsequent events (Notes) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Subsequent events (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation Summary of Significant Accounting Policies and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies and Change in Accounting Principles (Policies) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 prgo-20150926_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 prgo-20150926_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 prgo-20150926_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Texas Medicaid [Member] Texas Medicaid [Member] Texas Medicaid [Member] Loss Contingencies [Line Items] Loss Contingency Accrual Loss Contingency Accrual Loss Contingency, Receivable Loss Contingency, Receivable Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Other Nonoperating Income (Expense) [Member] Other Nonoperating Income (Expense) [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swap [Member] Interest Rate Swap [Member] Derivative [Line Items] Derivative [Line Items] Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Foreign Exchange Forward [Member] Foreign Exchange Forward [Member] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument [Member] Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument [Member] Derivative, Notional Amount Derivative, Notional Amount Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Maximum Remaining Maturity of Foreign Currency Derivatives Maximum Remaining Maturity of Foreign Currency Derivatives Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Subsequent Events [Abstract] Investments [Abstract] Unrealized Gain (Loss) on Investments [Table Text Block] Unrealized Gain (Loss) on Investments [Table Text Block] Indebtness [Abstract] Indebtness [Abstract] Schedule of Debt [Table Text Block] Schedule of Debt [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] CHC [Member] Consumer Healthcare [Member] Consumer Healthcare [Member] BCH [Member] Branded CHC [Member] Branded CHC [Member] Rx [Member] Rx Pharmaceuticals [Member] Rx Pharmaceuticals [Member] Specialty Sciences [Member] Specialty Sciences [Member] Specialty Sciences [Member] Other [Member] Other [Member] Other [Member] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Beginning balance Goodwill Business Acquisitions Goodwill, Acquired During Period Purchase Accounting Adjustments Goodwill, Purchase Accounting Adjustments Currency translation adjustment Goodwill, Translation Adjustments Ending balance Income Tax Disclosure [Abstract] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Effective tax rate on income from continuing operations Effective Income Tax Rate Reconciliation, Percent Unrecognized Tax Benefits, Including Income Tax Penalties And Interest Accrued Unrecognized Tax Benefits, Including Income Tax Penalties And Interest Accrued Unrecognized Tax Benefits, including Income Tax Penalties and Interest Accrued Unrecognized tax benefits liability, interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Income Tax Examination, Penalties and Interest Expense Income Tax Examination, Penalties and Interest Expense Incremental tax obligation Incremental tax obligation Incremental tax obligation Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Other Current Assets [Member] Other Current Assets [Member] Accrued Liabilities [Member] Other Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative Asset, Fair Value, Net Derivative Asset, Fair Value, Amount Not Offset Against Collateral Derivative Liability, Fair Value, Amount Not Offset Against Collateral Derivative Liability, Fair Value, Amount Not Offset Against Collateral Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Other Noncurrent Assets [Member] Other Noncurrent Assets [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Cost Method Investments Cost Method Investments Equity Method Investments Equity Method Investments Unrealized loss on equity method investments Gain (Loss) on Investments Loss from Equity Method Investments Income (Loss) from Equity Method Investments Unrealized Gain (Loss) on Investments [Abstract] Unrealized Gain (Loss) on Investments [Abstract] Equity securities, at cost less impairments Available-for-sale Equity Securities, Amortized Cost Basis Gross unrealized gains Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax Gross unrealized losses Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax Estimated fair value of equity securities Available-for-sale Securities, Equity Securities Schedule of Goodwill [Table Text Block] Schedule of Goodwill [Table Text Block] Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block] Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block] Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block] Collaboration arrangements [Abstract] Collaboration arrangements [Abstract] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Accumulated Translation Adjustment [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Accumulated Net Unrealized Investment Gain (Loss) [Member] Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Accumulated Defined Benefit Plans Adjustment [Member] Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Balance at June 27, 2015 Accumulated Other Comprehensive Income (Loss), Net of Tax OCI before reclassifications (net of tax) Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified from AOCI (net of tax) Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Balance as of September 26, 2015 Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivatives, Policy [Policy Text Block] Derivatives, Policy [Policy Text Block] Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Comprehensive Income (Loss) Note [Text Block] Comprehensive Income (Loss) Note [Text Block] Fair Value Disclosures [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Senior Notes Senior Notes Debt Instrument, Fair Value Disclosure Debt Instrument, Fair Value Disclosure Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Interest Expense [Member] Interest Expense [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Statement of Comprehensive Income [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] Net income Net Income (Loss) Attributable to Parent Other Comprehensive Income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Change in fair value of derivative financial instruments, net of tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent Change in fair value of investment securities, net of tax Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Commitments and Contingencies [Text Block] Commitments and Contingencies Disclosure [Text Block] Net sales [Member] Sales Revenue, Goods, Net [Member] Cost of Sales [Member] Cost of Sales [Member] Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Earnings Per Share [Text Block] Earnings Per Share [Text Block] Subsequent Events [Text Block] Subsequent Events [Text Block] Aggregate Indebtedness [Abstract] Indebtedness [Text Block] Debt Disclosure [Text Block] Liability Class [Axis] Liability Class [Axis] liability class [Domain] Fair Value by Liability Class [Domain] Inventory Disclosure [Abstract] Finished goods Inventory, Finished Goods, Gross Work in process Inventory, Work in Process, Gross Raw materials Inventory, Raw Materials, Gross Total Inventories Inventory, Net Statement of Financial Position [Abstract] Perrigo Co PLC [Member] Perrigo Co PLC [Member] Perrigo Co PLC [Member] Assets Assets [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Investment securities Available-for-sale Securities, Current Accounts receivable, net, current Accounts Receivable, Net, Current Inventories Current deferred income taxes Deferred Tax Assets, Net of Valuation Allowance, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Goodwill and other indefinite-lived intangible assets Goodwill And Indefinite Lived Intangibles Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements. Other intangible assets, net Finite-Lived Intangible Assets, Net Non-current deferred income taxes Deferred Tax Assets, Net, Noncurrent Other non-current assets Other Assets, Noncurrent Total non-current assets Assets, Noncurrent Total Assets Assets Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Accounts payable Accounts Payable, Current Short-term debt Short-term Debt Payroll and related taxes Employee-related Liabilities, Current Accrued customer programs Accrued Customer Programs Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable. Accrued liabilities Accrued Liabilities, Current Accrued income taxes Accrued Income Taxes, Current Current deferred income taxes Deferred Tax Liabilities, Net, Current Current portion of long-term debt Long-term Debt, Current Maturities Total current liabilities Liabilities, Current Long-term debt, less current portion Long-term Debt, Excluding Current Maturities Non-current deferred income taxes Deferred Tax Liabilities, Net, Noncurrent Other non-current liabilities Other Liabilities, Noncurrent Total non-current liabilities Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies disclosure [Abstract] EX-101.PRE 12 prgo-20150926_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 a2016q110q_chart-34020.jpg begin 644 a2016q110q_chart-34020.jpg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end GRAPHIC 14 a2016q110q_chart-34032.jpg begin 644 a2016q110q_chart-34032.jpg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§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a2016q110q_chart-34259.jpg begin 644 a2016q110q_chart-34259.jpg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a2016q110q_chart-34294.jpg begin 644 a2016q110q_chart-34294.jpg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a2016q110q_chart-34295.jpg begin 644 a2016q110q_chart-34295.jpg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×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a2016q110q_chart-34301.jpg begin 644 a2016q110q_chart-34301.jpg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�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×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end GRAPHIC 19 a2016q110q_chart-35134.jpg begin 644 a2016q110q_chart-35134.jpg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end GRAPHIC 20 a2016q110q_chart-36091.jpg begin 644 a2016q110q_chart-36091.jpg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end GRAPHIC 21 a2016q110q_chart-36943.jpg begin 644 a2016q110q_chart-36943.jpg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end XML 22 R39.htm IDEA: XBRL DOCUMENT v3.3.0.814

Investments (Details) - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Jun. 27, 2015

Schedule of Equity Method Investments [Line Items]

Unrealized loss on equity method investments $ (4.1)

Loss from Equity Method Investments $ (3.1)

Unrealized Gain (Loss) on Investments [Abstract]

Equity securities, at cost less impairments 17.1 $ 17.1

Gross unrealized gains 10.6 5.7

Gross unrealized losses (11.2) (10.1)

Estimated fair value of equity securities 16.5 12.7

Other Noncurrent Assets [Member]

Schedule of Equity Method Investments [Line Items]

Cost Method Investments 6.9 6.8

Equity Method Investments $ 48.5 $ 48.9

X

- Definition
Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments for other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
No definition available.
+ Details

Name: us-gaap_AvailableForSaleEquitySecuritiesAmortizedCostBasis

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of equity securities categorized neither as held-to-maturity nor as trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51813488&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26610-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

+ Details

Name: us-gaap_AvailableForSaleSecuritiesEquitySecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=29638308&loc=d3e40346-111594

+ Details

Name: us-gaap_CostMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting and losses recognized for other than temporary impairments (OTTI) of the subject investments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (c)-(e)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(c),9(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563

+ Details

Name: us-gaap_GainLossOnInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 323

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.12)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 11

-Article 7

+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

ZIP 23 0001585364-15-000156-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001585364-15-000156-xbrl.zip M4$L#!!0````(`"2%8D?JI_D&[:$!`)+O'``1`!P`<')G;RTR,#$U,#DR-BYX M;6Q55`D``W38-U9TV#=6=7@+``$$)0X```0Y`0``[%W==Z)*MG^>6>O^#QF? MKXD@J&1U9Y:"=N>>=)+6[CMSGGH1J!BF%3P%Y./^];<`45!04#ZJBCH/9W6D M@-I[__9G[2H^_?-]N;AX!=`V+/-SB[OLM"Z`J5FZ8;GXEP[LWQ?/T%I>_,N"OXU7 MM=U>W[6Z5C6MIW6U+NCWGH7NX&F@/74&$L?Q0.=TM:?^]_NU,'AZUKM`ET"W M(SQ)ST_B0!`'FO3(XJ^NK M*^_2I0VTR[GU>K6^>,5WN&Z[P[6[7"N\S840T9EVW_JJ=Z,0OU$'1O(]Z$+" M*Z_N>OM[>W2O].".1\K<(4& MM=$H``UM<]_QF^(WK.#VL8,IX="7A!M=NSU5UM;GG6;6?_(FL+R0@`UV!U@+8B??X5Y)O M\IB6?)-_)>DF!X)Y*I^D*W0]'.I=T''[K^J,Y29*N_*N;H;:>-!`]EKOZ][>[F?8"ENIVL'%\<'LS&V2@ M_O;)>]FU[5^9@N<+_^77+S[P/*BV0TA>HIFTUI<]07QNV<9RM4`T7?G/"2R= M9ID.>'%8Y`I-IP/_Y?P)T/W?GPV`+SPIP)B9(38 ME&__:-UT$#'B0.SVA$]7NS<';[G:>\WZ+4C3#$N/O1AQ`CH*\@HW`:QZ;7X0 M/F![+7H',/7(>*G-][8OU#>CP]^VKPQ_67/H",_^_*'\6JO6KY%K&R:P[:'V MEVO8AH,\W_#=L']YXOGUL`1S]0M8:.K*OG.7*E2_@>43@%5R?,-,,/?\;/!; M\*..7OZ^6AB:X03SNM`--";PWFL"KU,(;-UX%%ZG4?CI*O$%ZQE=[4^I6<"X M5QT7OEDOBR^S/V8:XMJ;^D$;--)I;!8X;@-LS%Y4".P'U_'LNQ<18VMV`Q?D M!.S@.NUN9_/4]96S=44DR/$(/H2DS!`2?`CU"[4OMS[/!&P9%H.,QZY^H9!9 MJQ`AY$<-2&'DBV20OP/^PL@7R`"_$'N45I(5EN:U<[RY/BD2?!#%E=]:+L%AQJ M!I&FP`19?=(5%666I"LZOJBD"XE^79G(AH#U8-HP$".K2G5&R2-?O&4.$FD= M`22;5.FLNU57:XM%MUXU@,/#VVYNF*#(PP%WQBO0;TTTH;GQM`!#VP:./?KX MIO['@O)"1<^+1EZR:SO6$L`I6*C>&^P7@S[%SVK\<[PP!Z^WH>$!9I,<79QO MCLZ"\`^HZ@`]Z[<]-'7_CWMU":@#<69#5S:*#_*;F>#<^%7`*UA8*Z#_`-J+ M:2VL^U,[29Q\9C MT33#DF!R2I$X9,'4%=0;DU/@@V-/ES8[8QQ<5+JD+G!/)JU+.4IL3 ML94SBXV+QT]#8N2B<:VD[$AG84:U19]!SI,)HN,+/)D``_MV9VB>Q,SY<`X! M\+C+K%OIUBV5Z23;ME-S)@;?(DQD(R!;=#H1NN.\9P>Q+*(DOQRU2=E.#-J. M+ZX.7[$-:T@K)1YV#)M&2JQJ72Q%+K"&UI#<&.O:WEF`OK=,S5JN@`/HC2KQ M2XK2N=Z@K*A`L]R`U`@CHTQE?E0?>!L2$V,$8!88%P[B)L01&"$8CP"BK!K5 M:4M&K*6!SL6CRHM43;!E>%2HZ#1CM8"V$94I/%#+BE(E%Z4:DA'A5Y?")C$J MHQGIE$-Z3]\OB5R;;?EL4D/71AM^L=BTGLKG:@/ENH\BW@.XNO`^\#5[`<"Y MLS1U@_!-R=0RYS\`7"K@R=G!>E;E(`K)*?R(5#7W&%(4J(O1(BHA6U2VS_(] M5KLBK;914(-T09$V;8#'(U7#K[N;Q(6T7(:J6\%'[CV MQX=?N_XU_CFE!RBEU@.B_&O=A`R\1@RL%I1UM[WFMTG."X`!2ZBS3+ND-<\^ M5584RGAX`XT?] M-;VCTRQH@%V/065F=;1LN\AT(*V!A8ZCKKF6=G2RD%C!H_.9V MY2'_B>6-,P-WM;+/B./H!LXZRK6$DZB;ESN3?&(UF3DS!@?HYDX9D'S0.YR/ M1S3.&9KZ&$%IM6V4:7@"<80[+)THU8\DEN./Y\`Z>/;-U"+)3#%8^WEQ!AY1 M#FX<%AAJK6[2V]Z!7TFSWE8/'.J8M4*]"4U\^($>EUX^'."?]'V;2D)SR-:`W`!.S;- M`8V$>A,J'K@@'9@KOX\)E)T_='5F3M=7]\X=2)5K.Z1WP M4@HI#\^B*0@6CHK57%A=`P=74LKYN[1A&*-#'YJ]$9ZT;DDZ37J#NR5KVT8JNO>]C-#$`6%YT)*;K#(ASP76O3V!W]WXW!KVG-:QG#(O]MQ)(91JDP-JMF=6?%D0+NZ07)6V]A!LP<-!F/*XFQO'_.T?A] MA<0':`-V"77*`RS=HGB?IY7FE;57TD_:N'3`7N1),JG=M'24/]6DG(W>L%1? MPMF(0`2?W!.;.*3N-#0I#MEX/V_'@?,A6\N597JI2ARQUG)IF3/'TGZ3A].# M)$9@LDMCL_Q\]5\.&4&5R!YNO#NY_$E$6=NLU?;SC[UM4L]6OH-Q">S=JCO0 MK"SU5PP$-17.PK"^9AI!@K)2=P@>Y#*B?T(#K&)JZH!0?*626BX_=3_]NI5W$KOL3#8)LF;:[!/`K0.KRHJF00*>5 M1>)I=#;,))P&$F85&$2.0,0O.0-=_BK3B8U=^AH&BA-"B4AQF38P1$@C.F38 M/7*)Q0LUQPOE'LQTBKQ9PDBLM$]SY,QL,_?-##T%CCVGO)FA)UK:.=TZ2]<( M,]$(HL&;#G">9G/2$7^I)!L/B,?) MJ?Z%X01;G)3N;]A:"HM(UQ9#->#_J@L7C#XV__R*6.ZEY!]WGHN-GTX9CKDU M5ZYC^P,X\K"0C>K(H9/I9%-E%Q@:"$(#";:AVTPT="FQ#06C@6\F&GA*T%"P MIV"V@6A/43`:F&T@&@U13W'TC'N_3=E;*O8/MW2BI[>3)/_CA]4?()0J;\`D MCIG$J]@0^Q7H<\.<*\`VYF;"L:KKWX$^M-=#;]%,H$MFIT,RM='EB*/DE@L` M[#;.!@<)QB"CH&>\^L?/;7DS->S?\>C`@@"QE52535<4[$0U>BJ%R%Y-S'-I5YSLTB^@8I, M:GC,%)DI,A:*C&GPG%_]2-*6HC':"-O.(%$?)#"U$G@4@EFR35LIF:7==*7= M12LQB]Y)[2:A/)IGBEZLHLN6[3P\S]0%B1^R8%I]JE;OB9VI,+$J[$MQ"EZ! MZ8(OEJ7;]X#:!@ZFR_OS29=_`Y4:X^YK%H`S]28_`,>E4$:+HC/OW6SUQL)[ M,Z5F63739:*S:I)5F"U@L06LAB]@X:"^NR=]L'Z$2OL1*CZYIUG[P[#?FU7Q M"7],MVO4[=*EF^V,ICM#?3(6AF.$X2J6B1=)N,MX9M0>XXL*=9J3NI&@D?E/ M3<-`(PFW_$P#"?&!I9]32HS&,1_84`W$S`=B86JW5,5\K5E28B-']FS!#*$(IW[89% M+C1@G44N3.M8S91I(P7G MUJ]'`*$QMV3K\4XF1[R(G.L=:'`T^DC7KY1'WU0R[N[ MB+]?(_[>>O5IYD2^(Q#XF?O#FIZ+;*IL_@%ME^P=;1#($_LA;4^CCWAMSR1? M[CCH!]ZS:))Y/IJIP@&S^@19_3K1(%SN1;U);.$I0T-.LHE'0^:(D./%%+XH M0`OXPJ/G]6E+_O+137Q,F!D/K`Z`1QV@DQ!E9E;.S@DRO59#$&D=XEAXSIK6(>DCM.=4QCOT?=_'!21XGZ,HXCE-*1=V!;50@5VBCLYQCX+!'(33H57 MSX*(_53';[Z()KP#RK"0G63B[4)6%#"[@*%=J+41@5+#D)[J8V,6L%P"S=1,:5!!H:60\M&E#9QIK#]-,A M8?Q;E>MT[Q2O!Q*Z';9F-T]#6Q!^IV)@Y^;S;FACJPS5K#)@!Y1<^Q9HR!'P MW[Y6WZ%)E!8#""@G8E13IB,MP"_Q(]GTLUTLN&QGJB)]8/U)F/)A_J;_H)+0YOMWAB[03RHZS&+FV80+;'FI_N89M;#XRXLOX80GF:D!< M9J,R!8YJ+$:62>!G%U*8L49$A!L'$5"DJ=KE9K7VJ-ON=O+8H^CXXNR1,%-. MAVOPN1@M:++6UG_\&O^<9JVG".+62S!$'WUAE-^MFY#AUXCA%>E,@L"JC.NB M*E"$O=ZJ0.JN@238%VG6>Y><1*(.I.]+*`'W6+F.)(G1H01EX!MEB"QH*2[; MKC9D(1EX+%XF/%XN'WS"=]XCQK!MU_LX(FL5(*Y5H-OFN'9G0)158DD/2TF. ME9!XUHR*13/J3HWP:)EF9WP199IU35%'C()@I7Z44*TA"3"DU%P*+Q<*$3^7 MI5P8'5]4N?"$@(G2;@G2MDZ4$"B%BQVY2F=$VZ!*:UZXV!TO2DO4^%F6'<`(0A['%MYBL['M1?`LL4@>``ZTZATGM.+U=;$,D6=JH6`) M$HDM%.667TA=;<.R^$+G0M@1AQ)>FH)7:_%JF',9.5K#F:B:L4`$D`>I)`,3 M7CM(9(,<"=L/UDA'4FELQ?NV8Y$AV<6<7 MDYL'6RH+N3GR9FH/4SN<1>-YE%I)H=!.?:U**6)74"IOY;_#NI$*JW+N\9)D MKUPJ\!Y>`52@^NPPS)V#N1TVD@RWE/"2-5;`.2A&8A,3/' M=L87V"S$.ODQ5^W*._GQ5.W2=LJR'MLBW5#U/;:XP;7NO;+,]A)40&;[M`K? M*,YVG@T,F$.CW#IB?':JJ]#I%?Z"AYHH`:Z3#R;XUHU4O_/#`]VP? M'J#:9Q+T\7/I M9RJDS*9"\,'3+]Q41!XEFN3DKX^/W,0I+W)CO]RT?QD:[FR3/2G'0/64-/O@)]#IH"M]/8TC`([O8FY,;?#ZB: M-OJ7U]6D_\<-M+H)"#M`./']"^<:)0:*JD&!I6&)%OP8AK#'4`4%P',-BP*> M#1/H(V"B?SB/"\2I9H$C`P,::&C.BF!8!$U2!%UR]'.VVV)H(A=-I:]Z,G]' MG+^K`"%G>2^&$+P04HI'.C>^8<7GVHO/!,0M#"68H:2D>*0;V5%@VS(:@&(O M8&H&L$6\BY]%1;0,.BL M.Q$42&%L=PG@5^0OG1=-A02>])\%'&ET,I!D`,EL!30#\>UCAJRMJ1%=ZCJ` MD10R&40.0V23A2P6#\X+@.%%ZD"RR342"64PR0:3;V@01&HV!>AYWG$1YOP6 MW48O7`X3S&"3P0%-WQ]?5+A4->`Z*(A?T`<6WP&ED-DPB*36P)A9P<6L5--B MPGP+UB#`LH4DO^%@86L##043>M,,0^+:*W,FN#B3NE;?F97`PS44(7'7-`)Q MVRB+`G9,3DN@VBX$-^M)^P/")X77(@_W'I7T9-?6'Q&;O-MCC]>-5R2Y&'W> M/?=>R5EUK-@.S>T+#=L2>*Y__7.F),SE;['9[#PJ\I+-F6EIKSE"<_P]NT\+ MKVTI/,8CZ/6\'V#^"OWS!-8_0DMW-2=9K'[ZO%J/..'AWNG5C^/IKP3DG"?: MS6G-5(@6P3^1_8>!?.RIP(4'GYK,P[VG>ANIA\@6Z9X]FBS4^<7:1$S!=CIC\=;D<9B[WQ<##JCR<3<3(>A*#]Z>]:3,5Q=+\XTB"$8^^R9R@W^P,CD6E+\OCKB0*DC)"$I$D?M@3 MQ%YO/.!;GKOH)DWD#H<)(D3J3.8,*+$QF)0A@KHC`66S=V7APOYX>+Q3HY.)/XR?R:&WUUWK2#< MOR*O_PKNK>";8<.EY9I.?$+[9X>%=VT/4IH:]N]8"#ZQ(##FYOA=>U'-.?#Z M>R`B9!V)1Z#1%B-DCB>.MO-=#EIN4`1_`ZR0R,@0.V6;,@H?`AJ/LD?A4&9#X\TB9C;*>5)_=K\YL M=K+`*CM-)C(0)J^MA`?K5(YLLL3S%8T7&2@;MZ_"<31I[[9-+RZGE[/A;'HS MFP_RYR![Z/>)L.WIY'PS*&\06^($@8D&=9%`II*$84M5AV+01:,[KP-DLRKW M,V1:4:!_U*;=WEKB3A>@#WLZ:*.N7K:^86:B91*6>! M3"$D`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`V0';8HKRLKSO\YOO[TTWPV&B;C#]/Y=?E\-9E^772JW4X`FM][2![/ MSR;3UO:Q'PHZP0VC;7*)"^980Y+M5DUB#@*.OC_QH$=\\0CRGE[YAP/#Y3?$ MK_=__:_Q,!M).O9UL:,>GR\NO^:GRZN;Y?;;D0<1^58PBEGX(-:B8U2A:(_" M#;E"H(U;_:]F2+W#D(8+>/`Q9@'])*0P*G&]Q7$=%J;'L%>(LQ%5>$X!EML&U*R913T+5Z']B3^:Z]Z#7AC4NR.42O9`MB M#85!BZ/ZTHI>H=;N4/>O[I@[X2V3L)YLM1,V5[1A9R1+:\6:+)L]=GG,20SY MXW1Z_N_Q9!(NSUNCWX5DEM?#^_&7-F'M6A+/<>LMV"\_TS74I("T8H^@7;3! M8Y1,&PJ3M=V&([WDVG<*/DNF%ZNPM4,(,H4HZ^!T0(V)A=$ADF/Q?OEK%\G) M(.H7J/#3Y=EL&,W;@^B+/W^Z?%:CT\.E^\V'*XJXU!I=U2":L)=U,18D(5%% MU[XZ#8\;LIXMV%%TV=%!$W1(`%:;AN=6*P^FD,VH4)(N3EU]\YT]ABIM*XTF MUZ,_IK]/QA\79;[GE`>>'!SZG'TC*<5+$`H!2Y&/L>381-IWT.D\=Z*OD6-5 MTO/A\^7X8GQ;0QU]&8TGKJC5;%%& M,;;&%D1G,;HHV8XUF(`"^%52MVB2TT3'L]K/ZSK41*KQE_'UEO[JC7$R18DI MR0?)*%R,GH1<^:R2*EEB9\_W]2-:M568%9GO#CPNIK/%O-%V"+)F*?6O-[\/ M[>F\EQW.JD<0W=9(@T9'2,;[5*OH57(ILGJ\NE0/=Z7,4KLU8C\H]Z]LU+&T5FU;H<_^ M91=IV"#P.FE>(/;6,RGKV>EH:TX&?50!V5%D#52=N'Q?N]-&;[+S<\1N7GWO M^DD/EW6;>P,5D*&`B)G2N>DCR*U&UT:C2,SVCO#]4WN5(]D5K M2AO=/AL^M1$%[>Y36YLVR5E\_Y<+6:0];Q!5BYHEM@9K43GC4[$Z,!N=77"Q MOR6A]!JK[R/?T74[[6,A&R-:X)0#RY821JP5>@0K_W+*UTJ^![!WO`:^OE.[ M'?ZHT\8S,4Z5(P'*7S`[:'>L6$)!R12MZ>]BO`.W!JR^7W,^XZV)C?FRUSJS M%VH6"M9VX3@7*B3LC8!-ZNY5O#/J3V.Y;8]B;DSP-(-A*S92&27=\#E7,JXE M19:T[3,/X?5OR6!;LZH43"C@,A;Q!)*4D#TGERF#SS5V,=3AFP*E=B"P\3+C MAV$V&W^F]03-\DYC&((FB M\BZ;5N,M)KJ:2W#.D+62FW4)[AN+:=_HVM^7INN[0[;8M\9_#^.,G^=GARS`; M?1S^/A\N;B;OQQ?K[[,?7+S?(D'\^M^C_YG.4FNO>_@A/T\OY]/%2+;1Q]DP MK)IZI2MF@7)6,@9"W3I"R.FJD0*J['/YC__\H/^U:LG#K?$G,.OR>\2R[;AB MN!["TK+SSK29#$"KMWF.0O8A2)X"PC]U="1&CV):9-30'TQG_&W MZ7)B8RLD/7C];].&^Q]FTS;>ZSQ^E9\J_^-?KMJD&0D*X?9L8_RTGO^,T^+H M$\5J:J[:8V3+F+0ER==`-C/UU\0TF*ZD=")=OI'!=IQ-.4VZJJS!<444WA-5 M-5GB1'%6!]559S6;+C2\BL$FDB6TJS9U.LO3F]^OQ0W[?;@F.)\21%T= MHH1#([^BX'R(GLATE=Z^4/,LH8ZBQ]8*NZ1`LFP,5?R]*(S@`%),-H&M%OIA M%5VP.D"/S^VRPO\NPNHO%T]18^]]6W,[&Z5:+,I2A."5SY*KL"=DCFNJU\IU M;KA5HB,(_Z(GS39F&IY5ZP2Q*E@"H0<9S?)PJAT0K^FA>I,*;WRN:_.E:9.1 M1'D,2?0%"?]QJ7A*_>9;D\N_)?TW/02R.<-T)H/1/KA`"DHBP>"[0]EB4]^+ M>-_=\";5W_00U\9^(JJI>"H^Z4#>X*+6?Z=^E.#3M]AUI?XWHOX]XU@_DGGS MH7RN%:T/&B7T&NT>FGJVSB3?Z`=*!>%80K:W M-`-`[LSP.A;8D3-)DD39Q92#4BBPS0VPLD2MC%5;TQ6(03+0UUN^O9X=V"]8 MF4R4#&(UX$TJF=C0/68+DO5SY[HSA;>D]]XQRV%MS0&2F$0AL0:B*FF)6CGV MP1JXRQC?DO[[QBSE5:I.)5 M5>\8,K^&%7851$Q:=:"]QCDWRW*2Q",*Y@1L;(D+@23-PI;O6SBQ M[W9L@:E;D9.IL7<>4;61[+](S-#0B$]F=P^D%7)WJBPY);S>JNR;%E3PVJJ0 MT)8<0E`.!03O=@N%OM5$.T==`\#)M-DWRE>58V&;B@K11+28-2VU<<5U1S_( M=-\N?%)M#@S:DK/DD(-QXF.BF38VWF\=0]@7>.]&E;R6.@<&80-D*WI!-\F[ M"Q2A)/=;"->,8#E,G6U55R0A0Y(0%E()36#AJT8Y;UE)AD2E.XT6;%7F!:#T M_%>B]JQ`BJM+C!";";537M11]X4XJT-W*Q2#NCMJ! MA?LLG74_I=H*!'>5Q9.ILR^VM@<^BA0C(DE^_AC8'8JL3_\K>&';.9JLDY:A\ M3XA\Z".?Q8X3G5*=`[%5%)"U@4H<;`261:"'HISE=8.E=ZISV%6,I&PA;:JV M[7F7UBF0JW+6+`8!Q;XCO#6YKC7PVC;P[8)M/7'S)51,A6MK5):<^G88J0_. M<\FVPW[M_09'WBS8B\<,:9]U816-;Y4*],(#0M1M4%2[1X%=B+3]^>8F05X@ M[FM.SA#O1<755G$:!,E.245O)24UQ%!C7ZC5])U98-?(BRP.Z2`7U]X.(QN# MK=SN-4E\9)/[B3Z:OS<+[!I2(7Q$.QNR0J.P>A"VY5)[V"$%89.P;KKMR53? M?G_+":*I]DR41>]EM_HV!QU5).5#ZCBAH?6` MN`5V[59(Q`64412*(#9R0.#HJ3K9%=!;X$#56Y_2(0D)$,0JC@E:(@M+!&F% M-5F<6JHJH2?3XJ*&UB/J@PA[RK<-1"`KH<'!9;$B&N-\M`Z,:^U,.G+IVM_` M2?*RWHAPKG2]_KC;#J?/_0LMT[E.%Q,9\/>=^IL MFT,70TU!:=1BZ4AM;FQEPZI0Z>(X=B8_CM2O8XEM"YRI``O+H"(+G&SUDI97 MMD*KJO6"$VOZI-ZT*5I#X(%.X104MJV\E;A="6#!CJA,S+D*45AS[4AUQ9?C MB/TZIMAZ,9D)7$(Q@`,L1`%TCDDR?MDT/O:O5:VI>'P+4]P>A@WG:3J_CJ/Y M>,_##E4+0PPA8NY;Y$ZMX,,W'D;G54TEL)&@:%'E)$H$UM':]JB'[EGS&CJV M2Z"7BK]UCDA[Y5;R$I6]T$J=6!-Q7;Q)4I*U_22R/C\]DOA/EW&_90A6*R%` M[&UA!!*WRH*=19A?C6?[E8^0P<>QC3PX*F=GNFY(;Z:+UFM(YU M!4'^J+)$PO8NM'T'ZIV!!YWW$_ZX>N]_=V85][T5`$Q4$P44PA@4I391+Y$* M[=K"\AEL\W_L75US7#>._463(@F`)!Y)D-Q*;3;C2K+[.J6Q.HYV;\T),3\>G7\Y^]?I;^\OLB/#TOL, MF`22:DD4FL8"KJ+&A;8HNXFH3_CUY/,N;;\;2[\]LGM-X__\GV-7EZXW.,N\ M;'N()8?2BTTMML86Y&KU\6\N[O?J?WY[=);^=?1U@""W$'P?!%@RI%AK4Q1T M`SBI.7+&MA4(EJ/@2MCK^\^?O_1>YO[_?G)??QED#9A/%2X#5P-T:) MDVNDP4_2#>&Z_A=8!(`ASF>#M_,B3UO@0UB]N1XI\_=?_^?T?%%)N_C8ZV%5 M\Z:;F3\Y38G`>B0:!$JZ7:199TM3_H8VXETB?]_$:(V%3<+FB?OGYF0-?6:< M;AMOO8UD.*860U(P&B31\.G..4I,(>PB,NILWBQJB^W]Z=&:/.J>X^;N'11* MY=I8L!$&WZ"%J-Y74*-K$VIXCAVT>-8JM4L4P=.EYC15` M3%W$\;H\UZT0^ZIXL3/L\)W';\+PQQKN7.V-R7CC^N:S,Q1RS,E)B!H,#WOS,KD_ M!<2EF?MS5UE^__W'+N2[O/J]_@(G1U>-Q%="J9_>=PF#ZY;QZRE--S3[GCAM M!FFNAH$91Z`JUN_(D,)3?SD=A(NCWCA6X"^N')EQ^0SQB MTP,O;<(0V:0*ZGY+48-4C0E*:QH5)1AS^4KPIIKM]BB$/;#6'\,KC=LE M]SD4-51JPGI\^-@[\5%9;M##F-LH24^W4PN3$'LNJPPW=).,L]Y(;I>"I(!L MDRUD(F9K/=>D3U.DVN)06#KW='H^XTPY_+O:M+>NRPTC.8!BI*E/*AD585N& M"O&_A=FGR'QX]5L_K<[.OW;YPG.E[?VJY]/3IUO?^[&;]E=8L\6(P#8[:KYE M4;;KJP'!$HB&!P+M[13/EO#<%1O^97^V$5.NY]VB=99SGW]3U'39]DF=TB<# M6%^]':NH[KNZ/'133O%^50'7(*>5Y!1RC2!M4>]7(?37DZ-K%GMUCZ:?=R.@TG_[\D%?'-LK+B[.ULY6WEK$M!`KVI9" MB!U61B]08*@0=NOH2);E.E M"E9,J*[8U/UM!$X%X]B1$!*JX[+W!.$U20.GGOH`4P*8VF>P4^XR%4*<&RKC?;$P M3V`1$E..E("\%4`+RH)[T0X(4%?.&2I\7PC6,VB%,&/+AI-QHE&&-YDO:44F M8V1(8>',`&/G`-\DVVC-2ZZF2ZLS(3>VV6LDUZL"7),XL`V+,[G&;D$]GX-( MSAYK`PVA-2Z)O7>WZ3Y/P6K3TE`?K^I5)@ M&S<9MD*RH127K&4FL"!K@@0IOO@$O4,S)OVJLR`N@9F'V[^9,=-^ MFV<&<=+HJI3$*";6BL@&(ET1IXQC2<+0'_UJGBDTR]DD-1;Q)0<29]AZ#=)$ M[00-PCA=%X99::^&V18I:]55DS7R`">2`&I&7DA9@6!J_M;4B@,VTA^C4B:3 M,D]-Q#I/2L,$@)!\[5<:+5LI&+^E0+R-Q>\5VFM2KI*;JQB+<9G["$S],G?( MJU,G1:,4VW%M1*V8`3'J5XO%?T9?$E/7];8 MKU(/,X)4Z\(E7TIDZI@$B&M4WAPF^!M-<64H[(&#[QI"D;(12(ZB4W@ICB[> M^;FW3CN+^WRR8SASRUV&0T(74&XEXD)V&"V[..@EP-8"ABT:XK[VC(US&W*F MQ$PNV&3$%2^Q:SUE'VPNK>'6LF+#LO<$X37YC.-<3%+:;@MQM-QB,QUF]%9Z M;\R+A7D"?6D)+),5#6-3*E`ANAXM037)IF:'8GO8`GW9&<1G4!9TP>7B4A?H MR]F@$[JD+-&+&=.0ZW1W'0[@FZ0II4;#":T/4,DWI>:&O`]9CTBC3GS,SN`6 MV.&.0#V?F610DIB;SWI*+GL^ER4WQM:[4.V@BWBP?N5J6.V;HZ_#^-R-,Y3< M:4API?K>,A5"EHNCTS=;RQVEDEL#_!8*^XG_FOREEZ8"-K'6L*6>C$>[\!R&"&SV#CWT$0[15%_*4CEPO?JJO;+$#-9CJWCPE)WQ M(.QK\C%<%1KW82$#S=Q"WG%?S+%)3H0M@L?*K.23,AJ6P`)](DW5@!;'+@4< MQ@*]5$O,ITPEF9:K/A&D3HH#IGZOIO_%*@@TCO<:9G@>JFE^./WX[I?5V8>R M^N?Y/4_(\>KD'S_H_G]?]4>=?_VVWLFZC]'U-_1?X/SR%_CEZZ?5'^]._CO+ M/Z\^GIR>_7AZ_J"ZC)X_)>86V/E$A1PDS\XZB(F"Q-'"9F:3T+>!WBW[/MIT M%S_M[<6.>'OYEW_4__YI'>/B=_33ZOSHY'T^_7C\4"Z"S?N?E?TZ3ME6:JAA2;;HU$'K0RQ_&HRY&)I> M#?VLAO[[[ZNS>PJE`ZW-^*UH?FPV#?R:[W0#S`,VZ M(=H4T`1B43;,Y&MQ#:JP)JK.4<%4D)30I$U38C.3B.7/LH:=:`Q6<9QQ9O.\OYHLRX+EWQ[-%E\,QL MG4.LGDFM5JL8(IM&JQWBF5=6OZ[T!Q__GF>'W6;MPK]/1.=]P7]-?U1Y"X7$J0U/8K11Z.'P.*/)%DI M;EO5>?ME@AD]>]0E3TV.01@-12N]^CU!#):5P0.RHV2LZTF6XL+.=\QJSQ, M%:S<'T/,YTP^@35]?FY,5:Q&RC7EA3/I*S'C6"]$,]-:SV:9^Z;,;)PC=0G& M',`W4Z&Z;-HR$B8UCQ0QFSO&MM\[NW+#Z]X;;->9O92__M?1_YZ>R?LC_;2; M0O_RY?/YZ8?5V3+@2S__\V\G#Y<6^V`=$U!"LC8;%VVW68VYD@DXD"IT,R_` M7YS)?CAYN_JH/^5=>G>V6L;'/5B#(5C`D/'54R2R,?D>B-@^(;W<<>"\6FHS MENJ.^O3#IS[B8%U3215N)G,"U*_`B=(U-94IXM$`#]VAKZ;:C*E^.3LZ7FD@ M\W^?]7==_O+CT8?5@Y.9&E&@XIPZQ"20N*6P>,*DQKI+#/1J\.*+M]JZC>FF M5^H'7QO'Z%'FM)P^/@[,SFB;W%=^L4(2=7:K!0?&NUA)K0=;O5 M$#*#C4/V@V=F6U^FV?XZ30"F%G(I8*G8%BTTMPC\@[>A1-G6?>7+--=CN$(V MF6)H.=7><\EZC$3#N8ZBWZ\L?--&>QQKP*Z4U9!]C1`Y4;.M+<[16PS9 MCX*]4Q4I=L%R$VZ<`UOOH[!).12#7I`N&I&#DK8*0_(KND,_@AX/\J.>D>53 MWIR='G]Y>]Y.SSY\N60/#]5-E.9,02ZT3`*,[!PN=G-4O3Z3%8KJ]]7[T\_K8Y_6;W][>/I^]-W7W\Z M>??;@UR"&9SRB!H0E?Y5\8WK8KG^=Z!MZ3:\8,L]CDL`1:%<&(LE:8(:=UVH MRS.K9P%KR*L_B^E:\$WYW^LS,3Z$.320Q1M_[@/O`#-&'[ZI(&:0,1O.' M'1,]E^D>RQ^2X6H2FKF&>RQ]X&B)"ID58`M'W;VXDD]8%L@ M#B92035.":92"3X#1FJA9HK%"F]KDL8+,M13&`-GQ]!%!241<>LGCRG6MD`4 M;RE+7"9?>:J6\@LTVV/90FT9K7$Q22S4(J8`C4)1TX56DXPB^N[`V=ZV#?1,'`_CV:R8-6PO-"^:HG!#!8%V4)D%](([BW``SI29?[?BX M"@GGG:NAL>$"&BE5[RDL5HQ0B>]P@%-%CUZM^,C"B?YL>2]ZC(D$2,VY)MVK M:GR6&H\MPJ\N=;81'\='3*N<],33*+N86JW1$W)Y')T-+HS=?63WWZG^KN\_ M/?LZ>JNYY09U0Z\,-JXTMM:J1)/>V:[E(@GJ6&'A(7MNYE7#/ MB>^,-&BJT8(A-'T:1`A7^;1H\E#E'F:.8GYF>#3];%2#24&WW7Y*@=OA-V%4I\H+V8>('4.9F:3=+V[BN6:E`$=>A.2 MSX8=%)^AZ/940,G$`$B#5W!AYAY]#CQG2%>!;DKE!QKK=IF>9K*5A2F(\3F, MA8D1#@O4&=3`E-"U(3ERXU(*U'95[!F]E3A.?( M*X1%@IY1N>>D]-0:>^0YPLP;FFW#N84L?(*<6Q`JU'2/8DX]R,V^*\!K_#`V M;)+9V_UZK2UU\>9M>5EQ+=E`I,Y5;"S1T](3"^HC3`3:5OWP[>4_)\XS'&]< MYJ=Q2!%L<*YYV\61+V*R9L,@;S9U&^\2UAO5]Y,"T0C$")&<%/;..VN\R>JA MH[^C3.JP4'Z&ZYPF(3!(*L;'C(%+-DL&J$81==7;:E^\$X-G1WR&(_$E.VM] M\5B87(GE0K=O<22NU'$2T5:V^$ZAOE&7`@C-LR!71]4VSER+<0XL@PV5P MG"JYMP.`/S!M9HJ3P2REH;?5F9K_G[UK;6[SQM6_*!W>0!(?"8(\FYVV29/N MF3F?SFAB)?&L8V=D.VW^_0)R;$MZ=;,LRW*WF22^O9)QQP.2``MG0_ZF$H1L M">CP&&6%/(Y*$T^"8FQQM0E^";:+7Y#S]QO2(=A#[3F],$7LM;SHECJYD]([!8TNM M>[8!$G@`(V7:X!)F#W]K^0"W#CY$AQ5S[[YVLAFQ3D_U>72FM.)RSL.9+.*J M?TT=OIU3KZ/*S_%`_Z`/?1F?:5E"N MZF@R^7YZ_NE_1V?7XSG)=15=^"VL+N&2#@NV5-$"A)JP8D.3(#B$#G:PVYD0 M%VNXK:C:!Q\2`%>#;Y-S`MUKZ$[WQ'-Q5,`V[QU)83HL17%PW/:`?*S61Q8; M=#$B)+%+YY&2*[8"Y^1;0C-8U$\9%G>?#\9'7*>/7DUTC:!;!CUC;F.+!FWO MDM]M&-@5F/A4^G@[GIQ>G+P^_S`9CR['/+[Y.,\.WYC7;[_SZCR9C,!+=1/V MT%I'T5`O\L(83:C#"\IQ,`+P(>3MD:^XGB\6Q3`3(Z8$SG+NG`)%*:&HAIP' MGO/*I<%`B-TYN_CRY?1JVAVEKQ?21;%2.BPN7FWTFZIWMSK?FQ6Z)9-:+&)F M$*MUV<;AR;E9XE?3L#NMZWPCZDB[%H)'9(E5%0W>T9K+<)5R1UHOSM]?77SX M-Y]^.Y5D=*+JF.)'4<29PLAM/,#/&HKU/:$7(J%U0H>YPBW9@7V9)_OVMPGY M4AG`/`N;2-L#+T.KG^4%V8B]%S*1FHE!;,:T&UZLSO@,:WAQ>^+E[6CR9O+^ M2L#\R322W;YNH]W/\J&W?K.F[&CU'G?(W*/O79(@$<#<"JS6XF_;N_^_U%]R MJ:P88Y>RLHJRQW.RX!6SG%`+S;)@#XX&>G;%D'.2\$JH.4G$/0@GTQ]>ENNK MSQ<317&;8U"!MISQ]]M"EE;T(1>)># ME?3E0\=J=3(B.[N,Z!`7FV97D+(;N>N"OBL]$'LQ<'%50WKK==<[)-!EE\#7 MY>0N[L'N1.Z;ZZO+J]'YB:2*AXFX"PSPL;:4*G2,0#ZEVXA?G,\[BGB&GD<0 MOD[8$/6>DQX1)9AXR;!$[@X-^-9V%/86A.\`^1N+,^5D&C-#C27G&`KG'/2R M:-/*H'2)SBZ>^U^DX('DK9,EEBAJ9Q^::1!ZI&Y=,)6KC[U:,SBC!M_%K;9L?_SJ^>O/Q]]&?#P;IN?O<0A1`:P@35^.HWBJ^,PW` MK!^L_Z^A9G>J-T#PYH).S/4Z[KC9A,%:NO,S*K_MJ;Z\^F4L07G: M['5Y@R27FNO]4LOH;'3^8?S^\WA\]?/%A]'=6LOM`V^N/H\GBPJ^BHXYL/9M`BJ*'RQ[#2UJ"2.[L"JJ>5I6L^2DPGKJD3JP10%KM@NF M*3IYCX=W"<:A;V_#ZIN/_W-Q<:)5P?OQY-OIA_'E^XNSK3#^?#68G`X#3#IT M+AL=8Y#K+3"6>G=@BM'A8DOB:FIV)GJ#_Z1JN3;?#4@]51P$L'?A7K+K($0E MA&5"WH)HW0IX?7YY-;E6+<@O'YE:3VF8'Q?[DS;_. M+\=B7..3^XV4RY/K\:\7WZ9&EE46FQJ<,F-R(@7H`#K981Q#`H$78PV<8"?2@19JW[N**AQL/(?GEH6\)N;V=G8O)$^_\:S7B-R;=>3"QZ? M7WS1'0F=@#CY\O.%0-9K78^8"D9D9'%3SF*I2X(@?+(I"HKVF(T7?-*JZ5G" MR>(.^Y/'D.>0T>CD9+JQ-#H[F8S^X(LOH]/SU:52*&@EU<2"Q@M^J[;(;X)` MM;IJYT#\5&+^L!([@,W4%).\&2=#DH$5\'`4"8C9-%^IAT4)R`\7*\5CE\"# M+");783K)363BGR(IJI%`%(AJMD/+"+FQ9V<9Y.'AN`S%<#IG0"LYES8B'5+ M]0$%BF449!\88&H`+45.T:UL1WT^GF]_]&[\[>+LFQ3V5;++J;ZE;M!N:FW$ MZ:29:@H52WYZ@W$2?B6Q-+UG>34K&U0R;O>PW<'%1A%AFY MLW`_*"F.AMGP$]YH]D<$$TBTB=D"WEOGV#3.WB=O4@C";,G0!#?Z@=ON"Q*= M3G98+B,?I6P.I5KM>O.ND6TV8$K)IL[#Q1(T@TZ6%73L3.O]D,';Q^C[W:?_ M.!U/1I,/G[__K&.IYX+.W3.OS[]>7UU.']CDA40^.P&L.E6L2447+%?I>^5]["D#O2V&&'II>O]')@PD95%V58(BU)6LL%N;[IO60 MNDJQ=L'0`J%+$L9;;M#(=ZRBOFKR,!UF.SB5L@/_XV4Q9*-?)6\+YZ`93<)> MZ.2:+D1CCXFB30._"F8#J>,M0L!J4M>9E6>DJW@*5?)^:8MF29I!*B# M#70_N,CYX:2^%OHFX\NK=P(0;W84WXXG'^0'HT\;@L+*2+W[@L_K7_OLBD^C MW&H,6$,!MHS%689<0TRMY##;>##1-$7]6Q^/C$=".$6BN1M3%^%2["RV"Y*M< MD(J4QC4"U!3*BOCS$J2S71$YM^\GU3$$D#(*&V!MXCY)@*&G*(6'SV:I,+1] MYR4(8YLB<\YO0DLD:#AB1Z"@)Q@QN!I)H!6'')<+`U^",!Z1F^;,I4>*/;&@ M/``NB$'*'1.;)//&J?3EF6D-TCLF"6U3IL\/Y@W.1.`8H$`*EJ(6YSU:#]U; M7"&,%V$NC\C4"TT=SA;TQCL'MMFL?354VP=CEB0B.*=2NW0N$E3[UR^B[ M\_)6:;@F/7_4.R2#`HAM9_`UBF!:ML&"(#[GYVZ2F[&@8XJ^:_<'S4`^YPOR MP?7RT?N,(D>7$A*0(_D+7<)S$N\"[BOLYYC"S88&S?ET_<_KL^\6-0JO%PLF ML0V!N;KJ!K&U7).Q38K+CK$56AYX8.[0]U&+Q<$*M[K;^W";?4M*`AT7V<6& M*F1J%)*X6\^1@TZ,X4_]=0!LZWD4G'LB[=.B\]2?*]Z^-Z57`-B]LM- M[CF3^W//:YCM$#%0?.H=0O62Y2BWG(H@!SUU:0Q#6@4!PC.GMR>4GMO:9[LO ME00I%2<.FZAHQR5**I0\6%WQ*V#ELT.#IY)=_,GB.KL+Y;[\RQX95UK]9`Y-G?^!C*'H?M[D_3VB9NKGP%L#Y2:[%9T-OC8]:E MF!F>W&-Y^D7'X)Y>?=?GEK`4'FR5L[5,P,($J/<_<+'>A\QB4!"XEW;:'C"$4(8.T`L"XY03&V4VW(4,,AS'^F"6?_^W,S M_57:EP/5YQ`E2A?D6C,YZV(./@/_"'-6.,U'P>F#-MKNLU*3^"T)*5("D#BF M<[I;P-:;R3$!3MG,1\3F@_=%[MZ+4Q80%?3=!D,!2,9>0Y8L?OBNL MVI6@XJ"L/GA-?Z;MV+A8JJ4""$[*,\@U$8%)SM46IVX:GH'5=0U+#S]&?Q^5 ML]5Q/P2D\UHE+PM@K-R=V#+('_J1EM;"Q;VP&P_"KDU5IY\(@X4$B@B4%*-N MSID&W8@]'Y+=_WO2(,S8Z1F#Q:$M^5TMR#L3$W= M2!`*DFMZCCE''ZI>!F@DJ\9ZL""\+9M;%3S5@'2C0ZKM.U M7.T4!H1C4N#N,,")@4KFMUWT",(4(0I^-:$$5RU&=S`8L,#JOO;H9P$`-"M% MN$>!["YCCL`-*7<#V;=\6Y;`J]7'4@_,Z(,VV^_/;0M_D9.47RC0IC,:7R@B MHRW>.#*W!?A1,;IYUWR&/V+7>K8]Z_B$FEUT4F=+A>FAZ=6!/^KK]&KU"N7A M^7O@]O=,-5T*95-BMQ8$WN0DL+46B;*&I/",/\Q60]'*)<$MN?W7^>C+Q>1* M!TGQZ>4'/:K_=C+^6Y1,BJ?>CY#R@P1#A5WEP$]AC>+HU M+QV<\5E>II_?#,4=G^S4B1(+QN!2,-BEU)7J2.>&:GL*E1;3H&L(O+7+^-E, MUUY863OJL39O0TE@#8(A+T$`B`2-!':]Q$&G"O@TF%6_$RL?QY.)WNBNDX!^ M'_W9_OPZ%B>G\?GXX^G5JDIW];B>VKV/$M@\&#VNBS4QIMX1FW')#0U,WG+` MQ5J2'D?^AODP9*6V=*%1*PXP@SAZBD%"0+=<12$#\FU8O(IP%_+EJ9L)03/S MGL5_[N<'/7`T,'E#4$4)DCQ]$^>HCFR-L7/.S@XBE\=A/_F6A.V+G76N$5@2 MACBXQ5`%R;H2O,GHBV_B^@R#F20N+\:<48J>\&IKI3` M44H.^:/7CPRZ^R2-#@<>K*1E=YK7"3U1S5&R'G4=/F@80VDY.1T?JI-SS2+- M<4GGW(-)GE'+3H*&["@PZ>401M<4,">34^S%Y^G-M\/I-6L,?TC,8\A>._$Q M!>K&ELX"L9PFL^1T#JB0[WC)5#<[/:>S5[IW#34H-I*;2V@<`,98!-B9:DS* MOJ9DA_>HZ:[P5K1O=LHMR5\G^19JKA2"(`B6A`52,5I)8=V:W#SFP70Y'4/W M2/*_3H24Z<`X^?QL/-W&.M?4K"AJ^OT')UT=8!4]V)@#06H))=1+#N;0=39/ M&E[,X>+0[C?3M0=&-HTWC-[&Z:SKR."9D*Q\=*DG8ZOH9*B.P7S#'1B9G'Z3 M;W\;W[5,O_EX_\UIZ+H!3E+MO/GX4;_\)/7-Y56].#N3:F0R.MO'7,0ZG!0X MLV9R2\X]\GYW>OGO^;[SB\GX]--Y^_/#Y]'YI[%\^<=H'2F!%O?P\Z=>]<3'A"+I.F<2[6EM*X;4.#B8#JI'^:X MQVOB;]6N4JT$I),[[6Z::1(@)4FD&-B"#ZGH@0BP/9A2*FAZ>$C:H\B-#U&M5X*W8*F%M,(!/^48G3;V+9DO`EAX"E+*JN_57L< M6:=+O=!B30V8(:`EDW4IAGN"0E)\#E0Y+(+^"U6Y1P5@:E*UM3YM0XM%X'>- M4A6AR3'W,$1P?P4%/&%H:J54XU$J2B0(L>J!.D?8B2AQBH,EE&YFE+L958.[:5E:SI MSK]?0([E1-1I^53259U3CDD0QP<2^/`2XXXOU$)B.*P2@V4EPQB4TB8&323] M5=WA]M=C]W,6/P_X?IQ?R!B+\F&O+*1CD8-MNKL[-/T5RHL]T`>T MDR1%Q!Q*0A#2_>)RM9YLY23&E*I4=S=U3'9RGPEA"2DTIUN.'N0VI25=,'!J MF)$,=$\(+UT[]\=(S\#='&(GRK+3<149>P&GI#GJ[(*1ZBWM2+?NZG-?[/7S M@!_[#JU2,RVJVA*?56J,H*V27I)`4$#UE)[]3?:+/="'!-5*%0/"T8@`%G0B M(JV4`&SM_(4_]GH\ MG;ZYO/VSKMII99/)T[F"Q=]=EW[,NX;E^Z]T:3?]Q5^K0[9J?2)3$31YTMY+ MW:>^F5MD"G:9^:L5[,!;1/NC'L3-I"X9JSZXFKLB^:+=SD7F6&1=@_@AJX)F M(U*+2;>M=@5HKW1?FO*XYW*?F%0;9R@WK>1J/2@T8:&4H:7N[?_5AFOU!]J\ M?Z%*N9]WR$`IQ9*<3DE[`X7\8BJ@PMK%Q/6/13^/X1Y]@W"66G+>F4+@O'(% M%Z?BT?YQS^4>?0.6DB@YS-4$6YQ/VBU\@VJQ4\E7\;X#\^&VN90A44ZF&>>%#](Y,G9QEM[&[@IG/52\W[/YJ0`' M*V+KM]M=Z\?RK%,U**N3]X-_S/\'(VG,\X MY=UN&R-J`#%D2\I!T$*B6]O"U3OJW,/ZF\D?5A.^(YOZ:_#Y:75@/_"9$"HK M0$N9*K8(K?EZ<_Q)QZY6[-5ZE'.,Y_^`5V&F5)MJ#"HGQ;).!G'A@ZW5_:5` M/]WIJ"3_5%G&TR$S1M8*BTR(*/(LU#@)]S<:``1=HT_?J_13`9ZA`AR$S`AB MDUX=%[,1HJ-HXV+$>0/==^"MOPWXJ13/2"GN@,PR)&\H"K>VDJ%RBH/$(D!@ M6G%K_%,5C@F:->^4AV!,+EII&8@%V`UA!O)8_Z.?/L92W[\Z5(:^W^[O"Y"'5]\G@S/6._F7W`,J?&&8K!< M%!E==2.O*-5P:SDHG$[+YP?[0JN[R/:%'-Z#N\SU+U+*$N:2"87PQRJGS>*F M$K7NBP/VS8A>YJD]H,2I0%9R`92B50I43=8MW@`9=?1\#^L?IE^TR)\QS%S_ M2!-]DP%&CE1U03GCR-X<7J;:7^+^/+MGX.1:*AC!M^PX2NG08M1XF^#EKF?] MZ,_K`64MHP-*3H&3*&`89QOJ!8XSJ_A@'MU"ZF!RR3N:OAU.WI\-)L,\F(Y. M=F$0,-_>(U4*,N4$+>H(4KCH%RKEJEKJC[SY5C)"(7Q#V+5R*7=9;,\2\.UB MFRK.&Q3"M`2M.(;3!4#F8WJER,.&Q89#%EM&YS-6HGUERTF`-@ETR9YS,8\Q MW*B03MZJ34*MD;75@C#=>6:AWE._*!<]U M^\W'FP`HOO3-)0VF9WAY*C_5_YNQ]9R+S>Q-B@%D?<:6,1F$4AM;<26%KJ0V M'WC>7W[HY>N/?=9WCQO;0I+10FA5.!62,T!5IT@1;&0SD&)C[)J97^F.8NO` MC2V@5+#*N^/V# M\F)^"V/[Y3WMLK1[VU%_4-_NR&:V;J&71RRD.7+(-+NOAM_L=W9TNR,7#]_1 MQ>?S\9?A\-UP?B-P**<2D=!WZ`P1$:+.O"LEI)W6UU*A[YW7UBZ_\&U=T:'K MWT3Q0QS1V.N6;!JOGS)FXU`0;\K6&=-3_`B)Y4'K9]NY^O+[\.ILS'']/XP1 M+WH[OUM+W2VIT+>MP.N?9FMV%F/"$``04G3DA9F/`[VD:5V!INLJT-;LY6[[ MW;_E8\_]N@SL!*MU*AL`RKGFIB(G,@9;:;W+=W$9KNVTW[_E268VFI[)WTG1 M^X>K%8R/7\>7G/+?3H:?!U]NM[[S+**UEXO&5BWSZ1+Q,7J?`VF&1"XE75+H MKO7!=O0@Z_?P)%N]??J[2>7U[&(P61;+^F\]S5]^'_SO>$)R(7S[K[R=C$]G M)U=M/)G?"TN,6/HGWTG<_\[B?A_\/;J8773LVD(J!H1-*=2`-F5?5;7&.`[+ M)COS7__]5IM_W8IS%SG]6(+E;[)*L"VFB&ROQI@,#'V0\WFC.:JZ3+8&8L'& M)Y#K`1.7]A9GG@PN3Z>=9(I7)3)XTB#C2W.+C(N*E6E<,:5ZK7+I>$5SZPVG M5PS\)G/<(:IV-OK<"TN51,Y$3G.BC/F!#$18Q4Y-02M38=X:??S"*NP+SL>? M9;[,R=GE^'S\ZSCB]E=\>74E/$T,FW8H&Q$ZK#S]/=A/;+]8+_`V]E6E`G%*X:SW+#IM M$[UZ$0>+RX_X:?)<%[&M`+84:K\X\G MM@T^S?H2L,F$C((J5@>EB&ER'FNQJRE]TRH:R8R!X_X_' MRR>J;B8U9[*0#(7F4617/!4'+A?\,66W0=E*,*8(AW]%8TDEUV3@4?$!-&=E MV3Q=`+V;P-Z?#";XU^#+HVE/`MPI M--@L\\0R0"J!TP//_X4A;BVV"U1BDCNE8L>[EHP5F'HG2* MB!.N6!_0:J??%.RNGY>P[6'.V@G>T?YA1T$Z/V M7^-#;/'N]X=E-+V:C#[,Y@IT>7H-/U>8RKIZT9S1.6R:X12PTF*DJ)TCC"&Q M(G35BZ`ZCM87+,&=G/3:UA+'*N=SS3D`-9V-]V@9;)&)L;1^Y(CSRZ^J1R"Y M+5=C&^8K&,YUV!XYOY:VO>A#;!FCK_)^U4])L]$NO^`=@?0VQ;9U%:NHJV&U MTQ+66JS2V*(2%F.4C=BS[G)2>7QRZX/:NDHA752609N!L6BU/K7JLQ>GES*I MW$>(CC7L&4AK4VV'-@A9"KJ"5^"-RSZS6;5"S5L9`K!"'6"9?N!Y;/')0F!B MJ;42LW4>(;$5-;8P[[17`0RUOI@@=M2R+UB"AX1`W5*EA+8I5:"5AE%STMR: M1A-*C+UUQ6=J7D\2`I5R6;>8BD,1BXX-PNXJ[9=;PAY.6K],QM/598'KJYT*AS53&"J:"L+YP>"'9`8!Z>*K[CCE M$OOQ/=SU?$6'+__)@AEC&^EBXOR=835:0K:.(HV`,66&!%TP\\JD/0#B4XKG MD$C5$@N%TS(C5T*03&S-!03KJJUL##U,"NZEB>6N82@@&8J<1MA@0<>(206Y MP'46R+/`^DL4`WOXT^<@FCO$F!:,WG M()/=XX=2L4"-+4JQ,)GHG&JZH3(:0ND=KG5JF>GN@46Q<:B\X8P/F[`2.P"Y M)I8;8:=R]!(P.HB:!%(\^O*?+%PT\@PJR7-V'-@;MFAB]*$%PZC4K2`IE0:5 M/6ZQGE(\AX2+JC1FH[5M6K/6L+9D26N\SYA;A=XGQAA?F%CN&BYJ8X6I!G)%U1I7P$EV5?_L>;6 M\T]W;!G/7"8[APLCCTG*D8I@),=(+7B/-8`O2972WZ8H\U#^MNN8:JI MEJAR=8+HNC;M:)+:0P6[I5_S-MPTJTC#9#L?_R7-Y0NRZC_'>?@M3T^934:7 MG_[@+6GS.^_M;,]07ABT,U9%]CH$C6PVD#B5;;$:Y,RVZVWJ!@W,>R[O_O=VZW1N/I:_ M+'[YZV@X&4Q.SKZ\EF#T/3'(S6=^N_P\NYK./Z"WN9XHE_N"54T"*C9+^28G MOR`%ZY@[&SA:09EMEP0%DVG20,U^.7$B+#EQSFQ'F9,>W7%S';E>V2WB`B4E M8(QU./^36?"Q)72<6`BEOU\Q*>CY"&J3.S41H#!L`=TL9$V<]UCP8(VW'*Q[ M[ESH[D.>?&^/Z5P*E1QL0"J!85Y&U$5+,X*P/[D2.W$=K:"V.9>B+$,HE2V# M82!M4O2&O$PFC]:D^J/IU3;GDCDXZ41L>&0@L&>6N8<"W'P1TH.=Q;?$4934_.Q]/99$_@DDPH)E,P5;7YG1$PL(Z*J+3F;>V+%$R7(NZW MO'O?VF.Z%H:P!)1<:T)20("6DTEJG#GQ#]@Z8'ND8MKF6)`SZ1BBJD$52)9] M<"&32E.&P/CV@RG5-K^28J92K*IL=-!JDG9#>0ORKCK)_)ZK4FV"+"ER+AY# M+B0U8\%%WRKEZ#RG1)MP%`-JFUUHA.&J=VN94"@3(#?FGUE@X M+ALI%_>!V/Z:HNXUY9[$=#O^;"V[S@ZL84*)&P%#JPUL#N2H+"95(MI^&IU; MKCA=N8YNI5/YR)`_M(I5914IF/O7GSMVD*UJO-Z%-%WD>C:8?!I>+V(;B9#+ MVB6HT?./K9I$T5,D*WQ7H;;.9L-+&8.+EZ=X>C&ZE`>M.5WD M5X;WO6GOC%:Z*G":./BE7(WV"]8QQM3]56A7E+9E18>M?HN6IIH<*&?8IIJU M0B]6%A,+8NEG26EC._'OL_SQ^/2OT?F*LY+2[1J@Q/Z5?:>KGC<[,$Q:?$ MVPI8'#&8C"KZQ`ZCTQ;-4>%QM\*NC$U[_-J^J&6*`(^E+`R'AC.A";DHY+6/'N_VP M8?>6_:`[>O^95\XZ]N7]R8AC]-;92[JAUT*K%\$#A)K)<_JJ/2$[+NS+?_E\ MEHMD]MS0IN3`.5^M!2_CP87Y#E5`"QP"HE!+E9[Z+L70!?B]E_,@/@EUYIA4 M=:S9@P\Y-<'L09AVYE;Y_D=8N\QFA)"@=JB548^ZJBH`F# MZQ_(8XK+Z?O#;FD7G\3:93(?1(W9@I!I)C:`(L]RUEF?NUW$KMWP8?>PKT_" MUBK:UHSA"*AU28UAO$E6>RPUI_Y)U1AX7$7;UR?9'&NLJCD?+127L2+OMXUL2Q`VD M]\&@M[Z9S,)ORE6V$\X1J1@-V%\T';!^]\N=Z9#6.UN*QFGG8@PM((#U2=1( M2(#9+&I_"'?'&5\WL:L6[4+N&ALG0%H;;VL`&RDE"BQX+\:A4L]AJYWQ=P_D M7WW2V]F'\]%).Q\/=B337$GFLOZ5)W&VQ*&.52HIS4ID79->^T8<`FL?.+S= MR\W.5SBYJ59Y.YR,QCN1WB\5/9IL6PE)R.Z#T`8+.5$.D:1R-JR@B5Z+GU:M MY^"%/PC4:CYP1,_DE)."1H[K#0R0,LTVZ0C<@1O[V6QZ?U!6G;%>RXBHQ$Z" MLA9"/2]E>NPE\N[.^LFWO@MX4]X[0SYQDL*Q%&TB":NHEX-R&O4_SZ[G\>*"NV5SV[?+ M__MRK?/&1T4['RJG"_J!YA5959AC: MSRY^4V:8'*&";-S@(E=G*_GF``6Q);S5)>2A5.:[UW(>SA2SC-;$G3YD3FI?;XA3I4&O**-9\:Q;B4'5#3F>($%8&%!U(SRC!(`X;N_.+;L,+4 MN";`&+R*KF[*4(%B1,E%<,LN`Y[=WVN=Q0H?X+BN;Q]./2:RF>I*]J[HY(D< M11\"?+JCJDHM(?1S%OOWE(6Q=S\^,K0;!`-_C@6@@>#5W MQ&]?SO-5:#W9?1.%3?:-:X[(>N%;5JJ:I"5.;)D4P") MDKYX'$KR,8D67.*.^3J8'L/I?2'K5:@\U54';7@Z=-$A-9+1>38&HU0CJ?B^ MF+V$FJJUIZYD0AA8].<]WP[90<*W#V5IU[Z@>?/SQ8HT$"%+&MQ3XK"1B MRF:*H,"3XU(5N71$E8P_5JS;`ADN1^%)\5QXM#L\+LT_KM;?9\QAE1?+U7IQ M\^U^Q&U<7O[X4XZ:^'7$:@1K(PEE3*A<8Z.ULMN:)#$0TZ7PN[G:9U3O]9AU M9#=YD4P./AB^E@.3E##RMH@F^KX"0G=9O==AUG/M,S@?YTRMS7/#10EGQ->O MMS51IO0PY%W7;?%436"9^G7V>7$[EOC]?`EONIA?;VQS:Z8#=5Y<&;<_>TFQ M@0E8,C@^6&N$W!BD5?`9B$*J\V1^ERA/%'"?<.EV+Z3@-=+ZL]DIPF[!RJ*N-'"2 MM//K][/%4>.&=WHB.F5TSBGH2KJ$E#("GHN2^_X$ZC"(%+MY[1T)IDDW8D,P MH%*"XIG:FDA1:*IBNYH@G4IEH"5EV`UT(]*MYV!X97[[WY^6=UP/W_IM]K]7 MT\LIH]`QY=JPQ)*<$;&US$_?8&1AJ,&)RSO5;4VI@VA40 M&0@)-RSSV`&G,59=/AM?C%?_'722L!C-Q>K0JR*5"-/J-:I(;P! MO/F:^GG.\/I':_%=KC,H,E;CZC?%E5"@$.E&W,7-@S*4K'0&;>HKL;O6R>=1 M9/UE?OG#:3KMB`1-)DGO9#66X+2]MDW8EN#"N7B@+^WK+MPG2'<^K<9N([(& M41=)%+XO(NX?U[)+QAK@AQB/Z&ER=JT>S!V>3GQBHA!;;*:!`L']YA:S=3S: MHU7A.[AP]!(]$.H,6HRY,FG!$,"+9,A4)$\H<48*.#:<)=D?'=L5MY]!C_W3 MH$]8%8=]YEM,&D!.RNA;C;+4FDU1WO3Y`MU=0D^1[XR*C1%:8)#*U#EPAV;5 M`GB'J\Y:KW!.^F84[U37!^>,BC%&7]Z`G9RR1`2ZX#F/93/71GB=9-;&^M2T MJ'UO(Q5V4[<'Y7F,Y"-KP&3`!^8\/!>4L`*6\Y!P:9&+E+OT(W5W:8^1_(XI M+C_EV9^+F]G5=!P+I@I2TX(LB0P/=:Y9\QU^U0#=9:".?_RL[PKU:!W&CH%P M(&;`N/SJ2C;GM=3P8(S$`0!DMP2`F.=7@M.VNW^FZ[!T#``#9`?KB16Q`_C7 M^G?<*=3:>1!0(`;LE4GINCJ%:1C!/9^5OJ.LH^2^LF-,+;>FDN*<^*(:[QO MU*R\SP21BS1@A$$D=$XC7,X_[F\]5K]>7'WAT4FG/553)@H5&30$2R047T;$ M8L"8E&E%=@D6I>Q`[FN:A.=7[\%KSX,_;6__OI^6[]>KB_DUZ-'UG%\$Q^7E M70M(7I'1]LF"RR&!GR%-KM67XL!X2E$&Z"WTV?D>RKQY"Q[=`9&K%9Q6L0'7 M4K8F^2Q=-O"HUFHG.DBKU!!/?U%['>PT2"W8[`Q)Y8AG6..O''D\LZE#CY/@ M<+H[OI=7[X4/E,RQ)I$$\<%B!415E#<`)&25R?Z"T'4A!/LI>73?,1T8EA)\(^*@5T#"13P$PC,N3 M/;>5L_TS&81HI7M:-2[6&?0X.'X(K%!MQA8K0Y4;!3CKL2A*$W9QZI+#$AQ% M]P1^NAZ;BYG;--+=3<(I@+[DF+)/6KAB#7BBIVKO$6$>2-R]4UVWLGVRG"SP MTW6#V/RA>U'PZ6.#`0(%2B&"%$2JP@679;(I"5BKQH'4S.`./:=QQM+*S<"M M.B-52HE38REM;Z>JB7V:W^C=\6Z39A\X_;" MU[_/+_E(3QSZDDW:9'*RDXXY0G7Q#8IPDZ2&'Z""- M=#H7`>/YDF)4$BY=A@JR5?NT'XFNT'&*I)-;7+._=J'BJ!I#SJH@6!P5)<%:)QRT6HZRU!"^H@4TZQZ)D5S,U*,4IB9(H:.*$LZI%%:\IRC;`=46/S(^6\[]7ZS^V*'B:00TW8A).4.`N6ZHD MR;,*O2A`1%6)'C90U]QC6(R3)#W8=!P'UUE8+W@/!)J3X<8J@7*J,+#N'T7: MKI[S2$GO2F@>W7L3)-TT57W@&Z*D>7X-SY6S13CGI>U'':DA![1?FL<*_IP] M\!`&2FZ.&QID"JV%8(N65131M,]FH&7DV[7%:*,[G\FDYK36X)PX9("X,?`K M2""F%@X]BWL[1AAK8.>L!7M$9$[P._P:H:E4JD.P*0T6`4C>VI[U,*_IS'60>^OA<5&!]+Z'TJ(NKH*RFM M3>Q[-;YE6XQVP_6ZZ:)RD&#>P&]>U]@03Z7`1C[\RO7M&&'L.#>C,O:"404X M%H@L.I%K*^"GC+A5Q]]/,\+>,H"Q4(Q8T\"=8S`Y@;/(H&,06"F3^#E0[LA` M$.1V@>.^._Z#0AUR*)&S]J!16ME"669?2A8>(#LT,J9TEY@^.+F+$H\0*BXO M_W&SNOCC]]75Y7Q]?5LP/)&KF&!3J&PZ/NXN6HU8'A.5!OPH^P*DX%0WZW-, MI$?*?S!3+J3QE+RS61)''LD-L."]E&ZB]!UX(;_H[IY.E?^VT>K4`4C%DB/R MNCB@QJRCY2GB3GA@AY@';NMMZ'(^O0R313PXMB+S[!O8$/N8C$^^RIC!STH+ MV!1^(!Y:N8O(CQ?QT6CL-V91AAM:2;-5)TXP^U)'\[1AA+&R'S-6[20&[>`K)>]N\T[R/ M"2Y-]4._W^Y^&,7BT@BH).5*X8")S1&1YL\K=S/>9AE4-2\-;Y5[&.1O-12@9,HF6V,/8IX MDT88.\S"(\`KCP_6BI)VR0)2>:<:N(DW:GS4S=LQQ>BX"9(XO8'?=X-_!)QJ MS2V6*KQ\4+G':H\V`@_I/`7BR-B4LMBE!40)0`S`-XK*_5-K#JX/R$[;K@_\ MH!BG"'H0/7IJ,647?':D>*"CP!:K_%#71VT[]^BTZ$:6'R/H7RYN M\+&;D4';5?CU8_S,;RI^Q2ZXF2WY/G9=$J`"4B?,W.!VM-+4#T\/JZ M^@(P<'!73!-L5*M?9E\7G[]\3JOU>O7W;5TBOK*#Z6]WC_K'CQ=E_F%U3XU" M.*\REL:"9EI?B\Y&@]T%T-&',6#^9;9X\\`WC]F7_VY1P#_];8Z M0JJ3**YU)*7EP4C64$Q`;7SAE"3@>,W-=BFC_N9I0(3I(AZ$F4&$Z!L%4HYR M:%'!]6>1?0TVJO[.Z7$BGAI(N=>Z\LV;DAPYG(X6@'YBE92%%'_>3E?_//G^:?955W>\.B[K2-X/U^O%Y]6>?7^Y[&&/5E'[FLOJ.&? M&G1,M2#ZBBH-:$KJ?1K4ZG)VYU/K<"K$:1[:6G*&7^6;1K1/DHDK!E\3C$8VL-0RT`CE5K>OKV[8.GW@@T>81 MW.PJWN39>OT-O[EW]JQ^$'D>_@B`K/1MTQ:8@_N#G[PUPH?YU]GU+XCZ%[/% MY5@5L18YR=!PM.!$N>#*,(`*3BONR=N5V88.9!RCWSDL\F,L?CJ+D#;9.Z&J MKQ715W@-[&6KB-&EYOMNM;)KOO]HD^Q[\_R<&\.$X&71+>*,$$690FPF5Z%# MBL[8[GAT;]KVZO2#YG=X]+?YY]EBB6_]A>7'D?[UX\XDKS)?XX_S?*%K.5AV M]K">\?LW_[2\OEE_X?N7WQ;7?_S(/V\_H'Z]^)U?C.!__YZMMV9YD*Q6T4JN MW.21$JDE9[1I503"+THI__*O[R7]\EWODS3ZT28[#5XF!LP*(HS%(VX055N, MUL;-J_=6`3Y*_XYR9]UV/WVB:(>M"RY6MNW_CY6 MJO^8W_!4VO?KU5^+R_EE^O9?UUQ[W0#%<2R6G^(%K'SBPV3:"$G&P(QZ2 M!5JOX1E*$+*?Q_P.7]PQZ/'2G4VIL3:)N1EMH^3[7,J@4YY'0>@009_]0'F" MZ6Y?SJO3[27IXQ:JY!),J40Z\/M4_*L&U;!(-5-Q::`'8#>1XWCISJ;4R$*Y MVD0(*I-LBB3IJ+SG\:H\9$&V/%!JW(_J.*]6V_>6CU@J%V+8M%1RS5+P/I$L MPI&Q%&T-`W=K@7938\=+=S:E1GN!U=)BLC'RW$>3?#42;)0`+L&J^K=K\F[J MUEF4^MXU:_)B:/((:3S)#;C>2)F4R,ZUK%KE&NB.B`0[X-^^?_X4R<8&11BN M<59\&3@X73?Z`3%.%?-)NO,&2UHYXY6LD6L!7?/; MMGB1^H;[+Z_:Y!:\SL=LLO'->%LM3Y02[GX5-?6W[JX;KP@/;RDE M?DF92TL5/FG[EBNUOI%!]_#BA12=VF/6&7Q*TT"(1189E))RZSQ$Z!657<>< MYU?T_KOBU=6F.\3]%\>2<;6(:`L`HV@Q2`29X._/)[=NZC;O+AQY.4WO'T^` M7J^6?,6#S\`?&UU7^E$0*^F[A>WU0&TK,QNV#^+SB,!K%7MF^7> MWLDV*9TV:AL;FNQ;T4G?]:T]HYA/$AM$:2UKP%Z>:YK)&4#(K>/4I:_4V7U+ M^$(*3HX0J5:@#K`N+@%M*JE@MHHVU_?FY^5^':I.#1&"*(&(.NX!DJ4%R>'K MLEMWTG+K=FV0NTS@A12=&B)2X2%/-1#8:#%-J5#T_9("%'?TM$L>/[^>)T8( M8^#S@9B%%E$8XKRHOE]2)5QWU]B]6WTY34^,$#$Y*V0#UT)TD-7S0)!M`Y\< M!CKFA##@?-!*W`84E%`@]3&JRUVA8R#RUQB^MJ'J0+YJ'AN25;6E?)\+$0=:F+\B:^U]V=3<:?7E)55_062?R6K'LASQM4>2LQ0K-489D MO,JO#S`DA\/I,W/F7#KP]+0N(J'%NS MJZ>A#N]O>#-?G-*$Z&XOJH\)O MNKCA[W2=?[Y=S'A%_V^V-LOF>>W'BI*HE%*!3,S"7%.B$SIVS5Z;$F/K[O%D M;SCXAU[3P1EF(RL98K5>FAML=*C)).U5!"2H6;.1':@3V-OE3+F61R,3(8%2 M8(7J3Q4C93]IQ3[,;J2?WN'PD/LWH2)CSL\U6UM6O$M`8%A,O\JO*F5Z9ON! MO.#9%/EJ[@R:;\JV`E;2]5X'CGR"QE9)BEY4EZ7YXZW.]`ZJ\4'"+,P(##R; M%!8D%0KI6E6UJJ=SV#?J^?TMW`D>1Q7G"R:9G]M0JQ1R"RXK.6[02O]IF MW[WQ@N\ST8=(?'2;%))7:&705--RM'_QU3%WKMT"G23[V*M&,>Q>:FY%F"\9J]>RDITA9X]R"T4Y[J8G(T/@>YBK$RRG$KFQI\,#L(]E4^HSM MBP56*2"[-HT,]I/SV<6HBDZQL27O]!G$DPCD.E#M]NCE%XS*=K,+8;!?E6@I).Y4H.Y51V56(";X.\(U-H\(/?ZW7 M4AE]N\F6O,^#/9`GR%K$EO&B`72+@7$%H&70W]U]W;$Q#$AQN)2CD\1X/=E, MU4@&A<,`;8S%&3DF69>^%C9LVMQ]I?QION1Z7\R>:P=F=\O!YJ]$KD\T!0\? M9\(MNQ]=_+N'7R\6%R,(FL/Y*OR*K6G>%3;+5LN$#R@<[MN`7=@:.@\YILBI M6MO]M%TCQ]\>;V)S(6>^Z$8(VE1,'E36-I4TB`=,#)WK>7-U?YG=7%Y\OMM/ MZW][_.*Q\B#%P:*)L89$35$V5EG>9(3&T"A35U8);K.V[6VUYLOX8<\9",NV MRM_FGVX>*\%&%*_)Q5IR0_XMAL-$8Y?C:Y*W&JKI^1(T6]`_E.:K;WU.KRV_ M_O+I'W^AGW_D@DZV(Y&&H-.GOA-Q^^IEJ7 MY9.DA+E/GSE$(UIROI@&-QQ^"/=?*ZH8+`EI?AR[V3R.T2N"14:Z\T%%R$R MFA$6%RTU>8DTG]_F&-*ZOG:%@XQM(<7IBG%D^WFVN/\BR:/[='LEK]^?CWKT M*:%$1>R07)6&X\(7L%@,,N&@.D_=:P+HT;NX5;C)=!KK@V0,VFP+1MJHF\HA M1;Y,E99MQR9U.5'HNDB.U6DQ^^N,[_DCH?+[B\4/B^4;T=62`N3];+'T)J.O MS'8]?RUO5ZXFXZO#:/GJ%&EX#Y!)*[TY:/3Y5_!]^I85TFL:[27:)-ILO$JO M:R/]QJ1-L@R!42697\1(F"PKXJ*O\6S:/,V6?;C_-%](OFS\Y7^=@-![PU8@ M-<_W'Z//V3*>PV@B-$A1KP.7YVFWNH8@R#(*E7(.93VJIER6F%WDEB*'NXQ-M8-`\6>S=9&:^PIIJJ6B85 M>RN-UXX#[%RHT50('.+:U'*DDI*R;/Z:,:KS2EOE[/FD]I)M-U./!&`UDPP7 M3AE8.LO7S52;*PV0"!TFV^>+ZZNG5!:[SK7&EJ.H%J$$G0I_D68@AC4$]O6H M8BX0R47;3Z*R'47/'C*=KL/.>7Y&U]I\<(5UB#JR-R$H,O1-,T(>8`]Q/40Y M6(>79,AC=O&GB[_Q;W@XYGG=495Q3Z"!%&9?.6*UC!>-;\82F^CA+,VZ\-N% M.4'JL42&*3%R&`+@A&*'XY'&S@^RMYC;T,GIW=Y18C]26#TRHAT12B&I6"&! M%<)"]G<99/('^B;#(`?X<[JWY!W"G"#U6*$'PR3C-6>A6U(P58M698(`C9T M'UA,(C5[R8O;RQ-S=NS\?-8:6F#+XMFNH&L,/%B-TK3K*YH['II1D4Y58&SM M38HR1)U<#B@]%PFK;U4S4#)6Z8$VR>D56'RXN.'O&9IP\S*1>'L#KC+(.,14 M'326Z*.+J6KGFP=MV5IV.Y;/_ML MZT3*_XZB4VM=<=R5UIXK\QOJ/,75IF3V&%JT+R/@P:FHQ>9EC M:G3K^Y1\7Q$PL?Y7#\^M7O7Z[K&_D/]9YG?W1^RNU#M@2"[Q)H>8.;1?M3$7 MUU-YZXZB8[=`)\D^5E"@"\H@QPRAL0M`FW'%\V*CZ?+LIBN=/$SVX3>Q@\=' M1V#HR*N(Y*EZ*"SJJB_00]\N'\$,K/E684Z0>G>07XC0)&@I84XN.]<\.UM( M%*1MIY/:#)F]_:3>[#"1B[-6U;RMO/@I$#BQ;1.-EVPM>][`@!-M9*/'J*@% M-(R,^K?\;S8W9TKIS[LL7ZW1HQCD4X6V!.DYSBY0-I1J-!`,8X9=$?D_Z&I/ MWSA2LTO$5[:D&G@W:HX8B8U3@0:D!WK'_GGN)^A$<50;N]EB366S:ACX&XVF M!1"FEP&@_,_U/JJG10;(DD57Y#@]L:'?5B\ MV0'GS`BH?2S@=+0$"B5I'GSU*07)"&;VG/*=(/@;3 MJDS(D>&7R+#,\W5.+RDJ$#0=V]LW6E!T-2'"'F6#F!:@Z4\3)]L`EKJ#2C/4* M*8$6[\#R*?^[7S]?7"]D%XY=9,/^%'GAFDX9*;9<4Y;A3ZVI:*AWIR.+O%.X MZ90::^VI#(LCI<1_8=4^JT(*5:N-G"AWX)87U@ MY!N2,5XL#):(R=7HK&:;J&IHTM'?[TZ$K@=@7*:35=@Y5PP<&T9VK@J%FR^' M9).1,%AUH7M^]R)J+0/Q=1B#'I;HO6) ME-*JQ4RV]E.04&\"A`T1CA'O3?AE&P7=@BDEUM:,+L$])\1UU!JZS-S74^EP MSG%OV-=R/%8K52$;=%D]JQ:R[WIZG%6;5^7,*A[*)-L*(]3FF^!6-@N!8'4LCR[]!-0P9JE#5&X`]7>UA5]W0<]>8#Y?D47$5:AW'' M:G:R&.4U7$;X9=V27]$!VZ)ZN-!1XY^DXM@LH.P*!]@RM(1!8;-).,]1I\*P M)A,.C%^P':/]!/*]B>W+C2^\EWDOJN*A-M`5U7RQ*<86"N0L]0.KH$#['MJY M::W\V]-HE^(4*:$JY5V,D%C^E8;9]GWI85HC?P[^;#F+9$Q&`SF0U$_@BDU: M0T\T:CHZF?.K>"QQ=C`F)1.E.L>AHU((*W$5UW*RI"! M7B0;.4QZX4/N2_BUZWIA]A;Z]GJ^^//\?C,,'0O=;'&),@2;2D,LE%JM.D'V MQFIGJ&\(\?V8[+5??I!0:Y,O/]Z_S+SLM;#9"1IS MT<%'>2NM&JIJ`_-MGMZ,IM6B<<2]K!S-7U8?_NEZMI"WJ"_OY"7J]23/YZ_Y M[O;SP_W=\@OTV.#;$$*%VBRHB,+.[JH3P\111*B^G[0.\0WTW#%37G\+ZF<^ MFYI6Y!K,^8](7D.Q)N./J"EE)MIDIFNNKJJ;#^'_+Q: MFE[+6_F!ZRJ&,0ADJ.9$,6T:9 ML;.9>'>J9PT,VSNRPKTF/?-2=Y\8HG>EDF?>-/@VWFUH9,<"6>'?D,ZX2!E= M]8S<*J%G$.`;4#]LVY]7(_NM&KMLFG&S@=$$,4>Q*$5N@9#W*H$*04S3E(E+-IQ\YF526KZAAZ8T.;7(K:^Y(UM:QUTIU&]KR;AM+J M-F0CUS8MCFU:Y%#>QN9]2%@<[QHY:HYRA(JE=2IRD+]9F?2V*FKUVDC^^\/- M%YFL8V!$,RS>%J+K7E;?5S."6&U=GEX^6 MQ>QQ[3P"N1H)(TDNN*4@U#'H/>:J!OSX,VO&V?0<12MB0.V8`45#11-`R4X) M`5+V4AY=I9I4%^B34^>]B^\?/MY<7XY.PA0BMM3XCMG`'J#F&#/?/QVBYBWL M^QRF`I:["E+2FR^EPV3UI+"+OZVPD\VD5#G1/76@[%8-.BH MI8I%HG"=@V<5;:D#+WX3+OY943WCVAA\8MN!P59I'H@!E"]))W)=HGPJ@+BG MEE.@>KY`##.(6-6*`"8#6=^LTYH\[^66X5%G4_$(5!\XOFPUM"*L$0Q]4S!% MRDD8"%/EB.4K;]H1J)ZOFHM-*$Z5D%O$J`BK%7ZGU'+IJ\NG0O5[:C05JJ=J M5>'CUPH?Q59\%.[G1D8%9S7ESJA,A>KW5O-T5&]T$NSD"(A1/7N)DE%'GX6W MMK!-'4#UW0/MFZIX,*HO%*2BA2\<.LS>)-ZX;($1A92$])LV%9+84Z,I4+V7 M)YP:.5CA74)&A"2S!"U9!SD,BQ#JJSX M!BJ?LQ"&]*A>3Q*O[*_9-*B^1!UCE)EA*;(EHEQRJ"DH%PT'TWU?)J/Z2:*7 MO?6$9LD@AE^C46T38HJ7]3Y/GMU?73[V>6Y^\=8H0 M=!/L9%`5QE59J9:CLFPQK.YIY^``^81#(E_[>LD#Z<-=CP5:!: M6X/&:,&FZEQ1QF3Q2-23387NF`S*<92H8RUGT1C+7B2%%K!F*]A42QB$C@UO M/V"KKUW>5]8A)I:G8&Y?=LM]Z%MK1G.787'%9C2U@8RU!1X%'X73A>I3B@C`L(',FBWU1G M&S/*JFDSSQ>+^6]2OW?@C`JCG:\M-,*&#);Y]%#,C+6JG/6>>+[CC1V0X'`) M=\730EK*7]((:L/22C#"_)3`.!69])^+CR?Y[] MMOS48/6O/;QW9*V1?[2D!E&.C).&?&E"PZ2UE[[2QC#+FL'SLZGZ7JKMOQK+ M3_[P>3EHB_XV6UQ>W^W)J@'K*)_`6_*0B_@"ONH*7MI\LQWBD])+$I8]%1N4 MEN>=9R5;C$*N37AJS:95\:>9XOYC_LKCX]84K M+/TZ?[B]UYT9?&P^N9I=_^4=&[D;NKWGX[SV-#=;+*Y_F9?Y^W=E@W;SR$:5 M+6#!`?BJ237-\"`)/SN[.(9L1J4HPY*V/8I?@TO[F:+>Z&Z$3&N\N#IEC)VL!NT%,PQ$:- M@2P;L<9HMJ?]<:ZC=.F%.%C&70Z&<5U*0I3MBD/0D9$I!PHJ!]`:?>OS&LH_ M<<:?(N-WMYC_V;NVYL9M)?V\6[7_`>6<.6=F2]:( MI*YV)E62;,],,LE,8J>R^PB1D,0,1?+P8EO[Z[<;X$T7VY(,RI2,/$PDF0"! M1O?7%W0#.IZRVKT$+WZ_2M0QD9?,XQUMH71T)M&KVOD]'AD M\`N3Q()DTYNX"#(W]#ZIR0^S4[R^,9,C>U=55;S!H#CO=[(*8 MWK"[LMO47CD/1M:4_V+V9!J!&KEE`9VPWV+D/[P;Q8GAUR?.FMS$+V]?@&G? MUOL#H]5J=H:#BZ;6P2(T=9'X[+9PYA-2V\9 MOKZP&BV!MV!L6Z&S15OIX09KC0:T-`V=RC]:KLL!F>UGAY!_AANXM[B!ZXUAW*%M\8O34/E0-Q1GA-KN*%$:-%<: M-UQ3P30'SJ.'W>6S-)H]HWF!`0*\%K*A7S5Z0SP!;@!VWA`,NI_^Z43GEGU+ MPFCNL`\G8^CR=$QGMC,_N[%GX$>#VTG^\&;4/>=_"P%XSK2&'YV?_',2G2\U M!\W)3J><*&>:WGASCN,[M5T+3.:S9M>_?[`3_'W=(/J8:+ZVUR)>V8RQ.=-R.I3"[GH MU&'CZ*P!5"R2%;\77^-Z`?#[>=HF\GSL^#[OF-L[Q&2.DSS#C0W\'OK43+]O MSQ`S&DQL5PR2QI&7_A#P8?%?[FPKFIYUFG5=,\"(:78ZO6ZGJ;TY'WD!+,"I M"6M"_9"=I1^*],*."[,(LD^HA''L[H<3$/'`NQ.?M>S9]Y&5?PS6]L!']N&D MTWJST$/>\]K>\H;:GMOI^EY>^!"Y$NX`V..E2LD*S6S+<_6":C(W'YPM\K`-/%IFT^'WD19$W6_A)C'`,>'DVA35F#RN#ARAI MNU,6V-'Z=G3FG_^@M1OG6Q`N&ZY^LD=N7`LOZ_F-TUD:P[7JS=*Y2HY@2>`' M:#<*B.DP&GPX<3V7G;S/YKD!`78"K>/#)F&O^(%M@J$4+9A"IN.%C,"'7S'% MD!B-&D&'0!:'*7AZ`I*$M9/,7O/O2>@YMD5^$-[^\Y'IA3CO'_LFD'QZR$5M MK=VIM^4!]Q-4>=7X72%;J2SQNO$BZA`>.$`G5MF@E0;Y7>CS(+$3T>?.?$ER M7Q7H?XK?'B-?"522JQ!ZC6:]5[IH[H%;#E1+'(\RP/.9%R.7RGI_@>!"V9;\ M/L%)KS4ZW;JAS%5EKLHS5TN!J`I1KW+8M05>&2"3EA?C=M!S`*OD@&)5#-.G M2/<ZW6-NEX._F]#L"/4#._YKNO:Y]=\_O&]Q#R!/._@VIPR*\9K MW:YLUXX8SQ&R\.X5^/(%[PO\[$;4G=C07-R/N77&@6%T6ZU>N]-H]?H7`TQ2 M[&5'@`\-H[.?C(,"/Y28@<#/^2-V1C)".E8R#2S00601:HR$O;T!K/S-QP.CM.W%@/PD`+]C. M.)2!JA5\T17>I]346^KS?"RPFFOG-M^CEU68+3.=HRF<.X9G&>\`.<]0<>7Y<6/ M@1>&"N/D8YSBM"5.*UQ11/H%%U@QGV(^!7.*TXZ$TYX+8^@VFQ`$..HKN+)%)]ZF"HNA!X717PK:W+Q\.LN\K`'E?G$,"C,L0Z M7M15'*/&NV.;_!XU.@D8/]_O M1;V_*I#H^1E02P2H>AY3N]9H-^7E,1U+-I**;BCY?Q7RW^KJ];:2?B7]2OI? MH?2#]M=[\HKLE/PK^5?R?T#RWVKH\FK8CD7ZR]Q<>I'XP<(0-'TI5?V4_R(M MQH`7['D^LX@?>%9L1B1BYM0%DDSF0/R`[_JE\8?T$3[-;6(/3]>K%B M4ZW6T-2A5O+TMPHM*]%*&C5!`TI+7U:"I01+"5:FL_26Q`,2E&@IT5*BQ1L9 M7:.N*<$JTYVK@-0I+%+3:YL+(SGT4[ M5OIM+ES'=,.#UBKK>._CO=Y!10&5,*T7)HEYYDJ8E#"];F%J2@Q7*&%2PO2J MA4F3>,G@*Q&F$K>W6GN1O7*O\;(V/WNO)$;;10*/_&:J#2EW\!=3]6K-;DMB MU'57>AT+UJFH[.X6A<(PA6$[V60UK=>2=RR-PC"%80K#%(;MV0X#1E,8IC!, M89C"L`/%,*W6:+7JC1>GU[%@V('<2B:!?9ZXG2*_2?E@[J#Y_(_`8G%`O`@H7/$]" MPY!M=9CO%EQF`)=97HROD18+.O@DA$TI5/5D!$VK=5M&66??K2',L0"1"CTK MC%$8LQG&E'F.DX(8!3$*8EX]Q&BUIFZ4=1ZVPAB%,0IC7CW&E'D,TA%#3"%D M\SZB,,.USZ_Y_.-[/YAX9]?FE%FQP[Z.K_B^>]^U\H.#ON`>_..;WG_[K/__CQX6>O#$U_QW;H8V'$@7,H1&S3"]<;@@T=Y&P?[#Q MAY.K"[VAM7_7?K^Y."&V!3]0,SHU^H.+RY:N7[2T3F-PV1LTFU?#7N_RLMC,';C^T0Y(W,@6,)<_$/*\RZ_?Q_CEV6*Q"]4R/` M$:ME[]MW3-["L.$9!Z8;OCM;'6M1.#9D!A,8@`6;L-2"@FH`QQ19"+\77^-Z MP0QF481L#9_).A8,8L+")\]\.&F<\.^`7F;Z?7MAF-$`&$<,DL:1E_X@;`S^ MRYUM1=.SEE8WVGJ[:S2-KM9J:<:;%&D!01WJA^PL_;`B//DLBJ'E#'E;:W<2 M-@A.\Y%]..DTWCR)Z8L*)&FH[]A.V_5][;V\<+=,LQ+2%"L7ZN??[H3(C3S' M$KU\`4$DH/-FRKB7OV7YU,%)+\!WC_/:"L)+YK95=?>0(;A6#;[`64P'*NR\ M4=^:@3T;1N*@3&D^1G4(5SG)EXZ,JOSZ(-QXO2.&'LH/*^9&Y$O&H@J9#Y4A;"?.697&7`2X6( M=[BXE+AOH6R>2BCSLA#IBQ?R4#UT#X.+[7"*I\L0;TPL-E+&3P6S MY0\*BWKJ%)XJV4Z-0X8JD0Q?V"P\339SQ1ZDLJ2.,3GFP=5(WL;W)$O"@JK$ MX)ZBZW."=&604;(YV^WL,0WG)?FM4KKG6OC&4'SBF,`-DBO;I:X)_9%K6!&&+E5(IO06DZF82_R` M^300"4S8<6#!TTPD1/U9OZZ3"7-90!UGCG]F/G9),[G`U"CHW'>`4=^>?.SW MOYV$V./5P@",LS(.'N[[8XQA8=G5O%,JC3ERG;#*(A-_$-((H_T$2P!!K4& M\M(?;!([HM7UZ?_429^/$5[MS&LB#\ORB.M%T(WIQ!90QW&PG>AY\95CSXO@ M489'F0(DX*Q'CG-*`''_' M+I]S3@BSV-&Z,2Q-(IDQ[]"+`])WW1B>_X/Y7A"A(WT%LPG$0B-P_ M,P`*"3J*2M9"\W=\`6S0K$`6E^&1MS28<])1,J9V@+*2X5I!A-)UJ$O)GU-@ ME[6"U2\R+')5C=R!B+LNX($RQ1-:<1YO_#<*>/H`KPQ8A,4#9?\3$$R8"TU MOO+X=_CQ`I9X-@(>,#3D%D;-*6]?0XD+!!,5FG*N;M=!PE=&-+6AJ1`G;`'B M0%(IJ*4C`3YRP'T2D$/QTBLW33,%H/1`K@-OEK3MBK8(AH5!BA_KY"]&?(>Z M^%<+QN)X(4](Q>.98R<*4_!;?0.B8(X)-\4G`HX9=<6_4OGW+R96'^U$VXT9 M+IE8+V39D>=]Y_%.7*UK&L6@>N?B[V&$CW(^%8OY;^!!4*BU7%DX%!Y*?L8G M$W8M\`MJ++#'_`!3GLUD*)Z+BGP\9F94[!A^%"S`=3IG%X&2J%EY7K30+2L/ M2<2\$A>B$&!X_-,!S.6:HK$%?/'U9DC\*04=9[*8^Y>PUIX%EE289J.C:1+/ M@!L^,>I$4Q,,/3#3AI^&8*6%;,+#Z_A;-/>Q/7!!&(_^YKSAP0,T]%SH%6_J MS]O5\2;Z"I`SP0L#$TEJ=SF#X":?#R8*_@(+WB`T&LAD)M$TG8D=S/I0( M!0LFZ#/Z'2FU.`@.P9805M#L8+&AD2=HP$F0T67*1R&,6>8X+IZ1GTZ/FRX8 MXD!XK7%YIZX]RUME=,`A/TQU_L8Q@)\8N0U>9]:2*S^<1`CCY08.KOD=<`20 MZ(Y1;N#,@(6F>,MBML2<\&)ABG->HCGZ<&9@^UP]?%M@LW!SH_&Q`,%;"1;B MR1_W)^]JY-IG:"K#^EZ;-@/+(+E)4NQQ)YP>_JO`)(AKN6>SCEL0M<7RA4M> MAP?81SD(IBHW-:\ES`B6A+%DU81-(:%3&0/+A+-@ZK?E5:*DBY(:WC8N"RR` M"90&0SO1@RG!.>O/0%V"884I#'SQ$DL]=H1U]K@UDT>+M@OZ+,:)XM!&L1]Z MLQ'X:\@L%\(DBX.MJKE:PU[CXJ)OM"^TUM7E<*@U^I?#?J/3ZW8&O>;P:I]Q M(G2([/%<8JAH)<.[/_S]S\_7GV\^?_WM^GG,L[Y_Y8C)M3GZ>4Q%5.`50JK% M8%(2&$ID,8:Q!"M5=3,633UNV!;"2".N9#TW4934F2>AQ*RU"%'Y<1(%2>ZD M28%>8(/8@1,G4N6M\.^.34>VDY7]@1%A+=7O`9YP'_^6.C&>:K7P\F3H&)E1 M3KYDWKK*J0Y^#YA(4:*B,YZ@263N'G1S8`OC]^_8FB0QL9$7P]K%X#]!#[=9 MG`S888[&UBUJ$LPJR3MW+<$$?J+=,;*7=QCC:]&Y9N`8S;#R"?D@;6XMLDD( M)!*/\_B!"6X9'U_*A.MY;Z%&E3]*\$AO8&83''M\#9(K,TRX5!3<^\0`X6._ MXJ8'^I0+,HGR)^(2./C%2E:TQ3U31+&X@\@<&^9)@SF/KJRXK`%6/`LJ%%H6 M3,X9F$Q`?>Y."+\0+":<(/%&$4U\D6(P%CK%^*8#G,#GEHVO``E(EC#D2U(C M=H0C#81I-@+"^!Z0'C?+N"40\:K<--("7;D3ECE!N%3BM85U>0H<,@.#@QO- MUB1;$??A11%AVBQ^"T/EBZ*0HX2]$,9#&4+DB@ M:<_[^0V#HW?>U$D"$>3C;/2I6B,_>##]ZI84),`]$$E!`FZ>I+NTEO`5"O`) MV"OA)5JC\49&0`-&LY9OR=N3['>,75'R:^R"H58C'\'M_9B`E# MMTBQ46P[5I@:,X/AIS16]J^\BWIK-6)#N M\@=4[.>#19B\4=A<7'6EEIZ5Q1ZA/6CN4Y.&4[$C1<6V.+>PN5\F8362`[&- M=O-<,XQZ*SWT1,9"RXAC_D-K->I-B:-Z5R=?5\*4-`*6&L7BI!2PP7/^I&M, MH@([B'5<.?6YZ)DG;?G.)H:N@^]BKXI*D4D9Z''*MVS!NQO'#MC\8P;>5AQ& M'D;+>>P`5??4]L,#&#CHEE,$0LQ6H9.`)9:IO('S,'0Y8^?N-WPVP5#ECEXZ M_D,8/M]^CR,;7=W[',KS.A MO(9@AM^FY?FS3HW]&YA)V!U<=M M/RKF$W2:@H;0WU*6P;/(?,@Y$%5V3OKQ!-"SL'W9E>N99)@AAX%+9U<9TZ:9 MG\"3A=%9"&'VA31-X8,47`<$^L#FL7U0FXCE:49#36C12W!YHAB^??DRK'&X ME6%AZUBZD:V]1/L?TWG!>4G2K8KN5U$5XV2I!8D6::8 M$M-;T/))^[VZ?$8D,]HZ_V3X:5@5_T0_5#-_#(Q9QM"Y07F@WE553?S41M_9 MS'_$Q"W%O%7F+._GHT/OO>L91!^.4<&O?J"L0=?,<_AE(5HM=CA-+5X`I%2C)"Z)"#KTWR3"*ZN-\X_7O^2 M?=,PTKEB>(WC@&=^.@P,&8JY`&B`9?%JQ&<&TY[R=&&L"+GW^7!X+D(2Z_;& M8X;AB+"*06R]T:@W*A?$UG6CWMYW$!NX05[X.E/?B9E24=OP-LEB>M465IA9 M1/*L+&4BR1W:`W:$R,O_EB"ME-2)"E.RW`HS7NZ2,:J,O9,[3X9&6;MOC`7> MR`<@A-(,U.1FB&45V:GW*J<@N_6.3/58S,$LA9Q5+$9Y8*CEEJ>D1;Y/&AI' MBU^E.,LK;NNW-!'X&T]4[N?IQN!(J(R[/22#K1XZ-.;_Y2FW6=9(34K&6&5C MV++W2EX>.A]?6[2FT9D"']D5-3D./PH&?':6UJE&:!47"@9$,L>:*-#>Y\;[ MR$I&\IS_0ME!+<]%J"T7@1!Z2VV'^Y1RG/5R]5%:7Y%542SE5N1)%YO7/-2R M>F4L6EBJ&"FN6%GUY;-71NVU"0/>I('0;9G['?V]!3L5NBMUV8[=G.Z8/=UU%1_7AT2IQ4^)6OKA]O/YE8T93 M5SH]=BM!YCFFQYE*O=A3'9R_]\LKJW\N/J]>+)U4K^+8^P."L,7,/YOC_L_>MS6T;R=J?SZDZ_V%*KU-K;U$, M;Z(H>;-5LGR)WW4L;:2F.2%@"?";LU;Z%K]XJP%??(,')+([:];8I_%0%)A2W.E(L-.H7A`7" M`F&A&/NJ*IB@N/0*GOGL8U>[`%O?%8$?HV[PBP&K63\GAX4"(X>CEJH!*XH' M$+P(7@2O`X+7L8?;;B,1C-$<7>UGX5^Z@^,9V*/>"6O"%>'*.*[:K3T4I>P0%@H-18Z+7,Y$U4!`T7D5C#+U\"'Q7FAB%6W1\:'D5`]-RD0]T3: MJ[%Z#)5W:RA>0/&"M6%%J7X$*X+5X2>F5QY>QQZ,>Y^/N.D6[Q:>#RS:/"R@ M4>&+X:[5-!C]?H8P5<$=Q2P(3'M38H0IPA1ABC!U6.'$TWZC2$<[CS';R MSE8F233.*9I(88^#4G*5`!:X7\:*4Q"N"%>$JU1AG=/9X7T&$LMM#]X',7>I MA%@*G5[#7$BP*@BA\,21HJ%U3CE[!`8"@P:#R1[L54%#D4E[)36JGFFS_L7A M?<=U8@`6U6M\GD0*>E"%X$+X)7^>!U[+&WZ[01H2]B9HN!@&\VBS<52 MXU@9[[EQI-9RCUMG^*D94WFNB MH,0^@A)'@V&N>-#=*O]H;79_EVZ?H6P`9#=<@.3-8@V1[6NZ!WUY>;%*,:WL;A60C MR<8R5Z0AT4BBD40CB<:JB$:3]8E(-J[K;?\8JV(#RZ[/?$*RKV+,?@T\[K]E MJZ:T+"`Q=NQX=-GJK"/IY_EV_8LWBXD`QV["GD]L8P\6/R?#&[C*3;<51U'? MQOHA_<"U]2A_W1GEL-:-L+BPV-7@[&W#PM.;;D+A`]E8G[O@KK>3.X8SMX'C=E3?07+HKWCQI1/#X-8*KKN-G"!BMR!3 M`YM=82A-JGZD3[]WW?MR2DUY-V8+^([XX5U-A= M_:J.WZ_K__L,#JI$>\<'PSZ^[&#/-G-SO?$7*;CY*+_PRF,S1#9V@*F0WA(L6Q'I+>(S-0;7`MW`7QG$0^$R,&B3`;?B=)^$ M-?+!S1E.\)E!$C&9A*$[8;#!:L_#7%%/WV;]*.`@KV`\O!8L%RG`FJG!I\!. MK)@A9@;`WH`4O-R"20:>B#!W'Y>`?*215&X"G!`R_D".@' MD$3<%=G.@""`9XKP-`DS[.)@`A6CXS_`I(-H@E],J+U&O3L3R`;5'ZJX""L? MYR10L,RC`\MFY%@C=0.(T&B(_!\`<62,:QP&@2TQ=$2*THBBK(/9A/I-*3JE MA4!*Q!/X!'L2*P$B0`F$6E$*T"/CR(ECX3/@QO[$$,]=%,)SP#;`'$XT11P( M.0Y?432*.`51/P,HST$T%8GQB,AC&&\3BMHK;<1 M$F.@6@Y?DOD!'O5#BT(I=!3N>-(/#,\PD&(',5XV[W!/GOF-)X:2+@1/+6BK=\!)N/X`6QD^X MBF$4C$'#-(3[@6Y").:+H,Y;)%X"S54!:"'^.`V8EN6^"!+0KB MTH5;!A&'B27H@HG,F!@!/Y[V>03WXBNF4V#&:#)/'BVN83;H;\$`PA_"G7ZV MY`4/#"T1D)W"'Z6$D3!M[5;8CM2>EM*:LRMPG('CXS=<>!0,8`2]'^([[(V= M703.EHA\GFH)<"GY4"@=FW<8=PCB':>X^'T66EG??'OJ;:`)Z7-Q5C\_-Q5< M0U9WI,1"F\A4",LX92LY0C<_BV]DHH>]-O#D;N^LUN[T:JVS^5.K)$;*&T)DTWSO%N-M^D?IK\TW[Y1:_X9C'\K8)_9NP^+-^D_YN[!6VI@ M"@Z%:FZL1%`ZLHXXYFZ^4_$?F7]B;:7I*[EOL3H-Z;6G%W:L=NLV#@ MU1!<$"4$;#7@5S`+T?!GVMSOL-=XT\FJNT[>9"IB!$20:=0@LR(-[!OHS5:G M7;OH+;8\WIH)P))E((FY3$!:ZY](ZFTXU\?A2FTA8+19X47&@?4-@T*^Y)9V M;SAH<&8ZUE?=3R.O+.7H-J3=TQ5,??+?!$&;B'J:0!)N5OGFY0 MM*:!:PG4ABLIDAMEX=UYGJSX/?\8'VP.(%D^A:>!F&2.>8]NN.*1$R*)R M]&X%F-S#@`';J@2,3*YK(^5)Z4`9I7LZ$%@$-[[824"399:H$,02-JF>;-+V MBG[7SN,Y4\AR`["AX8.*$;&5H2$ZK[RM>'I:)!5]1KFTF>L;$L@\/0R?7.R> MU[M[JX]WU/+[@&RE8@O\3-^"DPUZT$*>#BUM)_HK?2;IHM'90P^D8SMR=(Q6 M_C4&.NW-E<+$5$'1+V#DUT;R*NB MC]H?`A<6%),P?)K^((S3%K[DKK>*D?^;$*R"FF'UJ?B]3(ES6Q:H,?FTWW5S!]DZ)M+*L_/W,!XW7JOD-SW1Z&P[%1%Q!UIB,`7 M%Q=@(1)RKMU`RE%>@3A4>)<\_SM="#0AOH,)68KJA2\ MH`_K2\_VPA/A.;/TN)49M@V?/>^OTWV6GO=]=_SP[[?V[^GNBVL`IY:JJ M$P2^+W12Q/1`?#I>+K=4'0;6JF(H?'6@9"Z=0HWVVH7;W!KKR\!%R'/VAV4B864!-^A4>/9H?4N8<'1')G2=691#SMQETW ML+*Y<>38(%+$FCODKDG5%VXPAH<`L[LZ43J_1K6(&F8FCT$:X/^UKL,TD9&P MA_K$2^P\I*?ZI0S2FZNVD,\4?G-IQ%([VIS@LV:]W6UU>^U.N]<\.VNV#R@GN+%M MCNZ^ZMO"W7"O@`0P6(4GJG`&@6Y9]-MOT`[D&=H^32O M+4AXP]RVJ.Y6&8";9'P6V$VCK&!7-UW9GN,[ZKPPO=YZP==;.TC&BK^]6I>E M#O[EU$5]\10NG8`P**ZK(Y4_HXK%6B3B>RA\"=ZG+V*ROLQ;7\\U8RM7^E/; MG(0Y:D%R0.9+41+F1L7UBA`O!T2\\LJ=:ISY;+(&&3\O((2JE!M^450K'.YEX6GV?E6]@R1+ MZH6C:-2/K:`8W''W8VOWJ%?E"^B>\F2>4YKJ7.+3PCPW'^:5 M\),_5(4G=;EPO"L.3E5%7ANS0G`"^B*&52EUPI_,LG5ULA',&9\#DL3%O@$# MB37,8U4*!Z_4$U"6$^]T3:#,5(I6U%(@/C+#1$J3V>OUZ8P48N MS<5J!$;FS>>*14_[^!CL0-,L:.(J#_-!N$&(*$^K8^?Z':DES'4GB)`?,9$3 M19R!60V")%I[F*+K.)LY<]`T4CP7=TNJ1%[NRF"FAK)>$-EYG^<[0:AMGJ9W MRUQ[F;$2*R#B=$JMDOV@W"R4^7+BBVB(V:^VD!8P-]:CQM-?BXV+UNT]I"I; MKQ)?^,=5DNU1.?8,81NW4-+/>(+?-2!62%'J]+#;7,O6**EY5F\6V5^KK0BJF">8(-!2P-#Y..W_"`K6*0/*"6,@V MU4QKJF:C6;\PR)'Y[F93D,-G/"V5;8;%HVB"NSJW1>J,I#O1;)&>/U9=G_KJ M4$P4*S6G*K]'6MOK8];.HPR@&2/-V&?NW!]A:MZD.-CKQ6$/##31]"3 M\##4U-C1)3W,[<^82!L-R$=:SZ8GB'P[;8W9ER!!4'R$?*+&S-]=`W=SB;?/ MUZ/>^]?&L\^[BZN.[BWH@[EVP]Y/,;#GMIQ?4E`,G/VLP`C;U13K8&WGO>AD]2X/;9(T^52 MW8`\--/?Z\:*@[D&B>VF[IAB1F+G`C`\UQT*Y.4X`!GV%\E&BL\L765:^0UI MF&\)'];8ZQ/]\\D;'"]R'D"EN1/86!=,V&LP(D`>#QSU[1='2A"<3MKJ&B6S MH_R64'6:LT2B>VE-.W^I(_N+93H,&;V]=C>!=;+BMEA"W,IN0>)%$68.7* MED*%LGH#,+`IT!23ZS1*GI[9Q$U.-VVZD\O.T_[Z?>WFR7,Q8!-Q"$/GX:>4 M0DV>I#U^]Q#4,14C-%0$HKE8YFG[@,S]U/#6_I$RX>Q'_NL:$9'J:JM"#(`% MU32M;7"KWIYG71,_M&'.:'G?Q479T5D7P-"R-&_ZMFK]XI:OJ/ M)K]HW;V>1?X![,^]BY!OLA?X$0XL=.0#GI.+ZLQ$2DYLO#6TU>?U3B'!ZEFH M2>UY%F/'Q>XV_-,*!"N\3,.:0'7N3L#$SA>G68QSSF:GHE%]&;A"6@)AB>^^ M(C!U37BTIK"9+U]8$),_BN_7'@7X4X[-WKBX(K.?DLT68FR[6OJ5U&0R*O M5U`5N'D<9R^1M?7U*!$IIY34NPNTMM`<4Y&'!["IIQ7_LF[%"[)S3O-IQ.8Y M(K.>TF`T.DL@'@6X\]8L7#R%]6RR9+$83[S+[.TG>6#[W4?XM4HQR03[YJ&Z8"1(=;=FP M;J,WRWW?N5)8L[5CJ;#V&9!GNQI)93;^O69>45"WGJ0/?4X?I M8+H6TIGDJA\Y[M;-==\^Z@/%)9)B!Z=>26Z1W-JP%*'A3GPDNDATD>@BT;4' MT:62I4EN&9!;)8G2%H`W-:2-!\64BWBI\X4<7^CAKN93S9]^@[9EI&,_D8SJ MR_N*Z4/B'^(?XI^"Z%-@^+195E6H;KK&HVVJWR1^P%S%!^YB,NU!6O*'0+&# M,-8/PA[O&"S<6_42XA0I."#-3_*E%/*EV:&^3"1@2,"0@"E(P&AFZ;6:K>)A M5A4YLWOHL-P.TU5ZO`*K30EPEK``]A9.>J7:F_7J:W=[/9;N9A2P.E(LM+H& MK59"`Z&AW&BH+Q8!/W(L4"AZ96M=74_`$9L$GX^L<>/Y'E*WJH(T"HGL01U5 M`U:MQGE]L>L#`8N`1<#:+89O+C10>5@=>VCM.HDBK).T4-%(%SHY>F>J8>Y] M>U4@0X&%(\7".6&!L$!8*.HU9E4P0<&V%3QS&XF0.W;6Q$;7D0U4/P`K-<.* ML[JJX=JTZHN=!\FUH8@!10QV*ZQP02%NPA7ARGSTH/AZ)56!U;%'XF[30N;S M!(AH:Y[(&J8(%";RMXY5/: M;(%<%3I83!&`4NBB:L"J6>NTNI3F1M`B:)7@%6SEX77L0;;/CSMY4;4Y<_*' MW'#B'^(?XI^J59MK]G]+GAMY M;L;[(70N6A1O)&@1M"@H\O+P,E"9O]06XG4B88(BTHWLL8WUR`FU@6@[,HZ< M?J(:8?LB'@=@1Q:!OE*!K$L'H.9C$'E):GJ1:T.N#44.2J6?"%X$+X(7P>OI>MVM/332K`JNCCTB]UX\"#<( MAWDCZU\;]4D?XSB'`>EXRJ!JW;M MHGE!!QX)6@0M"B&6S5*LG$$(=#LMOK9LJ5!DL"9?5;!"D8HCQ4*+L$!8("Q0 MXAY%W;;BF?L@YFY90FUIC!BO>"9`O$_8=<[V4'I\_:67&*4422A;).$P$=FM M-9I-<_W4"90$2@+ESK&_KKDS5L>-2`.YA24U6=60MK""2!TUN00&$)'K^$(/ M]\7A?<=U8@>+PTB9>,*FZFCFI-F!\=?!T8?XA_B'^*=\U='*'<&YLBQ88"Q9 MR">\[XJ#-T]?+K&#:J&1UU=9K^_E7L%UVI0M1<`B8)7@?5[EX77L25-WHR"* M3V,1>DMEX:7L<>C/L2X*PI\8T<+`HZ4-!A M1:?/SKG!HLF$!\)#J?%`.H*"<)ORS-=JS MUC!86.%(^JM1,(.PM*KWC+D#$P0F`M,Q@ZD(4_!(,$61Q2=;$;RP>5@-3ZUG M,"UI6X)5!:\4(*$`R=J=0QNM'AW+)6@1M.A8;LDLS/U#JK`WU"+K%,JX]>_$ MB81=C#'4!F/(#A+L5;^+$[>'GA6[$?35WLFW9VH9%E5=@W6FGZ/8430\.3S9 M=7#F`(DM$EL[5H6L7?3:!CL9DN0BR462BR37'J*=;7,Y_22V'GF0/\:JJSLM4ZV'6<)U4V;_Z:1Q MHK[#9EG9]R73N'<\(=E7,6:_!A[WW[)5E%_F=(\=.QY=-M81UO/@AT7WSO2<@.91.(>EOC.#:QO?_^?__ZOOSUQ MRYT(><1CX4Y^%58P]&%Q]GW$?X_ MF_^Z?_]'^H0_LB=<86A'.CC$U7='_A%&P^"/KSQ.HG$P/.@L>.^>07 MX?5%=,(<&P:$9YYV.Q^OS]JM#^_.V^\;[8NKZUZ[>WUQU7KWOG-V=M[KGOS] MT>8_)016R8!->"?/+9T>,,NFJN`Q[ZB[%L.<`_4O?=DZ$JPOP`YD6A["XP$P M,:PMAK^$262-N$0._O+ED3W+FMHIC);47)%&>NO@]_Q@_B#R@7-X*:LY)+V/*XM',/1X-'5]/ MDB=QD/V@;7KUB]889[WNS`:#?71Y*,5E]F&!E9;KH)EL:RT-X*^A1-1L?CII MMX$_-]1@Z:W=K6\\W_;.SK8WGM$B2[W(DKP!.3A??#K=YSJ0%I',]@PMGW:A M%A3$UB[E@?&Z0,S=A\919!(^X2H]X>MUPSB_ MW><=O:LPWE*_>_?9$MP(;L7##=S%M1FMP/S=4J==Z/3=J><(?KQT@(N4V_B2 M(%Y)^B-Z#?`<]Y4Z_-\\:^RAL?=1Q/U+),8.3KN2X"+!M6'&Q;G!]Y8DMTAN MD=PBN;4/N=5J[Z&GXU$(KI($J@L`G!K2%E:@/<1+8``18>1)#W'+FV`L,7UD6 M[&XL620L`3X3GFC9PE>O5%^7-C4:I[@5]3A2-S7,%8XB+!`62HT%ZO=%<>E- M>>:S_R#\.(BHE]=3*:C4<(@"(X>DEJH!*XH'$+P(7@2O`X+7L8?;;B,1XJH*9^(?XA_BG-*=B6[TRJ[S[B-O"X]$W66,Q?F8^ M]P1\P==._0C^2UE)*XEWUC38!KSJQB4Y;>2TK9OMUZ3SUH0KPI5Q7+5;>RCD M6A5@&2@=5FK3\#J1,$$1L4BXJH28'#FASD>R'1E'3C]1'8M\$8\#,""+P%VI MX-5NFS,'JP(BB*F"@B-P*9OD:^+`X+Q2Q MZO;(^#`2PMNP4-V1.38-<_48*N_64+R`X@5KPXI2_0A6!*O#3TRO/+R./1CW M/A]QPQ"7L$1@(#!H,)GNP M5P4-12;ME=2H>J;-^A>']QW7B1VLY"IEXA74:GV?1"Z#4#H88I56FA/'$<<1 MQQTLX8X]CC%M2QCR"?4D1(.5#A^2\T;.6U&)%(0)P@1AHIJ8H.2AU496E`A, M-I]&,8K`437>PQILA%OYM[#D+U-Z`YV6(G@1O`A>Y8/7LKM-&A+Z(F2T& M`K[9S/&MP!,LYM^+-A=+A2^#5F%5X$,AB"/%`H4@"!.$"<($A>4,E`A[61OL MN7.EU7".6F?[JQA1>:^)@A+["$H);*&*Z0S:O/+;ZP M55LJ%+8;YHYS'4L9&0K#$)@.1:41I@A3A"G"%(5&-PF-BC@M;L&X]>_$B81= M#&^U@;?L(,&*:KN`;^6>I$_#6XMBX]TH_6IO='V6;Y^B;P%D-%R#Y,Q@#9+M M:;D'?GMYL4DQKNUM%)*-)!O+7)&&1".)1A*-)!JK(AI-UB]XPG)OHHQ^S7PN/^6K9K2LH#$V+'CT66KLXZDG^?;]2_>+"8"'+L)>SZQ MC3U8_)P,;^`J-]U6'$5]&^N']`/7UJ/\=6>4PUHWPN+"8E>#L[<-"T]ON@F% M#V1C?>YRWQ),CH2*W$2"A9%P'<_Q>32ILYV!NMY.[AC.W$K*I)__]F,B3X>< MAY?O$@DSE/(Z\/JP?"PJ=B="'O%8N)-?A14,?7BL?1]Q7W)+]66_QZ7>PQZ] M
?[S_??+U;X`P#XS^-E>U`_B**:I.IJN^.#\Y`?-G!/F_F MYG[ENBP8L'@D6%^`TZ'#RIK/)1OQ!_Q=^/"SJD(.K8C;@3L0>N)M@?Y"YAZ=3MV'\9^0P\=:F M<_\XH[H`P>,!C;7RF_($9]@*VA5@68-U*]36_)G80]7PC_%^D,#>)7$"]X@' M_1ML.;##A(T$?X#'XRBYP7U;,T&H^+?.[F&?9P,F^-@X8+:(103*5R@^R&ZW MY]E$`HGTY8);(]@!^$GQ=LJ$RWFOA@PV!G,3_Z\NA:L>D)DM#@B!QR"Y8-Z. M!_9HK%`1"9FXL1H\"(4NM`ES_Q@@Q`(IYC&)^!N/')@23CY,(FL$Y`38.&!A MP-"!I09@@+*?XL$18620&&15R=]I)A,C%7SW!)5`?R<=@ M:DY@U]D5+I`%_9@[OKK(\6%.GKX7!H4A@;_^(]3:IO/+B00DBY1J2VK,B7&F M$3PG\$$S3U@8`.G1B(]'@%QL[Y-.O`]V_8C[0R!V^F#<*OW8W+X\)QS4L!Z? M:.'&IWLRW1%_]::H07%]OH5WP%35II#D,"PY$+;@?@M+;P"?*:DY*-A"6I'3 MATW5NDO)?<>WW,16.D7=<1W@%!'Y\$DY\`KK'Z>[>!?##UI`@.Z1(3P5$`N< M.(@"3PV!=^`$E"#(S:#.?O-=@6(!V73L2'RZ#9Y)K`1!3K]8@8R1;=6QEE1! M.=Z4]9"MYI463/[*!NAB7U3-XN)[B,LX3EXS9[&JBR^=&`:W5MB8V?GO6R7P M6,[R?SHKDVB_">UU/@,'Y3X.1BZ['7'0(>R3U__YL&9>>F%ZXR^*C,U'`;8KU$\>U96;,O+O^&2QL M907_93;XS?TU:CP[`:LG#*)X`,HQ4+KH0Q*!T<-1;WF>B)2:!"LOXJ"-X&JP M"-,G:IM+J:[,TD,+*PJ2(6A*'S7WJ<4EV*JS"(RVL)5?9F`WTBR[=K?SMMEN MU\\87`_+\$UL]&L#@[Q2"3`&9_6FSFZT00I;F%FI/-;MTU7T&VSP&7_R)291 MCAWT/B[TS\Q[YNF]'/?0%AZ/OH$]'L/V&L&D">EQ.@&QC-[=(,$S%`,!WE8B MXP!85\<.4'6/G%"68.(^'GX&00ARD/%A)%++U-S$`9UBL9RTD;DK]QL^6V"H M*D&P\LY9W`7OSP5/T&7ST^A'?Z+T.I^&%*:7J)ACJOYJ M6LY(<+RFGA[>7D-AAM]&DQ"=+/7:9WX(R;W9.$AL$%?9L]08>A7#(+!5&&$F MV200#:L+H`)4LD^1@G]'50:NO9#U8[1$BS3W[RP>78WYQ,";@<7!<1PPD)YX M2?C$N[%N&.<39,X[FH8P7N[7Y])FGB5S,09^;G9/?SK`N9MQ3JZ2(4C/V4I; M/;.>R51FF&'@PMG5Q++YU$_XK7Y75\Z"A-4S\$?X,.>#Y%P'%/21HV+[H#91 MEJ?N!0HLWC0^I%:I#X""%O"9>QU=DZZU7C[Z>X?TV]-C'0N&%Z#),)W MK6";@B'#,1<`#;!IO!KELX!ECW!D%*OB>ZBFHW(1TEAW,!@(#$?(0PQBMQJ- M>N/@@M@J'7_?06S@!G/AZZGZ3LV4`[4-'](LIJ.VL.34(C)G99&)9'9J*^R( M&R6=;U-):R1UXH`I6:"U\#NFY,E@QJ@FWIV,`Q,:9>E[8PD2&_D`0&C,0/4Q MK=!=4)'G]8N#4Y"]^KE)]9C/P2R$G.HU&O/@CR.0J!BN,D'*0J:Z)/.DU35I M]*IDVF<-CFQI@> M&9GE_.>.'=1FN0BUQX=`&'_@CJM\2C/.>K'Z*#M?,3U%\2BW8I9TL?Z9!Z") M;6<9AX]/C-AX*E"_?I\8J,J:7Z1^[]R9 MA]=`V-30E&\NC=#)@F>):"5A_YQ^3VG#Y?/W\_.FK>6 MEII&]0/26[M;WWB^[9V=;6\\HT66>I&[EVH_SC)*T^FV M7Z`*[C.T7$*_IQ3$UI4DEON&4[]C]UH@Q&[$;L^QV\Z.Z>JA#]%173U;@AO! MK7BX?;K[Q]J,5F#A[U+7_=;M8::>HP7.GV.G50E>$L14J+'B=1C-EN\^ZC*+ M)1)C!Z==27"1X'K!VMHDMTAND=PBN56ZPM='+;A*$J@N`'!J2!M?XRH/\5+5 MZ\3(4WJ&8/ZU\64188[]A#&J+_`KIA")?XA_B'\*H@^U35QA5%WCZ2UUK`8_ M"%![#]S%E*>#-.4/@6('8:T?A$'>V8,Y7A6+FT(%!Z3Y2;Z40KYD!YY-MHDF M.4-RAN0,R1F2,R\=02RWWW25G>Z(A"7`9\*68UOXZJT"?/4-$IS,XJA=;YO" M3U5@0G&K(\5"HWY!6"`L$!:*L:^J@@F*2Z_@F<\^=K4+L/5=$?@QZ@:_&+": M]7-R6"@P[CM-A(A=^RLU:1LD;-%`0@*0#P*QC4)"X0%P@+I!PK&;<$SG]+:X.33K*)0MUU?+'%(S@S% M"BA6L&.*L;'7J`0K@A7!*H55C]X<4>QM[5>QC^H3TZG8`\XYKJI@)OXA_B'^ M*UD'!=W&D8S+5<0[:]9[9%R2TT9.F^%LOR:= MMR9<$:Z,XZK=VD,AUZH`RT#IL%*;AM?+VP^C86@[4K=IQHY%OHC'`1B01>"N M5/!JM\V9@U4!$3GN1PJ&"W.E=PD+A(528Z'3,I* M6'5[9'P8"=5SDP)Q3Z2]&JO'4'FWAN(%%"]8&U:4ZD>P(E@=?F)ZY>%U[,&X M]_F(FV[Q;N'YP*+-PP(:%;X8[EI-@]'O9PA3%=Q1S(+`M#&*<$6X2A76 M.9T=WF<@L=SVX'T0 M%304F;174J/JF3;K7QS>=UPG=K"2JY2)5U"K]7T2N0Q"Z6"(55II3AQ''$<< M=["$._8XQK0M8<@GU),0#58Z?$C.&SEO1252$"8($X2):F*"DH=6&UE1(C#9 M?!K%*`)'U7@/:[`1;N7?PI*_3.D-=%J*X$7P(GB5#U[''GN[3AL1^B)FMA@( M^&8SQ[<"3["8?R_:7"P5O@Q:A56!#X4@CA0+%((@3!`F"!,4EC-0(NQE;;#G MSI56PSEJG>VO8D3EO28*2NPC*'$4N'R!@_($3X(GP9/@62ICN$(VKSZW^,)6 M;:E0V&Z8.\YU+&5D*`Q#8#H4E4:8(DP1I@A3%!K=)#0JXK2X!>/6OQ,G$G8Q MO-4&WK*#!"NJ[0*^E7N2/@UO+8J-=Z/TJ[W1]5F^?8J^!9#1<`V2,X,U2+:G MY1[X[>7%)L6XMK=12#:2;"QS11H2C20:2322:*R*:#19GXADX[K>]H^Q*C:P M[/K&&/.6#'9:GY,TNX;LKV/YTT3M1WV!PK^[YD M'O>.)R3[*L;LU\#C_ENV:DK+`A)CQXY'EZW..I)^GF_7OWBSF`AP[";L^<0V M]F#QCNY8SAS&SAN1_4=)(?^BA=? M.C$,;JW@NMO("2)V"S(UL-D5AM*DZD?Z]'O7O2^GU)17XWP2KL5#R3Y\#X,H MYG80<68+]HOX[EA!C=W5K^KX_;K^O\_@H$JT=WPP[./+#O9L,S?7&W^1@IN/ M\@N?S+R$9JO&6HWF8I_,S<>ML;&8!JU-3+39:/Q@8!@6#-@F3/KZ)+WZY$V- MQ:/T*NZS(!2Z2*+$(=\GT8A[-?85!ARQ:QZ!Z>CSTSZ7L/I;#C<&/OOL6_4: M6!J1"7J\:G?K'087N3`'$X1Q?&9Q.:JS>UAEF$36""8/FLL!53;FH,?L/Q,9 MPW+L)$(UA\0P\-QX%`G!//C+2#(!2%E\Q;'%8@R,<2?"6'A]$H:PP>+ M`X"'JOJE.(*S<1!]0[H"LSFJJKFB-S9#9&,'F`KI+<&R%9'>(CY38W`MT`W\ ME4$\%"X#@S89<"M.]TE8(Q_#(AI)CF^YB:T2_]5BKW^^A@4/D0)ZQ0M]?V8"9GHO M9W$$T_?F`B:GDR^&'0T M,/T,"`)XI@A/DS##+@XF4#$Z_@-,.H@F^,6$ MVFO4NS.!;%#]H8J+L/)Q3@(%RSPZL&Q&CC52-X`(C8;(_P$01\:XQF$0V!)# M1Z0HC2C*.IA-J-^4HE-:"*1$/(%/L">Q$B`"E$"H%:4`/3*.G#@6/@-N[$\, M\=Q%(3P';`/,X413Q(&0X_`51:.(4Q#U,X#R'$13D1B/>#S3??T@-1,4+R)E MTH%X"&3CUDA(5*2.G-(3S(P<!#*&,;KM(+6>ALA,0:JY?`EF1_@43^T*)1"1^&.)_W`\`P#*780XV7S M#O?DF=]X8LC9+0@LCP.D8*MB]A4\G,.:?.G4IRDO'-RMF8AI-\SZX:BX71&G M)GW><0"T*L9`%8X1RCA7'V^B%;X_42=Q`9:1PKWJ":`P[O*QPOL[X0Z=Q*OK MH;2SR&#S,(C,/B0HL<%AOKF_S@;4G@,(`1!+#XZM90C8^B!D0")]$Q.00+X8 M.+&LI=(-+^'V`VAA_(2K&$;!&,2=C'%6X-L$22P=\-IQ8K_5[^HH^V?#@ZN% M)B6WHD"JV:'>AD'<`'0[JA)P:2)/6]T6Z`^,-X/TA&M!+N*$ILM0+EL$SE(- M92'X,0Z8G>BV!=[_L?>EO8TC2:*?]P'['Q+>;HQKH-*(NBQ5;2_@JV9J4-=V MN;<_I\B4Q6Z*U#!)NS2__D5DDA)U6D=2)JEHH-"61.81&7?&`;HHL$L/7AF& M'!86HPDF4F5B!/CX=L!#>!>OF-X",H;31?!H=@VK07L+!A#^([SIIUM>L*?Q1`A@)R]9FA>-*;6DIJ3E_`L<9NCY^PHV'P1!&T.)E`"3DC\*)6.S!N,13KSS9!>_SUTKNZMOVVX#37"??J=^=67*N8:H[DJ) MA381J9`LHP2MY`C-_-2_D;(>=FE@YFZO4VNU>[5FY\K$/M1*Y1MMS%Y[4WOD M!4I:PF*3..]FXWWRP^P;Z_T;M>=_@/)O!^PCN[E??4G_F'D'7ZF!*O@H5'-C MQ8*2D;7',?/R=^7_D=D9:QOY-CIT=N//T()HAB M`HX:\`NHA:CX,ZWNM]DEOG2QZ:V+-ZF(&`$09.(U2+5(`^<&0+[FMS1L.DAR, MD@0-0=AYP;.6LCY*>>UY9Y<@6A-S#,7Q#QLL40;F8<)I`$GYF^T-BG94<&V! MTG`C1#*CK-R=9\&*G[/3^*!S`,BR(3S6PGV[L?B&I96#HO'H^GJ1/(Z"]`L= MPJ:^T4$.5^UZTVKU6MWVU56_=]6V?DZ#9&PX$SZ1XEWZQXI!L#Z&8G99WUF; MJK-#"(1:V2\75YV?]XR^2%ZT3OQ>LWF2"?>+&!F[CN.)(@5"YA6C]TV`ROT8 M,$!;%8"1\G6MI&SE#A11>J*$P#RP\=4R`4V66:)"$&O0I'J\2>LK^JZ=1PNJ MD.T%H$/#'\I'Q#:ZABA?^5#VM)TEY9VC7-K(]3T!9!X>AC,7NU?U[LGJXYTU M_RZ0KI1O@9_9+3CIH(5F\I2T=!CKKW1.4K_1/D$/I'-+.3I'+?\6'9T+GDO2 MWE_!N5"E:D/-6N.J5U^]YB!UE=35@]757%A4@:!7.-ZU![_*.]6^"%B8DT_" M<#9](933)EYRUYOY\/]]`%9!R;`Y*_YD"S-S+;W_17V>BU5'GG.0@;VB:3,Y M"I[]-`:/#T`&,'VKCD$(.A(.0Z>G&)`0C`>N#GE#IXTC!O/X\FBJ,EZ2R*85 M>.R_W)^L;"+#P%Q0>7;E!L;KUGNYQ+XON<+2K(J0N](0@/O]/FC(>:P=V]1@ M;@L@@\H+P7C[8Z*"RA9*?3J"3@+>&,<8,I5G@W.-?7OJ_6P@D(8ZAQ*C%54(7C"`_26YO3`CS#,/ MC]L8$8=?2V''F(T83_`]`YB6K+?5;;]OMGOU1B[8;"+^\J?FU54^RWM39[_M M%YQ8FT5LJBAS3!,=#EW/51EMZICBP1_"CE0*KK',+`/CZ"1+'_MA!>.)B%3H MN`X0K\TR)6<4D<=&G@.CVT`G@NU&&,3/!`?N;N-!95:=TJX.W4."2\AU$Y6! M;,<79$*I.@44I4@H=*9RI.D6Q`D/0^Y'*E!?Y=F"Y`=A'\W09\)#E?.,`XDH MJ&[>Z.FX=?!BOK<._UV7[7US^X]YMO?OZO=8M8%3PE55)PA\7^B@B%E"?#)> M)K94)0-K4?$H?)50LA!.H4:[].`UK\8&W%CQD10DJ=]3`40KZII?D2 M\!Q^H=%)J5@`3?@6IA[-D]3Y&!-$,KFD*B<1L]VXYP5VNC:.&!N$"E@+2>X: M5`/A!<\P"2"[IP.ELWM4FZAA9/(S<`/\OY9U&"8R$LZCSGB)W*]OV>D"GQRJC>PG!H[=#'7A"E25\FH)OC//V-?9))(K\Q56\A& M"K]Y9T13.]N8X(Y5;W6;W5ZKW>I9G8[5*E!,<./0&-U3QP1W"Q@3G&-;AL*Y MO=6GE3IAGX`006,48U..-7)RSY?;>H5V("_`NM(SACQ6^O=D6IPE].]>NK6;B4`6&075>' M*W]$$8NU2,2/B?`E6)^^B$C[,J]]O=2,K5SA3RUS'.:L&4F!U)>\.,Q7Y=?+ M@[T4"'CEY3O5R/EL-=L&F_N0SE,(89X71_J$-:BPSN;"]4$:N$'*SRLPH2K% MAO?S:J5#<>&'2*Y&F5F5#@S/7!:^3>]7U1TD:5*O[$6C?FPY^>#.NQ];JT>] M*E]!]I0G\IS"5!<"GU;6N?\P/RD3TF1#%XP)6HC;6?6$U'2PO&KK`N9'$D6D MJEZF<40JPNHODHDX#-X"_`)L8X;/+[6(<6(5X`5?^8^J\*0N%XYO1<%;59'7 MP:@07(!^B&%52AWP)]-H71UL!&O&>8"3>-@W8"BQAGFD2N'@DF8A2*I^N8@B M3Z0&U&S.S2NE.&WS-6UG?5@6JS6N-&QYIZ*NX>#<2+S%>O'8;H;[#@:SL:4? M5),0YO.Q2)JA&*FTK4!D8)R5ABBUY?7KC1ELY&*M5B,PLFZ^4"QZUL?'8`<: M*Z>%JSC,)^$%$Z3RI#IVIM^1VL)"=X(0\1$#.9'%&5C5,(C#G8?)NXZSF9P# MRTCQ7#PMJ0)YN2>#N1A*>T&D^3XO=X)0QSP+[Y:9]C+/BJT`B],AM8KW@W"S MD>?+J2_"1XQ^=82T`;FQ'C5F?ZTV+MJU]Y"J;+V)?>&/FSC;4CGVE,+V;J&D MY]B"[YH@-G!1ZO1PW%K+UBC)ZM2M7/*%=NZ4I`/)]VF3M-KCB&&0'$M#P8]J M!F0"J&VKWC&IHY^^`]!^X%;=@G)N$73MI,V(O*EFI`H$,\K0;`\S6J6,Q\>V MO5(?5T(Q32!'H$D!2^/CLK,9%BA5!((7V$)ZJ&9:4UD-J]XWB)'9[F8S(H>_ M,5LJ/0R;A^$43W7AB%2.I#?5:)'D'ZNN3P.5%!-&2LRIRN^AEO8ZS=I=B@": M(](7))G;GR.15AH0C[2< M33*(?"=IC3F0P$&0?4SX5(V9?;L&YN8::Y_O#F,&)#?\Y>*_9+?;[=Q=]_LW M=\T/G?9-__K#3?_FOO/!NN_VF^V;FR,DU9<`,+"W*D/YX4.>C_)PHG9VKC*M[(;$S;<&#VOL\D)_??$&QPO=)Q!IWA0. MU@,5]A:4".#'0U=]^NQ*"8S335I=(V=VE=TR49WF;!'K7EJSSE\J97^U3(OR>P*ECRD=HJ`B$M5KFZ7"' MS,-,\=;VD5+AG"7[=0>/2'6E52X*P(IHFM4V^*9N3ZYU;GC"6.`[X)+?-/RO MYTQG>[Q%1;6P?%2(U3OGH?IO?J>7,-GUG@U7UX[R-$'-;8BTG_W:MY*B'1$: M11/T]8UU!21\$7\Q0.:#52=5QA"JS3U6VBVI+"%=>(/Q)^YZ2MSPJ`QMH8D6 MC+HWO[N(I]K'[:HR2C,4JH%6\N3*M!Y2IN[&G&N-^--CNOY2\M?E6[NYQ[_H'87[J+D&_2"_P0!Q;: M\P'S9+PZ96Q.@SKTI MJ-C9XC2K?L[YZI0W:B`#3TA;(%GBW5<(JJX)B]84;6;+%^:$Y$O^_=J2@S_! MV/3&Q1.I_I0!_2)9S'%8OD\I/3LA#H7%_8"ZA"H^A!>1:5]55[NN30"O9>4$ MO0Q(YN0:3]`GG0;:S'FYMC6UR6B(Y?5RJ@*W2,?I);+6OI8"D3)"2=U=H+:% MZICR/#R!3CVK^)=V*U[AG0N23U-L%B-2[2EQ1J.Q!.Q1@#EOS]W%,[*>+Y8T M%N.!=ZF^O14'#C]])']NJY;OJ<;L3_YZBG'W;JY[MMGG5!<(BY6./%* M?(OXUIZE"`UWXB/61:R+6!>QKA.P+A4L37S+`-\JB9C'4?/L-VH&>CM-X,JK/[RLF#PE_"'\(?W*"3X[N4ZNLHE"]=(NI M;:K?)/Z!L8I/W,-@VD)J\D6`6"&4]4+HXVV#A7NK7D*H$H5M5H31RB9Q`'%6#K)J-J_IJUPTNN;RSZM"*>1T.%-:L%J-^IJ> MG40-1`UG2`T-<]$#5:$%5FO!]"N]\D?R.1%I$6.45>G[P,5.8O MM89X&TM8H`AU(WML8SUR)UI!=%P9A>X@5HVP?1$]!Z!'YD%]I2*R+B5"D?E. M41C)!5>KWZ**0T0/1`]Y*6!5H0ERT6W`F0]!.(X3U8M,&S)MR'-0*OE$Y$7D M1>1%Y+6]7G?S!(TTJT)7Y^Z1NQ-/P@LFPF&3,'!B.V*1L$<^G/7C-!<2TPU8 M$[BL]F`M%:7E(@$]5Z(Z\%D13ZPM$F+RN)6(B8CIG8B(!54078KD#V[^J M,F+NA;)Z$8E)DM]:P+'/]U(DHB2B)*(_V_77-Y5B= M-T4:B"TLJ0=((`(/=<7>KA/+A^XGANY6!Q&RG@L'*J.9HZ; M%0R_"@OGJ1RNZ$6::=0QNU_Q6XHG'R4H18H0TX08Z_Z8XRX M$_2L.`Z@/YT&EF%6U3589_HEB)U%PY/B\:["J0/$MHAM'5D5LM;OM0QV M,B3.19R+.!=QKA-X.UOF8OJ);2U9D'^+5%.9=<]G_L[L"]NQO1T)Q9RL9N/G M]YF-VL*/1)A9+QH7Z#(=EIY_7+./!'0O)OHAG M]FLPYOY[M@GRZXSN9]>)1N\:NS#K16S=_>']S'Y`X'VP=>54%X]C@0VK71YR MJ.K3LYYD$'B.'N6O1],V['5)4+3WE)K;D'J)>G$CZE?7!_D:O7NK)SL8R;]. MA`\+9P/N<=\63(Z$?5BI\Q!R7W(;?Y8/..(#[/[&"^P__^<__]]_ M_'^\XMK!1V)7S;%?+.E;87R#B6];=A^O[EM7N=&^M9J_WH7]] M\3]+A[B-F#?1\F$XL!L'7SYR]=9Z&KC]^OGSQX?/]U\>OK/K+W?L]NN7AX]? M_G[_Y?;C_?>5HS'RN'L?I^E9LFVW0.J-;?VCSY#!H1$PJ*`12/! M',#Z6$HD&S80H)+7V+-@(_X$A"U\9%8@E<*(NSX+5!2E)QZYQQ)*4T4';8^[ M8XFI-W&2@Z-&]H-P#$_:01Q*P8(A&R247&>_"Q9B_U0'QK'#F'L2Q%C(9&R/ M%,G-:)(]CX3/W(BY$NOL#)34C$8\8GQV1S]ESZ[GP>+G*\!5X1+X&)O2X=SX M"8A;,IO[^&@HN`Q\&&[*A(S<,59-K+-KB<\>A\D*T,"A(C$>B'!NC#2[-08, M9/5>;O_1YT?D",PU!Z@Z&BIJFXO]9P/;524AG]UH-#M*_/E1\5(&6X M@%@=ZS9(_9XL@"?5D/#X8'(XZ-EXOJ,/1A]H+!#CQH'O1O"HX'#2:;%*C5&N ME+&>F#M_Q#):1`T?>*3K#Q&EU*KQN6$<*HQTQ!,@[@29>IWI4%\`A@^XPQ7B M.)JQPTQS!(=%2==13XIUT("U(D*-<;MX#C`YT+#KP((`$#A[@N7\\3&$]4=B MN^RK**\R)VS4P^_<"`:W-T@#$,MH"K%2YB*?L0\AA&"H%'^>K):SO2G`]%:R*$93P8NTH(XU(GH0(-_+8T M%K"<1-;B]*%PQP.4KYIB0@C.'S,'X6&E`L"R55,'4`#4LX%RP;F MR*@A4ZTX).+(D(+PD]6I-^;*`3SM`20-#(S;MM&]F@&T%%'D:32!D]?G%\01 M9DH#$.ZT:+9!9`)0%)*YH1V/`1Q@Z0%PG3C4"("J5R@$2O%H)!D,"EULB`F:9RFUR-#97]4;S.") MAP),<"G\*#VE1.V%;8@?DX04[,#S\,\9PX5WGEP@+!8\^ZCQP-XV\CM%*:`/ M(FW#>\".(M3,%2+!+$K-"P9*L^0+V`8,!?13J5B#$&/$#-",$98U1,5T#+Z$ MHNMXQ%S#3'A@JO6G1`XD/`+1F6I_&4"DAUD_2WORI#K:O1>%P0_W2+S>H)&< MQ?$M77Y8+5#S3N@BN-/,_JL=!0.D3!"77T"5])2:18>?Y:QBZP(U`M0OK1WX(F'BO.@:R!2$N>C#+GPYNT+ M`I8B4@V&1/9FA^Y$^RU&TS``96BLM*+$://C(9DZ@+-I> M\C=LR!7QH;T!.C:\H?5WP`W0BN&A&IMH+';10$#X3$93Z=HNQPT-0%O4Z*.4 MQ-102+E5;69&C0!P@!C"BU&)Y`SQ$`S2?GZ\"AD[`&9*96"XS@:DOC<=.Y/ MU)OUO.`9QT[,AW<*L),8U%\NA=26FR);?0Q*SWYV8=YG99J@\J3LLH$0R+.` M8($!S38PXHZ>5?W,GY$NDP7/$49!&J','40<4/">--0")K'NT6PTO3%/==)A=%3KX""",#5X8[E^!K@K@JRA" M)6J_J8*+'LP@R@K*:!MA1T'P)YL`*!6IW0%6I_*WI8[BGR`S.+!P^*)=9U]] M,,*FS+I*33`<^TY)/,#%6Q2RR;1N@LOC0-O]B26]50@FXC/AG"#+T[<6&6B& MX=0208E?[R(JC9UY]^1G_C5Q<%G=%/;IAI5+)U('FX(;+9@)NNNUIP>0`Q[#(H0$+D^T2AX3`PP].W,)D%.$/'IW)$C'(V, MB?S/:F=@&[E>%B$VKA!=/\X?L=*XT([*>-G1J^2&V;.&UU#5`UR1N)8H,>N& MVH$CQ8P)H,_,F^*KF976MOR684VX20!N>D?%YP`,_.R69GLPYY_/$9^N$T<8 M[.Y1:+>6MKHSMS"I`8Z;3+PX+$@O,A)K&4APB`ZRVLH-4-:$IBN+W*\LII(/ M0M>T-;Q^,AQ8QI,MX2=;XF>ZDR@;/7G5UD"&\8Z_"]AU`^Q;HC]]FGE]/FD# M4W-3YQVY<$#%@B@!G5=<#=O!6N^"Y-H9G MZN[<29?8^V@#`3,&OHSZ?B)Z`EL77](:Z#?LFB-`S@!#_XSJY#``7&6?1/QG M@,^`.>(%H%:.D(>A.:M,X$'(E7TT%+9VU>*BTQ\7=>*L%N((&`BO"48N&F'V M/%!AV>XP0K#%IL;$X[T)!;*GKERLZJY^D)J4TD5'."H*G<;/>)!X.9+!0PJ\)Q7+DE"#MM84O:+K`@YN',Q,R^Q*M/&G'\>G08/%*R#EA@?5 M[U$%SOV_8W5^C"+TVNW;JL4IW=]>_O;Y]\^73_)JT^R2X!ZH;G71@-0`0 M2=J*TC(G4KQ+_UBAJ/59#/-J$XVU)2!V2$-0B_GEHF7]O&<&1/+BP>^=?$+: M(&V0-O@*&RQ)X9/"I>#.EMMZA1J6+\!R#?RV"?6#,TG7*]4?P&"#>5CB/YFR M").=DEM1'2VOS*H]@$W(2,AX(#)R-V08%BSTE4[H/NF8ZZ'K@UFB)T'/.4@5GLX_JK@$S!-0+C4I@*&J/"G"4L+2DV+IMT!&;T,1 MN:'V[JJ`*W1O8LSD/"UB+MH)0PE#3XJAN@XV^AMW!6>.)<5+70GR)@F[XU&2 M#'>UP6-Y0C+.N?IH40H/O81$UA1.$Q&'.D\-< M6MUZZV30F!-+?O`QBBAOB/<0[R'>DQ/O,5DQD5@/L1YB/<1Z=F0]?8,UIHGU M$.LAUD.L9T>?3J-IL#-'U7TZ!H)I&F5V'JMX7\R05LGMF+SI#M-"`WL@T*R=57ODAZ5J^F^H\>PU#;]M:I**S,&/390P%)J*KTW M#SI[*7RQ&NVY':F)+(DLB2Q):A)Y$GD2>1)Y M$GD6@CPK07XFE=:JDU5)*I_D%JNABF+;V5J%6(,4ZS._AO@[*(9LY[[RIW6\ M&HSSV!5L>SEF=X=;T;VVQ2/7$DO`LZ'01MTZF7*:/ZF]OB0E*B0J?-4`%J)" MHD*BPM(X;(@:B1J)&C<%[9A+]2/;T;C_IT"^UA-4@)I5L&<;"]<;P#$WBK!WDCS.Q/-[[*1ESLY=[Y8>!PEIDE,LU`( M24S3$-,T65B,F"8QS3-FFD7`N7+PQ4*POFZG"*RO*L[`S%W*WU3SUK7/K_E[ MH>'VUJ[92RVV?<7Q56FQ;_"7/=VGO7:S<=7IMCY\L)H?^C?]J[OKVV8G;:_= MZMZU2MQ>6SW\SHU@<%N/\RUT?=N=>+#H8,@6(+?U>$^^_L,Q<9^EYMC^^F$D M$+XPM!1.!M+PX<.LW=SW"+[0W>GA7+S8$:I7-K=MG6>/S96P,_;L"S@T[GEL MS/\(@'RG;X-G'P;$?O>NX_+0%;+.KCWL8Q>)$..YN9_T7`14Q\I[:LBT#3<; M\2?!!D+X3'CN&):%RW-]I)HY8M2W$_X:XMU,CTN$*Z-KW[G_5PQ;^2RB4>!\ MG/4XDW>NM+U`QJ'8AYJMWDWKIG%_W[AOW7_X<-V][MU?I=3<[S5N2TS-*XV. M/G[YO_OO#Y_OOSQ\7SDB`\,;Z1I>-HZ0$_-=#^'K)^YZJKWY,`C9=PY_?)]U M]BL#D\OHZ=O_*L%>OB+C73@0B01W2:A-?U=#0P;IW] MYH<"`/=OM=39)(_K5M^%K!G+N$W#TP]>!.V#5-[*$K> MO#-QK"O=X#:RV@4+#G\8-P#+#)6B`6/C,;6&FFS!:>ESSSRT7C M0GT&M=M./^\O),8\?'1]O4@>1T'ZA3:RU3>J-_>[=M>:NRY`V_?X1(IWZ1\K MF#]?>#8^:68E]-:&J>T0X90T"F]>=2<_#NLQ?O"+O>:A;[8/?;%S\DU>';S6 M/5\L20ICX=Q&L^52(\TE]606\3>'J^G0/\(_PK^-^(<]1S.HMV?S40KI7>_L MU.;V0@MQ'L%:9,0\(25SQQ/NALH$?TTJ/Q/?>ME=Y]:5P2#;JGO&2\1]"BY MN85EY(Y5_->0NR%[XEXL,-Q,++N+C:%:+A'91<\$.%U4=B624JSN*3/YJ%0# MV;W$MHAM'<^VFN:<#,2VEK2SS4DE)UO881'%1Q9GS'NA.2=##+D=!:%D?#@4 M=@0DK3,;T)\B56PJ*)N9V(-90@0@_H@]"E^$W&/#6>K$F(=_"HQ;\!UWGMF0 M3B(GPG:'KLVB@'$VX4A8L<=UC7ON3^L,E[2BVV)4+V>/Z[P^;!)(-1%&2ZS` M?'^0[!-A<$(%ZO[(" M\'!\0+6WD0C';`(@`9#J#)1H$^A"X:FD#X0Z/B3%$]+=5!V-$X?ZQV2$#'PS MQUY+$E0P:29(EI\L"MZMP;[T0A7N#%PO'1T37@!(,/$H\/3JYV'/>)B1Z\'1 MAL)&=6.*BYC;.=LS7"C3X?A,!TSU83K%AV5R?(JUF3*SV=6#N%B[ZOT!@GD1 M*CILK(\O2U91`',!I1J8YJ=NO9^F%IA@@,@4S"RK-^?0)M=7!BEB"(@[!G+N M/W`-&+J22^Z3\*9:=G`E^)3N8"I+1[?'`5[P%J1=B'(&U98U[&O_H>M&LNS^ MB&7D#J(@>&B42A$ M8MPS`7S>V7G0;;ZR\V$_ZU:I>=!J3\WC>1"Z9;#NQR0,,+L<4(I'@LD1\J5% M?\N*2&6@(OB`.9*A:T<1L?9MZ;^U'VC&+("W:<8D?DRP,$D-V:A\ MPAN+3A@QF,^VZD2_66^T6IUVLW_5[;?ZS9^-5:"PFD>6H&C]?%B=!*M]X(N` M$P=6D3ATPH.W>.A[AZ[TX`FKN4$S`?(46T,0(X@1Q`ABY8?8RU5;QK!23[S< M`/44T%T#T=>O([3)'C3:6I!PEW#W&-Q=M7=-H.TF??+EDP$XGC3Y:SOT304X M;N`;HR",=/R9(P91;CR!M]W.GS+/( M#2"^17R+^-:I^%:WOGH%3FS+8-65W8R`BNGZ#ZCE>P'?JUK75N0BYD[P.=H1 MDA^LR@`?PA_"GX/A4]WZV\=#\Z^'(%G;@$_03#6V$RKE&'')9LH!>:[-!X#MDZI*I0J9*,>!#^$/X<[:F;K&@62+`G4)K4',XF,&G M2B"]@WV+$)-.]/BW03QYH7D[P?9`V-[%HH*`)6JO"N!V%LJO'#%8.,`5!EB$ M<>>`<24I+5\LH.T7G%3J-C-6O=5H_)P/8,H,ER^`D8MY(SUUY6.LF5DE0+5> MJUV7N"WCR19'ZY;2#]U)I`:Y;.EV&C`0>5I>^RJE7#2C,AYHS8:II5WBL!JS+KZ*0Q5-0%V&IUZCUR`1(U$#4DU$`.<1/: M,-F>Y!G?;(T:#30I$*J=.@+%F.2N-@Q7-.\2AZ84Z*0*QUC/S*G7-7E]7WFG M'A$6$1815E'L@R+I%>0MS\=;WJ!H\C4OK8MR,5:!MQ)@(D?Y>2@+I=()K%:[ MWB+7(%$#44-"#191@P%%F,Q.>T<2VRCOPB+"(L(BPBF(0%$F/(,]X3G'D#8HC7WWIG[&7<8U;?:6X M&_.Y50).Y!H_#VVA5$J!U;'(&4C40-204$.#,BK(-4ZN\7R5Q;;1\)("H=KI M8L@3U[@Q#;O:0%Q1O2F(O)*<]CWRZ!G4ZHFPB+"(L*KK*B\<49V+S[Q5 M[U,T^9J7-@:\M,OKJ"J9WSSON!;B0WWQ)\ M0K57C/C-V^0W)[\Y<=9S=>^UR;UG4*LGPB+"(L(BOWDQ[(`*J?MM\IOOY3=O MD]^<_.:5X7*[JPY!Z(@PA80U^<%DX+D.^Z^&^N^<-8@7(%,518*HB:B)J(G\ M]J6E/50[=H1@SP@(7U,#>P@B[K%)//!UK!(!F M0]?GO@U+S(-*2T5L7:JH2VX8"G],:*%+M&!*=KR"WO>:O1FQKS192+1E@)C:_7J!N[\ZN\.D>6%L7Q[$I75_4.T=6I M1%W%)-J=&(HP!'$V,Y;84(A]G-S5U!(O6WT#EW%+.Y^?_[Y;?Z7@G3=D39$U MM9U.V@T#TN=LZ(0LK;WN70=!".N!)4H6Q)&,N._DY,XS"M?$&8U/O!!Y<4I2 M[=1:5YT31'SOOOL2ZY%DGY7-/BLL45K6"?PB9T&4E*-Q)$&V]S)^S>1KG%!- M^R2D9'(4A-';2(1CYHA!Q$"G8'8,-C`,-D'G;N"S8,B\`'>5/I4+=ZM2\.JE MU>X8J$V^)VBJ:R@0UR)"6T]HW;:!"TRB,S+(#S'(%Z4B\U"@+@G/?'"S!;CI M!/'`$T>1[6OJQ\=A]$\G@^N+&&W$R-H=C*8-KF:SGU?49M4NV&V M\+R$#'ZY:%RHSW!4=OIYS3(>W+&0[(MX9K\&8^Z_9YO@OL[!]^PZT>A=L[T+ MYU_$XMT?WL_'"/B[#[)NJ>:`Y['`T]'[=M"IKM?O<92#2TUTW3&HH=)A;DU&"TL%=XI3SY0WQA#V<)@S+Z.Q2.O$PD1 M"1U$0KD5."TN">THGUJI?"+:.CO:.K[)?''1'R6((_Q@[/H\`BIP?2;B,)!, MQH,_@!!8%+"A%]M1S-'-+?$!I`E\".S4M[_5O]?!O/4\'C+QPQYQ_U&P$(8Z M7@@=!H_=[-ME@!QIW>ZS5/79]0'HT;LVEHHQM_;?!7L6H<`SLH/QQ'.Y;\-7 M;C1BW//@NR?A`R%&`M\`EA?,%S5Q?=?TW3`:'XOFO_"CBK;N*\@/OJ M]$/Q%'A/F,)AA\)Q(S8$*>JYT?2XTTL<<]:PW;]*Y(`)1!/<'K$1?Q*P=B:> M\`81Z,P10QY[L/0`CD7Q4$5^-@P0!AXP7!ZQYR#V4$MA4>@^/@K,7HDG8'-S M$\MJ=5:+N!Y`C0G_GR^]SJX]&=28.T2I@:P)6,OJ8QF&9&`9/[7J?39P/6_= MO>P!NX)U)J6PI/!=."(_B."`+E$.SET7"AGGFN*;FOH"G@$]$C;N!,_^8\B= MF:;I^D]"1LAMF?J>#:9L$`"K_AP$SO0ODGU4#\!TWT7XY-I"UN`KNZZ&_8Y! MX3P$WH=,"_^Q;T$0PEN_@IP&6DC>J8%`F&-.`)MX5&(>I'HP'`+(X8]03.(0 MCD0*)24"=52;-\8`%PU`U6I81E`.#X>']>UNHSSYK'%7^)!0FV,2S:THF6HW&SPSDQRQA5:!Y)EW'Y>&475XLO7@!LB?QR9N0IAU5 MH76VX[$YP0IV"G\$FP-E$IN$+K"5"?<8'V-A"4/V1ZO>65.@_H#%+LA^)Q8F M%M=L-%>CAP]8VV7BIFI:[`NN3Y]6K]FTW@,NF$""JY(C0;_02&""?V@DF)U\ M0XV[#AT,FJ8%=\^CZ/NJCZ#+QE"<,T&[^R&7V=J"6N;O^F#YR\6;MQ,,8 M]X4SQ#Z8O(Z+OE2UU\>8AQQ`I._/>8I-L2^%':.-#ZL$.,&"4R%_&XPGW)]J M[0"'],&64R>7T0D`1&N>G\\FE\Y"K1J!`/]\-`EE%+JV]OAJVWSI[#!="#03 M/E"N%F5/#B(.)S",\6=U&8D/S-;D"IAD6<,)X4@!F`Z6D`)"#VR`@_)\\`E\ M^N&.@0$`D$QP*ZO>G?,J@\X!M5,W4=K7&<_#"(LRBH2*QCS\$_::5L]:!J-T!;'LXW_]E$,SQ^17N:[(]][(].CO:'4*P;,03(FV?=KND] M`?KO@#TICQ-2K8D])N*CU6V_S\_RN#3!4KI6N]YBYE;UAD7`G>T1>NU2(9QA ML$[(G]%KC#>=6GX8!G<+P6UP/V:@W.KVLJP[%W"#G(E#1.*9CJ'IJE]+U`(C MZ)(;-J]<@&"',6G:#V&LRV>OIR,T6-9U0/)MQ5"JC2GS%NF`\1`\"VV5P0&`:#"B8.0I M#5:1$Z`M?DS<\(5@D8IJFT:6JC^N7"5<)T&A=VFMAU^!Q*?(^HJU_-+K]1\Q MU,;WA;*5YVK;BK321)N=NI6HVTF%":GFX+5CA8'8F:SE1=F%M2,;';K M5Z7&S*89Q`Q%Q%TO2=TRQS)7VXT=HMD:YI&]0ON/K'ZWS,RR7>^LZ_U.*+D5 M)9M%9(Y6JU%NYM@H-B:N%EXYY*37W#[^JM>K+HA0DO/-X=#:.#&+S9U"BOI. M&UA3/MB<\7MIU[`M0G7MB3?+3LB',WB[>,>*U:/61DH>!W6KWBX>T/.29?I" M?<&,7)9YN9F#D=CN#'/U6 MO6L&.?*#@QF9U;#J_9RH7-\,X*5`BFT95TZ=74O%:&7L1M6[EI%YC8M]19K7_)FO4X%YP%Y)QF\D9*6^C=UR?F93UFS/[OT,WUP^7FB MLV"91P\F'E6*4#+-XP]#E*(Q1&@T+\Q$7&]:LO&0H#HB!9JBWLNB$D' ML=)7H7R(F_C(@'L84B1GN>1"ASLZ?(I9Y/`_'>A89[^/7$\LX/_:^9,!E7\5 M9.(`'DHDKL)M8W?/N24&U[)Q/)F;=779/O[_['UK<^,VLO;GW:K]#RB?S-F9 M*ED1=;,\DZ1*ODV\-9E)QD[RGH\P!4G,4*1"D+[LKW^[`5*B;K8D@Q))]:E3 M68M#@F"C^^D+@`>X'[`@\^?QLL9O0BTN44L._O(#5($XVIBGGD^&+EYXJ,=. M[?P_3)LVTE7],ST/O#Q\OP393[?PF?@&6ZV0V?@KRKAM,EZC2;OX,@R+/P-: MS&*9#FL;B\NW3.^!,QF2/E\319=IX"U6M6&H+KHPFZD"LDH*)76O).9R6^]E4"\`.3HR#!39%5,LTW+I M'K;&1GO8,`7'OB7.Z[DM;"I=KUG-R4:R1O8[V!I+=["E7XQWQG[UWS*U/4WO M:9,1,E?'!8B8903WCE58P+UO^&'B[XE)-XC+>7 MX(OZD?J(9]^.WWH'?WA"IC:<)2'!R@UG1@HAU<;_9K$D7FTQPP%8LLVLL>8V MLR5#BD5=$+\3NIH09H24,J$?/*6WBX&=2D[LFQ9\V9_+]JHU=K57K9'> MJS;W<2J%GMM8Z_7EB_U7=0MXJ]?3XQ"($6;$:!+QF_V`RET9I!*3NLB4KOI!:%XD M/1(30D,<]D6',>/'E/<8IVBQM5IJEB4<87\LO%A)OMBAK[9B+%<1W#,;PK`[ M"C%3G$R+7=#O'G*D=X+FDP[WE('I50S:HZE/FKC0&]1\K>&(%I?)=P),C@!D MYB>Y)M-6,359;(83[60X?60K74[5X_229[UU!$]0@@\.P`TXL7#'T+8BOYJT MHKE-X*NA/?C,-2:6DK]_^#Z2QP/.Q^\Q^T9.5]>7T)U;T)\SU[>__?2O?_[C MA^D]2H[@!ZZG$U]=K_>SZ($?'G31/2KA+&E(,9;!CZ^B_^/1U07&(K]9O]U> M'#&G!Q>X'1Y?MLZNK(O+J^YEN]OL-$Y.+VNG5K/5/K?JG>Y9IWOTTYP9I!5V MGN1UE<*OQXSZVNK&0OGHXO+K]1_=V^L_+MGUYYO;K[__[F7Y>%UL(]O"I/^-MO7H_6[)ZI3>QB)01IF:%<:\8 MP`N_YXZK8EU5O+=]&1X+-2V,3RHW6E&1!%B/2D<0-P-'?L-:O@^-A@D(I9!D M,I>,K+$:CP"\0#I>?,::_33++*O(2?L^;H"2[P_'+1K7AQ7UR^OT>.C1`R#B M`^UPCDU$RG]JOR`>Q[[4SD!%MQ"BV^',@@;5A417PF'@1X.A4JIX%4+"H*C5 M9CJ+HJ+3>`(+%!5);H6>D%"Y'7C$>`I+?=C*NE=JKH[[2F*TK'OO,H>L?J:["CV!\T(WT%'\8<_R,%X7,?>"I>U.Z7:U1_/4F5OJ(9T6ZN($M)R2 M,7*B^W8D56F-AR&FBY@K>U-I0;2OBTC0\:YMJ[QS@"67AQD'G-!O*QY<,,`X MXXP[""*/EY7)%5))[E3Q-(3>MDZG)\O*)N63!9<*TA$Q?+B.9IEPL%QF8PH0 MQEY?#1Y\')840['$,4ONQ@@0KSU[=:*:3=@SKNX?1YIJ:&6LU'KHTCOEG'[6E MRCZ"%XF5Q@<%PNS230B%U9+)U?U$!;'C6^]$W"0#B!@@Q=/=$QO,MQU76_W` M`5S@;GI]I-)>+"XENOND7'[/5U6M2(H70UJ5(>,RR,C5=XVC`,.15RQE/#AG MI3.RKBY08`C0$Q+@02G$5/YQ0PA9MSC(`P>8R7,&V,5R MV:M56DK&C-NJ&*S7$#K@@QR>D(",!/=DO'1P?J&]?MA)K6;&4&`(-CV$M%P$ M$\(_Z^0#UOFU[U5@-!J#ZNI9J"\J1,`Z/#P'G@)-[MJ#6P1[>_3E_!IG,Q&; M\*7\41?/>J(O`BP7+4`#`@IV9^"I-=$JM%5MQ:4I\+Z.W]-E:%572[X#EZ.) M4;R863*P+T\G#%U<,.!-L]GX7._9TAMFNYB\K#(C M22V8V'TJ&537,"D4`(*@.KH(H4R/TJ3_*@CY.^)!B)!)$?@6&:HK?7U2`PP6 M'I!C@V_QCE>,APK;8O?SO,DIU9;/NDJ]_%Z[RN2<^7A&)XX'=9@G,/.*9Q)C MC4^2Y*EB:Y>-KC+M5>7B6V.//%M]CF=%`@A\,?_4\6]J>T#LHU.V5669!ULY MULF,DL#EQ=!)J>8K9C(WD/=KD+R-BP7LDV]_6S+Y7P(Y[RK[7BYX`P[[^MF: M#=IC*B=,345!S*1/^%#/]=6TR2.8GOJ9S,ZRMW`=S_]@D+!+_FZZ(\AU^M,] M31,:1\R/_2@&E&DX3!?)8I<^X\T7&U=>&D;E*>7%4UX#ZWZJZ8/<8;53HTYJ;.=) M<6,Z3[BXH_0`A+_3`J>9HF6JLK90JH(+#WABT@16*[HVGPKH-)MV.L:K8(2. MH7JP2T)1D?7Z8+*/$J,CE_&B-?^)(*PLZ#`%#A MRC5HS'AEIZ:%O*1#&A?7[%.5G:$LPZ>Q/KEL0=CQF6<@PD=G%(V2R9*GR29; M`PI@)L$?P<5A[##4!OYY!Z>`6H?0T\_#%1X&WOY=JUTWRBEL;M%JRW3'C!=\ MV`'4>2JIS=NORNL+[)AV&A53TO+-9,E2SG*:'OG,?>XA9R'EZXF39J!HZ]K`XU>E, M=KWJ9"A)%"$Z<:.>2&JW(7^<#%\R;1QG>3KNB+T/3=%L8S'QKELYQ.JDZ]MZ MBP/*>1!`ACQ7UU8+.E+[[U?8D9K922W',H$?+VPH3;6R<.A[6H;X._T:SP]& M()_DF=`?8\.I@^(5FC`;`NOXGA^/:D?JMX2P.OF]^9K-$0\&CJ<[R:/03RZH M?1#ZRH/3"X?O.^UJXZ1AM5MMJ]-L=MK--Q_N5.YQC+LV^%B*]\D?"W@[_8K) M:>IA+W7*?&WF^/G)Z"P]AGVF"=6U'X\:IV]>/,`^U=KTP7I[RP>M73_7*DI' MMWVNN9,7KE*DV'#N11""MW9CY844//1''V8LN0Y6F3;3]&]]_\PE;4=XY<5N MIK`#*Z(X__Q^Z/0`+S9&VV?WKZ\73\T*>]+=TZ/G915C0BP):_S(5.3"_J>F M_B\+62Z1WW.`?;J-NSI=N>:[JQ9[K%N-(U5\M2KF3?U>D-\.5?%,1U%3J=Y@ M.#7]^2F.JTP)FY1QVMV3/>!BCE#P"N/S/S`^)_C;(_SM%=[FRE^&-:P,PLJ= M,DVZVZ"P;E;=-BF%D?Z1_IG6OS6+G$:<*\CHPQVWOPT"/_)Z6,_Q@_?_8]M" M]/OE<"EZ>_#2Q9'/5P4W23WR(\'O"_M^%!5;%#9E3,E,-&!.:VEDS5;1X)\7T@MX"6US!YI_D9.5SRMIAXS-K)/_ M(/F\()^U9RT/<7*2](?T9[>3VVNF`C3K7;3$*MOI\`F?H-G)[QS)+U^&O8^9 MJY6#D0>;WMF4UFLRSUS8:[UJ;!W\UK(J2_I(^$7X1?BU6_PZK5I[EU59\.N0 MRU^W,0G?JB(8Y>A4P\B#?+*98Z*II`W6J.5_QBBSH'[9C-$A3`P1:A%J$6H5 M-90_5-1*Q?/?*][!9?>GOF7&"$O`='A2;3>L6OVDWFJTVYV3=HZ8#INU;9D. M3X@(,"?/-8CI,,?Q"#$=KJ(D^92<9DELA[D,CXGMD-@.B>V0V`[+I'$YDP^Q M'199F8AM;I6Z$=LAZ=\^]8_8#HGML#QV3H++'"")>XXTCC2N.!M":-]'(4+F MS.9HN[8=1!"*N'$-V:&5<7FNDN3!SHRM@BC*DF2#JZ_*LA*!;/^5H1]1#YH1 M4/ZQH[8KD90%6ZAJM.0AHA[,,YJ3X/*TC)@(M@Z<8&NGVR4.FF"+D+$4R$C@ M5Z@]TIDE%9L(JRP0=LB;I(DC<.]`3_(ACC?2']*?_$P)$T<@<03F9A(Y1^++ MEUT3Q191;&TIJ4:UN7=9E25[)/PB_"+\VG7YJ[UW694%OPZY^D44@?F`>I+/ M'N:"\F"`N>+3RH5KRRPT7R*3LK@P@A>"%X*7_4;.)8:7M4CW=M:QE-#2Y'U6 MO?9F@?-N4RG.J\T.NYHF)FSBS(*YOM\.!1MPQY/LK>M+*>0[%@C;'WAP6X\Y M'OMR?HWE?Q;"C9#:"1N#?S;V`R0I8GZ?^5&07GEKH+4^=K2F5A8_^L&%*MS*!S\4D>FXW4&L-7\SJ>OI+6L=X$Z6S'"MC: M]L'VM@^>G&[[9),^\I65$8HU23[KR8>XVN))XY$?01O@7S^"=_[^[2=PSN_8 M5W#-\-F)8UX5>+R]G#CJ7[6C?I=-Q9/TEN1#=KV)7=\.`R'8+_!O0\DN(0SM M96J9!TVUFN*2.L>LY`JSDI]55D*6;=ZRB1Z.Z`E)_W*N?YJC<.UIE%+M-I_I M@56?*P8=JRNF:LG7.+1"ABP`_\/D`Q\S/@#7/X)7T?+/7<)"?9<4:1M8O]FY M"RVC3MVJ&\M:2K^ZA\R+S&OMJ<$3,JO,8H;#"@W*S,188)S:;]W)+%R]K67% M\;%:,%.%*<@"F+5KXF1F9&;+S:Q5K9.9F3*S[0K<%*-36>J\KK3*O MUG>YE$[?$3W6#_P1Z]IV-(I[E2PBCQL[]T3@00^%)7!)X[=G^2+"W1]TO MY]='[YCCA3X#87B@VY+6^D^09M]K_5MMR^!:?\LJX&)_JTYK[P_T(VFY(RUW M+'B:Y=V#59`R(IE<^2$I`]U9;F)E$%;NE(EV M.M%..]*_HN@?[;2CG78'`0M%$5Q6@?-$`<7C6'A25)@GPA+*+W>*=V![T-[6 M#-+?'NXJ&+(XLKCU+>Z4+&['&SMH0RAM"*6*W*O/KA5P/W=IZ<<^O%_1G)QE M6DG*Z\O(3`[43&KF#@-W*P3OI;DB&/%>TIK8 M`P;-/.A<,7`Q+]!G[E09XKU<)Z4K/>_EOKJ["^9+3ZA%#B%_9%R3_6"YVD;" ML]!G=V*6"]./U-V*[F>6XK(7!?"_BN72@QXSJ\Y&OB*#<"3C"]+8O+/?6=7. MU)?`S>XR%JS-VV5(^EEEQL;+W/`47;4TVZE,.$[A`XY3/*>`K,X]1RXHN,-3 MBG/N8U\DQ"!0#VB(SJI%!/%AJU--:M=5NUQHG)XU6 MIWE::[_)#T]JL_YF2[+3+9^K;_O@SI]K%:6C^?Y`HD;=E)_A,^!YBA[U8HKG MIN)O2H1)_5:J'S&C[G#N-X_D=G./Y(49U1]X\&0/TJ.8#76+C)H6XY$1DWQ( M/KF0SUZ=P/K30?N-1O9$?WK`:DGR(?F0?`Z&F+(HCJ`PK*G&%EJ0YI97ROW_X/I+'`\['[Z=;1*\]&0:1VM/?]7H_ MB]X`Y-:UX9^N;W_[Z5___,?WDHG7:N3SM6B=G5^VK^D7- M.CVQ+MM6L]ZY;![]-"?ZM!Q?V&R_;.06R`8VQ?!R,D3\*9A:T*AY1&PP5NYX M*58(UG<\[MGP.-PQT98*>Q@*C_%[[KB*,,&''S#H,CS6=!/XY!V7#MP)S8Y` MG09XA#D24`2._,:XE#XTBCN6'YQPR.PA]P8PI/!N)WWHN63>)1 M/Y#<8YA\HA`,(L;U0?_$F]\[(0C"GILF48?0J]$#D^,#O=WW>%'@6RDA#P3. MP_A2,]X@#XDS&@-0X-[.&968Z$HX!/\P&"JELKD\\`1X9,Z5BC$-@<.MN?''S;W]M6ZZ7BV&Z&O89'$_W+0 M]$=\I"?N0F@LC`(%I(R[/ORSTG3P2D,PJD?1.U9?@QW%_J`9Z2OX<)5=@T6! M'\.MU&!M`EI[2EMJ&`@.R/QTK."6#P(AIA\^*R_YP,?I.\!6$SO7$E-=3\L+ M6N>>A,]7_"Y3N:"DU2"!2\#+R\<%F\([,6CFKJM@`84R:?X5-#]DE"N6*4\1 M,2,#!8_>B\`@[E#5A53F((4:8GC=7WZ0]`7UW5=K4T/HD;*EWZLW50CP7)<' M2CO0V&5T]QCF&UIF522.Z&I M<>"'2L`P`/HIL$'QZ&A[7W"I(!T1PX<+8(0B@Y&L0$]&X+YCKZ\&#S[.=L9* M)`NMJ%/:U&WQI/JK.;VR"7M22??S?^6P[UW`U%2`E@K+E&%IO>P]I\`0H\$0 MPA/NDV*>2S!=CUPX!`4,^3=0L]X]C+9"_C[\$]R,+@T,WN_W45NJBG4A5AH? M%$B"`;H\G/KP9_HY1W"GFV0`$0,!W;I[8H/YMF-^,A]2/PA*70;)H0C<)^6^ M4'OA7R:Z^Z1IGH5Y5= M+)?]2("A*!DS#GXH\I0[L"%0A9LX)G:./82[.$9^8&U][@13_X%7],,.VCKZ M,4VR(H=@TT/?A5=)+>A.W3KYP,3?D?:]"HQ&8U!=S=>BMZ^G;.L%77NN/CE?5IRI/E[&7_2K"&X0?#8I/K:[%R>GY[7N:OF5W?S<_7K)NI\O M]%\_?_ETV>\#_,H6]_BN!'BLD@/ MD0J%((BY_/7FZ!T$MJY.*>`]3KI4S=Y"*9-KE9(OY*(I/\RC$W`B.-/&0-9&*_+,E MHHOIW'LF1:)#S,SSITZYDP_ISWZ"N6*7?/Y4Z(7KV'$[U$#H%4"2^5&(*R=[ M\7Z;>-W0Y:\WVVCD2\1Q1EWKWACEK*;!+&JE2,J27A4X?LT/U!^(834:.SB& MH"R&=>B3&!>XKA5W(NC](VJC//JT8W!AZ.?P1*1-#D):W]CVNPK,-%6PL=F` ME^12%L.C'(5L:84M&5M9=BBV1/G:*_.U9'='5AG;JSG0]G&$M_E\SUQ8NK5` M=\`/MW\\H&QQYT[W0(VZT:RNO6J6C'K/F>H^IR_KM;W/O.6_ZI\K69%>D5[1 MS-*N,I6N%SK'O:08MUB"0_8W-T+BF'[@CQ3!3A1.]K1GG;^4HC!N\#ROTI?% M*8.@^28RJRQC^/4XW;>CJGG=@&[UD;GEU+E)T=7]FUTJDKI\?^<\CE['L5-R\/ MGB9EX857L[%K5]0N+_U6>$YQD2IV()<_J&>ND0K5ZVU/'[K#L=H-'>YNON77 M1.$4I69[Y;B'`>]IFEP]?]$<>].QE4\CP!#V MZ]>/7ZKL1JG8XEOF]4=Q!LZ]33RP__.#;^Q&=>4RX7!>\2;D@H_)JS&T5^S5 M>!.W`;BDD\3[W8$CX=Y>),,`6;C?6J>=QKOIZ'T*>]5GNG@GA*?ZB?,?<4=O MAY2H@X9UTHZ,DX`F<(>($'+PP"/JJR+Z][]V+>VU?_ISOE ML2]VZ&-L6Z^;_5+N>?!2&XN,)L;FNWJUQNXTSZ4Q')^1MXO#<0^2,`7()KKY M!/8H*ZDC@DR(LE6K56M3'1^9D^K<:0Q3\?;2'J\/P2/$GC&/N$K2N`MNBP?J M>Y4:/A_]+=(]K^1QGF%[ON).\`=R74\/I9.;,#Y?7C5/SUJMLY/3LU/K$@+C M\ZOVA/'9ZM0S9WS.KMRQ4-RXZEY_97]T/_U^R7ZY[-[\_O7RE\O/MXMS``9> M11[1K$>\FAXFX.CS%\:!8PM-)__@1VY/6Z@C+FC M0UP\R*L/ILJG)Z,@C;%V8'@40/JL+V@[?,`L,":7'_-`G_6C*.$UQWR:]QV/ ME=$G,VA.8[5P;OH%0T<$F"$^X;)J8*AEA M1P=X<`%^QBS*DB?K,GJT0>H[N#A8NH3H+.*@#[`$%\=IU:>>,T8OS); MU:5E\ZZ:6MEJU=:9>YDMZ&?%LAOZXTVJ_B\1H,],J;1G**TW']E823?9K[SR M(S>:V]BA]OX6^1@D*%#21R8Y"(/8^9GS(Q!B]+DI&DI>.$5IGHC]`&K`:#%:W$C^N0QITXYA5ZZ9U M56CD]X1[K([#$3T52NB#$Z>G-^&IHGCJCM.'=WEA'$GH0VONI`CNE6DM8M`+ M)]$0"!$(Y1>$&J4&H3^F9IY8OEK2-C%_%@I[Z#E_1R(%!*#DB#0C'P^470X( MB"Y34-A9&(('8CG]IWW;]X:]S3"SGYTTXVML/-O;5Y.A<'?N"\UY/4QR[JBBK35N4VU: MG.*:+D=:O28AU8,9&,[M*4>Q.ZS5S!U:9+5?>6I1\W37A_K4BG+Z$'T@?6"6 M+RSHEJ[7@[NI%=96*]_,"#L[XX2MC$W*M9LP/ZJ7C\-XP().^(31BJC6=G>8AY#^X,/JMMCB:X+.PB5'H@XS\(X]=#WZE;=6-C3QA` M&$`80!A`&$`80!A0$`R@),!$_6#-\DOI"PM7?B#@Q128*R61Y;VWOR4F\:3%74+B[-T&ML M8>J+AR-O8V#[/%`Y)U/=KS_%V\BAW6680:?SNZEPNI<].`2-!(WFH;%N58UM M^B=H)&@D:"1H+`DT9C%O3@A)"$D(20A9#H1LG!A<^T#0:+PPN7M8S,IB/\6' M?3DB&\JC#"15>*=!3I7TA_2'](?TA_0GC_(IUQY`4Y$2[>_+5\6G[$NZJ69# M.R76-*]6]93,BLR*S(J\%ID7F5=!S(N\UDZKU*5<)>M.R]?&="F3*3V:N9L7 M7Z$GZ/:RA.$0IN.H=DGH1>A5H,B+4(M0BU"+4(MB+D(O0B]"+T(OBKEV71+[ M/N3P^4OO3_V=^B[7\<3Q4!^?:=5K;SX\=TCG;)=3K+J3/`K]Y()&9G7EP>F%0[@;!!&K#JB%R\=2O$_^^#"O"M-^I^N14W5J M+ZTKKU'25)WY\:AY^N9%39VUF?A!:]OG:KM^(7T@?6`>/[`@2^)S%R1.N]O: MP\G4.3J'^C^1)UC]I,+J-6MM?@C2.CH.W:P:?A+WPF46I<&D:SO2M3KI&NG: MCG3-&+L(Z1KIVDI=4\MLL@GA-M@X4N1](UU%Y)?)YMJ,I;=^&;$(-D[+4C,' M1U)'4D=21U)'4D=2QYWM/UZ:Q93^/)MK[U[(4!U6(X4=!4:7P+^Z_%ST)0G9 M?:]A_N5Z]<34-Y=E70"5.\CX#\+XZ>@5P@#"`,(`P@#"`,*`P\4`2@(,E1#R MS&*VR]H",9WERB&7GMR"RL\&RL^'85[@ZYID5V179%?DMLB\R+P*8E[DMK+. MW7*0HAE+OV!H)9[_Z]L.#P5NX@J'[%H&7+@.&_LR/!:CL>L_J=G?.^&)OI-1 M2K;?;4KY=W$OR*EA65 M?HDZE7URL+BO'.;9K+;)+,DLR2SS99;D-I3`_DUZQ[&;U^D)[&9;U MNM-Z>S:`3>?Z9B6^0L\H[F7-Q2','U*QE="+T*M`<1:A%J$6H1:A%L5A%X4<^VZ`/9]R.'SE]V_LXZEA.8ZGC@>ZB-5K7KMS8S^3DF<4V)-DSHW M<4G'IG*>U[KI4[?PG8(]X'\\GX4!]V1?!)+=B?!!"(^I4X4ELRJL7F'J[$8L&42^_H)*(N9X\-\1 M#QW?8_C_$5Y::-]WFUUNI>=LZMFO5L_MVKUL_KE1?.U M4EJR!?:U4N*LYT@[DE*)J<_`<3CW(#005'5KQ'NMWUC=9^/@O$,L?HG,$>TW M$!(O\9$?>7#E0;`AOQ-RSX;7PKS)T MP@AU7L)#$CY+D4G"3?I^]4*`%1M#[-4]4?8#_YMT6=\C!#)40C?_CIQ`MYK< MX/*'*@-G$W>.!PG*Z2Y_`7@*P`-YQWJQ7Q@3LBB7<\_=2.AG>B(4P0C&J,PHKIKSLI@GL,*.#J.`KA(06\\(2#IZX#@+``A*K[_N0(MX*@#"`,KX':E&X(KMC\`!0MM_1[X>PQ#_U24+,VQA78D0EOO00&F.@7;^ M$WDBU<$38QVL*&_9=QY!65'7F>MC_`HF!!9ZAPKM24>B*H.XQY![.#:[\\'P M*V"E(7?JC"66>^JK"`J4%G\UB&',(_9/`@48$V$8N!MWS6JI]//N'-<%QR$ M*47FB*JO,/8T7S\'%$BC`P!7#I"2MZD=A M!+[7YG+(L'HHDW%%E6VG?_WS'S\D=W[T_=X#*'?7ZUU[(?<& M#G2PJU+ZZ;.31]6&/OCQ%:MD5Q>`_>W?K-]N+XZ8TX,+W`Z/.Y=7[<;YQ=F5 M=7%1[S:;9^VKFM5LM<^M>J=A7;6.?II3E_3`WCHC`/?/XH%]]4=\]73A<]IF M1)G4SP?=ZIWO]G0S'[]\N?CS^M,GUOU\P;[<_GSYE5U_ONU^_GA]]NF2=6]N M+F]O7@<1R]^[B&CKFEZ!4,'<'$-<'\;!7,.O0DRP*D*48H!^HZ/DUCF5*5^4= M;Z&MV/?+=XM$,*E/GUD:4!O/'O"*O].R\7`^PYV=3\1[)A^ONV4+UXWO^?&H M=J1^RS&WD]^;(^B(!P/'TYWD4>@G%_3J#G7EP>F%P_>GC6JM8YVTK5JM7>^< M-JPWR62T#:+A8RG>)W\LZ./T*]+[&:9;8*RE^U+6V!*AN@8---Z\./<].PL? M/VCM^KEZ43JZ[7.%&0D:P4/]P-VHZ.'2I:DF>SA%J&;HW^NI.G!VNKFODZ4, M-]K);L2GEC/QY6XYX]I\/5D\6I"+G8=&95.JL[$\;45K(3CU$]>4?00]!#T),1].`V)((>@AZ" M'H*>W5=N.@9/K2Q[9O7ZA53%+J2?G?^\3U0I&>JNS;N_C:SV1J]O55HMRURU MIBS00?9PJ/9@U5D<\@6RBT M+4!&<6)P?4E9[(&6^ZW8[S6_V_?KX\X*?H0]AW**H%6I-QITDJ`Q[TVF1:8U M(R.S1["0>9%YD7F1>9%YD7EE7>&L6CM3J\.M?)+%D<5-4[%ZB_8?95LX*G%] MZ&8LD',U?&(WMB,\V]PI[X1%)2U)UVNUZI)CD@Z[($W6<*#6D$%&239!-D$V M039!-D$V039!-E%:FZ!,PE2%XA"7MJ@33S,O?!'X;%!2?8&ZKAPEUT['(%W" MMA(K"]J179)=YC?")O,D\R3S)/,D\R3S++EYOFWD(*JEI3UDL;2T)\DS6^9V M"Y?>$QHXYJM6IN+8K1]R=W*LIBDU(A#:Q/$UP/'U_`@/#'W-X0UY\&_F:,/6 ME5#>Z<.:E=,3@U0_+\JE+$!-$$,00Q"SED0LZ\3@=@H"&`(8`A@"F#E"JHR* M/L](Y7"+.P0]!#T$/1IZK*:YI5\$/00]>82>N%&\8W$2)`_JE2M_T2SP_&(%DTC!MX3V3 MAI5I,ENX;GS/CT>U(_4;<,=.?B\1^:TS$I)]%@_LJS_B"W'`@],+A_`G?&,, M=P!E+A]+\3[Y8_D,E^I4>JIO"H'MI7.V:\P6JL[\>-0X??,BNL[B?/R@M>US M]5V_<-?/-8K241K!O8Z@@7G\@D[C&U@7<_+*E6P9+X^QP?&(P(2LEH=(-V(< MBM&="*92K+X7F-?:@>2_(<;^Z M^#'P)1$W98!QI&ESFM9-I<#=5`I,RD?*1S!'FE8237LMS&5(XK`3534@6#5: M/6'[@9+<>_@L$6#)43=W(?J.YX3BV'7N0@*-@INGYG;9D_V3_9/]%\C^6[5ZM4'6;Z!,L&:A92_U@YDN*)+R]%+U M8W7%6(U!W`O7'XL>&P=^+[)#%@I[Z(%(!D\@_$#-^B7UA^06]9F;U!X.C*K, MJM2L5K69>66U+!9,I64#I>7#,*TF>$`ZWI,,BPS+O,^JM\P%EV1:9%ID6OJA M1J>Q@W/@RV)8AS[K>QY)Z*`(]#9KW"<]=,9ZXW4O/2'LB?#!#[YEDH85RKRL M2L?D&41EL2,JBAZJ/70LRA]@>FFV*E8SD''F> M0C*E+;G:WM4-Y/!;7\N*IR&);5 M-DB62W9%=D5VI0O5S1HY+#(L,BSS1]?0HH5LD[$2Y5R??0]&=C06X98[_=8W MKOU2TAFVL=;N3NPMBZE1%9",:;DQ&5QG3L9$QG38QI39V3YD3&1,AV9,F9TR M7%YCRG!ZJ[43V\ML>DL="]];GWLO(T7;Q@(SK@/D9&?F2Y)[44OSOJ7SM-+L MM`Q67;>55UFPCJJRVT<4A&&$85O%9!7KM&6.EH8PC#",,(PP;,=Q&"@:81AA M&&$885A!,G4K7KV9D8X0SA#.'.8.%.OU%LG1%=*&$,80QA#L4QN<.;0-^]>>\?C MP+>%E"P0$H1H#S5UJSYG`[?R;E,M/*@M'CM<2E@6LZ/*.]G2SGP8V139U"'; MU`ZWZY`MD2V5VI;(/]&NWFQV]3J;K%G<@5F6@\D,YY`[!D^S.?0EQE27S8'' M+(=I[L&5DGF2>9)YKCUCV39Y#AR9)IDFF29YSIR:Y^LG`LN0A/HA2#B5>3(N MI=B(S'<#+6N`EO7\"%]CK!94^$4(ZTHH[XL1+*O2:36RXKY;(IBR`!&5G@EC M"&/6PY@L>9P(8@AB"&(.'F*L2K/>R(H/FS"&,(8PYN`Q)DL:I!)#3*ID\WW( MX0N7W;^SCJ6$AD1$QT.A4,JJU]Y\F)>B^HT3_E[XOHGKQ\U6!A4./?_7#KYD M/069_Y3I4^>@W=SQ%JM1C`>"P1O]D>/Q4*V48'84!,*S'2'C&E8XY![\1[#? MJS=5L`#7Y<$'O!"(OA^("O[I!&P0^%*J%>^>")G-@^`)((+=%,SOLX7OV/PUWUG-DVJ;P5TN-&Z@0:5)1CI6:U=;)CL&NJO,P4!; MX3`0`G3?"X>2"1C_GHD.&FCC1HQ#,;H3P13HZNT*J]>L11*)_8WMLEZ>J%XV M#;1>P7T\8P`LYUZX3U5V"V/N>'8@N,0_EEO3`Y>L%PDV#IP1#^`%B'9A\B0B M''>7/PDW(!CVF*_1=N4:M@EVVW]'#C[0#_P1^S(2`_X\>"9___!])(\'G(_? M?_3]W@-81M?K74_:[ZKF+QQIN[Z,`G$+X'3F^O:WG_[USW_\D#QZ[=G^2-SR MQR4W0B3D(:1]%?T?CZXN8#S:OUF_W5X<,:<'%[@='EO6>>.LOT\OE[2^:4EE=9C8N$@U;]/O:TEG('UD`P9`R M90,P8C6KG3_Q(%4XAQ9#HIXKV_ M(AEBC,"PPJ:,ZXZ[W+-5E(X_(:P`J^N#RX4PX@D^7UN+"CE"OX*1!>1<2=X& M^9=\CX$%>.KI2VW(YP;@/^^>V`#?XZF\2V5T[*\H<&3/L3$RD1CD/`P=>\A\ MZ/0X\/O.)&4,10`Y([P9^GT'\,D#_('Z#.\1O0^3MS@ZFL$T4,<[\"78'(0W M0H4[V*\DHH''78??.:X30O[Y(241B2\2,H2H*M0/0=O1&-J#*`E&[K^3QN\A M[/(CJ;]7A%'@+3:$'8"`2@3C_\_>ES8WCB-M?IZ)F/^`\$[%Z]JPU2)U5Q\1 M\M7M?KO*U;9[WMV/-`5)G*9(#4&6V_OK-Q,@*!+N2)\,`\L3,"JDLHVQJP"7:&0%([$T'>N;Y;B8))&?`*]N!&0Y@?C7\N(Y M)+4?-GP/A&;Y<1&"AW3Z`$XD5F/-T/E;<@2720=?<*U'",6#V(M\/F@1P?JD MMQVC4N9_@1IP(3"')9O[PG*%U-7C""83>Z`RE)EH@BN66*\>G< M"D%@DAPIBK!A"L-'.F8:O@MOT8>?^&RZ!C@LLMR`A8*$XX8E@I0$0'J=E0\8PX_8M7W`)H+[!O2 M/^%F4/]@+J51\M'>0C`^(Z623WYRXL%E99'`RDNB@S6T7/0#X`9767W_55T# MDF-)V+*J%([28.`H17"?9=M!%-N,5SX>.S#%JKPN:+R%9)10 M]74[C5X^`R05F(,*)*VE76N-'90)F-W)'F`7`"2`)(!H;.6.(I-$4R]V)Q?0P$,4K4P<"X<"1 M?M6"IV40)Q;2@N89XE=EN6%TD1M*^V!Y:F#XNL50XI'(Z-!*1Q/G=G%?!0GG MSSG&L.`"IN\#IK+$E&%)4VKOX2[''ZG(6<6=8(^,H('(MK&,]HY"AZ MC"/0!,D;%M'L#,)?()(U^L8#`3J9.;.Y92,Q0>B7)B$PGR!X&+IJ3_QDX8Z< ML"5/10@NQ('MF^>FT5&T9/NKF+=0%P,G*!7*[H$]A[%:?DK5Y[7*H;CL%D3: MBSB[X\$W!Z3P^.CZ]N[H8YHE?YFS0]//S(ZT^(9\H;S2:LHKIN)Y>$G"Z>,W MWR,]A^9@\9[8V6F".(RR>1((@FPWP@>ER,L4CA!1DF6T9-@3@6P^88;%45=Q M,])V9*4&<.@PFD3`?4F.N<'^9XK&4"9FEKYE30*N=C03=SF;B,.AHO@@&_NV M(_7*W'I2?]14EM#7FCDX05WE1@+WB62(H>00+[,O6,$"[J8DB=*S[U`2I3?` M224N; MV*BN_0J-WAML2K1W1JV8,M8*,KQ>5#-AR)]N M(]A3*YCPI'@BV3814\Y#-H$%5\;?\F!MG+E4-9;TG%76VHXW7-*E@*E[8`S& MUC<_D,0'1O'=*-TJF$K3'P(#O>)T*..>.!V8>9(9C3?)#)/2=S#[ M);]!^3R!LDII0)'N+*P.`C+.2B8BD6_P0U`(8>Q5P$JA-<:9J-OQ%K"KSC=G M%$G_38`[X`#W6I(4H9HP^'!.HR;%JF\ M56GRK"0%EAE5UY8E*6?MUN#RK-/JM,X-\V)P.4!-KDI2#'-X5:^2E']=?KF_ MN;VFBI0JA(^?K7]CD)*D-X6R7C&W,PA+*%^VNV_P*+4M*E%7!H+'H))CWT-\ M?+M3[9IL@EN?/-B9+U;5J#\?769$2\=;FL"764;%W]DA>WXP@X]E#WP8>$\Z M2'D\`-QYUXWO^?&H>21_"S!XR>_-->0,S+?CJ4%:X(`F%]0))7GET1F%TT_= M5J-EF*UN?]`S>^UNJ]7^D!S4L+$V?2[XI^0?+V1T,8TL,D5Z<*._$HAD#6P+ M.;0?C]KFAW>/A"R?/XD?-+9\SNP6_<%Z3K`B_;Y+=_!N[::F>4#7OD/+%?1[ M2Q=O?5QHM0OTBCE]S0M9:<7H0"CQI6Z^?.E`Z6#)S?0GT*Y,(&UYG<^]5!)N67_9Z$)77)[ MLTN*BQ379F1JXQ8/*2X=BFMS'ZP^KM;_^,&?N(42=^#;)E)X#Q"W4KBV1K?5 M,'6)55T$A.+F0Y6&3I^D@4+V-3CEUGI,M_"I5]#69#3-)O4[H(BT2@;M0`33 M,(IK85E[P=PUXJITO_.DUYZJ0G$V:JVW`5MIPNL\H'R1!C#/\N>-^OU^@3B? M!Y$_HO"8]!;IK;SU5DMGOIOTUK(7]CIX\7LEYJ]7CB^5F'_ACT/;Q@,"P'E? M`]_S$0E`5O`/O=&Y0LVY]K+W.)[MS%TN-BE%-WN]=J=[UAH.+B^-5KO=ONJF MI>A-\ZQ;X5)T>?,G!WQ'QWZE1.668Q$,6Q"1W<5`3&R9Y/F7F5>NC%;5R!K- MIKZBV-Z.1;'FMK6?VS[7ZA7\0:-3=%5L.__JUCU4QN5LA#8XP+)*]_PQQ^-; MY$WOPYL^,/:[X,(.G'FXZM@K\1OQFW9^0Z`S?\R&(Y^8CIBN&*:[3&%9\/SP M57HH^FYQ*-H/V(T\\7RW.([,/LMCUVNGF_=5%E6:V/N-(Y_.;.XZ8]FG!=<@ MX_7@2?+/W,)(&)?B]*L"LQDNX#M(1^2L(PZ*%1'E(9HK?(1)Y"@D*^XZJC&1 MB'&"9<,+B00A82>\I`=&("&PV$,D(`87`D]*/R0838AEI?A:/C3+,'6,T)3% MI`EX&/C9KA_7G@BY-3I)/R78#,%O%J"5[[QQ%*5XH_%?4UAMN/:TP-*6MRCT MB674E[0]`>K*%$XJ`5I0#ZAW/2Z@*%*8#%D5J1!Y4E`K1V$)60MY1^">!\X] M>S%6B#!H&0C(QU/.GXS=R,Y$LM>!98@_B+^VIJ_OB;@D2F^ MLU"@C;YM(_"CA_&$,C72L"5F8B2[_3BNB_",J5T?+2-!/K/:RUTPE$U,7Y@` M1&7L:VHO1T`VQ$[*8&7&4%$),N<+:*@$0O`_D17@X!6FVTMI>@=82>N.F8Z- ML*6=M9M@8GEQ&X_S%"T+?L#KO@9<(.@<_KP9IY'B(E!<;-O!W9E8,?-Y>!_V MM-QD%^[\O'W>-7K=CG%QUN[WC>&98:2`4,-FN\*[<"_A"O[X_'EX^W_9S16[ MN_[YR_75]?GPRST;GI_?_/'E_OK+S^SKS6_7Y]>7=SNB^*S^_$$"1A6ZJ6HU M6,:NO/FOG[DG`?BN/>P&8[V;$*3EV61YTG#W'"(MB.#*-=YB2)LC5-I7'H#3 MXB?497/7EK"1B)D8S/U`9A@4RJ]LZR";*XT3Z'1T$A0^9E_:U)9$`WW@-N*J M2H#5R,8#AA+8<.((1&25T+S//HM(GI_!67#`J+'DPQ(<&CZ0Q+D+B3/BK\G^ MR[[G<7N!R?T\!H>/7<)0X4N9M^(LCX_P^M''!OO#Q$]"&?D6(%$M)9(W^!](9PD5]05*V@J)RD3 M`L_>(-<('3*+`],M@=,1Z7XX5%ZXAR32H'_%+=BD<#QPG*Y2-"P87@A M.I4,_#\>^`*<[E$03=C]D[`>`FM M5*>;CTZ2/Z8U2P!VS>;WO\?,.%PPX"\L\$T3.1)!LF!$^Y/`FL^E2*W:.7QX?,I!#:'V7DC3U?K MS$*M@.8D$T66:^25=[KNX\T$:2^1K2-/`D"#KH=8?H3-M^2_%AC8*[=[I563 MNQ!QIY/1JM8F$B1\HF(4S/:#0S97>-YIMF6>)AO`\&/ORK@10[*5L$BS.(L8 M1]F=M">"!Z(EXD^V.`MRIWL*Y@]D#&T_]^HS>& M!MV?&U*PQ/*7D.=SQXL]$O)^Y[Y1+[2*3S!,4C44_"-7\A:OH,]T$;1FJ%ZX]E<^? MH,0%BHDRCTJN[D)8\7)$,EFMQ"F-:GO)QFJ2[E9@UTKE6*K!B`HSXZRW=+FS M$7$'E6%FD''J6?JA&);"7T,BSU_3]%4I1U9T'@B&V;Y=^%;`PF^72V[H^_&;K3XH-1>BXVR M&(+_Z*9WI\\W%DN"+1G/,`T2>UHOIW-V_@M. M1Y(ES8]D.[XE$TF[B<5=<^;L\:U:F..,YL\=0B>;7,+NTL3BG>P"E>0Z54EKS.GBOS),@GIM$=FLXA;4VFKYQ+.HXV5?P\2] MUC`C6!+.XU53/H6&EU:A:TF\*(GCK3)`(^"W,&XBEO5Q).O';1ZQY[13W,:",4@( M-0OA,%G-6[EI(S<@7#/(D=C:Q2Z&S3([^-^8TD*V6T2#@Z*C9&MI M=_AFQB=6[!PQ1#:`D.Q+XU\-W`/%/Z%K\BC[>H+7.EILH:42&2S6<)RL(5C" M`&NZE&3+>`^H=IIT]PNG3C`ZG4/4]K247!6A$T9*2H^E*[+8HE+L(3);-!\; M[&L48"O:,.EGJK:G8S.;'8*<@L`-EOC.^'5IH]F4-B\GE>H*F7I0T\!FDP+_ MA)L%,J3`WH:AZFGZ;9%=%K(QI#6:86^',%!NP!A\(QR:/#B#?NQNKL>*56\V MC/8'[6]%VN4QU$X.0YW+0Q[??$>=.5#M/D=)HF*B]O9DT:>T*"^77?8:>NA\6(_0AYA_BM8'XCY!UBNJ*9CI!W M]GU4F9!WRJPC#HH5"7F'D'<(>:=2(R,=3SI^NRHI0MXA_B+DG4HC[Q0-E+.$ MTG/+;1>WT<>R`A(^$H4W8W@XFJGMZNHGE8(T,K(W@XB/*0DSGI$@@ M0^0X,E\B,U-T9L='PYOSZZ./Z+OY"Y2%PRA/3/AIG(X9Z]=%?%9(?%K7:WJ+IKC/R(/Z[/[-K`!<:C5(*PK]Y()2X_** MVB#L=(V%3M]YA]`P=MTB;`-YMML*ZVS[H&&V"_]F=]L'>X-MGZ1)[IH2K$*N M]H4BV[H_V*L;4HEB/D?%?(6*^1>IF,F'I[V"W/DO]BM2%Y+]YMOO'ZX@[MN$ M^[(%/X5SXGN]J)\]8B0>6#'L-TQ+>G\&#_F[X]_`0?[(;E^ZQ^#U8L(Y9M?7 MTFK'EZD#_%4YP!_SV62UB=2!6Z9@I'6YK#_K['5KN5Z-O MVOFX%KAG_ ?TX""'I'I_'I.-OF?#PN@5U9&H%A/MN*.957=/DMU\EI7'G& M5CQ:.ESS/7ND MDX@;F!U)9VU\=MQLK&U-=F:K!8M4)'Q=.SM+$D<2M[[$#4CB=I:X?9WNJ8H' M>^4'$%!X#&&^N6=+R.Y'/,V,Q6^(?DO[]Y21VY"GOO!0H856ES2E8YVUK5_5 MC)RAFTGJ:\M(3`Y43)J-KBX>*?(DQINKZ^YVHFR[$DT*KR@N/53"Y66^SGTA M*]^T>GPEHEOI&.[`$B'-AID[5]7%*I)8D5BM+5;Y)_3K(E945%V+?%=%Z'-X M26AU4CB/+6QBL@WLVGXKK\N;65R7,)1Y)#$[/#'KDYCM9[.:8CH*AHEP1+A# M(-R2:6B!:1CY$4+D[&(T7UV-`J#,=C,H_RR,KN]R[%OTS8&,):YJW9F4&_DU MI>=1JHD]+*59!IZKAEXLB^KKE8=:!Q'2;0NEJ0?-<@D@\\Z>\E'D\K7>@V`V M&R-C7G;Z@V:[V^\->F>=[OGE>?.JG2!CGO6,09V0,<^GV/`5>W-*D$H)\I-T M;Y79;`GX:OUU0KWN=Q_A,YA/=@Q4C[M5BH^?M'3\.UC43ZUM`YA@E3103`<>F$X7ARD"P/+$Z[J,6116RQBQB*9T7("]LUR M(]FU$>;N?+-4`Z:T?X3CB3"()$MF8Q1B3V+/0MAS05+)IXN?P(>.]XTK=9S%"'I[17`\D*VVJN^D&:TBD'KJ ME\^]@/.@F>UVIN4 M>]03N_*X-=!W1)RL-1GENLI)4U^.C\2$Q*2F8F(VM.W)UL7](EDX4%E0I.B; MAJF-5T@F2"8J+1/'K9X^L/SZ^U%YUH-5.J8?SF!^H<@$]'S$QH$_4\=[\Y"S M]\H7ZX$[G(/1VIIPAV+M*,5/XKD'6'`22Q)+$DNRFB2>))XDGB2>))[E$\]: MB!_ULEE?K"J"?));K89L-6)G4>Z8(V'N]I+3V:J&;&WHUV(3KQKK/')I!7`X MD+ED`4E"5UG)PCKB%"!J^[>D)(4DA7LM8"$I)"DD*:Q,PH:DD:21I/&UHAU] M1_TH=M2>_RE1KK4`!*@4P9Z]"EQ?B98LI6?::O1K*7\?JX&15VB_"2G)P2F7 MIBR=YU,BU4C:KU+GL1$!*R<'D=I5D7JKG7HCS^]`/+_C9E[I9.I@2DJ3E&:I M&)*4IB:EJ1-8C)0F*[+-``/.1#2;60'\ M840MF_-IV3PP&\U6J],V![WNH#4P]?5O-LQ=^S=OV\FUO>6#P!/;/=C9]H-; M3W';Y[8=:67:_Q8S03U%$!2*$,6(8D0QHECU*98.]]4FDS,8J=!W7? MCI/S;COY2F3S6C2MM8".>)=X=Q?>?1GOZF#;U_S)]U<&Z%AHJKN8M.PK>F/J M!^$I+.^,C?A#F)M.H)T"(EP^A(OU*&T[;T6V>N\J][L%M`&F&FO26Z2W2&_I MW!(N`#SI(-36;D%`S7S]>_3R7=_:J`/6F\Q%RIWHLW,B)#]:58$^Q#_$/UO3 MI[X'QW>GYO_>ALG:&G*">GIL%.B4FTVCS5+G@(TBSBZXK4[;=V3QT29!]/M8 M&NNZ\)7`.>T8O48O=V>]+$)%:8026,(#$:R6SG-T=1[7Z,%U;/;@ M>R,*=2E4H5"E'/0A_B'^.=A0MUS4K!#ABO`:Y#=&W/8#*W1\[Q/,FP=XZ$2] M_]R/YKY'M,V#MA<1KR%A2=KK0KBUC?*>*P9+1[C2$(LX[A`XKB(]E,I%M,V* MDRK=/-QHM)K-#_D0ILIT^0(P+\VI7'=P6T?R-1.N+\_*+ MSW3GH7S)<4OA]<"+*-.R[ZV4:NV8-)N-IBXNJ;L;)=H9:KK M=]2CH`D$G@J:2+!(L/(0+&V>?NT%JR*)\DIX^C5RZ#L-P^Q0?OS%0\E)B(4B M-DR]SGLM:%5E'YT\AIJF`%NM3J-/*4"2!I*&6!HH(:[#&Z;8DS+CKT>C6@M- M2L1J15>@:+/<]:;A"\^[PJ4I)5JITBG6`TOJ=75NW]<^J4>"18)%@E66^*!, M?@5ER_/)EC>IFGS%0ZNJ7+0A\-:"3)0H/PQGH5(^@=%J-UJ4&B1I(&F(I<$@ M:=#@"%/828GRU_>CJ(1\YU(4"<]I:E-6]29BGJZW09GQ\GLA]4C@:3W85OL$ M'@D6"18)5ED"@C+Y$909SZF.O$EUY"\?^C5R,ZEQ8R`==VTYMUK0B5+CA^$M M5,HI,#H&)0-)&D@:8FEHTHD*2HU3:CQ?9[&MM;RD1*Q67`UYG!K7YF'7FX@O M7&\J(J^E9CVPC%Z?,GH:O7H2+!(L$JSZILI+)U2'DC-O-0943;[BH5<+7MK5 M3515+&^>=UT+:;F:9@I[!+],TD#20-*@V2VF()3RYF\4GQ#VBI:\>9ORYI0W M)\UZJ.F]-J7W-'KU)%@D6"18E#_37GSC?+F;=$?M?3?F?0_8@WJ%,71P)DB:2)I(FRMM75O;0[5B3@GTM M)-RG!W;OAY;+YM&#Z]CLP?=&@C(Q^PH:B7#%6J;9T-?:=ENBU<7: MDFB2:&H4S69#&Q[OP8OF:XYP.J/.6_Y<#O*Y3Z_M)@1"L['C69X-0\Q#2BLE M;%U"U*4T#)4_QK+0)5G093OVX/?MTZ[\X5DS'PCP__B(S0,^HU.B1719FZFEFT"S[F00#F M+`V6V)CS39+<]?02CUL##9MQSV:^6/]-I[ZGXIV/%$U1-/6VG+2;&JS/P<@) M15H;[;L^^`&,!X8HF!^%(K2\44[I/*UTC9/1>,<[E1=%BFKGI-7K%%#QO?[L M*^Q'4GQ6M?BLM$)I&`7D10Y"*.F,QHX"V=XH^-5S7J-`-^TW+@034S\(3T,> MS-B(/X0,?`IF1Q`#P\OFF-SU/>:/F>OCK)*[/3;:'0W8Y!N2IKZ! M`FDM$K35@M9M:]C`)#FC@'R;@'S9*C(7#>HSXYD/;[:`-T=^].#RG<1VG_[Q M;AS]S\+H^BY':PFRUB>C[H#+-`=YU1UN0LV#B,@H3:+[$`1I1]*.N6K'=E=? M5QW2CNLZG]^%%M!EY?V9?V?F]>+@_^L3[6_#$OV=)BEGPVSNNK$8_'C4/)*_ M8:GLY/>*8=P[,R[8%_[(;OV9Y7W/7J/[J@3?HS,*IY_,]CJ:?YF+U[]YLQPC M\.\FS/H&F@.NQY).Q^S;5JNZVK_'MVP--=')'6H"![`3)?,2CZ^9HZ',$2+B M(^9[+($]82:"G1CM$X9EHI$0\.<'#FX&CM_E=NA\X^X3LP0+IYP=X:WL#-_5 M.&([JQ&2PL.4PMP:C)96"B]D)A^D;X:E;($_8S9+R_[HP49<<^?.9X5@A0X'N-1X`LFHH=_@R"PT&=C M-[+#R,(TM\`;4";P)HA33_]HW#4@O'5=*V#\+WMJ>1/.`GC5[D8HN?^'[R)Q M.K&L^:<[>\I'D[SY'@ASYOKVGS_]X^]_^V'5C8'SS4)YOO9$&("E M]$)Q.1[#U&X\>6#VW)_-`S[EGI`WV?Z,_^8+L?QV6"\/U^"6CW\\NKH`A=#] MW?C]_N*(.2.X8-GAZ57KHMT?FCVC>7DU;'>NC+8Y,-J=[KEA]@?-R^;13\\6 M^2W9?DVT-^$1^=OQ8'7#3VW$I-DT"?"<:Q9/W0,'3"P'V.'8!5IQ\9$%W/8G MGCPC!BQRZ>"P[SY[X[/PV>]`\RNW$[3AG=`_$?\MQ'_]=1V;CY&9P-D MY8)-CK3FS)F#Z9=92E_27B-;E M50NOGJ[(@XA[.U:A:-0W#5-;U%)[+!T2+Q*O-<5+)PAWW<5JJI6ARQU@!IM2)CZGK$D,2,Q6RUF MG89)8I;W46;RT;<42B)<+H2CDXMZ3R[N?-:N%B<7\W/9MB'E1E:F]#RJS=,C MI5D)I5D&GJN&7BR'ZC,KJ_K*P&G;.-CK'==^NVY?2SG^)L7^U]Y=:(5R"^UF M?*7PWBWWJR\<+'&[LIS@7Y8;;53JWVSWS?Z9V3UOML[/+\][W?-!-RGU/S=: M!97ZYU?:_V"Y0"7.Q)3SD`%1Y-D/B1D(0B`$&P/5V#[6SYH%/U< MIRH#W?:Y=B$?I+KA'1.G`ZI>>E8!+P28K(4CL/:N&+%B[@'<@142GRDO:D'5 M.W2G%C]_B_TJ7<0F9J3S`C'K853#9%A#ZN^@3O`4!HQ;!V*5CIFH*)T.11#_ ME9'_?HV\C",7GX=8F_5J=1Y"5P(Z<\YND3!\)RM(FVY4XE$-!;G?_@BE(UQI MB$4<=P@\SJ!RE[$8S9:19&D+@?E2+>0;B'=L@9!6J1;\C^$6Z+8+2_!4CT`1RO3 M510"[UN;$^&J4%M?^L,>U2B\+_^!I-P<>FJC1IJ1-"-IQLIJQMS"$=*,FK/_ M50Y6OOC>Z>I01=O..MD/HL\[]%E[U_(0-R>)?XA_BMW<7C,4H%WOJ@56^6Z' MQ[24+48U;GZ7B'[E$NQ][%P=(AK&2\I5'@PC-RR,#6A5E_"1]!?I+])?Q>JO M0'L#%$ M6HNT%FFMJKKRAZJUU@+@S,QE20AK@'38:W1;1M/LF9U6M]OO=4N$=-AN;HMT MV",@P)(\UR*DPQ+[(X1T^!HDR6^.]>"X3OA$:(>E=(\)[9#0#@GMD-`.Z\1Q M):,/H1U6F9D(;>XU=B.T0^*_??(?H1T2VF%]Y)P(E[N").PYXCCBN.H<"*%S M'Y5PF7/;HQW:=A"!*^+&.62'*N/*G"4I@YQIJX*H2DFRQNJKNE0BD.SOZ/H1 M]*`>`I5?=S2+(DE==`MEC58\1-"#9=;F1+@RE1$3P-:!`VP5>ESBH`&V2#/6 M0C.2\JO4&>G<@HI-B%47%7;(AZ0)(W#OBI[H0QAOQ#_$/^79$B:,0,((+,TF M%JE,&VYN>8K:%(7$T;JA=0+J9?]>LXU5B]K@>ZM^O>"(-HQKU07'MW(?B>^.^;\97C69X-Z_?5 M%P["Y""FB80TN0=/__C[WWYX^>Y+*_"`Z<17'MQ-K8"?6<*QA][H MPG$C\&SO<>SI.V2B&W[<\O&/1U<79M/H_F[\?G]QQ)P17+#L\-0<=-I75]W. MT!A>&@/CTNR9AM'N=,\-LV^VSLVCGYZM8G9%WL'\6\4$63!"PVQ^>('AET4O M;./VPZ9L\EPN%D\-6<"!(K;C.A*;B/EC%DXY\V"%`BOT`\$L#X,#SY_!`LD+ MD8!PP?'D?0](:W6+HC;C\6JP.0^8P/5@QT>77^^./C*0)3MRU7<<>+%@8]\% M?L,_QM*M@EJ-E1 M/DD[8L.WV;`OG:/; M2E&7:,NX,`W^)8FS-JD[)HR87-*!Y6&_TA&..&X;PNWNKAI5U79*N?&0.9[M MS]9&)2;HF)I`QQB&QI1[73+JY8M4RZ4O2?IK(OV#;J-%PE^OD.BYJDBV77I; M[$>1?UI&(I:&<,2)A\R)E.1?3A%=+/;>&(\F6N6=S1U;H('L4H)$NOR%).**_UE26*UW:,UY+3'7E% M;#M#EVX$AZ&I0$]_O*?/+27X9HH62V5T#U2H6^T"3[8?ME!79./HE9TWL[GW MG;?R9_U+12OB*^(KVEDJ*E(9>J%S.DJ2<2]3<(S_9;O1"'Z/`W\&@YS-HS`] MTYYW_%*+Q'BS85!:G"*($D40)%8')E8;@\YL@J.B:T&WF^0;Z#@;(=B\@H*3 MPN4,A>"A@*=_6Z"2?^:6B`(^NO%N.4*_P\?P&V)C;)R.<=X9#B[-0=L<7IRU M+_H733/!QFE=#5M%8N/\.Q*A,W[*$Q[G?LICC!I,A$J&%$Q$LYD5P(T2`><; MT#QU,_PH8.,$R(@Y"Z@C9EM`=7160C:&E9*/41]\[=+]!\-[_DU\CC#`\BZQK4,*O2F<+[%<;NK MQ\$:UK)R>$0*;,AH-O7!"QG='?&%VH.BX7>:5<$)H@G2!//\8$63K^6)A8Q. MN6L8"D,C8:_Z)O7*^Y>'].JV_+)G+;K^=RBNZW+MK[QL7(6X0,X'[\EH[B.^<#R:T MO(+."'3U'>BK2QT0I1Y(^`]"^-72]TW#U+;VI`-(!Y`.(!U`.H!T`.F`BN@` M"@)TY`_63+_4/K%PY0<.`I.5GA'UAVF`]B52V.Z^1@C6M_ M;(=RRQIRRX)5T7$BZQ6GF';H45GL/:"64+XMF,A M*LFC$T[9M0@L[CIL[HOPE,_FKO\D=X8?N,?'3CX16Z5DD-*DE"8MP&!52B8H M;4C"0,)`!H)D@F2"#$0N`^.MZT%7KL..^B$M$V)T[V&;/4TUCZ0:M2>F"Q>+>8EL1G`^EP@CW*@5.6- M!AE5XA_B'^(?XA_BGS+2IUYG`'5Y2G2^KUP9G[J7=%/.ADY*K"E>'8U-[$FL M2*Q(K,AJD7B1>)'5*HM8:K1S]YQ\E=Z@VTL)PR%L MQU'NDK07::\*>5ZDM4AKD=8BK44^%VDOTEZDO4A[D<]5=$KLN]""Z:^\/_/O MS+Q&K\'?V,YX?S(`SLKQLX#WI MB^4_#A74Y=EIGX06/;YYI%?Y`F2!,LXP0K4A)?.B=Q,=S.'CI3EZ@/]:^1 MQYG9.V%FTU@;'X*XCMJAZV7#W_@W[C*#PF#BM8)XS21>(UXKB->TH8L0KQ&O MONNG$:L@XU26FKMR)'8D=B1V)'8D M=B1V+.S\\0#B`=0#J`=,#AZ@`*`C2E$,J,8E9D;H&0SDIE MD&L/;D'I9PWIY\,0+[!U;9(KDBN2*S);)%XD7A41+S);><=N)0C1M(5?L+0" M^__ZMF.%'`]QA5-V+0*+NPZ;^R(\Y;.YZS_)W=\'[O&QDU-(MM]C2N4W<>_0 MIRX22:E4DJG5=JV75Y-3$B82I@,3)C)0)%,ED*E*R8Q.`U078*Q\-2PU@"Z-KO1O`ZMS3IP:PE,:M#RPBJ<8#5XWF@%0CJ492C:0: M2346G4$B#4D:DC0D:Z7+"?SIQ^$YU3#UJS_=05E3[$G5*^Y2@N*\> MXMEN=$DL22Q)+,LEEF0U23RK*9ZU$#^=5K'N8K5[HKT.9;WN(M^>C\*FOKYY MD:_2.XI[J;DXA/U#2K:2]B+M52$_B[06:2W26J2UR.O^/T<>J-,)>=G M;HDHX*,;[Q:;+@7`>V>6<,0]?O4>2'3F^O:?/_WC[W_[X>6;?_;]T:/CNNE] MLKH!?MSR\8]'5Q=FT^C^;OQ^?W'$G!%;13\_6*4OS>V?&!?O"']FM/[->UYV9QUW'XZ=3U036,)L? MOG_9:C:+.]W&JI--6>&Y8"R>.I]:W@2&['@LG')F6T'P!"1FULR/X%W^F$UB M&IZPAR<6\+D?R`5G@D\0#>V$/?*`,TNPL>^"U1#L&-X%7W4=WQ,?7Q;B9J:^ MI)J;\V6`;?R=I8WG!S.81%8?&7A/.GDU+)N[;GS/CT?-(_D;A,Q.?F^^:#,K MF#B>&J05A7YR05E7>>71&8733X-6H]DW>EVCV>R:_4'+^)`H`Q!TUYH+_BGY MQ_?/A7LQBVP^>;$%8:S<%U@C)2V'!B]H?7A7]RQKP?A!H^CGS*H,=-OG*K,2 MM(*'.L%B6/1PCZO(5XZX[0=6"&;R4P0F+T!CIUYW*ZTLFN$[960W.L]2,O*5 M+IQNI7[J#&AA0_GI4CM6#[X[46\XLU_)L<.9"]FOD<6;V3ABX MR!UB/F*^/)GOY5<4.T8"5*(0;&C_)W*$@ZIRKPUWB1?KSXOR+5^CP)Y:@@/G MV1@'HRD>COX=J?;/Q(/$@_GSX'ER,.<^L#SA2D\MD# M#YC9W796=P!U2:4FSZ&2?]0:^A M+7BM?5$[Z1C2,:1C-BTL&)!^(?U"^H7T2R[ZY;C9,`LCQD)6\B./5C[Y2*J' M5`^IGIQ43ZO1)]5#JH=4#ZF>/61N^M2^>6U1V;V0JMJ)]+/S7_:I56JF==?& M/=F&5OMK6WC2Z1CZLC5U41TD#XPX%Q=4X M,5LM0G+59KU)M$BTQZT2>+54VD,22Z4]29S9 MT7=:N/:64$.;KV:=DF/W?FBY:5M-76Q$2F@3PZ>I3W09[%NI6D&7`CZL?3+H M:83Z>9)R"%`PI&%(PI&">`5+EE/1Y@RJ'F]PA MU4.JAU2/4CU&6U_I%ZD>4CUE5#WQ2_&.EYL@96"O4NFE/*BE/>?3+S(D*X!_ M]A^O93+WWX463'_E_2O^_<-WD3B=6-;\TYT]Y:/(Y3?CG^.$]SU,^,SU[3]_ M^L??__;#R_NNO6_<"_W@235`#N_QP^E#0$T/27;+QS\>75V83:/[N_'[_<41 M^V+GM'N=,\-LS\8]IM'/SU;@BPY[YT9 M%^P+?V2W_LQZ735F'G<=CY].5>M)'UWW1)GS/YC@NZR5#E;\<#HQ!^ M:O=!\O6-_;/U;Q^&[L_F,&PO%,P?,R=9:^PP_&(2FW\C;5*\L$*O=BO>_.W, M\D8Z1OEKY/',`'O:!GC"'GG`F278V'?!O@MV['@,'G(=WQ,?/^E@DQ-0\DK]! M4=O)[\VUP\P*)HZG!FE%H9]<4%Z:O/+HC,+IIVZKT3+,5K<_Z)F]=K?5:G]( M+`I8"]>:"_XI^QN:FIE^BMWQ?\_>U?;FSBRK#^?(YW_T$)W=#,2 M86QC;)C=68F09).],\ENR.SYW#$-6&-LK]O.R_SZ6]V\!`(D0-K&-J659@.X M[79U/4]5]4O5!NNQLFM?*J;QX4W[M6A))PWU'=L95M8/+.<+*EAG/\C@8];= M^CMWFZ4@R]<=QB4NWMF'EI\>QO1Y%WB]5\WI.B]DI17#H!CU4K5>+CM0*E1R M._X$V>5I1V!:TQ#GKN]R",WD?J6])B!:*^P#FLIY1V&__$_A-#25\\Y[U);] M3]S@5N:4YJ*1N)"XEN>>K:;"W88'35S;^V#E<;7^&T0_B.N3,`HB&/I`1C9GX/14K:-FLZDP MC0#N6,3P&'D+>2L#WJJKG.]&WEKTPMZ_T_KU'=1KMEW+E+VG\(+W-';O&;\* MXE/&05@T9KTVOV"]`2CJI<_C*!F)_;O=&'Z1?UWWSUV?^J)8T9]`=F+WI>^P MMM][_CK@;NP&_M?`H>+_6^_I/CO3SL]/SO7&B=XQF]9)4V\\[^EN->S,]W2G MN%'Z=L@(1!C,&>^1#I*(@$(=]V:C07K/PT0"G\#(D4X@^L+A1_A+8D1>^3Q( MXE;7(8ND_/G+C<*?E_W8.R-0O0^U3/VEO[V'W]EMS\R^:Z%,'+!OU:X^"!.X!#NGOU/4_'7T-./]( M;I@3#'QHV1.;8,8JFLXD-BHIR@?E@_(IN1'8?.)LO][([3!BC'R#WX:R.JF\TL\Q_(;50O2YT$$(^(31ZYW.D^D'T0/-.K)A<6(.K&Z?5WY$7CN MN*,H@MNGILI5=L(>0[%66R4^BTLHX&)IYDZA-1[I+?>1WJ,L3O0NHZP,F^FP MWAHR&C):_AA-Y:$99#2)*[+"<. M$`L'B@5P!)4OIY2W>`M.R^\N9'FZ&F<#<.8=!7=8@DOE$#%.4+U]5+;<,UC- MM-*^["+*`YWB0M)$TD32+!!IUFOU_(CR0$E3:7:'/29J6),ZHLL&XO8W+`Q` M;<2SY:U%^Y.GR8_;)'LXU;2Z?5JOMTS[Y*1A=,X,JSY-]M`TM9.R)7NX8V"E MB%0,3O@0_N;,8TY,^M-A(2-&>1+!SW=/))K*&2Z3LLV^REN),SG4:UI3MRU= MTRRCV:KK"C,Y6._,Y&"TLLX?8!8ET4&^$R3@"Z;7#FOKY3GD64ACL\\UE/P> M8D0MVER+ZG.O\=YDR(KDNE^U.Z&><.%%^>39&12R[:$I)+>TR6TK7=2+QWZ[ MZQZJ&6*S.`<9-X7F&\+<+UBO&!@+ZF&N,52W+-1MDG34'TQR.I%QOB=4/E2^ M3%*-@2!^RKEHD7#LTH^I/W#OD/U0`><58P M&4;7;84;;Y!AD&&089!A%ABF5=LXN1@2#!(,$@P2S%:2,*NBTBZ&2:E.R91B MYF7E1LB3SL4N4XBE.FM=UPQU`"H+3O('B=R9W'*BP53GL"(6$`N%QD+=4C<] MA&!`,!0:#%;5-IHU#?&@(*#(T4Q&5I'&S6,:"%(JR+U!R[`T7(?`:<(\F:9R M`*NEJS-8B"O$%>)JLJS5K%F(*\05XDJQ(UAMM&R$5KK!5REB+-FH&S*1>"1^ M(EW'9;ZSU7[YH-E`8*4;:I4GHOKN4\\3Z?M9;UHD%==NQBS3-'1# M&3^7!2[Y0T9QS4VA,'%4;ZG;&KH\XMN^>MZ+N"!.#A0G:#L0$X@)Q$2:X<>& M<:I6Y,!$;3EH+)>83M:2PRZ7J%?KIEFS]R_-##1N_U2)4Z"[^Q7(CLB.V9_- M47DX![D1N1&Y$;FQ)-QHJCQ=A=R(W(CY&*PN?C13?L+%:PQPKV\#-6L,]+1_$%U[3#"O9Y]I>?NXL5 M['$7P+NU""O8KZ]@OZG;EV'O_DA\1@R[FL>^;5-F'=D_;?9/I;1ICLQ#EX4Q M&]VQ2,(!=$]9+O=#5S/$YJ%6'4X-K%Y(K8^TS:G+-X8ZW$E$&K5Q,[%YU]`AN7LTN^6FV9693,.(B5Z`*Q5>XL M+A(7$M>6>4A-=7D7D;>0MY"WD+0MY"V5]:RK]::>04F= M@Z"N@JR"9E73]*1SL?W]RX*6_`$C=_8<,8&80$P@)A`3B(G#PX15 M-4U=W8G+LN`!U]0W"S]N'M-`4#FRL>LMA85`2Y^-O4#@*JYI*@>P+)69]Q!7 MB"O$U=A@V>J*]2*N$%>(J\D!S*IEV;460BO-X*L4,99LU`V9`S_%3Z3KN,QW ML"S/+RU='7S*@I+\`:*X=J908-!-!`."`<$PWLML8`UY!`."039J5%MV2UT, M7Q8\X&+.:G6YCD'F&+:OKZ:;P3&9LF"L0'`JKC$J!ZYLA0F>$58(*X25;*3A M9@.$%<)*N1?8T'%5--U0JSP1U7>?>E[@T)CU"'L,F<_36;Q)(^-OF;9EOR6? MLL`M?\@JKKDJ%&:.#%-=[J'E$=_VU?=$MY@Y$G&"1W[0=B`F$!.Y7RG2BAS8 MR+RDZ7CG6#TR,[F6.\U*JZ$KG`+%TI$X@8J5=9$;R\&->MU6F#L/N1&Y$;D1 MN;$DW*A9Z#?V*OW_]E/#C M`:7AYZXS9+W$8]?]+AN,F!_?L%`4OO('EWX_B$:R_M7)T^3'6Q#&B1OL'B]:GKK<\0*>1&QV/0C9%Y*\8?TOE?-30].MO_2_;D\KQ.W!%]2) MCVVSHS4:9KNEM76C89BGIZ:EFPVKHQO-\V:C4_GMQODXA$4Z4E?*S%G-"($SX3C*6!$$SN8DWM6@8 M-K]XNV48,`G;\/];4%ETE,SP\5T#.UEK,ZSW>WKPGEL9NFST=S5Q=2XZR]RU MO?A<@5HGX:Q'PL@=T0@N)X%/XB$C`R^XHQ[A%$`0],GU;0?N'0#4[R+JB^N# M7N(`^EW?\1(QHB"N9#"L"JGUJD1<0SV/18.GV;55,J`\C@(73!L'#H';/_]$ MX>.`<=>!OWW7"6(A7F`;CSI,\(SH5$3#)W)4N;JYK7RLDK_=&%[0A^N_P;41 M];A\:C<)0X^-J>FH\O>WKKB6^O!Z'ADRZL7#N:>Z?I_"O87E3CPJV_>#H,?' M+]!SZ<`/H*O.K$GMW;[&-BJT`!9SL30BDB*2(I+B'"F>="Y4D&*/W3,O"($" M0$^3/KC:X)C+3]$/%O,),0"/N7<)\!B$2B/)D&=)%(3L?SD9`6.0!X#$\0\_ M>/`E=4K2%&0IN=6G<,]G.A)W!)ZJSC/H/(%6"3!>E80LXH$@34=Z7*(;#`*. MXS$QLB26W.FY?2;?=\+!?NP>AS2BW(T!N#1F@R!R&?(8\ACR6#YY[.8Q/1J3 MG#!C,B)B.8C;W$`0V("!%P6NCKB$SY)DA4,*).-(>I$.&^-.Y(:RS'F`2B2R<8`3N\B"_[ M()4G>!IX(21B#G/OX?=^%(P(E8799S'I)!(%I:>#<0P(;2%.BUT(\`@'_$4! MAZ<A>Y"CHM6O$D?&5,7U%(*XSGEY]L.(=NTWGY MV?5[H#:J^_Y?\+X]'I`AO1=^.*G(3"^5Z8SHG-:#O@9)1,#X@I*_-*4@VHCU M7-'BJ-+^\[+RD=PE'-Z+@]%^&+K.D*R+11:L^/CF<`,B4?,01%X/>)^1NR=R M%T!\,6_892`B\+C8%]%EZHNX8/Y@$!^(Q"'$BT/XFS./ M.3'INS[U!?62$:-<.F@P:$MS[.0(`D=X#CAJ/O^H9(;=@=NR:)-UGP46$+OL MYX4E/L\_QA=+8-["XJRNS1ME96[0BYX#&@:N/^XD3>)@^L5XHU MK:G;EJYIEM%LU?4/T[5/L,\>#3G[//UC=4V.)3_GV:Y;*P^=;.`JR:Y]J1BM M#UMZ:9.&^J[MS*P?F'6[1E$ZBB^XIIV5R0,+DEDA=[NFGKNK[_<0WY)!VWEG MSNH8Z788,4:^P6]#3LZ$#_7N$!&U:$F+ZG.OL8\L'2ODNE^U.Z$>>(@09L2D MR\*8C>Y81`RK2@Q-WWA7+9);VN2VE2[JQ6._W74/U0RQF;;)R!Z:;PASOV"] M8F`LJ+=5;BQ4-U2W'=7M.F01E=-5E[XC-D,A;3EZF:J?F&.SO>E M=?2L<]'9)[!33C&;EV-Y[SAUEXN#=9;=4)B0H>QIA0M$*[DSC<@PA\DPNFZK M2Q&+#(,,@PR##/,B.4#-1()!@D&"08))A6#,JJ'K&"9M#)6"+-6E`)R5&R%/ M.A>[3"&6*MEW73/4`:@L.,D?)')G%`23N0H?$\KSI"Y,3%J M7QNU&PJ+8Y8]9"\0G(IKC,J!*POW-2.L$%:J8:6AM4)8(:R4>X%F`X&5;JA5 MGHCJNT\]+Q"EO'J$/8;,Y[AV,RO=HAO*^+DL<,D?,HIK;@J%B:-Z2]W6T.41 MW_;5]T27F(@0<8*V`VT'8@(QD?N5'JW(@8E,4 M=U@["I.GR7I52TE+\R!;=5E+WI+K>]*:I"%&Q;O/JW73K-G[EV8&&K=_JL0I MT-W]"F1'9,?LS^:H/)R#W(CS75[#?U.W+L'=_)#XCAEW-8]^V*;..[)\V M^Z=2VC1'YJ'+PIB-[E@DX0"ZIRR7^Z&K&6+S4*L.IP;6*Q:3+L4BUZANF:C; M=<@B&D/WR*7O!"-&CKX&G./.>E2^#)2O/0I`$#]!_P*?!'U0P9CZ`_<.V0\5 M<%X!%Q_Q])FW.6;RQ5F+*H-6KB9V+SCZ!CXZ80$P@ M)A`3B`G$Q.%APJJ:IJ[NQ&59\(!KZIN%'S>/:2"H'-G8]9;"0J"ES\9>('`5 MUS25`UB6RLQ[B"O$%>)J;+!L=<5Z$5>(*\35Y`!FU;+L6@NAE6;P58H82S;J MALR!G^(GTG57EJX./F5!2?X`45P[4R@PZ":"`<&`8!CO93:PACR" M`<$@&S6J+;NE+H8O"QYP,6>UNES'(',,V]=7T\W@F$Q9,%8@.!77&)4#5[;" M!,\(*X05PDHVTG"S`<(*8:7<"VSHN"J:;JA5GHCJNT\]+W!HS'J$/8;,Y^DL MWJ21\;=,V[+?DD]9X)8_9!777!4*,T>&J2[WT/*(;_OJ>Z);S!R).,$C/V@[ M$!.(B=RO%&E%#FQD7M)TO'.L'IF97,N=9J75T!5.@6+I2)Q`Q:989UJME7Y[87LY^5XZXX8)U?L@=P$ M([J>7^>:>Z[/CH?CFDFZH7W8>NQ>ZKEL)3\NUS']?M(]^^O[V=4M.?L;_NTN MC:&"AVQ<+CB=-]]=9U_KVDN`S9?/,A>K9ZGH^^YC,CX$X9-K)PYDP5I#%JQM M5,D#(]3W@84)`SUA5=G#GLO#@,MK M^[-7IK)(6>UU:ENFIW5TLT!*M]!9WF<1;_N]KGP#>/AU_]SUJ2_.QH\+I,VN M6OI%UC3]$TP$B/AM&FO6V^WSNM'6SK2&7M=;YW!1NVV=-:QFW6A:YZG3V'M- MTGK&D1=_%OKC.N/[M!T']#KFY(8YS+T71H8(*001B%@9YO-.3\KI:.*L&`WQ MWT32G%``-$^\6.!&P(PZ_R0N=ZP/QW#!:B3!S<>$I#:<<0\N2TQ'KI1[SBD M4?Q$^E/4`-OPV(T3T3%.CN(A(]-58D/[9:P>?/:-_LO'&ODSB7A"04+`N7D=C,BF`ZZ*N/B)NYST M`U`-X#DW)C24--J;W:A&VM"J-P*6`SZ3Y$SZC!'1-2&G?A2,E@WP>T==J^GF M!^5W%;)+HZN-%+H*EDY8KT"8'1@BL$[1`(8E\.7H@W//`1@C,41BZ%<,.Q<: M/S.A!*);D5RBO+;DXZ-4:2N*$O=O$Z7M*##U);5NGH`^7JA^9_]$:K M5G^>)H#&'F!3_6"!T)3?M,O"F(W`HWKNOV&-72OESP(')0WI&[4Z24WF/39Q M"L&E`HPH?\`?B<_F1&^G)/IM73^%3MV"L_C=!VF"5\QZOX,Y$17%K_VQ,97V MYU:@=)NHMF6VV\U6Y]2JM^QVTSQM:.=GNMFP.KK1;&@G=N;N8(H!U+/L)@&' M$!D9@!S!#?!`E(Q_E,;WGKK>V,\`B\MA),"D.TD$K@R\[@/0,7`V_.9YP0.T M!*L^00__^%F%4[E4''RM-!?F.<6>JWGIB<_SC_$#\+R\A:DZ75PSN[&7@]&8!-=?]Q)FL3!](OQ5+7\YL'MQ&FM<%($2$W@YR60814?L@59/TLM6EA'KLCN=NJ3]V(W%,O86(7%WLY M7:Q,U5(YUX3'EUZ*K]BGE#(]P'D(!Y'RQVBY1?J7NF[V?INM@;-%OL??H[U=[/U:73VU/[)KFK2M0YU>[O[U\M7^_UIMS\M M/^&7S8?UH<.^2']S.KU[>7'Q_OW[\P]7A^WY_O#Z@A'"+\J?+\J%9P_7GSZ^ MP_48>MG=+#=G9>R'P?%4#]>\.92ZU3^M=:I$Z62DU]PZH9AT*;CDG%\/9YN+-B'K;?8^4!FT3XSG:(3#E[:" M6F9(E5`#,T8H)^N(YM[Y2%*B)'A9!C>,:J89KQ)J8(8(46(IY5D%X8WS4G`B MTCHX=\$(:FJ$6I@Q0D(0E5G@@5%+)3'*!(P=I5%:Z,\0:F#&"$F'@2.C,7-A M),E6KVJMLRJ9)*J$&I@Q0DI39B673DA*/6&&EO60C$^2:%%=0RW,&*'$'=4Q M,H?1J*&)RC)X]"X3I4BL$FI@A@@QDIR5B?D<$Q-4!2Q6#)ZE]"9%YVN$6I@Q M0M0QS+9*/'&9N338PM1J[ZB`E>&L2JB!&2,DI+*9V6`)D=C/EB091<)F=MD' MIJJ$&I@Q0HJQI+,E-G(.EZ"4U*M-,3Q)^YD9:F#&"%GNF<)TPS42GIAC*I8= M0^&>HN351=W"#!+R'FY298(5P3S)0I0=DY601GA"ZX2^C!DE%(GSPM(HK:$V MFTQ6SZUH<-RGSQ#Z(F:,$#:KEI$QV#K87V>STZN1=..7#QW#L2Z;%/5V[R M8[2B0GM574,MS!@A!^L?O56<6DFP8X*31:U6&9+K:ZB%&2(D&8G&2Y@41P*+ M*AC-UL&ICSD+5R/4PHP1I9(#2ERPT(&[/0FI=(]3"#!%RA$8ADF-. MDBB#E53QU0TH2Z"Y>@K;PHP1PEH(SDJ'<"L0G5BD:\!NL(/@**N6NH49(^1@ M[$4.M!RM2D$C_,*Z8UA@\)W51=W"C!'R*C"1X`.HX,AA),QP"=B)"\*94/7V M+K%0F6W0?L@5E\57=9"S-&*!O!9$H(2Z/D'"%@$AI.@-*D MG?C,##4P0X0\YQ&[5>$NX%DT\T@"\A1DDE+W7(EAD$;SX;4'T M.OWEJ92I9JXMS!@ABYV"W0R(A^:HO:V'&"#D6DZ9P1SFG MJ),3ZUE/TMI;3DW5V[4YFF*')]AAJ8(4+!4NQ4 MRHR%Z64D^>!-=(@H+$LPQ-40MH49(^2)ET8CH$G4*]B1&(I-(<$0ZU.HGE.W M,(.$M'7!.(XGD(X(HZ,GL"M$>^]9JB:*+,Y>#]@)ICLY)65\UC"W,(*%@,_'6<8&?.(,IX64] MQ*!*$EI]>:J%&2(467G9-G*:!+?(_8PWY20C&*3O4I'J#+4P@X00\WD:&`O* MRJQ23.7@("`-=)ZQJF%L808)99NQ-9!9(?-SU%,$$4G(9'RPBE0-8PLS1LB1 M[,LKEC*6\Q3A2%CC8Y."X%)5PX\69I"0@EWS649&<">03Y3E@"TLX*M8JEKJ M%F:,D,^8;1,)\XB/>?EQ70^)(:V1OAI3MS!CA**66I1C7:5\<,S'>)\6>VFU MU=6LHX49(@3WC!60D$,@'(6!LUGC_\2(48*FNF%L888(926,HIP+AOE/`L&[ M+2_&!23'\%&^>G#>PHP12BP13["#60B.\_+RU[I`(]<(+*J^K(7Y2D*/Y5ON M<+U9"^760KA[V.7ANE'*]7#%Q:O"Z'&H1WAYX]"G5%_M`7H8ZD6.`@F>1=C' M92!)2A9H,"6P@EPJXJP#D5]I05_EXA%;CWP)6*+0%TXMH&XR,7'C,5*]G# MURAD_T<*$S>"!Q5%Y$H@T98G]U!*SECBGG,5 M$/'A7RH*C?+`T\K+/-]*84]IYYS[L*=6=%*%'<6GLRK\^FK6.17VE,=.J;"K MWG92A1T%O,_O\9]#84]%\)SWL*?$>$J%737+4V%/5?64"KO*M.=4 MV%/W/:7"KD+RWRNT@>4DA+/%XE)7RIIDR9Z\RK3Y[R'/:7N MI'F M5-C3W#2GPIYNJ2G/:;K:KZ:\AUW]7',J[&D0FU-A3\?9G`I[6MBF5-C5$S?E M*<:3%4YSBM'51CCG*NWI2YQSE3Y5X42KM*.5<\Y5VM,;.N596U>SZ93WL*M[ M=5*%'>VPDRKLZ*^=,C_L:MB=\Q[V=`#/J;"GI7A.A3T]RE,J[&IZGM+2='51 M3WD/N]JRGTGAPU6/W>)/R5X:LW$_%7^8A7M6A^6XOSMGSF7NZOM[?7F:K^[@?#C\0X3M-]MXG*]O+U:#AOVPX81 M*G[8W-P>K^^.1_P94O;ORZ?6;#%YM_]>MA\WE\=UQL[*I1M?QCH_>_+D]-B5 MYYD<_C`Y\2LU\V'-/1GP\VAFCYK+=KG$0GA;/G40)F;S\]OE]>73UWJ/B7D6 M:3^_6W:WN]>;JTL\?+ULCF^6Y73<7!Z6S;O#LKTM=N'PL2;P#P_]A%_P$\7 MA=7MR_(=O_X'4$L#!!0````(`"2%8D&UL550)``-TV#=6=-@W5G5X"P`!!"4.```$.0$``-Q= M67,;.9)^WXC]#UK/,UJXCX[NG9`E:]<1]MAK>W;FK0*G5-L42U-%^?CWFR`E MFY)Y%(M51:I?=)!(5.+#AT0FD$#]]M>O-Y.3S[%NRFKZ^POR"WYQ$J>^"N7T MZO<7?_^(SCZ>OW[]XJ__^>__]MM_(/3/EQ_>G%Q4_NXF3F;K'?6Z=?K.J;?7]S65Q5`0`0V5&8`_K)#%;-O MM_'W%TUY)?;3O<47[Z_[RKBFG ML6G._+_NRJ;,0[-IV1LM1(?1[V_5;#N66P6'T:U=1V^7W%^[\VHRL:ZJY^;V MK*[M]"IF(]ZV>]O*#ZAIJXYN)SV@ENVZO*5X'WK>W)2S>=5GTW!>36I\Y>6O3] MH2_M)#LJ'Z]CG+6`?8O@@+J=VXFGG15$#V@EN]M#1UX'6>EMY/.VJZLI5^M M'Y'--M>7D^K+3OV_L8+A=&T]OEI([Z_E1:PAZ)G-QV@SJ^\>+-)_QW`%%NG, MPUL98&P]CA&YO^7^;!\-T1\6.$=M/\>OL#2AW.&*NTV!$M'(L MTEO#ERL;L0WMXIR.U?70COM%2GC6*X@(9M]>3U-5WRPFPOOOMBJ_0QW[:_S* MUE.`I'D?ZX_7X/1MTVY=^?XU:3E4MXCUKU<["FZ6VE^K[[["VVB;NWKA7IXU M39P3_4UI73E96._IA^CO0'IZ]=(V95L+V%?]`[5TY8>OPC^^OU7584O MY60"`VWN>[V>SNSTJH2'+`;@-B7;R@^OZ-X5]7OE]-VC%]O40?VGP&O'LE>M6FU4[7NO*]:M*VD]8(]*-+ M,]MM:*V3Z%6;UGVTJGROFK3OHY4"^^OR,5[E>I>BXVW*K)<80IN6Q-DJ.(1N M[3IOFUP/FMVY)O[K#A[RZO,.@VV+6/]ZM1IV&X7ZUZEE'VZ4ZD.KFQM;?WN7 M/I97TS*5WDYG9]Y7=_,-\??5I&RSZ;];+6-I#7[N?$GC77I?QP;0FX^!?61; M\_LHU!L1Y_/K[(B^GBY]69=37\*3FWY)M./#5F+@[<3G%#F`+*_IWQ?-+>XM ML7+QW/AU%L$5#6,\N6O6XG<=YQJ"CI/*/^JI>[WF";#)-FZ>KGK7H"MK;T]S M#Y[&R:QY^&3>IPB3^U3:O]Q_7*S3Z4T%X4*AM62VP^J_U)58=8 M__Z"O#CY$LNKZ]G\ST4-MO8_D?QQ1O5]B=,F6X%<(RIG\>9!/F>(#TV(ZI#@ M0O,')^%3?2\!U!96X_RNSLE$[V-=5J$%*_M\3*&-"WTR?3V^!SWBION+Y.R=H]/K5E^O483QRZ5_=-@1[)]5VA1XMI=(-4(3D60GF# MC,8221<3,EAS9+Q7AAJNDU*'<71!Q1_SVX;6/2I71$D]S"\:<0Y54DDITL)H MQ*+D7'$1C8C'[(SVUE=5ORB-X54^E\!NJQ?X#/DQ$'B'I,TE!%;EU73AGOIO MGV#>;*R?]]HTS/];].%_V7*:FWE6@^.$],(M@@(84! MR`G\P$0AIJ*5@5-NF3]FHW:P"/NPG7!(\B]EO/_/G9V4Z5M.=VT6YPD>VO2^ MJN=8S&9UZ>YFV9O\5"T._'1@_+Z/+)(2Q!,F$5BKA'A(`BP9X2A18R@.Q"C7 MD>;CV.:#T?P`R!^2VV>?(1;(^J>J;NPD?LQII_,4U+/P?W>+3>9A*-[3DPLM MN77,&81E"@@F:H*4FLS\WTP_7`<.M3K4\R3I2B/DX,73% MV%@4*&)*GH"E0"DHBF+T&L40#9(\8JR(,V2[L1ZR!7^KIGZQ,+FU+3^*%H(P M%2)SB'NF$$1(&`&+!;+.!V"%CU9O#8UQ6,I-FW]Q.[ M."'SK[OR]G[X;^CQ36*%\I$H;3FB7`!V5D%$+"U!0E")C95*"'[\O=^UZZI! MD=K,B9_W\/,GQ5*><4[$3.44`'@#LT'XD7&\RE:U%RZHIT$SZ2!>Q@I9YK)' M'RPR1%(=#%=8=)R*QW$Z>^GS0?$:PQIY,KRA7%&1ZD- MBC(XQ*)P*`K/$&.4IY0K7,'&FA$44^/C]B1XBB.Z`C-&Y^9J@O,D,O[)C^]E.YMO.\V.\ M>?5L?K1STYYJ&_DB#X@0O4.".8DBM@:!DP3Z6*,X\1RFQZ-.C=NC)ZMQ\!K% M$#PL.EU6]<='BTXMC,,VV8)2ZH15'!F(G9#BX$`%RR5*WB>BE`C*/P.#T0=' MAL!J%'XLLL>;#]%'8#8T`+R;%M38(%;P0'D4,B$K8#A@!1X1%EBC)!(1C-D( M7Q]_X-$+*_J%:0Q"/)Q'_+8Y]EPN5@!`RH`;C')B+_+!$!238\@82U,BB7+? MT4T<,W+HH\/WA.4@066K`;]!J@C6V9`@Y($(.B)+8=)S,ILWR9V.X%I'T7&A M8E<9:BXZTMPZNOMSF)\.%.A+;A0POI(A$M!5,>6>QR/H]58.&, MA6D00F.=""%1=F.'?&;L&`:M,5CR<5;Y/ZZK"<#>9!=X]FT#*7XN7`2<(+JV M%A$-J$E&&=+2!B2E2%HIYK'SSN`8K MGQ1SR(.)Q\QI`H0YYCAIW^[ZF>0]0#1*&%W=W%335OW^M&CA(\>609W&28=, M\@RY!&%?2,[IY$.BQAUSX--SI_>`STC!SK:S-"WS=7>LJ0A!.D6Q1#D1#_$` MDS]CQB'"I/%"^11Q1P]YG)"H9[X,#]\X)PEGMIS&\'!+XE*KP!$L?;G)==HN M7)`@I/`!HZ!<0B%J`TUW8$"YYACB19)BQQ6X<<*JGDDS"&)C\&1IZPB,\(0#\C)9)'RB"+M(D`U!<<6EL&GKIMW@K6[7P()'A;FD'D61CPK3 M8!#VX%NK1!BC(3B/.YYO&,>3ZK>SJCZ!&IGFK;8<5Y8ODJ+">NN1\T&BE,_X M$$L%2C&9P+W&-!YU%EOG?EK?WWNA,TK/5].K3[&^R;?QM>OZE0(%6&=#\@YJ MH#9!B&`T(D;GOZCV$3,E+'DF?=^USYZRH"^@1EY9W-46;!,M`C,8.X61M#8B M[0U'PC*8WBV621,O@J3=J#%.P-4_-0:`;+3$E%WIL5ZH4$EX"``"XOEH$Z?& M(R:L0U3*()61A-..-F.7TFY#(_K>C/"^7H3LT8VXZO[??\IYH^^WFQP(%I1Y34(3 M(UBXX+G0$%LZH3I."J/["YTZ;,UN\]XHC;*E<%W5L^S:O*SJNOJ2`_I->PH_ MERZB5,1(3Q`WV*/`&,1506.$M7:6129UUS2#T8=]'[W?#T1C=/VKF]M)]2W& M#W&^>+.3^=\J6\3@&0>_!^)K@`^SH)`"_"#(EBDZ32F3'=.81W<(^J#%$(!U M.@\#UJF^B^'\KIE5-[%^7U=7M;U9>P)F3?%"@<.B-$R0&'XB;33\1?-&0S[# MX2TXN.&H%T5[ZMZ>,1IIUL_:[C39(F#P<5QBR'-PF(F4"5$6$G(N>D6$ M=U%UW%X;)\=D&#+T`M3A%HYV2DI;@2!5P1,+;97>0`P=E46$)X4DT2Q*AV/G MPROJ.9*B;[#&7EANL33P<^G".V9(U!PYBB&*#EPA2[.;$Z(58!4-YAV]0?T< M2=`/1(=).0-S-KD+\TO05UR.D5>YJND,P`55KEY/9[&.S2:V]/.`PEAPFVU* M*$;)D.6)(J&(14P0X42@TK*CS@0:=-/R8!@?X,:3>/)>AHMG% MJTMRH@04V6J- MANB7,2;'M^6TJN<8;QV[3XMN;[*+@CH*Z(9@!:(D8D0%]L@IXG5,5FC3T64Z M5&[K\5%QC%XYP!RXN*'L.LY*J'K-7-C#A=>K[[FVS?7EI/IRF*O'5I\17ES# M"?2KHVWB15S\WI1HOD,U14HB.+!+2#E#D+`BH&@(1UA0Y3"U&I.MVU_#H)&/ M/4$3WM?5YQ*P?_GM[TU>CG@'G6EGC]Y=OP&+]I44ALA(HE,P+L!'C2)A9(E( MX*AB$8-D3*F.9XQ&NCE[L&[_^2KMX3`=9=WP^U6)\[P&:,O\)>:?J@\1C+@O MYR=L?V20?ZKVY^%0CRQH\CA?Y0@3",>(4*61-HX@K(2QWA&B;#AFU@Y%IJ>K MF<>#_S@'L!^/]R7=S^UM.?LQL:X\EKU-N*!.)R=#0-01?&]#\O6YPH;(J$J& MIXZ1QDCO$AJ)=H-`>1@"_7P-P4X4^ED<@`T:.Y$CHOQ>)"XE`$M"WF9D..<9 M1''4M[KWW;E;N=,+AH=AS](;JG>BS9)<(8SABC`(7+@1**\W(Q/A7QB$,:7H MG#;[&YT_$U_V`^^P9N8^_ZR3C;F7+2R1*E+A4=0P(]OH-$I,0.L559$E+!/; M_PZ9(6>I@UF8[@@>AC7K$Y1V(M#Z:@!GGD\<6Z0,1$V!>(>DC2S#$206+BK6 M\5P9_Y-RJ53W+OECK2LHL",<*X@`Y`(PRB`6@!EYD2VE;91A_TRB M9TB/P6$\V"SU)%-JUXGJB7A!HJ5&>8_RU2U($3"R,EF#++-)A<2-Z7IMIGS6 M!!H8Q(/29RFWJJ.[L[J6@D5'J?46<14C8M1@I`.-^:7)EGBI,,$='1_UYR93 M+U@>:($GG]AZBM*V^_?:5E*X9)UV6",N.,G[F/EB4B>0T)BFF#A`=-0I4*,3 MJDN]>?WK,V+*@'H=?:U_;L0JZUE11, M2VIHRN]S$QYAA@T8Y84X%3DCHJ@TR0"IS-P!"&N`:&'(V$,@-?[7_X\$]$L>%P/:#G M=5E.[=3OZ7FMJ*2P4FE/<6[I*5%&F,(;UP04F(E@C[JNRX.[7GU@^D8 MS/H0;^]'R+NT?&9C`X_6B13.21DH=0CCH)&FA*$`$1$R1"@-P\I'OO^+/`Y@ MD_;NS9_N%^P-P%$FN26[N:SZ]WL`LNYO[6S^/O#7TT_P[/BVFLZNFW?U&_`3 M-\UZ>U9=:,RMX4$A*Y-$VEGH!FD4XIK2(!@.P70\>C=.B#@2XPZ`\]C,?-TT M=SD_&`*2'W<$MZ3>2ME">XDU9Q(EK#Q,"?E-CA;P=PF0-C`MV.U9KX>K<,$]C5I%`;%OP,@QX9`,"7P+9IUP5#"%.[XS M=:3-X+'X,P248Q+H7;HH,T+3T";`6RI="(<3%3`T0X]Q,<8#9:AA81[G8*J7H9^_2JZ]@+:=7\8.=Q7?3U5'O!H[M4DW! MF?;$88-,$AB))")RTB:DE;=$8V6)[>@.C7,?TFAK`@.C.LYIN^4#;XL-[\=: MC'3:[=&!B\UK6S_*%5%2'[73B.?[3*FD%&EA-&)1$TRZU?81F M/=[_/V'4KU"TI"R"%$FB.`0VS\`H(_BHPFBRM52=]5_#) MZL##TLZC8)]5I]:WW>VE47?O5CIH&DUD!#P:>VDI(XP;C#$E6",-FF!W8$9E MIB7KHP7UE."/@"A3H!66OL=\$2[J;E5G`7^>-]V@[1MN6!5,E:9$DEX7C"A> M<`PKC$(_4..T7S#M3ON2O2/E]SA:&A>L/%M:'2"=Y&U?P"W,FSZ#8(W'X+[6 M0+M*6>X=E99$XRGA+"H2&(TXN:9K.7F@``>>[,3Z0FA.6KM-0%#OMO1&&,43B MM"M'CZL8XZ.5R8CC[Q,&+-3?>JBR4C!J)CK8M-6JRQ"ZX M4!"M8V3*LM+;D\Y#&#N,.`Z;+-Z`G4/W$7V7Q1*&3\`\>+.2G%L!I2#:&$N8 M"AA<&[#$EEQ;`ZJ0_J0K*!XLFX<6_VA<$HKA$#G^4,J4*P9CB7]4C/(+E%SQL]6KZT<_ M0YXW7[^U<(WCHF^01LK[YK9/%WEM_?F,O"463D40E\W-4YDVV7CXG&I:3(9$ MXWO*Z70GN@')P*/E7\WN=\\F(OVG;1?IMLH/T'ZZMNU4.#\D,ZQ9T_H&7WJC M"^'L%AV:&5PNOSIH4QKM?)F2O!)[W=7RIKNQBU2V?L!G>.:7*F^-`P?H(=&2 M$U>R`@UE*=%5IU0K:7B0.^/DK)@\ZL(?MJO]\Q'9_IU*V^BB`8]X1$:LIQBZ M!#!$B6A4#/BP/.E5HTGEW^1%-EOQG329V?GZ*$//_:\W0O3_82\@K'.1S]HV MI8SND!>[JX MX:&!FM3>W_OM[\%VRQ6,W5G70>][;!1FNUI\!+]LV_6XWN&035S\O^?OGO6+ MNO/S)G$_,":?;%.9,AIF4>L$#1B'6L&1)"N)#TRSR)GD:F?=QZDFJ?MUD^=U M=KAA92CUD@L@ME26.`S"B2\I)YR57"@3P(D#M\/R&+N19/EH&AD9M&$[]D3! MTS?+14@#L/%UBD6_U#?7;[O6PKS^T'0WJX*LB>BC'6IZNB=#R43!'& MI<`IVGKBJ+VK[LGP43SPF$D>NS2NZKP@K#FNF&?9T5]FAEJ>A1S:-6& M4_$\)1IN6!6&QC)*##2KN5 MWJ216TKM^%[/4^;FNEP:QM*S&BFNC,\+D;U[/JUX=W'Q\_*33(3*\7]U4$ON5ASQ\:/ M7;EDY.#1-3:ICH3CQ!C+8BPB$_Z%7+E[-M^D7/EK"'V&W3[] M^J5!1:U@,I7+X5RA?RZU(32J5#VGM%PJ'G1QT@?9#A?7EE674?#)LVNP9O9+ MT_[[=M%7*QD\)+V]0061N>@+19R)Z+!:H*20*FV12+!,%9RZ`Q/&3;Z97P(;4I-?$AK8EAQ(FZ_7$5/]6S11UKGXKQKRY] MK!>S#\V\]O4+$\<@N-\DOHH?6NC2SGPB=$S;J75E3\[.^Y)A]Y=LIH=MO?#U M-Q3W/LC__EMZY&P'^.-_4$L#!!0````(`"2%8D>RT`*"I6T``(TS!0`5`!P` M<')G;RTR,#$U,#DR-E]D968N>&UL550)``-TV#=6=-@W5G5X"P`!!"4.```$ M.0$``.1=6W/;.)9^WZK]#][,LV-<":"KLU.X]J0VMTW2._/&HB7:YK0D>D@I MB>?7+RA+M&Q+(D61-)5^260)!SSXS@?@'!P`_/6O/Z:3LV]QEB?I[,TK^!J\ M.HMGHW2GWU/YC=G?Q_'^1]G5UDZ/?M[FOV1?(O.SU=29_>?)LGLC\LHC\]^Y,DO M^>@FGD;OTE$T7S[Y9CZ__>7BXOOW[Z]_7&:3UVEV?8$`P!>EU,X2Q5_GZV+G MQ5?G$)UC^/I'/GYUYMLWRVO4ORKY2_'K>%X*;!:F%_<_ED4+V4=5?\?+LE`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`:5M=".U8KA?Y9UOO:\[NWLZLT MF]Y/A*O?*I4_H([C-;91-O.0Y)_B[,N-=_JJM-M5OGU-:G;5"K'V]:I'P?U2 MQVM5^@KOXRA?9/?NI$GT=TETF4SN1^_9YWBT\-*S:Q7E2=T1L*WZ.VKI MUB_?>B^[&)ATY*N(QW)>ECJFT<<]JJ/VOXN_Q1/\.9U,CFG:SEHZTKK.#%0I MV)%N];IU#='C]?LM3N0_K);CM5[G<7Y4J[:E:*O/KVGLW1)M M:#..+WU46V1#C/_4(%%Q0!7MZEMGX-]5OEU-ZC%]MT0;VGSS>!\RA.R6:%6; M6CFD7>5;U:2ND78(M*-+/C^L:^V2:%6;VC;:5KY53>K;:*O`\;I\B:^+>C>B MXRIE=DMTH4U-XE0*=J%;/>-5R;6@V>(RC_^U\`^QWP[H;!5B[>M5J]OM%6I? MIYHVW"O5AE;3:93=?;SZDES/DJMD%,WFS]W MN:3Q\>I3%N<>O64?.$:V-K\'H5Z/..N;PA%].]OX,4MFH\0_.6^71`<^;"L& M439:P[#ZN(E$N8,RF7<=94SVUUM*GD MC:\K&RTNX_,2DH:J[JEIJ\*>),ELN96OR(BM2A8ZM;;A]_ZQ\8]Y[`.Y<0\/ M;KJ9ME1QJ:!7<9*.MAEA:8"K*+]<6F&1GU]'T>U%,?Q=Q)-YOOYF.2">`[C: M#/Z7U=?AYW@TB?)\.2@N=]6-_[FX=\L_+N8?KVIH_W&VD4WWZ,7+%?!U8R;1 M93QY\\HK'W;]R%`[@"EDT"`!`!/:"4*TX($SD!C+[&.`)\4VE#1;4Z`WA.LV M8FA$25\.R M)S[NF;"J^=D1'=+N<%R2K&.^/%'3//*MMO!D:_F0(,JP!H0SRP$D!`38K-O% M`;#A5O^R,Y[L]&N?LZ0E>Z7=H?3SL*!_ZS]JQ["-W[_1-\;"KUDTRR=/IO'W MCT*8+2RH5T&HBLD<*NP'3HP$YXY06N)H4%_.S-;`[#DGCK1>V@-$/9/C0SS_ MS6/P+LUSY^%ZV*?[,?O?131)KNZ2V?5Z(__]%NA#J-.X^A`$!FDIF:9:,0L4 M)J+LH!)KU(A8Z.2(U1>`_=/N]UD6^P;\.QX_Y*/633V08M55A=[7XQ0:C11# M!!*D?>RQ1H/8H!F=\"G2J76P>J:.*2P1CU4\\Q_FGR9^X&TVK=6H*&1&&X@# M0!"3B!(HE`!K)*"2M!%MR,G1IGVH>B;-KGBP(+WO$Q^OOD8_ZK&F3DTAUDX@ M#AV#*)`J0-!Q6ZYR$$*&Y14-;K&G6[C[H-X^M55\E6;Q4]#KT/"(6D.BI2.* M*<&$@X(Y0A!Z\$)I,"Q_:G"4[`_Z/NCY5-?"M:R!J5YDQ0GD3Q[8=%R#KVT^ M)G1%A*ZT@PHZBK`UE/`UBAY;-2P/;G`$?D%;O/2`>^3(^M#J`#HL'23"A^U. M"V=1N6PLO"=N>K;9RV[6O)NHI4[U%GSK9 MYGUBH3;2`*6M=%0`Y"DD(=`2.`*]N2G@+Y,Q+JY`&R\F\<>K;390=QM_526) M#ZTJU%@J*'VPQ()`4H@1]4/L/2(!=D$S#ZWEO'`[)GV:5NL6J<&F$5R]X!:0@NMYC@(..",2LP=,FP-'+2DLM.]1*JW M.W:D?0'9AP.T1_L'W3]$T[@R_W=@32'&+'`0,HP5HY9*@?S$O<+".8V&FQ_N MQ.+U6=4BFG]NA@TN]WR*Q.J?4%^S:!Q/H^R/ZGS/TZ(A0=8)P:!0F.(`!H8K MLFH-P\`VB\4Z6V'MS%9IJS#U873M@U`?/F6?X_MT>7Z3W%;;?X]4:(32A#"K MI0+.,,FM#TI7;=0PT,-:V>R+"NTAU@RI*]8A'P.8-G,0Z:E:MU6P^G4$Y6R\_*-H_2%>X1:YT!`+ M1.`DA%H[`Y0DM)SE*`I<(U($ITJ*+C!KU.U5%LW&NVW[K$P(_>CCK&^K4YQC M;#C!LN0KXLW.)[!3M>.Q^/31GTUQA5EZ&X^_QJ.;63I)K^\^)]`V-,!,U,?G@(/\R\Q!%(U;=W'H]>7Z??+D:KAQ7V)N5?A:W) MAJW7WX=R,EFI5]R#M6O==U_Q$&HC+)1`(JD"J`"%I!R<+))BN.F#9H9).\/D M9[#VX);R7\[(/1O7_OYYGS']SV'A7SI*+1,$D&+1T*IU@I\%?NX9QJ)[.Z`_ MM>#A[>]CLNWH1#C21G%/=6E]`(B,$RHH%W\PPXWL?/CJZ3"GXS:A.YWCO[0( M((P,.+),`N"`I&60":&6PYVE6[)7K7/`S5#Z>5@PN-E[2,9_@5`LG4[3V9=Y M.OJC.L/ZM&RH,+(J4,JWB@?:66=X&5I23@8RV[=DDZ)5* MQ83_O'!()#%!0(715'`L#$:F3/DY:YL=4CL\)3;,6?YHO/IG0*VM5[M$0M\R M8XI5/0>YI`!"56Y#8A@#-MP)_AA3[;7ZT>C\;!P8W/0^!-.WL'@NBYC\,JU, MBSTM%P(F*25.0<&D'\ZX9(JN=.,(T[[V<]>]R!-8&Q!)JE*!68."8 M0.OV^8&TV74UG?D#;1BJ]H;&PZ#IP_0;K\JI-/FSLB'R74,B(0CVOA/'5OIF MK=M#B&JVNZVS7>\=F/I82/HP\:[2_*ZX,6GY[ECO[]S6NJ>J0C+$RAH& M+:"8,>889TRL]^=R[T`W6XGM;(-[!^9O%Z!>AOIT=OTUSJ9%&%0]QC\K'!H+ M.7%26Q_=8"6%4JJDMW>8!W;]1!>#^[&8]#.JKW".)UOWA%6/]#7D0X0*+!Y@U.\/2V3;W%BW9*BZG MO;T=28L%+Q'S4VLCTG>UZ[\#TK>#2F\57]^+5=.IVB828 M0(L%#)BUBDM@#>(/4Q2CSFCX,O^^H1Q4#*F6+:YJ1\^UD/CA5 M5%(5!*6O:@ULN'![2HMW;6/43[A77`98;C.KF>7;(Q5B%Q2):F6YU5`[8R0K M%RJ=L,T2?8=[],-,]+4'W`N2HS*]LU(HK'Y>;@PN^S<\2O1/A=_B69Q%$SD;R_'4PY_/L^6=N_;'K4UP"0?W439M7=]:^7UMI8O;EMR M0A9;'2VVVG)@RFM7!*.XV;I?9ZF];LS=!C)]6/RS#TSCBOBN+!,6@:_6/NJU MD@,,A;70K/5'KOK%V"VMZ@\SFFL*4V]FKNS.&Z7"H/!6(;$,`8W]#&2H*:E: M;$H9;ES6P`[;+'D4#J=IT\'%4_V:LG\3OO=P3A?32B,^*A<*0&U@*"28>3\! M*>U!6;=#(SZPM]0VLD#:7OM[L6/THYX=-\N%G'LOWSMZQI)B"1BHX"$R`]ST M=4]0GW8\HOV];%]_[B%4G7#9+A$B:J6DS"($E87`^_>!>>"H;)8*.SSW/4Q/ MJ1W07HH0Q<EPHQLP$.#.,(0N[;1!Q!I5XL:':G M1'>G4KHQV5&8-++5;U_^9[^9R@(A]-0)-/?N!Z,*8,U0>1>L0*CANW2Z.SC2 MC86:PM'(.,MU[/O'[3?2LX*A8$H2CIS"AA17MDL'RL8%0`[MR$*$06;]&D M`*+&DD`W#PXAH,[W.@$#")&A%JGRUE\I'!Q^3',\&P>%\,EQ>?-P@Z\E]NW> M?'=\UXS>\?C0X$!XQ\P22P"!GA4"K#?32`EDLXWF?4:"`^-U.SB?&KO7UW#< M]43G\GDAD0A*80,H*-..J$#3]48CJ;1IEIOO,S@>%G^;`GMJA#7Q5>Q[ZOAK M]..^]*KC]L3?78\/'758`D)-`+10U$`+UI=12V107Q?\_2QT;@GG4V/WHUGH M4Q;?1LEXM8?6EU\NI=W_]A+>QSY]PH`AHA674%E@,(!*R`TG$`SL=8V#YW]7 MP)]:A]AY3U1/'6#G\T/'J2$!YE:S(`B`U`:*$G>LF\65?:YR#8OP;0'=RXFO M-!U_3R:3/1Q<%PD#'D"D!94*0<@,4ZY,]4J.7+,<4'=W@G1!DX98G-I0]7#H MO:_9>>.)(598`6)0(!`P0@1&\/4>4?/C9DV`*'@$)8:Q)``*C&9=BJ<,.]^MW=I3)T!A\)\*G1N%?RKA"5Q&(A ME;,ZT!1I1C0N8U'!75Z7IQ6$^-J*O(;O.'T2A=S'R8%]T5=?0;VN_6 M(^3,&N.P8!BQXO!F\?K,TEV33=\7^B=.G;6,^.DS_\6H'EK#%38!)AYG;3@) M-*8/RXBJX=#]IT^?-8?XU,B\L4"]\>.+)2.>ZQ`R$5C"BTM7@1!"!5"BAX5! MVW"K,/SS9MC:1+O11KR&C8FV-28:C;)%/+Z-[KR-MBUD=?S$$!-D&(*<*8J@ ME)@+6D8C%N&&IT-.(V$V+&Q?G(OY39K-YW$V'<>7VX;.;A\8!@8+!95&?L*" M4#DH""SC8BX;NKFGD;H:%+0_APOPL.[RHE[`@QJAU(0P@YP"E"-@H*'EK=N2 M:-!P/^Z?-U75,N"G1ON'AF[\MOERE]Y7D'?HX>V@J*5^^($T@(9SBTT93FO` M&_H8IY5\&S+B/P7S7Y+MH4`^TG#`&DJ403%E.9(F"2$K,Y*$O"D&BOBH`=4-57MP: M_?N&_?*Q'9OV-)C?-]9W.J87 MDL\=!'\K9\6RO#75XM1(\QLO"4(@%0F6T2YFB!D*HHW<($",SC/-T.A#;-W` M=7''UK-;;K):+*O'LOY<5_=U\;A/=(;Z=."*,Z!26VZK(WQ:LFU3/77;NHU'TIE/38V6.>Y=M'2 MDYXS'@D6CC?T8HGR@JEH7)&FKE$:0BJ:4OR;BN#/UPL.JU5O#0G.22P=H=AA MB#VA#K$M=9)E>M'1..(Y'8,S!.MO'HHXTW=Q'RMO#[![][&0RI]B+1%70&(B MD#.^<>YH)7AFS_IQ!$HZ`&1(_76'9G=W5TY2EQ0;]:@/=SM_`UOHL.U>%%*K M=D)0U,\LYIX"9%R3V:^!SNQCC,898N@%LN'VA`^KY6(9U9UX@!W=&':>#40Z M;!&,JX!08Q&-9MU6Z;&4Y-7M1.-RMI^+RH6VB(]E/8EZ2I&:=_RS2JI+H8K'Y1?N#I]!CH]R/JWJ M]]7R8!QAYZF(B[;8`VBE(1(ZRB7=^O^)LG;:+MV5P`=5N3"6=6E,?C\#,.!-H0^T6C MPQQH&/^_Y?3^85G>JB]E'57A?RS*N]7LU^G=HU9.'8K'7*CW])4%H!)2(!V^4 M<(2Y`'!;?5L;DMOG=QQNS][ANE"^1]2TODQ3XY]B]FY^5]6/ZU_?)385L^<+ MNVNO3#IH9^6R5+?_MUHL4Z`ONP),-]\,@,:--^)KHQ5IN8/,;OL$&@I(IL]D M7"[8:T%WC-*;50JVBR\&&E'5GEDL,#>8"<>W2JH!48'(D]QQ.H,OB^WXY+:C M$H%]S"`P3:$SD+"H$D/O)1.D*1YMD+9YK3#(N+S8UXGU^.0\ZMG%?!(?RT[8 M[_CC04ENF8>:>VP3Z,331I\S*>B9)]WC\M]?';"-PR??%2H7RO98!Y0^UM-)FTIC M>\<%*H0ASAJD$&;00215$WPVW/H\=9V,PQ'?!T*72@UAU> MBA;O/].VI!:+Z?W\U/R?$UX=X'A?`L M!6%GAJD3E/LV>2CF]_MVDC;#`G=Q=0@*M3,.:ACGC;9'720GSX%*QN$_[P&@ M0:Z2/%?S_OCLUGU1:%_4V$-V2:OQ(4+FI!-1]['QC[%_1!.\GMY7?XF:["]KG/8`L'B5 M"K;Y?/EM6?^_2J+=MWWQO\;-VR_[23\T5J%(\Z@P%6>LTU9$`* M2(R"J3"HMU'%/+8">DH(FSR4MZN4=;*/!?IIY_\^'2EF>^JK`I14."8)(DA2 M3@S22CTCXE3<(K/VA-.]#<5+O;P3-X+6+/T^,ZQ?I-9[0B+W=OD?DUFU*&__ M^J=EO2I??JRB&O)MZ69EVG+^^J=%>;]Q!PROLJIOTQ-75!H1F`&0>0VU`I9C MAI!DX@40-I3H/,37UY/5[^6?XZ_E//F(WA:E_KA^7/O,`.U"-LQSTLISK^83 M1>/5V&`C87%)1A,>">N@PO%/LSR5X"Q$*2A6L^5`PK(5D3]_]]UV/:Q/XF`+ MB>@"JY]?1H:7C5#C>H?WM$$``A M@3UDC'K'D,;VY51V(+<\XH"61B[^51_X9/'SPV-Y7_RMG$V*SXM?5X_Q\X>Y M^=;S@6FA+2/4(@&2J8RCW=S,U?#,+DA#1ABZX&5'Z%PH0GI3?HXS7I:SIY>Z M')_J8KXH)B]FWJ>HCNHXI3]."X">]NZ`O2)>:BRCU#L8E766#/=G?5W1H;3& M+GP0N:;'T"!F;1^^":)5=]%464PCSNN9+M.L-K5:I_/??TQ5/"I*';X]`,`1 M0Q0+8I6,*&`C>8,#D2"S\LXHA.ER,&:)4V-X57<[TZ@W=:@FJ0Y5.[DY\35! M>F"6'NY>?GXXXB-N_ M)"@&A4&.`<`<5M8P"U@#6S*7KM%G?*X$'!.HKM`:PK9\/?GGB1]U`1X8%:PE M-AG/FEH!I8106-/0:##SU^L@[H.1!V6E"^!^3B&Y.@_QE'/8M['@T4&@DEL8QY3Z`"Q`'2S%!RD%?9K#'XR[J#FF&XU,^(R.\H,(PH]J)C= MP'0!\?BMG)33+R<9%SMC`H((&@.!)Y)JH3&UDC?T<:WS+K[TYLOK7PRRH>G/ M*Q-M\ODBU8V?+ZK9]#8YD6Z6\9]KRSZ=;(^?Z_(A'9%?RDV]WHO8]=LYM;'G M?WPX>,X$Y#-]X)9YPE M4`+E((0<-&`X+8=2ND[+V,KDYUMB<08@0YRIS?3^,5]\+B?3NVEY>]1R>G-, MH"HN(&$T8LJF*^LHM4U^IH\P3Z_7N#Z37S\D>W:+T,\G"5=G05^+``S/^/?E M<[.#I!`>8/:KYX(3$BKL9%0\F;'`6^ZWR`"CAO*LME2?.SSPSX%A"'9^6#Z4 M]1[5.$TWSOW#W:?BVZ8J:?P]%2_/'B%&42"",F\ M]=1SCF&#F(E+XKKLK@X%9W#L+BEMOJK+Z?W^KY3HW MIOI8'&D\W]5;;>L65_6B MF)4WY20NV'5CO>W%UG[$O*,O!RM0:KR!B+"4N@@S=5O5#0F3M['WEJMWA=)^ M&49:A M+)>7230]-R!EL(U[L7&6$N*X)U'A=D9XSY&5GK*C/7VN*R!%-:(VB@/W6@BI M+39<-=18G%GFK/^`5&LF'`Y(G49]SP&I13GYRWWU):Z\:>([2?^1V$UVV!U_ M"K^6]\7,S9?3Y5NYH'N>"L(Z:0AB0E%-@..(BBUBUMF\$W78<%-K;E5=P=#^ M*&S+O,U4WHP=?/]((%AJ(8T6RFL@L7"`TF:^T@ER?4&CLU"O.H7A^MEW-9&> MBW"M@\S'CQMEPU0??S6'$Q]_?#(`3Z5V'AKL`'+$$RIQ,S_.Q95X+_-AK;HD M?Y`P:R>9%1!0QX@"W@HJ!9+#\SLK'FZIV[(HZY+0,873X?(Q:U:1>L& M2P(EA-!OZ6/0Z^L[)#OB5^O`>AY"/Y\D7,UY>VT",#SC-_W66H357S\8B!%Q M=U36&T2Y1=81(1I*XK_S0N1#YE;DVJYGX3"(4Z]8/*0KQ:F\Z_^OIE^*V?J2 M<>L;"JW&!RP9\2JY1[EE7%M$I#02,JL`]A!>&?]SF?:]DZ\':`99Y$T4Q%?K M7JXO49!-Q/O@NC\V-@BD"2(.,DD,UI8R:UE#+]/JRD*R'8E"U[`,(@:;PKZ+ MEVL4[\ME"PDX,"P`RH`E@!*&(>$.21]5Y&'R!!\W_;H MBK,\P.?=QP)CT:H%U,<=S`A-`#?$-U10)O.28WL+_77$US,0&(*/MMS4+_I4 M?-L0W&KY'A@5%$#46*HU-9ICXH`"IJ$1,ISG>NFM)T)'7.X.D"&8_K$N/Q?3 M6_?M<[IH%K6/=:QY,_'CS&\Q.F"C".9X[WU..CJC#X#@F'6]1L- M!@\?TH>&!2-Y/+.L@QIHJ1DS7()()0=60(I0WGWAWOKR=K:2.T,D*_;1M,^( MGWXW?T;P^S;E;S8]:S4X**:(E0(SHX$D!&+.;$,%AIE\[:UK[9E\[0V7(5;U MVTWJ%X?7]>&!`4F@N1!>1!*E%$9CZK9RS$AFM9?>&KQVM+0[!>4B&OI.?\TX MX_?5?'*ZOO[6.P(R"`&"HN@#C2A4U*PMS4B_!$":S/MMU^Z$ZPN?P9)VGP6X MC2SL?3YP@3U3F)L$FW!$.FX:NI#)S`J'U^YQZP*+X73T5NS]D1H-(Q`>*&4% M8$Q9YEE##0>9]CB\>G?:>3`,Q]2CK`R>@4@YA=@)!`'R4MMM4@C1/#.1\]K] M9EG$#\&VG:,A:I(WRVKRQT,UBZ`N-GTO6\0]V[XB>(R%06"W-^A3"(M5# M':Z41,M"79TS[(WXR%DH#9+V\E#5RT]E_:BKNJZ^3N?W!_/&6)DNOK41;WYP_'Z(AV.X>/\^JI[+\;5/U?P>5XSO`T;'!8FFI M1%8QC;BV&'K@U_1&.+D41Z^F#!L2[5TDN@8LRTFW+B!9WIK58ED]EO7'NKJO MB[UWC@X]'I2/^J<&CA.H&;6<.@JV,^4RK^]3;]I=;ZSM$*.!3ODTTY.6^9MC M@L,<$,:XT$0?AQ3%`, M2(DP,`ASJ@2(T*&&/F)XWEW7WN*F0PG"V4`-[*<]:5>XNS]BX078(UB+.@FM\GU=66O[=(J]GS=!!<$,BB^:PIY!`0 MC"UL:#(T\_9[;_'7W@7@?(@&]A&UX/J>8TXA1*2R@`N@4Z'M0P`P"Q`D&DB/B#!"&H`V%T&&<&Q8:KYNP,Z@&5A#:G15[Z2*">F37)=FC MN`O/+)(-7<2K:POM#JDG9*,T,/?;\3Q`(+'2DCJEC"/$`$:WESPM4)FW7\?G M)3P?FT&N2QYHQ#I=I`)#J[I-V>F3WA.@A1!9+GPT>3##'BJS+?J@%<_,YQNO M%[%/]`:ZI;%1(\])0PU`.B^8!,?K+SP3H($""*O'U3J. M>6;]U1/?%+B`DD;EB!H!(77::,"WHL\RO4QPO+[%?O$;0I9^2VW>Y^6M*^IY MRI/8H2A:S-/)])"V<7QP@'&U>!#/2$4\D9`Q)]2&8NRLRFP>",?KF.PS=?EG6Y.+0/?/]H<%%T(;$`.J^`3+<<.$W4".==DN@\AH_7^7@F0)=9X_'\ MFJUN4VN1?27ID[LD&D@1YCB5^Q9"TLT'@@$.400$D)1`!@RBV#7(1>L]SV9% MXW5B7@36:\B:;^<'VSLT4!OUL)3LET)_-BKUSNXX@');:_T4;M`N`!M"/':+ MQS\G=;[X:-J4DFOW@H`$C1H[$8([IVVT!>$.I.[[YN^7SJ/M\$)%+_@,[P6[ M>2CB=-\M%JORMK4S;'=0H(A0(85FP$$L5=PE+6\HC(K:4&7Q6TI`UVP[Z!`[ M`Z>!_6(MQ>"-$8$:YRPA@E@.(?/6RN5T4LQ>SV4D[4:XQ#Y=)#:-EF$;DK3F9ZLJ[:VM^M2[2G8?0SR<)PTM`5I7VX05@K"["%J9YMQ]*$5S*!',`>Q?U MTG]Q=VW+;>M*]I=POSSBND^JDCB59&H>4=HVG6B.(V4D.7MROGX`V:3LV)(H MB``I5QYR(VCTZD6@N]'H)EQYW>W85.>Y\#6KQ.>;'"/B6-_5CP;^U6H+W\WV MZ/Y3L]KZ)[W=_GTO"$`J;K!`+&[RC`M(./&[;[&:?=*;0>.H_6"H8"!LQPH@ MJ?O-]^5J_I^3@TB[@0$1)0"T3$B&K;$24P);2:U79EI!A$FRZ$Q,*P>=,A:D M'J,#XSSE!``MD??&D6AX=-N!1B2OSDO!D/0D>#0\L*-$,'NM0P=&!86(YTIK M)BT`0J;&<9U9J0#+RPLOEA8^/?*<">A8^]?5_6:]F2T2<"=N8$]&!D")2"6, M,5,$I`+6PMANM14XSUDKEB\^$?(,"^HHJTX_]AP:%HC'$$6A!'7(.A<_#-EM MU)!AF46=8HGE$Z'.@(A624R^NUO^DPY<_')EE_=_;V[O[UYVJ3F4C]SK!<%@ MIQ2C&`+IJ.7"&M8%6S`V$SN-&]"A+X+/R/>;CBPH>T8%1B@0R?KW0F"B$1)6 MMC(*G]D:J&9>1BX'A@.EQ@EL)_CZZC9UK/.1P.OGT[B0PU<(N/&.&X"TI=8I M'!==(Z&0!!FA[=&J5MC]U,/7WDHX?/AZ MFO1O_/!5"$\)Q81S*I'3$^NSU^'K:8!\A!Z>TRXD,/7^@2HK_C4'C#:3Y]6 MRU_S:"SIW_^U3F4.K^*B.4L6H+K>S'\]9'`?/V`]_65!&P?2^;95`D$HXV)+ M;8N(-GQR1V"#F0[%L:K$GMUUU,/$V#T7H#162@>P!0+&G30506GE()S4RM#K MJ?.2BGK)B6R8J@1B;O[G?OW@(Z;(5$1E^PU\77YNHJUZ/=^V"MY)\'4YW-)2 M^D<'K!UARD#J"42,>F\1ZA9[EDG*8L&?BJ2<&/(U>&Z;GZNX<<^2-N.?[YJM M6A,">**6UD!A`H3&CTH-.'<1.K*O&=$CPHO[>X%A7 ML;=3V%W/(BRIMD.T4H]QZO4!`6/*I642ZOAA466P05LKK#4_B\TC_E6LI-E5[#PER#4MO"1J]`T9[F=*[V`7+U?D>4 MGSO!H)*(4X,A=`3NC%_N\ZS[8ADFDZ59*<`OV7D=P6D-!&*H&8"(4(\8!%BQ M#EWC_,2Z<+T!9_5$Q&OP.4JQ:J+):IN'WY_,V\Q^SC>SNQYAE?XO"0QZ`2D7 M5E*N(.?I`V\12/E'T]JI*W*N&(;CL.BDS*H^PP-&CEIH."4<$D"TE+B3.K6V MGE:HHX0ZCS+F;-3&X0QQ:Y6>O'X]B@D*(`$$6AC2AB*PPQG3,L89Z#6,S4&77Q MR(-L'(KL;YQZ$EOVOR9XIBF+,`C@F'0`,+:+HG#%\TK$%K-71B'.8.@=YM"> MMK6O$OF41K:]7Q"X)-'%!2E!7D"F&=6F,^T0S,PR*.;^%^1"4=Q&VVS^Z-%Z MZG[SQ_`0%TFK<70$M'3..\V!Z*26SN8EL1:[4S+6EG,>:J-RY4D;UTP3Y?6W MA+C$64V1/-ET4>9A2+$V"*/09R#LIA&@.RLP%R0&F*CH``+I)')1 M8-\ED_+0Q-M@O6+>:V0=SBLJE1V MF/W>'IE]7:KK_[V?KQI]OX[(K-?-0X^A).'C_QRL4W3":P(Q2D)-A650,\0( M$T2U*`#%)E8]K:2:_ZSK4`[%4;@4,8M+Z.;WI[O98J,6-ZGNP<\CB1W]7Q*, M%<@1Y:"5P@,$J6.=L:`4FMC*,R:/AL*P)HO\,@6CKIOF9NTCF%OK_Q6P>E"I MYYL"]A8JX1!6AC$5OR>^[:7VL+=[F7=863NUHB2?R@`Y+2-I$.,H&*01\QAB M#BU0W&.\.ZK3".0M3;4S)DI0J1B&([+(SQ>SQ?5`IO:!EP7$C*6*.82(Q-0E M![9S/I1%>>4>:U8H&=C4'@ZK.@G\/Q_7T:O;]\O%MZ_-ZH=M_C[<#O/U(<%: M:`W#PC-DL$[>+9"=\>=19A/,RNO+(.I[D6P_"&)5#)TG6^G3:7_YOEQMVGE_ MF#W<&WBW^!I_=O-AN=A\7U^MWC<'+]V>^^H@883'&<0I[TZJ!A9]S5VAN)Y$>W5LP%!PP(!&G$M!96I%:W=N:F9C MO-I&=6DF#0%=9=\LDO]^=?U]MN[/E:.#`W31EF1&8FDQ\$%C=]O/4G3P?IB6?>:>P\1=1)YU07XT*,YRT>M4\L2O(A M'ZS:.\L3!F_C!J^@TG.?Z?&F(%(39`&9T0`5TYY32"`$6RT411*ZJ#QR'?A M"FY$WJI3L"[^8%PIB-)X7%%QI5RM?L=%<=L>Y&22_#$^8"F-XX1;03Q$CD*' MN_44.3@Q\Z8X.\Z#IP8MOMS__/E0RW=VU]Z8?[>X7:Y^;,O-].E@U^\-03E+ M:914,DA2]VQJ[.[LC8J\R%VQ1-(A"S(7`:A.MNA# M&\Z8P-ASB>23,"*H5F>UIYJ'ULV+],]L:*I'6!^G^G#=]TCSM_W#@J%&6"Z` M1)83I[@"NI/2")47&BF7=E>8``-"52D_?'<%XLA'_^S)@+@$PFE%F4&4$N0$ M[63Q3N1]]^6.@(M_]^>@4__3?YSMY^;V_D@P],"P@##1V`A.M$:I*)AGOJL. M*P"&I4CJ@X.'&EN%<<\TN MK'<)4=%[1";Z"\`YK8G5DK72""".2C-2[Y+>2CC);WUU;MU11Y";X\)]1F0U;ND/@%&4/SLKEE_;GXUB_OF\!WL/YX, MCD`GH25.0\LQX4KN]DS/1%ZWXII=1[(W_;.`J!([7ZXW5[=_+9"=?0.$G%A=L`'UF@]"#45VUZ4? M"U#WN02Q=TS`3DK"*),VR6@D!JC#R)I,.[SF87FNDH>"I%)TZ^;^^K'OAIVO M'QI8Q[]NR]P?CF\=&!@,B&R.>Y+17DB3.@[3;I424JMI;=(#:.QE3&LX>.K< M;5DW\>>DLUD;38R[Y?9VZ2,>!WAP<%S0VF*XK>1@-).(K?S1,L#AGH>P<%A#B2!#O.4M,SI8P0G=_A`,Y; M!HIM],/K?S!HJMAQS2+*?Y=ZF]S\B+`GV3?S7\UQ!AP9&:"U$J0@EJ<":`LM M>[*3*I17\KZ8*3`\#8;%I])V\*3ES8E-B1Y;X3@-H%$.*V^E$ZG;/-:M5!!G M-I$NE@%79/$_%Y11K/Y3K/V`B(D;&-)&.\$!!@9RU,J#L,ZS\HLEL@VOY',1 MJ:KA7OU>7WDZ"`6,PM)KO+V10CE4G4Q83^T:3PE?+AN,FOEG#Y-\9.*QRI:O M#PF,.V4HP!8S)Z.42()N@4+&YL7<:F:FYJIZ($2J?-#ILL_'Y6+YG)W'#;7# M`X.!+*Z"1BM.F`+(:X%\%UMT/*]XN[C)=D=8#DP_+3I_79HJR%43+7MWK=S;1A$+[8&P M!`NKI"&$$=!]Q-SF)=T5*[D[.('.!:32S=!>)NJSYX*@B'-$"$9`>Z@@U;@[ M2($ZT\^$X`(T>PX.5>YHSE:+N%*ERU_;+LT]SI/V#0F88&.AEU8:;"6@DI-' M*TPH;DUF6MS]?SZ!&UOGP_$>R8I9HH(1I6GPNI.+@*/IZ;6 M/3PZ7SU'])T#RAC*MO.[^\W!^S![1@3I"(S[CP?1G<+1MJ:Z_3*$8A#E^1W% MCHF**SP/EAHJ_^]F_NU[G)KZ%6W/;\W'^X14JIT59[V^NM^L-[/%33KP.+[0 MG_JJN+WI5'R4`0VP(Q):CD"+AHY63-ZJ<`G90(6AFA)QCFT8)[TG,*^4E9XI M;%VT=!U@!+4X0$DF=L>RG)HS^90#XHAD>EPV7XAQ.IWVO2FDRBJ,.2"PHMY2 M3R3"+198XSQ"%5N"QB;40##6R5SMZK!U];BZ[;BYOIL=[I[09WA@G$WV[B86MS\J[GY M]JPDDI[=I8*/7[XWS>9]TE7\2;;9S.9WZ^Q?4XC^O7L@14[3*O'(@G MRXF".ME+D2_%.W(K\O4!`5B.J0">Q]]220TB@&CA$#[SSGGA:Y%38,>R`+HU M+)J7$SUZL6[?D,`8USXBA3`2GBB''>ZD@Q&ZZ=ZP/%==1[5_%D)OC0?U]7_D M?N54U%]?[>TZ M6`AD<+6?#TD--;]F(QTQ&_<-"9KA=!M%6!V!LLXSY6PKG2%_]H8OIO!+-QP' MPGZG]1<#@A">,Q`W1T\Q0,H0([N/!%J4=W!?S&(L MI?-S<:GC-+X\_/@\7__[B.EX:%C`PC!J`78`$N&<`D)VQK'6ME;[L$LW'P?$ MN"Z3GL)RU&@X-"P0%GTLQB@P&%/KE0.@6R&-@V:Z9N0PRMO+B,&P>JO,F)Q! M.3U"U">"7ZZ:N#:V+67B7_^9K8['I`X-"PK#N`]'\*P!T#",F%*ME$[3B9F7 MPRCLSQ/5X?"I>74U=13Z\L_LYU']OSX@>!+-9V*Q1I0I"BF3<7MM]U67V4ZA MF)%91/.#(%-W"^@,K:O;W3]NW2+U8WF_V'Q<;JYN;]-?OT5DUANSO+N+TJUF M=[VVBOS7!V,004AR;%.A%N(0=KA;A/G43C?*)&>,`.0$Z-%+,3W)^4> M[ECBL,4""DW3E51O?+136@>9.F..;N2EY3J6)OC'D\$)$5<]FS)8":%`4>G; M*`^E++/V5;'PSW;74YTOT/5`Z/2A3YE+5%602:(]3#A M\@B,TIFMT@LGY&4K]]4KZ4/@4J\&P8O9'HU9'!P7K'8<8F>IBKY^]/25[GPQ M2C2?<#AK$.WU8\196+U=;DPNH#4]2HQT7K:WB%"_T[,CPP-SU'%O)*?2&*=E M%+5-6TIUX/.2<8JYI0-I\*1B35E`7>KA&M48&(X90\0"`@S0I-M_K<6U&B2, M8D,,",REGGL8!HTSD&!`$(3<4TU<*Z7F?,*=CX91WBD'('E8O55F3,Z`F!XA M+O)#+PB*>Q`UJ3USTD!L"7&/;)&:`7S4;QY!^BY5['-SM_6. MUM_G/_7O/:[3TX2SYQME_[ATZ4D$KPB`CFGOXUYM@".N36"16CB:6:FI5,A[ M&$+U<$XF@?9D`^PEW&,!!&6."PDP$1$2P11IH2$PLVQ]M1#[=)ASBN=]&N:7 MZE\1I("Q%'FCD*7>&6PZZ!CE[D(][][*.RGU,`NKM\J,R_*\1R'$V\A%M8A; MA@%F#E'M)704H%9*;4$M*VB0C,2^"CLE%_4T?$8\RSOCC)\R$+\>!+7QD!E' M$!"=C-:SO"S":O'YR1H@PT%^N4?$5#&`L$':X.B:H.BC*-O*R;6_T/2!WMH[ MZ:PX#ZNWRXW)V2#3H\3;3!_`!J9S<4&@!!!(@I`&K=243\TF&4B#.>D#IP%5 M\W"H+Q]>?3[$CX@Z3!APF*8XMW*8M7(9CFH9)*,28`AD:FA\J,J/"#,8O37D MH5,::84<]IVA+3/O$!2^@7T!1N@@:(_#H_P*@`([C[B/L* MR[DE_WJKID?)O],@>0N))'%_=`)IZ;U5&FL'72NOM#ZS^UKY8&;AP]UAX+J< MW)*'ZE7+_V?ORIK;1I+T/]JH^WBL<]H1OL+V[CPB:`J6V$,1'I!4V_/KMXHD M(%D621!G43U^DB4YG=1\3X4.2:?XB")]7KQ M;7%P'MS\N=W/-?VPW7SXIN;S[?TVEH+>'*/B*1<;9:4,] MVUF),0D<"<8%LAIAB*6AKJ+.0YUPI*8KNYJWSV^#T&N3@VLY,X_._BD.4T-/ M3Q#*"6.$BT,!*!(>6NLKFIUI.8U^BND)#5G78GK"91!=9X*(`V'O=-H!*XTG M@4B.:_N-.Y]D@L@TID-_*%YO7-\(")`,J%'`CƽUK7J`03=>2Z(5[%P7X MVV'U>F4C.>LB/9&XUJ`^A"1LC$3'UGK02XX%!K5*96JL\V?\H=\M8/R^$V98]`RYA7%RC-L+->^WDX50G`D M`V)2WO<&SVM)\_*.&&ZU@%(`RXA50-'ZA$;/NX][ROB85"@&`&H,\3#%.EC3 M.XD^*PN_79M9"$ULZTRA@X8QX)FJQ=WKEI67Y+H8WQ65<8.U_14[2N0%5LH% MHRG\PQH#HBHJ$37M>@$-G.8US5&R1QBOMTK-Q:;B##C'B&,&/MD7B;<\W9-D M/\R[K%RM#5:O53*2.T>F)Q#3G2.[=@ZB##O)'!'>$."0!D0^:E3%$O-*]\.D M9IV#+D/F6FM6@5,$<`>9-2`8P)1C5;OSH6HY]6"B*1HM^=\C/E-9DG6J6S"O MBMO5XC_YS9O5,5/*??N6Q_RN_&-11L8US13L[W498TI+JH@'6D$I`<>^1A7A MED&0P;1.$DJ=!F5[7J_#Z9GKT[B1^++]>3M?LE_;.(2$FD"][;E;!`-E+918C#$@2&$ M85F/+Q-$G*UD&YJN2V>#2$"E@1!;2B0S.D[I`O5H+L3',K:3K?/X_M\5#^)`7D?YO?SI9NM8D3AUYVU[UP508% M9L0XJ!`*&D7HH.T>2:5JK+9`G3IU-V97T1<.S>V*IMS;+^6HB^3Y)1G7AE-K MD3&&.AT.$4S5,Y^U3K'15R?4BUYA2)]]R7BS)N%:&D9\U\"'8DC8``X03#F@ MN;2L:NKLC01CS<@;5;4.`,RU.JPM9`1QXSVA4&+&L96^HI*+JQV"T)AYEWBN MVV'U6B4C&>6?KD!<;R@#>F`XTY8C%2`#@'C%ZFFCBHP6Q^K!E=V82K:;YY[L\;UIC<^R6C"ND MO4,X(`41(=RAQUW3<=/.Q39:\ZMNAX.>0)F*Y6>-O^,W981@SF/G-L`TQ`J; MN@%'T&Z"BG0/!=V9UD`*.J'T&N4AN:-`2F(P/OO[ZLR`D10(6!4P<\8@3#VI M-:>VHEW;HLOSH2?1_KU`RTT9EV+ M7@N7032&6'1O6XD)\`Q1BZWC.FR4R&#Z>%R&[=R_@WF`>F=[=TC&]?L/T;82 M*8"0$!Q*::QSX6=6A_,7J(5]OHB3@P\]1!O`3&=C_ M]LE2WQ<1ZME2W1?;U4N!PT%L?"8\LYQ+CV9:F6;4I'_ MB*20QWL-&>O&(>6(B#/0*$40<>MKG0R\;]<1>02GSS;9<;'Y^^'9PIIMM6>:K^9/9`FMX0@I;/2]#6H;]7FN&$'=: M621][?"''+TYE,P,]LI-'H-DC8)@)-7 M#@0K(?]U27410+6NH9>P\VX>JT3HNHABOGMQ>.\^(?+-ZEM1WA^.5?N_#?-F M-RNCOEI_S,O/=[-R()"?OV7*LH['_AT-JCI^OSC#,&SX<7X"-TA2*F@X?AA) M"+*QWO:\ZAF8JG,U';]>F%G!&.`J'*D\,EH0+PD_4$-I4!$CG3A/EG1T8<+S MUDM=J!^XH*,#\[=?U_F_M^%5[B'2%E9[)OYTY([,?I<-'J!9`PC[865GHT\'+TGW>'8?JB/Q/.^V%A/@[SLP1@&:2W,F8U!SB]';@3ZL>J_]K!D#[[DMDT)^': M)=SZ7MX6N]T.2,1V_(B_R3[NW0FF^/C6'-WECER9"82T\QQ1@#214F/I*DW. MA/>)C!!O#VO1)_FMV/-^>Q];UA:E^KK>)>H?X\YO%V;"`HBDM=1"X#RD0A)4 MKV3N5PU M'7M2%K9C"3730:=-0H+8Q6K M<>.PW1%DL-2X'D.A4\`WBEM\4\S_]6:]WE9Y+V'%B^+PQ>S^^.%[)"F0FI?S MQ3IF-YR(EE_ZL$P*RKT#DG!K,>$48^L#8S6:]'S*OV_+ M^5W8G3^6Q6TYNU?;S5U1QD31O=B?2IUL^(1,7@X(M5JO\UU.XMO% M[.MBN^%0H@"88+9HH4A^PQ88V6#8&FZ6)Y+`>SM'1G5CCF)!93>,@,?LP8FDYGG:]D28)YNS^+98W6[R\M[F7YLD++YT>2:9H9`%^P`J(U', MFE>@@D(@-%;/O(OR'280A*)W*,.SN]:+^F?]XQ^+O`SOOOOY-G_(EV=V MB&8/R"2(K0@%`<)2P;%4"-=:$X631HHY5RT7,R M#:$02%BBE17<8N:AKW!@%-ET]YR^&7U,C@:$\>\K5LEM95$#"2>*!AHH4RABC:(6&))V-.Z<\=`>)0P=[Y:%&7LJG&R2OSQJHP%(BQV M%FOCB8T=V)2M/09.)Y+,EX:4=,=O+`?;EX-KZ(Q;K;HLLQY3Y`$",96=:!^' MO-6Z57N=Z+XQJ11T`'`,,8C+>FQ]4T-V0B*.W!$,)^B0E[%^PE`3RQUD[53T MVK9K8CQ8YE,:PM$/EJ.D<^Y@JE=H%^L83PP@G:A!:7QO%FA"%FKB@,(`B6!F M/<'/(]I*=@;+ADI#=OI&=9R:A=C_\U<#_G'A)T3H](V9M-Y:8@):B"'.&5=" MU_$1G)KCHT?._59\T"-,HYQMG_6S.PQ[VB%TF81<^*3,60",HFIKT5\T7L!O[/Q>;NS;J<"4*J=-,`%K"]_)=J>EP9*^T[!X!X%V"BOG:=?>BJB?JM'I^])'98HS M[Z#2!``L$43(P?HHB9%(;+)PWRR^H'UR#^A-KZ!:*Z;,>&2<$,9!!K4$'')& M*TJ!M^VZMP]F#P\L)[UB-51ERNFXV--?[M3N^V)C9N$1^CB\(;5/-PU.^#6O'ZDQ]=E&@'DJ(482,,L`L)R!"4F M+"@+CV<;5)#V]*G/!!D0V?$J0`!P^+\7"9W9`%#`S5C>29D4EDXC2 ML<#U-!QXU24FE"GGH5'0"(.DL9SS&@K"1AO$VRY=>'1Y:%)I:Q!0Q M++QQ''$`/`:&P8IR!%MVUAZKTF3JK6,0C%]O90#0D"JJ+(9<`(HHBWU]JZ], MRH2+'/MF=*<2@78P_GW%*KD=[:JD:4(IZJW@!'LN'*<^(&H1I@PBQ2L:H<7M M(ER)%)PTYM\%!2>7X76=Q04"26:DU-`)BX+%![&T%8U>Z'9V<"(%)WW*1#N\ MTDP/I]Q:'SOA0NJUA,'(\[7O"E"<2.?O)-UW[6&\KO1@)2!PL9DMX`(S8(D6 M]4D04>H250LIB$@_D(X:AMIKN$_%2C3`] M.6[6R2,FCMUN[D'\_;[,$QSPX)QR'M"1$A'L*W`L!V.=NJ=U'#:6D...P\[0 MCGK\Z@[<G?&XJ`,:1G2"@>F<8DLK?"&EJNK\$MVD:/A%&FOB/]7 MTH?&/657Z:L2\-<;4.1<6HNX$D1;8X@$3.***B09)P&`@&L:$3`M:M"2"2@V)A_%P2/+L-K#)G8#T-]G!(26139<=H&.G%7 MYD@@T3E&F&4*`>LYJG$#W(TUH^LZ#9_^@)U0>,YN0R?ORPCTL5A+,:>8E-1Q M)&N_9\"3IVO-],*]9A+1":O7*QO)F23IB<2$8<88-C\261QB%-.0LY_^410W M?RV62[6Z^;"YR\LWJ\UL=;L(+]S77$_SUNKO4T9QJS4T"<'^=FW&``*(,BJ% M$MAY3B`S1@K.PQX:;+&SK8$&2K&9W^4WVV7^X5NUXG-AT"-W9(!P'"P]`C0+ M%&ENN285?9C#L138R6AF!ZX\SY;I!85D(XJU"M;;=,E'ZO%ZT4&=&=&_S9VLC^$QLG!VRWOK'7SRW49TL`* MHAATGIA@`C@G744'E-RE:^GVQ)_?DNNZHW.]W$[.=DV!R99V\/H,6&H`X8IQAC4@XWS-6K950.%K)8,/)K^UP+OI' MHA77=#F+QJKYPYSFUO/K,AL.4\`#1*"5"A'!O>;5VHPDB?6^[H%+'1%HQ9U/ M/S[>SG))AE1T.P//&0]"1"TQFE8KXH(FUI:Y!]:T)WX,*[$Z M"<6T>E^4?\W*FP:ND"=79YY8P`&%1$-&/+54!2H/-#F!QTI];LC0_MP&W;$8 MD[\-F)J)8"KY6"P$2$#$!&N)P&KUFH^7<'89)UOA?X27%T(P)@/5_-_;19G? MV&T,\GW,RT71Y$M]Z;;,JVAZ>13;;X3-'%EB?44EY2@QZW,(1O<`RYC,_[@M MYW>S=:[F\SC^)W9#O?ES>^C*WD`*3MZ?>4,0LSPV&PR[FR!::ES3[1%I)0Z# M&;A#B$.?^(PI%[NQ4,M]L.XB@7CYQDQ!B4B0?R"H,P9B0'GM"?5*MG/\#V8W M#R$)O0`S5+SR7&3M\?]FMLEOBW*1K]M%V8YUT8^KSL/KWZP.).1O%P_YS?[U M^N>[V9]%N4NM/A58:_NHC"KMG4&6><5QX#`0E?T-4?@JSY:$-SV$UG&"YHL\ M%FKK]L!,BF!W!/WCA93!/`V'#JIJBH5J-UN\ITC<\&PL)L`PV3B>?Z3T^7?_ ME.9SA0'-GY(90IV#P0P63`L!&.785\`AW-),'"C&-Y:,/,^C'`S.47)MCZ_^ M<>WO9_?G^Q=>^*0,((D4I;2U6/:/Z])2RY M0.8U"E8/[F.[6&_*Q=?M#NDX`V0>\,K5;9GO\^/^G[TK76XC1]+O,@_@P7UL M[/S`.=$;GK;#=N]?!$V6),90+$61]#%/OP`I%B699)%@5;'HV.CH;EL"4,"7 MB41F(I%YW+-\6N^@'&7"8N&1AIA08#V0VW4XXOLZR4Y]`M`5EM#I-CT M5J%\*B9?BO'#O)R5]S\_3>\?CG#*B3U#JL0!/&9(2&L5A=89O%VK%B0OXU1W MZ80ZYI)N4.N#0TPTV\O'HOI4;`SYQ8I$ M=T6%>V*$U@#KY\W/*X_`!;Z4,T<*RGJ'8#PMG=5:.4\C!O7V<#[OIKRC;`M7 M\J=T"^D`V.M,JS=CM&"ME4A`XY0DS,8MS46MLAL'!IRYO3/JG\=E+:+Z_QR7 ML!FVV-.>(')+:.6T5$3"J`=:P^B#`9½W2JTE[/@^J?B3+QZH< M%XO%IV)1I+0340%X=@509D,!5VNVZ+Z,"BD?ID MD2[PN[+7_Y]5N.J-K&!(3U=M8[L8[PNW* M7*+&X]7C:C9:1K`>RVHY_<_:P93'-P<&"YI885-"0L2P4YH[`_D6$:@RG[JU M+G>&Q$GM(#D`G=C]&,]6D^G\_H3PZ'.'"LXR+#U"`$3-$$9)'S=;[?*PJC$[ M0#_.XM[YJF,<^^&JUW/^LUB>QTG-W8,%$`-&M!#44J.Q9CLM$#B5)Y5:=S5? M@7M:QZX/CGDI)C_<'+O,"+3)RO1E]*.'#[0:>?QBW/=-H<7[V@8C#`$<.:DE<]98Z`34 MPDEH(#.T^0KO_'D>#0E^VRXX@I4&F'BG&"7(&<#0=GX>Z;[LFL.1OI>A6K:W M]L%&Z-;K4JOE0UE-ES]/RE#YMD,@3E&A"2<.(`>-HMJS&E2/^DI8>OH]43Y! M]R:-NQ"0?C3!MQ,],6?@KUT")%H!',\@1:BFUGD3C[SGU1$SY,38EY*KD?H7 M(?2[\<$`;U&&0?[^R>[N[HKQ,FJQ]9P_C9:%*=/3P56T2#Y$R;D)B3K""*D$>S/6WR"LCU(6(.+RN'QUH8-0!L(""&<,Z4MP/UX2@\"3E%D3ALI&,I51%VF M@`FI(8B'>HV%<#8OO+X;SV:K_-,M3EDG69S2)OUTG,3H1_EU-KT_=,%VM'V0 M(%IY6#LD-9:,,JUAC8GG/$\QZ<8/V:K_H@TTNO(O)C_KUV4Q2:.;=?EYP^YL5KZ!$`EX0;J217"'OG,%'>2`@-(MI*+,_UY76QOJ;< MVWM:!THH-A0HFW+A"PNLDF2S+FPDLGWE[CR:=_MBFAPM1)Z#PV#]@=N,M.MD M0XOI"25K#O0(@+($*V;1HC91/Q64U8!H01L9_AK9MB\B;-D%+GVH5_MFNLDU MU1QZV]@W0"NY!5Y#`["@%@"=7F-NUDN8&W#5F8LI>`)'M('5[\\C@W,C#H\U M6M"P/SP6]Z.&K*B[)D%PI&!4'./!:7P*%<6B7FO\[\!JU+6(<-D*(*?OVD4Q M?G=??HOZ]C1M6)+^D,A'7NS3^*/P/DYEYN;+PY=X>UH%B1W4"$4;0$--)/&* M@NVL$7!]A13V?DY?CD7[%-Q,Y:!`?=LD2(4EQI08AI!B2C/CZ7:^:6\/[VR] M"/6R51B&3[[!''M7H5K_)YKW6GAJL2=&8`8=%KY>DF2@+Y.EX43+!_+0P77> MNK,H\7'C\3'EQ_<-=2=^;1FHL4(@YY"&)-KEFDM>+Y`RG^=C:/V.J!VZ7+S\ M/JP!LZJJ8CYNBA5ZV2PXS84`AGGCC,$2<(YJ)H-.]I6/Y&K^@`O`./^D&C]_ M;'-<;?_V]LS:_CRHV>QY>BG[ZJ'SZUCS(*+>#$$4'LJC5,6&@U0;Y5E[=IX, M3Q6YC#!E9YC\#M0>C.9R?2+W3%SWUZ=CQ(R_#EC'=3LMK=:8Q>53;O_X^SM/7YTS#J?IKXX`,APPCQRVDB`,)HDJ^79$5F<\" MS[^FOMK9>C$D_1/YI,06A[J$=<$'P#2!FBK,&'(8UL:7(`/.EW()J8Y2_6)T M?C<>&-P9/`32MV#**OH.@[_F\7Q>5<7D&>?"G788#N@,HC/FR63&E*K('^YPT3I(04 M*LDC+QN-#-%.F&WL$A8NSP+O++UKRRS0*5:Y9X'<3.1].9K'><2CB#2*_4-= M(M\R:(2C6CKM(>7*IL?DFQE3*V$6=3O+V=JZA&\)ESQ*XG=R44N5]>=1$R4/ M=PG24(<%5=(RR^.L*=A*(*(98'E*&[L12K:&2^:Q#"!9%M7C+/'1M+#%>*,> M)-E`FX[CYK[!2<\U\^FSP%OIO4>\YD::>5_(;X2V[0.4NUWIYS<\!ANWZZ$N M@5.%O'"1)XD@B@`I541%9C=1@W17GFD+P1FET&1CZAW*HJ;3$OUZ^#4J&-ZO'YN-Y*@FB$07D" M*<\:*9X;+IX8SC`.90I:H(#(>GWQ[WE.$'!#U.X2K\[Y8329K,$?S2;5Z/M! MYV]/KSGGXIOY>S;='YOHMDW M7?K1>#J;+G\VYO0]VB]0P#5%7@L+([Z:":=(K8E*GO?&$P[?G=8%.GUPP?MR M?I\4SP3$E_C5ANO2?>E\):M(9$7F;WZ.IN. M&V*R7[0)6L&H7V"NB7!>,NDB-V[GI(0?V.UCF]2Y`(9A.C")C=.&&F!F)5", M$.)K_YR57@WK'K%-4G8`3VXP"43TTSK%A2[GD\:0D3VM`\1>`HL<09(A0XG% M"&_GB9S+DY>=W06V2L8V`,DBW,98NGLVEJ8O\I<<)V%3OV`L45)K#0%6P%N$ M9"I#]^QIS75:=';UUR8Q6X8F[\78MZ*RU>CN<*&@?5XL7F>W?&T2[3(D\F0F>P?E[M:_063N:QRXHU&;=DIKCB405%E6ZU7( MHKP<4)W=W+4J,5O`(_ND`X2>3+?]S8/"$A)*H0?86.64E-K65XI,YH4^=79! MU_99=SDBMW?C@PB.YBX!-N5'U99S:<5V?82#/.VFL^N]UI74+L&ZI8`W;R#Q MSDFO`7=*(&5%'?I##,W,)]S9Q5^K?-`I5+GQ;O1@'.Z_1C]3H6S(&^[WSA@C MT+@>(2(_0R@=`IY:6`,'!I9;\7-U MA=,0HBXQ0\0S[UEDV,C#0&);WVS%_V4&==V$TZL]6/*M\M<3^)_5[">4Z055 M\^G=T#4H+3%@BGI!+4;*>"=JV]0#GZFTWX1CK'UX;NN1(H%>2A:E#_,2:"$] MQW7XF'&9+C9X&SZV;K$:PK,6B@&QCCO#'05<>&UAK5]0;#(SMMZ&'ZXU6'(E M]G6>GVON,8_XP'@4(8\@PF[W!(#E5GN\#4=*[ M*U.K<-Z&1K?A7FL-EFQ7VLD!`'O:!L,YB1-R4@N`N3`8DOK*C5J>]U@4W8QK M[$(\LFW?,X(V?FD;),'(2D055I!X8C0&=>D)*F'F=KL51]:E>-SN8P.N#)!< M*DR!PC"]TC*UQB^QR"QW-W3_51?8Y$7M/*2R0M-Y*J\2/#SA`BK89$$U\?^BX>'7D*4E>D;:LH3C?H]+'#7R/P MQV*Q&LW'A1TM"WAD?Q_I%>(^T(@["V54&B#&@KO:X^XDSE.1>WI)E,\![2-S M!>H_%[1+M5H_+]-%^\=C(N'\00)Q+H&'G-(P;@.**-V%:>#,P)6>S!V9[600IL&8HG)A38`R95_/MV35K+O*.A MIVP]EQ/_6PTFB\^CGXV%,%[V2P8X+6G.IH746%!B@FN:K%&+!UTGI[+ MZ7H!%+ULVYV?YMAVW;4*<;+1/I0:0:>0`$`K7NLH'LN\V^6>DO6TL$VSD<@+ MM=X4(2TF5?&TJL8/HT7Q-*I&C^5JOBSOGM9O;79^UGTDS!DF1(E#G6<*2QF- M3&TP5W6$G&"96GI/27LNU-*[A:J/+?UA^5!4R2C]\FR4'MG8O[0-GHDHB)3" M\=QQB"7$ZO<\DF:6F>LIN<_EV_M2//I7RO^:1]ZLEJF(N9TNQHE-/U;%XW3U M^&=QC/)GC!(DA\"J%"H#G+`>*Z9J!V^$,R_[0T_)@]I6R]M$JG]N\46AUJ+L M9,ZH>X3DM0)*<*,\B/\Z(F@MZ12PF2^.>\HJU#8;Y,+2%\FW3DDUGZPMB_1G M4SY^C3!,3N*`Y@&"]]A#"2F)>I!4.IHGK%XYHS33ES=X9UZG*&5IB6DFM?TX MFD\VI4"6'Y.<*N?EW?9`.Z0>GMH_*,^AEC:*-0.]1X"376I10%5F29O!.^^Z M!*D?JWVGT/Q9SC>%7HX)@/T=`N/4:(*)=YH0"C%TM([<,$IG;OB;\<^U@DHO M](Y+_7#WYOYH]&/ZN-IYE\SH*?YF^?,8%YPQ3+`&`(\19U'E,1(XX\`N$YHV MF063;L9]UR%65]`21^.SU<2Z2S!,.>\,2'N!8DJ%DW4V-(EQGK^ONT#ECO7$ M7%SZH/JVWO=&8QDER#\5X_)^GJR;/R9Q^M.[:7):X%/HK+S/OXX M\?BT6,3?Q95.=@+QQ>].]$+T.H_@&&:(Z@\%@3O\@4)CC+#,F_&@SED ML/L7=?\:+5=5*D<[6IY^A_FR4W#2"LU4_(^U%@CGX2[A!J&9]]G=Q7!W*^XN M0.;6!)X9@K0[/HF`N.4.:`FB]2F1E-JC.@:)8YV7NZJ["/0AB[I6DN$/S_&13$I)D^CZMMHMCH8CW6X1X@H$JFT0O$K6@.E+*CELO12^F!G&,$6#26E&[HTQ<>%[X MU_[[[SNHXE?_O?GAZY\]]WV%V/?OW]\] M%54UO2_?C!1>.'8K*:Q;WBHE:5XM>7#^7DQ>3J M/7HL[NCD00+GQBI,@$;,<,\7NA^4\:I)+-RO2-_[QMT5Q_[B^7[DR<_WZTZ)(M3`:BD%<,FQ@$`&, M0;3S$42<2P]8#:W&F4\DSV?$LXI&M,TU9S)EBWCV8I`>._3\Z)4A'4XM874M M3F@4&H<[!4J4%T1I!4&J>AXQ4V:G9/H!%SRZG&@G<,%%*/V._#"X`V1(;-`_ M^=>A^KL+Z,T53F/F@2.]@N<:0@F)L]!RX12S$FW7:+W-S+#7E<>S#6+M>_W0 M"CA],(`I%\M?3L,CI-_;/@C*#=?"6>&@@#PN"=A:XQ$R\R*L*Z+WX$-I`Z;K MV!%-#'"@1U`:,L`)L`Y[%_>.H*)&"I',FM-%@-T%M;<`P.T`5,?Y/]C/BX?BS13'V$Z M7R*>;-?-DP9P$&PU'B\>ES-4A:"?U81PM>@ZN*NK(HOHQ^7 M\-EI7PB4*0,HIY1!CSF.&I^K9;BWF0_^.E.-K\Y\G:`Z;(Y,*'?+D:^^$`"V MGB%&#(]FJ.20>E+?4`"?F2V_,UU]N!QY":K7X,C=FMZN\0RF.SQ(8!(P"J-: MZI7UR&.@1.W@2(4&AJ7D]\U7K0'77>!CO?B.0_A>7KMU])G/FP"B/^9Q>SZN M';M]?>?_JKNVW;9Q(/I)2_%.8%]X$=$"W4V0?`"ANG(BP)&]I':3%66MYT_."K`5TE:J90V7QIA*"X:GG2\+G40'H2U MW/GD9MH[3\WI\342AIIHB6-7Z MBVY'ZWR<8T![AXM:@90BV$"H0S/[_=I,9N)CM4XBHB"['Y3 M+BK_'K_=+ZJR7I0=D%T9[NRNGRBQH7J;MIDU6ITL.H),7,P[7;IW.&3C*&*2 MH.!JM>.H'8_I3KK?Y0E.4\*85XBQ6E*,)SI2/5/8=;NU=7>H.I+X?Y[A6_@?* MPHQGE@&;`8+Q7@YI(6>EE\^H/^OIA69;;35']N&8R M=TQSF3'$*`PUE!@AY/^AAQT(+``ZKO_BZ&_@=`;SN/J*(V_LJV^LE_6Z;DHO M7^.742[*ZG7GO&_7JZMH]YCJPBT,@S00"&MEF2$0HR"!5#F3621[Y&!FPF5H(I`V1%G`(-9AU2;#PA\U,PE?3X?T MF-I*%O;L&XS2C^$4^UJ_^["I_"_7QN_9/K&V/_$'WTOMJ7_YU]02P,$%``` M``@`)(5B1W`\<(Q)M@``8;L)`!4`'`!P%&F>?;K.^510N>5'QE?4^K.^L?*U[^8=T4^;WU MC[SX(_V6G)UU?V5M?UJGV1\_-_^Z3DIN/9;IS^7RCM\G%_DRJ=KP=U7U\//Y M^??OWW]ZO"[6/^7%[3FP;?=\^*N#WVC^[ZS_VEGST9D#SESGI\=R]_G;X:IF^]L7ZL,[Y/S]>7+5YGJ596279DK^K MW;"LK1]%ON:7_,9J_OO[Y8>#\L+SYAOG&;]M+/_"BS1?755)45TDUWQ=ZVB/ M=E?PF]A/;QRX^O'`?WU7IO'/"QZW7SMHOZI^V9S^",8;J-W<-T[,G^L>+;BJRT\GQS;2E>_OJM_ M6FS*L]LD>5C0_/X^K9IK5(FS%UE)=16B[7>;DI.+XNJR)95@L, M@';V^U6OJ?W(9-!W,F:]/`\%+_-- ML=Q>RVJUS=5\F\!?]W1:2;:RGBBU=E*M?_5B_^>7\UW23^W/EZ^UJ%;C35)> MMT([@VK!CG?.UU79?W+6?')F.]UE^D]*3CX_(_G2\!G9&KQN.BUYT;?T)^T1 M%TLK+U:\J#M4_5\EQ?*-4]E]XWR9UUV$A^KLR5EM^E63))=/T:BW%M8)OVK? MBW*^R,OR2>BOR?6:+V`4,Q=!ZKN,>B%R*'%9'RT*;$^P;A6/;JY`&T'/JO)? MK::IZ_!U9XX4G*:5,ZDLW2SR4=N7;JV0'Y^2JB[2SS>[CW_@Q[1<8-$*(A] MV_9C%T?4CVR_5\`HBE3K1SWB9#7UP]I*K*]QM:Z3U]5!QV1J3=_VN=;?")F] M59-CF:=8IUWT*+]/TFP113#R(A`0+PJ<,'2<(*)]2.KZ3*DPY4),5XGOAU+< M2CMM,3YQ2;CZU+R=9;DIIG*TOG3L>;.@'HK;?/&5/R;E1[Y*ETFZ^LCOKWFQ M\!P:.B&,?)\QZ&`;QC;LXX3(=A;5,,%QL)24#RY3/]6!B98C1=1*LGI-UK^V MJHZ4SDB6'0?/)&[)T>941JVZ.?)V8ONTACV18LZX9W!N4FN1:X=@.W-T*-E7 M**OMRXG1JJ\_'ZF!Z(X>+M*,?ZCX?;EHQB2VQV#=Z8DBX#K`#X?Q"@X#J#I: M$(\P[8B[T66UPDX^/!@LDAD.R/LZR_Z(6B9O=?=5S5'MWN/ELM@D:US1I"A^ MU!_^=[+>\`4)?">*L8WJH;^/8H<@UQN"PQB)=%'&C6BXW_)B&-[)%+P>C^RN MTC!J`F,UIS;>]'2*<=3K-HF/J#1MGB7+M),Z/LH:Q3)5PEWR)4^_M3.;P`$. MI8[-8.B1@+A>%*(^("(DT*":1)2)2?;>VFG3HYF,DTH$,V2B[C20B']3D&NG M0YQ6"I;.DU`JB1RGDK(UPB2*>%$'J-)O_$-65L6FOUOY&U_=UB+PLOY56KU^ MQY(!""-`L1NQT(M]$`0VP-@+?((]ZL:N8(69E&"N!G>JK3W9[:*`3KBU4SZ+ ME0$:/A\IYBG.WDS*?9)4\^F+0QD9VYNQ<1``&$<8H@!"S\9>R*(^C.<#5Z;+ M(GMLPQV5O2)_)IU%L^L$"*5G&FSHX^D_(-$4;%!F!(? MLF5^SZ^JI.(-L_IUZNUM8<@8CB*((^SX`8R8TT3L0F(2V#+$T(ECF!Y;:=:@ MS>K%O;ER8GQ'Q;@RE9ERC%'WT0AQCIATA#YC6#L3$HV22CY^RQN'4/V==A(C MQXTC#T>VZ\``$SP$A031$1@E&.ETE'IS48D)7[5(9<#2T5AUFB4Z1XV2YY6D MP?,FEFPR8LQ2LDB86I^K.UY\RK/\@1=),T^T51$_/O"LY-T=;C_V8L1HB+R0 MTIB$=<"@CQU!&LO`:Y2`AAG6:K3V15I=(?ZYT_D7V>4KX_HM!K7)K99CVS@N M&Z&J\3-AWK@YY09;Z@A3UI=I^4?;5_2(:U/D^CZ`D0UM:A,XC&:C MR/75)J,4`DTW,[43IS:NU/-3?8[?B)4C3.*?9E1YS"')Z7=I8V="K'%R$9A` M5S1(@5#-O;QF+OYK?8"N7TA]A\;4@:X-@>,@YA$8]S$)0DR-4`J!IB-4+TYU M1*GGIRRA#%NI3"@)%PT3ZJ5#0H32,'9VA-+)Y2"AM`V2F/NJ*YJ7U64]=KWZ MGCQT/;:PAB%UL8N<`$$/A-!G0X\MQ@S+37HIA3`^V[55936RK$:7ZL!0U4+1 M^2WC[LE.;"D89VA&ZS5KCDYE:7DY$_;H9O%B\FH$4Q1Z1!?#ZO'8C=S`"8B' M0PH99;9#Z1"*TE"M(R1^_`G7#ER(/`\QGG&R/1XSGJDO)!"RRW`?YT+@N1$= M!V="%:T4#G9D5.U0X,G?ZUY2LVKR<[;[[!.O%A#9+(QC!(+`\QP_(+'M]H$= M.Y;JRNA'FXPU[ZU&HO7G1N1?K#RS]G]5*U7&C[+/LC":PF)5-*F[:YA6!TP3 M8I>NX;,CF79"![DVCE5O4F[%T\4%OTW6<5:EU78K#2=P?4AC!P,`,:XCP,#N M0C#/PT*W]%2.:YAR?P5=NCXH M/SXA2+CLI0YJN.;[)BTW&2QOS=O%;LP5N4H7-F2$*M]/^4")*[DR@_I6TYUK M-@?)D0O+"Y[>9O'C\JYN`KS^W^])T>],X?H!='R*D&?'-G40"H;1$H,NEEIT MJ!7(,`$Z;58OSNK4J<[%ZIDJ-D*9S$\Y=FA8:61,&LI!#+.JTV6UPC0?.%,W4HQ0DW@H!R=%^XQPZ9`] M1Y"D[>A,:*2?1SYR4QN!0=VX$D(7(1(2:OO$<;%+8R<>^FJ!ITTAP3`GXI#: M`D`=.]599,#)<6ATFO5_ARV2))*DKS-FDFPF`E12,D>82]VV(1$OZV[9CH(N M"`-@1[B&84PI<#T&AUEL$@61#),40QCF4;\GSYXLM4Z1JH-B&)K`/#D$J?AF MA#ZO.W.$/)I6SH0ZNEGDH[8O;=IT=/-".V(0AA'UW#"(*?9`_]P%"T$@M3A' M.<@IB*/6_5'W494Z!BP<@3NGZ?<<*/9*&SI8^LGF\R1\E8R36"6X#\14N MN]B[Q\"Z::@((]_V7`JH$]44]`!B?A\:`0KD5@KJQS.^5K"7:"7EL%?A_N./ M:I/:HU@MQJNI799#UP@&&UHM^*9K1]<+CN?Y3.@V:DHOU@R.;9Y48P(0`&@KC>$"ARIATY5CF^8:9_RRC+%-24[Q3AFVDDY;HUD MHA%VO>+4$5;I^#H3-FFED(_7S`39DV;?>%GMK92N&U/=N4O6^#[?9-7";C:6 M=&NJ(3=@;H20X_8+I!G&3&B"23>&\7[5WJ,`G3)K*TV0.-HF'J?.E/[)]I@4 MK!-8"[G-N*&,V_W<\,7=X\L;GKS"F+%]X5K9_T.Y8='/#FSVT^9>\:`0W3W/0&.`8!B&!CN_]?W39Z-VJ5GUA]N=PYYD-VP=UG[_O37D:76) MZCVN-F5S$!VTSKPEJ#+[A(U@NO_ MC\EC>K^YO^3-)&H]5/O8O"PXK7Y\ONF6WM%-431ODMDE53H+0,*88D)\`%!, M<`1"QGHQ#I+;),^,`L-7L$ZT-:BV>ME6?F/U*U1[Y7M/^9:2%R1#YT?LBG/Z M4R-W23%Q5HQ<(92,/7(),'NB9L)XPTGF4[9]M>_8.O_>3*\-CY1_ MS0FO+R[KI"S3FY2OHEIN=ON)/U8.^)AGU5VY\($;```@%[E+@(3GU*33Y1HGH0C%XR)S_),KB!39_WZPRS3FBY\C;GBM^W6MORA M&71DM\-;X)PPBB'S'`ILE\2Q36W;<:"';-<.HM`1?9.S\O'-H:*39`V:3O=N MQ4/N'*EA;4-G4I7Z>>0CMS39REG>\=5FS3_?/(_\(;O)B_MVF1+YT?WR:UW+ MI,[_CT7HN[X#`DB\`,=V@'SB^[T3)#536CCT'7\*F;"Y--I_D< MV9/8*D[TS77)_[VI0\7?VO?E]E<0+V1^!"/BV9$;A3:"@8UPC%V/^2%@PN_I M43Z^P0H?)%E;32?L"QUPYUA9ZAHZE[K3SN-Y88UCC,2^\,UM_/LGH9!+;&"N M:X=P5?R>%3Q9-S?]=AN`[H5ONTF[BUI$46A#'-DWS%KZN,ESN0NQ2X,7)C%D*&'9=Z&#M.&$0,QC3`WELC==7# MFNQO]&*$NAOCF+3*E^WJE7;X=5*SGB@Q9=HS4C5YM?RQ0^"W]#F0Z2M\T?7D MQ`31EI^/TS249V*C.N(S\K"Z1Q?'V"$AC!&"@"+B]3&!+[=H22O0A'.JC;HQ MITM5;)6=$S7LJ/K$I[29AN],^C7CY')P"E+;(&%>_3W/5]_3 M]1IGJP_UM2V[3>NHN"QY549IN5SGY:;@NRD;-P[L./0@@K9O(Q(X#-`P0,@! MH+Y&$<%*&S>HN=+K=5I)MK)V2JVM5&NG]73S+U)6'BE.,Z=D)M5J*+E\BE:M MW/_HY;0<6=@0N<".H4W\.@!!$2*P#^1B3-CK&"IW>[%4[VY(NBC; MTS!GH'HG0]P[P[V+)^8(=2S4[)P)I;33.-B=T+%%G#SUR)@W`V2R*=-FJ-7= M*BW;[;EL#U#0A(/0\^PH<@@)^Z`L1(X4?[0BF:90IT5M:SY-$P7Q,YE_DA`2 MMQJTFYS+D#L*(#8=V(&J8]!'(=Q'\0) MQ5Y"I7;D:7BCNB^?I$N"@#%FD"I03K/MWA,?WEY'*^G77)"A)O[U%;-*%HC= MHJ%Y5F[N>?$;3];5W3(I>+>/C!,YU`8(^,AW"8`,>;[?!X.>0T30H!?!,"+H M;U1VYRA-QP1N;4UBEAPN>DG63M/$ODG<[9K$/[5[7FH^BMWZ.I3VH1M@VC;- MX3:8?A+YF"U'AKJD2+(57]4(ZG<,C'QL,QM`)PHQ@`%B!/5!:`B%W@^H=F3# ME"7T-R5:R#LD0%>CYLA1M9-BJ5Z%Y/V1H*A1G]3H*>>7?IWF(ELIVS(&2 MZN+S,5J$#!4O'[_<)<5]LN2;*ETFZ[*+%3*;N)B&/O&:9RHI\:.AWPN"6&B/ M0:T`AAEY^:B$`&6[!$@YA5-RP*Q->B9I6M,D\#F%>6H453)1#*8'DC[$5%V/ MYH!6[1SR$1N-#&BO'O@RK;NY/ZZ6*:_S'&+YCL\\EX8>")QF5RL8#%U=BF*A MMW=H!3`]*]C+LGI=2@Q1MD\`O%,X)SE=>&+3),`[A7EJX%4R40R\!Y(^!%Y= MC^8`7NT<\A$;C0QXVXT%AY?D4N8RFR$?U6#W(DB)UQ\?!9XG#%N9@QH&['8G M4!4\2#DCP%%3ILBQ%1?- M7J09_U#Q^W+AV\`&GN^%`0[/#CR'UG=>]F6J86GJL0OR_&;].LW5+[>OO.<45^O&V4'#1&=4>-%"=" M@P`/A,V9&03$=1^H?,G$Y9_76_Y[DQ;][JQ?VJ):,-SGG63I^U)U`17YI& MRW%L.H=5@:9LLE&R'?5-`''C^#XSUHV4U`'HC6F9-/V^%DE6KML;!/M1L1," M6!/7#KR84L>U/30\>,EP*/4,MF8HPQVTXE0SZ%%FG:JL])F0+77C1+`F:;#,^.8;C8'`#:*2?*S2(CZD#`'$HH"-X@19.$P;/7K7W6S M2'&VDIQ#>NO`\G-(O0;A0JK_0&CZZ.23)J)>S:P2Q'4?FC212UQB2^CFG99? MD\?7]F&AA#(*0N1Z'HWK?WS/)4%7%)M)CV2.ZU6D7CV\W5EW$T,7$=B&+L>]!$%/;!WT0!@@3 M7MXE?63#O=A=]?!2.L\:\2:ITFLC%^B6\$^3?/0 M!-=94NVGBQIGMH3VQ1J1SIN;EW/IEBEDF0/5+TD71TMOR1S>--`BD9(STBO!B6S]*`0AN!."2A'TPS:Y(:(9QW2&B9.:I39>-&/:&&-&(?.D!XX71QX5 MT/=F9@-(A00.#")5K1#NV,4W-WQ9I=_X$/0RJ3C-F]O9FS2[_?S`B[8UE0O7 MB1#TPY!%N`X,;!_BN%<0>U#J16#;,ENX9BG0:RC>*(S((?UG?E[GZ6`:.!,SZ7*:R"PWWHQENJ7-6^&6^6W6O!>NCDUXQF_2JJS%K#>K]KW. MG:HO/$O65-WH*[Q<%AN^6D1^$*,(>C@(D0="'&'?[H7Y/A6:M9M. MC6'>[N?0EGN?Q7MKR&.?!D,J%MZ^0.7_N3NSYK:1)(]_%3S.1*AWZ\)1CW6@ M9KRKL;UM[T1L](."EF"9.Q3A)2F/]>T7!T%2$DG5S?)$=$3;[K8R\Y_`K[(. M9`W!9-MH3,J_.+G4J*V32Z,9M/_5,VA0\">72;L)PIF,SL]G=&:44;U9A0]1 M3\U"HB8LA5E+W(#;2[T;%C=9'_?M;9<`%A`00N<-\\]?38HJ'GQ/<]-8S0'R5I>I.J5/+E<\#V#'5_ M%V-;"GUF)A8C?8E,S:*$>N0*[3CRFN]KUC]G#_/E4!8=G)=KQ=T`.'KTYQ8>NU[?:HKWP8[II>(!76FZE> MLA!VEU5/3IW-5\^)283"P<([M54;1$;M'=S5<$%79W7VL_VRF-^/,VC:"4
W<\-(9D^ZBJIGM MZX97SWIOUUA%[!U$RF%Y1+W(%J?SXUAM:MF\]7?9XO'9BV;U?S' MK-\W6?/Q4[5/WYIF<]V+VSG`G_;_0[^7TG_H\;FSQ9_^VMS=SY?WLEG/[\=Q M9#SGC#&0JJI$WG_]P8J:,"A8_^TS9RH'R*B]W`7=##P2])%E8VC906Q7V3:Z M;`@OF^*[RKX\'?Q_V11CU@=I>>WT)9\!O6+\%TF_V6@6-_-!JOIP>3DS`4C@ M84ADKI""$FUR;ZKA"#@T;AX[1VS8>MULIO[T2!`F:HP`KXEDE2!$P,F>4LAH M8(!!%0S.$6\H7A,6GY#E#4F=%$^&@>QRM MYT?-AD'7VTVP^>Z&C*I290$ZN*D<`\0$$51.UJ`T;5AF:<3D[;'J4+9=S\\. M7'-"D(6.!@`**Z`-?LQT"\>>5\J\11Y[*5/BCD,4QZCC*HHV"`CJ'#(Z&962&MTLX68I<`7T;.:UGY*Y7#KAJ*P>C.*):L8D M-SV#T.FL5&<@Y4?B1%CE*9@VQ%-H3:Z=S0]?]W\X%&SLH>^_^+[=?/CZM?_M M_6R^7&]$NUC,.DC,%C="]`W-:(DE0B4B-<(UGGSC9:EU.UA4AZ)Q<)S''+Z\ M5]G[QK1[8IPDF;(RD?S8(O58:D;'L\[S;'0]V_J>[9V_&'#M]=;B0('F\Q"BBK;O]2.(_M;_&:!(@;K,1)93PVJ/*I]MO MS=WCHG.J_K_'SH^_-9MO[=V[93?/&3LBCUM2"'>F**H0E9"4`E2"%:-U3C%7 M1A]V>#(9>$28O,S:K]GH9S8ZFAUX:GD.P9?H>EB_@-YFT/8D=1`VZXEWAKR> MU4^$J[ZC:H,^LIZ9^/I/F^;][*$9FM`5$`&,`1,405265(%BYQ/'V"LIG1P) M?O!W\O(JZWVR:U09-A5^^!DM"V94-4[`1?AY3CP'JGK)R2_"6C^Q&A+8H\#Z M_9I.V-RVWA.4%P3F)<8$UCF%>8'A9%60VJQ'DYNIZ&RU:\CI*J@>/R-JZ4K( MRS3F/"_0&0IZ4C81SOF*YF67))\BF1UT>M\%?N1LE2HYA!226D)95C4K)$63 M2:FD4=]@%SM1CESN??-QZM)648-S3Q'$M#G\9*-CN"-0QT5ZZQR4H[2)<,I+ M*,=.1'F1Q]_*W_YX0UD*R3`!'!5U"0M5E3G?S;.[7WM=_=,WF\8*X+7U\2F? M&?"T%!A&_"#+@5JZ7V9-\%KCS%6`5"3"QQ"1F:X/VHJG34_1KC>OK-Y4>2E* MWG<)J&$%R\X.D+MBLJ*U"2CM+`1F8N_4D;?1$'R6XNDQ+KQN9C@SEBP(LXZJ M<@9/;BHF0B+'(%J?#Y;S6M?V?EH."U`2(&NLZIRP*J]V.$,$&FTOV-H(S)B3 M8[[SZI:FA+;+6O[5,R.-A7"1UK/>HHVKEHGPQCF,-Y>N;&31OZ1Z-E]>M^OU MA^6A,5Z4LB!8%%WU)%4.<27$9*R04I@0Q\Y"8-[TK?EFBZ$!Y*+SK;_BH!G? MI(?Q39I;(\A243T`A1?3##^]/]F?>H_^W&MX.?X<%>8,?=R$3(0]CD&\O#'< M@R2&C2A[?M)5XN!N=2[-]ZRXJLB M\B2T'I[B:VRZ^S=TD]P"RU;G@#TDWY#N#-#\2I\(X#P'=;1+I%_)C%JNCQ7( M4>[NKIN'@BM`ZH)7DE2@@*20N[I/<&;T*9\OF_&*L]/U1?;'Y*[I$KPWY?68 M>`G1S:CH3^]@O<\U!#S#1M\I2(2.WL,ZTK_F]ZQ?I^&P][XI5BFA>E92CNL84(5ASNO.$=*]`WX'])B^8`'F9YP54N,2LRNM=_:PD(UZ9[,FGP*`>?,L> M]V77\.6?;R;[RH\G4%\@-4'HO8\C&_/XHGR^RKX,P?1W5J2&=;TP%(5J""BK&!)2Y@KLCN7#93"-\OFOO\AGV., M&&:N:6&)CEAZ%87]P-%O7C7Q1@[#=(4>.0*DZ%(C1Q_*+SER/,M!D)'#+LN_ M_,AA&;:WD<-%=NN18^_82T=O"@J*'")&%9,**0Q8M3MT1;@RNG'#H]G0:SKK MS?QA0,;7OJ'-CZ'=9/MU.JVP7^MQ'`-_?/^6+QN?FYX9T._[@I5%6(0A(F2\J[?V`- M*DCR$A`(,6'0[J,=VG^:8R&L'@-C:6H&/6#"T*3R9W>Q:)SW M3^\J4E"-FJU5GOWE^Q*>;OT@N M`(:H\X'#G,&&6"BHN"M9AN>K(2C]#/?LD/GS,\9^I+4@*]QI;4#J*/$ M>F1\4XA3Z/.G8`IL\QA-&^0Q,UTFWJ]2C[?7M0_?5\VW9KGNB+D_QOV^V7SX M^GGV4U`"FK."X9PJ"06MBNY?1"*BO709R'S`=UBME[/O\[' MNW<_/'9V-7P7WCI?-8^#DS0 M)(E=4_3`N=.C>SII,V-\Z(P%H;R3V&=8'R>)B1`_4K#M)=X3T]VP;A;2[)L3 M]^;;Y5"2]DV):X$E$5P0"3@0%1-`E9-151&C:X_<+,7Y]&/OE&7K=3YV3Y]S.EQ=9$R&[GYYE,BPJ]/.UK8%,4%YB04@55E7 M`!(""BPG8Q4`1EWC["Q$)I);OW)C^?10%%XY-P1=MCOY"UW.L,=-QT28XQC$ MT3Y.;I+8K(]]7LV6Z\50H+&[_WT3R<`4.IP+';B9[?VT;4WN2W+C%I[.J_'F>+^=>G^?)>S-;?U*+]YU^;N_MFZL\."HD$8Z7(!2]K MP#&ANUJ188$L21K.H8B<[3<3#ON(#&V6]J%TCV^V#R;KH\GZ<+(Q'@\\#IA6 M8UJGD5%[EA]-YJN<)4MU:_GUF!\^N^F-"!%B/CU>Q!+<;9?>+S[BYR$ M`KA?!9*(`M`-$XH2LCLR5I=&NV07Z!L#OR ME>2SX'@:+.YC$.6PF*\T&9PCB_YD)#)^75Z'-TZ?72@QH3Y9N,&=851!54)4 M,%X@J*IZYP8AY.9[YWQ[]VDS6VV,9R5>/#!AUTMGM3'&9]UO;YN^55UM/!?O[A1WWC"4ATR>UG($8?B*3]58B_KT&T%R:PBI!^!)PX?Q+NIX>#JI8_9 MGY;C&[^9_?RS(7N#ID:/PZEDQ8S)&AS>YNN5]QY4)!#E2-K!\<',:`N,FT6_2Y?`+]+/2,"=.JYZ^V9S(W MV1C.!8<-G]DP6,^)DO1$!I;+Q/[&NDW$!'B93.QM]SWSF8*$*HF4H*I&NP\8 M:07`S:;=S!;NLP9M@T;3@YUOAM7H[3.*S+?5Z&*L1O?C@\JU_WK^:E[>H9=]@P5;ZU9_XLME>KF(I%W.%AXCDNE M9C)JO]G[7:]WR_5F]3AV[%K>]<>CY\M[=MO]IZ%CN9RO;[N1_7%UT&Y0E23/ MJZ(&>2$E(RQ')!>4L+HF&!2Y,EDK#>I(X,72O>_9@?-#"]"M^]G>_VP?0/:' M?4/RL(G3JYZ2R9E9514X74'X[2+U&9A'R6`B9(\3:WN!5\2:^>N/[6)^^[2W M2$&E`*B0K&I*:U`"3NC68C?*2*,S=0YFHO%Z?96-OF5_;/_M@\CFLIKR-JBB MMC2U%#,P+U]*I45#:WV38YU])"=)YBB.?G.'_^XW!YPWD,:U*AB&L*%$"%?UJ M.IO<`9@8G7X)Y4/@XN#P+H?7K^-5-C@_3!:V[ON\7,ISMO0XF$*BS#`9-D>! M;ZPR$OD,;$.G+1$6!P_SY"U8(675)OF1=<'W[>;`+NJ_VQ+=`,(!Y0)Q5B#1 M%5\<0-;)#84)LIV-!6;SF9VPK'?494'-76@]VD;5V`RKGN0-PL^W9#L#2F^* M)T)$?_&T@1Y-0\:IV7SU]_[RXOTBV/[6$%C0$E05+"LH`,NEI`1#V@&5(LB* M0K>QL).-<*]<[U8V^'6PT&QUZ8V?U^R<3&=>,2_J)O)Z^8FE#?#XV;Y6U_/9 ME_EB6&;^6S/K;=]]6/[>7T:\ZNJ;OJQ9__>R_;)N5C_ZFN;=\OOCIOO/G5S= MWQH.9HUMVFM&"B2K@D,"<`&[UU_4DY^@$$:WK$=W+G!ILG^1K[*#D+(IIO[+ MV5U4PP1E?94=!I8-D67/0[.\.B-^Y@TAG&+2;<$=-]]AJ>\I+SHC1>Q'(+71 M)7K\IT:DRR1">Q2[;I?W'8\?9/-E\[G[JT,[_KQ@M8*"05$)1(4LRW)GBQ1Y M93(261D(/)KT/OW6.Y7U7EUEO5]VMW;8R:>'\^#*F2'92K0@/#TFS!DF.NF8 M"-?<8F@]/EB.?-DVX^]^8%7"HL"`,BA17M&<3M8J2;D+831-7(0Q=A=QV(IH MQYD`^OD@S66NXS@NC@%M#-5,E#>F4;Q!'"M1S&?F_&GWR[_.FU7W`[X]73<_ M.@V'2X=RP7"E1%VB$@"%@2C@9!U!8;2T[\EDQ%GTSCN[PL>7QH8SVWCRVL]7 M]94-.]L\JY7.'-*/V(D0S7=4I^9[/D4S)]YVBCF<@WWMQQ:[H+\7/&<2P[(" M.UJ,L^2&W(PNMK6^RXF0H?EH8YF.ECTJGUJ M=/0;W"E(!I#0G)7#4MMZ8#/<-NG%JJSJ,E<=IB7">0$1*R>34&)J148+.Q'K MP-&[JVSP+X.V7<>=5#6$7V!![2L_2YR%N=YUA^8(H#J7$`,J"HE`)4LT^/WJ&$,8.NGB9A/G#;"W`&:C8R)<(B*]=??EQF';Y!=X\OFWVOD1VS M;E@%00TK#$!9X0)(PJO=5C;*<\/6'G8V`A.A=^N@I<]5=O3K"N.V'I9ZZG$C MAI1F#'%5,5`_CZ,RG2&-J[")4,G[1MM5'*`EIZ-+/+OVLF^+=0\+C];@+(O_9 M82.Y9R"9D2@]972Z[:60/.WQ\MVR8WBSWM0_OS?+=;-=%.="Y74W%H,:YYSE MD-6XF(R)$AG=1VYG(?`H-#F5;;VRW3JSE$]O>`BOG!G)+40+PNVCNIQ!K)N. MB=#0,8C6YZ/ELR;?KTRR4H&BXEP5-1402T)J,5DO`#8Z?>[)9`JUL/WFDR_= M/12S820/4(A>;K='3S_;2M(\`8EPSW=4)A6WBV_ MMJN'89U@U\0I+TM)!):8(@1AV57LA`^&D:0,Y_`-:O@S%+!BV[HW=%8=']C>7F_>RAN2ERH')<4W_W;?_OCW+LJ^6"/]+WK2 MD(,:[90"1]#B+-:%2>+N?^OIJ3'FA.@(M9HMWBWOFI__V3S=='-KRLJ\A(!4 M#'*$%"XG0XIS0U"8_O0XI-AZE0UN99U?QJPP5DT7%B$%LZ*%@5;>>/%"A+/` ML!4L&6)8!_`*&6Y2:#%C>Q6WFJ]O9XO_:6:K>GDGNRG;C:CSO%!544`%`"]J M(C'8\0E@K6]CG`P$)L?6KVQT+.L]ZXKTNZSWS8`>]OJ]#9`HTIDQQ$XU#QPY MI<4)E#A+EP!-W&-H/3Y+QG6(FB^:E>A,W+>KIQO&L!2TR+M_=Q,BKB3S^,_6'79*)<`) M)_=?U1PN,FC185I%Z;OTWSP@?4G$78_/=9[/GIE,WNP5$W_W0\GF"4$M+7R MR(-G(KP!!CO!$B*$90!'4.$BA1$S]I,2U?W)^H;7#+":UES0BD(F(:!P,E4I MJM4CS>7GQ^+&X21Z\,R"',;:Z;,CI&R6]#!0S",_7@CQ!D%L94N((=8A'*&( MFQP6'!FQ-1IC``A>P0(*60JE2EBR?#)&45W:D<3$0F26;(=7-YH8*6C*DU#B M_3]UY]8<*:[D\:]"Q&[L)<(](4!(L/O$19SHB-[IWNX^YSSL@P-789N9,OA` MN:=]/OU*4%!ENPHKA01,S*7=MHO,_`%_)2*5FJ8H_M3N'-YZ=]L\_*;5'>75/&PC!Q:(003AW^E4_2WBICCO1-K\'43-44K8M6 MZ^.5U7EIG;@)+ZZ8A%?V5<=L9)7>?*A#U5>%,0)HO"1#!]D5Z)'.:-X6:^B# M)+_>J5_U_OFV*Z@/R^V9,ONA.#7%@4Q'KNNYV+??G5DT M9=;N6*48SP>[KK4V$C)PI2 M)XII0K&?V@'Q@MZ*X\6@KDC`0QO.-H[WIEI_(B@HH+;I9Z0J77U3@44"9`-R'YRZ`[\=>/)\<$QM7T%%AD#U,`8/*"*RJ,Q*R"D-&251HK'G;*\D*6A'T<."1//21(G#%AO$),4 MU,!*W8KIA.3@F&AC/[BFNGO?!):24C,+1C6Y@1(TU$K@`J`Q!9H,=2TJ-#V0 M-PO[]:"!)SN?AK8Q*26^1[DUVTVB@%&$F==;"@($VI-*X?#S/1!]4FY2I4(- MF-N8`:;\="3%RFQ^\TFBG=0$?&O1E`D17$IK5&%(J\BO^?[8:^2:B9H3EP5> MBDF#.6$7K#5`O@'SDI,(<&IA*""HO&QR%^WU= MW#SMVS9'^\KZDHEE43/KQ@L\(Y*AAG$E:J'H?*7C2@)JQ%A[(N[`Y]OOV<^N MSH1_O\ZS)D_R[L_C9'#H$MOQL1^0-$F]E%+7[CV+>58$$989W#&L1F.-QG;B M/OPOH$K-<8;DI&UE)P>FA^\V@+NRA&16MQ:/8KE78],9CXCJC"=P)4H\9\35 M8G>+)LU/JSHO[LINO?3F^7N=E0UW0[1X*K?MW[KF\WU/T[`NFJ*\2Y[$UG%= M*'U@U\AUB(/34(<)OP)N7>=!`[1,2C,Z:_A4>,0BK4YQ&+MC^Y;V?:W MIV;?MI/5-';,>J:G#2YK/]4]D5^G$4,T]!%CL4T"%"$4Q;V_GD=#'6.G<2<-#YCQ/?]; M;G$5O!5;_/UHM_CC1&<=P[.RQNH"/!T(KZQ#F.N8"S-UPA1&Q]FND94/B?-QD!P'9SXQDP>_ M\$=6[(0#MU7=9+O\F]A:O-UN/!R>8F3<3GPG3E/L8#_Q/,8]]M@PW>GXL9;G MQ[E\76@H+$I^T;1!6,T0F8'Q;[93/FT87./9UCX:#D%^X%%^$&%:QSBM8Z!_ MPE%1T_E3&!SGOG)6/D;.CD-RJ%SF-$F/F&<\'IY0L1VGB"21@YT`V0R["1HF M>A/'MZ_WU3[;R8UV4^R`1JK!)?F1ZH5T*;VSGT11;@"9"R!,_"7?7%VM0\1' M&(X(L`[R*Q%/+:%4^B],N&@]%-VKAW9)6+GGCQ]YN>&BFA3-9E,`AREU`C^$9>V:39M.PH_>MI/U+_RU_D]]1SC=9T!: M`Y>"#Y;%$>Y'7R5/@2DQ!,`^3=$?!6:R MN9=)7-#T"D;*4/[T"LAHBJ0*;R5Z,B&`-XG.-!32ZC&Z\?G7?+/+FJ9=-)?R M:$^WQHT_?BSW5?-::V']EA&*7,HQ%A*.6)U\%?X@4( M(D*+.6E8RXYQ61]/RQQ.*\1.P[/$)?=R:^SXHU7P$`^32E?6$&7_8J#-+X#R MN-Q%(:>R?XKK`2;6*[@4C.B_J5,U,HPL?G6L9#1:GD.ULML6.#:RK"Z+\J[Y MDM=M:[R3B04/1U[LXMBAC"2>G;B,Q0'&3NRE@4M!RZ;4K1@>G7K'1%5RU_EQ MRESH!)AR@\(\'&&JKHS0B!9?)#0BIM.IKD0--012Z;[@H/..3S=-_H\GKIKL MAY#.HT&/$$86^C1TW2"QG=9HX'AQZKZW`8<>(^;NI,$OZ]2QY98> MCW(:N:'T\%W)3:4IF,K$)0B>EKO9GWNC&?/$(G(BGEN$C(8IBV,2].:(&X,& M>E4;AH?YES>4^@BOC%!V#LH\/>@4TLU^)543%^",3MI,P[D2"9HPU=O+>VM8)7?#/;[I[G&UCL/+ MIA.R<>`R8\#B)WMMX\CR0"Z-1 M/*XN-7F>L.^$-,/U2I0;4'W/`%*7GRAJP'>KP_U)7C=HN MVAJTYP4?&=E1`[HVQ5&,XI+83($"UYF_5_7O'\LO=;7)F^;:HXGO1K:=$GYT MDF(6X:"W1J,0M->,H@G#.B.<$:U*'CMW5(4&B`TH-.:(*0M-S^W@U,)*\P*0 MC-*H$5V;TBA&<4EIID"!*\W7[(__R?@=6V2[YCH.0A00EH3\'XJCV'92?TB? M4`R:I%*S8%AGN"_60^^,JLK`D`%%QA@M98T1S`:7%E:84SHR`J-$H MR)7U1`H24$9T\U%6C_G7A9PRD-$("*JU20/(]TN*``<`W['N\VW:]]W]4C5% MVV6KG[1A?LH23%'@$AK:Q,781K&?IM2)0Q2YX-W8IM@R6"$[[,]6W5J#@U;O MX7*3E#+1=JMZ_7EMXO@?[!]/Q8]L MUS:/V\=978MV_&WAR+4;$)R&8HO#*"K[CN>TTH,G3=*22^=2L-($IUM@>%5>'_0_GGDM^%]A8*J8- M]DI$36-`KQ,VS:CDQ6RSJ9ZX=G[--WG1EN[^FN][F\@C*,'(P\2U,65.D-*P MMQG:%%3>-\F0Z0>^@V]6/3C7[@=T==AW%MKC;1I4226;BR=0Q'J47T]0_BI0 M+J1?(YC&I$L'W;6HEI987@N6/D!J+]4)22.$O)1G=K$?841CG/8V/!*HE03* M''B&=.K=U^FK>6TL"VLEMX*:[V.OC6$``#TJ;G-^+VV_9S^[N9R3NRM$CA1NG]5V(+)*OS:]@523PD=[NFA[M=]4?&[Z"E1ND1>"-*I`/Y2H1)2RAO^EOH MPB,M6U_J_#$KMNSG8UXV>5ANVSWI.NN]:3<.,:6,ZV5*6.RA,/)Q;QH[%"1? M.NR9?@O?N6CEG8_=;CQ5NV/EX>'"RE3>-VE!+2=MR[?;$;37 MNV4T38+:B+;I9+X2C=,:4F7N$E5Z+=X;P5Q3D\AF'L$1PRR.&(HZ([83,3>" MU/K"C@S2,=5BWTF2!20%>4-N`I+*"_+%ICDD946-UDH$1-'YL^_&U1``$J'J M,:_WSU_X-;+G4CT>-MJ]C@/*'QH39D\?:F55PLC,%IVR6,Q-):'K3N75EM8ZU+-F1Y?RK"\8XC28T M&O"N1(CTQ/(FA=$&2*X:6BSD_J/8[;@MT1?TMBB+??ZI^)'SO^[Y)5C<[/+F M.B0A3@+?)7&$`HQMEY*DM^S:J=/'E**P9G/^R$MV(CF(.[L#1( M)_1Q25N(-TS8!M3<0>OHH=6Z:)WXN`!>0''V_)C5ZK6/7;4W?;%4]B!>X5SQ MJUA,!_*+W;K)=F(:T&KN\WQO;?EO7XD?W:G<%;]8UG"*^=,9=TW4Z+1F7GGP MC@-_W!>;>ZLX?+3;N$;LO'3XL'CNXS%L?WMJQ%9-MU7-W7P6/ZWWQ3^["N_UK>CP]J/M\,:_P].;`P(KVW`1[^:NK:KD/ZTM[A8/ M\ZDIVA[,F^KAIB@[)_=U5C;91GPMX'U\E_`1ZUFJW)6W'^E@WF>"GV@V\5N^ MV;?''NX_/@@5U59\^B8O^3?WUG_L[IU/[/N MZNKIL?WR\&G!OOM<5G;?[`YX6$/&/W^.[57KO/AU_N]65`SN\JP1R539V16G M^WBJ?['8S^SA46SM^)`]BQ++0EM?R(UAU<7[8B/VI1=GA=]_[:JGYI>IBR2D-.=,+F9`L-:PE$)S1)4Q=8?V M9#UG;9C*OW8"%%'?3WUN+@C\.'(]-N2$!,-:1D\S93@K^WP0BE=BIO(D.96I MW+/DC#AA25?GV(?7.=;IJ\&Y&Y&.HAIYH-3$>"6/E+JB>=V_4RJ%D^ZA MW.RO',EA^LV)'0=AAZLFBAS/#KVXK13B#@0(!;`&@OJL&I8S[LF'CXMW25PR5LD)J'R>A7(H`&`GNO'D(3.FE9/'DG>6*,^FY* M0I?&8F6>SW#`:-P;<^(85`^A9F&6[*T\$3VEMX>*].04S3PXF'J]+&!83+'. M8AE1IVD85Z)$$X.H=%Y92K4(IW8B.TUIBL(P\1$A84)2TMNA2-2*0LL1``>? MI2)ALJ[`F4$*$PSA4JM-6$Q'`!*BC&TEZJ'N_]DZ!6400,VX3@GB6N39+O,= M&SEI$"5>WR,`1Y3!E>+=0\ZB#Q.:>;S/!*($6G&HW/^+W//OWNG26%9U?\M[ M??:N!@8M?2^?/-&$Y?;;OMK\?E_M.)%&5!/LGX>.(*GK^HP%R!6[&W(7@L#% M1_L,M'I*FU'#SR$G?K:O9MJ-Y0^>_KO5^0K4"7V\Y91D$=0PK7E-N7-LN<9! MLLA&A$H[]95(F?ZX*L.7J^+B]B_9LW@CW==\VK;GNT'D,6;3T,9)%,3MPY?K MIR[%*4C\%$T8EKIA%?9CYY;B^G4H-\ETR#PR8'K4TSIXM/1:]9=@QC*H:217 M(D-3H[BP,GT2%/G^SO=5O?^>UP]15=?5'T5YUUR[=A+$_/$,V?S0?H3BD-J# MJ<0#U7>K'-^PN+0N?>`??+#$;O)`;5$")BJG?!L_-?OJ(:^_U-5=G3TTUV&* M*(H0H]B.B)=0CWEHL$4#)+V&1-6`^<\B&=\:FTB MTI7DF!H">3O!I@4-5(`^MA72W\73X-#&BJ`@<%P4.R[U0I_C84YO$,?45A`@ M!2LS"="$"O$)!$$*9!B>F@)U3EFM5PM+T%L^[TO0!*;KDJ`I@9R7H,EH5%:T MG-$]W_4("6(<^(B(+MTHI*PW&D5II+B*1<&282DRU)-3!:F<+LU'$Z9-+U:G MO$B1%NR5/0IK1*CT0%Z)6&D*YO+:D\F(Y*O!JO).O,40KY\&4]3'-O$PCCR; MV@B[;F+WIF+/!V5,*L>?2:!$$X)#;X<=]U+Y;:420CEI,DT/)DB?!DK"GT&! MQ+[W[V[I8J9NZRV>L1*M"3!7(CR30GA=>#49ATK)Z?`8&#H.#L($41]%,8M< MFX2])3L,$D@IN<+A01(SM1&F^JR0"CA)93'+#"@LR\__@)*9"?#6(B03(KA< MP*D&0RE7.5GS$@7,9S1Q4(0I3X2B*/1;T?(I&>7%F[ MMG71RS1F0M("80G/6PQAG):ZL)_B?99X,;:J)$9J]=M$N&M1H(E1C&0SRE`F M3O6"M6A?$JA*::"Z$GW2$I1($2%X%LD0O0D3 M28LI#U1TIE%Z5<9)R@$[XLBJ)%1=Y'!-8.K724%6,YE9#3!FE*ZU,$>='HI]VW0] M++=Q5>Z+\BXO-]QD4C2;7=4\U?G0AY+AX@G".WG)G3LI*;TE!PU1Q7-GRCV6XFI6TJ M(G8RSJ\#[-E>%"$WLDE`'(]X7KNB+;(=EB8!N?Z1US<58&M9L`7(;7KJC/2- M.CAE-:)Y$4^$_Q7]@A"RQ989W3J@*\M&UD.QVXGRE^ZWK.QI?U_58LL.^":S M<,QR*8)IOK!4X0BV=>>JW1R;L_S8-$]CU$SM'/L:S8BD30&Y$N&:%,+;G6`G MX@!E%U5Y8H-NE6>7``D"W#>`!&93FYFDDFR=AWEP*39M:\<6 M?20Y$Y]/OR`E4K1LT6A<*,Y+*LZ%W?T#^&?CUO"D0'#&9O(3%"Y,>_949R`\ MQU#>2:2L^,U$T^KJN[YG*I']7N(,3'>M,4 MLO]T\VWQ\Y(RE!-&%"D80D2*0L2TU[PL+V%:Y-MZ<*D:.+R_L>YJZ/)^#7OZ M4T`0BB.O7ZCVF,G;&2R\U^>(`F(T?K>_5-O% M1VD54;$>1O%4I3G*,LGXSG(B2RY`-<4\F`L$=%Y&%5[%X%9@P^@9GG$Q"QA MF46/L?,N^K>A+NX=_/>)5?!]9"/"YY'W3+3.9T1UL,X)+8OXJM;K) ME&=9GBM,M=VBLR2U>"X;*(K#&-Y M^6VYJM?Z^1_V[]BEU/*%TC)&4O$X;^[HHJ2QPZ22C:I!TB/PPP,G0\TBN;NN MP)&9J4I06@$TY8CFAW=I!A&98VHC$F,->"8"8^]_[:FG.>%;'$!,*K=$XA+D^1(FQ?7;E0VUVY, MU4*V>=79&\==-R^B/HAH'\5,I=0/?E".%[1]9R+;4T?];BXY`71O]RQ=DA+E MI"FOVQR*+;'2@^G!?B:"+;<:VAF;>O]ANX?(@\R[4S83\$D!PZ3Y[=N49G:% MDMD61S>T,U%%?_$`KTH"@C)6,K&K%?RU*16\+Q9^V,6UZ;=Q848((REC5$I1 M8I2@P05-,@:5#?)D,O"H^^O3X^-]U59EOH\&_C4EA?811&T(.N^YJ=RRDF*43:IO,JL`YZ2:Z@6CEA MFYH)ZSR;$Z;"AY;L6JPM3G$Q:+.F98=^O]]\0>39&^T1+9^^16GS:;CY6/ZI[_%OU\+U:7PJ>*:YRH2A20F",>$P[DTF!0<6/7.Q, M*/L[[RZBUK\(1W_L7+06=1NJ0)D.#-16>&U8AE78UZ!,--,![]Q4T"644[KF MC&?2Y/?C'I:SV:>!#>!1&TD MY\B$`0T\738;).J=U_^X==_P8Q*H4<8_%N=O#]>/P=^H*:[K MJZ=V#W:SNWK&3?+"S_,WS=&GN.'3?F#C'&?MY]6*V!N?S[#DS_QY#!Q].#`'Z>7%P8Z7*[X/B&S<4DUZHZRW$B4ND4AES),8LX+3 M07:M,(%(@[NUP'JQ<_"_@$+A`:*9>DS+#R8I758S6*,K9W"=P+O(1A3('^Z9 MR)+'@([+:WI&!=CI]:/:[.XH>,/Z95ZJLDR+7#*<84HSRIGHK+($8=A>+R=3 MP7=[==Y%FV:BQ.9^(%>89BHV(4>8A`T<.Z%CDV_R&B,UNLW+"^*9R):O:%YM M]?((R7R]JUY7R]O5[L+RJ^?F5I5&'UL!?;.7#XWW]W&B]J%;5S?)MR>=EGB048Y$4I4KS/(M%GZ.2E!OMC)K, MF=#BVX00+?H8HK]T$-$^BNA1AQ%5?1S1]WT@H#6$*5K,9(5G9HT%E.RVG0[N M1_\8ME,3070((>IB@.KXF5H/LB@TLU:T7">:I#4-%XW9Q?GLNDLLUDLC'3F0PJ/`1B.GD,1&-3U'5LRCHC>9Q165)18L*E M*!3KSV8HF8,."GLR&7J]_.`E=!',%U/#=?3I<0)7V`\.SFY-S`S>V-*\7_HS M$3;?49VN^^H/FO6T\V)SI^[KO_Z[NKZM.L^>^6&VYI+33$G$1:I)YAAA+!'K MI1+[4!1SSSW_!Y1 MP.2SM\:9B9Z&B^^=Z6?/(#VEE9>%PH5DK)`H0R*/*:(9Z:S&JLPL;PJP,37) MV'9P3X#77/)]D#YR2*\,@5*X7"U65\MF>F!W2NNF_X/WT\I9Y9+6.:0Q_9EH MG:]H0#DC$))%I<=FB\1*@WW>:>OVJ'I7'#-,DT1(@6*2BIB7#*&4T#@EJBA+ M4([HS6C@W'!8MJ_W]&*?MFQ]UEQTA6^F@F?A#M-#C\@#5S\<1SBBAMY;82:Z MZ#^ND^4(O8(SOU7E:;-<59M-43]\UU_I9K'O<%U!09@@%*,TCW..5)XDA!<\ M5BDJ]#`?F[ZB3C;"O9:=6]'0KS->W#%":>3-\P)W)F^;GUB.K^;P!\@B`^FL M\ZM_/BTWR]:Z>![\M"NC5"1<((Y2G0%EG*`$DT)T?B0*=BNP=^,39B3].SET M^2+Z_CS\`\N2=OX;!9JAG*$][#,53TT1.&,Q0VJ4N7ANG9EH:KCX3F8R04": MKQ0L5\MM]7'YH[K^L-KJWKW4QG9+M.+YM\7_U>OB?J&=^[G<7$HD"Y9D&8L9 M)3QA"I>T["CSZ%6_]C5J'=4:D70973?+9 M"H:+!6=J`/#DF$?V8=8(S$&.+0\$:(Z9:&J0T(X7!8+A\Z&D!P=^7SQ49?VP M6*XNDX1F"J%FE$J))#S'6'5N*%6`#BOZMGU61;UX\4XW7D=_[/SV**MV3>(L MK<%;PZ>\6C7$U!K[%E$[G75JF_EKK5MXYGKK`:.QYGY;+ZZKA\7ZS\V^;&F* MI\J4-/S-=:>X]LJQK#D9F) M7E!6,%4#00JB5\_]I3!X)>K_FTV=8/U;J]>+@9;-\M'SN3 M92Z*-*6RX")6)>5,TKPS6:"L`%VQZ6`GXM9C#%+ MBCSF)&/:,BD3V5E,E0)5AW`P$UB=#IY%!]=LQM,=,E')+7W/@?>[7I5K39-=>YC@TH;$U(J4B)<I#7&>2(@^[V MM;<26)-ZQSQ(D@-*,T6:AB),D"P!!MK%>H+/Z`965Z8S42,/@;S:MNH'C5GE M%RU]F_I^>;7<+CIS>VNR*!"E6*1E'"N4:-G+NQ52&B?$:$+=T43XS.B7O6=1 M[QI4AEPICFO0A`#!&='YV0$JG$S#T*YNB2U+LTHD)R-_0YX]H9I#U1`/4=1> M^X_U7#Q?7;<_-//__6`YE7&>*8Y04:@R%CPE_6"9X`QT#:&;I<`:/9A\;L[S MM#^V:V<>9NRMP$*G[T,SM9[+A^,,/+?_!BFCB7X7PC/)(CT%"^,F!E5`($_-;`>[7RQ2G1@<`SRPF!<8)HR M&1)`NA<,C5V&9XS(+*4;1GE9V5PW5#]6U]^JJ[M5 M?5_?/G]9WM[U8W6"RHPII6A:HH3).,FS/BLLJ9GX^;(56!)[]Z*#?]'.0=L< MS9FN698V)5B8IKHQ#9*HO0-K)%7SA7DFR9JW<.HPO1&2L'U>U]=/5UM5KQ^> M]DNR>VM)G%*&XA3G&.=Z5)MQVF\7D24W.I[N:"*P;NT=BX:>664Q#A`-LKQI M^,'D:0[H`-G@-`CM4D-+E&:)XLG`3V6-[J3FD$)ZB*+VVGW`>^IVQ9C:\Q4Q MSY'0S\>*%R0E18QY=[Z"TCP#U0D!/3CXKKE]K3*K(UXP1&;I8#`Z,'$U!A-H MW]L!PNA&-PM6,TG@['Q_M97-&L"[.M"53KSD]_=[.\MJL]_[CXHREXC'''.1 M(1$3E/9IH,3<:->:DX'`NJ!=B@X^0<\JN:$;UXG)J,'T`@QL1#*A77[?UU9_[`8I(L!29$$PI MEA5*JI+U`Q3"4E!I'_C30X\@6H>BUB/KTS9P9(:#B:"T@",*&*@PXXIC'F.# M"VMVD MRP19F@K041+XTP-+Y,`AVQDB"V)F&5A86#"MA'$*DG"]PC&2:=FCFTF*Y1!` M[:L7`97C\[I^K-;;Y\^ZXVSYZEK^\VGY.#@'EPA94B1CDE!*%664YMWI9*8S M.]".9U=;@56E<^\B:AULCU+U+MKJC#-?,]69$BU,@URI!E&E=W"-:)0OT#-1 M+&_AU&'Z([0`2[VZ_5:M'YJA:7<@3B*6*EY(G6\E@N="B%XW$N+?Q MC+QBCCQG\DZY1E%[[60>+SG9&4XQP8K'DNJACB"=7-/198EG/%$T*S(V2UR\8"UKA83<`).DA7HJ=U(]D3FL!W)P?O: M2[>PF3AZ*3M,PE@KD!A+SA?=BZKV+%U33[8H MRCB3G,4)RJ5$96<`*PI:W3=_:F!I:1VQ.Q0+(&.F&6&@P'3"C$<09>C#'U$# M.**9*("%X[5K[[!YT[O\):-*HE12'!>)'@&5I.S%I-ER#7[7#9\[S=MN=U05 MQ`?PQ@=`8_7.G^<`Z@#!>^\]$-2GA[V1/"8R M*PE*$ZK'*U@46FLZ(P5FH.L984\.K`![9VS'#$!*9BH0#A!,!\S9!%&"%QA& MM,`.UTS4P-+YVD>/@2K"XN?`"&.,)[D6&YDV*^>QR`Y+2#$K0;.5L">'5H2= M,]:*`*-DJ`C!``$5P9A-&$488AA3!"M</%<$!@;$BB*?-(%1!ML;016B5'D:3\H4D2`ED#T9 M:YEE0`:JYH+*\&KZQ?9I_5=]=__Y;K%^6.PS.*%2G:AAI'^)$\&+4H_C.DLE MP>;W4MD]/K""]4Y%.Z_L;E2W`S,.1!&@:`R4,R`5F&1VCEA))10,0",#`K(31P`H,U%\&>$I M-;3D,`<9M'6]=N\&$.'[]>O_=*=ZM:YF!^2,# MRYUV!/(^`U`8:%P8"C!YTSY8*1N`!$#4PA"QTS,S,F92UL=U2L7@@<]!P"R\ MKIU:&R);[6;JW?.[Y4TJ>,JP$DF94HH%5W$_Z,YB;E2PS/+1@65LM^_?YCVV MH&2@;&$!P13N)9NI(`%$+RPL._$#0S/3P5>AGM)#>R9ST$4'[VLO'0.4WE7W M5XO'0S%3MG0`D.#(M)NA>,"##E MV_EAE_;!J$!2OV!T+-,_8TJ&*>`POI-IH!6$.4B>I>>U(!3#C:[RP2_0@ M/"`I7B`NELF=(1_#G.X0V\ELSB+\.8B:E=^U8[M#!.WCT\-BW1F0I1`HSG.6 M(]U(@A:,R=Z`PD;'ZN!/#2QI.U^L7F88'`-U"\8%)F^3(0$(7#`T=@IGC,A, MXH;1G=(X*P)S$#D[QVO7QG??N?=1_\&';?6PN2Q*7L:BD%P1G1OF::K3QLXF M(['1C75>#`46P[+:`S&]^6CPWGZS-MWJ_ZZ]SHMK\NJXWFTN2*&U&T%PP7%`44\R[ MRJ&\1!14I-C96&#-^E9O%_?1H_[;N\6FBG1?V"QU1VJ_Y]`;GYRYFDG6I$AA MLM6Y%FWK;C-Q=/#N(FK]F_K*IW=PC@K(^^=N^:KZT%->/UW.H>_+A:;N_V%53\6 M]TTTER@F2J>).2;%@6*-ICIO?OA8B&HMI)Z MKV,%LIUI]M M6%EA=6/5WK&QC758R,G$F\,56I<$"1J]2C8D1LR)E'HW,H?CA%B]*@G'EW6R2Z5IC=4%.'574WG"MUQ/B<:S5)1P,S/@][6 MY6.Q6?=/WK"?;X\\=9_E(/9#C!+H(>J2P/50"B>3NFYFQ<3HK!IH=M<>V_@> M5".KW<&^G^?';)D^G=<:#,^G+M80K##BEQ.L;S>U2TW,>G/FCK*):5@EK>X* M[5L#24M-U"H,J1&#OZVKQ[(^/-\R'3KTZ[2/#VUVDD0D!$%"<0P`<"$F7CJ" M#["QW3[RB+4;>`>,Z6L#[6;1[7DQBE(VW3\+$S[CN M&1+^4LU6-.!86$.&8L]T7#8L1'_O,(C:=K,GC@+J9[R(_ MP#@$GNM&.!AW*Z#`V.XT8:":'>V$Q_RB@W@0ESZM:E&#$FP%5VA+H@QH-".I8)C<(S;]H#_T>5L\ M-]^1)S$E)`O2./!CBFF2),&X23R!%!C>&S8#^5*G9WL\YO=^S8FRL3U?"P78 M"LL;]GI-/FQ>,N5M1]8[XL60+KNQ2T'3ND(?54B._HU.]FMZH>RO:4KQTF.3/PR_OEBV<6X6T>A#Z)?2^)4>1[$`9)&HUKH]0/ M8N[W:PQB7&ATV<,1>?K%9.#.6Z1I>._.$(OWV0H$GA-Z)ZU![G$BTZV"[\TC M?2%X):VQ)>@VO,=D`PV577W15(*R_U[5!V;3#^ORVR$')$B1A[!/2>)Y*//2 M!F>_=RN!7&O.AB%J3D_^;,`X#1JG@6/*F`3#MG!VHB]B5B0G^W?9!@SE)OK: M@E6I"7>;6#XU^2D"2V0FFGJUN].%7- MZ`*&1+/ZVZQAR'"S^#*&=``-GPR>?/:IVMU_96D%:=(*B%%$(Y96>!'P2)+0 M@(Q;_[";Q/E367^KS!X6EL4N(LS3:G+K22+W MTYZ!4T,B(D-1^\SW8DP7L*[5LFX[O(L1<8NW-4#NUR@U^N?9OXM9\A.R MM$$*ALJ(*4[A(HQHP&+LAX!ZF,4:I\-J.XJ]U-B]BR(8-1M@=ZV''1.\0J%; MWO%T1TF0:Q14:F10-&NU+/BQF1G+E(0\P&V>"U(LP#0-/>`#'+DH&W;S MH!"CN3MA9(O5;!*O*]`$K-.C=5JX\PU$FGYI;UB">16R+T'Z4EK^!H5B,CTW M#O8J\.R:7197->09.[NY.NX/U4-9/];5?5T\[/,8QL"%*$A#@AAHE`(PX@9! M`$T>XA0&JUFCA].<`RYG`&;X1)]X4,]KN#4XWUW"7UQ-"S%[^%-K2['JJ(5$ MBS%V'O1E5)8X?C&W05S;08S9?&@^*CHS4/R/]Q6;W?Y3Q7#MO^SHC\-F=\_R MLN]-O_YRUVZ!(32+$2493K,8Q*SDA,9#P4'J"]V!.+\TS:E)"]#YT$'\S6$C MEY]1.M7=A?USNECF&RXN2[!8KC"?6SU/+5ZB[,RH4!W=E@P&%5;HY:N-BJGB M5KB/.Z8#Y?[PL3W)U#\OWDS149H&*0VC@`9>D(41]<%87@H@R'?E?3,P_E>*V)JA)?WXO6'$?6<97KO.0QGZ`4C^&;AJ$B4]Q-NPQ1C") M,Y$$2^B+->=2'98;IT,CJ"YB#/$IBC9RQ%2$EQ"GA43!+.O+\;`_%+LU&W#F84H#XGM,P<,($S]*?3A.HI$H M],13+9%O7RC?FD"22KJ$"!/)O'1Q)9=^<=&D,0>;E'\Q$9-ASA+%F5&!5U,R M>2KFY&6W)6M,NT-QSZ3KGU4S>34,&UO?D9FY(@26=N2\='108W.S1+Y7(^Q\!V/R&Z8U\5ZYSCW.4)%QS\ M*N):S[B8B[US@V6U]%NB?ZIK]7)8K8,T;E6\K:M56:[W&:MV4U+!*/E2_UEL M60I)F2`?GG/@`]^/@A`T]Q&[<1:#<#Q*Q<;\0NL>"HK3K(8#0J=I",Z`D;4R MIT'9#-,ZG((ZJ()G/@UR1I6VUBER!.GC M;ET^[#9WFU6[.[AX*C;;9D-P4_?A,/NJ>G@L=L_[?;G=,MW(71(E(`E(B&+H M0AI0-Z+CJDC@\[\+IZ-PS2KX`K(S8NXZ[H#:Z6'_Q][I@8L<$-$2E/,B:44\ MQ"3S_89"X.R-Z9#(G:71$!J^0S$2=+UB8-J9M^'0BM;Z50LU8<&D?IA*R3:[ MS:'\M'DJUQ]9V][=;\8S,/]=;NZ_'\HU?"KKXK[\Q[Z\.VX_;>[*'"<(1P0D M64@R""'V$@#&$\!^+'1O@58@FBUP///6@?]]VZ!W3O#[LW$WSE`#IZ^"T]7! M:2HA.$K0&SB^\8,U,1.S2E4+;F8(M1JV^01Y<:+% MA%<%QUK4E8>W,RJJE'9+U%)MG2J-[53F?IGBM!-BOSL^?"OKZNZQKM;'U6'_ MR%KO]V)?KO,$^2Y,@`^8V/I!G+A>F@P(9=QT0 M.R-DF;L^%(6`8Q+''/MB\OB^B)>X+F7Y`,R\^$1%(,3N+N&BZ*T)&CT\VS`U MHZEFK]T,HH.\.9=&WM;5$\-3[8KMQ]U=53^T?_N1&>BFV,+5JCKNNNU[S8S1 MMCR4[6S;ZYQ^:#'*#(H]@+`830 MR[(4)&$XP/<1H>9\41[SN_7)H3&,",@_%64`: M\&$6#;/-N+E5PYQ92\%]MSZ]*P_.NKPKZV;WV*'XH>+UU<7;B@E;UMY,;''D ML:)V/="J.'2+>?"L=G.5]CN/$:W.JR!88KMX5B?8=\6F?BJVQ[(8X>0^"0E% M(8ZI&](H)2#`PUV@&"2)+[Q]9V9Y2]G>!*;3X'1:H,X)J0'[KCP[T=2*^>:H!A1 MO:X"X]W$PQ5V5>T,E;AQVFHX0ST4O`"B,G[2ZFDJ="KD5674%GLVA)]O,9G6 M$4A[=5Q+;3F>&=%&LM@L\@02+O;?Z8_5=]9=RCRFS'22R$,44P]YK$1_G'U@ M0,1/?\H69$3%&X3.`%%F.E.:5H&9XB4852&NYLB4F!1>@M29L\$RY(I-`[]! MPJ7YW[GZ M6!UR'&<8>3`*W31*O!B!P",X]9(T]#'Q(>!^W&)&&1J[W@"K62ALT_86F?.O M`=OB?>X,3^EE2NKRRT,5R@@2[U=_KLI=46\J^&.SSY,DB\(H".,X M2GV*?)RXV5`8Q9'8,[)2)>C.%WHLK!,Q-,8ZT)02GIXC1:%M74:N$F_UE1F4 M<'>2S^6AZ9#M)M]UN4;/_]@W5_!]>2SKHLWYFW>?VXV[8W=%F+H>@2F!B>]Y M:>1'T=A=$8Y=D1ZDH7C-W6OB4LT[%,Z'K*I_"'/IA#BS9Z128Y@LT5&=-:P6:_/B"MR>G2@_ M5?M][J68I"EU`^(FGH_CE)4P%!+&89@_E?6W2D!>!;Y;I--.80CUW4V+9_E^ M>.+A?!>3X,N>WB,#_M>.(4T!_R,3IYG$SZQRK"-^9"G/_FOU1]E4=K,M?X+Q MM1+MJP&B(8#8B[+0\T&49<3WQVP)A$+[#(V#U9S13.KG'"J'M=+-4^DT]73N MFCQ']!T*TW3QOE5A&J>^'&E2M1NGKYS3UNZFB?!80:<1Y*Z*SH>FDK\U'[^; M[$IW!,\8A36-QQ+OL8>/E\]M6`-,S"%)^5B7JTV['8+]>5LV?X"[-7QHYJ?_ MK]N]$60AA`@E:>!Z"0I`E&;NF)&&)!)Q.24%:G:J*<;V9IMB`D[0IM00S&#?."+!E&'(QK$7>>5@[(]%*2;=$9M76J=+82D7GZIL]_JBY2!U7 M#X_E;M^7%D1Q2D#J(3;LCBF,8B\[#3^PT'MRDD7HGJUO4/W^K8'E3'&)+N9+ M\L>Y>JB?.L%U0V'6]"QVO,K+N=6.>41:HD)S:_%RO4,%*=Q*\T?)$K?CZG"L M63Z'J_UAWTA<!"Z`7(A^D($RC4>Q`C(16 M.E26JUF36*+\>SMDK*>8G56'3E"9E/+-)U>FJ!;3L)]0.BW,+N-J@#HGI`Z^ MQ+L6;1,@\8S@Z0B%)2JHI6J5_I8L/!#M;K?KQLA?BQ_T1Z/1)2IWY=WFD`-" MHI32&$4Q"8CO09^@99MLX.,M7P;(FF*:O.+T-+E31Q:]>7P_>R?F7R M;MB"-NZT80!BF@`/IGXNGGF MDSMKLZ(=&')XV;PC/BICX(E,JBA8I7N!FS)"GP>>H&' M@.OY893YP',#"$:\F&:!#2OO%T'JGO0[?CM4AV)KRJKE=4OPTGA%N#;&P1(IUU*S2WI!GRV5_JG_/]+W< M/#7W*^6!3R/BX3@*8R]T0Y2FP5@VCHF?[\I[-BI9RTJE1)%<_3;M^NT4'7]^ MUV-RZA'4;%V4H596$75QJE(+1X[_X.!X(0G\E3NQHF4I5W<)F!FBYH0B;)JIIP] ME3+&Q>9"\C7!(J1;,@1;*UA2E;FH5/(4*_OJ#IW4SB&U9,M*WD(\*U&_`:O3@S7X`J<(D4*B MJ"`>UNJCBKI=E$IE!/+=,?ZJ5M?'E,UNP+: MOR_N[^MVLJ]^G&M^:+^G'5/O_G'L/ M.C?KK]B7IK#9<#>ZAEI56MNZBKF*!L#4*-D8@J``LO^DE&84Q6XREIU2(O0` MDI("%S*J+4\^J9'6&?,6.AE5-771$J"['0J5"5Y2XD>C,./REE>:;X:298 MT9+3<$2JM&H*]W7^9+1P1A1LE\0Y5>-5QMGTS=EP^=,1AGXCT^?RD,<,`,GB M`'J(P#3$&9Y,F_@9F;O&+EVP]@7W%MG\?972Q,I*HEY&E>ZK?'FHJCD+W0UX M)UG"3;,=W[A0OL6JV#;+N:&Q5B;GU^SR-DLUY"G MR1)NK\Y)UTAX&[D@61H>B`AB@74T*))R"L???AC#AJB(4E M(JFC9M+O.PB2-UR?X4O4SM3Y3M+`B1( M[!L`DK=2E<2I.'OW81Y4BD7;JI%)ERCG)OOK%Z!(2G8D&@T"%+.5ASB.K3Y] M`)QN?#8A*8D$%A)-S`]S=VRCLLX8\XX7&(\JZ^R+ZC3U=7K`UBOKC&J)47(Z M52-8E=53#3&[RCH#S,*5UD8SS5MQK7BHI[SVR-16X$_+'\V-]B]54V1\6W0U MQXM:@MQ7(FS_9[4(!:,!CY*4!)P@$I(D9!T&GQ'0-7&KAIUOZ_3UUVMUUN1K M"_6J.;NRV@I[D7(Q^FMAU,]4Y("\<[(&U6,/NBJ.Q-]IUH M+(3)`75UTB`ST54WOE43].BQ6BKU7>;2NQ^?9*_>L7*5R>\^-2]6B31!6
>0W2JX;W[&W>IY'.LRQ"A'-\4\Q5-BUX]I9HVB(/+)ER+BMMWQ;% MJE8SVF93ZD0VO,!Y&K`D0Y@)0IC4[=B/^W6(G"*3#-26;<=)Z'Y;=]T!,Q1) M:T3#E/(2'!O*Y5VU]7[OP#:+U7^T6^JP91:GFJG)IX9PVFZ9F:FG=??.2*@; M&ATLI"X$XHCD.,!QD/HLSC$^7-CGDFH+NT\F9B^P^]1KJ?7=)R/>;2^76J7< M^3+I;-=&K:R):K?%3.33A6?&:Z!`\L:*9KXNE^7MZ5581$0:,9(A%%(<9>KH M0+\/QE(DP*7';0.`C&FC^N2G=Z!ZR-9WH$:UQBA)G:H9K$KKJ8:8W0[4`+-P MM;713/-672L>ZJFO/3(!Q>:>VASZ^NY]5=Y_*;:/:?%UMTC3(!4$)SE!`G.I M],*G_2IMCI+^&"BDP)RA+9/#G_`I?@]/[6IL)+Y_["1`;R41@BO*F9*J)YEN MB32L%==!4NR][]E+!]ES5!?N-#L#XC::T)E(V'@_?BKO9H48_17)HUG\L>V; MAVJ[ZXQ_6.[+S;TKO\A^4WRHRMU#?;U]7]3U@@822"80R2*>^GY``]2_(Q7E M.6R3W#48QVN6O-INJW]+;#)9W/;X_U`#M''AH&_-5CIT3=-Y4VDN)$Q3+\>1/4-!'.G0@.+9H,IDLUTJK>R9#\OZE>4@$U@003%-<9AG0@1I M;SE/$L-S22,,.C^/=--HF/?O]>[AH=BLFNW?HUEXT3Y]6/_'_D>J3?.2V&[Y MO7_9Z(?Y5KQQ,X!WWYWR/W[#_0#OTAKX)F5Z>^IC^9Z+"EKTZ/S.N1VRP#IX M?9>NU>IGN9)99![F),\XSO((11G-,M8?"44D1@:+C29FIEEG;/8/5ATH0_D" ML0?3*^N,C1,HJ4CIVV0YE:,C1C3TQX2_F0F.D0MG%,:<#J/9XI&P-<>`3NRI M+)*<^30)B.!93G.*`\Q[&")DU'3N:,/V).<8>V`C9H]6B(;/):?F>-2*WG&6 MU9UCA&W6.Y]J:O"I.?&TV3)ST4-7[@U,2NW3Z.!(SB(D"9=_:,ASS!*6^93U MAX)\@2,+YQA-S%[@'.-=/YYMGV,TXMWVH1NKE#L_;#/;$S963M9HM\5,Y-.% M9\8G:8#D:8MF=G=7W.ZN[[+O^R?T/\MIX779W'@L5^HO=8WGVW*C-'T1(1[) M:33S29SZ/N$B.)0YXCD!E1BR:MAQVKG'VBSIM6B]K7K\?_^UG.3M"W\#==,N M]7K*>3'68=IY(+P#ZBFDBNA&4M75P^:+([@3BR>$R0'Y=-(@,Q%0-[Y5$_1H MH(B>MO:IJ3OR^E6Y1>B3$`LN6!30*`M$CO+^[%$L$E#N:=7P!-GGNG]C<77\ MQN)M-Z:;+PJ=,3U!.^@IZL6:`*:H9V7SRMMC]4Z\?SFQI$*H')!4)RTR$TEU MXULU09>V(JE,ILO;[0^9&?]KN7DN%IA2D<5AG"9A'J`L"C+<)\4H"^AB7_OI M9K?<[L8H*M0N9!R_A@@?TJ]5\\K[6MRORU)-+F4*M3]>_G)B*+VO&:E9J'1.Q8A8_6#J"- ML5K([_[_'J6Z_/]2HU3;*:-1"J-,>Y3>/#\];8JFS.)&(5!W,=^5=]7VL2F[ MV%_78ED:1=(8)4$8RB\BD1Y>&H@2T#T$6S8=K_$T(_1IN5[]Y[:X+=;?BM5Q M-"O2.0E[MSJLG>@"+:YG\FFFC= MK4T2/+@7XH/,5H`]VK'`=ED;E MP#5"(`3I294S;F!ZU-/R:9`61\4]#A0,B(H14S-1#C/L/Y7F,";`[-).:^]S MFPHL1"22-$Y\BM(XS%C,?-[;%`DSOZ\#-3251G1)T)@+.F`2]71C,OY@.O+J M6DY'Y.J8B-H,,Q>6I.?B[MG=7`=X9!CD<0AYXC$W,])'O2K27X`.KW MU7.I7J_]5&W6M^NB7I8KOJS7=77W2?9KM3;^8BW83BO,X]`5C M,299EF;^FT69IP/B-/OL4D4:=K;%Z0KBG;[$+:_H%'*XN-3@,(L'U M,+`ORZ^;8I&0Q(\(%C'F*"+<3VG*&_MYBB,9HW2R8^M&'>?'`#GXJP%L(N)V MV-'R4=RRZ]>)\.2`.)M1 MZ+V<+KW;%8_UHED3(CSAN:"<)H&?BJC#0**`6XY$^H9G%(T4:*]![4`>`4UA M+2RY:05WH6DN#6`]1KEI"/=Q2JM!;`:KGJAQ`0O.]Z\3M`Q\@P@L+,<;R'R14-F/?SWU?:.U^ M6C'D.#CU\+P&G]<#]!1"R&D*.[1J!)XI&84%FKF1"0@B4Y)J%C1&D:L7(-X@ MX5Q`L,7='`*`-5\J!YT+(O!<6I/N5G=E56X+&5RD-.[/IZH)45U7F]4B"6*: M8N%3'`J>QVF$0JSL,I[%+(B%MLC;,.9ZSW@/4>5<$J37H?2.8'H*)T2@K'"L MH?A3TPO<(YXKLP#YGYIALQ`PGFF].*#!QKE88)/(.<0#J_Y4CGH<)"Y\/&6N M?<;PQP(%:8P8C2@6:<1S/T9ALUN3!B$-_"C6C@CCS#B.!6<&3_>:HVY]`1M\ M:JC_=%3"=']&+`*4?CHVS33>G%4];1_T_YRJVR%M#GINR9/*>H\RNMYR(SM7 M'=JTYZL[B%=[K[[&6X& M3AJ.97,F1PM'NW'REL=86O3?\5C*O.IS\:THGXN/Q6Z1A4%&@S3,N!RB.(P9 M94EG)B>)UGZ3I:<=$O,%DI*.L@=4V` M>3>0]1=+#Y*=I6A`9"SP.A.]L>')Z_?&;)&CK4+_W%9U_6E;W:UW"X:BC-`D M"QB/4(@R.6D@??Z3T!3RV#'D? MWN#$B6H<$3`@$R8TS407C*!7XWL)<.1?/Q7;I3KXD7U_*LJZJ/MY$,XH#4E$ M:*J,"HI]U"<\J6`I)/TPM^(X^^B!>46+#*@-(_C34XIIJ(/IQH&U#M3EUD/. M\C,@*^,YG8G(6'"DLMW=X*]@K)YOFTL[Y2I=2V/KK\_JGRH+JA?"ESHGIUN" MYPD5693&49_P))0SX#L88TPYEJ)C0/`',$9QJ*=$$]('DZ,#L&8R=`S-:[!- M_PK&`%$#NF2)X9F(DRUO?GX+PQY)VC+UN:@+^BT^%9LJB>U:-R*Y(+S M%`":@;8ZP`,*UD@V]?1J.B*AJ\!' M'!XAZY*IB=5JD*8!L;)#[TRTRI(SE8L>"-UH*C8;58>P7'U8;O\NCG*Y!4(Q MHB'.8A+&8?1M"FN0\U#6,P,6I!-5K4P[J0 M$ITG:&B[:CRK,]$@&YZ\WL2R18[^2G)1R@GD1EIDJ\=UJ=(S.9W\5G1F@S2E M?LHIR:/$YVF0DL,V6LP0ADC06%N.=>@8%'A*-YI'S77H"2D$KDWOD37"]!+; MA=3I#:J&5K$MD3P3G;+FSNO5;JLT069VNZV<4#:58\3#VAOLV:X=V:5L+%[9I?>*(-LD&D3-Q,%&>'`6QMB0"K@VK$_F/R^ MJNM%PGS!,,TYEA,T&D1QP'I3F,?(2#T`G^]8/PYC8H_)5#<@C`&5PQ%9IMK1 MWD/X70&:NM;W"4YT),2`P;F)B(D+YV3$F`Y](=D]%-N/55F]--E-HT1`*`T% M9W%(F(]RGJ"\/T*8Q=FB+.Z7NT*SG.](8UICAN['S#$N_:&C\'6)R957#AV\ M=\*FIMY,0*.9]#3\'2/K-:@%-[D,#5(UI$AV.)Z+.%GRYK5.V20)>)]0B:*J M<"$J]135LS3>JF95UKRXJ[;%466>#^NRVJYW/[J*7JQ:$VW&NUH[ZKXT_WOJH M;(]1O:]Y<`:ZCSH/R.ZD_D5NN2\H='#5._C:]8&]!][>!>_(AZNC0D2%_%?V M?;==2D%95N2L54J32[23.S3ZH['FZR&W:25IV(#+-L7_-),S-DIJ3 M-XEGAM&P7F4;Z'E1%NK6`<$)S_TD#7&2,BK"D(1^'^_C%%2&SM2&XZV00P6Z M;II@6L`2RATD^+BES2A0J#)S+2;O]Q;5U).!,^2\J;7F=,Y*%T>X<:[FY2A: MM/7F8[$[7@B)4!RC,,3(YWG`@HCC_FY3P"-02@[[9,=)LWH)8?W&TJ:31F0DG$\SD121CI1V>Q:(R4F76^>=\5J0;,PD'$[]Y%( M<8+RB'?'IA)&`I2-$1E=&XYEIH5A7VBT.323&A?TC1>;%M6%Y:9%`1`<*)LS ME1RP&V^(CADMVK+S/\7Z_D%^/OM6;)?WQGNP3?V;/?U'>'OYN]R+!E!J!R3262O-1#O=^5=-U-T= MJ>T^TR0Y8RG-"<-IEOM)YI,0=2`"&FI5'W5C>8IYIR,EU:36KHS:9]6IAEYB MO@JBTH)FPIKD%Q-,H'.&:FE"X5BI;,/[3U@6.1$I(9F?8!;E:92'%.$.!N:8 M+N3G?*U&RJ6Q=ONOY>:Y2-?U[::JGV67 M_5)\WW'I_=\+RIG/<(X%29G`&9"8J9LF9RD4G!.K6SP6\ M^Y5(0O.$1SA)(T2"0,ZL?18$813[F(=QF.I.N498<#>P3M:LO]2Z_7F&!@:4 M!5IG,IIL>%)9[W/0NY/;^V6Y_M_E_CW1LI9F5\OVK=%/LB-V!?6N[_JJRGT% MJ?HPX%79AO5]N;Y;WR[+W<]N'/2`(\X$)WE"XSA*.,\3Q#H_J*"P5];G!MYQ MEG+S_/BH;I2HM90#8.^4**A7I,2#_&5U=>G%3VS7DHBGS;CL9G;,ZUX[G1MN M=Z'BV-4K[X6S3>\X=E?UJ$/!^X/'1]G;ONS.&[WN@@G>U"T[$.)FV\EF$CCG MR\_KN\&S!0JON29!G+EB=0!Z`$(H00SC,`EY&F`:A:F?RZR=^U$89+Z*:.J>$,@U'86 M2D%%<4T^W_6$Y?:A6#UO"I5?OJ_*^W_(SWCT%%#O@%2EC0HL5#V-^-331]=4 MPA30%HM.5.\$50.Z-H;8F2C7*!_U,4WV>MO?5@D5_8O^_R[JXE4*WNBG* M=;7]6.V*>O5J*3HN M**2%?_HZ(%`'@A$_(DCX*?*33*;Q+&>X`^$'OM;&@QO+CD.:@@L9M,A02ZTW MB$Y(NV1;P$+:+]L,D)!VR>8P"VE.FD4SI`'9.AO27+$^BY#FS+EJBHX+"FGH MY[A:*A`=@D3VH:0%D"?#=S# M0$W4.`T2,_FTV@8Z$>Q2],.BUZ_&/"1H7:H%S`*6[9;0C%4`DL[&*1=$SR)& M.7&L'O.IS"0%@.E010P&LN@*#@2(<\2L<<0.#'L.$(% MVBLD^Q%*S+32=FOH!*H+-@0L5OVB;0`)61=L"[.HY:)--",7C*NSPE5*L"YF@C MSI<"Z6_=T%/@FI&GX)DN-9FSJ;>X-PF1T'6\V7`(6YF;A$O313AS3K77VL[Y M/["L-IJR6:B[#3\JRWT)I-KX3UKW4Y[&'NKL41%E.(D834D:2YN1W\UU0DY\ MO8.JHXTX5FVL1D=]F.:WHP,9*LX8-G54>R(B8:H](PXAJCT1EV:J/8933=4^ M[_]9U;9`V2Q4VX8?E>6^!-O-\(-0G539ZCN`\7\KN`70P+UESO7DB(7G-V<]/D..O"ZV!ZP7[:&QDNG=N@6FNS M8F*6@9L4\R88M"Q%V"-?=@GB;D_-;#Q;YG$5XL.I0Y:KK`=/\Z.95 M@`I:>W'$4)YD,CJ%2UZ6J6/Y_W%U=<]NXDOTK>+E5,U6>77Z3V#>``.YF*Q.GDNSNPSRH9(FV M><;C1`X(O,'H?64)<]8OEK MN)]M<#G/X'F2^C@3,8L]]7+S'@:3W\.*?KNVIY@"*,2_G4!&"O.Q[]E74.U^ M0Q^;5ZR6PZ([0;A<1`RF"V\U&-#)Q.6",F)J83\X@*D&B+'!B8<;[F>1OARZ M]V)2XI)&^\ENN5Z7:L0O']:;Y5^L?ER6U<(7<2YG2]Q/O3P(\M0G60^*AXG6 M^][3()EC(CPZ@I0GZ(^]+\ZTV"R$EM.D\^A-D#3?1N`Q ME](X$#1COD]CFF2<1/V*%X8=XC_.DN-$VX-#>W2H@P>=R5CB=3@[3D\I+/N- M8=/)\2N#1+VBBG8)GLF1+):EV29%;$@LC2*T6?.7FN MLC3E8@Z%HC'VVL)@@`CBQ]W-0[GJ#!`_)F&8TBCC`B>8T\3K#)!,Z"\;@#[5 ML13NL1@]Z3!R-#30&2\P`9R,$H#R.:/&3/:T*=*3O%/OSNF=$0-S$#LSX/78 MX`./Y_.#^%.Q798/M*[6!U-^*+#'`AX%.`GR.&)A$':F`LY!A_"9?+YCZ6M! M_0WM82&%R_0,-R/R=-JT[GF#2>.%*8,=;N>:.M,C[`PHU#ZB[A6?S[8FQS$T M!VD=ZT)M;\!`Y'8_G[\]S.?+:EW<;(MU531=*9NSB&!*J>^%Q!,L"'!,^GTR MD%6ZT98<2_"AB=4!1*<(C91E/+4:LCPIJS"!GB&A`-&>E%@S^1Y)L)Z0_XR' M4LZ#W@:GJ=#6 M=^@'.Y9S!0>U>(RT!DR3AE:[9`@FS5.3`]!=ER29R2R(+#U1?>;D.0TUY6(. MDFF,O;8P&$`-A^3??'P\@J7;'L[C-&:<4)J&V,MBPI*^@QNP(-3O-QA]O&-Q M5)C^=GKND-G4V8PYG6:#<])@>GE1OB"=!N>\F4FH"7^:?8;7/#[;9AA%SQQ4 M=:0'M;6Q`FWI>E'\PA8)L1_%L2^\,&>$$XPIZU^<3##@V%Y#`^Z;NA*5!=TP MY4^SK>N:.G!?][*L`3N[KMDS;NT:L*C?VWW%ZZ'F[AB29J&[8WUXWMX=3XCV M*7_QV=/>B)G?'S/H9[Y^+\"J5<IAAPQ>)@2FIPY:#H7V483:+)W- M+RZ8GD72<>)8[7J0PG=[G`'0G[82G*`0N9^QB'E!)E+Y'Q;)<<])Z`M`CK)N M>IH](@./Z/&\H6",9-J/B>9$Y'+A`$]1WFHDP-M6+A6143M:+$<&LN4%P-?P M;A@7Q,\BJ[GS[N4>&G2J!PX5KL>I."5F:='I/W7[N&'C]7MC@>[A.+02T@LLIB%`.>!/P40^[JX\-:SD1Q.MNYPS(A)WI#V`=MB8)_ MNOM6CY7W-0UHTVS:.&4,W)RY%%G`-HM3THS;*:WWA[U!CQ)B;68CJ*`>> M-SI&4J%]UATK;K;OJF:[:5=DH"87IKQIV3<^S.D/.*SMBB;S%]WQ0)SD0D:\CR* M,*-^1"/17SG!J0CT7Z4?;\NQ$NT1HK)"!XQ7J$>)CC!!;W];(%BC#)R86YA( MS916R&OUT])K^&+]6)HU7ZW_*1?G2DN++,ZAT+3I3NUFL(TJ0M\US6XI:6#+ M;>$OO-"C0K0(05O5#D*Y-.D)'5' MY:BR5)O%"0K3)Q1I%Z=FQ,ZR0#5T9;!('4./J3I5\NDNFNTG:?+S5AU9__&H MCQ'GJB(..*&^E,DXB./C.TFAWCN:#LQ.KET'L$BAO4)[O.@CM.)R$0`C=9N* M^[%B9TS[%/HW0**^'-J(Q#S5T8IGPV)ICSQM[6R/>?ZX_+&\>2@6N2>HB"G) M<>A[`4FRE/3Z'+%8:PWO;K^WA MR,UQ&^FL?,P7@ZUVUT1?<< M6H_.?*LG&*_`TO5Z>U]LWM?5G2KO5"6]$$DF$R$A8G-2W+^@8*'+-J9M)I3O" M@=K6*!K5,/SO2DK79EO^JUBSLEDI%?NX*1[+W>.'8KO`J>\QXA$6>#QC(B12 MQSH(E&'0;9(V[4[=,CQ!BSJXZ)<#X%^OD,0\JFLX,@HF;97%?\A&/ M:=UO--:&;;LEI6*W5Q[&TQ;N4$P)^)WKFA;J2V25!HC^JB$M9S MHRU7<#9G*4T&;@S*D"DM(,E11:(J[DFU_GPO14]]G=>/-V55K`_6A0B%C_TX MR@.&"<4D2WKK21QKM2HMFYR@9+LZF?@LJS5JH;;?7J$.[4\?-Z>TZPO7Q(S# M=?T_43J+/(_(^6SZ=4K0FB=-+V%'&6ZM:>FSG(LYCM9FL@"4!6$ M=57?=K/J!1&I3S&3]5_N"Q%X:81Y9]R+2:2]@F/-XB2JV")%7[HG]0`6'="J M?K7"V_X"9-7`'NT:RS478=Q$%6=/-F!MYB*DFRW*6"1?;SU&EYMS"S'6N9W# M"HQ]IVJ7PQ&Z74CFL>O;_4UOXG#3V^_+[^7C[I'6FTW]EYP&Y\NO\B?;'PN6 M>YX(@S0A"-F])R#MA/9-.PXY2BLZD$[7&C8P;U"!\"H1XPZR-!] M25;#H%>27RP"L!1DE7PWNY\`1`[MCG(1CYD4ZFY\>[Z[RAV!IOW3Y:IKGN0) MX8+G7A3[81S&<<9QU*]\A2%H*Z:QD:G7F!0T\^Z$&8]&C50W%([MI.JP-T4K MM6='OY<*)W0F2C7>C^%NJBDQV@I$=TVI[NC=-RG:&<>G8E7?56HAZ=U:8BAO M2[4!E31-L6W(ZI^[4DHFJ=;OY5\KT2R+1OY,PEU_D)SM"]*3GSU9T.=)F`1I M&B49\XD(LRC$_:F?61J`=NC,"[ECK>R<12?>7J&CO^C48;3W&'4NMS/!$\?0 MP>LK=/3[].=7E]T^,VE@!S1JG@-L)L(W4W+JMZ`1HXK$WY?;W4:6I.J5R@7' M+*,)D7\PQKR,"_]XI7H4CWGY&F1FZD*Q`S?^W6L8FR;%HC,B1Y:+FAQ.4#"> M,J1=,AK1.A/MM.')8-DX@IR+%([YL*X&*4NY1[$7RXHWP)B*H+^J*PTIN535 M.!+VVRP9\S'UXNQ'DI["SPBQNXPQQ_$S^_G&<#0GFFQ8&E(SR99S9,;A-,-J M\#3/;FX[3&OY\<7W55&LB_77Y>;;\F%7+`3G$2:4!'[L4>H1PKQ^2B-$J+6& M-]:&XSRY1X84--1A:U]F;-&!SB<>P:/&!I")*(1EB7FP!SGC>1H6S?9PF+*I M>=SS6=?/;=&P0-8<-F78<*.V.X:`LRW^?5M6=[NRN5>#ZOI6Y8+#P@!+Y2PN MC/,@#C.$B8B$:;4I MATZJ[O,,#53)%FB=255KPY/:^IBSL!U,+,O-_R@IO+[=&[_>;9NMG`Y*;(LH MD+4KSP+.`A)@XH4QB?L.>4:UMA\[,WZI;6$*-&I1JQ\?2H`3X!8VAXT+BOD& MLC,1$_=^:>Q;I-5`GAG7&B!*]U=$/N\=BHZ@C M-\UVLUQM%QGS_``S%C/?4]NI,AP%!RL)8Y'^7>'PCW:L*CV@_X"LW!DPI+'< MZ98@N8+QP]MVYISL@G@'C#?=$SI>^'I.,73;'^N/RA M?IEL-NH>2/5ELV!A&+(8Y]07)/&ST/-QU^)+F;Q@26&$_!HCQ[MX:-3_&A; MHSZ(O`_BYY,@'MQ"IWY-/'T?'XB!N?Z$49Y)8V!*C^N+/5+`W/"_17EWORW6 MY)NLX>\*6KS+*DQSY-:$P$]@(J>))VW=743S)9O>8WJ#Y"1+>RKEKO\2/^\?/$@@$D=$`=7(5F M)E+@S+UZFA$.?,A)M2W7AW3WN5BI=S;+HN'?5P^[=;$6DAZI2E]W^[G$]2U? M;BJ)IOE8;%J(_>8^Z@D1X41PEI,PRQE)>G"I#SHK:!I$CLO`4R?0T0O4N8'4 MP$,GCJ@:HW-%W<>Z+S@,-Q=/%%2]FG%^\825C9.%THGN6V%_(!M,&]V9Y(B) MG:XO^4!!U\*W]>I/=>=ZL682674GS9;U(9^U/[S^JG!)O,5F5N4.=4@\H*[3V'KL4[")_F0OUE(P=]KS?J%?-]5O$7-/4\G$;JI!?L)X12$N>= M^81ST&5UMFRZ5G`%$QUQH@-06?'U4,WJ>&ND`R1X8KZ!NFN#:G<:^G/N?B:< M%MF?DUK:=.LUB;1.F[8N'BV3NTVQ;\@>SKZ21?DBY"++N2!AF,>A$(FLM7NK M/HU`I^.--.58!4\>RB.\_HRW4OLN=%O$ZDG>A)S"E&X$G4[T;9BH`5FSQ/!, MU,R6-[6380BMZ5;WQ7KW4*CWM#?EMZ5J*!Q/\&O>59^WRVVQ?Y-;[*^87#Y\ MK)M2E9S]"X=?BN];*CGZ"!Q>I%8^ZFRK4;G*%J^$+#8"9YYF+N/Z^N+QH&6YELOXWGNKK>WA<;U:_; M%/=%U;2_M*H?B_=UT[2/UA&HR*A/.H;UGZ!?EVZ_.U\YB[JE\AF\."8YS.'`^%M M9#27!,!RFO-0`'I+JX=ETY2WY6J_EKN369:L5KO'W8/,NNMS")^CHS''W$]Q M2@D13$+*H@Z=EP6@:=E$D)SWJIYZH?;IM:8,;4XCIFP^5!O6=&4=Y4"29K_ M+-9W975WDB#[*5]S.NUNA!X59!J_6(J^+[>D_#,N9B3U),YTX_#%`?$ MHS%EG7-QGH'NYWT;'DTX,ZOJZK=U[S=:'PDQGEW-F5GPC&S.SDPSB]LGQ1,* MD.0`'4E`RP8=:'@ZS3LR\:QK>22CO7[CM7YFQ\CE\^XLAH+6G/$M#-699/TW M1MK9N>F;0`\XI.'HF411;A6<=]6ZN&V_>2\]7.]O)J$_?E_^H][DJG9J82UP M%@14Y)'(,"99F"=$W1Z6I:GO!U%&M%JQCB%,E=6O6[&5:)'$CH[@48N^NP&) M_D"M`ZCUX*"SH!,0'`9K.$O/*$Z&:?7_08@`1UG,(U1F!UXX#IG>^1C&!+Y2 M-TP4D3FJX-SV6RPKGF:4U:I)Q+/98IG4.>L>U2[6X$@J]T_U8\U%^+]9=B=5_5#_7= MCT_J1(+.;!!PWQ-A$F28,1+[C.=A9Y9F4;;X5FQN:OV;W<=9@SQFI\#TG[(. MH'JE9+U;;=$1Z;\+.85637OU!*JV5OQ3\B>S`H2?H+O6P#5`U\*#9('@F#YD55VK[XP_X<'W9+-?%XW+S9V<')YRF M%W/\M:5!!3X*]$E#XYV(= M'<<)8G!`]ES%8B:JZ,R]%Z=JNJ31EJ8>07R0>?EP21%C#`>9GW."HX0%.$BS M?KZ?G59T["8T5SG4?&MNX:!>426OP:L^9Z/"I. M;T.3Q[D(TV4+=`*T^>.F7A5-\ZEH"OFO[DFU/G1\'H_7.9$LB&(?ZBPXH40>SG2^>`#6]Z,T2X[H".S794$FUP;,C!=6@ M;E`S;5(_&Y6TZM0+7;1/F=YF`OT-#>_+JGBW+1Z;14RHX'G`$D'2,**^EV'> M]^8HUK]-"BN)/(:.Q"N'108#KZQN,!V+%PZ;B8;5\X MQ&?Y)#Z_C8^/WH8&`\[.[6YP2?\:!P#YP#B_%3D[YNZ:19I[N,P M2466B$0$:<@CTO?:O2@!-6-&&W->^?=S^N7^P6QV-_]0QSEL:[1\K#?;\E_+ M_3L\+5Y@]3^>:[W"?U*:37+50?Q>::'\A%8GQ?[/Z!JH\ZTQ/9,2WYX_M:,A M:4_>3EY$)B>/]H)&+&,T3>,@"3FA*<_]M$/BDQ3T1JX#\_.1P-/#!4Y=L*>* MQB$:K9-31,>N M_U4^/"PX2T(L`DDP%YZ?X5SFAPY'R$A@<4$0;GQR0:[J[3E1MKOZ9Q`(*TM_ M;F-@O.YW1GK1+SU>U`'^=5XK?B\(-5_N,X_-3!37G7^PA;ZQ1`+4]JGA#\7V MI6WF^:&71#3+8A;G-*1)GO3E-R>@HM>*0=?[0M4-IZAN3_\HGRLL6$5M$*RK MG!-S"U7+%W6I1#@/A?PY<8.J:)'WV2BA39]>J)]UPO1O=/V_\JZF.5(=D=[YK#1!P>NPFTBRH4'JNSQ_/J5H"CCL@M+Z`,V MYN+NMJN=+U^*IY20,@<9T>7M*9+K`(8N10%RXR1-`Q1@1$!O%5-?:D=3T93U MW'&8+#K%G[QM6R';6E6173&ALTBLG,0-@?'23V\DSW9[TU&B1B1-$\,+$3-= MWIQV&M5)DK"`)7E3-FVI1-ZYB3>]JS;EZKG[^E*DB&1^&B0($D+3$*1>%I)# MD2)*81"F,D*FR:1A06M1'@J;'G!>.!U&Y\?AS^E%:771+J9P,S`NIW3:R#:B M>V+TC>B?9OX7HH.ZO:J,#EK9>\'5MF&6UJT)53.@V4FKER/4+7B+)I87DA>J;'E]-; MU_H(DKEVO6UNV>,>;]=71?U8KIAZ#NI4=AGE\5-O?G*5;XJFPWH=P<"+LA@& M-,X02@@,&,(890E!OAN%KN2-;6NX3&_J]2#;LW9'9UX7Z.WWI5X^_.Z/6[7J+J^+@S?_<#I_9%O>6(Z5V%2QX##)31I# M1_H(73A'9YR#-\[0'7[:[[5#3N^1\Z/WR7H+&:T1&9E)9@K]0N:4N;P_[W-^*NM7':X#CD/B1AT(W06'DPA#2 MWGH`L%3]-DTF#<\+1Y1.P^$T%\Y#7CN/'*+D]*"+8C'9GX%=.3E_(;9%>.$P MC$P4NC9A:Z>%R7N#.2U0RQ(MQMZ(]&JF?R&2JMNKRNB859+`UE03[W=W55W^ M5:RO/1A'P$U1A)&?DA3[`71[JRF-I8KZ*)JR+GGY$9N2YLES.D7KC-*IJ'$= M-B<6X-."KITR):QGDRE>I(Y-]V94OQ1)DCCB<7]?;<#.1.>JC;,ZQ@ES5+K_/Z63EGT\*MZ$$/N[3*GO?@Z):8J@GP-GKP M0Q_K"Q$WK2Z].0:BFZXI,O=&66,/TC!.$H13`"+,JYN3WF0,D%0]?A4[MF5M M[G?-+M_R?;YK M$,"(Z6'BHQ@"F)$D(NDQ\XM\J;NBJK8L+QZ=Z@6;AL6C%*O35X^F"-6S?+P4 MH=3:^G&`1G(!.87EA0B7-G<$EI#3:9J>7`UM0NJ['C,1!9F79AF327Q3M!G(EA,W'3R;N=,N MQ-R(WFFF?B'*I]NKT[ON)DB32MK*W?&<8M6>32RVJ[)HKA$,0,1?.-`H\F'B M>5&*>Y,1Q=(;_E/M&-:]`;3NV/`0W(2<;3*=XBF;#2;E,[8))!K+ULXP]$&R MILKK0A1+BROOI&IZZ)$HH?;(S%7UJN6.\WQ>7M5?&3J^3WXH&?S.6G;UF:?]_>>4^> M#S_\K4OI4LC?([B\NP1*89K2N*O#!C"*22I57]>$?3Y^XD>+75;UC(1'3`SGCHR<1AH*BID[$/+,CLBJR3@M1&V-NGAZ9<$X MG3([?I>\Y.S!5M_.GJ`@#!%(4B[]T,^2,(&]-9I0*+G#-\6$Z9<1;:'='M/4 M[IE3Z1/>KC/-G)P"2I-F:B_N'5K&]]Y4>%R(0JEZ\79O39T489WY3\Z>T3+? M?"^XM^6&:QUO(G:PBKE5'*$X\DF441Q1$O96$R!7/DC1E&'=^7V;;]JA5*S[ M:K>R&VFJ7(J)CT4:)=.P8^IU!-8U)IQ+C\:9&M$E310O1)]T>5,9&8>R:];S MB=F78P/$S$]!D(&$X(`&U,,DBKS>-@!4JGZ,%H.F5Z5CBYXI+5SULBVXYK1- M]%1UF\ZQF16E`&]C2TB=M"]$\?3Z=+I(U$^8L/I=/A1UWAE=5??%%]X.,4$> MQ"DA`(;LBQ<&@7LTA3,WN'XLZIM*5.ZF6)!YZ(9@Q)]A$?MHF0XV@AHUP6]>ER?8K3'X[EMO?WUWRWKY^JN\VGJW]? MK?(Z?\J?#]EU!#PO\JF+4$`SY"5^ZD(2NUZ8$9H!('0T6=6&X:3VB.S"8=@N MG!Z=[):@,I7CZ:M-%N4RUL40N*Y6>YXR=9U"ET#D*T0V"#T19.YK*[,`>Z@5 MV0^\?T=U=?$ULPQKI% MP`<>]9.,],9(F`J5C5*S8/IM#K]I1TK[`?SEEY=,84ISX M+&%/,C=R(7)!#RR-`ZEB"N;1&!;VW@%GX`'+>(X^."]..$,O#L=J5%JKF0^D MV(;TLF(H-[E8"9^99FVJK(]L4-B+Z$+V-BPZ?-K]S3+58HDZSX$_+,%N;/F58C:G`*F.!X92;-OX>D918]"PP MHA.72&J1_=59YTNNX3??_^6H9`IG5EUZR#ZW1K,9"*:`9(D/8X)!@(&?1&[:8PA]3Z@"LA'#IH\5 M#>Y5#`#_)?="/U75^JG<;.+M M^C,;X-N?);/:'51X[WJI2UT7X!#3+,DHCI'OA@'!,`$^Q*DK=Z=3LVG#,UR/ MMDULNTLT+Z@/IVQ4+J[K#H38QN6,,9";WE[1_Y;X9=QXEV-S9/?14%@6LM5H MRKO*RMA^([##0?:%_8U]L_\6^W*3-P7[SO\`4$L#!!0````(`"2%8D<4O`HP MIWD``-3[!0`5`!P`<')G;RTR,#$U,#DR-E]P&UL550)``-TV#=6=-@W M5G5X"P`!!"4.```$.0$``.Q=6W/;.)9^WZK]#][,LV-<":)K>J=P[4FM.\DF MZ9UY8]$2;7-:(MVDE-CSZQ>435JQ)9&B2.J2?DEL$Y>#[WPX.`_?3X7G]6[=V_^]M__^1]__:_S\W_* M3Y=G.AW-IU$R.U-9%,ZB\=FW>'9[]H]QE/]^=IVET[-_I-GO\=?P_/RIUMGC M3Y,X^?TJS*.S^SS^*1_=1M/P,AV%LT7/M[/9W4\7%]^^?7M[?Y5-WJ;9S04" M`%]4M=:6*'X[+XN=%W\ZA^@OEY,<3S.,EG83**WC@,SL[^FJ63Z%-T?5;\_]NG M=]\UIH7< MA4P_W6;1]<]O[K*;U$$`*>#(*P#XRQ9-S![NHI_?Y/'T;N+^=M&/O`V*Z&@6 MQI.\@Y%MW]D@&'P)KR91%^/[OJ'=99?S/$ZB/!>C/^9Q'A=3,V^HC095^Y'O M?3JKQ[*V8C^R-5-T?I=G"W(HL"Y.;J##B3=7;M'Z/DC92=+/: M/4K93.4-JW5W-O#EQ@8<0[,(HF5S'8SC:?O/]66)=E8K_!9M["ZQ";/$09)_C++/M\[IJY-N7?GN)6DX56NJ=2]7,PINKK6[ M5)6O\&L4YO/LT;T4>1XMB'X9AU?QY-%Z)Y^BT=S53FYDF,=-+6!7[?\[,(PJ=`U$8W%K"JURZ!WZZJG\5]&7Z,)_I1.)KL,;6TK/4G=9`6JK=B3 M;,VF=8.JN\OW2YJ.O\63B9MH"]_K73(+DYO8=?(X`>N$;%J_?TG+YPU)VK*Y M_L?Q_+MR@<5-FC7?@NN@Z?['UXS\V[6RN]3E.]6DF9,7U^C"VF^.KRW,2'K:W0J3:,S MI'7E.Y6DJ9+65.A&EGRVW=1:5Z-3:1KK:%7Y3B5IKJ.5%7:7Y7-T4[2[%!W7 M";.^1A_2-"1.;<4^9&NFO+IZ'4@VO\JC/^:N$_-UB\E64ZU[N1I-NXV5NI>I MH0XWUNI"JNDTS!X^7'^.;Y+X.AZ%R4R,1NE\<=3\,9W$38[3MVME**F=G[O8 MTOAP_3&+8@[L4K%(_HN67J8QYJK4.I7P?S;H5]&6# M'A5G'6*]KN$/9OT19'G4K]>LFNY0WG863CN5] MU60W\K8@P^RUB`TT?[=D\XM#R:>R19N=Y5P_=AS=SR(72X\?$[Q=UY-TM&I\ MB[%=A_G58H#S_/PF#.\N"O-^$4UF>?F7A<$_!_`I@_TO3W\.&LAUF>:Y,T4? MKK^$]^(JGV7AJ#I&FQ2(_?S&R1;LV&*`C*^E$D(BCWK*:LH`4IQ(``7BOA7? MPS,IDF32K%1,;_BLD+[P3HM#:>EZ_'T#$'55`\2TT@IB)0&7"DGA(56.&`"H MZD:\3$:1C<[2;!QE/[^!;\[U;L-["@MNSEY9D3`;O:+T]Q6?2ES< M+=+=SD>W\61UQB8$VFOT+O!5A;@XJ4)Z-\PM'W?X(+_SJ@AX?YD[LIJ]A;$!IIW8#"AWON;'& M$L\0@0GS>(F5M%S_:7P:LRG=GUZ6+%-O_*V2<,T?\WCV4$B>)HNDAOLXW\#/ MC?4"H[`F2BJB@03*%PI85H[3^J1VN3\>_@W$A[0_](=@V0LQ=3H-XV0#NU:6 M#PBB#"M`?&9\``D!'M;EN'P`S.FPJB/]IMVC.@1;EJ;/ERQ,\LFCQL;_FC^> MF?P:3:^BK)F+L:&!0%+(()38S37L/$[?$DHK'#4ZH55R1\VG`\`[,+&<0_"+ MPZ#P#:R#ZSD[_D/VO_-P$E\_Q,E-^?K,XXL'V]"N=?,!\#1R01%35$EF@,2$ M5Y-;8(5:DA+]0*0<"OSA*?M;DD5N`/^.QL\GR.50MZ1G?5.!%#4'>36++Z#K-HI>@ M-R'R#JT&1`E+)).<<0LYLX0@]!R24N]T+?/>Z3R8 MC]*`ZUUV$]ABFU`J"R6T%&&C*?%+%!VVLO=PKBYCYN3GP![5N6][OZ-A?QZU M!RT6%A)N-;**6X,JGY&["&FP`/%5LM/)L[<'_9RV"^TF)X=8$*T,E,76(N&B MQ$(1V'8S@[9SH5\F;IX\7_M5UY[3AE:]L/##I00)P3T?N+4/4T"$-@)R"@EE MP&E1`EV;8]=32L7H-AK/)U$CSA?C6NBR2=+ACBT'"&%`/$=EQ#1$!%&!_1(O M+O$)':#WSJB7"1F#:J9/V]/X4MZ!K$TIC\/Q*DX>`\,&)F53M4!17U*&G$<" MN("68TR%$L`2J#S*$=NWW5BE`_FP]%M=]N"V304*"PD%))!YGJ`0(^I"BR=$ ML/7:;HP`_A)MLXB6?1I3-2XY<76,B'7\-_I9DJW+N:M,`M M6@D,-,K'GK.W/BOLG46:E1A`0_S3X5Q_]$B'@G_/%'R6_7TXC6KS![=L*<"8 M>19"AK%DU%#!D8M=G["PMG72S0%2L1>&-&=A!^@/P<0O63B.IF'V>WU6S1L,P,&UWJ+;FTM``A'RL.!/5\-U*JL2E'2*SEIY/.-Q2? M.@-["#I=QJ-B$R*YV8)-:^L$UHU-&F.IAD@+XP$'7CD^`47;W/D#3-0;BDQ= M8;V92Z_O!RG^4C`Y7USQ,0O+WM>28W.%P"@%&4.2:``LQ([VO(Q=&,"TK2^] M]:G'\3.C4Z"'=9M%,E[\4HQ^&Q]Z1;U`$P.X9P6$2ED-I""T6IDI\FQ+0GD_ M'J'ZP+N5N9%9F(S7\^)5F0`ZJV>-&ZN5OH^Q]@D6%=>1W_:%4O;C<6!7;(>P M([JX@#N]*W*$1K=).DEO'C[%-[<-')::F@&%VO.MM8QHB'T#,/VWI MR`;W.6Y-'H[4WZ]6+TU%G!$E+]5C"$+#&D_'L@)I,G\8H[I]<= M0FPJ'D"EN8$"""2D!R6@D%3FT"#1=A/F`$\:VBDR[1S#WEEA?ONTB07N<5`X M5I92PS@!I-A9-!*4$GO.^!V_UKM1V$OM;X_=$=^9@Y26OILFPKB("VG+I5?M M\F"&3V=[=K"UI$O`C^>:'%KXVUIX/C),`&"!J))8F(OI3^CRI8[TV^B:G.U0 M'<1A3:?3-/D\2T>_UY\SOBP;2(R,]*1TH_(]Y>)_%_=7NSP^.8$EJ2-]OKY] MZNGK0[((L#'4GF>KD:H@7="^VB[*[D!:UJA^CUOCAO1;0'82_).-U-QZ0.!M7'C MJ[*!BW6P0)P3[)8\'QO!:>G:^(3(MMD8!WCDT0--=H5S"'I\S-*[*)L]%#?' MS40R+L+GNT9W_=74#+`TFD$#*&:,6>8SQLNIX#N?J>W&U`'N.QKDJ`"328 M0X\9(WT!C$8^K/9D&&W]U3_PXU!F=UCW?5=!'7MJZQ;7P"/KQLEZGE`5JF M3K3=C$&ML!V"0[]$292%$Y&,Q7CJS&IQ3U9Q/:>YOXN2/*I=ZAK5#XIS+*X` MLQ;X/C;%;9OE\LXQM2>4*]*1_M/^46Z50^*6V\CI8O8^JGE]_%7!P*WN6/@" M2^8ICU/($"OWKSD7I&VL=8#G2MURH!,X!PNSFMJ-UX4#SU"`$22,>`(I7TJ" M2#4B3=L:B0,\/>K'2.P,Z2`9B'$^N@VS&^?+-3HV6EF^.'.W7!2)5P8;97R@ MJS?8.:,8GL[)43]4Z0+5(=CRR<5V44V(5)4)BMA1*15FF^ M%6Y#Z/Y7YP1/Y]-:[7]7+N"`&D]32#!SRQ^2RH%2CD,A_X2^!]U*>VEWV`W" M@?"^&0>6RP6^[YQFY_MH0XK-02"]YR`)^/J$WNCOA`,[8#=(UO'KY:\N?7UU MC0!1(P1E!B$H#03.7?;T,[]%VX.=`SQ!'BY[O1.H]T6CXL++SZ2:?);*MM'*`2X[.VN\`8-VP;;5GM?[<#;/OJ6WDX\N9)J& M-=$*>4G]Z/HG>%M-U,CB:C<,/-_*\+!YK1.\#9;E9/HYL:3VRI2."Y6."'.8I6C]"EHFS]W@,G?^]SQ M:8OW(&_"A@^+%W*^I$]3J)0_RG_)TGP3L^JJ!A07)[&2<>DCQ2!@2)09J$)# M=DKW%W2B])=OPW:+[Y`V:NG#DY^B47J3Q/^.QN_&;C3Q=1Q6FT`'-B>ZT=&QS8SRII&'@:9"U5]`!(*"&P]RRI0ETE.T3#H34NFV633' ML2UV6-QOJY1C([M^XL67\/ZQ]-.D'XC[Z[H/++58`$*U!Q275$,#RAN(!=+H MA*Z\._BIT)&.CFUF?+?Z?/^6`N_*+#?C'9_OPF#;)$W@,$25]`:4! M&@,HN5AR7,$)??7MX.=.7TH[MLFT]@JN@2;/VOX#ZU--/.P;Q3S/`T)IR"O< ML6H;@Q_'_O9A39:NE#3(VYUI.OX63R8;^%L6"3S?@TAQ*B2"D&DF;95,(WQD MVYYV'V`"9"\4:XGCL9G(Y_L6AO(HEGH,L,02$(T\CH#FW-/<+Y/0!0.Z+4[4<&^6+*]R6':2!>/^RVX!A`RP"$F&EB`.L2K MAPZ=_3LJY]BFP*#$?T)4$(.YD-8H3U&D&%&XBMNY;UO?0_*CG*#N727'1O*G M*'CYP6B4SA,7$H,OX\EMV#>HYM(BP=0"P]W-M! MU6L9`L8]0WRJJ0&<<^E!@9XW;TWK%U?@GR>W^]54JQ3KEH,)5PTF'(VR>32^ M"Q^PB^:.W6G_J1Z$&IY33:!+SY:_QS3X"<$: M.9P>)#74F2Y(/:A]W^#_9^_*NMO&L?0_ZL:^G#,O6'MR.I5XRNF>1QQ&IFUV MR:*'DESQOQ]0LF@EUD)!)"7+E3PX5@@*^/`!N!ONM8WIP0"1+!<=[-1]RJOO MY4=?-EW/UT6LFU.NE2!1U*T\<)82[;VG`(CF$A&'.#6L!O[E4#[-#+VW%3'\ M.EC'5AOM<*02(LQ!$REEFHJ2FD.9&DV!_G(H#SDO[XWS7_+!Y*-\%K")!RF3 M2&F*&:DS8#?71#57+#6U!_K+BSS$?)R(VVL(_IZ/LUE^8\KIH?$/6UX2A$`J M#EA*`AEBA@+M5^8$38Q.5631!W;>=@/URU3/=((&B3G/BDG4:NM,#5\G[L>L MF-Q%/._K"/EEM8%=P>C[V@;K/-T(=8LWH)$OVL:#VGD*YY,\DOZL/ MJF_ODT8=X3L$>Z[O(TS33W$;S6]V,&;]L5`G2L=:(JZ`Q$0@9_S*#J>5X*EW M$]&E>^(Z`/-$V<3<[6T^JDNJV;@JO]ZN_0]L(?:W>U'@T`%"4!1++>:>`F3< MZFJ0!O%O*JT^F@^K%[B'VXN^SF?3693RXMF[=T-:>S80Z;!%,*X@0HU%-&K1 MC:QG*4G-(X\^RA6]8Q$]T=9TE5>C>MKJ:EW_+FN);77Z-BK#85M4BQ<&:YRO M$VXK1U3)4!4->'>RK7/IIGI%?8AR#DMRK/IO/J^7I6COY8KJ`6K-O1 M*EBF.<`"*P"LD:"N^=V(B,JY5)L"_BANA^ZP'>3(RR=%67TI9SM=7&M/15RT MQ1Y`*PV1T%$N:6,B=B+YGB/^*";[="P'X4/-VJ5F8.=5W`3CMEB4-TL>?\G_ M7/S73JJT>D&`Q#`NN#%`1"'00:K1*AF#UCXYNR_^*&;V7F`>@F!753G*\YNI MCSC5G6P`]0UJBE.+@B%+]V,/1#@0^Q3*YG-%Y-BEG\NGM9S M:BP]0O^;%W?WL_Q&/>555!O^-VNF\C'O#88H0VU3$3%PRNE#!1L M=<%;$Y23,?S::/\VITGTTW6@X.?TD0&@$EHK`0 M5P?"7`#8%*+1AM#D0_32S>F]0WVBL*TH63[%H42)8/QIV?R\R\1^8GY9'OXAL#C:AJSRP6F!O,A..-4&Y`%'I26?_1G`RGG9?W MQ_F.\OSVT8/`-(7.0,*B"@"]ETR05=4*@[1-K61'/HIWY#SGZ?VMD:A79)-1 M?"SYCE+'7QZ4Y)9YJ+G'M@:=>+J204WMQ$]=&1_%+W1V4W24GCEZ'<5M5E1/ MV7B>9TWO]BF8NUL'9(EUFACN`'%46H;-*F3-,"%2,R612W<>]8=Q$E>^O.BS M-;/GXT5/MEKQ-ST;&*)2*>J-N32'3Q]H'NJD.*%,[.)E%^X MTK]6"Y?G]W'^[WH[5--I<3RC M>'0&A?\H@6BMAW694/=C=)]-[C;M8&V:!>[BRA(4:F<BK&?C'V.Y(,WI[Q%, MO5=#+MUCTR?*:^SZK[^O`QR[^\?RXU\_?6G_!J_'.`'%7?FW*/DO8=X`PO2G M4-!E%_(?LWQR$X_!P0TD4_5].JNRT8&6OZ990-(:$1>O-Y1@KEF9\J"._N.6 M8RZQ3+V1-(L-\B:^-@HO4 M_=+O3QC34]3TZ#Z_F=0ZU`W+T80I*)U[&Q"^)2 M?].^7T--@/I4-%H&3.:V?,B*R8&$^JEML'%@4D`J%1+6087CGY?Q>B5X@D''8)MFJ\]F\^K/\G[\C^M_7H^R*OLS>_XMKRW(6RWV6UL$`1`2 MV$/&J'<,:6PA6?77@?1DT>^#"XES5_:!;1(7OC[D=]D_\O$H>YQ^GC_$K]_- MA&W/!Z:%MHQ0BP2H;2Q8.[/JJ^')]4+?AQNO"QYTA.R)3I?&X'+8P?)JIU$< M266`E5YS#1F(^#580TF^7CY]=L;M^J;#*- M6D*C$"<:60Y[=\!>$2\UEG$?=C""Q6H[X@M>BEZ0.-T-;?;;7WJ=@*3#T*]B M)\K;4>Q`$6=HT=-9W:OE'!63[V^C^??2L,.W!P`X8HAB0:R2$05L)%_A0"1( MSA-YX40\W10D47%U2)2W:]VHEAE71W7&U7:<._`U07I@G,9$&0FH!%@+:%3J%^L^;,[=\,S6!>=[Q&*H#CW1$K,!.5:2^T0DE)ASS72>J^LV0\6=4[E MGWJ^SP^WN4$@\2C'49]FV!LJ>9UTV:]&9P5(KF%]'BNW]=R5/8`UA+W@34?U M\\*6FG^]??WX>8_WK/U+@F)0&.08`,QA90VS@*T0J`UQYT:78R=R'R^Z0FIX MKKQT?*\G;$>K8"VQM4E64RN@E!`*:U9C-)BEQM<-QX8.IF\G0XZ!*TEECM)$ M-OTM:O"CK+C9[<78\&B@T$@HB67,>P(5(`Z050\E!Q<48-7)/)6=PGF2\Z*- MSV)[HU!OEH!Z$M>$M0A#Q&2SD2HI4N^=H/=Z'J0B,J715].8G%H^O3U=MF+A<[YIF\M M;`X'OBG4D\0)\!Q:1I!GD`IBXJ1ABHF`^[-2]XS'WJC?GQX,$"`=Z:NCX,R) M\%`R*E>C0=0D%SX^OQ7=VSR_R9=\!,!#'`E-!Z]'^22KBG*/$6+C\\$;[X0S MSA(H@7(00@Y6XW)ZN!L?0Q243YW2;%Y; M@>.H(+9:.EXG`EF-2,KT>EAGS)&.MI)4#(=@Q9?\I2Q@+?GN(,1/SP4G)%38 MR2AA,V.!M]PWZP48=80A^VRYD#")97<0#D&%K[/[O-H@;=7=C7W_>OLM^[&L M*Q$_K\O:Y#9?_FPAP1__\N`59A`)(B3SUE//.88KQ$S<9"]P`SJ>=(/C?DJF M^K+*B[N)F<>YC-K[6BAHU",6ORTS&]5U=6L`5%5,HZ:_7C)EA4D"E3O\]@`P M8@A@BPB%3!%EHQRQPIQ)=$'!)$,2M.7:.-U$GG+QV-CQIZRNSCG]GWDV+FYK MDZF:_G=^_SD19+7"8S:KB^WRV"$(FT@D1R>>85CV&:Z4TTSBN>@,1VH%0=8):@$TSKLZ+9*S M%C6B+X?[0PBWY:$ZF+KE+!M_-.H>,1-#\&]#CUO0;D>K0*#Q@%E=7Y4$T)'% M@%_&:)%(M9D?OE'VSK8.MPT\=AKOJXF/?=5 M^7(;_""7Z-;FP0GO+.%`8L859)@0&`\,[WE=4$KCO3;;\_*#4HVHC;3A7@LA MM<6&J^5HK+0X.<'S&2K%W4[N;N?G8:BVW]2G^>AO=^73WV_RHJ8&J?]1,X*L M,2)^%#[G=]G836;%;%ND]8:G@K!.&H*84%03X#BBPC6]=C95*#AG+APX7657 MX'4_Y?79[`Z8?OMD`)Y*[3PTV`'DB"=4XE7_.!<78.1,GY*R2^C>3\0*!-0Q MHH"W@DK!97V#H,$'NL$,>B>(6#ET8^\2R/<7L0*1B^>*BLH$E@1*"*%OQL>@ MOZ!D*D?.;^N(E<,0?0\1*P9;(JQQEA+BN"<`V^8`]93MC0)]/S;/KK>25`R' M8,6R,G<+#?GG!P,Q(N*BK#>(X!UD,UEY:GQ977]DZ=F&0VP<[_9US8`YPA%UDBDN.!UE9G:B;,<+Y3^ M@C)<=D2CKB$=A$++,A_3U[M#7_)9"_;L:!845=8`I1F@QB-%.(%\-4K!0.JU MP#.49+HB3G=H#L&9IIIS[.4.CJP_%CS%C%+K`*9&8&^98HTIP0.77&'U8CEQ M!'I#<,"^@/XM^[$<<*MM8T>K.G`=.X8U,"3ND5YY0ALC$:$V-2'N&5:3ZX@A MW8$Y!&&NJOPQ*V[L`N2:"2$($\!!@S1EM-DIB M8:J\@#J=1MQ!1?AH'$5%QI%`:HJ$"A@&@&Y62:I5J73F\.ESO M@1)=R21'P#?,?E(^YM7L^6J<36:1N[7B]O@2FK9S(]G>+$A'E,=QB((25I=_ MA?Y5/"?)%X7$!>\@G:&9Y-!;%2V,7_UIT=0A@CMH8&*>Q>7CP:OXY>:)]MV+]>XVQ>V@P6LOY"_#8\V/A\H%W7B M'Z^-E8Y1I"E&C8--R.3[SY=KR>T"Q^%TH5;4>#,:)X#A2C&$.)0,QC,8P5>? M/$OV,)YA['BG*E$RA,,18B\-@F<@CIQ"[`2"`'FI;6-0))HG!R>?X3653B?_ M0."&F/*UXRQ*W=>SI>:>><,#Y(.HQ)Z0G=([^!5]EQ[I=K[!7]N$*PQW.*($C(>"X0L%LW(G/#) M:M#Y\:;[R=[B*SP*X4'BX>[+:O8MKQYT657EG\7D;F=`W-NG`S+2"RTLLUS4 MP1=:OQH=D=07E$*E=]8<#^\0E'$/C^/R.<]_7Q:16D-E_\ZSMVU4[S@`$%M* M@66>VWR\M.L1W(*FF[NE!V\O6-J&NV80,UU(X MRR6W'-&&Z=315,_B&<8M#"';=`+R@"1:7A__EOTX@$1OVP0#/1)1'R5Q07!* MA(:F,2TA:%)-=&<8NS`4B8X&>6#?P4&[T,&^Z_#^R=0ET(,8@\K)72WFV_Q[BW"\#4\'[B@BSL"X,C"F4%HH&]\L`"PU MBNH,8R!Z)\_Q\`YL/VS!F+>+0%/I+&",$B(]QTYZWQA4O=&I\L_A`1*]6Y+[ M)\RQZ`Z]Q;3R/&UN$*Q6'B(6P6&,$4<0\,WF:3A*SHEQAJ$1@^XTR1"?3N`Y M-$9B8]-`E&(&0.`U0)`+ZQQN[I%B9I)]6A_1RMPQV(/%2AQ*JNV-@@(`<2,8 MU-Y+"2P%KHD&H5JFGFOGG.YTZ@WE@@:C=^;9Q7)Y3RS%!$&IMD+1*O!I` MC4/)+J\S#*\84BY*1GA@YK3C2X!`8J4E=4H91X@!C#9I+"Q0R8E!SC`.8TB6 M'(CK(%?_3U+0'EH(D>7"4P$QPQXJTTB`6O'DJLT?T3K=)_(#W+V^CJ1,+KQUL)EZB(17O?/I>(2'VK?*22O*_/IH M8,9;1SSSA#OGI:>0-;(=H"`Y\/A@2_1%\.5(>`=RBLT?YHN8@"-SK1_XIH`\ M=(9)0K`5W$#L'6BV6P72,ZP>;+>^"*KUB_X03/P]GV7%)+]Q636IHYW61F3S MVV)4[)*Q]C<.]25Z@;V1WF#IG**(-,A:1E.S%<`SO!?8.]LZAWN0\,8W..R* M;GSS<(@[-L%'F[_>O^1T-[Q"$^:V8E%7LVJ=) M7++Y=-?^\^NC`7%BE7/(`"HP\0:95V`TH*EJ'/J(INTCP3W-WA+/W/'_LW=M MS6WCR/HOX7YYQ'4W5TBI4>'!FJAI%0B"S!4%GGL[+,P7SX! M_\N#['V`78):S]OB[%+1#Y&X-D5WVST@($&IH$2(Z&=KBR"&SR!UH%R7I?=T M[6T0;,O'2;]\C\"M/JQ6F^JN@4EO#PK15Z%""LV`@UA&UP78NH06XOEW;+:G^%_'GWX`?D:> M><<& M<*G)),$86R0%=-XA3\U^-0#(*RK#WJ]PFQO`=4.UC+?>1R\ARA"2T"I)051$ MBBBJ2`U/]-U*L>4"O81:B[15+Z%N0!8A2*^]A("BT1272/C4S]9:;$"-%@7N MBLS),^7;NI=0-T2+JI2/>;V$N,0>Q3?'X&@,1Z>=2@/V*T(,9,>+1\R1GE1) M+H;O)RS+!F3(H'V:) M#L[-<@O?W3:YY7.UW/IHK4,N;ST@`*FXP0*QJ!H8%Y!PX@_:O9QA58)]EZ%, M8YBF)[E<*O"G-NOOB^7TWYV#?X>!`1$E`+1,2(:ML1)3`OMA-_[T!VBI+(-Z\:N;^]3_VL<78/5R*N43#.J) M=$LL>#4L&.Z-AHH2(*F`7#,,K9%02(*,18J]KX0")(S1%%%EM"<4<0LUV:^& M,W6-)W]G";4YD:`;FN\GD4`(3PG%A',JD=/(".#WZW*&7N-I2T>!MDHCZ`;C M^TLCL#HNA!!BF4]`(2(LVZ_/*Y)]@7'$-,F3;^LT@FZ(OH[H&<-K^Z/RQHXT#*W[%*(`AEA)G6^[K)ETZ1PXC*]@WZNOBSNHV_3V?5BQ5\7?2GU(;^ZH"U(TP92#V!B%'O+4*U M\<&R*3W"C;4@H4#_O?U[`\_;#`_8 M$Z6T%A(#*#1F5'I0BX/8[*)?X^/J>`CTJAIO[W(JXGZDXQ@]B;"D^D'5?'6* MC\<'!(PIEY9)J*-2X$Y1#OUA;S*YKNH(M>5H&=B+9,K4?8HKW=RN-\L(@%FL MMH'X;>_6#S]^3J;+A*V)BWEH/!CI\)2@.4$:`Z8@T8A)1B2MWSO&=:X[,\*# MDM&R77?6*?LQ,C`K*72.:XIM]@BJ)#5-9[" MY]9?'&'NU6BIV:^(2M!Q6_#O"!3[@Y@ZJ-%`S-;/B.OG3C"H).+48`@=.1SF M:.YS/:$19FF-EJ)#">L]!PDN$!P(!&*H&8"I=A-B$&#%:G2-\[D9.R,T)*X@ M*-!16B7>A;B*915-=%L]_?MLWF;R<[J>S%J$OMH_)##H!:1<6$FY@IPGY;!' M(.7P78]U49"O@^%_&09VRFQL,SQ@Y*B%AE/"(0%$2XGK51MNOK(7DW!!E.\NULS"_#M`_S7Q'1Q;)Y\VX<%S@3@#FC)&-(I];J++$QV:9318'Y:3HUE? MW1X0N"3>(I`NY0C(-*/:U.8L@MDY.R,,TPS(HT$QO]@&F>:>J[E>#P]1.5N- MH^.DI7/>:0Y$O6KI;&Z2^PCOSUUJFSP/\8ORK(ZB5[DFV?&GA*A:K:;(.0.< ML4#AZ+?7N;O$Y.JWSHVJKIMU9P-_H3#:BP#Y#J4_JHYAM#<>$G@$P'J.%=16 M26*\>68HH.Q#NO:-JZ[=Z>P)^7&$<,\*W0:)`28JNMI`.HE<7+"OKRCP_$R: M]DVK7G+MZ^!=$RY#N/-@']<=@%YR_X/UBGFOD77,,4T84.AP6@)X+O&Z^P^# M,ZYL!O?#7A;K]YV:ZK/1F%9%9K:JGAI9IA;O_TUCTK\-C`C%*0DV%95`S MQ`@31.U1`(I=T:7<(2GR>\&AX21P$1Y&S*+J7C]^GDWF:S6_2T5U?I[(M&K_ MD&"L0(XH!ZT4'B!(':L-'*7059UN79*%?4F@)`?](L4=;ZOJ;N4CF%N7Z0A8 M+8C8\DD!>PN5<`@KPYB*;R./>]+>(O$R]QQ_A,=A%^#B,$(8EUG8BSD8#-*( M>0PQAQ8H[C$^G$+K*.QB!V27(8-UBB0`61N\'N4>_>73CJ!?0B%MXS.^#Y MM+]\7RS7^WE_FCS=G?HP_QJ_N_JTF*^_KVZ6'ZO&,@WG/CI(&.%Q!C%'M04` M2HCJ'!WJ?:Y7/,(83$%N%I9*:0ZGGHVI0F=T[P^%7UN2].C8@*'@@`&-.)>" M2N@YL8?(0'83Z??CB0S-PCY@+^P,QQ=GL[S]/EFUY]G)P0&Z:$0S([&TF'AG M#+3UBKT0P_L:EP_`#$*UOI$OR;6;>SM-",WOV@17GGTZ2$\\\TYCYRFB3CJG MZH`F8CQ7;;4_4KMB^^Y\O$MOB\]>@FVTYP@J+3?)%D\*PBL@!61&.R^]C.Z[ MKK$P1%U1D?L+;9G]"V%0B:!,*'C?Y)HCY50#DA5!X^`P;FEB;IG[5TJ M>#<$#0?#OP0#W?U]=;N^N7?_BE;`_*'Z,VY--_/M0>#\+OV3#F-^36;IW6K@ M8)?'!(HTC?:$`HQ'=XEI`P\W3;1G5W3'HL=PW8`(E^#9\8E^KI;3Q=WO"6$- M/.ORF$``(]AHHRB4U$'CD:]C2]R(7&TWPARJ'GDV(,*7XYF*&GJY?(S*>-M/ MKC/!?AL?L)3&<<*M(!XB1Z'#M1Y'#A8SYWYNQ1*EOUR_;WZ=!_#U$"N^3I9R MXP220CLCI'=UXJLPKIB!]D0L-Q\VYE&<5MW@+4&K+YN?/V=;#":S??V@#_/[ MQ?+'DPQ;]'-I]X2@G*4TKE0R2$C\@1I[2%V@(O?LH/VUB?=H=0T#;IF;$4_M MXCY/IDU)F<\_%IBA$'IO.&,"8\\EDL\.,L`UM;CH6ZZO[CADPUK\?&@WU:?R M)2?:=K\]+!AJA.4"2&0Y<8HKH.M5&J%RPZLC/)L)`XO+XY!]GR*F$V!I*(JYRR8GY&I6"/&IRF_G$>A+HQ/7UU/IEW% MP&,C`I+`1UV.$"*&<:60=-OXL^$1]%HJB#R$0''CBG-;%:LOUJ!!"Y MK;!&:$N>+<_FMHO=@"SBL_;2=A$;8QV6EENN+)$B_NCVZV)0Y5[C'V67HER1 MMFJ\V`W((@3IM?&B-,Q;G*K00R:LX11QN%\?-0-Y@1GKI4`@J>JJ*D%464KK?QXMFJ)!?#(JR8S*K5G]6O:KZIFLO' M_/;)X`AT$EKB-+0<$Z[D82V>"7V%.B-#D+]SXBP0BQS"+%;KF_N_+19WJ6') MEVKY:WI;K;XL9DU1A[<'!>><<8X1'#4A$-&]H4^7J=(*C=?7J#;.ITEO>)9@ MS-^6B]4J>K?-?6&>?2HH1!V3PD&E*2+(>P!`GJ M`B^[7C)M+B*^.29@)R5AE$F;UF@D!JC&R)ILQV6,4:?^"-(7G(5"E7>;VUW+ M0#N-\YQ^VZ1?MYVRFH.5#0.#`?%-B/NHT5Y(XZCEM-:.0FIU/49)#])^':#L M#]HR-U-75?R>E)1@HTDU6VPK6NSP:.!0X[B@M<5P6_/*:"81Y8[Q_3J=SRZ[ M.4*#I7\*]8EL$>^GFLU2^O#\[M-D^8_J&19-CM";@P)"'$F"'6>I/[521HC: MZW<`YZJ?$9ZV]<^=WF`M8O-6\[C^66KI>/=C.D_*,J+QJSK-GA,C`[16@A1B M\%0`;:%ESW9_A7([;HW0].F?0OUB6V@+>]8EM&,/V%WW4*^JBU<5$#%QTT7::"E/= M;\8-[F[W3Y!ST2S*CD//P#;\.'PZ"`6,PM)KO+T_2CE4]9JP+G!O]ST&9,X' MLF22ZM,D=RP^52C^^)#`N%.&`FPQV]`1J M$7V2;O?^L9@O7A+\M&W;/#`8R*(2-EIQPA1`7HL(Y#YT[7AN&Y7V-R\*UIKH M4\_TB6JY;-6D#U.NFUG,XZ0W<=X[A;F8KW1UOUA6SS(J/TWGB^5T_;A_2Z() M__(IZ<;)^O%3M?Z>[LBEFGT_3MR7+3B+(*7E"C.LJ9<,>^VBA5"?]CM0[N+' M>]H_QRN@HBG=N_=81]^U^03MC1&!8:$]$)9@894TA#`":@7`;6Z*;OL&&N_Q ML*0?,`L5L&AEU[_X7!`4<8X(P0AH#Q6D&MX(K.8!>@BAV.MNL M&^\:OC$B2$=@W/D\B.XGCMX$U?NW2B@&4:Z?-L(3T,')D@=I";K\;S5]^!ZG MIGY%:_NA^F/SXUNU3!59XZQ7-YOU:CV9WZ7SN--;3-='Q8U5IUK^#&B`'9'0 M<@3V:.AH>^5JHQ$RK,=-:V"8QT2Z4YMN7RVC.Q7?>E)()>\8U&LN?N_0#GE_VU;+Z:]MULN'>&@R4DFHH M&+*I6!IQU&.EJ&!:>65.FZG#X.0GT^6VU-;JL+:CPM2/AP^DZ'I:T]#_>E`6-@O1"&,HJUBB^I@F:/,@79+0!':)T5X>)BI((K ML8F^GNF):_/'!P1@.:8">![_2;6DB`!BOS+ALXN>C)"28Z#'8@"97(9M)V_@ MOS4D,,:UCT@AC(0GRF&'Z]7!"-WU,.Y<\9YD2Q:B)?BRGV-T4U:[:1_V@4]5 MV=,N?#68(BQS;S$U;16T." M9CA=U!)61Z"L\TPYNU^=B7^X'K*,T"[J22J7XMQ)V^CM05'Q&FH=L9);'%]6 MDGZJC0-S3;=ZSQ=R"]9DH5HL\=ALE@DIM5I5Z]7)/>VM(0$9HHQ+J3MQB4H8 M0DR]6?L2K68ORIFN(CZ6>B6L8+>QV$^W.Z^L<)FZAI6,#",&H!=@`2X9P" M0M96G];VBKJUCM`NZE$R9?GW'):3UE'3L$!8=#D8H\!@3*U7#H!:*QL'S?7L M=?T(^TT&G8UM"0;YQ;**K\Z^2UG\]:_)\K3WWS0L*`RCD;74C[!_/V7I#]N2=T)3@[LO?TU^GN3.\0'!DV@-$HLUHDQ12)F,FGNO MLEUV,Y,1Q@,&84TOJ);=LU:U`?"Q1179QG$!>8LPEDQ[S0P$CD(E]^NT5N9: M32.L=#)JJ^E\T92E8#W=F_O#'[=.JOJQV,S7?RS6-_?WZ=>'^'*NUF8QF\47 M;#F9M6)J_N.#,8@@)#FVJ6`1<0B[^HQ>\VLZ?NF)/6]RLI@01D#=O=/\.!Q] M6W]%X"D]UU$E.+/,8Z0-0[6_KEENI'74.WI!"@\EB%$D%+;^8`U-^C]IW/\G M'1X2O3PBQ"*CL/62.H:$`'O!4Q-UV662#@\K.I4I^-LG@Q,B:F&;DF`)H4!1 MZ?<10$I9=CV[46^*`TK]37V3@W:Y.@>'?.QV1]`-H]+52V4M459!)HCU,"UQ MMT:EQ54FC':4[M%B!WV@>4'&G`R1-HX+5CL.L;-468`A$4K741A*-+^B&&DO MTF['H"QL+U_"ZC_L75EWV[B2_D?%"$^\G@G@((/3DFOGP.HX MU2IOJ.S)D)H-TPDU2>EJ M2^L0SFN-^CF!'3C,*&($8QFX95#-TDHYH:9MW0B[2=2O&;;7%+/1$2M'#958 M2<:)9B+4"A5,F%`N73<"/B]FTPS5835.LTC-LP\,J*<**\O+.FC!!82=J^?D MW(1:AW>_*:6B."PS_A%70EGI[&;Q_-GQTL`GW\V81$$#2*(4Y_&0L6W0L)\O M1C!)_9(@[8/,Z0;7ZW((?RAOGET#O?Z=SW(+)@&,(@ M;`C1UG0(&%1)9MHJ."V%:]1O/7+UC&/=*`1YK9X%A107()6.3.#M="UPM3IXG3HIFDKM5IP8A!SG,2G"&>!W#4U=`)GMP#X$KXV%S8C5*5 M&V%[K:G*GD@O**(""+=!8^!5J%1;Z]$D-^`VPFZ2JMP,V^L,'W.!XLHCV+J` MA0-&D*KGZ(-(S=(;M:]]M#MB=X*ZWL@T-P(1ZHAU%+0CREKCJWE*&WZ2R/39 MTFX4F6Z&[50BT]3A,FRJ&-8((\T(L:B:-9=3VB([DGY*9+H9R$.&B,[ETIO/ M9W$!SP\1/J+Y[6_&> M6SRO&:+74>E,>D45)D%2Q`51Q@I<[]>$V0DEHK<7ZQF5SIK!>2GW>:V>FR5! M'/N"S,B`1#0'@HAV`::>,7"UYP71U//:".^M7L&&UXO,II"%$9$$1:P.P1M+ M+>`Z_J9]2&[N=F4<32!`0F)&$ZBO*S%C5P>L>(I#>HB'F>T+Y?+^K?BZ7=V_ M$C1>!KVI=SA(#'$S=)Z[H%69B1H<0JJL:'SR8E(_.'TJ>U2L5O//\YTFOMFL M;SZ;V]O-TZ:\;'IW2,:GPG5#\IJUXSZ_=WP318:SUOFOW*P/*.05E67E.5,#>AVK.X)*[ MN%\%BYJ*/:%V?S-XKS.S`5!4U&`!>>T"BY.45%9SE!`F%+FYS.[6'?;7FZS@ M%$9$1]0X$DX)#MS6NAZ9Y.C@"-54)])NE*S0#-OKB2ACS**N9;8LQ86#EE11 M5*\W829D=7\]6G_&N^V.3_*(J[U8?\M&UT^*4,!/9" M!,.I"8(Z+VVH];0A!$]G/^N'-YU!.Y6\J`#,26\5U@IYP;Q!AM<'%6Y23VHC M3%7HAU`]@#P$M5RQBN;A=C68U=6;>88L!,"!6'JI1)L\H6O$8;[ M^B%-6T2O]>:5)D%18R`:B?$_:BEBIIHEX2ZUILL(EJV7[Q`8AB1@X1V*UAR7U-0N6FR22YR/\$C6"WV,W= M?V]6ZU+WGKO%OTR6.2L'KZ^?S*R+QURNK-"4XKA,N1&URPZ%Y+/?",WXRYAC M(Q'<85LE>*/E=B")[*07W+II811\K)?4G M,R:QLG'#MP&XM`)0T*Q"5W"=6G)\A&;/U:V6@61Z77F[?^1_K\LA_*J@]ETZ MI:4!!=",>XX4`>V0JWL#$<=.%I_I&Z>FO34TXMIA3#UG6CA;-HU#=?,O(B=Y MDN]1ZB=Z:S1#^_PM=I7?_MM]\?7?[_)Y21I6_E%RA;W@2OPH>Y_?SQYAL2[; M![WMEW[CJ0PK*I@#;`B)ZDW9J'J?1\W-)`LN-917T15ZW5$6J@]-H MDLW=TE1!#W!>:XS)8\&(="$PCC45DGH=JEE*]=-T&3A;V$UB3,VPO:88$P[( M26&])"9"AA`+1M3]$PV;9&2RC8#/BS$U0_5:8TQ4*(:%DY(C0`Y+J>H:ZH'1 M9$_]J+>I#KG3(;878%`%1%,*??]>1@Q10C`3!$@6%73$KF[);B;:NZ(_#K4" M=P@2O=5+_82E?.B53!IB`Q`:D<*$,0GD>:<'Z5*=*J.F3CLKN2,H+T64D_;Q MX9<:H5.,-)U8`J:*(FU$2IK7C/ MO5+>#-%I7"GW1@K$J2,.^XAF7&6A/BY*XB;4^Z.]V!.NE#>#=PA*M2^22!D* M@G!//4@;M3)QE#\?&'"JMV^$9^_.*=,>SF%=Q.\3VT):9*PO4SDHIDH*)JBN MVCT'Q9+W)CX^BG0?14A%<5AF]%&0D!A$B%(2:^T\0/R;UA$VKMB$]J)6TFY< M?;`9KLT#U//%UWRU+EE$]W^7_*$O^+/[],50/Q2ED&:/YJG8+-YBS8DW,E2V M7*5Q#Y54!>JEQ+1.V#`FN7CE"#>A+KC2+9ICR`R]AOQI!\0`4V6W+LX))M+7 M+8(#"B&UFO2HO81=ZK.+B6((@O\V^WO^M'GZE)<&930R?YNM-\OY^MO-Y[UC MW6VB@!>W+VHBK_`1!B=]7T:LCM:KM8(0"=9XHD/M_,>2IEY`'K6OJ3U%A\!Z MP+A:-5HW6SV$Q^)_RV-/;4S\4=C\90JUCS-=W'_(_UYC\ENQ6#\<.QMT\P.9 M(%010IBD`8.U5G)>RRD>N%(5Z:B/$^U9>A'P1Y$#'ZV;_/MA_;3I[-AJI4S4 M.Q0H`N9%8-)I9@`8]9J=O,,U&IS*ZPHVCN:O;H&JOS8+DO'(:D!<>&^8X83Q M"BDD^,23V#KGTSE673^B&?9XLOI8/,YOOS6CY^N7,HU40$@1KT!K0!)9IOBD M'Z@?G'Z_?&^6*VN)W/'C\6JWG)FC";+_]K]K@Y M:\OK^)MJBQ>5UA`;XXD9[GPS M-P=]-]LS2:G?.N!^\]_*0GG;UP&*YRR-*5,$>U?CJ4GJ07-BVW!/[.]=7I&"X\LX&(FB1L*<2DT, MLMSZ2F['(O;[>SBX'<7EM\MMO/9Y2OM_JWA:?'+ M\K[8J@"DB=@J@/*3[-@O'3GGG?UNQJ7TS%%/-2$82\HMLYAQB8C7AO*3U=S/ MR58X[SK]I_Q^7@YJL?XP>WJKWL:A1S/!4>!4:6^9T0)3C(FJYH"82*T%/:(3 M5`_R_.'2?2M0^ZJQX/+RCM/CN[AV_O[/_-M15KQZ-O.,:2.YQ(@I@RTA@J<%C_^/ M(-C@,3;5Z%U@J5?'1F1(#J$TVF#:/2.JR997<`]0X>4CF8^*S0E'5=EU!?L@ MG:JW/NE#:E;LB)(?^N5`"S#[$WX\<\R+N^.;Q9O/9EJ$J,8H#@J\)]1YK$1- M7YJ\4XB?C0YM4.V/%\\;6(B?'*K?=N#IS()!!C18IY7&QF,4SZ?[6:B@4RL: MR)^-&^UP[9L=.^:>SX\7SV<&(6<5%MCYLN2#Q-+P:B::0&K-'?5S,B0=V>XY M8N*P[K9#>YS='^#%=\]DBH&DDB-LO04AG&.X9K4-.+6&COY9N-`&S=X\%,73 M4['X?5W<_O7[0\1F=;-9K]:SQ=U\<8@4IU_,)(`QGDA;EI,B\2\E0C4W`)+< MO1S]+%3I'.,^_M!G)%&=.B5C%EN"/C@G>-<*&&Y MPTXS1AP':.E5[FZ&YX2W#KZ3,1YGZ2AS1(+P''L*L)]CT%1.Z.YD>S$7_8`Z MY)J\9,WV+I>F$4(1`4I')<<`&4Q!;A'VFFFC3Z8A]!3EKL*$IXJM?_]@YI40 M2!KM?"#1&&1!LVHVG%/U,RS"LP7Z.JC;!LE!,A\V?Z[R_]G$$<+7O3?I1'FG M`V]D7GHCC)**2R^BQ6`%I]7<**83"!"V%>IK;G0"Y(5(2TN#BCU;S8P&E=I09(U':2O@T8Y(PO0!G3I;D>?/YC(G`XK'$@@M!E7=B ME,+5O+!TR4>TJ^!*4]D>9TL2HMT?Z--:>5`5SZ1"@+<$"(E;KN!0C=IJ2(T8 MCBC-H*/-I3UX??EPSN_DX113<6"!``V>(:HCY_?C%5:BU%C0B!9]*RD=ZN31 M#+;C8CZ0*?=Q=X!SQS,M5-6H&1="1J,L5-J#8U`2RY]L&(,H.Z/BVTQ3!I MP7_8/.7+$OI3>;`_/)@ICS#1WG./$03,E6:D&IWW[*1[?+`V4J(:CF`G4"N\K0!?5]1L`5_20O?Y MHGB:+\Y9ZF\\FE%)<-1E2B*%+6`0`=MJA%(E=PX8LWW>3MR,WZ_5R_N=FO;VD5&P_BS/([S[.OFTC MVLMEV:1E>_7I"/O:?WGF*:6>:V=Q,`(KBK"N7';"1:O^^A5/NHE'9=T3(:I>16*CAFO,44:#7PXT^_/O+0H M!*9%`.\,5,F<>I1;\R'^73K[Y+0#^,9*F[_>K=:;:JRB[MTTMUJV_[C MS9=R2G&J^?)V'C7_4<]1TR_+M.(R`-),>D^9Y%1"I2PDCP9/(AE'=+FH!S+V MCO-@S/N4?]DL;Q^B1?%Q6=PO9T]FLWXHEF5MY=V2.59M^,QOR*Q$2$NFK/<: M"V.MX95?5PI(#D>-Z/)27QSK'-QAJM]4@S;WRWQGF^Z+(\_S8P>/XR]F%()R M$`RECM,01%3A]4RQ9:FU.4=TZ:D'&G6*Z9#)C1G^NGK*ZX%O/1YF<;>W^A-J[C3ZQHQJ)4TDM](L."*L M"_N+N!$?1-F$2@VVI\C!$CA]0M[GFJ^+&?Z6S\JJ0+O"0:M5OBT?]'X^^W/^ MN-53-XM/I%DK:B>9_J62/8BNWLAFOC`AV*Q_$Y2IY*G._N-C%L0H*G".GCA$,BR0OT> M0T_X!!(FNJ72ZT8!%Q+$$!;I^V)Q'\7RY/,_S\G9?NOQ3`O'L8A6-C9.D[+E M@D'5K!0AJ9=FQTROX9A0="Z`2]#J9);WVR]DP")"SEI+`K?86T:)JF9FO9A0 MTX%V@CW!DB0TA^!)O:#LM_K/_YCGR_C;#]_>YU_SQQ,*Z;POR#32T7I4#"G/ ME:3:$%HO-V*2JX*,*.HV'A75BT@&)>-+F_O'*9S498V^)[/QN*&(\LP:KZ2G M(N#P;)60U$Z-(U1Q71/C$.]Z@'U0^KU;?-FL5UM`\,GK+D?>R@1!A&@=#\Y4 M8R/JC'$[IOV9/L#S&L-=:7XA-)XM/^K;$L^\`>O6[W_%0FXB0\!4^M"\P[#V!\[3L".X&\Y7$PK#WV M0_EW_]@[&$]X=:O',A\H)P$15-XT8C8H"S42P@;[:^?LED$MP!^"0N6PGEO/ MU)`=8=.!-^)1"0,)NKP:Y[@K;[+IVJT=K#>)Q!IAHN8XB-6-'`;)>M_"]$90 M^(RLA)/O9G%.Q&-;EO&BB*AXL'J!7R`G>X=?3_+F.'C7M42&N8[V-5^MOS_N M/P_\"/V.OYAI'[QG+J)%!)%22*-L'1FD4W+M=BCU'^Z5=0CQ(!Z38IG/[Q>[ M9BZWWURQV`*P1:@9NQI^4P8>(6>@;`$@*0B%F:BQ`,"IE?-':/WW1[=^,4_S M5VP6=V5687$[+UL"_G.^?GBW6L[RQ_G'8K6&IR^/Q?8NI?YN2JLJZ_. MC->42D(LC08$TUJ@_V?O6IO;QI7L/\KB_?B(Y[VSE9M))3.?48K,.+HKBUE9 MRB3WUR\@F;3C6"()D13-V9JIJ7%"T.C3AXWN!AJM:Z0I4;G[#1.,&/IGW964 M<%6O+L>;"]0819@2F!,"&*'QAUJ^*'BN:>L>/0Q6#CN\:>L+W5%2%X^>:UY@ MT.X%@5$)&'>61TRI.AIS,C4HG6),SC>A@$+5O/3B'QY,_KMR9Q;Q M%<7-DP]D=G5,3'(@!.0"&J"HM9)@*#%A\>-7C#6Z`P-+>G[%/BS1?V[*3_?% M]EO:TC\<,(E_76Z6<=1C__2W$39I$_9<.$Y]1-0B3!E$BEB%SG7*IKR8CLZG/*Q'Y=/E#L;;+A4J/?ZZH!%`CEH8'6'# M+`+"BF@M=U`%P)"%RZU1UP@1FP1(LZYD>4-MX1]@H7ZRG0JQ]UC+X1=?0]/I3K M]=SVF+0F5BJDC5;`3($9DXU4BDW>F1M]C,AY[SREV0GFN(4+I M%N$'1)40?Y<]IM;$&GJ/J9L^1L[NUN<\S'IQ?]\^J?OKN.`)CJ)Q3CF/@DJ) M"/:5G):#.6;*1J?(Z5SNQ0IY93'J7O1T)PVVCB7UB*N!-'6&"(!D[B2W%F1>]G"O,.-WHQS M?YJ9[T9;Q-9AQ@@V5$$#K93:5#@8QO]^=PJV)L9%&VW=8'^=&R-,*X]5NA@? M2<9I%!#`2D8$W(RZ$@RD^PX;(]VP'J><.?42?FS"DM2;%'E^73TS*C@2172. M$6:90L!ZCFK<`'TKBY6OMI]K!?,>$T/292K4*F)$C2IPL[SEYMJ&<@)Z''UW M).T6SF9#A#,J.:641SL'B1(\.OY&$N4=HM2[:Q?=/)ERFT9B9\<%J150V&/# MK#+8:2*1JV2%>I9[[!>I_-2WW@.XHW^T5^P(.,1GBY@3V@$@(M:"(`N@875M M+&N^*7"@8R]U4[FN!>^/5^%VZQ?8P^\)1,;/P$B,K<"IP3.EI+Y[U&([QU30 M190ZV4EP?&4,:4;^498W?ZW6ZRC&[[LOQ?:W^)+-[2K.]BC>56S)DTD]GT^G M&SHZO2<@8JD4G#A"HY_H/"0$1]NN`28Q;O&-H>`5L6AC3KJ]*$`/(9!<>J>= MEXIAR&F%AH5V1A?+#<22F<@- M#M.E-E3HP(@'`<0U$"-(L2:6ZY)I5\F,,9Y<8&TOM)'^(2 MG$8V[^I^<"TL`*HAATGD2O'#DG724'E#SW^/84^=&/ M/G\YYI^/YGE6G+@VU)2;^_U=L?UGL5COOBRCZ">WE,\^'Z"%!B".&&=8(^(Y M9:R:*Z%P1E(`(3`>(B>!>\VIN MT:^=T:4$/6CX0O2R-/OA^_LOB^W=8EGL=ZOE8GU_7L$G'@_2`XV5D4Q33JDR MFME:7B1<;III@MOX/>BY'Q"SU/WQ:[%<1?OQX^-R56R618.Z3SP>)(/,TQ@` M4R2@8#-X8K7@4@;0F4H>1G!N%G"* MRW;/(=NE6([)C50#Z&(!!Q02#1GQU%(5OX`'F9S`,ZJ+ MNT"?)YB1C^.8W&A!B"!BR.%353D@$1$3HPX"J]EK/EZ1SM=BNRIO8G"]W8W" MA2P-GF!#1Q#'I(!:_N]^%75@]VD_\_T!Y#9)]!>&!:]2(.-1NM,ONK?($NOK MW"E',XH#AR!)#Y".29SW^^WRR^*^4,MEZG^:KOR_^??^H=52"P:='1^\(8A9 MGK;-H\\FB)8:UW)[1#*IU#G4_%9L/Y6OD$Q]HCLFJPY===='M76BT\L#@X(2 MD?CU`$&=,1`#RFL/SRN9N\TUP1AV"!;U`NK4'!IN&-$^8F*XP,)QXF6]%K/X M5V/%OT>'QFUN7ATM.D)XS0,,CS^;Q:ZX+;>KXO[O=YB!$:,%H8HZH;!R@&O[ M8.\A@KQ[7X)3>Q;V@'[6AE"T^[OMZM/^H*!T MA'U9;&(H>+LMCI4DY_>*VHT.RE$F+!8>:8@)!=8#6?OCP^KVRQF6M1P94KL\X#%#0EJK*+3.U+Y*=&)R MB]TZIQ/'R`$-S;%A,!^#7V9_OROOBNV'XIB(N/^R^MK,K3.C4KM:H*BG0@%F MA.>"^D=_PXO1CK',B5?]X3T&I_[8+FZ*N\7V?YJ)]/S1()G3/+JLGCE'!-9" M>5+["=;DIH\FF%$ZFY\"XPL2$1W?%)3U#L&XQCNKM7*>1@SJ3\OY MW#,=$]JBO5(R8EA%3("4'9,2&6\+UEJ)!#1.2<)L-`1?1QB*#J;"5W!;1&1T0&I->0V"?E7=LO]:^/7-@.?=5@2KMG4&6><4Q MT1"(ZH!W7+JUS,T73:@\963?9B1-7'FWY1_;\CYSK^\P-'`#)6;<"^:91QP[ MHFIK#@B;@=LR/!':;ZKD8'YEAJGE>@ZSS.G7A9T,0* MFYH(((:=TMP9R.N=?95=8#VAM75*+.Q'"Q,(Z]SWY7I_L]KA%/[H#.L5\6N>.K[B5:W7.6!,,%00,13U8*!A0+JH M%$(Y(!`:2*]TO>(+9;^=KF;]951@,>`PS!)EN=0\=3,'HI(3$S6C6ZX&TG_S MK6F96.==E-&82GGQRS['HE[>&Y33*-WOHXSWRE&LK*ME]]K,()@;AV?7T,:0 M"\^Q)\`X:A9R3D"&*##I>O$`2=A8X@XFIQM MEHYSPP)GW@HNH./1+8I1F?/I@/%14JO)C+I=]J+O%[O1]`+M2!_H-P/RW%21@]35/O=EW*[VOUHU8WN^8!`G*)"$Q[M`G+0 M**H]JR0S'LV@L>&%&CUE=2^!\3H$:=D[[MT+YQL,%+ST;C#`$<.2DELQ98V'T\6NA:?:Y[@F%7/V8 MAKX0',,JN,^?B^4N1GCU?#\L=H4ITX4H^]7F]O?HOQW+%<[8B?8O"1A:3IB4 MWJHH.`*,Q-#Q`0%'R0RJSGO0?CD2O%EFY,_-MEB6MYO5?XJ;.!5=;(K/JW2- MQ,-&1SW)]\5FL4Y=@8Z)BR)J;J>6R^V^>.GZK-[>'2P3CEM"E9"<(JFL8J#" M@#&3Z\%,V$SE4^Q:J(]AVDZ+EC=]X>(_JA+OOB[O5YJ#)ER1PW[^FXN8VOGF[-P5#N8JHRW067FH(4B?' M"@OA;.[1SZEM]_?*O6$QSG7BC\TNXR06W\M/Z]7MJ9-R9Y\/,@)+L'9(:BP9 M95K#&A//>:XC-K7-^?Y6R9Z0'#:U>E-\VA4WJ:6*C?^GMMO%YO98Z7?-7*NZ MO=T6$:WBZ01;9%O/C@O0(L2]D8CH:.:-<\81(R$T"!OG86.AWC"R)MQ_V\0I M[A/L3;W'7G@Z4$*QH4#9U`];6&"5K.62R,ZH&TQ/^OWE`H=+,1W#$ZA:'QWN MM+U?'91U/F%[8D0`E'&%,&8`.1-=;T%9+9L65,Z'+Q=IMAP"S6LQY7@1/8^)5);H'7T``LJ`5`I^MRCO(2YF;4Y?!BC;=@T"789OF#O]]%`]K0V>3Q MD2`X4C"Z*CY:4Y\JZ;"H98W_G<'NS@#:*7L!L[VIN"^6;V[+;_]U4ZR2E2#I M?Y+JR1/C$/\HO(U36;O-[O1>WPM/!8D=U`A%CU5#323QBH)JU@BX&1V?T?_45:*GN![;55^>>+ M.X8Y/+':O3]&O*9\_[:A`^.O3P9JK!#(.:0AL1)K+GDM(&5^!MN7_>CT8NC& M<(K-/N*]638=E;/ORR MX_I7_?1\$:S^/*CU^F%ZZ=+Z4POBN<>#B/X?!`PZY5'J(,M!ZBWZX`4ZG]M& M94*6_C)%EKUC.#@KW)\?SK$@_G7`.LKMM+1:8Q;%I]J:.KCL.?: M[X[=&(O!S^:N84GX]>&`#(<,(\I>ME-#PJ''&&":0$T59@PY#.N(0I`9':"^1+5G69*-9E:XH.@;#/[-T@""SP<37=\3#)<2$(8Q09X`$6-04']2 MA*H91-S]J;<<#^@\$I$WH,V<4!.).KXG*`8H0P98!(33D"FO88#.8\XL-DBIBFQ!NYT>TV0$M)4?1B_`Z.1(=J)!Q^?:"Q<;E0\>8_X M8OH,BG/N^B6/$WE;+C9Q'G'Y)(U+U:DAD?,,&N&HEDY[2+FRZ>:2XXRIE;GW M.TSHW-A@JU)/F.:Q`+^1][4U._QZU,2"TT."--1A096TS/(X:PHJRT72'DDVB3>Y'\]C@I.>:^?1K@;?2>X]X MS>3XIYF\X+/G1?_@YIH)^O$9/V&CF3@U)'"JD!:FH0_>\^<"`LP:BH&P`G-/2:0IJ^9F*7L]7T9D/E* M=OMM:8M->:AN2"W/MG$TWF)]LUW\=3(;W\M[`TSG';QWD`.#4@I;B5IV MAUGV6?KY9V+'17Z,K:`/Q;=R_6VUN351::N=7RQ7Z]7N1V/CCK/C`@5<4^2U ML##BJYEPBM1>N^2Y=75PSFG:(9`=@T%OR\UM\\L#@J1"&VN,P%A+IA3` MH$X+QJ5\1B5@ERFV@259:&8Y0-72V!`P/7LL:&N9LIQB9FS\&"SW4EP&$K<[?3W#[LD_X)I-%I&\@HA\.%>>ZW-PTGJYYX>D`L9?`(D>09,A08C'" MU3R1<[FV<8);D+U2H`\PLY1^].$_/_CPJR<5W>?5WS0N&$N4U%I#@%5D+$(R M]61[2'CFQ_`3])C[)$+/L.85IWXKMG:[^'RZ.>9+CP6D?9P%--H*+1W6SJ%Z M9D[SW'.6$]Q<[%/AEZ&89^?9&R@?#SDTF/F7'@[CM.Z4UQQ((JBRK?3=D M4>XU-!/<,.S5RO>`9?;*#@AMK?.7'P\*2T@HA1Y@8Y534FI;^R!,YIY.F^"^ M8-]K^^5HMG*4)[CCUKNC/-XNRBO:K>H5Y4D>AJ,G#P?_:_$#X3B&-VQ*=7A' MH,Y)(3B/8D@7`RYJ82T3%#"[9F3F*9X!,;X@HCTQGSK,1BW(T_5%P1LH++$` M"<_C/]*SQS0(ACZ;03-/)0T-=#L+/_N$T\1.R],WX!>SL7EF-F3C%]KZ'0$A MYBS%@GOOHZUQ6-)'EUNQ[+O7YI^E&@KC=M_ES),_USX_F`*5GR?PW_OU#RA3 MT57S^M@P-"@M,6"*>O%_Y5WK2[)Z?*$:F M;=78HE>2,\G;+R!9]"4624$D12N5&D]B`13PX4.SN]'HIA8C9;P3M;WC@<^N M(7#F#J+^H>VVU\[=%S/F=<-]&)^[YV.@:Q/[X#QW]\>8UZSWG62?N_/CQ/>] MH@'=^0#VC;9QR3F)`W)2"X"Y,!@2]31&GGO/#_T"CHLCLG;^;X5@LNXG+\_4DO-=HX)?QK1\:2NJU]`B` M2\*-5#+EH?;.8:)JOEB)<[T($[1GALL_E8MF7JS+3:JK,5_,JL4ZSO[BKT5$ M[F9^?U\N9VDAKO=6Y6WO&:3SPFOL#"'2:D@T\;5"&_6%UGK?[R]`I1VFK$G872$04Q%MS57FPG<>YQP01?XWVQ MIW]43\";-@@->>ZF@$8PB08H*K6IP22\\V MB=#QG#@"QE'$Q9,OL4E,/+4*<;"60ZD1=`H)`+3BM4[FL,A& M,2^8>UOQL+QRO+'_B8$"4==9XI M+*6.2IC!7(G=S`3+MH8F>"C5JS4T+,QCB)*+]4VY3"ZF+X\NI@:!\E/;X)F( M`E`I'-^5#K&$6'W+2=+LLF83/&?K6ZP3=_N/NC;&+-`4\)DD-@%5`6`2>LQXJI^@)5A#,WS<,$#QJ'-7_Z1'E\IOFR M5!L1VIE5=8^0?-]`"6Z4!_$_1P2M):P"-ONN]P3/48>E4"ZD8]%E=RRB%I<; M"R[]W51W7R,,EYW8T_Z`X#WV4$)*HMXGE8YF(*MGSBC-]A&?L9-X4(2S-.HT MDMK&+Q:7VS(MZX])/E:+ZFKW$MZG2G?M'Y3G4$L;Q:F!WB/`R5.\`:`JN\;1 M&3N%AP1X'*_,DP+W1[78%O!I$CQO=PB,4Z,))MYI0BC$T%%:Y]90.EO0_`)^ MWUX0'84K<:H75Z].W8OO\[N')\^C*>[C)^L?30PZX#'!&@`\1IQ%%<](X(P# M3^GAM,DNP/4+N(4'Q/D$&G4Q.UBEKKL$PY3SSH"TCRBF5#A9!X5(C'/]R%.\ M'C"P3IV+Z1B,V97RWFIHF\7Z5,ZJZT6R(G^_C,.?7\V30URM5N5Z]5CF^S(J M=Q_BK]/^F)>K^%F63('[V64K"F M>,NA;VY/>:'&%['_*M8/RU03N%AWCP5XWBDX:85F*OZPU@+A/'Q*%4-H=DS) M%&^&#"MFCT#UO0E:,P4IVSR(@+CE#F@)HI4OD93:HSI2E6.MW#WCC._3U"1)%(I16*WZ(U4,J"^GW@/[[.II9#_/539KYQ55"HM6.V=\I6!Y%/J8&<8P18-):4;L; M39QX;MCF+W`ZT!NJI_*U^&*^_$_B^<75=MP7#^O5.F7P7%P?Z&]I>E0@*(I1 M)Y"S2"&I`*:J]CP)H7/=P%.\TC6&SZ5'K)\Q[Q]_?PYS_-X_M[]^_=O'_C^A M=A^787Y=_=^LNMN"_?NSU(\I6.CE-Y??UV5L3X:]34N M4#%KDIB-_0)F0!CEM'=*<(6QM!`9&9=4(FH\;C61A[.^TMGV;;5Z6)9?(L(Z M?M&?+:;7&SV"(9IJI$UDJ>/*.V.8W,V/86-R-8GI[=>>UOD-X^MX7,?:G)O; M4*L#M^<>A7;[W)9-MJ=EP`9AQ['SDG@%L:%*02B%]<09H6AK?HV!0DMG-^7E MPVVY?<%OP.JRMYJZ!1_?!=$)AK4,2I=C0!V5+I^*O_X5=<3EO+CMQ);G[4.T^H!DSJKXAT?S'R(O M:IB`R77V3C"095"R'('IJ%QI#OU^WBQHZ96ADEGE&`808N7J62"=G7[A\%"4 M:EWN_;E<=#.](NS7)_3'6; M4N5(*EO(M4_W,:'D`D)".2`T+JAK]=P-[4*IQ_YX]IKA3FE^1`!`I%,7[30$ ME&B@[!,"QMI?9/MVYL%>-TNO,`^]E5?K=-QR M5V&4F)L]PVVMLMW<,1BI&8$TOD8)=%1" MRC#WS35FN/Z353NO:+._V=0EQ MIH&6^>[IML(Z?WIO+NT"MXKB&4D#@++1=. M,2O1;H[6VS,Z3^UCH=]*A-,+L%-0Y%8*I0D>IYU82<_&?`S6F6JU_FG`#01[LWT0E!NNA;/"00%YG!*PM0HH9/:- MB7?(I8S%KOJ'^#367!MY]O0(2D,&.`'68>^BM!=4U$@ADE^ZXI>D3S\@CT&@ MW^++_4.U6ETLNM'GS?9!,VX9P:FN,[.>0BQ,K1TP:W-CK-_C>^QX\O0!\3A1 M(K/JKDPC]1&FPR51I_Y!QGT"#=1">"D4U!Y[LILW1VJ\N))SH-80D(]!M7\O MEF5QFV[%OKDY.IQ1=7Q"@$;[:.$P+2P1@$'";(VLR8^&G&`NE!'H-@SH8Q!. M?2OFM\DB\=7R^=(-3+XDZ#C;/9P]W";4E7_MHP0O@15EU?5LOQ2?#^& MH]V^(5"F#*"<4@8]YCAJN*Y^=WB;G25Q@F;$R8D[R(I,F\T)Y6'9_.(;`L#6 M,\2(X='"SBV1WMVODELV+S;7.RR^_,*F/69A3D/II3J_G>`!O M]S\D,`D8A5$;]\IZY#%0HO9%I3+CYV,7C^2[NS(3#/$9'83SD M#OY<7F_K4D8%]6[3_21;^'$8G\K[Y-187'?8Q_NZ!`X0L,0:2KA#AFACH=G< M;U(:$M5^GCS.#`][&7?H'3`"3FK)E3,*8`_UIF;%=M[2YR?KG][&/7[I?RJF MUS>\X^[94UZYZ7/K.L#_S9$N@? MCQ]VOXG3^6G!6,*5UA!%19)%@ENOV`X79>ROL+4[4V-O@-50<(\2WY=J1:V#X3YJ/\H(P1`@LULI^^ M?[PIXEMK5CZLY[/B=O\]D:;F`7J6$B$#SX%0S#H*.*Y'JGSN!9$I1C\>O\[] M@)BUW)_OR]D\RH\?GV?S4Y^J%!H/O36Z5F@HMKDA#A,\ M>>MAN?L!<90#W-O;S66EG5K2>F?L[0[!,,IY!,2F1$`$.\TUV!$N4]4.87N$E?70EIH,D;K8..]K6TQ@#"XP_$*84U-G&"H^6- M_E8NOU;OF2S'@SN*>KR-D]_,.2746Q>+ZWE=FJY)36[L&)076DIDD%2*4.@U M9[693Y7,O7-Y&!+UBO(H?&KES7;DEAA!29Q\G$+*N^]=*ESXZ."CV>4E M#[:VW[V8R<)SW//W$P:_]7G\#J5U)%6%0`!KYX`!8)M.%`-A9?M5^DDO.UVP_.N1=)$P>[H$Z`P2!A(C#:($2X"CA9&"J!"S0+!6W7N< M&7:2(?OZ!.H8\8X*0YP"QG*,E=S-D5)Y3B?C1R_S:RG1$ZACRH'&=W\/8N#N MKEC^B&)S?KV87\UGQ6*M9K-4<#3*SH_5[7PV/Y%<^'D874IZ[NT4F$Q)_J)F M1Q&#R6H$"NZ"HCFQ)[I2<[&\+A:/]DDZS(^COMQNS<7EQV>K>G'EYXMBDPB2M!(*Y-R+TK.J=#:"Z1V*Q)WWQDE$.R#EJ^](]-> MK6%%9!>A%6>V25MP` M:,7<&;S`AEO2JA]01R-%:S3#LU9!TSA?A9QBW"(!5#KCVLZ!4D;!&>4!1U!`SX%/U9/(=A[1HA3\#`3#4:OW M.G#E".S&"7#ZWHT#S]L%K9%B4%'K%8^X8J&(2_/P`,5)M?NBWD_D22\<.`*[ MO*#73B^U#PUQ2#F/"1X:"9D6VJ>,:0(":^CN_<@HS+W=,"%6#*XRC(![%J-J M.[O8G"B6RV]Q#(OKJ[)V7Q09( M3(SVW%)$<)J!THXKF'WG\GW*ER/9TC_>68SYXZUOC_;Y_-M\_6,?5QH[!01M M2EA,)3:6:@\X(AO+WD(BH\)U!L%%X[&D3Z0GX34U-TF?^WWQ[,/E/$K-^\CY MLSH1(EH@#HU.(:C()+65/N:S]1XP?:)RYX^.YU?C_K']V>4DXV:A\4^*GTUP`8CV'+OC@JZLZIIFY1:Z).2\(1]B3* M-2)DM/\>9ZD`.Z,[%@,PJ4=DQ^#/EV6Q6,4U22^*SSO]^=D9XS::LF[UTR>; M&P#;:3;0K<=O"8)0))PBU"O'F#:$1@@5<]HP#$7V-;()Z3H#LO-T"S$&F?\H M_WJNY%2+^-?9]H2\UH-6;RM"781F'X\/WD$-F6/"&\*`1A9PL%LY#>!H<=[O MDKXG6($V%?X??T^-OQ:K,O[C?U!+`P04````"``DA6)'53/M+Y40``"#O@`` M$0`<`'!R9V\M,C`Q-3`Y,C8N>'-D550)``-TV#=6=-@W5G5X"P`!!"4.```$ M.0$``.T=V7+;./)]J_8?N'K*/L@Z;"=Q*IXI'TG&NT[LLI.=>9N"2$C"A`(T M`"A;^_7;``_Q``_(M_O^V?W%U57OYY_^_K?W_^CW?SN_NW8NF1LL,)7.!<=(8L]Y('+N M_.IA\=V9P'],T`^F1+L`1<^5IUD`%+-$O$9EE_0`HLECHZ')^/7/0<$I>*=3^CW#/#CA/L'C,\`C6!%1X)D`@.QK\]OGZ7INZ!Y9W'&U[LE@R+AU:L-D4 MB8E)_AM!2R]L?COJ'HYX3>LPU]4?C)[*Q&<%V;,1X M.V'C9("XJ\P-EG-E'S\N?4219'S]$?YNQIK/>8;*APT1Q>.)XG'T^BD\:M(4 MSU00;\Y3&FNWC%@H)L9X.@/F*-Z$CS3FEQ!QE^QLQ\H3^#"GD8:C*$90/1]; M]BFP>S!CJX'+`BKY6H6HPR:QS807_]'?$-F6FX!S*(4TV2,K=M*(R5_]#9DM M&?(PL>8EQE$_GLX!?G3GC3-/`4G_VBK99.@1NL)"6CM)"BWZ_707H8BX.A6/ M;#C98(4_^QL"6_(AB&O-18RC?NR``[GD]BS$2/I7%1.(4B8U)?TL?KI<$CIE MT2-XJ'+XNSB1W^&IH^O5=U$6K:YJ!TO.H.:6!(JKU"Q`$YAS/#WMJ1*]'Y?B MO[O(/X`Z.`8I=)`M,72^`A0W\+48UQLF8PHJ?I_V!.C;Q['P/UPJ#T]MI0(4 M0DF;A?+1Q%8H0,%^6^59`<`A,^,YC9QC M?L$60'R.J2`K?$5AN@H4%,:WNZO2":WFJ0FEA).8EXVW_30>C8:CX=#I.VJJ MZ04^AI\IHHZFZF3(.B'=]X,\L7P_@0"NZ$_Z=UYY$78$4H69&_'-$;.#RHP7 M/8VM\T2C-0"YQ!(17^S.O!9]5CK"T6AX-!QOXPA-P5Y%?/QS[SD%$WU%$Q_O MT"LB>I46/QP-#X>CK2S^*J3?.4N>!X)0+,29^V=`A*8K[$9T%87J\3D\N`+JR"7@6! MZB@W'(=1KHEM.AK6+I@/Q3KCFI,SSA&=Z8TCR]A62Z:F`#DR!+@,32=-M+M1 MKE3/-J&NADC-I.'($.^J3-7-H%>J8ZO(5T>EIL@[,H2_*E-U-@8N%D1J'9Q1 M[X)124`GU"46=BJG4#.<3.5#BIR#J.=D".ZMDZC"-D?5$JK)4E"&&\93A:VZ MG*BH!Q-'K/0LF$\\-:^\!XG"6',SW7[A:RO259:%$3@>ABMA,15MV*@;)]W/ M!D0X;+I?'0M-G:CG'/GJ,,+]'&/9?%R6X=<8[8*&B;Q"7[+]B;06E]YD(34=N]Z4`7GY6PFQ/LI*N:Q?LW1\/#_*QATZ^3ZEA/ M(**NG4W?`#^)`J]0_3M^Q$!WIQ>-[=88\",B_#_(#[!JL9U:_C!VZEWM^&FN M9NF8BDUGI?ATYIK1O4ONS@>^J!`CR(RJS+#!>G'?K..KWDE?_T`G[3O`;]]+ M&':\#<=[;]V=5Y2=1_C,5KJ@>6FO;_=`0ZS!]&,/-K#21\##&(N)] M[\>[\Y.O^%$JUEX\S!88J??,PA[J\WJF!`X=Q& M#28[0^LMW+UA2\>IS8ZN+=6:`RYO##N\EL;MZ*9O_!HVZ/X#E42NK^B4\44X ML8_:FMJT":DJ0PZ3=:'DY?#43V6XD*Z3(IRT=\UP'Q"GX,/B%O/[.>)-8VH! MK29LGAC"9DS#`2*.IM)UY=O52&78-87-B:&P*9JBNR5(7JU6":D$N2;OG!CR MCLDD'4TNR>K=9XR4=L(L+P36N?Z:H`GQPTDIO1N:@;> ML6'@I5;\%JE>H07ICG6Z\C==.Y"JD,/C[IV)ZK^[8]5H,N/#*XD7JL"_0*`X M[)W)!&H'3K)EC_7^4E@;T?ZBB3CIOBK\B"@V',JDXX:,.$@ZTPWXWG?2BKS& M*^P?WC'?WX%;%(G56[RPMU5N65^1=PX5@_[>C!G-6ZP.E./7E+3'AI*VS%C= MG/,;56M53E51J*FIC@TU5:EY.EI8?6+,>R"^#^6-7L^_`FGHC(`NPK*GH95J MR=2,I$/#2(IIZ@(H?(%R0]8)Z>[-E=5SW&Z7NFRIUN2P0T.5V\28:;#.)K,Z M6VS^OD`2SQBW/K;_E![J+5^H7AI:/O7,3;K=NT&9D:QR:$-B->GTT)!.&QFW MJ[DUOC[@L;&ATAC5&1/^*V;,Z$8!C=]A9=N%0P-B=90;C0QO+:55W]VH=44] M/)'84Z^#7\*O[=]_;D*I)AF]-90A:;+*3!/IH!3E?SJOO+WI;.;.!;2:0O^M M,6REC4*[.$].J\`JM1L0:]+X6T,:SUJ@L^EZ!0)L45`;$&M"D^EVAA25+B>0 M1`DV%S`4T&JBD.G*A8S^NWG'0DH%ED$HCU<3@TSW*&3TW^$0).16Y5(!L28$ MO2X)01&5;H>@2`FV(2B#5A."7I>$H$3_W0U!D0JL0U`6KR8$O2X)08G^.QJ" M[O%,*2!U,*ZA!0R(-4L8ID7_B$KZ8-[>`G:YH!R_9EW#M&YOL$=W4T-1LU8Q MJA2].E2-3`NO1KMT-60%$X'_#$"(#RO[TJD,NV:PF(YR;4@Y>-7M*BJO59M2 MRHQ;DTQ,9S$,]NAF5977J%W8,B/7!"W3X0N#/3H;LA8+Q-P.:='Y&/7T\^&9Z MFY+X*;BVN>UEN:Q9@Q@93_(?_8H>I+] M/)+^.%+T_50'383DR)6G/?]<^>_@34:<\>C:C[>M4G:D(&!!0EDLA`L?N)LV!YVM,? M*7VGCLWWG/!3-.%W5]]Y;($(5@&/%DT&-K*/BT*H M?5"1EN!M3G`[G%9*#1G@0\#9):9L0?1E(E\Q7UPS&&'J'0E7,W\,8"=YV;?` M_(MK`'F>'J3(]SAZN-0<;:./$CIMU M&R2JAVVCE(<'QYO8`[XV'HY'.>$J0=HITXG(,7Q4D*D"I(TR'1T,Z]+D".+# M^#`GJ#U>.Z4_+A7C,UJ/#V&CD]*H4]+X M/EDP"@.:K_/,1Y<^G_9<\`,B33(1*B12%U55BK10*W[ZR/2CB[&'O27B^J7B M1*HJB&<4#'HTR]7,5M&EW&P*/L"QRP(N,/R+R4IOTPGF>[&$S4!;)VKI\#KG M4#F"'_YRD1U9AN,DO]B[\H#6#(E*'GS4HL(/:+,[4+0%BS@81@:W2@T+G.1 M\\=TU2E5+]%:7:7RC!K>]-`-Q8HYXU*M;*I<^!QZS7?0?K6BU&=R(;I"=&93 M&'!>X$JQ##@$.8&]O*J:(K4NX1;$=S=&5W=0Z:((>7\$X<'KO-RUT.T5.-PB M5A>+4PEC_N:!8B[F9`F47+7%NTEXC2"WRM^0O",B5=F[RGU+2X[,=T_3+]&> M11B)=`T`M[: MI%[WS$E5#]>".E*]MWVOXK[:XX2LA,-<526<"W+GV4 MFC39ZF4\/^+,3>T;8Y=$49YH%O3]FJ[Z/NC9C.,P0&1]LS%T"\=?U8W6!>LU M@WTQSA66:ONMPI/\_#N\]_`JQ7DPAEX7+(;&`6^"U-\M_C*L2-H7T M+8B'0RP9R:`&/9T4JSA]\%E]D>+<9^[WM&IV0NT)8T#&9';@(1"$J$M`U=K2 MF*^("ZXWQ5@L$4F*W'JPMA4_']6).0PC5-V?KS^@/QB^4 M/-=@*GT/;$K8+5!;,-H#ZJE)%P-#04WP*Y'S*\$1]LDM$_+#8NFSM<(XQQ3$ M2MV(NSEFF:A@)Z1>(B9LY2R?[O^=S63I!RU,5I^P[Z)E+OOF'[:@#$Q=:Y8; M2YL[R))AUQ3X+^-5J7NK"C&FI*U]%6"*49W"#`+$SYLQ[\EW\[6*^L%$B_T\ ML1#8XQ@)M7>J_]7'T:MVN6P0VEOK:"G4(YCRHD8&UM>/C$KMA;A"PMZA66%B&9IRB'.1DNGZF-WB*ZAQ/!]J*O3$MFC M_I5L*3''0G[!,IO-3`TMS,37P0)QE&4]]ZR%7']!,N`/;.Y#G7/O`K,/:)V5 MH1*BS1+=SA',Q$N$R36VH$+Z8MJ;1^&WRM8)_S5`+[(DMJ6=PB^_NT2B>%DH M9ZL*@#;8*]K94>L]T;M<2:PN:=O>.@1BX`SS9Q@M:EW25M"2-)+3VRZ#*#9W9SU3^QAC]:V18R;!9ZA:%YGRC05[2V,T9I;@P"M MYEG=F)WC.?.HW3R787W(TS66&XN,6\GX;OC9]P6ZO<\?4C"UME"`\ ML_`QE<1R@E0`M%$>'>=S(F2?M9#KN\>P5G4QL.$B/V>#\N86RJ+F#V>%&4;A M:2LYGV,O\/'-M/F>0&:5["D$VK2<5B^'\8L5A=VS'=!IQ[Y9+`B;IO;X./95 MN>DR42=_<[07%;=\8"RQV@V4ZWN78)@HYL)3>7,;!WFCBTT**_CV:.U;W&\F M0S:B6:&T((;5"<^J)4'1]4DLNOZ#'>7[^BKA]XRL+QMMLMIA!@PQN7XK7R:,`Q0````(`"2%8D?JI_D&[:$!`)+O M'``1`!@```````$```"D@0````!P`Q0````(`"2%8D`L``00E#@``!#D!``!02P$"'@,4````"``DA6)'LM`"@J5M``"-,P4` M%0`8```````!````I($$O@$`<')G;RTR,#$U,#DR-E]D968N>&UL550%``-T MV#=6=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`)(5B1W`\<(Q)M@``8;L) M`!4`&````````0```*2!^"L"`'!R9V\M,C`Q-3`Y,C9?;&%B+GAM;%54!0`# M=-@W5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`"2%8D<4O`HPIWD``-3[ M!0`5`!@```````$```"D@9#B`@!P`L``00E#@``!#D!``!02P$"'@,4````"``DA6)'53/M+Y40``"# MO@``$0`8```````!````I(&&7`,`<')G;RTR,#$U,#DR-BYX`L``00E#@``!#D!``!02P4&``````8`!@`:`@``9FT#```` ` end XML 24 R48.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies (Details) - Texas Medicaid [Member] - USD ($)
$ in Millions

Sep. 26, 2015

Mar. 28, 2015

Loss Contingencies [Line Items]

Loss Contingency Accrual $ 15.0 $ 9.0

Loss Contingency, Receivable $ 7.0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of loss contingency liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

+ Details

Name: us-gaap_LossContingencyAccrualAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12053-110248

+ Details

Name: us-gaap_LossContingencyReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=prgo_TexasMedicaidMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 25 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`%*%8D```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V9S4[C,!2%7Z7*%C6N?V`81-D`6T""%_`DMXW5.+9L4\K;8Z>`9JHR M@ADJG4U^>J[O.L3ODV M+)G7S4HOB8G9[(0U;D@TI&DJ/:J+\]LUA6!:FEQNA=)[7FGO>]/H9-S`UD.[ MTW7J%@O34.N:1YN7U"E;TU'6J\F=#NE&V]R";7HV"MLCKXO.OL)^;=YE=7X*8?= MA7]+9FP9FA^6?ZPH]__X+#LO<6W[JZ"?S([!^F!C*N?::C/L&]63"ZM?SJV^ M:J6VJD/N3`DLV>7Y.*[K$:66_^7]]M.:5R@3QF6P@-^%)T.U-ZGD.>[ M_]OXO>!P.[%````*P(```L```!?.0Q(OW[CMB`PD.MQ-*O>X^NO`ZIK`XTHO8< M4M?'5$Q^#*G*_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SG MVL7.U49V[M,41Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0// M>997'L=V+YRO+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ`(4QOCLEFI2"(S>C M@KN_V/P"4$L#!!0````(`%*%8D=AI.76UP$``"`>```:````>&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'/%V%;L;B`#-^/[<2*L\HFVZ8W@.RQ ML6(#8J9J??>A7E1NDCG*PM+9@`#IFW?U@(;'+M6K'_'8Y$/?I?8PI-F?T[%+ MJ^G^NFIS'E8AI$T;3TVZZX?834]W_7AJ\G0Y[L/0;-Z:?0Q:UXLP7L^IGAX_ MSIZ];-?5^+*5:O:S&?3W$T+3(_/0_S.\OUN=]C$YW[S MZQ2[_$5%^+=`%J`$20UDK#E)"&N.U@*X%H[7`L`6CM@"R!:.V0+0%H[:`M@6CML" MX!:.W`+H%H[=`O`6CMX*]%:.W@KT5M*W-OK8YNBM0&_EZ*U`;^7HK4!OY>BM M0&_EZ*U`;^7HK4!OY>BM0&_EZ&U`;^/H;4!OX^AM0&\C[96@S1*.W@;T-H[> M!O0VCMX&]#:.W@;T-H[>!O0VCMX&]#:.W@[T=H[>#O1VCMX.]':.W@[T=M)> M-]KLYNCM0&_GZ.U`;^?H[4!OY^CM0&_GZ.U`;^?H/;_2.[7-&+>O>3QT^W3K MFO^&PZ(KO%,^'^/M4RY38<.5UGE:*8;+\>:OCLO4OR'AT\_@IW=02P,$%``` M``@`4H5B1PF0,V@1`P``J0P``!````!D;V-0&ULO5=-;]I` M$/TK*T[I(3$!FBJ(6$H@;2*U#9)I>E[L`:]B[SH[:Q?ZZSNV@9A@KPF'YI+U M^+WY?+,R(XG=X52K!+01@&P51Q*'9+SIA,8D0\=!/X28XP5!)+U=*!US0X]Z MZ:C%0O@P47X:@S1.K]N]Y39)(^-P()=T?PM<*U<*P M^Y4/T\[8X%Y6%.=4_$, M&O-*+WL77?K;M6!K+WT##X1<3KG0Z(XR,\S`-TIOQI294Z<4*#\?.C[/*#_L ML#E'R(\WG8QKP:7I,!1_Z;'7*<.6UN(<)6BT^UOI%PP!#(Z& MY,@>91F*AE=MR>XT5A)5)`(25\`\0_]R#\C4@JB^:N($()$(M>SV.'<\XM(' MYAV,ZA@\.YORC]8RYAC6YQA/+*6@4=#PV:WOJY0Z6,NY2U%(0"34 M:RI0Y,VEK'XJ`_BIEO%-J>"/B*)B,D\F!$W=-;1Z8AX!NZWE/,J,LE55"Z-!I'$:%2,M&Y??FQI"$B#EU9""KV)@ M,[Z")G'%L3!OQ9!P#.4"TA<-#`^6Q6:UK9.7SA%>TQP*66M_K>+K77Y$?#-. M2CI%?;U^N_ILSAOE5Y+:]6=S;A5@[\L1`K1Y/Y2@'6_58K][K'#L0:R:Z/<^ MHHD)&"ZB4T31'YS`^=PN)&M&34HZ9QP13#/GN>#\J'(VOMK59\W(*K]!_<#M MG/J=MG/J9V[G-"UU=34F=&9F.WN+?>W>SL^"6L MBW+PR??N`\_9_V'B_@-02P,$%`````@`4H5B1W\LIM$^`0``:0,``!$```!D M;V-0 M%M9\*/'4]=^395W+@,MNW.K:[^/7<5()QX3U\.2M`X\*PM5>-R8PX>;9!M$Q M0H+8@.9A$BM,3*ZLUQQCZ-?$<;'E:R!E4]VODDP*0@TH,%@('1"25:_F*VQK:G(J*^KZ+CA`1=6JI4">=N-9;]3 ML3."U^$H!SFT3W__])`R).LK]T$-56W;3MIIJHL#4_*V>'Q.9Y,K$Y`;`5$5 M%,/.P3P[=7Z=WMTO'[*Z+.A-3FE>E$LZ8]621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I`DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7`\:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY`\FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z>`HWEL:\4*Z">P'_ MT=HWPJOX@L`Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^`VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+:`'@Z]1`O)2 M56`Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41`71%`B.5 M'`86%S+D4.Z2D`83``>LX=SFWJXPD6L_UC6'ODR MWSEPVSK>`U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X`Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F`6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0````(`%*%8D&PO[GGV5'N2 M^B,0B!88C%;AQL[Q.;_S/\:.3H)285D2.E'.??R3&*4Y":(4:_O^T./(<)A%/""39C*P4P47(5PO#4!%W\O M$AS"IZOW/PJA[MX!-W8^=#I^UW^ZOJNO7)5+UQ`XSN`W'5?^M`9HB!_!DM$M;\M9+HX+CIU(ZW?$>R[1NM>_V0FP@\X; M"YE@N)`3-!4?4(#<1Y41C9YC21_/& M_)[NL5SMA3>;; MGIHS)%Q@YTS=1%IM^V5-FZMM%%[;ZAN/%LKK=]>:8/_E.:5 M#=).%[;7@VVM("X(581O-"#3-3\8W72O/:KZ+\U,5E7K95<5BO6'\5X6#4MP MB@JJOI&E4'8QA-7\BY&O^[:-UW2+"&$U_XH34C#[\>557]_1"U!+`P04```` M"`!2A6)'-GPSX#T$```8$```#P```'AL+W=O.*E%4-;X2FU\LJ/YU]#\QDE1^DK*4.L.5@MEDO?O M_&2EM+R3S@.8B\]!L8' M3!1!;>6M6$Z38<)$$^Q'I8-T,Q'D)V>;C3)K8"5LI9P/BSC<]LM:&56KWS%N MN/.5O?]LG?IM31!Z43BK==LJOF@;00_^[Q.(,:BB]V$0R__C3$R3\1"`6^75 M4FD5?DV3]EK+.)+!LZ&TZ7^Z8J9-SN,4,V%*=FT"4-C<=),'J8DQP,?SLNW8 M311V17P"HM`&0)E)*B4Q@.%1")0CD#Y M"Q%="BU,(5F;8(\@'$'X21!V=B,0:(1`HY/R M[F,^65O>*ZU;@[Z%2CJ8\"#,.HK(/B#0!0)=[(/F9@L9@J2>R83*,1`?4.M^(-C?E!!X)IW:BKA40")\<$U' MBNGY+,LU1FT+A.93"$H1II^G,/!\(=CO1$L[.,0HKG!$*]TN8B`6KFQ'J[A8916..PP^QB@L M.']ACT$'@[WFI^XVV!E&8:_YZ_8;=$S8;WZQ.[<]'=7@M`KK6AD/LK[M!$Z" M13S=PD^W&>6CN'N)]U_@Q#M-XK$43J"-UE?P[)OYSXKV\-:1'\^S[_\`4$L# M!!0````(`%*%8D>::]B!1@(``(\'```8````>&PO=V]R:W-H965T&UL?57;CML@$/T5RQ^P!GS)18ZE)%75/E1:[4/[3!P26XN-"R3>_GVY M.%ZRPKR8B\^9,P/,3#DR_BX:0F3TT=%>[.)&RF&;)*)N2(?%"QM(K_Y<&.^P M5$M^3<3`"3X;4D<3!$"1=+CMXZHT>Z^\*ME-TK8GKSP2MZ[#_-^!4#;N8A@_ M-M[::R/U1E*5R:>=/C+WKQ<_S M+@;:!T))+;4)K(8[.1)*M26E_'[\8?V["5>Y?\*"'!G]TYYEH[P% M<70F%WRC\HV-/\@40ZX-UHP*\XWJFY"L>U#BJ,,?=FQ[,X[V3PXFFI^`)@*: M"2@+$M*)D,X$:`B)]=PFZJ3JR,5C(CU+W-<&E&5 M]PJ4R5V;>4(<+`(9!)P1B;(]"Z!E@0-RZ,@G<'01J5\@#420&GIJZ)F?G@7H MF:%GAIY[#\!%%'Z!/""0._35LT!O!2PBMR>+V/@% M5@&!E4.'_J?R!%EX*^N`Q-KE>Q_+X0FR\%HV`8F-R\^\$D^0W"^A"\1R3@'7 M0N&]\PEC+QT!N/"P8#!WH:NS\F>OQ106LUY0"23P'B)79>-7<3$(+*B$LABF MK@7H.[/CA)D2)2LR@$#Q]>`2I_YUA%]-7Q!1S6Z]M(5NWIU[SQZ9^OD)K\H! M7\DOS*]M+Z(3DZH*FSIZ84P2Y0MX44G;J.XX+RBY2#U=J3FW_<(N)!L>[6_N MP=5_4$L#!!0````(`%*%8D?T!I-6A`,``$X/```8````>&PO=V]R:W-H965T M&ULC9?;CILP$(9?!?$`@`^<5EFD#5757E1:]:*]9A,G00LX M!;+9OGW!..PX';N]"8?\X_G&F-_,YBK[U^$DQ.B]MTTW//JG<3P_A.&P.XFV M&@)Y%MWTST'V;35.E_TQ',Z]J/8JJ&U"&D5)V%9UYQ<;=>^Y+S;R,C9U)YY[ M;[BT;=7_WHI&7A]]XM]N?*^/IW&^$1:;<(W;UZWHAEIV7B\.C_X3>2AI/$N4 MXD_U'3-BF+S5E"Z"=_F<0S)=I%0)2&K(IP&7S-0 M>X8M!>%H@M)0,#P#<]3`5#Q?XKF9HEL@%DFZU,`X#U),5D)9'I,@QF&X`X9# MF!B%6229DJ1Y'.0H"U0E-`?$!DOL8(DA2X*RQ"!+S+,@0UF@BE$"5`9+XF!) MU!!L8;'4DCKB4U@+2KE-`27EEFF%(L(#CI-D#I(,DJ!)MAE(PDF`3GT)12P! M(H,D=Y#D@(1%*$D.RTU2RZ1`51S9)F5V1;N11!"&H#!:HVDHLTR,(EV42Z)D,]TP"[9"S`*4N#16%SFK2N$R30-=DN&MJ M3:S+QEEB8W79%H[+,TD"4=`M:ZLUMR=@7<:&+,JL"\?EP02:,,--F!@&F]O6 MC:&B@677)RX?)M"(&6[$6J,W_BF1!0?*\L2*XS)CDH,=CD?X"-1EH11:*,Q:G@]UN1Z%KL=Q MUZ.&G7&X$(R"3-=C-I^A+M>CT/4X[GJ4W_'@V[PL,Z610(````'```8````>&PO M=V]R:W-H965T&UL?97+CILP%(9?!;$?+C;7B"!-J*IV46DT MBW;M$">@`4QM)TS?OKXDQ(P,603;_/\YW\'F4$R$?K`&8^Y\]MW`]F[#^;CS M?58WN$?,(R,>Q)TSH3WB8DHO/ALI1B=EZCL?!$'B]Z@=W+)0:V^T+,B5=^V` MWZC#KGV/Z+\#[LBT=T/WL?#>7AHN%_RR\&??J>WQP%HR.!2?]^YKN*MRJ5"" MWRV>F#%V)/N1D`\Y^7G:NX%$P!VNN8R`Q.6&*]QU,I!(_/<>\YE2&LWQ(_IW M5:V@/R*&*]+]:4^\$;"!ZYSP&5T[_DZF'_A>0BP#UJ1CZM^IKXR3_F%QG1Y] MZFL[J.ND[V3!W68W@+L!S(8YC]T`[P;X-$2J4DVFZOJ&."H+2B:'ZKT8D=SR M<`?%DZL=40QSY2WUN*2B+&YEE!;^3<992`Y:`I0DG!6^"#YG`.L9#L"P`UN" M:J&`]@QPHP:H_)'RPWR98M`06I+J&D+@)3959:KRQ%M!B390(A4!ZL>9V?WQ MAC\V2HGLI6A)IB0O,/%!@_^U9I1ZB[`?RZ4[[167I,+ZKC,JG9OZ*Y"= MZZISG0GA6,`%GCC2C?@_O-3-J>SZT^8U;2]-5>[&H-,Q M!6/R]%0>SLOU:OSN2[->U6_=\7"NOC2+]NUT*IM_-]6QOCXN[?+CBZ^'UWTW M?)&N5^DM;G?V4)\73?7RN/S%/FQ=&"2CXJ]#=6W)\6(P_U37WX:3/W:/ M2S-XJ([5^Z/]M#H'T^./JOXVWV]M_*MMJ6Q__ M/NRZ?>_6+!>[ZJ5\.W9?Z^OOU7P/V7#!Y_K8CO\7SV]M5Y\^0I:+4_E]^CR< MQ\_K](N'.8P/@#D`;@'6J0$X!^!=0#HY&^_KU[(KUZNFOBZ::3`NY3#F]@'[ MGGM>]#?3+H>?QNX:%.O5^SISJ_1]N$XDV4P2&"7`*;94D64W2=JW?S,!B@D8 MXW&*S_EX5.)QC'=3O(\MGJ>;F"1^DI@\R3C5EJI\R!+!BU.\..HEL%XF21@E M5K(2B2#QO)-,<9)1)P7K)(L:04B`]1++`B26=Y,K;G+B)C>LFTF2C9(0V+[; MYL1*P)`4O!.O./'4B66=>.(D9[MNZZ,^@01Y(T$Q$J@1MNHE4 MSDI>"L5+0;T@ZZ4@K4`()N%'B,K0]LDB#-'`6!E+AOIQK)]9,[54@$O8L=S& MLC['G>!'Q:2E?M@9NYDU4T,>LTR83;-NRBX/*`#3:L2T0/VP6;&9-?-<@<(D M_1+^\2?T511BC4A`J^'84A[G/(]GS9Q-7LBE2(6%Z$8#LJ5$SGDBSYII2`!X M(EN*Y%XD4=!J4+:4RCQ:-C:+9WU$E\A1+,S02^N$U=!L*9L]SV9+P6L+;U": M;G=",.*H:9"VGM0$7NIIC:Z6XM7S>+64G%E/3F'&4IEW/I&FK$982Q'K><1: M"L^0)X4QGTY9&I)+<`,-MD!AZWG8`J6HM5*E$,L0)?B#!EN@L/4\;('"%G,O M9..=+$AS%M3RE,+6\[`%2DXT00!:)`,GCY?&5Z!\]3Q?@9(S2`")5!E(,Q4T MOD+$5[Z>@JB:-4ZH>2-97V!D!?T3O&FT!4I;S[,?*$2S("6VJ(K=:)R%B+,\ M^R'"9YY+2+K3%2B1'S3*`JV%`T]^\%&.0)'P!?&=KL]M:<0T:D-4%`NY'=6[ MWF32Y(]U3ERQ0>,V4&X'(;^CHM<[J8MBF;B/0HW62&D=^'4-*88]&FG,[G2Y M$QUIO$;*Z\"O;$A!'`IOA3&+=(7)^HKF4P2@!F^D#Q>"@%M4GRY0W`9^.9HU M4P')SJ.M((E]:*!%"MK`+T,8$33O=SML]T6^XA"PTKQ%C;1(21N$9S"4H;FT M/8I4UHC[-=10BQ2U_*.$#=+G#6"0+7RV&->S&*3=-6J@Q0BT//J1/G6PQJ/0 M/]&3!Y/GXK*-&FB1@K;@T3]KU*RFC#72LH@:8)$"MN`!.VL^[9OBA[X)O".G M(=91Q!8\8F>-_W1#="^4-T1.@ZRSA&.%D(-.(Z&C96S!E_FS1AMQ01+[T'CJ M*$\+GJ>.%J8VJI,C+_`$-("I[83I MW]>O4!PY5C?!AG.OS[7!3CEA\D$;A)CWV7<#W?H-8^,F".BY03VD*SRB@3^Y M8-)#QKOD&M"1(%C+H+X+(@"RH(?MX%>EO/=&JA+?6-<.Z(UX]-;WD/S9H0Y/ M6S_T'S?>VVO#Q(V@*H,YKFY[--`6#QY!EZW_)=P<0R`02?QLT407;4_(GS#^ M$)WO]=8'P@%UZ,Q$"L@O=[1'72N<;9;A_A/A>#S_5M1WD=5)/\D*' MV0,B'1#-`5'B#(AU0#P'Q+DS(-$!R?^.D.J`]&F$0-4N9^X`&:Q*@B>/J.4> MH7BKPDW*U^;L\>FBOG@D%T0057FOUGD9W$4>`]DI)%)(84/V!K*V(8,&>*9P(I_``T_N>=.ARY,-'/>)NHL M4QV&Q\?1//\_J/X"4$L#!!0````(`%*%8D?8U8:Y\P0``!89```8````>&PO M=V]R:W-H965T&ULC9E-;^,V$(;_BN"[)7&&^@H<`[&*HCT4 M6.RA/2NV$ALK6:ZDQ-M_7WW9F7%GB.YA;;7=3,^^M=M-\]%7IW/YK?6ZC[HNVG]V9=57'\KEQBBL<-]4W73_][^H^N;^M9DY=7%S_GU=)Y>K_,W<;HTDQO` MT@#N#>[CR`UP:8!?#::I"V9G4UR_%'VQW;3-U6OGQ;@4XYJ;)QQF;N\-P72K M\:MIND;%=O.Y-<9L@L^Q(Z;9S1J8-7=%,/1^'P+T(79`FH,T0,X4*(^`CB!P M:H]+$"!W8!T=V*D#.W6`&?=XGJ.8)*&B4(M$8P338:9D=-R$2VKE*$O[K&]DX0/9B@.8F MA$H7+E(9I#&!D6-"8M;&V@Q3592H4^SBGJ'@BT/9S:R)YHT5B5LT7T2WW9=I MJ6!\6S>+&9#*Y%M5B!X'L"F['!5)#29K((#4QBQM\,65R+D/K M9XH?%TL-A6DBL]103JY#!>Q,95(5%2Z"&HK01":HH7B,C9:;*4.%EIDNBAJ* MT42FJ*&`-)&654QE-3?@HB@PBH*\D8$"EM`$71N'_8!0H']=F MP(F\5@^Z5$LL<'$4@,V/>.#O%M$LAD3Y M%(?'(E(NL[D,,RV_T<4_9/Q#NZ\(<,?RC#&%EYJ+#X M0:2<#.@B'S+RH4P^I.1;*S-#P;=.U&5R_FIFM2C*!0[BB@-?WCN<5!6FLF::0< M>UR6Z1AT<1D9EZW,9:3`C<)8J;N8+,V,9LBZN&Q#>M989G]ZO^ M%QBOJQ^>[\Q3/E_8?W6SW5R*]_*/HGT_G3OOM>G[IIZNL]^:IB\'=X.?E7/;9'C?SM?V\X>^N=S^"G'_4\CV7U!+`P04````"`!2A6)'B[4A M;,_XG#-G?"DF M-*^V`W#D7:O>;FGGW+!AS%8=:&$O<(#>[S1HM'`^-"VS@P%11Y)6C&?9%=-" M]K0L8N[)E`6.3LD>G@RQH];"_-N!PFE+5_28>)9MYT*"E05;>+74T%N)/3'0 M;.GM:K/+`R("7B1,]F1-@O<]XFL('NLMS8(%4%"YH"#\=(`[4"H(^<)OL^9G MR4`\71_5[V.WWOU>6+A#]5?6KO-F,TIJ:,2HW#-.#S"WW<9#/M/('/!/Z-P%*A:/.W<*(L#$[$I*,=1+C!U8;[@ZB( M]V9IV(K=!T19',I5?E6P0Q#Z@MDE#$^8!<&\^E*"_[_$CI_0^7GZ^@>'ZTA? MSPZOSPOD/PCD42"?!6[.MO@5\^M;$79RIAI,&Y^.)16.O4N'MV27UWG+XYU\ MPLMB$"W\$::5O25[=/YFX]TTB`Z\B>SBDI+._Y\E4-"XL+SV:Y.>5`H<#L&/6.VZD`)>X,# M:+_3H%'"^="TS`X&1!U)2C*>9=^8$KVF91%S3Z8L<'2RU_!DB!V5$N;?$21. M![JA2^*Y;SL7$JPLV,JK>P7:]JB)@>9`[S;[8QX0$?"[A\E>K$GP?D)\"<%# M?:!9L``2*A<4A)_.<`]2!B%?^.^L^5XR$"_7B_K/V*UW?Q(6[E'^Z6O7>;,9 M)34T8I3N&:=?,+>P"X(52AM'4HW6H5HHE"CQFN9>QWE*._E"NT[@,X&OA-LL M&D^%HLT?PHFR,#@1DXYV$.$&-WON#Z(BWINE82MV'Q!E<2XWNZQ@YR#T`7-, M&)XP*X)Y];4$_[S$D5_0^77Z]@N'VTC?S@X_J9]_(9!'@7P6X%=;_(C9_E>$ M79RI`M/&IV-)A:-VZ?#6[/HZ[WB\DW=X60RBA4=AVEY;38/HP)O( M;G:4=/[_K(&$QH7E=[\VZ4FEP.&P?)#UEY9O4$L#!!0````(`%*%8D>JBC2J MI0$``+$#```8````>&PO=V]R:W-H965T&UL?5/+;MLP$/P5 M@A\0RK*4%(8L($X1M(<"00[MF996$A&2JY"4E?Y]^9`5)W!S(;G+F=E9/JH9 MS8L=`!QY4U+;/1V<&W>,V68`Q>T-CJ#]3H=&<>=#TS,[&N!M)"G)\BR[98H+ M3>LJYIY,7>'DI-#P9(B=E.+F[P$DSGNZH>?$L^@'%Q*LKMC*:X4";05J8J#; MT_O-[E`$1`3\%C#;BS4)WH^(+R'XV>YI%BR`A,8%!>ZG$SR`E$'(%WY=--]+ M!N+E^JS^&+OU[H_;4=)"QR?IGG'^`4L+91!L4-HXDF:R#M69 M0HGB;VD6.LYSVBFW"^TZ(5$^4KXED7CJ5"T^9T[7E<&9V+2T8X\W.!FE_N# M:(CW9FG8BMT'1%V=ZDU95.P4A#Y@#@F3)\R*8%Y]+9'_O\0AOZ#GU^G;+QQN M(WV[."RO"Q1?"!11H%@$;J^V^!%S]ZD(NSA3!::/3\>2!B?MTN&MV?5UWN?Q M3M[A=37R'GYQTPMMR1&=O]EX-QVB`V\BNRDI&?S_60,)G0O+.[\VZ4FEP.%X M_B#K+ZW_`5!+`P04````"`!2A6)'M&*K8J0!``"Q`P``&0```'AL+W=O5=2VQWMG1NVC-FZ!\7M M%0Z@_4V+1G'GMZ9C=C#`FTA2DN59=LT4%YI693Q[,E6)HY-"PY,A=E2*F[][ MD#CMZ(J>#IY%U[MPP*J2+;Q&*-!6H"8&VAV]76WW14!$P(N`R9ZM2?!^0'P- MFU_-CF;!`DBH75#@?CK"'4@9A'S@MUGS,V0@GJ]/Z@\Q6^_^P"W84]@$P1JEC2.I1^M0G2B4*/Z>9J'C/*6;=3'3+A/RF9`O MA)LL&D^!HLU[[GA5&IR(2:4=>.C@:IO[0M3$>[,T7,7L`Z(JC]5JSPYV6!XAN!(@H42>`ZNYCB M5\R_2;*SFBHP77PZEM0X:I>*MYPNK_,VCSWYA%?EP#OXS4TGM"4'=+ZSL3UR5FD`0``L0,``!D```!X;"]W;W)K&UL?5/+ M;MLP$/P5@A\0RI3L%H8L($Y0M(<"00[MF996$A%2JY"4E?Y]^9`5IW!S(;G+ MF=E9/LH9S8OM`1QYTVJP!]H[-^X9LW4/6M@['&'P.RT:+9P/3KR_JWV*WWOU)6'A`]5LVKO=F,TH::,6DW#/.WV%I81L$:U0V MCJ2>K$-]H5"BQ5N:Y1#G.>WDNX5VF\`7`E$7[-H/!6*-A^%$U5I<"8F'>TH MP@UN]MP?1$V\-TO#5NP^(*KR7&UVO&3G(/0!+P_RV0/&)0!$%BD6@N-GB1\SVGR+LZDPUF"X^'4MJG`:7#F_- MKJ_SGL<[>8=7Y2@Z^"E,)P=+3NC\S<:[:1$=>!/9W9:2WO^?-5#0NK#\XM&PO M=V]R:W-H965TK#[C.QQS8J,"[@N/W[`G;<=)7M"S##.6?.<,D'M*^N!?#D72OC=K3UOMLR MYLH6M'!7V($).S5:+7P(;<-<9T%4B:05XUFV85I(0XL\Y9YMD6/OE33P;(GK MM1;V8P\*AQU=T%/B13:MCPE6Y&SF55*#<1(-L5#OZ-UBNU]%1`+\D3"XLS6) MW@^(KS'X5>UH%BV`@M)'!1&F(]R#4E$H%'Z;-+]*1N+Y^J3^F+H-[@_"P3VJ MO[+R;3";45)!+7KE7W!X@JF%=10L4;DTDK)W'O6)0HD6[^,L39J'<6=].]$N M$_A$X#/A)DO&QT+)YH/PHL@M#L2.1]N)>(.++0\'49+@S=&XE;J/B"(_%HO- M)F?'*/0-LQ\Q?,3,"!;4YQ+\_R7V_(S.+].7/SA<)OIR/AS=GY==[Q="=?\"+O1`._A6VD<>2` M/MQLNIL:T4,PD5VM*6G#_YD#!;6/R^NPMN.3&@./W>F#S+^T^`102P,$%``` M``@`4H5B1SZAZNRO`0``%@0``!D```!X;"]W;W)K&UL?53;;ILP&'X5BP>HB9,L4T20FD[3=C&IZL5V[<`/6+7],]N$[NWG`Z%) M17.#_=O?R2>*$5-2VT/6.=?O*;55!XK;!^Q!^YD&C>+.EZ:EMC?` MZTA2DK(\_T(5%SHKBSCV;,H"!R>%AF=#[*`4-_^.('$\9*OL,O`BVLZ%`5H6 M=.;50H&V`C4QT!RRQ]7^N`V("/@M8+17?1*RGQ!?0_&S/F1YB``2*A<4N&_. M\`12!B%O_'?2?+<,Q.O^1?U[7*U/?^(6GE#^$;7K?-@\(S4T?)#N!<:8,"QA9@3UZK,%^]SB MR*[H;)F^OI-P'>GK*>$G_IL[`ILHL)D$V.(2;S'K99/M'9/MC06L_U@ M0J\.3H%IX_VTI,)!NW1"\^C\!!Y9//AW>%GTO(5?W+1"6W)"YZ]/O``-H@,? M(G_P*3K_2.="0N-"=^?[)MW;5#CL+Z]P_A64_P%02P,$%`````@`4H5B1\6C MKF2E`0``L0,``!D```!X;"]W;W)K&UL?5/;3N,P M$/T5RQ^`4S=0MDHC458K>%@)\<`^N\DDL;`S6=MIV+_'ES04U.7%]HS/.7/& MEV)"\VH[`$?>M.KMCG;.#5O&;-6!%O8*!^C]3H-&"^=#TS([&!!U)&G%>);= M,"UD3\LBYIY,6>#HE.SAR1`[:BW,OSTHG'9T14^)9]EV+B186;"%5TL-O978 M$P/-CMZMMOL\("+@1<)DS]8D>#\@OH;@L=[1+%@`!94+"L)/1[@'I8*0+_QW MUOPH&8CGZY/ZK]BM=W\0%NY1_9&UZ[S9C)(:&C$J]XS3`\PM7`?!"I6-(ZE& MZU"?*)1H\99FV<=Y2COK?*9=)O"9P!?";1:-IT+1YD_A1%D8G(A)1SN(<(.K M+?<'41'OS=*P%;L/B+(XEJO-3<&.0>@39I\P/&$6!//J2PG^_Q)[?D;GE^GK M;QRN(WT].]Q<%LB_$:UE7TO9BZPLE)H>'%$#LI MQKZ`<7'*RNV,IKA0)M!6IBH-O1NWR[+P,B`GX)F.W9F03M M!\2W8#RW.YH%"2"A<2$"]]L1[D'*$,@G?E]B?J8,Q//S*?ICK-:K/W`+]RA_ MB]8-7FQ&20L=GZ1[Q?D)EA*N0\`&I8TK:2;K4)THE"C^D7:AXSZGFTVQT"X3 MBH50K(3;+`I/B:+,!^YX71FRLI0I,'U^.)0U.VJ7>K=[U<=[%&;)/>%V-O(>?W/1"6W)`YP<; M1],A.O`BLJMK2@;_?59#0N?"\8<_F_2BDN%P//V/]9/6?P%02P,$%`````@` M4H5B1QG^5+FE`0``L0,``!D```!X;"]W;W)K&UL M?5/+;MLP$/P5@A\0RK3LIH8L($Y1M(<`00[IF996$A%2JY*4E?Q]^)`5IW!S M(;G+F=E9/HH)S8OM`!QYU:JW>]HY-^P8LU4'6M@;'*#W.PT:+9P/3#\BOH3@=[VG6;``"BH7%(2?3G`/ M2@4A7_COK/E1,A`OUV?UG[%;[_XH+-RC^B-KUWFS&24U-&)4[@FG7S"WL`F" M%2H;1U*-UJ$^4RC1XC7-LH_SE':VWV?:=0*?"7PAW&;1>"H4;?X03I2%P8F8 M=+2#"#>XVG%_$!7QWBP-6['[@"B+4[FZ71?L%(0^80X)PQ-F03"OOI3@_R]Q MX!=T?IV^_L+A.M+7L\/\ND#^A4`>!?)98'.UQ<^8[3]%V,69:C!M?#J65#CV M+AW>DEU>YQV/=_(!+XM!M/`@3"M[2X[H_,W&NVD0'7@3V!O\>7)!34Y<7VC,\Y<\:78D3S8CL`1UZ5U'9/ M.^?Z'6.VZD!Q>X4]:+_3H%'<^="TS/8&>!U)2K(\RVZ8XD+3LHBY)U,6.#@I M-#P98@>EN'D[@,1Q3U=T3CR+MG,AP+Z>U7_&;KW[ M([?P@/*OJ%WGS6:4U-#P0;IG'!]A:N$Z"%8H;1Q)-5B':J90HOAKFH6.\YAV MUC/M,B&?"/E"V&;1>"H4;?[@CI>%P9&8=+0]#S>XVN7^("KBO5D:MF+W`5$6 MIW*UO2W8*0A]PAP2)D^8!<&\^E(B_W^)0WY&SR_3U]\X7$?Z>G*XO2RP^49@ M$P4VD\#=Q18_8>ZR+T78V9DJ,&U\.I94.&B7#F_)+J_S/H]W\@$OBYZW\)N; M5FA+CNC\S<:[:1`=>!/9U34EG?\_2R"A<6%YZ]&PO=V]R:W-H965T=%JL'O:.S?N&+-U#UK8&QQA\#LM&BV< M#TW'[&A`-)&D%>-9=LNTD`.MRIA[-%6)DU-R@$=#[*2U,/\.H'#>TYR>$T^R MZUU(L*ID*Z^1&@8K<2`&VCV]RW>'(B`BX+>$V5ZL2?!^1'P.P<]F3[-@`134 M+B@(/YW@'I0*0K[PWT7SM60@7J[/Z@^Q6^_^*"S(ES7*(\YQVMGRA72?PA1W6PIZ?W_ M60,%K0O++WYMTI-*@7-!34Y<7VC,\Y<\:7^>&+6.V[D%Q>X4#:+_3HE'<^=!TS`X&>!-)2K(\RZZ9XD+3JHRY M)U.5.#HI-#P98D>EN/FW!XG3CJ[H*?$LNMZ%!*M*MO`:H4!;@9H8:'?T;K7= M%P$1`2\")GNV)L'[`?$U!(_-CF;!`DBH75#@?CK"/4@9A'SAO[/F1\E`/%^? MU'_%;KW[`[=PC_*/:%SOS6:4--#R4;IGG!Y@;F$3!&N4-HZD'JU#=:)0HOA; MFH6.\Y1VBGRF72;D,R%?"+=9-)X*19L_N>-5:7`B)AWMP,,-KK:Y/XB:>&^6 MAJW8?4!4Y;%:_=B4[!B$/F'V"9,GS()@7GTID?^_Q#X_H^>7Z>MO'*XC?3T[ MO+XL4'PC4$2!8A:XN=CB9\SMER+L[$P5F"X^'4MJ'+5+A[=DE]=Y%R^1?<"K M&PO=V]R:W-H965T MVS&P`\>='*N#T=O!]WC+EF`"W<#8Y@ MPDZ'5@L?0MLS-UH0;2)IQ7A1?&):2$/K*N4>;5WAY)4T\&B)F[06]N\!%,Y[ M6M)SXDGV@X\)5E=LY;52@W$2#;'0[>E]N3ML(R(!?DF8W<6:1.]'Q.<8_&CW MM(@60$'CHX((TPD>0*DH%`K_631?2T;BY?JL_BUU&]P?A8,'5+]EZX=@MJ"D MA4Y,RC_A_!V6%FZC8(/*I9$TD_.HSQ1*M'C)LS1IGO/.IEQHUPE\(?"5\*5( MQG.A9/.K\**N+,[$YJ,=1;S!',T;J7N(Z*N3G5Y=U>Q4Q1Z@SED M#,^8%<&"^EJ"_[_$@5_0^77ZY@.'FT3?9'I17!?8?B"P30+;1:"\VN);S'N7 M[.),-=@^/1U'&IR,SX>W9M?7><_3G;S"ZVH4/?P4MI?&D2/Z<+/I;CI$#\%$ M<7-+R1#^SQHHZ'Q,WI44A`+.';??@$=JXWU1CCP_9R#!])> MJC==`QCT(7BC3T%M3'O$6.!7<0I"EP)PR(U3H':XPB-P[H2L\?NH M^6GIB//Y3?W95VNSOU`-CY+_986I;;)A@`HH:LU(N$OQU0DM,.8_;K)?L-DOQ`XK)HL,=]4):V MM(+?5%6LT>@BC;T(OI5+*0W8),([>YZU?6ZF@$-IW#2Q&PO=V]R:W-H965T M(X.I\A!'.)W#;VZF2,;_%F(=[OX MF1^#T,8`##)M):@9+O`"C%DEX_QW%/WTM,3;^57]NTO7A'^F"EX$^U/GNC+1 MA@'*H:`=TV^B_P%C#K$5S`13[HNR3FG!KY0`#!R(7YC6J:)E+T2`YWVU+["Z,#,1>1(1.;"NR1R]XBTN22DH@D^&*%9IC3 M@"$.$TT(;-0G"W+?XD1NZ,1/7RU$N'+TU1CARB^P7A!8.X'U*+#VICC'Q'Z3 M>,$DG@ELO"9SS-9OLEDPVV9 MN%K^A*=)2TOX1659-PJ=A38=P=5T(80&$T7X9!Y691KOM&!0:#O=FKD<6M&P MT**]=M:IO:?_`5!+`P04````"`!2A6)'ESQ?2+`!```6!```&0```'AL+W=O M2 MV3O=@_(KC3:2.3\T+;&]`59'DA2$9MD]D8PK7!9Q[L64A1Z#+*#E,S\ M/X#0XQZO\'GBE;>="Q.D+,C,J[D$9;E6R$"SQX^KW2$/B`CXPV&T%WT4LA^U M?@N#7_4>9R$""*A<4&"^.<$3"!&$O/&_2?/3,A`O^V?U'[%:G_[(+#QI\9?7 MKO-A,XQJ:-@@W*L>?\)40DQ8:6'C%U6#=5J>*1A)]IY:KF([II7M=J(M$^A$ MH#/A(8O!DU&,^H#HBQ.):6T(*<@ M=(4Y)`R-F-6,(%Y]MJ#?6QSH!9TNT]#\MJO2@7#JA>79^`H\T'OPGO"QZ MUL)O9EJN+#IJYZ]/O`"-U@Y\B.S.I^C\(YT'`AH7NEO?-^G>IH'3_?D5SK^" M\@-02P,$%`````@`4H5B1QXBES^D`0``L0,``!D```!X;"]W;W)K&UL?5-=;]L@%/TKB!]0')*L7>18:EI-V\.DJ@_;,[&O;53@ MNH#C[M^/#\=-IZPOP+V<<^X7E!/:%]<#>/*FE7%[VGL_[!AS=0]:N!L#)$C=J+>R?`RB<]G1% MSXYGV?4^.EA5LH772`W&233$0KNG]ZO=81,1"?!+PN0NSB3F?D1\B<:/9D^+ MF`(HJ'U4$&$[P0,H%85"X-=9\SUD)%Z>S^K?4K4A^Z-P\(#JMVQ\'Y(M*&F@ M%:/RSSA]A[F$;12L4;FTDGIT'O690HD6;WF7)NU3OMD6,^TZ@<\$OA#N$H'E M0"G-1^%%55J?9+A.]'6.OOUZ76#SB<`F"6SF$N^NEO@1\V\0 M=M%3#;9+3\>1&D?C<_,6[_(Z[WF:R3N\*@?1P4]A.VD<.:(/DTVS:1$]A"2* MFRTE??@_BZ&@]?%X&\XV/ZEL>!S.'V3YI=5?4$L#!!0````(`%*%8D?L/JN[ MH@$``+$#```9````>&PO=V]R:W-H965TS)5"5.3LD!G@RQD];"_-^#PGE')9=[\(!JTJV\AJI8;`2!V*@ MW=&[?+O?!$0$_)$PV[,U"=X/B"]A\ZO9T2Q8``6U"PK"3T>X!Z6"D`_\;]%\ M#QF(Y^N3^D/,UKL_"`OWJ/[*QO7>;$9)`ZV8E'O&^1&6%*Z#8(W*QI'4DW6H M3Q1*M'A-LQSB/*>;VVRA72;PA<`_$5@*%&W^%$Y4I<&9F%3:480.YEON"U$3 M[\W2WY&YY?IQ3<.BT@O M4O2;XK+`YAN!3138+"GF%U/\B/GLDIW55(/IXM.QI,9I<*EXZ^GZ.N]X[,D[ MO"I'T<%O83HY6')`YSL;>],B.O`FLJMK2GK_?]:-@M:%Y0^_-NE)I8W#\?1! MUE]:O0%02P,$%`````@`4H5B1TOYNO>F`0``L0,``!D```!X;"]W;W)K&UL?5/+;MLP$/P5@A\0RI0<%X8L($Y1M(<"00[MF996 M$A%2JY*4E?Y]^9`5)W!SX7-F=G:7+&:._]P MA,'?M&BT<'YK.F9'`Z*))*T8S[)[IH4<:%7&LR=3E3@Y)0=X,L1.6@OS]P@* MYP/=T,O!L^QZ%PY85;*5UT@-@Y4X$`/M@3YL]L?^(PC_0\1;_?W18H/A$HHD"QI%C<3/$] M9OLA"+NJJ0;3Q:=C28W3X%+QUM/U=3[PV),W>%6.HH.?PG1RL.2$SG-PO'R0]9=6_P!02P,$%`````@`4H5B M1YARA6_,`0``X`0``!D```!X;"]W;W)K&UL?51; M;YLP%/XKEG]`#8:$+B)(3:MI>YA4]6%[=N!P46W,;!.Z?S_;$!HJP@N^?9=S M#L=.!ZG>=0U@T(?@K3[BVICN0(C.:Q!,/\@.6GM22B68L4M5$=TI8(4G"4YH M$.R)8$V+L]3OO:HLE;WA30NO"NE>"*;^G8#+X8A#?-UX:ZK:N`V2I63F%8V` M5C>R10K*(WX*#Z?$(3S@=P.#OIDC%_M9RG>W^%D<<>!"``ZY<0K,#A=X!LZ= MD#7^.VE^6CKB[?RJ_MUG:Z,_,PW/DO]I"E/;8`.,"BA9S\V;''[`E,+.">:2 M:_]%>:^-%%<*1H)]C&/3^G$83QZ#B;9.H!.!?B&0TP=(DLO&8WV*;DXH07F-&*HQX0S@ECUV8+>MSC1&SI= MIT<;$4:>'HWNR1W_>$,@]@+QE&*RFN(2\[ANLMLPV2T$OJV:+#!QL&ZRWS#9 M+P3"59,EYDZ]DPV39"$0K9HL,?$7$W+3@@)4Y6^:1KGL6S/VVKP[7^8GZEOX M$YZE':O@%U-5TVITEL9>!-_*I90&;!#!@ZUG;9^;><&A-&Z:V+D:;^"X,+*[ MOB?SHY;]!U!+`P04````"`!2A6)'[UE[HJ4!``"Q`P``&0```'AL+W=O95NFA32T+%+NV98%#EY)`\^6N$%K8?\< M0.&XIRMZ3KS(MO,QP40DP*N$T5VL2?1^1'R/ MP6.]IUFT``HJ'Q5$F$[P`$I%H5#X]ZSY63(2+]=G]9^IV^#^*!P\H'J3M>^" MV8R2&AHQ*/^"XR^86]A$P0J52R.I!N=1GRF4:/$QS=*D>9QVUMN9=IW`9P)? M"'=9,CX52C9_""_*PN)(['2TO8@WN-KQ?7Z>MO'*X3?3T[W%X7R+\1R)-`/@O<7FWQ M*^;NGR+LXDPUV#8]'4!*VE<:1(_IPL^EN M&D0/P41VLZ&D"_]G"10T/BYOP]I.3VH*//;G#[+\TO(O4$L#!!0````(`%*% M8D=HT:$7I@$``+`#```9````>&PO=V]R:W-H965T-%<\I(O#R?HW]+U0;U!^'@`=5OV?HAB"TH::$3D_+/.'^'4PF;&+!! MY=)*FLEYU&<*)5J\Y5V:M,_YYO;N1+M.X"<"7PA?BR0\)THR'X47=65Q)C:W M=A1Q@JLM#XUH2-#F:+Q*U4=$71UK7MY5[!@#?<#L,X8GS&I!L!!]2<'_GV+/ M+^C\.GW]B<)UHJ\3O2RN\\M/^&7BESG]IKA:X4?,OS6RBY9JL'UZ.8XT.!F? M>[=XE\=YS]-(WN%U-8H>?@K;2^/(`7T8;!I-A^@AB"AN-I0,X?LLAH+.Q^.7 M<+;Y167#XWC^'\LGK?\"4$L#!!0````(`%*%8D=4F4.#I0$``+$#```9```` M>&PO=V]R:W-H965T&+"!. M4#2'`$$.[9F65A(14JN2E)7^??F0%2=P[FGG MW+!CS%8=:&%O<(#>WS1HM'!^:UIF!P.BCB2M&,^R'TP+V=.RB&?/IBQP=$KV M\&R(';46YM\!%$Y[NJ+G@Q?9=BX4!$P&\) MD[U8D^#]B/@:-H_UGF;!`BBH7%`0?CK!/2@5A'S@O[/F>\A`O%R?U7_&;+W[ MH[!PC^J/K%WGS6:4U-"(4;D7G'[!G,(F"%:H;!Q)-5J'^DRA1(NW-,L^SE.Z MV6YGVG4"GPE\(=QFT7@*%&T^""?*PN!$3"KM($('5SON"U$1[\W2$X1&S6A#,JR\A^--P.'^0Y9>6_P%02P,$ M%`````@`4H5B1Z8'ATVF`0``L0,``!D```!X;"]W;W)K&UL?5/;;N,@$/T5Q`<4A]QV(\=2TZKJ/JQ4]6'WF=AC&Q48%W#<_GT! M.VZZRO:%ZSEGSLQ`/J!]<2V`)V]:&;>GK??=CC%7MJ"%N\$.3+BIT6KAP]8V MS'461)5(6C&>91NFA32TR-/9DRUR[+V2!IXL<;W6PKX?0.&PIPMZ/GB63>OC M`2MR-O,JJ<$XB898J/?T=K$[K"(B`?Y(&-S%FD3O1\27N/E5[6D6+8""TD<% M$:83W(%242@$?ITT/T-&XN7ZK/Z0L@WNC\+!':J_LO)M,)M14D$M>N6?<7B$ M*85U%"Q1N322LG<>]9E"B19OXRQ-FH?Q9KN<:-<)?"+PF?`C2\;'0,GFO?"B MR"T.Q(ZE[43LX&+'0R%*$KPY&J]2]A%1Y*>"K]?FNL#J&X%5$EA-*6ZNIO@5L_TG"+NHJ0;; MI*?C2(F]\6/QYM/Y==[RU)-/>)%WHH'?PC;2.')$'SJ;>E,C>@@FLILU)6WX M/_-&0>WC&ULC53;;J,P$/T5BP^( MP0F01`2IZ:KJ/JQ4]6'WV8%)0+4Q:YO0_?OU):&A(B@O^';FG#/&,UDOY(>J M`#3ZY*Q1NZ#2NMUBK(H*.%4+T4)C3HY".]/E7:;N`\PT-<67-H5"T:).&X M"YZB[3YR$(?X74.O;N;(FC\(\6$7/\M=$%H/P*#0EH*:X0S/P)AE,LI_+Z1? MFC;P=GYE?W'I&OL'JN!9L#]UJ2OC-@Q0"4?:,?TN^E>XY!!;PD(PY;ZHZ)06 M_!H2($X__5@W;NS]R3J\A$T'D$L`&0*(-^Z%G,T?5-,\DZ)'TM]M2^TOC+;$ M7$2!C#<5V".7O47DV3DG\3K#9TLTPNP]ACA,-""P81\DR'V)/;D))_%FFF`Y MXW'I"):>(`FG"58S!"M'L+H01.,D&^_28U*?9+Q9+*=EXAF9>"1#)F7B6QER M3R6944E&*G<(TAF"])'K7,\0K$<.5I-O9HR)IT4V,R*;$4$R36#+[O[3#A]) M-)JMCNB!5+^!TF\Z^*8@.H)?5)[J M1J&#T*8MN,(^"J'!N`@7YF55IOL."P9';:>IF4O?C_Q"B_;:7H<>G_\'4$L# M!!0````(`%*%8D<5#/FGZ1$```>&```9````>&PO=V]R:W-H965THQ\[A]B6>@;`8/KA`?@(GG]?/__U7QX>GE[>K?9 M?'US=O;R\6[UN'SY=?UU];3]S>?U\^-RL_WG\Y>SEZ_/J^6GUXL>'\ZXZ_JS MQ^7]T^G%^>O/?G^^.%]_VSS1?S&O+O^]7WE^KO)[O: M_[E>_[7[Q^+3V]-N5XG5P^KC9G>/Y?:/OU=7JX>'W:VV1?]WO.N/0G<7UG\O M=[]^;>^V_G\N7U97ZX?_W'_:W&VKVYV>?%I]7GY[V/RQ_GZS&AL1=S?\N'YX M>?W_R<=O+YOU8[GD].1Q^<_^S_NGUS^_[W^3NO&R]@4\7L"'"P*^0,8+Y'`! M$[P@C!<$[P5QO"!Z+^C'"WKO!<-XP7"X0`9X01HO2#]*P!?D\8+\XX(,+]CU M^;[G.F\KZ-#9Y+ZD=#>QMR54.IRF/7ZV?Q=?W^1WR\WRXOQY_?WD>9]_7Y>[ M-*9-2;_'H'V=^!I'T'07>0USN$L0Z3]C[MG\D^AO8O3;=@,$D-=.U:*I0Y>3H.:[?34&C3U. ML0O@P1#6?*K*BTTMNE0Q9IVH?F%[5"$H6\2JL*:"7DZ"C!IQ52-![RE!&:1: M!_OF<':I8LP*254A&E"%H/I14(49G18\-:I5TJH+5#U2LC<=)$I=HJ+U M$M'C@2)&6L6:/N9R$F14J=8ZZ@;X#D&QHUKMVI;HD@9/E6I)I(0S'VHB:5$T M>BYYZI2J.FV'/E`CJ+&4ZX=D9'[V5"C78Q2H#T/!9J7%N=UK[!'L,(L8NLU;BU/3?E^Q1:U9J#2T,0[EF)<6Y.6VX9(]> MLS*L1X99AI+-2HUS\SE=38*:!N&=&:1K`T6;E1[GYFSG:A+4&P5!*6:ELGDP M[@&EDP>/]6*H=:QEK&V]V*%ULS&HF.T!OJ=0[;A6,L-YL4/M9ERKG5$5@4(G M6L/:RBL.H9N)5^@$"IW4&F98+G'HW$S(\6R@P(D6KW8_B4/A9E(K'*%G@V?E M<%I>*N30MYG4?C3`WH+B)MIJM@V7./SH3&H_R@0?$E0XJ<7+\%OB<*4SJ5TI M3G>!4BC:"H"E1F4:)K>"SQ*+,D1UV@ M(HM26\->B4>2Q2')`4IRJ-76\%7!H\BA-@`A2TH,6J[6""1]&"7BYD06LU`6I: MJ.7*L##!(VG!(6D!2EK0J0MUD:3!NBF(I2V M6*N685VBQV_&VF\>R?,(13!J-VGTG,=R1G&\15!,8^TC#>\2/5XS.M8^(][Q MT3-DHZL\FARCHRY0BJ.>:;>]2_1H<71H<81:'&N9-;Q+]$AQ=$AQA%(Y?HT>*H)_Y'T@F*)D&&>>FAXO:UF(JY(P@ELB>/>>FAI/5:KD+K M`;_O:[F"FMY#L>I%-;JYB?F^KW6(C6*@#O5J#[JS[@$%I(^N9XNW;/OCS_9Z M#!I?7NG10F8/<[NO\W9J^4II==K"K<`>)F^O\[)O%U9[I(1VC7J8E'V=;U/3 M5LJJ/1#5(6CG:V9P<2SX)BD:"&XVEF%HT!`W8"8I&TJ+13JW$CC9! MN4C:%[1?O53+!5I^3E`M4JT64P=(#2W0J\G0<96:(("D91`$+7O MD6'VY\[C%S-,[:S]0'.(GF>]4)N3(,G/,+USG=YMQSC/:FLL("W),,FS7H1H MRO`\*_/?X^)@GNY_?<1!SDO4^&Y"EJS#&&E7RTK;1H\D@AZMMA4K.#JY:'`B<8YI'7!H.8G5::=BJ6J,.`!.=RU&'0LDNJ M2.M-50L9C%\>\!!7@CN':"1U!VS6VWC:A\Q(57:Z"CH'KM>(( M-8N\)86E2X);SG2$3%?4>=O[SDM066K+$(<]`IXKJES(Z$B%E4.4DXYPY>2@ M%.-"UC-7Z'B*$K;Y8\"&=`0>UV!X>T(PUU%"QHR` MCD#AI"/0QL?(2M3A@V1P M%,#L-"DN6MCL'2PS(QE][`-E&(TFULNIS6G3HD2-?3P^;K/U6!84)-V>S2]* M$/Y8$::C:8(^-\WO@A3[S/#=Q0@T*;RY/95?D,*;"1HF##B3HI>-N?R"//@R M87Z9,,!\**F>)T$9QW0R*?+8F,DO2*''<$Z&T6/26'%[)K\@<;`>A(EBFN#" MS0%Q08H73@Q3#0/#I&!@8PJ_(`\-3!@')LT#6^]^[2U2CW,-B\B$Y[4ZS:,B MF.@E1>NVI^P+$KWP@AJ&H5T*>M7%*,^#Y!)F2V;?NB!+E>0*P9FK9M MS\,7I'#;(WX`8[>DD-KVG'A1@O"&$&&HEC0QVYZ<+G24<+3*PK*AB%AA*X^5 M;A@E82:6HIZ%6)-6C+%2=$%:A,%3BGK&T,R_FQ)%9<@UJXR37>&BP@983Q@& MI>A"ZPESG!3U*H.QE*0@3[6&.&Z36*W')"0I%%+$P`8) M(XXTXHM'6X^31R.,TAR<;DN49\4%TX[4JS03:^:,>4?J?3-GC#%2KY?>VM!) MB1H'+MQVG&6*912QQB7,*%+O.X8&TX>D\<-VV^4`:7*0P8=*/AOYXV^>D M83^\RH%I/U*XGX@!L1/&^&AD](XV'N>.)O3$:GSMZ:B#1Y019O5(PWK!O`M. MGN3S=IBQ(PW9A3853XJR&[>NS&KC/-.XG=UXG#W)Y^\P(4<*D;,;7_N[;?O,.!&&EYK'TQW6Z+*62:AMV"57-,NY$/ M=R/,NY$"WB0T%R1O2U390D1MQ[@;99UIUDB/.3;*/H>'\312?)J$YCSV78FB M`E;)KV:E<9YI0"U88QT&SRC[#!X&RB@[MD9F):J`CD?>>@R5D:+*)%BC'4;% M*+L\'F/^BQ7_97WDJD2-S1_P45GX:*I.IYDQGV<,=7'G\GB,02U6H);$-HW& MBM3B`$<[QJ@6:U0K&I-:QOP5=RZ7QQBJ8@5526Q^YO%J&M5<3GMG1TUJA$]P MTLQ5M,ZLPA@5=RX;R)B-8L5&&4]G-HTR])`Q%<6*BI)H':&%02CS%!Q)H@:K?[>AIEMAMGGJ:"HG5J,Z:" MF'P'GF%^AR=0@ M4+1&KB-',[(O2X^=ILB>7O,.1.3!U1^#KS^PD"CB1WK+VAPY M[)!]KA9#.CPY@["]:ENBRJHM6K9EC.FPQG2LT4-']<9TGS&HPPK4D=Y\1#A5 MQ35Q9(S5,#[2KSAH46?GDV2X=\T8L&%QC-3S253?IH_MJ$F-W7`&F M:UA\XSEF9EC@>#YN29,.9<>'*NG*'`GM/G MKE@?/X>H4\9,#`>'F;Z:1/7-P[?>V5&3&N&TU^Q,;UE/S,6P[Z0ZQLP+!TC* M'?K,H(_*"D1?6R,M@&0J,O+`/>6&,O+!&7HSO&)I$M1/YQHZ:U`@GLN9B M!K-=.)%]7`QC+H:C*Y$])YQ=E:BRTDKP+'6,SW!TK7#I*$M^S:A)C7#"1YWP MYJGL..&C+^$Q8,/1E?#1E?#1<6()8U2']2ED@^6B,*K#OG/(&.,WW+OFU[UK M?JT.+#.?#[EWK:;UK/:U7+CT27$_#2!"K<\MDL`P+1H)X\)EUS/GPX#+K M@\.LSU@=24;P@W>,P2'6IY(E\RXX50??Q!KC0(S/$3L\(L\!IB7J,/V&!S@P M)HQ8'SF6+%>&"2,>7'NWC+$AGIP29BSS#&KO-N#&X^16)X5)LA9P,&'$@V^- M"U-#G!QK7/,25>Q4R`PS!#-&G!S+7/-)5/M@UQL[:E(CG+.:5TJ6H<(0$B=? MSF((B9-C,6S!ZCPOLQ]P$FI0*5E6"=-'G'Q)B.DC3HXUYODDJGWN^HT=-:G1 MD2_QT5EJF0K,)G'R92EFDSB[5J*SXY->C/DEUOQ2LDP0II(X^\`*3"7QY'@M M0YO&J++.AI4)$TRL":9DV1L,)G'V[09A,(DSW`TJ.J#.Q#);C7-/'X>5S;O@ M?,F^Z23FD3@[-FSGDZCV%T/?V%&J1H+9)M%G6V7#J@@&EJ1S32@%`TO2.5:" MYY.H]C'D-W;4I$8P1T7#3]EL%_Y*I\XUI10,-$D'%Y!&E2Q1>%51,/4DFE2R MOA=/,*DDG6NN*)A4DLZQ5S,O4<>:C;^R2(-*V7`,@D$E(=?T3S"H)`2G?Z,^ MEJAR&@7\B+Q@J$DTKF0=S"D85Q)RN43!N)+H`X_:2K"81%GN6##4)!I7LKY7 M43"N).3RB8)Q)2&'3UQ,HJRO,Q`#:GHJ9:73YE4X1_!WQHYS;ATE/WW3T]G+ MW6JU>;?<+"_.'U?/7U97JX>'EY./ZV]/F_TS//STY'GU>4?ROKFDT[.??[YM MQ9O;75-^_MVN%KO?Y=WOSGX47DS_5FLW[&ULC9A=;YLP%(;_"N*^@(\-F(H@M9VF[6)2U8OMFB9.@@HX M`Z?I_OT`.RE,^,PWX>OXO,?V^SC@_"*[M_XHA/(^FKKM-_Y1J=-]&/;;HVC* M/I`GT0Y/]K)K2C5<=H>P/W6BW$V-FCJ$*$K"IJQ:O\BG>\]=D M?VZ:LOOS*&IYV?C$O]YXJ0Y'-=X(BSR\M=M5C6C[2K9>)_8;_X''\E_+7CS)^E>U4\>AVLCW=F)?GFOU(B_?A.E#/";R MN3;QO:;\T,>JG8X7_20%TVR]`9@&<&L`NG`M-)7YI51ED7?RXG5Z;$_E.(7D M'H:!V'I#;;T_/IIZ/T84^7O!HB@/W\=$BYA''0-3#+E%A$/VFP38)1YAUASB M;#T!16JD4P)J:K14P)`$;$K`3`)8=K+55>J85,=D*0DLA<:(3KS0H:LZ.H;K MP21I8.E.@L@D"QFV*I/,9.YX&L"Z3(K(I`N9>%4FG#E)/&`6*0QE MLF395BV&*4F=7(DA2+B+*^<0DCBVKI`$HY!D+J[,%HLDV.P"&*T0.?C2!,77 M==*B@R$-Q,&6,$R6BZ!LO=?"C M"4*=0C%&*7/PHPG"53",:>S@1Q.$JV`$T\3!C#1QG!N,8CJGF$:V8C%$*7?R M(@8?S5R\.(>/<]O?*,/08Y&#%5GT_^EC&)V,.%C1!.$J&,`,'*S(Y@`/;Y"V M0YM3^1AVCD(/\.+ M_%0>Q(^R.U1M[[U*I60S;0CLI51BJ"(*!O*.HMS=+FJQ5^-I.IQW>A]#7RAY MNF[+W/:&BK]02P,$%`````@`4H5B1YQ:T(2J`P``4Q$``!D```!X;"]W;W)K M&ULC5C;CILP$/T5Q`>`/39@HB32)E'5/E1:[4/[ MS"9.@A9P"F2S_?MR"[%3V_(^;+B<&1_/\1PPRYNH/YHSYZWW5195L_+/;7M9 MA&&S/_,R:P)QX55WYRCJ,FN[T_H4-I>:9XTOA.ME.,<=\I)732XJK^;'E?^" M%SM">\B`^)7S6R,=>SWY=R$^^I,?AY6/>@Z\X/NV3Y%U/Y]\RXNBS]2-_&=* M^ABS#Y2/[]F_#=/MZ+]G#=^*XG=^:,\=6^1[!W[,KD7[)F[?^32'J$^X%T4S M_/?VUZ85Y3W$]\KL:_S-J^'W-MYA:`K3!\`4`'/`/(X^@$P!Y!%`K0%T"J!/ M`>$XE:$0NZS-ULM:W+QZ5.^2]8L$+VA7ZKW7S;[Q^UM#?7O$>OFYIA@OP\\^ MD8+9C!@8,`]$V&6?AP#S$!N0PD$WP%9!$!UD)T.B2$^"6.9)AG@RS1/T":@E M`1T2T"G!$\EJG.F(209,2ED4).GC3Q>Q4R)PC()8SRRR,(L49E3+;,2P44*< M1M(X,IT1%HTP9*IS;"$3*V0B+9E8(@,D9@'6DE%@$)/`L/82"YU$H:.=]"91 M:L,B$NBU4G$42)#H"3$+(:802K2$F#P03?1:;9FT=#"*`X-8J85,JI!A^@2] M>9KM`[GT%;8Z$'98,A-H7C,0:'$[%0=1$A`#)8MCO6!0**6&%#:_P4Z&@VV. M@ZE+8:@T85-;/X%,0MM,!BLN`\B0PF8-.'8JB:V=L=K/>A?&MJ<.IJL'4U8`>E M0.Y6C'`4:,NW>\)!9"H,V+H:P$&I"30.19')9Q088<9G$]@\`HBBE*G,-H\` MZJ24K;,A8%@C!EZ2L4EU-A38',*B%V4BA5*V*24`J-Q8*J1S7=`]1V# M@8+-)X`Y*67K;$A=E$J?/(3IRR+#"$6FAP*Q^01!#CI-H$F`.-"^\^Q4%#:] MS1";YQ#%<\#@$<3F$01<5"+6G09Q4&D"3=.-#-VDHJCI?9/8'()0%XWD?0B6 MGSL*'06%_VOM4-IZEKP^#7OXQMN+:]6.>[?YZOR=X`7ZK>O3]0U>;,?=_B/- M>GG)3OQG5I_RJO'>1=MMC(>M[5&(EG?T4-!YSYEGA_FDX,>V/TRZXWK<\X\G MK;C&UL?93+CILP&(5?Q>(!,)A+:$20&JJJ750: MS:)=.\$$-#:FMA.F;U]?"(7691/?SCG^?AR[G+AXDQTA"KPS.LA3T"DU'B&4 MUXXP+$,^DD&OM%PPK/10W*`M,*)].01P\)U[[6Z?,!*Q*N/B:GI%!]GP`@K2GX&-\K'.CL(+O/9GD MJ@\,^X7S-S/XVIR"R"`02J[*)&#=/$A-*#5!>N.?<^:?+8UQW7^F?[;5:OH+ MEJ3F]$??J$[#1@%H2(OO5+WRZ0N92\A,X)53:7_!]2X59T]+`!A^=VT_V'9R M*VD^V_P&-!O08HC374,R&Y*_#-"1V;H^886K4O`)"'<6(S9''A\3_>6N0!JU*LV+\#\PZ0Y,NH')O3!.4[B*\R1$ M7IB-*BM6J@U,M@.3;6"\-9^SU38(16'LA=FHXC@L_##Y#DR^@2F\,$X3N[]D M47A%=;XZI2+Y]Y3@ZA:,^$:^87'K!PDN7.D+9:]$R[DB.BL*=6&=?N>6`26M M,MV#[@MW]=U`\?'YD"VO:?4;4$L#!!0````(`%*%8D?4+^5#*`0``&`8```9 M````>&PO=V]R:W-H965T[U\26;2J`/(#CV;=?3G'4&='(%S'@7ZV_&_$A*9N;;M[: MLU*=]ZLJZ_;1/W?=Y2$(VOU957G[35]4W?]RU$V5=_UIXTZ/OI/XN%%1H-D5/Q3J%MK''N#^5>MWX:3OPZ/?CAX4*7: M=T.(O/]Z5SM5ED.DON>?<]#//H>&YO%']#_&='O[KWFK=KK\MSATY]YMZ'L' M=E?^:OHMZ_+Y-OZ3AW,S>`.8& M<&]P[\?>`.<&^-D@9AO(N8'\TD,PI3(6XB7O\NVFT3>OF>[>)1\&B7B0?:GW M7I]]ZP\_C?4=%-O-^U9"M@G>AT!$\SQI8-0(FV)G*B2&=TW0.[C;@&4;SV`$ M`&L7IB**;)(7("Z$W04RQ<`Q`,X!P!Y`,@'D&$#.`9"ZK*=4)XV82A[:)+L% M";$1,38BPP:DUCZ>)TTT64T`DG#X6.U\D8;9HO0E,IT#AO/'GD+,I!"32DIK M"K'A*V4SH,JO"1!3"6,J(:8BJZG$["IC:K4SE5D(DC&5,J92,FAC>X","9`9 M646I-:G,L"KB:#DG(OQZ1XBC@%42)=A(`V_ M$?.\$:&,N;PXN`J3KJF=\2)R]10Y>^)H*0@NY<*K3W!L$XG+RT]P)!*IPWMG M%LT#,?OM#4&JLZ*EUCC&BD%DS8+?NP2:H0C$:`#MV<1:\0NH48XG@'EF9W4()UO ME'2_41S1('(A-7``@MCE7L?K);9+J!$.8V#.T1;H#,FZ#[N$^N!8""8+I5S` M*7#,@LP%#,BQ!<-U,&"X6HT%"?7!`0J%P_!`DSOZFC=C[U?MF^A.,^[N? M\NWFDI_4WWES*NK6>]5=IZMQG_>H=:=Z$^&WWL19Y8?[2:F.W7"8],?-M`$^ MG73Z\K&??_^GPO9_4$L#!!0````(`%*%8D<5BQJ3#P(``%D&```9````>&PO M=V]R:W-H965T:MH2&?&>=GKDQ$5+E&Z*,Y"]H.1H12T#",(5:$G3A65A^]Y$6?"+8DU' MWT0@+VU+Q-]7ROBP#>/PUO'>G&ME.D!9@$EW;%K:R89W@:"G;?@2;W:Y(2SP MJZ&#G-4#DWW/^8=I_#AN0V@B4$8/RC@075QI11DS1GKB/Z/G_RF-<%Z_N7^S MJ]7I]T32BK/?S5'5.BP,@R,]D0M3[WSX3L$H\PO0*$"3(,:+@F04),\*\"C`7P3`+<5NQ(XH4A:"#X%PA]<3 M;'J'DOA[-:Y M.&#V4??D3'\2<6XZ&>RYTN^#_<)/G"NJS6"D3ZG6[_S48/2D3#73=>&>/M=0 MO+\]Y-._2?D/4$L#!!0````(`%*%8D?6PG\"B@(``.T(```9````>&PO=V]R M:W-H965TL0_;O!+;FO?.`_%CZ:TYG+A;`JPY%W:#K(O;5EH2GO\,1I\^)=$\=\!%=6_Y![M_Q$$,J#=:D9>KIU5?&2?>@^%Z' MOO2[Z=7[KK^D8*"Y"?%`B$?"Z,=-2`9"\B3`60(<"/"%$.I05")VB*.JI.3N M4?WW+DAN$K"$(M6U)Z)GOORD\BL157FK(,S*\"8-69B-QL0*`T9$**R/+N)I M%YO8H,(G0YRYVP"<,0"5`3@8*&R1O8Y48W*% M>8/!1*[2&2^IY67A\K)-32_)E)=LQDMF)B.-W`;R&0.Y*3,%SF1H3*%W31XX M0;OR@V8K3/`DC-Q@L%,'5F#^'_. M,)BK`B"Q5#@WPF8`Z7"SP'D(=R^@8D+,7$4!5DE)<[<8LZ;`8NH/O:`6+W)" MHRETF)Y4=V5>3:X]UU5U7!T[^#J63>5E?0.66]V'GV:J\H).^">BIZ9GWIYP MT;)4TSD2PK&0%P6B9)W%W6.&PO=V]R:W-H965T6=]._T@C'S/MNFHRO_PMAU&8;T<,$MH@&YXH[?.9&^18Q? M]N>07GN,CI+4-B&,HBQL4=WY52G77ONJ)#?6U!U^[3UZ:UO4_]W@AMQ7/O`? M"V_U^<+$0EB5X<@[UBWN:$TZK\>GE;\&RQV$`B(1OVI\IY-S3R2_)^1=7/PX MKOQ(Y(`;?&!"`O'#!][BIA%*//*?0?094Q"GYP_U;[)4;PES>_ZR"X\ MV\CWCOB$;@U[(_?O>*@A%8('TE#Y[QUNE)'V0?&]%GVJ8]W)XUW=*:*!9B;` M@0!'PAC'3(@'0OPD)$Y",A"2+X10E2(;L4,,565/[EZOGMX5B9<$+!/>ZH/' MJZ>^N"7[*Q!5^5$E:5&&'T)(PVP4!DH,&!$A5Q]#0'N(#9S0H2G`5D/$)LAN M"DE3-"@ISD-01)-6"6'J= M.02R.67F#H%HB`U@;;YI!\,0,(J'W&:)[M@%$M@4%NR<7E4:";-+-(N!P(TED=<7D09%H6N7E/U4&6 MO0*XK`ITK]I2=5D,%+.J=9D,+.8\_\5T-[!M&3HJ#:#E6^-R+-0O M()C3%.CR%81:%L8]8#.`5+EI!H/8!-MIL"2%_^T5X>2+W^+^+$S5JJ0M&KH_)<1Q?JW]02P,$%`````@`4H5B1S%8D8Z! M`@``W@H``!D```!X;"]W;W)K&ULC5;;CILP$/T5 MQ`<$;*Y9$:0N5=4^5%KM0_OL)$Y`"YAB)VS_OKX0BKDK..JBI/>S[ ML=>0JG7S3-][Z?.,W41=M?2E=_BM:4C_^YG6;#BXR'W<>*VNI5`WO#SSIKAS MU="65ZQU>GHYN)_04X$#!=&('Q4=^&SM*/%'QM[4YMOYX/I*`ZWI22@*(B]W M6M"Z5DSRS;]&TK_O5('S]8/]BTY7RC\23@M6_ZS.HI1J?=*5#5_I MF$.D"$^LYOK7.=VX8,TCQ'4:\FZN5:NO@WF2^F/8<@`>`_`4@$(P(!@#@@\! MGE&F\_I,!,FSG@U.;YK1$=5S]!3(RIT)CCS[HK(PCP; M#-:8140Q1T31!/&D@$D%!E1@'1\:%3%:)@@`@D`3!&,:P3)!"!"$F M*Q20X5"\J220Y5"RP3(CZ#]G9`[:[U8^R`BR+[+]NU^A@(R']EM*@B'G87]# M24807!(+M%H2#'D86QY._14*$\2;RH)Y#T<;##."$I`XUB@?XWCS2:1CESI M=])?JY8[1R;D4*/'D@MC@DHJ?R<-5,IA<]K4]"+4,I'KWHQ?9B-8]Y@FIY$V M_P-02P,$%`````@`4H5B1S0&6:JO`@``/`L``!D```!X;"]W;W)K&ULC5;+CILP%/T5Q+X!FV9U.W;.U?.+^N@H`=+KA!;$&N MN!5/3H0VB(LI/0?L2C$ZJJ"F#F`8ID&#JM8O"[7V0LN"W'A=M?B%>NS6-(C^ MV^*:W-<^\!\+K]7YPN5"4!9!'W>L&MRRBK0>Q:>UOP&K'8PD1"'^5/C.!F-/ MBM\3\B8GOXYK/Y0:<(T/7%(@4@^(3^A6\U=R_XF['!))>"`U4U?O<&.<-(\0WVO0I[Y7K;K? M]9,\[,+,`;`+@'U`OX\Y(.H"HF=`K#+5RE1>WQ%'94')W:/Z,*Y(GCE81:)R M!T\DPWSY2)5+(LKBHXQS4`0?DFB$V6H,5)@G(A#L_19P?HLM'(1#TP:[$2(R M[Q!9DHA4?-0E`2148K&Y`\IL5'*!)29I:06*>E(2FPFR"P$FH9#$GQ^+J#8"CMV/F M30<'8O7-OBLUT('4JBLUV(',I2C9. M%YB+,D2%B[F$;!X&(Q/G,_8#-O^!I4M-H,V`,'2H20?ZHB935#XCQV9F.#)S M/D=A,R"$3D6Q&1!&+D6)!O^T<&'\[NPFH.F_(A@T)0VF9]6L,>]`;BW7/_Y^ MM6\(-U`V-9/UK6@4=5OWI"F+*SKCWXB>JY9Y>$%RZ2:GA,A'`MUXC/H>Q?1 MRO:3&I^X'&9B3'5SIR><7!^]:M\PE_\!4$L#!!0````(`%*%8D<$VW,3'@(` M`&\&```9````>&PO=V]R:W-H965TT9_Q= M5!A+\$E)(PY.)66[]SQ15)@BX;(6-VKGS#A%4DWYQ1,MQZ@T)$J\`,*M1U'= M.%EJUEYYEK).DKK!KQR(CE+$_QTQ8?W!\9W;PEM]J:1>\++4&WEE37$C:M8` MCL\'Y\7?YS[4$(/X4^->3,9`FS\Q]JXGO\J#`[4'3'`AM012CRO.,2%:247^ M&$3O,35Q.KZI_S#I*OLG)'#.R-^ZE)5R"QU0XC/JB'QC_4\\Y+#1@@4CPOR# MHA.2T1O%`11]VF?=F&=O=V(XT)8)P4`(1L(89YD0#H3P3HA,IM:9R>L[DBA+ M.>L!MX?1(GWF_CY4E2N`2D8X>LN42R.R])I%<9)Z5RTTPQPM)C`8?T1X2GT, M$3P.<0PF]&`I0#Y#A,L1PI4D0L,/;1()7!:(5@0B(Q!9@6TT-]G8-"QF9S#? M8C>&TY^_1,EGE-!]D-EFQ=AF:BQY4/SMBL#VF=+L5@1V3Y3&8N);:9+%8LQ` MOALO6XE7K,2S8@3+`LF*0/),,?3=?WQ=X!/E&$#VW*&[_&[,0*H>FR]NO,D] MIIA?3'\3H&!=(^U=&5?''OH2Z#[P9?VH>ZOI#W>9+&W1!?]&_%(W`IR85%W& M](DS8Q(K>]!5;UZENO\X(?@L]7"GQMSV0SN1K+VU]_$;D_T'4$L#!!0````( M`%*%8D>\]&1FDPL``.=2```9````>&PO=V]R:W-H965T_?LC2J#" MX6):DX?8EAK`D(-NW)J\?%UO_MP^S>>[T=_+Q6I[=?&TV[V\F4RV7Y_FR]EV MO'Z9K_;??%MOEK/=_L_-]\GV93.?/1X*+1<3TS1ALIP]KRZN+P^?_;:YOES_ MV"V>5_/?-J/MC^5RMOGG[7RQ?KVZH(ON@]^?OS_MV@\FUY>34[G'Y^5\M7U> MKT:;^;>KB__2F\^48XLY0/YXGK]N>[^/VNB_K-=_MG_N]@^'Z]W'_V6VG;];+_[W_+A[VH?; M7(P>Y]]F/Q:[W]>OTWFY"-]6^'6]V![^'WW]L=VMEUV1B]%R]O?QY_/J\//U M^$UJ2K%Z`5,*&&T!6PK84P%#L(`K!9RV@"\%O+9`*`6"MD`L!:*V0"H%DK9` M+@7RK]L*\6W*CXEK3B4HX"*G7),V*NJR349=I,LWJ1-.7<9IF/+)L?<>^O[- M;#>[OMRL7T>;(V-?9JTPT)M]J7WEHWV/WUZTWQTXU4*N+W]>NVPO)S_;FACF M[1%C"L;5,.\XQM@T6U6`/-;A20_6> M?.`85V_%H59M'3R#)0S>M][-V8,!8B22B2Q"))U4A2KY7_I&;LSGW>].7`9JDK&4ASPVDN M36/P/$8UD3&0/8:SIR[&!12[]`Q'\V-==ZPND^HR64"=3(JZ;2`3#6.BJ.KD1(!^6I4?#60KR:>[[[3`BKZ),S6[UA5?CCM[W(9 M^P.C2`1(?<.H;URMH<\%=*XAJ`^&33N,T.TLU`?;J)8.D/F6,=]4UX#3`4@0 M1`OEP1I%;RB@([5-0^.JR-^QNKRI3B?O"\AW=0E!XY6551![`!*F#18JB&6\ MMT*7LI#WUJNZ`^2]#9KNP$!6NK-0'*Q&'&Q_<6*M'U>W%NYLU'2'OCKLZQ*" MANI@DZ8[,)"5T@#5P3)UL+9>AX/JX%3JX*`Z.%)DJ8"*A`=!PAW7D+J$%Y#_ M5TT\9B@TCHM#7<*=434$Q<$QWEMI3P5OJCA5DB#OG5=PEH.D[N^@.+B@Z0VA MQUFR;KBET'6'H.!L`:5378+4."@U+BI8RT%66#L&Z8%=&;BQ:KRMIXFSW8D)#)YJ#2>R8,5!E$/F>]5*Q`/2>VM@DP1KNK'19<@HR%5`ADV_&PBK/X^U6KR`3!SF!M1Z*C6<"X:1D M0N;[J.H0D-0^:?*4^F1*$IGX]*$^!/K^XB*)9((BXOGBHCX$^JQI*$"E"4P> MG#!/"9#Y@31)"I#Y0;.X"/TQ/PHY8C5)@B?6Q$.&0A.XA@BSAP`U)*AF#P$2 M.F@.4`KH>,%.NG5>T;W%FGC(^/`D*+IW`15*RBU!`0EL5N"$65.``A*2*DF0 MT"%KDI2E*V99RIH.+E;%#Y^@.$0N#M(!%A2'J!*'",4A,DH+^\8!/%H(%LC9VM]QL!!KG[T+X)X-/A(E#-: MNK^0T5'%Z`@9';,F1PSDJ[?N7@3QTUE(U=0HI`AH;/B]."6@WQUXC$503P:*`TY:A+-SA_%M5R&M,\:VG.0%V8O M&7N5&*.#9.=HSKB,5)RF!CN#&CI_>S]TJ')_1;,<-=CHT_!EN63):"`?CU\K M+AS;;AK&MKK?\G:`"L)$B!ILO6D44_G;`2I4YR!3&36("!MY&L7B^[9#57:7 M!XUAQT^CV;H?H((@?]1@TT_3YZ>55@;48-M/H]J_IS,^0-(X?SI4N7](S$;DN3&I3->.NZ3DS9GZ(Q1CE0K83ICE2/%=O6'#E4Y9AXX M1C&UF*G.!^G"L5^.C&I?BK!CCHS1I-ST=YME*<7..N+6NB"-H-CH1D:U/478 MH$;=S':NS-3!^QD(]/GE25I(,9>-C*JHR3"[C+B]K)0W7R]Z5#EU*\A MT8F,+6;$/69!]#-CPNA<9H1M9L0M9+$ZHKWO4'3LZ]GJ/.+8>$;,+98EPF,C M&%G=U!&[O(C9O"3#NNT?^B+'^@#H@G2D2]@X1M:K*(*M8V1U'F_L"R-NYHK5 M1PEN.E0W]7%1C!D34N/HNAF@8G5^_5Y+"I.76K_J#5F\[5$F]S9(SAK!' MC!P;#:/D[<ET`9NXB!NTQ"OO M/ZKFG1.?P\).+N)6+NFY3L)>+M*9N0B[N8A[L*0K'_BYI&$.N["(V["B-.)B M'Q;IC%B$G5BDL6+=#%##,;73`Q$UB`BSC_NLDJ0JV$%%7K=H'F34("(L"=Q7)>6+HZ2A5$0-(L+RP@U8DJP65-== MQ>4#-FI1X,HAAHR5(^B4`[NG**B4@Z-L-14/,FH0$5:.H-CFO1F@DO"Z"A$U MB`C+2TBJSL$6ZK81YUG8W45!MU#'=BN*.NG`ABN*C.ZI^M*`=QVJ[,W(FU+8 MF47<=96D:1:V75'4KJSSQ6 M'547KGJZDK!SBB+C599F4-@[15$WK\:>)^)6)>FZ$WN1@OP:!6QI(NYIRF+( MF"\Z5Q-A6Q-Q-]+P'4.G"[>]A),H[=BT1-QKE,6[A^F2=`,?MAM1"JJ$A_YU MBTL%;$LB[B;*XMT[\R("W?D*M@$1]P&)UYW[RD9&NG#L%Z+,6"7.E[!CB+)N M1PD[?8A;?:11G'M]Y.NNDVK5M=7&6BF%Z<&<._]Z2<&V[/9Q?T\67TB!292A M/__4%A^9I"$9&X&(^W?JK_MZRU'RB1ZV^1#W^0P=[:>V(FMK./),>J]I6\XW MWP^O.-R.OJY_K';MNYQZGQ[?HSBE-W>'U[P-/F][0ON&15OYKLUD^YVK?^?; M[WS]N]!^%^K?Q=,;'2>_0K^^?)E]GW^:;;X_K[:C+^O=;KV\:E\]]VV]WLWW MMZ09[S/]-)\]GOY8S+_MVE_;R:WDZ=V6U_\'4$L#!!0` M```(`%*%8D?ESJ^$<0(``$4)```9````>&PO=V]R:W-H965TUXS;I@H.=-^`V\[`%6$JWX7=.1&^-`P1\8>U>3 MGZ=-&"L&VM"C4!9$/FYT1YM&.P\)@Y9\3,^ZT\]Q^K*.YS!W M0#(')(\`@+P!<`Z`SP:@.0!]"8BF5'0A]D20LAC8&`S3?Z\G:I.`%R1+?0QD M]CQ4GW1]E:(L;B6.DR*Z*2-+LYTTR:R!+LW.U#A=]I;BTR22D`_2Q$.:Z'@X M4R"W`?080&V`M`',;<9NRF*29%H"0++"+M7>5.5XM9`+\J`@*Y?4;9!Z#%(C M%X2^?G)D;JW%%[ M2[/&;A#5:Y>[36RB@(5<@+=A@6=^.\#724!B40!7LMM9!(!_-P)?QP'06FBA MN]JBA6X"?.T$(,MBH3<"7T,!Z5-E]74!@)\I*S;+*B\A7^L:&>=73R[T%QDN M=<>#`Q/R*-2'V9DQ0:59O)+0E;S3/"8-/0LUS.1XF$[Y:2)8?[^T/&Y.Y7]0 M2P,$%`````@`4H5B1UG#''-.`P``/1```!D```!X;"]W;W)K&ULC5A-;Z,P$/TKB'L!C_FL$J0VJ]7N8:6JA]TS39P$%7`6G*;[ M[]>SKIIN[1Z%.#WZ?K<]LKKH/'YB MC;RSYVU="'G9'OSNU+)BIX/JRH<@B/VZ*!LW7^FQES9?\;.HRH:]M$YWKNNB M_??,*GY9N\2]#KR6AZ-0`WZ^\L>X75FSIBMYX[1LOW:?R..&Q@JB$;]+=NDF MYXZ:_!OG[^KBYV[M!FH.K&);H5(4\O#!-JRJ5";)_'=(^L6I`J?GU^S?=;ER M^F]%QS:\^E/NQ%'.-G"='=L7YTJ\\LL/-M00J81;7G7ZV]F>.\'K:XCKU,5G M?RP;?;ST=])@"%L.@"$`QH"19SF`#@'T*R#4E?8STW5]*T21KUI^<=I^,TZ% MVG/R2.7*;1U93.>J6WJY%")??>0QB5;^ATHTPSSW&-`8,B)\F7VD`#/%,TS" M88E@,T/090:*%$%U/-7Q80K+"4(D0:@3A,,JQ/-)-GT9/2;I5R$`+URFB1": M:$:3+-+TF%1C'FCBQ)DTLED)(M!)!G"DDU9(%A.H)X<9K,%-D(EJ%^)A50' M4%\LH8&7&9@0VSX1L%#K`+KN<>:E!B;,OH1:"'8`1;UB#2R8QTEX7[$#YGXY MF,M)9"%',O5Y1KP@FWX,K)CIRA=!&D8"Y$2(+10Z@:/"]@0:S'\06\R,"#>102&S4F M]Y^5@-D84@LMIE;%8!Z&S$:+-QXV$%',PW3F8>-/3,R>E-A(D6+6HV`A13JS M7N:1S.+-0-%?Q]1"FM3B]4HQJ]+00I@#"&?!W$RC^\*DD04)YF4:6\AR`"5V M^^1/NK*:M0?=K7;.EI\;T7<^X^C8$3^!ZNINQI]EI]SWM5]I\M6I.+!?17LH MF\YYXT+VC+KKVW,NF)RL-(WK'&4O/UY4;"_4:2+/V[Z[[2\$/UV;]?$?@_P_ M4$L#!!0````(`%*%8D?4J2<*,`(``*4&```9````>&PO=V]R:W-H965T/4-J3S M]^,E!*83V'9>5>JY=U:5]"IPVZ%W!OB5$,C^[1"FP]8+ MO?O$1WMIA)KPJ]*?>*>6H(ZWM`,,G;?>2[@Y%`JA`7]:-'"K#Y3W(Z6?:O#K MM/4"90%A5`NE`&5S0WN$L1*2@;]&S4=(1;3[=_57O5OI_@@YVE/\MSV)1IH- M/'!"9WC%XH,.;VC<0JH$:XJY_@?UE0M*[A0/$/AMVK;3[6!6\O5( M>VI)YU,MM+YK9B,(6!I*O< M[21?<)+/G(3.*`:3:LR3Q!<+(8I9B,@9HK!RFA6K=6#]PA\A?>MK)HA==%GD MH*;73IBK/LU.E?VX^!(A:PUNEJ<*15( M6@U6\OP;^69,`XS.0G5SV6>FC)J!H/W]49A>INH_4$L#!!0````(`%*%8D=U M_C?)K0$``!,$```9````>&PO=V]R:W-H965T[#2E4?NL\.#`'5%]9V0O?OZPMA287R@CWV.6?. M>&R*4>EWTP%8]"&X-`?<63OL"3%U!X*9!S6`=#NMTH)9%^H3,8,&U@22X"1+ MDBT1K)>X+,+:BRX+=;:\E_"BD3D+P?2_9^!J/.`47Q=>^U-G_0(I"S+SFEZ` M-+V22$-[P-_2?95[1`"\]3":Q1QY[T>EWGWPJSG@Q%L`#K7U"LP-%ZB`^I.KD:N&(/]5C@NCRB+2[FEM"`7+W2#>8Z8+&"R-42U1&QI M/F.(6D^/EA:WIOW1 M':7L@Y]U=>Y>PV/?7U[BN-L>95UV47.1Y^'-OFGKLA]NVT/<75I9[J:@NHHA M2;*X+D_G<+F8GGUKEXOFVE>GL_S6!MVUKLOVOY6LFMMKR,+[@^^GP[$?'\3+ M1?R(VYUJ>>Y.S3EHY?XU?&,O&XXC9$+\?9*W3KL.1O+O3?-CO/ES]QHF(P=9 MR6T_-E$./Q]R+:MJ;&GH^=^YT<\^QT#]^M[Z[]-P!_KO92?73?7/:=I/R.
M`',`/`(>_=@#<`[`SP"Z!SX'\"\!L1K*E(A-V9?+1=O<@E;-WJ4<1<)>^)#J M;3",O@O'5U-^1\1R\;',,%_$'V-#!F:E,#!AV`,1#ZT_N@!W%RO0PL'6P=I` MH`VRT2%I:B>!Q#AQBL=YG(6]`4XTP*<&N.+(38YG-5`%$2I/R'DD;+"U#BM2 M%CE&DQ)D4HU,QA,K&X7)%9L\CS(K&0.%(@([F8P@DVED.+..>97IW7#A(&.@ MDLR5&4&0$1H984^,T'LI1((1L^$V0I_.0D"BL3;XY`2?7$].(NP-%$0#A8]P M1X-S+_'DN71GC$I*)M((K!-DPG@2H8,/:3G,0[TS:)XE)B*T$])A@D>Y@P_A M3V\,/`0\@^ZJB:QI7)NHS+6:&.54#)]+>,:H?C@P9I^OC8G#G+DDS"CK8]P0 ML2O'E&&QU$O&E,VPS$/&NH-@`BX9*U@ZP1('%\IEF/"1L&XTW*48X4&%,AB6 M^Z@WU_.2N193[L&%\BI6>$BWT#K)!.1VX1:&T7`6N0H/ROD@,83K4!U09@7, M1[A`^0O`<^&";AR0)8X9`M.%N.L+"93!`'J(=P:I:2JL'\@UH#%)D>/K!I2W M`/>0[PRZUS*.ZF%&*TYA)Z8;#N.N MR4+*;C#QT#+J)92`R.I_:S?*I$-9%[+G:D:]?DJ+H<:U^_&,2V><<*6'\D$$ M8ZH4X:#'1@YUOP%P:-E$.6M/I!P'?79RJ%M)YJAI#)!P?2Z1 M,AOTV'PIB!U,YF@WJ-!:DK-90#8F[,DZ.N1\JI MT&LGQRF#X1X[N1E#%G&]/W33V=$.Z;II<#N6&UAL%1 MEKO'327W_7@IANM6'9VJF[ZYW$^"'\?1R_\!4$L#!!0````(`%*%8D<0$&[O M!VH``#^D`0`4````>&POWR5S[,X&N=/<;R83EYUV^W# M5],HF>T$RUGREV5\FBYGBW_:.>SW=G[_CWGR^W]<_/XL'2VG\6P11+-Q<#Y; M)(M5<#'C,9-T%MCO#X+\*Q^/RM[?Q MO!5T#\.@V^X,RE]>C1:MH-?V?[EN83^=W.>++!HM_F?Y37GX)GY,\`D8XD,T MC?@#_&J_-SI,LMPD6^3?`3/ M_2F.,@1$'+0/#[J5C`J> M&?/SM4"[6\TK\W?:!W^L?>$ZSI)T7+MVPH<5="D_*?-Z MG_UCI_S)";PZYMA3&-P2*@=7RT6^`/Q* M9I6Q3M-9GDZ2,<'Z=@$_<-H\2!\`&4;I-(8+\?'V+-C;W9>+$22SX'TRF0!R MYF&PJ__T0_.($+]?_O)#O`CR:%*]::I0_)HG+/YH@S ML,D@_@PT(Z^^?88W);E?XLTJ?W<3YW":HR>ZB./X.9ZD8^!FH4PSG37XOH]&2)&+W^R1_CY/$)'XV>`;I`?`3+T_H[0XNH MF;'Z\7,RALN<`TJ-)C#RN'XI0Q M+#19)''C0`R&40$,B09#XRH\KS42U3?1!/89`VJ#M))_#3G]Y^7,DM,*:SK) M\]AS#E'.!&V$O\1_60+T)[X#N_`!L3+':(2251YD\2B&D>XG3#A"P0\/!7F& M3]/,,Y:1*,;Q0YSAM6BB+]=9/(^2L:6,M*64CU'&B;S[9]+:_,QUAJ07>"<. MBB`BLN^EB._2=/P"IZ/F3^#.`BHGB_A@`AB!^P"R\9@`;&KFNY+W2H]Y)_R0 MS@Y&VT"*!Y^IUYH`L^ES?N2Z3*+[9$*80@`AXOV43N"2Y]\&YP#)147`LR@T MCU:(/Q7N^I1FBP/@8U/8[WT%'M?1*DL%_ED\H0OFA0/,DRWA2Q"W%@"L#$6& MQRR:UCXX<9NI>Z0)[@:=Y[!\I(U`/";I[+%^)T7,;)C]LC!,&(!0E-OW9+KU M6-`P0145UC[<\``*H`DS!28\H#4!#P7F@6@R!FD82.RRD=_^P_O>/>;C@<(L9PN M&?O26F92E0$7H*,JH:0&)0!@B.,HYR4BT7G(PB:/\8!YX5K&WFM9.58ZNTW> MO%W.YQ,23V"`,WN\)*L46)_6:M>?>)+G>.6(SM9+8E<9?!IEJRU?`TDS2QY3 MD(10)PY^>A]/[^.L@H=-;'SO.L*K\A0O$E#OOE@W$HL!8&3PJL;P4'A09(== M^[3_G8*DT#1XX<$-!]^$S%LIFC9=>;%^CO)Z MMD+&AF=/)I/TA?`)[D1PEB[O%P_+26"YXXT5L!!E^HUR=0,'P+ MJ\DWU2+4&V^S=!KL@9*P'SCE]&0$\KV?D3J%(5BDK`S$+)H^X'@5Y2D&H@HJ M`FL;L-%HBOSN7[TTA-#RX#YB_6F*@J+W.1*I<,I,Z^3!Z`E-3YXE;"=TD;Q= MKQ?=PD$CJ?4HT%D,2P_V0$VDW_;Q"&BX,2#T(MU`%O(,\3I[![P[)SI M(:H].W7J?.!T]JPVK#GU$9"(/,&S((R[7^;`!G.GHC'0\*G,PVO'8WD5,&;N M%=7K!&Q9VB80L`]O#8&WK,8V0N`&M)<5Z59KQ<(W:9:E+V2RV,O,:_D^OE@2 MC?TF&^!_1%;@^;1(C[SW)0]>DL734SP9$R%2RXRG\TFZBF,@\?0(T'O<))IX MC)A0M1(3NAJ+A_]8++PV.98'"]SZ8SE_>(A'O.3/(S81H.4XX-\!X_@:U1BD M:F_=)DISK78=!O?Q8S)#*0\7-B?C[Q9OQRB_-+Z'ZO`KOOI`G,9,PP#`\@Z> M9L688^V#^'+MEV;0>AM?G->,H!X`OKGT.DJ6TRGB).)S\CA+'D!\`H03:H:; MN`9&-:HW/NA'&G2(S>=A#FIM2_H)`.HH`>D6)KJ+/R^"-Y-T]*DZUSX9!2]13OPG`W6/6#B"-J/CGD0O;*Q';1BQ9A:` M3!<'W2')=+U6\"-:<$<1G@P\GR]'(Z"]<-"]TO3@DP$_'_TE#Q&#G^_L MMX*/,])M\4W4;A#B64Q<(68G#G6`G M76;X8YG#OZ30)*`S1F0,F,$IY\$2I048.88=D*B'7,9S!*!9`*O-E_=Y,DZB MC`R,))!,)C!8#.2#@)I[0$F;Q&?+(]#1H+D[`IT^(NJ:/L?9`6SE@'`05K.W MDBY"NB@=80J4D>C"',#M M%'*QB.0!G.[3P5^6$9)R!,D8A"%X9A%$#X";8Y(^YUDRPJ42KP-P*L(&(.L, MATD!QD(&J."5XO"=(7X&#FQR)0,"X+E+9">!*`EQUF:)WDPSI:/P=TJC^ZS M)/BO_PQHA;*__?L?Y7A.W)%\'\,$3R/+(?0-9X"DZF"(HH#,Z7 M*'G1.R=+I!H@`X1X\B\Q6N-(\65+"`,:5?'9:+(DZ%[D611/A,X"1V\%Z$'A MNP(P1=.!)8/12-`77US.(AAAP0X1GVODK?4A**6&D.P^CO&00()BX9T&!@"B M;$3TZ6/KML5G#7=XA5_'"(3`@E\"F`\^(.] M[@_L:5^A3YYO+G-"L6[`U;J8T8-PGV?"DH#.`-5B>S\"5ZENP1ZN.6&M`!Z= M(;@G>,^76<8BZ2B#-6EGA'J=:382%5C(C/@#RB.XV(@=6'.-^PYISQT2GJ/1 M$[T?XJ%DO&OU*@'QL&7B&?2*GD!0$(A;\4.`'IJ5P,;1Y,%8&;$;D04#([`B MM=2BRP#OBUHD?\CT$04)-""PN9%9"$`3R*NEM=49\*(XM+G33V2$5C0VK9>- MUJ1W!SP#L;XT_43Z!(Y_&P%S&DC7,A1,O'IU\M)05G<`&R:\0'D&UYY,OKDWB2J@9O(M>+X`H@`('J)(^;C%.T6JI,E>/-Y MZ#TSJ*^U<'1=0"J@I,'.S>>=_3"XM3+K+:A>0,)$?F+3@"!4_JTZ%$1GQZ5] MIX.754Q$)0[JS%J&-AA6`>N/8]FB4"Z'>L;6;NY;K`Y`^$9S=D$1.9E,6*H1X8MI8R1R"PYYS^X/+5W%$]"F9K0\YOIN M*RVO)?LM#)@2OIV@C,J`(TL5;:"@*UY-X\=($$FLC,&'U@\MU(CP*\2F%W*= MP\4>.\DZJII%@P<[;Y1EJ.PA: M$,MY*SG(W*"W7B\SM+K1-73*J:"'GI*6G*/$+$_*,,$HSM`WZ&!1W80]`&)C MO&QX*LOQ*Y2FB;B"L)$`19ZC!N&$63QAI"HN0@WC;V(TE,T>$2YTM=NM3O\; M7!G\,OB&PI22V7.*G`B&9_OXV+"_1U8TIC@\H5AUR3F>3O(X(Q5*;Q?U_F5N MO98T>C09B4,U$OZ%^MV(MG[^\2:XO'AS=<.&/7KYJ"W;GJ>)E6#)M&X6Q:]K?,:*`#"675SAQ2'^9,JAZ7":M9 MEC[D0B=)+2&1@47/X[MX=AX1+PR0&?E!1[KA30I(K"XODS4']`3GI-TF5LQ+WG0%!XG>8K& M3).-FN>ND2*K>#Y\4>P9P07BQ1%%0`_`\AZNG3N+&,.*R9J1%K2,7!F"H@<4 M:9U5<&!D?[)ZB;)L%H]4EX1+E*KU@*W@/$*Q-C(HG=".IPD@*"A#GIMXC6:2 M/"$AP`$2-:(1Z&@(;D0S6AR!P@Q,M\GH)183QD;F]9XSR@+VK,<,13L@D7I8 MKCH1"^%QPC(YJ.HPKI)B1&?U:,)&2E'*@E=`:56<1^;4"BZWO0^H4>_7/GSJ MKEN31=WWO`KX:#21GYS^\>/%[<7=Q=6'6Q(VA#G>QZ`3:AS5\H5`4Z0H9_+6 M*#V-`9'&B@$A[-D'G,Y$>HXF*[$VV;?9)C1?BKP$W!(E/".-,K42;D21;^XM M_+X0)B,"R`NP,G=KHX6.48V*DQ=NXUOW&#H@IT0N$=GL)B*YU)]!U MOZ6K@J2D@$2(,/;R`DT#G07Y,QFS41I.1Y$E,9GPJ6Q%XEE%_\\PO%/(NWM3 M\07%081VM%#`A;'2>Y+JRN8Z&!3O_039#^[-KD_A,((EST5J3$A&RECAN0?` MS$'XHM!1(G?(U!U!,WY/F1B/*C)4:E-LMKH,W<;(GHD]D5G]H;`AS](U6&K" M*L&=Y816*:E>"XR31S'G'I4\H@YTL[0Y<+&EFC37(@$+@#C$6$0HPERU`NN' MLBXGH_3%1HZ0&SQ*<];"EA0AP@N=6EBQ?I\5F7DQ3<0$-+<"$S]JA"L-D0]H M:GI)GR9&'WHWO?\^N)HIEF!X;D`X[*0`CV;5:;>_P9_^4?=V[.>H8D7!^^4, M[E$8O`-J`!*+!-C,EHN,1H1]6EGATPP=.V0A![@8WPJ_"'PP7E`P@HT79,], M&/PI_13?BV"BUWJ_3";CW.#:F]/OC8'@6S>X\@M1+.P#H$+*J73DL2#OY70* MBJV8Z;/(!/V8&?E*T$&9BSBV!@X44B<3#NM1.C$30*+S/__;?W1ZO=;`:@-[ MJ$:T6WW[`6B(5Q5+!(C=E(A$N@<0!'<:D0?=U>9YU97H<,LH)+%#UFL=:I([&O M>%XCY@._CS!2%LF<>77-FV2:!1U\0H*:,.@D?N#KS#ZWE9$&$`/Q@`R!MF`( MG1?.R/J@&)*8:^3RFB'\(.+Q)IBO)N%A-:_[H>6D#=H\\BSXB?R<%'BD2T84 M]$",$:'V3 MFE#8XA`YQATX9>*SUHIH#-%';%Z%Q>*D14'01%]QDLZ1XL[J`2C M*#MY`2[U7_^)U/!D^8BJG74?L('(#*@?#I7KE_R`2$9`$\F4/TC\QHZH4(AW M0D(9H!W"POF`"0O/@1@NEO#7Y>5I2,O=[1ZU7)BZ1!:)E5]3.A#LGHG[$J7# M7%PT-`IP[\6(C6NTD!2ZP(M?2USTWGWDY?3[TU^$O'2_@%0\X)8K;Q4B%3:G M2_]=R82YYU],*AJN2>,5>3>)/J>WH$,__6&"4JS/$U)W=9P4X8GEB=3-@#]1 MFC\`D@,8E^1/!ELS]OH@[#=9R-[/?_OW=[=_8*-JY9(\+#.R7DUB3M3DRV+9 M/,<=<*RCF/SF-#U)V"(BF(B8_!?C_=UV6UUQX/W=;J]UN!WOASW_/:*)'7I.2>.%45_4P-V@4"SDJ?89E/PDDA M>F(-#C:M71)RG/2SN=8;6K\KJJTEFX$R"8N/SVIU:TP!=X!PSCOG#!_&Y^.N M],R3/,H:.(I"*Y37T"YF]BQ62-:2F9@8135?8_?`BX!TT:81BN&[8#:$M0GB MYONO'8I\5T"1[Q`]O@LX?\Q.:$)?>+;=@!6BW8#D(?A!-/*D>"RO@]J`:'BE M#R_L!C__[?^4?SWI#T&OU0O:Y5Y''3@"N)G^/_&F<3T=+O5H9\V[_<0 M-;T^S-''>WU1/JW7P9VE^V.3]*`@R[LR$SL M2I.C:]W0R]2;O=@<*&M4,R1YR?CMVO*C0F1J\_PY%@CIJ MJN@H!0O`1?41[7?Q9!0!CIQ_1BX4C=,L@NT$[^//R2@%(MXZ:>'?I^@Q!_GN M/5S63M>K%QEST#8C[NW(TV@B0DI#3X&\I*R`,.39,GN*IJ'$DIY&&3#+6206 MI&L,,P%,O)B-6J(M]0Z5U41I2Q5*AKY:ILA%\KL92RVY%",,/OY$*6#1/"%, MML3>16^AUQ[#BLI&*F`9&$V1/BP>XXD*6Z8EQ:.G63I)'UEC=!3D9QW+MM MI5S@-="VY07%MGI(BQ$B\043QX&1C5)HB7,*\G3R!9>I%*]F$O1"BM%<%//T M6-%ZR="C.PM@J_H/%-B;@,G``U&9C!@-@O%:U/*8+*=F7422 MK5'-:N6H+]E\%!)P<\EN8$`!F7FF=*A/,0K5L_@A*89/1.-GR0#$76#J")PI MN4]B(*N888V9#M86=K]2PT>4ZN22(BBY!`:9I/Q@D1ZP;:\`'L9)6`V2>A@@ MGCW"FS.SY:IW`^XR($@\>Q+`8`A%7)$60_4$1XA;CQP63YN(,9ZM).8A"M9@ MUSZ!PAI#-:_B$&QK+CD>M(Z.OK%I"=X"#&*6,0S6QO?M!8?#0=CK#\/NX$CR M5/R&CU-4@GZ^_EO_RX?H'6(AO\>Z-4H#2Z"-^?N(?Z04F'0M;1('V.2 M8NF,90066>#A6^+I%,07UEZ$)%Z;>R=7(51?%4(`N:B95=!/K,^#G98?@)@0 M466:VN<@PYVZMS!3CJ&'.;DFMLK0'J`!W7XO/![V;!D3>"0CO=1D`E>E&+Z] M-N\UQ^J!!9O7%#49H(JR(P[FYQN@-3VM,X;$5^<+5^\,]QN!*FD2Y$H)R@9W M4.HVC_![HK\N"DN2N/P*\0.I^_"H==@7B=WRT36S[@;';51F2`DM[JH;MH^& MH/+8^BP%W;:+P&YU"::CZLOY$SI%A1Q$]W#6HJLCS/E2FJ0('?=&M=+N'0-= MK.C:F<6B\FC*U>A'#T&-,MPT+=>C8"$@B\B)L7M\K&,=)14_,?GCY-MF1)%K MPGKBF,/;09R:)0\KI.`4=RJVC'FZP(`Q@))$I&`YM;@XSL]_^U]V@&3D$IA8 M"4^!MCY&-E\*QG>7JO8>D1D*\W+P>L[Q/;3,@HI>M,P>:6\,Y9MN=5U#2Y-, M-F?T`(0TL2$[*AJ_Z,C4-GV`$I-_YQ6P`*Z,\9*J$7)*6%X@=Y1P&XHY=2^8 M4^![YX)[:N&&82[P0FX-("C@(L9DL4Y.0M2A,.:%S7L=`1X#ZKIT&XR:3MCN ME,6+E">N!N"7M1`F9&N-FS_&+LS"1%UX,XYE/$7:;'!W:O((BE2$1MN;P&N3 M$&3+&6F"#A^168(0P0SQ(8ZQ.*"K2H`?A%(P%&Y@_!DW"U,_.=7)!"9:68^$ M8)3VQ![':XM4IDY!]6)0L9%OC!6D)GG%'T.;*$15\;U#ZO@4CQ^+!110%DU% MCO6F:A>U;) MZT*E0;<'7U4+F`:];A^N^"6*>Q18=`S-&J.OJ%WSS"GRKN;D:^S=6YM^>(Z&X^'SJ\&RO[-!IS-H=;:WZ#!-_DIS3H%"?Y4A M9[??41%P?W\SSG8;)9//KVSG.;$6)+VS(K63NF*A4S8_QKL6X M#U?@#BUGG79'V`G^3,E*)9^NT0&%H<8")$,`Q:P>424"B2V).0?!!H1KL:+5*5;-XO MN4K*,2\I3`,L_,E%L!1SDSVSA,'>#G^\LX_C437L>+(ZP!)<87`*N`P@>TCH MK_>@C<'>$O&8K"_X0JI8505%,@,JJA-AJ@8`D\'B-FC";=A`)%;$^BWKT)KU MS@6.'1$'T8F)@UB@58EB[7,.C6<9`)MTU3+H<,B2! M0$6.L`&77!.L4>_UPP4(M/Q<(6&3PH37ZFZ(8V9FD%NFH,6W/2!4RNO)IV!PHI0Q7 M69(;@8CJ/4@0(!*B"Q+O,86HTA*.E0M*PZDD,H0EF4&69:2F26Q#"=U"BY!U M8,")^9CTA!0NJ?WX90<^$KY>1RU7K<&!F!-7C<+D<(Z)%],@1)"A-A\58&^$ M=:^SNIANQ-<,[R'[%^&66RN8K>Q31K#"E>`3U'LNYJWAHA&';*I-2?PL+M90 MAL9%?_ER%RKX2$GJ/ MC^#_[2*A,->]=PP383"+OUM"<`C[[O3:K2'%3-EX*=Q=)^QW#R60:O.(*1TP MU<>(HK!_W)6E;QTP=4C+Z!WW)!KHK18$3`C/L`M[.&O2&_&IGEE$;7A4!X;I MA<>=8]@SC5G7DX'@V948HT(057\`T#X,VQT,71L>PJHWBZ+JX8#]G@"[5#"6 M/NOV9?F^("LDE?T^X!'"J;;5`KT^Z`!2Z'$JC1886L<2UU7L8D`?`5X<=22$ M:MO0++3_=<+VD0GM:VQX0"@Y[$H<7#60:PAK[(7M[E!V[H_E\M_UC8.Y&EN) M\/+5Y?`WW"B\4WFZD(Q=F\:]R;R-N=SOKJ[.?KRXO`Q./IP%5W??G]\$%Q_N M3CZ\NWAS>1ZW]TZ`G!:-%Q:#=15#G&6KGM3TXIP6>3]D&5M*NLXX>++ M1K6\X0"LX71D;M@);"(^/.K2-3@=YSRXM4?9#O&R?GQKBMU7\JJ.=FM9$ MJLF&KOM>5O"TH;F$&I[#**(#=Y/3[3Q.]$QKOCZK4PSRX/5&X;:[2..!K2,U M&0R[)`G`)]UC`NV@C8RWB2&]4@JM*61`CV2HO.9((3OH3>^WD?C!7X`7P,J' MR""VYJ&`GH0@G6&'!COJXS([_4/T?6\2]=S&&-_.(2!'K]_F"&@=O%R`3`<9 M(!79(6SJ=&R8<:TVAN`\#ON`L$.Z3)WC`0'T..P+^I9->'*; M;`;Y0.^P2_>9@]*[&,("Z]T5.>=`BDJ0[N3K*Q@,Y.H.A$7R_AKZ2>4TZ5"X M.TQX:#B]=!"LN55X2\/AH,<7U@*F@X)9C^1.`YE3\2![;B;5/W'.G\3VA$M, M=68TVZJT1'9+_8X]PMA!,!2KL)2.PEJ%5/)=VR0K3O"'<@.Z*4;+L,GP1UUQ M0U],:Y!$^WK_2"F`..MNIWVHK-5;UH2;%3X^LH9"9]S$ND-LHW*JJG=Y:*I% MC=05WA7=E-Z4ECK>-ZTSW)HXUY@HK!SC3*<5B42K%34U8RZLB6`C6(-L MOH'>EHW8JH_G[H7&D[H[7' M\^#]^^!2F!LEGB&*1ADE!"'V&3Y`>[1'J/ MQ7,C`DK.U<=I.>C,HBW,J9-40"7Y<:\36)J\]SKXXS(E7SN58>?:&F,,L1H5 M^V82:-BU(@6XS1A=WQBF#G[C"+\+_M(P>?TH\CH?O:FAR4.S&6^:CN/)`7?_ M&2LC7V!+;F%MF%Q5J3.UFC*LJ8.F2#$%U>RY]YJP.C(%97@B(GW.[$=B%'8+ M5_,"I0F,'ZIF?MR,6T,9B19<^#"G[A,F+[%0@J<8BZM!-Z(PX7+Q*%"*7.0@ MG@1GJK@R[AL2PO6BL>"!N%4M"E$H;X7_JHTD$6T.@%JQI2 M`[MH))EV?1&"\.?;)=GE2U%*7$4^P8)"BP/N3L-U&B1JG&T*AZ+ETR\%FXI= M8K=CQ330ZH]@0F5<>;WI@@=B2AI8R52;%,SP`Y*YW._%,_E*B'>MS=!"'#_: M<`,=8WFB7[X&YD=B"J)?RC#G15(LEUEE'R?\$I@;VU7?1G#Y8*Y31>E)+H_% M87>6L>269Q#4:BKOC&`EQ)$6?54H" M1;Q@Q$'M2DPE*K-DV](JB(I=$LP#D^A%"#K?AE*<8ZT=%Y%&J2^N3F2PS*61 MA&&@&56"9>F%ZM%Z60%=/L->E5^0PBD*@9YCV,,(QZ,#=W]I+LG2"B%4I,KN M9K89P9X&>,I,%8 MEV([M*)QQQ0C3,XR"#>;KF;X M8S6\'TX:T$UP]L`0"8>QH))ICM,`7(M':[/SXKV-'#,D1)KS+B5`M8"Y%'$2 M<\C?O6N;1\5IS-V9130_VQ5-4-(4/V2>('Q)O!:9:9!AVNZHZ"-DF MAMUV(:A+FQ5"_Y$.C_4K-,IQNZOB!'S&B9(A/C>B*5MRO*=CHYJ%E]6VR0M] M!;;5A^*M"C$WIN"@8CJ:D0[DHPXAA_Q]IG`3P10'#*]!PS9SJ3=HF$?J]>13 M$WC(S6Z#]QRFJ%_>PL!Q>\JRD@"9/:$0 MP.S)+R=BFDL6<\$0S?\?*?%CC^/#]RD0LW&VK;)>2%LRU@B-9-`/RFE6EDV55%_]$'#5F&M41>EQBJS?OLLHH%TY(MF&`?' M4C`97DF@BUFSE:CL&38?HKMJ*JY::N]=JW$\&*LGI0*;7BL@@1>B3-2&%)S% M)F\"U&CYL0H_,9(G:]")[>2"G(1%2,RA%)NKN\S(P"84[DH2)@5J*SH3$#WP M$`&\LX31$L>LQZ024>A(/BP3:YVSM[E9T\,82G&3M>)JJX&.X1;DM)HVT1\J M"SKMHC_4^_K[;$,[`-"78+*>@"GV550]K:^G/MA:O=O(ZA^JF*.4=+,4]1;) M82W>A`IL56>`K)`UJ1-XFK..*OSOS.IMU`?!"%F4/"UI2*YG<8U->;LQ-O(* M?/F0#8SU[/SFXH>3NXL?SH.+#[=W-Q^%QWXX"[X_/WN'75A/3N'KBSOT+?R( MFO2"G64N;]+IN74"T,M3K/EDRM794?VT312H*PE51IW"!AXIG!]+92?YIXIY M165U>;2RBNNKF.&EF/%KER9'4A--IE3E`]/V$M`ES5W\IZGF_5"<753\*C8DY*[":'$A5>J9&AZ2$?8L(@S&=`#PB8U M"RW=DJ#0@NRE0&@0"[&1B[-JDL0RLLVG;;\(/U3,D]B#+@-J+4U$G"3[6;2S M"NGP-V0(R:B3+)0LA4G>Z#B3MAO%4:0MV\P%C7+K,$4XM3:/B&`,?`T`!]J) MC;C)*H9KV4U MK(+!DBBZYSE6=8"D?0K>?V4;539:EA6H%P=H$9RZY:X,)B!+K>D-K1TM[#SE MFV>**20KE2R/3A(%Q8ON[5R=7F!U.JEKL8@^LSAE`TLKYVFLO:X9D,2> MUK<%XO6/.9$]DE!V(\AASS5T63O10&1"FXUGK[TO-=!A*NK&V$.;$L5*2S23 MA>MDPPW0A@HGDT8K1C4^';M^HG2V_:C+66954'++25"OF8"(G5R"9MPQR1@- M%];6_T,!3A2#0H)IT6-"!3/D"(U8XTZ*"8>5O.5NY]59A2Y@MN$BHDHG3!TD MZU&%&*@B@D(I%+*TG,!V@VSI]B62V+L[4ZKG$J2.O"37E>4,JJGD>$GJV`5< M=X=Y;3O$CBI4)_):"VT:,`>`P16,U,UB12. M-]$]N?CBE3]5Z2-K=F@Z$@ETW1M,JBEB1#PKY.XJ4:Z810@MVM@.,NJ#5P>GB87\^=3'5 MO4%9=<'9D4;PLS'+9^H&%O6>"G^O>%U#%J;5?::PO<(5IWHT%)-3*]]7I)F' M"99),Y5"9ZI?*OL+3,)-,2)8[,9Y.1`QJNRDX")#*P\!["L7Y:0?LR#=ZW+M MFEK!&TID7\W91%%U<=MF2Y^3Z7)JM)N5S0D'7FPL<(BGW.VR=*],.&.N*0/U MMAP'3-X9Q25\KY.C:##5\DZVU1?Y/FIVJG5>S M^9)!_C7'BQ3@;_(2;FGB2S.Q"OM;:[;WBWX;16Q<^7+)=BF;;)=J=9N`;J^P MH!_\4"M3?-U"T,2/65IWZ7LDK!;48*J5\A*""@1OMK#2E+[ MV+W7B=8PYQW9C-^SS?B<;,;J["C9\RW.\CW/XCEXCRVY6=*C@/_-8KOVL.#[ M?K`W,/DX_#?\TJ5?_&!UVB)7WU0Y+XUJU@GI62Q/6!/V+WLH3;"5=5@"[VY> M[5&6=XHG"HN7D3QG^TNVU).)/IZ9`*:@/P-,&PB`+*Q3)#J[WU M'J)LC`VTE=/+B=Z*[2.:-!"*9M:ONUX_F'HD5/2CC%Q(\!2":9+^!;BEB-/7 MXM/&?*UPQ)B(1\B$>7ATS'[,0TS8ZS`]()I,+PY-0F(O:'`$@59PS8&./\G/ M>K],\'DZ>9V#R!W_T\YS*%+BI]9)E`,E!'&^?_5RN'+3+18AV`ZR!MB(S/;"X$ZT MAZ",[`<#ZK'*_WX7]%L#?!);FG5[]-11L-?=QU^P2E:[0T\-6IWNX!NW%NE^ MQH_V>EAS`?]MHY71,_&0)CZD*0]E8GBZ-/$QC=;I];%.10]##GN\.#`PIUC>JS'XPVHM=X`U?0^SVE7)^/U:'E#&HG_[;6.?1/W M:>(C>H3_'93VRP_V><0^/2+_>D?L\XCZ05,C31UL/SRBU`;\B<:-*YU5`'A\ M"`##FEP?9Z[`+'"1:;*9Z_?5AIM MS14:A+TC/'?XV<%NAY=X.WV)"+8WIF,;I5REO4Y_P!:50\PS-!.7GJ((ZO)@ MNS!_U]1Y";M]C`%&N!:NAS3[H$HS<@B,Q?W09.BA($=.E!'<;^./D63S8(HN6$?7%6Y7E@O2.=E&HB+$""?8RY=0F)Z3V@"LZY M+B^A!)&G89`\<$$5-J-5'E.P**1ZN62Z/)YA043.3*).0PY+:+/NA/=M6>_"Z[3-(,W;B(IY47/DP9G(26]85CHH.POUDIM><:(A:S&32$/[;0[ MU+!J'F6FE]);2U((I2],'YRKZN4+0MM+B-_"C*\1)S9R-\V7F252I(OG"8B/ MV0K$XM*+*"*;ECZ#0B=Q="%;@6.>@2P,6N%$A3`@I_FF>)K(?)G9R%6%7RGM MB3M<[1YM.\-QS0S2HNKGO_T[_:'F8+?R=O/TZ^;IZWGZ;AZ901.2/Z@1-:1#$" M+U8=#0%S04.=28<-)C92AKZ(IAEV!GR.,TFEC"BO!=WB<+],$F,$:)7E"VXD M:DH$N4?V-,T.%1.X,(]@]S#/Q`]+W!?.L)S9K"3:ZR-H'$!E8V-$D'-:SDS# M)38DP((-;I]*`T&Z%!PO(C8K=172!]_S;K:\=!8M2>/G$AP8?@!T4^QWKD.4 MVI5DO!M?+5*,>S()FVYDNZB3&/0@+D\&".F[ M(QA2;5VUY^[O#*USEU#?\)-%VA&;4H'@0>OD(YX`*.+MEJGLEK?O$-8:B!MR`!SLHNPA! MH,#Y<.B.JB&`(Q=@7%<\PB&$7`^WIYI&-C#5<4\1YKUR:YO]<08RY-:S4Z.R6G?J4Z?63#&JW MT7>3],TD]:JT@65H_AY65>N>?D29!G>8.WH*XM`$L`/7YY-+57O5\-Y6:C@2 M$UR;Q<$&+9P(#XB65A?N_?I*>,^KA.N).:"-[LFWN=*P62T'194[.E-Q+-WTO=[FEUN[0YHO0E8\RL=#"ASRQC54`"2V(77]W%)^RA4UR$J+A;L)!V7F-&,A1;$L,_A+;(M[Z:0V:>=3 M(BD%2D?T1;NBI!$U&8MQ2=3*B'=ENOW5[*GH9%:FY:8R7_=8TM$LV)0FP^-C MFD=;LD1657NBXE)FGZ<8%435%PN2;3%PP7I2+#@QU`\%E*P@6;"VR>HV>J:H MXK_ITIO:0FMN%!<0D]LHVDIID7,3YPN7G_N+KW^BT0=^?G+SX>+#N]O@^OPF MN/W^Y.:<:G?0;]]?79Z=W]Q^&YS_\>/%W9\"._3<#GU"DOUL1.W859#'#*2P M+.+2351^7SQ5^($I[+QXXK#1$3^23)8(O%A/PB5<]G;.KV^!MXVBRNK7@,YJ=`Z=X591Y^`8$XH6Q?>EWV2$X<;<,PK]JIO.90!H9CLF MUW@_.(&K=#`V4WHFDB0K<4RBRV^YL(>I1\7@9?S_5D4J?6MJ&EV93AA(%`#! MRU:J'CMJN)HEH#A&EQ:*3A:^J?)+U"_?`Y$`]CN#S[)YFDFQ*9PVIW:&;L[C MVCF?HKPX+U-Q8%0&KEX+>4AHP;.B?='J9).(BRM>8-#=#'M,&@B0)G%8NQ`I M1"IBUX>3V[.3/P;O)ND])LY1S7,0EXCQNLGRU?0^G037-^^N3`O'ZBSE#7$E MKN)L\4OP)RRE?TM+L12P9J:+F8TS+9C82IU,3X#4(B=:HH^`"L$=#WO[P>5B MW&I8&9%N7)[2,>_B27#RG#R7U\?'_)[:>G1HT^T!"0^BWG0&_0!SI7..Z80/ MAH?N`YFU%!T9?XZS49)+P'1L[>/ZIE"GE%G.V_]UJE@UUCE]P>SH,0E9QNE= MA*7VQDHC,&#R@6NMV^T6[+&S&4ARHYAL[%UE)*\.AIJGF%%PK]22-50!ZB6- MLI*U8D8J-,7&1NR`0Q)5QT4M)S&ZI;EC(-FL*X%@&^5&?=E;`>>2A,0`8#EW MT>?&NI2U(W`]YR:.>W)Z^O']Q\N3NW/3QNOTZOTU<-OS#[=<1@O^/M<-O/#J M4*J/L8CH^,YPRT8J:^I)5@+H%ZKU5J1Z<[TM6"#7YY"H!*>WE?:GE?*9A>>O M,=4DBQ>)B3%$/H/`QQPFFQ6J%E=X6XJZ(_QJVY/M4@]%:@_603XMZ3AM_N58 M,OHZ5-V5#H(:ZZBQ1XSW*]<)13.^[O=X1!2J=3&UY5E\Z'#[:ENKP MYG=)HBU@G$@H9C)J=*)FPM4VMT8#F:;#[<,ZAY5T1;/=PT&K6XVMY.PJ[$=8 M_]VF76J\SS<&;-+5N#OYE_-;E;>6/'-J.*4ZH++1Z;>&WS#][[3ZW_PZK88H M7,G,FA0"KW00K+%`&_.>4V9(YL^QIP?1/%X/=\H-T;B$;$A23E`@?JVSX`M9 M'1BF3[830G[J_!3\&2Y2/C:>>M=H@ZLD4IGV4LET)M@H?HOQ`9M.CG]75GLJ M335\_4Y+"1>_*U`.5"UM25CN;$F^6>J@;3HNP>`FJ(SV&X-^-:L.9*MVS-'= M8S40T\3&].W()>8I+VS'9;3A%*R$`^UXS"*3[V0Z>V'M^(3Z,*O728SS"0CB M?2B"#AMIDJB8N3HFA45SXP'SV![B;/PYPH;-(1>VS+&M$964`3$M$O,7Q?'1 M8+/(-G-&>&$/@OW"$NC1=RJD0[[OT3EC=!P`-.8V`HV\9B2QW`U MT@^!I!M9)&GVDGU!G81@8M=0C?(;G$M)V%PT(4N%DEKK-EU-%=%U,TR]&P=* M,6!'4CR`>U=X)Y>[OP7L#RN@/QSHFNM?7O/D1Q0Q)H6:($(=<)ED>$"J422` M)D%O89KB%)/&S MM/,B%H9'*=33).]$.=Q[ZA9!`Z,YC>JBS"EU0]@4P(RN(C5O0F=L,:HWFL\G M(,488H@TB/="5-GR":4`JNM,EE@"'0!2MQMGE)UP1C`IZR,35&HZM4U6KO`3 MBT)N>TCK\).G!(-9I?>6/02B$[D[7D1C:HMQ]V3ZL7/(V(P7QIEI9BFR$EO[ MAU=C33(L=4N"(];S,N-ENJE"(4>*B;/)DL*)0B2_2]QDZ M8K)FK"6I[$1NPLIB[`4SF@F&!L4S*JY"\<+!WL[%#9KHC*15%6SX4G-\5\== M\UZ;/NGRJ<$@YJP>&L0E.2JP MHM-(M!E.S03U!ZL.+!]!Y+""H'$W$_=>=W\P2!'NH2Z#60*S(TSDM-A_CF9+9!(VI$("*M!.36PV)+]L3#X`;,;$ M\C9Y_XCHII1*0.7UO"LQ`MQ;D3!&:$())2O?A3?3W,@?Q^2_P#9["VDN!8QO MB0;*D]Q,0<;0<3Q+Q!GE>YX&I+K]X[I%6B"M62V?N_&,EL."(J=)@-":/<;& M&%@LX\4M'BG$6.5L2SM*:>7%.I<%/::D`JE[B)[3C%NGR75AT5`10+WC#ZVNAL1V@,)`$II3BRB44MGIX,R-"\Q!-QH33J_?O+^Y MG7\XQ4KUBDG;-'K;G"WG/!S7YP(("]%-&^-'1SN)'U'*5B+H:!(E4RKOP6V$ M+57)IG))N'NRJ;"@6BU8^89SY%%9'!7V2D5:X)PP:B-+[YFJ4$LQ);>;*#J[ M`L/973`+"?I8'0\0@TVX(E^NG-J^SE@M;>><;<&(K[I`6:4VA@!/B3=\*W,I M]">;(D`VKB(I>`5B^ITAN1>8"F3.'KQ M,%!3UDW_.)PC(QQ0C<=;8LNC"B(O")$D)Z2:I#;YCV^D*)4"L0HTV%*33!U] MTK==.`(=JHE::F&I(*"Q[_&.(V.Z<"RC)Q&`)GB$.%SNXD2NL$Z%M5N=+`!$ MLW@5O#/-=43BHW)-9#K'F4+2>F%1$U,*YC&2,$N,#.&.8R^IL2%%#P_D0:8: M1^)\NP8F,(U&\9+ZWN;6&8?[NX:[B8ZAR^@^)<\M2;N7EZ=AI0.C;>PTFTWN\RL3G MR#>;+1]5_YY1RHJ%P7SANWEE\49M-7J&=+U&TXK8X`9#BECP1<9-ZZ4BDMP8`Z# M0]!95#ZE5X4A0,4EF M5QM'JA69G%2D*MW2]HX*R3`20V*[8C$)?S%577C_%!+G;K-15RA9,F-O=]UE MHF,HB0?`93AB,68"*LE=40&R,XFR1KS#>"Z``C`*[CU'4@V/$96.PX>`JJPN M7S##P93]@-J`J\I,`@@#1@R?7:"^@!4/Z/R,4[00MHAZ*8A2"285LC'$5JE" MSH0UH",N+V.D3322+),%N]18YJ9B1J;:$;``0B)1J94%SRQ(E`*,2.,@M<73 M*DN!H$R)L@C5GRVQ0]DR,Z&1<",SBN4W/;LPJC.Y7YI^=#R=R@R43TZ,J(`> M>6,EF5,E/]4ZK?12F0S3NS#K*SB8IO%#"<6SB\]LU#V0,0S:#VV),@374PQT MX&DDG!X-P!G*-*GY2S^02U9S)9L`8UJ4^NE5CH5J+&0P^LVE,^BCIKZ: M28X47XE&+G>`(G%*K\1B!;8:`>5SI44LDF0"_6*4`==W]Y*L(I-H.4,GS0-K M7T#&Q7&-5B#A01:7U7[NGDIK4#.9+G@<2Q<_FCC$1>GX]Z)]S-^0\$VD]Q31 MBHL`&"\2L2TQ-B2YB-OSIU4.2AC6)`'J(37J784?]O7S-F`M["G8N]0%-M503;0ES=%H@D\Q=*2)@ MV:4$%Z)`[!LB2.)S*R=*\V9-1WIA9:\)L*ZN.DD1A/Y\#,2"7C#\A-/M;8@' MA<5,);G?;@`M3C0K?8T!7*I[;`'2"&4Q'W*!!*)D.:IU=C3>&`60(1ZBW65: M\%,R,7H`K!1:2'7;G([,JWA.T5TCASO:#Q!'RF/3O9=YOP5$YQ@O/GSRG\TH M'-*&C^'SR]R_.6RCV.?)9P4C75U@!CQM(E@Q#1E24YDHT:2+,1&PM M!9$#H)BY'#QX#\Y4DV/U/VVK46JOUVQC-$<1HJAZ"8=0EE1N+5D!&UGET7V6 M!/_UGZ`6,8UR1=2!GZF6\_)3B,\"D0.6. M@'R%)&.R@'&?<6'2!TX4EKC1V!C$-:74MVH^2&^CA[G8S%.POR2_:XLL^& MP6,$4$@3,NZ3Q]=]!3@P`4DF&6%<73(",C6+#V`O-@T#:6LTQS(['V[N,$/O MAV0131-T*;U/2/AD!+ZU>5L@;N[\\/Z6DJUGR90Y^0132.RL<%$CMIX@VV>; M6IJ.I5[K.(D>9RDL=61?:1'PWIQ^;VQN>:C5#_H+PZGSDLZ4LU"$HO42),'X MVQP0-%]0&YL#M)?,",0$7.OQ-3589=DX(NPGU)#6@`X#@`QZ9K.<#`"DEW!B M!"#J`0.0.#4L$YM`Y8O5)':E:0]`RXG(:X3\[#'EHBFXWYO/-=M5F5LHPR+F M`98E9'(CE4#R+JCI-6QB961[$1B*>BD9L!0J&JL?.7EP&(Q=,-/QRF[MP+?D M)XLIH9`"&9,27C\$6;JR<2YBB&21E./)S%TPK-*1)7AWBBQ@CDF*(P!VBNE7 M>XH>[I=*=H((L$/BP(ZYAFI1QAXIE4N+$(&KA-0/W]C;.;G&_@O&4&_X0QWJ M%0Z#!X$1]M;`O)PC:E'3.::>)?VP2QWG\>KWVEWX#=->>E3K,#SJHEL=;DGW M$$-RC[$B3`?+T73#P3$&Y7K0=(B5'-!$=]1M#8-!>-S%DI`L0G8QT/:0>CT, M@FY_`/]^Q()-*0F:CD=S+.XQ10&;<%Y3\;\3]OK]UA'^-AQ2AA&6!Z&?Q^%1 M&SMF-\._&"#EB57]Y4'?;Q/(C_H`"5CG(1U$/^P-L0(30MYL$O\_#/M]C"\& ML'>.$9B'N-T.6B^[X>'A4>O8!_9CK#T!2M:QA?L1'H+`'2<^H@0D@/L`C[$> M[MV^%^['@TZ+8[V/&(_:A_SW,97+/*SP<5?;1C1HZM6=5TK4J@?/^<$&J:+Z M;),H\?'-[?D?/Z(T?'XWK7)^8RQ8; M:\P(E8O8E7;GF"@;28(N@"F:Y*2_`[FE@]14_$=5/IHG5`=T)9)*\J\LK&:< MN+U"^Q"Q42Y';,09S#P9&],>)IBC$4E"FG+L2C"=L/K+F42/0/W^U:S09F`: MZ2"?VQI/-A:'\+DJ-%*Y7F)"M\Y/3N7LI3HS-=LP'HI3:]O23W!-`.H/8YZN M(,D;2@S&-"G[XA8-/=SKUVSUYYM+9L41,X,5%PLA;WT\WJH[FU-3)6QP[(L3 M)&:OS(EDU:?@"PN)N8+$#L8:2TP8A>$DTT)R2-'-Y<*S9GR:QOA^`G0*&#O< M5MS]#=4:H;=N#_ZEU':`+&/BZ3+F;)5`7/'1INF"4XAM9BX@+:Z:4\JQ^&F\ MB/V9N03Z+X,V\&?QB`%6L_,PG?U9C&P.$.OC3(J;2$RDFTD9HGH-HK[@%7V+ MAM9.^^`/:\/T7%'6"RGW/X>[QYS""5\A1XZJ&+>]8HDYB6O(,*V'+"[6;>[< ME>KU?>OYIB(&Z.K$F\G12%1;:*YQWR&MV3DM5^^ICCHB>-1S![$K,/1(>JHU M^W&H(E535];!7J=4Y0(.A>4I_2J7TFX!$E161,(B0SR=%8$>6EV:M4+K]<&8 M/`Y(D6A1DI#Y75-K2"?>]CJF^-N/DL>')?LDWL#8_TV0++DT*S-0O1V+-G?Z M"18AN5IP.9*"9T`@WZ?I)]LSXA:5)LP=H.^YD:S4J<>O)1M0E1J<@%)JDP1C M6X5([1"O(06\H%`],C[)&5(G#N15`T^TW&M"=KE.IO2IY0M3>:@ELI0HVQ4] MR>K;-`K>?PSQ"KYW+JB]'1"C@!0::9M"T5=S?!_CLYQ?/&?+WL3&23`A`C[Y M"G7*5P^3I9N0SM])?X:ALAO:I^9+JAE5IS)/V_?B&D6YB;LU%T`$\H5'1,HX&"!4)TOP MYO/0>V907VL%NVRMWPMV;CZC?:0J*+.,PV*Q,21]JPX%T=EQ:=_I!+;4;+EQ M3S7@?FZ`JH>ZNZR^3>XQ/08KIB3`T;)&.>W,) M2DEIL([",,3,MV'A1KI@8\&(LSIM+)WY(.4NNJ;RUP$7J"Y6OL4&)20=B1!7 M;)%%%@!3!\TQO'B2J,+O([V5"KSN))9;;'`D7PM_=EMC92\,W,/>KXD.;@/S M$P.*&Q?(\A8VE](=*A5986`62@IP@3F^'%+5//C0^J&%G6[P*[PAJJJG-079 M(U`!-`]V7JU<,+?!]BTV/@/#*PXXO**8S)PLEI+FB\?\\]_^G;Z/@,W/KYQYO@\N+- MU0UGO]++1VW9]AQMU[DGNXU/7<(YBJ5.?/"EY+7.X%AG"7H-7B%UT]1]O,>Q MZ,ZY*\SA).GRS<`2'`45,F4)584RNS`TOZ[99#C`^U948VW=_])4OD<^SJGD MYYEB4&<2WGDR3OF#T]][D M::$#EI="+ZGF1@N(%T`G0ZD([50Y4*5^H!,\U(RKYPM-[ M:^7"JE6L6S%YYRE6:6PVI^E:I@Y"ULN[:&8()^K4H)TY%]/S33E:&="DK:@3L1`VE6)4A*0DL"R>_,8,*^0I M7DFB;L]$TY"42K)L'QZU M#OMB`+=P7#/K;G#<1BL\-?TN[JH;MH^&P/)XP.)WN_#M\;!7K1ER.WJ*QTMV M5BM06WF+N\0G0D)S;*257$GZZ]'3:C8T,4T!]_&DIY M.%57*3'9VR^4S<4D5$(*+?'X@1?$8R`=MZL6@6G4^?W(?H M[.)_3SRB+;87QR)'^#VJ4C,.]0\Z@#W&578MM;!=K)$UU!I@B$N>ZQ-UZ.>[ M-!T3=SOLM0;85RCH#QE;Q:#P9`UV$?G;78:9[*LRP2 MB<2T55;;!!$NG'2FA^+Z-2,*_E//=SNJ.-.59-N4]AATVNB=[E(OP2.$A=PN M^9;:ZM%!\S%?%C/B4(U][8[/U%]&AZB9^$1R2G0NG3E7_/]4#@I)@$VI56FF M=>\1H+9XMSM0T+@K%&?!KWM8%LZ.'5O$,0A=A_??H<^:I+Q"XJ])`A09/UM5 MFXF210!H43P911B"<;D$3(MJJ9'%6F=.4Q@KUZ].E-%,S0ZTGH>=%HLIV?8' M3H-^E,%"%Z'Y'WO<]UU]JF#EF/:IKQ$T-`#PPNZ(2#`44'=#"\8P^9 M$=4]Z^,W1S@.AAJ$W1XBD,&YO2$UB82/NQBFX8DXZ+;;BO;A__P)(\-P"'/9 MP7JTON'`-MXT!T5Q$,=''=H&AJ907;7AD=E/!V,?]ODI^+33A$EOT2_/D6%8 MT?F!_CRXI'BH*FZN1[/:.S$2Z M%&,A_F3-UV<&$!,"1*)"55YO1+=W@\.P?=BGH(_!D(OZPB>F#VB[2_5]*7(K MM@&4P2(>/J433%2,I131!Q1#W:@?]-O(<.`O0+@>R$P8R;,U]P*\ M)\SK##LTV%'_F.)B,.1F(_;91F;1P>8_O7Z;6:GF@@7(=#"BBJQ8A*:=CN57 MXWJ@@X(0]H<#C@0*.\<#KI(<=@[;',44M@=X3Q0*^TYND\V@4M$[[!*A8.FF M&W8''/[%;H"7!X6)80_&;;`G*"O<9D"G=W_`=T,KFP-XM/PF M-DNRCM_8H`>.W-E,OW4DUL1RFF[B1($KQ1>]Q59)K$C8(J=:,DF!)VXL8RHC MNGCBC5%@/?&_Q-L7=.1G5W[V"H&%K\6=4RK\RL&%[KKSO_11I30M4&6L8,X] M>*.1*"5]N>;X\RWUG"QK^"8_:8YU9>/I?))R11HIV,?#T)3VEX(,;Y<(0G[/ MKK%W!!,J;/#4TO4O>"`R^,#27BU&F^$'1%7<[\4S^4J(=^DJ%B".'VVX@4Y7 M%`'ZY6M@CH3=_E*&.2^2["!FE7V<\$M@WA>>T+?6#Q_,M5;=K\:'.G#64Y"/ MLRS&$$B`PSMT[4GX+=Q@_?9ZXJ#&T=V?,1.DUK_NDXS)83FTFX=[Q3: MO0\_VR3-G]O*L<46>'%Y9>Z6(N*4P7GFZE5?*,*)Q.Y[,1&>.!/A)NRA9D0` M\*U.*71^LNO4M*5TG&5#+E&LB&7-5KAZ=L@684,!LZI;A"K6K;E&"3E>,]E0 M&\NM9G=+$U^:B=4&UJ+0&44;TPFZ=6QV<:]\=JA=;""&Y-=2C+%WAL*#*`W[ M'_NZA5!E;0S?IX7,:F,WF\,&OA+1_'3VV&EG: MW0AH^_#VMS=43NZUO0,VO+LEDEUT!F(1>..+*'\%SNE)-U'(0X;GMSC+]SQ+<_Z/24*QS@H*U\A?HKG6 M/$FUVDS&D-+T>X-*J7K$LPI5OBE5Y3=YLAMV@OC28RP7]-^P[\0.5OZGQGT8 M#6N<];\L$C2=I:S#,2E+:FI1Q]>Z`!9OZOFO:[[T9?CB=WWMH0V0VBT?>VY.NX'`I3;JV!>\J(-Q'DPRF*U;HW$$";7"$\V*O@!%%$W[6K38F!\7 M3@I-L(03:(&ET_(C$![H7H?HB4D3@Q>'QA3=JQ[JA6K"6"L9\D/T2$,J6($! MW6]BQ.$UUK1OWU2!YS!HL2N,M[?EW)8ZU^X&PT/23@_A-MR9+NYY\!T?H/V$ M0KUMT`['[!P'`]`/CH)!#XGZM>H@B&5#L"T$%F63+K2E-K>'<$+[`?K370TMACUJX=[T3#VEB;G1[ M*!-+UW$U\3&-ADW8>O1O!T016EPI;JF+&%C>!_9_AQ7^\W*RDFYFV*L6QQN0 M9W&`)$@:V]K5R7@]6AYWR>5_>ZUCW\1]FOB('N%_!Z7]\H-]'I%;XLJ_WA'[ M/*)^T+B^U<'VPZ,NLOX^I5T>R_5]L.V-*7,7R/+'F6OVC95DDN4TV#-=2/?Y M_I([=8@>H#/CKG0#40=3S,)%;]%>OZVN>A`8XM8Y=']=1>IS]@;G'8I^8_8F-<"U< M#XG6T?DPMI&GE*J-I:IHH#OCXGU'CK%#EY.:G+9V"+6(!IE0:F+MY%%MT>&? M;3ADSP[Y'0]H>S\R.XB7H*'J+`S3W3N1NM$D]L!#V..;,@['6%@F<^U(43S8 MH#'F1EI[];60[+6<>W\FS0_7T^7?^F#^_Z\/YI=VFML`+;=J6K==V,%OS>1^ M:R;WWZ29G*=>TT:WHUJ828U`<3/FB0W-J;\53_FM>,IOQ5-^Z>(I6]75\)>W M^$4&V3OC0'$D0W!1W\M%K5*C>OX^W9\'>KJ?0R\;K:4IK>.-JK,XHE5XR M^'327)Y.QN7W:AXVT>RK2LA',DNFH#3514`Z9Q3Y,*3XBM6<,!*X_`IE!U9# M2SXWSD.9A!NFCJC#>F43$V;4*PU8\<__]A]KS]!D`]6=H7X&45:@9"73]EC$=U#^3M6Q&ACSC=L;_-KYC5^A_]FJT:)E*#WT9WV2M^S'\ MJ/!L^1F@CO89LU[_S!_2YU;0EN;N-:.9R-CJ2F98YY>J*573M*E\JA0KN+#- MNC(BRJ2TD:^W;JYP7?QJ;1J#R3.N0^.F*/[RLS]U-LF%KNZ=P^_/F2*KR&03 MY\6,9<,XS]H57'-8>45-V#SZNXH-LRUBQZO)L)7P\$W(A?'/H1AK\U/=UW4W M_W_\PS\@=F\VPW6<828M*IPP^@^IB`-L2Y9G/PH*DNL.:U\M>7!>-;P^27];A*];^[=0=% M%K/-\IYT$N2-!&.C)ZI*MXG^AD0+X9F_!LULHV9E9I0K92^I&^IXT#HZJB#O M749:$$B=F!49!F9$X&@L7'TFG+>_JJDK`T)+L=966>:X"1P9^+4U.*%PU-.I.K# M9N.27_I<3+R5:]N0:R&57;[-J>@'5@3X*PJR%=)63/E^JO#X-4<-7RHYFGOBDIWMGAE-YAKX_=KP&FXSMDF MX'OCJTJA(OJ<;=*'D(6K!.Q)6?LII`S]B606S]4[9[7O^K9YP8O^??<;?LAO'Y`+^9V M.U\ZW!IA`Y4$R:,[<=%I7W(T/?\*UTY0>V#]+QS01D"EZX(,;U2+N6R*#@07_"MJ?Q ME\%AL^%JH;'9Z\TDL.E%/WG8[&4O5(=?`]4UU.`-IZFN6T+GV+\&EW1\9Y.- M@QM.*EX/DPW?]JYHPW?7;'_#4&PIKF5F^U.KB1$M#X6IWF MT?C2&@"O>]T#V:\=L0K<-2-V:LC6AF4\ZNSXC64Y#ES1C0W=>ZY(QTT*_[[E M(.+JA;8UYF39FY@OJJBRG89TVAP?4Y'MV7A7LT#T.=>2J]/O:[^[^5RO>57] MS5]55.5`?Z8RD-U1'@3B46H^5*F7<5*HEQ&PFB!SO5D%G/E^2IT$F]RRE7I% M.DQ1E\8(.5WQ*]ZOJW6Q?DBL[%CE)\LZ>3^)DA?S.9+ M!>EZ2U+M.]TO>*>WP3NZDG$ATK5T.[#^(Y-W?_F.[6F`6O:&B!T&'V?I/88! MD9&/-DOI7"JRO9F#JHH(VZZW$)?/;J;W\>(I'1=+)31,_[%8/H!<&#S0E`=R MX<%51*.\>;1JUL[=,%U3;8?:_*\MJBE4Q"QO.86U3W&Z:F4=F]94\'N5*C[[ M!C,_;&T]7#<^@.VJ.&SW]$&PP*CA23+[]`6XK.9JY!5"<:T"4$K/+>`52'OW M<3'_5KP@'W"EEAU6UV*S.J/<;M6!H$%D\B?%ZT45VY_M[ MM.[AK<`:(F6L.:M/)NX,)(ECZS7]HAL^%0EBHS/[0)W0,0K"*Q%M>X]KJJ5\ MQ9W.BS5;&BZX6JOXJC17]F"@>N'2]6\OR)2<J6_XG4Y:"BT5+@D MVY&,[:7=6IS=1`QNDD6V.>8O&;\6IZO(K^M_<,Z\:NZU'^R-#;A+V2IA,Q1/ MYIDU6-6EDQ2>J4U>\26=-#Y3.])9/(+Y!HTI(_Q,=^NTDL:Y&E94L'BMH:4E MZYC-)L%L`>_\@[HHTJO[2?)(=R:+7>>(*%.EVZ7(1<[)+3-?GR&&=2%2/8N^9"&?LUTJ6O1H9OIE"MAOH&VAH8H80RL^?"*Y_CZQR) M?V?>-U+/M:N7@1/0`U6;WXSL#Z?B+O: M@93TCDR<3U`%QEIG%&;H$L(:#))&47\,J M,U5\D$(?=7-11"6&\AV(:=I'^.CNUX2"V8,]:C+-*Z-KK4ZF\C!5\O@&4 M)6,2%1-P&6"TWDIMG[KU_M1=?\_AI.,:[)0"00TK*=0.^NDL115\`]*BY9Z0 MBV6-5?:0;QV5<_^I\S_#GWH>[0VYZ6R M@*[_;+DK>:5T4MVY2@&EFF%*!W/54RN\T,0&_>/!%;-0T&L?RMUGT4GNEFP/P?U$. M_BM,M>DN!;R4%H1-#N,QY6:*$ZDBYE(WY[\�O>;@+_N?IS[I2GXF(,")(\ M))&*2;*QR^4X@!,NB!8&_O30<(W8_L\1:#Z=NKOJ3XRJBP4P\!..?T-Z)M5; MJ\6-PO05SOTK0>IT>S"9K0E!?S`$/=':=JT)2%Z^>L:NL%GT4.]G,(\>MCJ. MZR#7JGV#GFPXB79_L-E`\FS3"559AIFHW]KPP-W*VE^`(179J!E!_?=O@VN^ M'1+_[T/3K]G@5Z'RFMROS1%][2%LC+__6\GJUQS$UG=G'OO_]7]O7=RSHA!5E=:]+@Y<4U*T\G`''O[URIM6J)JG6JC''>S*#]T] MI()[#H.KN50U M.?\<9Z,DYZ/BE.#*=,O[//[+$M\^?VX*7>`LXQMGX[W.TLD7G+QO=9JYHF?NN[]:>-U`OTP?;M/T^#ZLC[(?T.?Y*8U1K<-DZ@KM5>Y M*HVE+UW-S:H/I+GN9=.K=FTYUY$LEUUL`F5-L]--3@$=G=H71HM57CBXB']< M1I/D8<4V[5*+ADVG4/&(JM-7P0FWP4C4;1-+)G*T+E4\R#?9L2GTCZ5(MD>; MPMM-3AWGS<:B0]0K`NL@\^M2NA69(#94W$K^^CD%Q9BF',E/$,BSA%XVCXYYL3[2)BP!*S"!2KU;& MC_Q#JK6U$O[-R?W`&C<'AR-*%UI>P"\V2:8/V&9.$NHF1"H]ON+SJ09/E9\+ M&PJX>4O:;AT(W53?MG%+-05+*X\1N3?]H6LOM*]&J'OF59XO?O__`E!+`0(4 M`Q0````(`%*%8D```3``````````````"``0````!;0V]N M=&5N=%]4>7!E&UL4$L!`A0#%`````@`4H5B1TAU!>[%````*P(```L` M`````````````(`!%0(``%]R96QS+RYR96QS4$L!`A0#%`````@`4H5B1V&D MY=;7`0``(!X``!H``````````````(`!`P,``'AL+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(4`Q0````(`%*%8D::]B!1@(``(\'```8``````````````"` M`3$7``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1["PSI9%`@````<``!@````````` M`````(`!9QT``'AL+W=O.4[BB+04``"(;```8``````````````"``>(?``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0# M%`````@`4H5B1]C5AKGS!```%AD``!@``````````````(`!QB<``'AL+W=O M+M2%RH@$``+$# M```8``````````````"``>\L``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1ZJ*-*JE M`0``L0,``!@``````````````(`!GS```'AL+W=OT8JMBI`$``+$#```9``````````````"` M`7HR``!X;"]W;W)K&UL4$L!`A0#%`````@`4H5B M1W>UR5FD`0``L0,``!D``````````````(`!530``'AL+W=O&PO=V]R:W-H965TKLKP$``!8$```9``````````````"``0PX``!X;"]W;W)K M&UL4$L!`A0#%`````@`4H5B1\6CKF2E`0``L0,` M`!D``````````````(`!\CD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1WW/UQ6E`0``L0,``!D````````````` M`(`!A3\``'AL+W=O&PO=V]R:W-H965T MI0$``+$#```9```` M``````````"``3Q#``!X;"]W;W)K&UL4$L!`A0# M%`````@`4H5B1TJ]45BD`0``L0,``!D``````````````(`!&$4``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1Y<\ M7TBP`0``%@0``!D``````````````(`!&4L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1TOYNO>F`0``L0,``!D` M`````````````(`!M%```'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1VC1H1>F`0``L`,``!D``````````````(`! M<%8``'AL+W=O&PO=V]R:W-H965TF!X=-I@$``+$#```9```````` M``````"``2E:``!X;"]W;W)K&UL4$L!`A0#%``` M``@`4H5B1]+X@?CX`0``[P4``!D``````````````(`!!EP``'AL+W=O&PO=V]R:W-H965T@`,``"<2```9``````````````"``55P``!X M;"]W;W)K&UL4$L!`A0#%`````@`4H5B1YQ:T(2J M`P``4Q$``!D``````````````(`!#'0``'AL+W=OP!``!9!0``&0`````````````` M@`'M=P``>&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1Q6+&I,/`@``608``!D````` M`````````(`!;WX``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`4H5B1S%8D8Z!`@``W@H``!D``````````````(`!9H8` M`'AL+W=OB0``>&PO=V]R:W-H965T&UL4$L!`A0#%`````@` M4H5B1[ST9&:3"P``YU(``!D``````````````(`!68X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1]2I)PHP`@`` MI08``!D``````````````(`!4*```'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`4H5B1Q`0;N\':@``/Z0!`!0````````` M`````(`!-:D``'AL+W-H87)E9%-T&UL4$L%!@`````Z`#H`R`\` '`&X3`0`````` ` end XML 26 R46.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Balance at June 27, 2015 $ 102.4

OCI before reclassifications (net of tax) (37.6)

Amounts reclassified from AOCI (net of tax) 0.4

Other comprehensive income (loss), net of tax (37.2) $ (65.3)

Balance as of September 26, 2015 65.2

Accumulated Translation Adjustment [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Balance at June 27, 2015 130.9

OCI before reclassifications (net of tax) (39.8)

Amounts reclassified from AOCI (net of tax) 0.0

Other comprehensive income (loss), net of tax (39.8)

Balance as of September 26, 2015 91.1

Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Balance at June 27, 2015 (16.3)

OCI before reclassifications (net of tax) (0.3)

Amounts reclassified from AOCI (net of tax) 0.4

Other comprehensive income (loss), net of tax 0.1

Balance as of September 26, 2015 (16.2)

Accumulated Net Unrealized Investment Gain (Loss) [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Balance at June 27, 2015 (3.0)

OCI before reclassifications (net of tax) 2.5

Amounts reclassified from AOCI (net of tax) 0.0

Other comprehensive income (loss), net of tax 2.5

Balance as of September 26, 2015 (0.5)

Accumulated Defined Benefit Plans Adjustment [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Balance at June 27, 2015 (9.2)

OCI before reclassifications (net of tax) 0.0

Amounts reclassified from AOCI (net of tax) 0.0

Other comprehensive income (loss), net of tax 0.0

Balance as of September 26, 2015 $ (9.2)

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after tax, before reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 R33.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business Acquisitions (Details)
$ / shares in Units, € in Millions
3 Months Ended 12 Months Ended

Sep. 15, 2015

USD ($)

Sep. 15, 2015

EUR (€)

Aug. 28, 2015

USD ($)

May. 12, 2015

USD ($)

Mar. 30, 2015

USD ($)

$ / shares

shares

Mar. 30, 2015

EUR (€)

shares

Oct. 31, 2014

USD ($)

products

Sep. 26, 2015

USD ($)

Sep. 27, 2014

USD ($)

Jun. 27, 2015

USD ($)

shares

Nov. 08, 2013

USD ($)

Business Acquisition [Line Items]

Goodwill $ 4,987,100,000 $ 4,971,900,000

Interest Income (Expense), Net 43,400,000 $ 25,900,000

Senior Notes 4,722,700,000 4,720,900,000 $ 2,300,000,000

Proceeds from Issuance or Sale of Equity 999,300,000

Goodwill, Purchase Accounting Adjustments (87,200,000)

Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Total purchase consideration ^[1] $ 150,400,000

Cash and cash equivalents ^[1] 4,600,000

Accounts Receivable ^[1] 3,300,000

Inventories ^[1] 1,700,000

Prepaid Expense and Other Current Assets ^[1] 0

Goodwill ^[1] 63,500,000

Other intangible assets ^[1] 107,300,000

Total Assets ^[1] 180,400,000

Accounts Payable ^[1] 2,800,000

Accrued liabilities ^[1] 900,000

Current net deferred income tax liabilities ^[1] 900,000

Noncurrent net deferred income tax liabilities ^[1] 25,400,000

Total liabilities ^[1] 30,000,000

Net assets acquired ^[1] $ 150,400,000

Business Acquisition, Effective Date of Acquisition Sep. 15, 2015 Sep. 15, 2015

Business Acquisition, Percentage of Voting Interests Acquired 100.00%

Scar Away

Business Acquisition [Line Items]

Total purchase consideration ^[1] $ 27,000,000

Cash and cash equivalents ^[1] 0

Accounts Receivable ^[1] 900,000

Inventories ^[1] 0

Prepaid Expense and Other Current Assets ^[1] 100,000

Goodwill ^[1] 4,900,000

Other intangible assets ^[1] 21,100,000

Total Assets ^[1] 27,000,000

Accounts Payable ^[1] 0

Accrued liabilities ^[1] 0

Current net deferred income tax liabilities ^[1] 0

Noncurrent net deferred income tax liabilities ^[1] 0

Total liabilities ^[1] 0

Net assets acquired ^[1] $ 27,000,000

Business Acquisition, Effective Date of Acquisition Aug. 28, 2015

GSK

Business Acquisition [Line Items]

Total purchase consideration ^[1] $ 223,600,000

Cash and cash equivalents ^[1] 0

Accounts Receivable ^[1] 0

Inventories ^[1] 0

Prepaid Expense and Other Current Assets ^[1] 0

Goodwill ^[1] 48,700,000

Other intangible assets ^[1] 174,900,000

Total Assets ^[1] 223,600,000

Accounts Payable ^[1] 0

Accrued liabilities ^[1] 0

Current net deferred income tax liabilities ^[1] 0

Noncurrent net deferred income tax liabilities ^[1] 0

Total liabilities ^[1] 0

Net assets acquired ^[1] $ 223,600,000

Business Acquisition, Effective Date of Acquisition Aug. 28, 2015

Other [Member]

Business Acquisition [Line Items]

Total purchase consideration 8,700,000

Business acquisitions, number of products purchased 2

Gelcaps

Business Acquisition [Line Items]

Total purchase consideration $ 36,400,000

Cash and cash equivalents 4,600,000

Accounts Receivable 8,500,000

Inventories 7,200,000

Current net deferred tax assets 600,000

Prepaid Expense and Other Current Assets 2,300,000

Property, Plant, and Equipment 6,000,000

Goodwill 4,600,000

Other intangible assets 11,000,000

Noncurrent Assets 400,000

Total Assets 45,200,000

Accounts Payable 3,400,000

Accrued liabilities 1,600,000

Accrued payroll 0

Short term debt 0

Noncurrent net deferred income tax liabilities 3,700,000

Long-term debt 0

Noncurrent Liabilities 100,000

Total liabilities 8,800,000

Net assets acquired 36,400,000

Accrued customer programs $ 0

Business Acquisition, Effective Date of Acquisition May 12, 2015

Business Acquisition, Percentage of Voting Interests Acquired 100.00%

Omega

Business Acquisition [Line Items]

Total purchase consideration $ 2,983,200,000

Cash and cash equivalents 14,700,000

Accounts Receivable 264,700,000

Inventories 207,100,000

Current net deferred tax assets 7,600,000

Prepaid Expense and Other Current Assets 39,200,000

Property, Plant, and Equipment 130,800,000

Goodwill 1,426,100,000

Other intangible assets 3,919,100,000

Noncurrent Assets 2,400,000

Total Assets 6,011,700,000

Accounts Payable 243,100,000

Accrued liabilities 44,500,000

Accrued payroll 51,300,000

Short term debt 24,600,000

Noncurrent net deferred income tax liabilities 1,071,700,000

Long-term debt 1,471,000,000

Noncurrent Liabilities 82,500,000

Total liabilities 3,028,500,000

Net assets acquired 2,983,200,000

Business Combination, Acquisition Related Costs 387,000,000

Accrued customer programs $ 39,800,000

Shares, Issued | shares 5,400,000

Business Acquisition, Effective Date of Acquisition Mar. 30, 2015 Mar. 30, 2015

Shares, Outstanding | shares 685,348,257

Business Acquisition, Percentage of Voting Interests Acquired 95.77%

Treasury Stock, Shares, Acquired | shares 30,243,983 30,243,983

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory (7,400,000)

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment 9,600,000

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, net deferred taxes 31,600,000

Business Acquisition, Share Price | $ / shares $ 167.64

Business Acquisition, Equity Interest Issued or Issuable, Value Assigned $ 904,900,000

Business Acquisition, Cash Exchange 2,078,300,000

Goodwill, Purchase Accounting Adjustments (87,000,000)

Lumara [Member]

Business Acquisition [Line Items]

Total purchase consideration $ 83,000,000

Cash and cash equivalents 0

Accounts Receivable 2,900,000

Inventories 1,500,000

Current net deferred tax assets 0

Prepaid Expense and Other Current Assets 400,000

Property, Plant, and Equipment 100,000

Goodwill 0

Other intangible assets 82,000,000

Noncurrent Assets 0

Total Assets 86,900,000

Accounts Payable 0

Accrued liabilities 3,900,000

Accrued payroll 0

Short term debt 0

Noncurrent net deferred income tax liabilities 0

Long-term debt 0

Noncurrent Liabilities 0

Total liabilities 3,900,000

Net assets acquired 83,000,000

Accrued customer programs $ 0

Business Acquisition, Effective Date of Acquisition Oct. 31, 2014

Number of formulations | products 3

Maximum [Member] | Omega

Business Acquisition [Line Items]

Indemnification available from acquired company's sellers | € € 277.0

Administration [Member] | Omega

Business Acquisition [Line Items]

Business Combination, Acquisition Related Costs 29,700,000

Interest Net [Member] | Omega

Business Acquisition [Line Items]

Interest Income (Expense), Net 23,700,000

Other Expense [Member] | Omega

Business Acquisition [Line Items]

Business Combination, Acquisition Related Costs 324,000,000

Loss on extinguishment of debt [Member] | Omega

Business Acquisition [Line Items]

Gains (Losses) on Extinguishment of Debt 9,600,000

Inventories [Member] | Gelcaps

Business Acquisition [Line Items]

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory $ 600,000

Inventories [Member] | Omega

Business Acquisition [Line Items]

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory 15,100,000

Property, Plant and Equipment [Member] | Gelcaps

Business Acquisition [Line Items]

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment $ 900,000

Property, Plant and Equipment [Member] | Omega

Business Acquisition [Line Items]

Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment 41,500,000

Long-term Debt [Member] | Omega

Business Acquisition [Line Items]

Business combination fair value adjustment 101,900,000

Indefinite-lived Intangible Assets [Member] | Omega

Business Acquisition [Line Items]

Indefinite-lived Intangible Assets, Purchase Accounting Adjustments 98,000,000

Indefinite-lived Intangible Assets [Member] | Omega

Business Acquisition [Line Items]

Indefinite-lived Intangible Assets, Purchase Accounting Adjustments 18,400,000

2014 bonds [Member]

Business Acquisition [Line Items]

Senior Notes $ 1,600,000,000

Common Stock [Member]

Business Acquisition [Line Items]

Stock Issued During Period, Shares, New Issues | shares 6,800,000

Euro Member Countries, Euro | Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Total purchase consideration | € € 133.5

Euro Member Countries, Euro | GSK

Business Acquisition [Line Items]

Total purchase consideration $ 200,000,000

Euro Member Countries, Euro | Other [Member]

Business Acquisition [Line Items]

Total purchase consideration $ 7,900,000

Euro Member Countries, Euro | Maximum [Member] | Omega

Business Acquisition [Line Items]

Indemnification available from acquired company's sellers 248,000,000

Trademarks [Member] | Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 15 years 15 years

Trademarks [Member] | Scar Away

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 25 years

Trademarks [Member] | GSK

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 25 years

Trademarks [Member] | Gelcaps

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 25 years

Customer Relationships [Member] | Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 33,800,000

Finite-Lived Intangible Asset, Useful Life 15 years 15 years

Customer Relationships [Member] | Scar Away

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 9,000,000

Finite-Lived Intangible Asset, Useful Life 15 years

Customer Relationships [Member] | GSK

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 42,500,000

Finite-Lived Intangible Asset, Useful Life 15 years

Customer Relationships [Member] | Gelcaps

Business Acquisition [Line Items]

Other intangible assets $ 6,600,000

Finite-Lived Intangible Asset, Useful Life 20 years

Customer Relationships [Member] | Omega

Business Acquisition [Line Items]

Other intangible assets $ 1,393,900,000

Finite-Lived Intangible Asset, Useful Life 21 years 21 years

Customer Relationships [Member] | Lumara [Member]

Business Acquisition [Line Items]

Other intangible assets $ 0

Noncompete Agreements [Member] | Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 300,000

Finite-Lived Intangible Asset, Useful Life 3 years 3 years

Noncompete Agreements [Member] | Scar Away

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 500,000

Finite-Lived Intangible Asset, Useful Life 4 years

Noncompete Agreements [Member] | GSK

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 0

Noncompete Agreements [Member] | Omega

Business Acquisition [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 3 years 3 years

Licensing Agreements [Member] | Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 21,400,000

Finite-Lived Intangible Asset, Useful Life 3 years 3 years

Licensing Agreements [Member] | Scar Away

Business Acquisition [Line Items]

Other intangible assets ^[1] 0

Licensing Agreements [Member] | GSK

Business Acquisition [Line Items]

Other intangible assets ^[1] 0

Non-solicit agreement [Member] | Omega

Business Acquisition [Line Items]

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 2 years 2 years

Trademarks and Trade Names [Member] | Naturwohl Pharma [Member]

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 51,800,000

Trademarks and Trade Names [Member] | Scar Away

Business Acquisition [Line Items]

Other intangible assets ^[1] 11,600,000

Trademarks and Trade Names [Member] | GSK

Business Acquisition [Line Items]

Other intangible assets ^[1] $ 132,400,000

Trademarks and Trade Names [Member] | Gelcaps

Business Acquisition [Line Items]

Other intangible assets $ 4,400,000

Trademarks and Trade Names [Member] | Omega

Business Acquisition [Line Items]

Other intangible assets $ 2,492,600,000

Finite-Lived Intangible Asset, Useful Life 8 years 8 years

Trademarks and Trade Names [Member] | Lumara [Member]

Business Acquisition [Line Items]

Other intangible assets 0

Brands [Member] | Omega

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 19 years 19 years

Developed Technology Rights [Member] | Gelcaps

Business Acquisition [Line Items]

Other intangible assets 0

Developed Technology Rights [Member] | Omega

Business Acquisition [Line Items]

Other intangible assets $ 32,600,000

Developed Technology Rights [Member] | Lumara [Member]

Business Acquisition [Line Items]

Other intangible assets 0

Developed Technology Rights [Member] | Minimum [Member] | Omega

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 4 years 4 years

Developed Technology Rights [Member] | Maximum [Member] | Omega

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 13 years 13 years

Product Formulations [Member] | Gelcaps

Business Acquisition [Line Items]

Other intangible assets $ 0

Product Formulations [Member] | Omega

Business Acquisition [Line Items]

Other intangible assets $ 0

Product Formulations [Member] | Lumara [Member]

Business Acquisition [Line Items]

Other intangible assets $ 82,000,000

Product Formulations [Member] | Minimum [Member] | Lumara [Member]

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 8 years

Product Formulations [Member] | Maximum [Member] | Lumara [Member]

Business Acquisition [Line Items]

Finite-Lived Intangible Asset, Useful Life 12 years

[1] Opening balance sheets are preliminary.

X

- Definition
Business Acquisition, Cash Exchange
+ References
No definition available.
+ Details

Name: prgo_BusinessAcquisitionCashExchange

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs
+ References
No definition available.
+ Details

Name: prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedaccruedcustomerprograms

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll
+ References
No definition available.
+ Details

Name: prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedaccruedpayroll

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt
+ References
No definition available.
+ Details

Name: prgo_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedshorttermdebt

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Business acquisitions, number of products purchased
+ References
No definition available.
+ Details

Name: prgo_Businessacquisitionsnumberofproductspurchased

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Business combination fair value adjustment
+ References
No definition available.
+ Details

Name: prgo_Businesscombinationfairvalueadjustment

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Indemnification available from acquired company's sellers
+ References
No definition available.
+ Details

Name: prgo_Indemnificationavailablefromacquiredcompanyssellers

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of formulations
+ References
No definition available.
+ Details

Name: prgo_Numberofformulations

Namespace Prefix: prgo_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e845-128460

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Acquisition Date

-URI http://asc.fasb.org/extlink&oid=6919109

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e848-128460

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)(4)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name: us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of voting equity interests acquired at the acquisition date in the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionSharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460

+ Details

Name: us-gaap_BusinessCombinationAcquisitionRelatedCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to financial liabilities assumed in connection with a business combination for which the initial accounting was incomplete.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

+ Details

Name: us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

+ Details

Name: us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to inventory acquired in connection with a business combination for which the initial accounting was incomplete.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

+ Details

Name: us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

+ Details

Name: us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of assets acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary difference due within one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of identifiable intangible assets recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of inventory recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of property, plant, and equipment recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 55

-Paragraph 37

-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12317-112629

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 470

-SubTopic 50

-Section 40

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49170532&loc=d3e12355-112629

+ Details

Name: us-gaap_GainsLossesOnExtinguishmentOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e961-128460

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillPurchaseAccountingAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.10)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_NaturwohlPharmaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_ScarAwayMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_GSKMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_OtherMemberMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_GelcapsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_OmegaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_LumaraMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=prgo_InterestNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_DischargeOfDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_InventoriesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_IndefinitelivedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_FiniteLivedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A2014bondsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CurrencyAxis=currency_EUR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_NonsolicitagreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_ProductFormulationsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 29 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair value measurements (Tables)
3 Months Ended

Sep. 26, 2015

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following tables summarize the valuation of our financial instruments carried at fair value by the above pricing categories at September 26, 2015 and June 27, 2015 (in millions):

September 26, 2015

Level 1

Level 2

Level 3

Total
Assets:

Investment securities
$
16.5

$
—

$
—

$
16.5

Foreign currency forward contracts
—

4.8

—

4.8

Funds associated with Israeli post-employment benefits
—

16.5

—

16.5

Total assets
$
16.5

$
21.3

$
—

$
37.8

Liabilities:

Foreign currency forward contracts
—

5.9

—

5.9

Total liabilities
$
—

$
5.9

$
—

$
5.9

June 27, 2015

Level 1

Level 2

Level 3

Total
Assets:

Investment securities
$
12.7

$
—

$
—

$
12.7

Foreign currency forward contracts
—

12.4

—

12.4

Funds associated with Israeli post-employment benefits
—

17.3

—

17.3

Total assets
$
12.7

$
29.7

$
—

$
42.4

Liabilities:

Foreign currency forward contracts
—

4.6

—

4.6

Total liabilities
$
—

$
4.6

$
—

$
4.6

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 30 R42.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) - Designated as Hedging Instrument [Member] - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net $ (0.5) $ (2.5)

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.4) (0.7)

Interest Rate Swap [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 0.0 2.7

Foreign Exchange Forward [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (0.5) (5.2)

Interest Expense [Member] | Interest Rate Swap [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.4) (0.9)

Net sales [Member] | Foreign Exchange Forward [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.1) 0.6

Other Nonoperating Income (Expense) [Member] | Foreign Exchange Forward [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.1) (0.8)

Cost of Sales [Member] | Foreign Exchange Forward [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ 0.2 $ 0.4

X

- Definition
The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4D

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

+ Details

Name: us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_SalesRevenueGoodsNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 31 R37.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair value measurements - assets and liabilities on a recurring basis (Details) - USD ($)
3 Months Ended 12 Months Ended

Sep. 26, 2015

Jun. 27, 2015

Nov. 08, 2013

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount $ 0 $ 0

Senior Notes 4,722,700,000 4,720,900,000 $ 2,300,000,000

Long-term Debt 822,700,000 820,900,000

Debt Instrument, Fair Value Disclosure 890,900,000 902,400,000

Assets:

Investment securities 16,500,000 12,700,000

Foreign currency forward contracts 4,800,000 12,400,000

Funds associated with Israeli post employment benefits 16,500,000 17,300,000

Total assets 37,800,000 42,400,000

Liabilities:

Foreign currency forward contracts 5,900,000 4,600,000

Total liabilities 5,900,000 4,600,000

Fair Value, Inputs, Level 1 [Member]

Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]

Senior Notes 3,900,000,000 3,900,000,000

Debt Instrument, Fair Value Disclosure 3,811,500,000 3,850,700,000

Assets:

Investment securities 16,500,000 12,700,000

Foreign currency forward contracts 0 0

Funds associated with Israeli post employment benefits 0 0

Total assets 16,500,000 12,700,000

Liabilities:

Foreign currency forward contracts 0 0

Total liabilities 0 0

Fair Value, Inputs, Level 2 [Member]

Assets:

Investment securities 0 0

Foreign currency forward contracts 4,800,000 12,400,000

Funds associated with Israeli post employment benefits 16,500,000 17,300,000

Total assets 21,300,000 29,700,000

Liabilities:

Foreign currency forward contracts 5,900,000 4,600,000

Total liabilities 5,900,000 4,600,000

Fair Value, Inputs, Level 3 [Member]

Assets:

Investment securities 0 0

Foreign currency forward contracts 0 0

Funds associated with Israeli post employment benefits 0 0

Total assets 0 0

Liabilities:

Foreign currency forward contracts 0 0

Total liabilities $ 0 $ 0

X

- Definition
Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount
+ References
No definition available.
+ Details

Name: prgo_FairValueAssetsLevel1Level2Level3TransfersAmount

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Funds Associated With Israeli Post Employment Benefits Fair Value Disclosure
+ References
No definition available.
+ Details

Name: prgo_FundsAssociatedWithIsraeliPostEmploymentBenefitsFairValueDisclosure

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13476-108611

+ Details

Name: us-gaap_DebtInstrumentFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

+ Details

Name: us-gaap_ForeignCurrencyCashFlowHedgeLiabilityAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.
+ References
No definition available.
+ Details

Name: us-gaap_ForeignCurrencyContractAssetFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Trading Securities

-URI http://asc.fasb.org/extlink&oid=6526789

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 35

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=27723805&loc=d3e24584-111560

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51813488&loc=d3e22054-111558

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Available-for-Sale Securities

-URI http://asc.fasb.org/extlink&oid=6505594

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Subparagraph a, f, g

-Article 7

+ Details

Name: us-gaap_InvestmentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value of financial and nonfinancial obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_LiabilitiesFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20, 22

-Article 5

+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 32 R47.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Jun. 27, 2015

Income Taxes [Line Items]

Effective tax rate on income from continuing operations 14.80% 11.40%

Unrecognized Tax Benefits, Including Income Tax Penalties And Interest Accrued $ 399.0 $ 384.3

Unrecognized tax benefits liability, interest and penalties accrued $ 69.0 65.7

Income Tax Examination, Penalties and Interest Expense 8.0

Incremental tax obligation $ 68.9

X

- Definition
Income Taxes [Line Items]
+ References
No definition available.
+ Details

Name: prgo_IncomeTaxesLineItems

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Incremental tax obligation
+ References
No definition available.
+ Details

Name: prgo_Incrementaltaxobligation

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unrecognized Tax Benefits, including Income Tax Penalties and Interest Accrued
+ References
No definition available.
+ Details

Name: prgo_UnrecognizedTaxBenefitsIncludingIncomeTaxPenaltiesAndInterestAccrued

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

+ Details

Name: us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 33 R9.htm IDEA: XBRL DOCUMENT v3.3.0.814

Goodwill and Other Intangible Assets
3 Months Ended

Sep. 26, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets [Text Block]
GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
Reporting Segments:

Balance at June 27, 2015

Business Acquisitions

Purchase Accounting Adjustments

Currency Translation Adjustment

Balance at September 26, 2015
CHC

$
1,897.5

$
4.9

$
(0.2
)

$
(3.8
)

$
1,898.4

BCH

1,551.9

112.2

(87.0
)

0.4

1,577.5

Rx

1,233.6

—

—

(8.1
)

1,225.5

Specialty Sciences

200.7

—

—

—

200.7

Other

88.2

—

—

(3.2
)

85.0

Total goodwill

$
4,971.9

$
117.1

$
(87.2
)

$
(14.7
)

$
4,987.1

Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):

September 26, 2015

June 27, 2015

Gross

Accumulated Amortization

Gross

Accumulated Amortization
Definite-lived intangibles:

Distribution and license agreements
$
6,064.2

$
582.6

$
6,029.9

$
502.3

Developed product technology/formulation and product rights
1,015.4

402.5

1,025.3

383.1

Customer relationships and distribution networks
1,888.2

181.5

1,749.9

146.2

Trademarks, trade names, and brands
502.8

16.7

340.8

11.5

Non-compete agreements
15.2

12.3

14.7

11.9

Total definite-lived intangibles
$
9,485.8

$
1,195.6

$
9,160.6

$
1,055.0

Indefinite-lived intangibles:

Trademarks, trade names, and brands
$
2,362.5

$
—

$
2,257.3

$
—

In-process research and development
5.6

—

5.8

—

Total indefinite-lived intangibles
2,368.1

—

2,263.1

—

Total other intangible assets
$
11,853.9

$
1,195.6

$
11,423.7

$
1,055.0


Certain intangible assets are denominated in currencies other than the U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.

We recorded amortization expense of $147.6 million and $106.5 million for the three months ended September 26, 2015 and September 27, 2014, respectively. The increase in amortization expense was due primarily to the incremental amortization expense incurred on the definite-lived intangible assets acquired from Omega.

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R43.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) - Not Designated as Hedging Instrument [Member] - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Derivative Instruments, Gain (Loss) [Line Items]

Derivative, Gain (Loss) on Derivative, Net $ (8.8) $ (3.3)

Foreign Exchange Forward [Member] | Other Nonoperating Income (Expense) [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative, Gain (Loss) on Derivative, Net (8.9) (1.8)

Foreign Exchange Forward [Member] | Interest Expense [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Derivative, Gain (Loss) on Derivative, Net $ 0.1 $ (1.5)

X

- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeGainLossOnDerivativeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 R29.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings Per Share (Tables)
3 Months Ended

Sep. 26, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):

Three Months Ended

September 26,
2015

September 27,
2014
Numerator:

Net income
$
112.6

$
96.3

Denominator:

Weighted average shares outstanding for basic EPS
146.3

133.9

Dilutive effect of share-based awards
0.6

0.5

Weighted average shares outstanding for diluted EPS
146.9

134.4

Anti-dilutive share-based awards excluded from computation of diluted EPS
0.1

0.1

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R28.htm IDEA: XBRL DOCUMENT v3.3.0.814

Indebtedness (Tables)
3 Months Ended

Sep. 26, 2015

Indebtness [Abstract]

Schedule of Debt [Table Text Block]
Total borrowings outstanding at September 26, 2015 and June 27, 2015 are summarized as follows (in millions):

September 26,
2015

June 27,
2015
Short-term debt

$
86.9

$
6.4

Term loans

*
2014 Term loan due December 5, 2019
517.7

530.5

Public bonds

Coupon
Due

1.300%
November 8, 2016
⁽³⁾

500.0

500.0

*
4.500%
May 23, 2017
⁽²⁾

201.5

201.0

*
5.125%
December 12, 2017
⁽²⁾

335.8

335.0

2.300%
November 8, 2018
⁽³⁾

600.0

600.0

*
5.000%
May 23, 2019
⁽²⁾

134.3

134.1

3.500%
December 15, 2021
⁽¹⁾

500.0

500.0

*
5.105%
July 19, 2023
⁽²⁾

151.1

150.8

4.000%
November 15, 2023
⁽³⁾

800.0

800.0

3.900%
December 15, 2024
⁽¹⁾

700.0

700.0

5.300%
November 15, 2043
⁽³⁾

400.0

400.0

4.900%
December 15, 2044
⁽¹⁾

400.0

400.0

Total public bonds

4,722.7

4,720.9

Other financing
6.3

6.6

Unamortized premium (discount), net
80.4

87.5

Deferred financing fees
(39.0
)

(40.5
)
Total borrowings outstanding
5,375.0

5,311.4

Less short-term debt and current portion of long-term debt
(145.1
)

(64.6
)
Total long-term debt less current portion
$
5,229.9

$
5,246.8

⁽¹⁾
Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds."
⁽²⁾
Debt assumed from Omega.
⁽³⁾
Discussed below collectively as the "2013 Bonds."
*
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.

X

- Definition
Indebtness [Abstract]
+ References
No definition available.
+ Details

Name: prgo_IndebtnessAbstract

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R44.htm IDEA: XBRL DOCUMENT v3.3.0.814

Indebtedness (Debt arrangements) (details)
€ in Millions, $ in Millions
3 Months Ended

Apr. 08, 2015

USD ($)

Apr. 08, 2015

EUR (€)

Mar. 30, 2015

USD ($)

Mar. 30, 2015

EUR (€)

Dec. 05, 2014

USD ($)

Dec. 02, 2014

USD ($)

Sep. 26, 2015

USD ($)

Sep. 27, 2014

Jun. 27, 2015

USD ($)

Mar. 30, 2015

EUR (€)

Dec. 05, 2014

EUR (€)

Nov. 08, 2013

USD ($)

Debt Instrument [Line Items]

Debt Instrument, Issuance Date Dec. 05, 2014

Short-term debt $ 86.9 $ 6.4

Senior Notes $ 4,722.7 4,720.9 $ 2,300.0

Obligated repurchase par amount of public senior notes 101.00%

Other Long-term Debt $ 6.3 6.6

Debt Instrument, Unamortized Discount (Premium), Net (80.4) (87.5)

Deferred financing fee 39.0 40.5

Debt, Long-term and Short-term, Combined Amount 5,375.0 5,311.4

Debt, Short Term and Current Portion of Long Term 145.1 64.6

Long-term debt, less current portion 5,229.9 5,246.9

Line of Credit Facility, Maximum Borrowing Capacity | € € 1,000.0

Line of Credit Facility, Fair Value of Amount Outstanding $ 0.0

Term Loans [Member]

Debt Instrument [Line Items]

Change in control, Ownership percentage 35.00%

Public [Member]

Debt Instrument [Line Items]

Senior Notes 3,900.0

2014 Euro-Denominated Term Loan due December 5, 2019 [Member]

Debt Instrument [Line Items]

Term loans $ 517.7 ^[1] 530.5

Debt Instrument, Maturity Date Dec. 05, 2019 Dec. 05, 2019

1.30% Unsecured Senior Notes due November 8, 2016 [Member]

Debt Instrument [Line Items]

Senior Notes $ 500.0 ^[2] 500.0

Debt Instrument, Face Amount 500.0

4.500% Unsecured Senior Notes due May 23, 2017 [Domain]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 4.50%

Senior Notes $ 201.5 ^[1],[3] 201.0

Debt Instrument, Maturity Date May 23, 2017

5.125% Unsecured Senior Notes due December 12, 2017 [Domain]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.125%

Senior Notes $ 335.8 ^[1],[3] 335.0

Debt Instrument, Maturity Date Dec. 12, 2017

2.30% Unsecured Senior notes November 8, 2018 [Member]

Debt Instrument [Line Items]

Senior Notes $ 600.0 ^[2] 600.0

Debt Instrument, Face Amount 600.0

5.000% Unsecured Senior notes due May 23, 2019 [Domain]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.00%

Senior Notes $ 134.3 ^[1],[3] 134.1

Debt Instrument, Maturity Date May 23, 2019

3.5% Senior note due 2021 [Member]

Debt Instrument [Line Items]

Senior Notes $ 500.0 ^[4] 500.0

5.105% Senior note due July 19, 2023 [Domain]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.105%

Senior Notes $ 151.1 ^[1],[3] 150.8

Debt Instrument, Maturity Date Jul. 19, 2023

4.00% Unsecured Senior Notes due November 15, 2023 [Member]

Debt Instrument [Line Items]

Senior Notes $ 800.0 ^[2] 800.0

Debt Instrument, Face Amount 800.0

3.9% senior note due 2024 [Member]

Debt Instrument [Line Items]

Senior Notes 700.0 ^[4] 700.0

5.30% Unsecured Senior Notes due November 15, 2043 [Member]

Debt Instrument [Line Items]

Senior Notes 400.0 ^[2] 400.0

Debt Instrument, Face Amount $ 400.0

4.9% Senior Loan due 2044 [Member]

Debt Instrument [Line Items]

Senior Notes $ 400.0 ^[4] $ 400.0

Revolving Credit Facility [Member]

Debt Instrument [Line Items]

Change in control, Ownership percentage 3500000000.00%

5.30% Unsecured Senior Notes due November 15, 2043 [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.30% 5.30%

Debt Instrument, Maturity Date Nov. 15, 2043 Nov. 15, 2043

4.00% Unsecured Senior Notes due November 15, 2023 [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 4.00% 4.00%

Debt Instrument, Maturity Date Nov. 15, 2023 Nov. 15, 2023

2.30% Unsecured Senior notes November 8, 2018 [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 2.30% 2.30%

Debt Instrument, Maturity Date Nov. 08, 2018 Nov. 08, 2018

1.30% Unsecured Senior Notes due November 8, 2016 [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 1.30% 1.30%

Debt Instrument, Maturity Date Nov. 08, 2016 Nov. 08, 2016

4.9% Senior Loan due 2044 [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 4.90% 4.90%

Debt Instrument, Face Amount $ 400.0

Debt Instrument, Maturity Date Dec. 15, 2044

3.9% senior note due 2024 [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 3.90% 3.90%

Debt Instrument, Face Amount $ 700.0

Debt Instrument, Maturity Date Dec. 15, 2024

2014 term loan die December 18, 2015 [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount $ 300.0

3.5% Senior note due 2021 [Member]

Debt Instrument [Line Items]

Debt Instrument, Issuance Date Dec. 02, 2014

Debt Instrument, Interest Rate, Stated Percentage 3.50% 3.50%

Debt Instrument, Face Amount $ 500.0

Debt Instrument, Maturity Date Dec. 15, 2021

2014 bonds [Member]

Debt Instrument [Line Items]

Senior Notes $ 1,600.0

2014 Euro-Denominated Term Loan due December 5, 2019 [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount | € 614.3

2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain]

Debt Instrument [Line Items]

Debt Instrument, Face Amount | € 368.6

Revolving Credit Facility [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount $ 600.0

Euro Member Countries, Euro | 2014 Euro-Denominated Term Loan due December 5, 2019 [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount | € 500.0

Euro Member Countries, Euro | 2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain]

Debt Instrument [Line Items]

Debt Instrument, Face Amount | € € 300.0

Omega

Debt Instrument [Line Items]

Amount debt exceeded par value $ 101.9

Omega | Euro Member Countries, Euro

Debt Instrument [Line Items]

Amount debt exceeded par value | € € 93.6

Perrigo Co PLC [Member]

Debt Instrument [Line Items]

Long-term debt, less current portion $ 5,229.9 $ 5,246.8

Omega

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt $ 1,471.0

Debt Instrument, Maturity Date Jan. 01, 2016 Jan. 01, 2016

Extinguishment of Debt, Amount $ 539.1

Omega | 5.125% Retail Bond [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.125% 5.125%

Debt Instrument, Maturity Date Jan. 01, 2017 Jan. 01, 2017

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $ 326.7

Omega | Credit facility indebtedness [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt 544.5

Omega | Over Draft [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $ 56.0

Omega | 6.19% Senior Note [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 6.19% 6.19%

Omega | 5.1045% Senior Note [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.1045% 5.1045%

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt $ 147.0

Debt Instrument, Maturity Date Jan. 01, 2023 Jan. 01, 2023

Omega | 4.5% Retail Bond [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 4.50% 4.50%

Debt Instrument, Maturity Date Jan. 01, 2017 Jan. 01, 2017

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $ 196.0

Omega | 5.0% Retail Bond [Member]

Debt Instrument [Line Items]

Debt Instrument, Interest Rate, Stated Percentage 5.00% 5.00%

Debt Instrument, Maturity Date Jan. 01, 2019 Jan. 01, 2019

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $ 130.7

Omega | Euro Member Countries, Euro

Debt Instrument [Line Items]

Extinguishment of Debt, Amount | € € 500.0

Omega | Euro Member Countries, Euro | 5.125% Retail Bond [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | € € 300.0

Omega | Euro Member Countries, Euro | Credit facility indebtedness [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | € 500.0

Omega | Euro Member Countries, Euro | Over Draft [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | € 51.4

Omega | Euro Member Countries, Euro | 5.1045% Senior Note [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt | € 135.0

Omega | Euro Member Countries, Euro | 4.5% Retail Bond [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | € 180.0

Omega | Euro Member Countries, Euro | 5.0% Retail Bond [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | € € 120.0

Omega | Omega | 6.19% Senior Note [Member]

Debt Instrument [Line Items]

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt $ 20.0

[1] Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.

[2] (3) Discussed below collectively as the "2013 Bonds."

[3] (2) Debt assumed from Omega.

[4] (1) Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds."

X

- Definition
Amount debt exceeded par value
+ References
No definition available.
+ Details

Name: prgo_Amountdebtexceededparvalue

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Change in control, Ownership percentage
+ References
No definition available.
+ Details

Name: prgo_ChangeincontrolOwnershippercentage

Namespace Prefix: prgo_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Debt, Short Term and Current Portion of Long Term
+ References
No definition available.
+ Details

Name: prgo_DebtShortTermandCurrentPortionofLongTerm

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Obligated repurchase par amount of public senior notes
+ References
No definition available.
+ Details

Name: prgo_Obligatedrepurchaseparamountofpublicseniornotes

Namespace Prefix: prgo_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of the fee that accompanies borrowing money under the debt instrument.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentFeeAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date the debt instrument was issued, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentIssuanceDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22(a)(2))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of debt discount (net of debt premium) that was originally recognized at the issuance of the instrument that has yet to be amortized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28567-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28541-108399

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 55

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399

+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the aggregate of total long-term debt, including current maturities and short-term debt.
+ References
No definition available.
+ Details

Name: us-gaap_DebtLongtermAndShorttermCombinedAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Gross amount of debt extinguished.
+ References
No definition available.
+ Details

Name: us-gaap_ExtinguishmentOfDebtAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Fair value of the amount outstanding under the credit facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13476-108611

+ Details

Name: us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a)(2))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_LoansPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including both current and noncurrent portions, carrying amount as of the balance sheet date of other forms of debt not elsewhere specified in the taxonomy with initial maturities beyond one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_OtherLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),16(a)(1))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Subparagraph 2, 3

-Article 9

+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_TermLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_PublicMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A2014EuroDenominatedTermLoandueDecember52019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A4.500UnsecuredSeniorNotesdueMay232017Domain

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.125UnsecuredSeniorNotesdueDecember122017Domain

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A2.30UnsecuredSeniornotesNovember82018Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.000UnsecuredSeniornotesdueMay232019Domain

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A3.5Seniornotedue2021Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.105SeniornotedueJuly192023Domain

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A3.9seniornotedue2024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A4.9SeniorLoandue2044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A5.30UnsecuredSeniorNotesdueNovember152043Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A4.00UnsecuredSeniorNotesdueNovember152023Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A2.30UnsecuredSeniornotesNovember82018Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A1.30UnsecuredSeniorNotesdueNovember82016Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A4.9SeniorLoandue2044Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A3.9seniornotedue2024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A2014termloandieDecember182015Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A3.5Seniornotedue2021Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A2014bondsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A2014EuroDenominatedTermLoandueDecember52019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=prgo_A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CurrencyAxis=currency_EUR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=prgo_OmegaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=prgo_PerrigoCoPLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_OmegaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.125RetailBondMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_CreditfacilityindebtednessMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_OverDraftMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A6.19SeniorNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.1045SeniorNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A4.5RetailBondMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=prgo_A5.0RetailBondMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 38 R30.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accumulated Other Comprehensive Income (Tables)
3 Months Ended

Sep. 26, 2015

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Changes in our AOCI balances, net of tax, for the three months ended September 26, 2015 were as follows (in millions):

Foreign currency translation adjustments

Fair value of derivative financial instruments, net of tax

Fair value of investment securities, net of tax

Post-retirement and pension liability adjustments, net of tax

Total AOCI
Balance at June 27, 2015
$
130.9

$
(16.3
)

$
(3.0
)

$
(9.2
)

$
102.4

OCI before reclassifications
(39.8
)

(0.3
)

2.5

—

(37.6
)
Amounts reclassified from AOCI
—

0.4

—

—

0.4

Other comprehensive income
(39.8
)

0.1

2.5

—

(37.2
)
Balance at September 26, 2015
$
91.1

$
(16.2
)

$
(0.5
)

$
(9.2
)

$
65.2

X

- References
No definition available.
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accumulated other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

+ Details

Name: us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Information (Tables)
3 Months Ended

Sep. 26, 2015

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]
The below tables show select financial measures by reporting segment (in millions):

Three Months Ended

Balance at September 26, 2015

September 26, 2015

Net Sales

Operating Income (Loss)

Amortization of Intangibles

Total Assets
CHC
$
675.2

$
117.3

$
19.4

$
4,211.2

BCH
302.2

4.4

36.3

6,728.0

Rx
260.3

91.0

18.6

2,597.6

Specialty Sciences
84.5

9.0

72.8

5,920.8

Other
22.5

6.2

0.5

245.5

Unallocated expenses
—

(39.3
)

—

—

Total
$
1,344.7

$
188.6

$
147.6

$
19,703.1

Three Months Ended

Balance at
June 27,
2015

September 27, 2014

Net Sales

Operating Income (Loss)

Amortization of Intangibles

Total Assets
CHC
$
640.3

$
74.8

$
16.2

$
4,381.6

BCH
—

—

—

6,441.1

Rx
194.5

64.7

17.0

2,667.9

Specialty Sciences
91.9

14.9

72.8

5,979.0

Other
24.8

7.1

0.5

251.0

Unallocated expenses
—

(24.3
)

—

—

Total
$
951.5

$
137.2

$
106.5

$
19,720.6

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 22

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8736-108599

+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R8.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business Acquisitions (Notes)
3 Months Ended

Sep. 26, 2015

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]
ACQUISITIONS

All of the below acquisitions have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date.

Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets and liabilities assumed, as well as asset lives, can materially impact our results of operations. For those acquisitions for which the purchase price allocation is preliminary, we will continue to refine the allocation during the measurement period. As we obtain the information to finalize our purchase accounting assessments, it is reasonably possible that there will be changes in the valuation of assets acquired and liabilities assumed that may have a material impact on our results of operations and financial position.

The effects of all of the acquisitions described below were included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense.

Current Period Acquisitions

Naturwohl Pharma GmbH

On September 15, 2015, we completed our acquisition of 100% of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe. The acquisition builds on our BCH segment's leading OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at €133.5 million ($150.4 million). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired included a trademark with a 15-year useful life, customer relationships with a 15-year useful life, non-compete agreements with a three-year useful life, and a licensing agreement with a three-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, the lost income method for valuing the non-compete agreements, and the with or without approach for the licensing agreement. The with or without approach estimates the fair value of an asset by comparing the value of the business, inclusive of the asset, to the hypothetical value of the same business excluding the asset. The goodwill acquired is not deductible for tax purposes.

ScarAway^®

On August 28, 2015, we acquired ScarAway^®, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for $27.0 million in cash. This acquisition serves as our entry into the branded OTC business in the U.S. Operating results attributable to ScarAway^®are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life, non-compete agreements with a four-year useful life and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.

GlaxoSmithKline Consumer Healthcare

On August 28, 2015, we completed the acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK”). This acquisition further leverages our European market share and expands our product offerings. The assets were purchased through an all-cash transaction valued at €200.0 million ($223.6 million). Operating results attributable to GSK are included in the BCH segment. The intangible assets acquired included trademarks with 25-year useful lives and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes.

Other Product Acquisitions

We also acquired two OTC product portfolios totaling €7.9 million ($8.7 million) during the three months ended September 26, 2015, which are included in the BCH segment.

Purchase Price Allocation of Current Period Acquisitions

The Naturwohl, ScarAway^®, and GSK opening balance sheets are still preliminary and are based on valuation information, estimates, and assumptions available at September 26, 2015. As we finalize the fair value estimates of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period. Tax accounts as well as certain tangible and intangible assets have not yet been finalized.
The below table indicates the purchase price allocation for our current period acquisitions (in millions):

Naturwohl*

ScarAway^®*

GSK*
Total purchase consideration
$
150.4

$
27.0

$
223.6

Assets acquired:

Cash and cash equivalents
$
4.6

$
—

$
—

Accounts receivable
3.3

0.9

—

Inventories
1.7

—

—

Prepaid expenses and other current assets
—

0.1

—

Goodwill
63.5

4.9

48.7

Intangible assets:

Trademarks, trade names, and brands
51.8

11.6

132.4

Customer relationships and distribution networks
33.8

9.0

42.5

Non-competition agreements
0.3

0.5

—

Distribution and license agreements
21.4

—

—

Other intangible assets
107.3

21.1

174.9

Total assets
180.4

27.0

223.6

Liabilities assumed:

Accounts payable
2.8

—

—

Accrued liabilities
0.9

—

—

Current net deferred income tax liabilities
0.9

—

—

Non-current net deferred income tax liabilities
25.4

—

—

Total liabilities
30.0

—

—

Net assets acquired
$
150.4

$
27.0

$
223.6

*
Opening balance sheets are preliminary.

Prior Period Acquisitions

Gelcaps Exportadora de Mexico, S.A. de C.V.

On May 12, 2015, we acquired 100% of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for $36.4 million in cash. The purchase price was adjusted during the three months ended September 26, 2015 to account for a working capital adjustment with the seller. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life and customer relationships with a 20-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $0.6 million was recorded in the opening balance sheet, which was charged to cost of goods sold during the three months ended September 26, 2015. In addition, property, plant and equipment were written up by $0.9 million to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.

Omega Pharma Invest N.V.

On March 30, 2015, we completed our acquisition of Omega, a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company, and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with critical mass in key European countries, establishing commercial infrastructure in the high-barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, enhancing our financial profile, and expanding our international management capabilities.

We purchased 95.77% of the issued and outstanding share capital of Omega (685,348,257 shares) from Alychlo N.V. (“Alychlo”) and Holdco I BE N.V. (“Holdco” and, together with Alychlo, the “Sellers”), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining 30,243,983 shares as treasury shares.

The acquisition was a cash and stock transaction made up of the following consideration (in millions, except per share data):
Perrigo ordinary shares issued

5.4

Perrigo share price at transaction close on March 30, 2015

$
167.64

Total value of Perrigo ordinary shares issued

$
904.9

Cash consideration

2,078.3

Total consideration

$
2,983.2

The cash consideration shown in the above table was financed by a combination of debt and equity. We issued $1.6 billion of debt and 6.8 million ordinary shares, which raised $999.3 million net of issuance costs.

The Sellers agreed to indemnify us for certain potential future losses. The Sellers’ indemnification and other obligations to us under the Share Purchase Agreement are secured up to €248.0 million ($277.0 million). Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a three-year non-compete in Europe, and the Sellers are subject to a two-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto.

The operating results attributable to Omega are included in the BCH segment. We incurred costs in connection with the Omega acquisition related to general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded in the fiscal year ended June 27, 2015 (in millions):
Line item

June 27,
2015
Administration

$
29.7

Interest expense, net

23.7

Other expense, net

324.0

Loss on extinguishment of debt

9.6

Total acquisition-related costs

$
387.0

The $324.0 million loss recorded in Other expense, net, consisted of losses from hedging Omega's euro-denominated purchase price due to changes in the euro-to-U.S. dollar exchange rates. These losses were economically offset at closing in the final settlement of the euro-denominated purchase price.

We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an eight-year useful life, definite-lived brands with a 19-year useful life, a distribution network with a 21-year useful life, and developed product technology with useful lives ranging from four to 13 years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above. We utilized the multi-period excess earnings method for the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method for the developed product technology and definite-lived trade name.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $15.1 million was recorded in the opening balance sheet and was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment were written up $41.5 million to their estimated fair market value based on a valuation method that included both the cost and market approaches during the three months ended June 27, 2015. This step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed on the date of acquisition exceeded par value by $101.9 million, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see Note 8.

Lumara Health, Inc.

On October 31, 2014, we acquired a portfolio of women's healthcare products from Lumara Health, Inc., ("Lumara") a privately-held, Chesterfield, Missouri-based specialty pharmaceutical company, for cash consideration of $83.0 million. The acquisition of this portfolio further expanded our women's healthcare product offerings. Operating results attributable to the acquired Lumara products are included in the Rx segment. The intangible assets acquired consisted of three product formulations with useful lives ranging from eight to 12 years. The assets were valued utilizing the multi-period excess earnings method.

Purchase Price Allocation of Prior Period Acquisitions

The Lumara opening balance sheet is final. The Omega and Gelcaps opening balance sheets are still preliminary and are based on valuation information, estimates, and assumptions available at September 26, 2015.

Since the initial valuation, revisions to the Omega allocation have included: a $98.0 million increase in indefinite-lived brands and an $18.4 million increase in definite-lived intangible assets (trade names, brands, and distribution networks) due to refinements in underlying valuation assumptions; a $7.4 million reduction in inventory due to additional analysis related to the fair value of inventory and obsolescence reserves; a $9.6 million increase in property, plant, and equipment due to the completion of additional tangible asset valuations; and an increase in the net deferred tax liabilities of $31.6 million due to the valuation update. These revisions resulted in an $87.0 million reduction in goodwill. The purchase price allocation is still open for verification of the intangible assets valuation, related deferred taxes, and the resulting effects on the value of goodwill.

The Gelcaps purchase price allocation is open for verification of the intangible assets valuation, tax accounts, and any resulting effects on the value of goodwill.

The below table indicates the purchase price allocation for our prior year acquisitions (in millions):

Gelcaps*

Omega*

Lumara
Total purchase consideration
$
36.4

$
2,983.2

$
83.0

Assets acquired:

Cash and cash equivalents
$
4.6

$
14.7

$
—

Accounts receivable
8.5

264.7

2.9

Inventories
7.2

207.1

1.5

Current net deferred tax assets
0.6

7.6

—

Prepaid expenses and other current assets
2.3

39.2

0.4

Property and equipment
6.0

130.8

0.1

Goodwill
4.6

1,426.1

—

Intangible assets:

Trademarks, trade names and brands
4.4

2,492.6

—

Customer relationships and distribution networks
6.6

1,393.9

—

Formulations
—

—

82.0

Developed product technology
—

32.6

—

Other intangible assets
11.0

3,919.1

82.0

Other non-current assets
0.4

2.4

—

Total assets
45.2

6,011.7

86.9

Liabilities assumed:

Accounts payable
3.4

243.1

—

Short-term debt
—

24.6

—

Accrued liabilities
1.6

44.5

3.9

Payroll and related taxes
—

51.3

—

Accrued customer programs
—

39.8

—

Long-term debt
—

1,471.0

—

Non-current net deferred income tax liabilities
3.7

1,071.7

—

Other non-current liabilities
0.1

82.5

—

Total liabilities
8.8

3,028.5

3.9

Net assets acquired
$
36.4

$
2,983.2

$
83.0

*
Opening balance sheets are preliminary.

X

- Definition
The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies and Basis of Presentation Summary of Significant Accounting Policies and Basis of Presentation (Details)
$ in Millions
3 Months Ended

Sep. 26, 2015

USD ($)

Summary of Significant Accounting Policies [Line Items]

Balance of non recourse receivables sold $ 159.3

non recourse receivable activity $ 12.3

Minimum [Member]

Summary of Significant Accounting Policies [Line Items]

Financial asset servicing fees paid 0.14%

Maximum [Member]

Summary of Significant Accounting Policies [Line Items]

Financial asset servicing fees paid 0.15%

X

- Definition
Balance of non recourse receivables sold
+ References
No definition available.
+ Details

Name: prgo_Balanceofnonrecoursereceivablessold

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Financial asset servicing fees paid
+ References
No definition available.
+ Details

Name: prgo_Financialassetservicingfeespaid

Namespace Prefix: prgo_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
non recourse receivable activity
+ References
No definition available.
+ Details

Name: prgo_Nonrecoursereceivableactivity

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Summary of Significant Accounting Policies [Line Items]
+ References
No definition available.
+ Details

Name: prgo_SummaryOfSignificantAccountingPoliciesLineItems

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 42 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Jun. 27, 2015

Derivative [Line Items]

Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months $ 1.8

Designated as Hedging Instrument [Member]

Derivative [Line Items]

Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net (0.5) $ (2.5)

Not Designated as Hedging Instrument [Member]

Derivative [Line Items]

Derivative, Gain (Loss) on Derivative, Net (8.8) (3.3)

Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]

Derivative [Line Items]

Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net $ 0.0 2.7

Foreign Exchange Forward [Member]

Derivative [Line Items]

Maximum Remaining Maturity of Foreign Currency Derivatives 15 months

Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]

Derivative [Line Items]

Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net $ (0.5) $ (5.2)

Foreign Exchange Contract [Member]

Derivative [Line Items]

Derivative, Notional Amount $ 562.3 $ 452.3

X

- Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 12

-Section 13

-Sentence Column B

+ Details

Name: invest_DerivativeNotionalAmount

Namespace Prefix: invest_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (a),(c),(d),(e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeGainLossOnDerivativeNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

+ Details

Name: us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 43 R2.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Net sales $ 1,344.7 $ 951.5

Cost of sales 795.9 629.7

Gross profit 548.8 321.8

Operating expenses

Distribution 24.9 14.4

Research and development 41.6 36.6

Selling 167.9 50.4

Administration 123.6 81.5

Restructuring 2.2 1.7

Total operating expenses 360.2 184.6

Operating Income 188.6 137.2

Interest Income (Expense), Net 43.4 25.9

Other expense, net 13.0 2.7

Income before income taxes 132.2 108.6

Income tax expense 19.6 12.3

Net income $ 112.6 $ 96.3

Earnings Per Share [Abstract]

Basic earnings per share $ 0.77 $ 0.72

Diluted earnings per share $ 0.77 $ 0.72

Weighted average shares outstanding

Basic 146.3 133.9

Diluted 146.9 134.4

Dividends declared per share $ 0.125 $ 0.105

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(a),(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfGoodsAndServicesSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1,2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.10)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense related to the production and distribution of goods or services to customers and clients.
+ References
No definition available.
+ Details

Name: us-gaap_ProductionAndDistributionCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name: us-gaap_RestructuringCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
+ References
No definition available.
+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 44 R45.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings Per Share (Details) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended

Oct. 22, 2015

Sep. 26, 2015

Sep. 27, 2014

Numerator:

Net income $ 112.6 $ 96.3

Denominator:

Basic 146,300 133,900

Dilutive effect of share-based awards 600 500

Weighted average shares outstanding for diluted EPS 146,900 134,400

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 100 0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 154 186

Subsequent Event [Member]

Denominator:

Stock Repurchase Program, Authorized Amount $ 500.0

Repurchase Agreements, Maturities P3Y

Subsequent Event [Member] | Perrigo Co PLC [Member]

Denominator:

Stock Repurchase Program, Authorized Amount $ 2,000.0

X

- Definition
Denominator [Abstract]
+ References
No definition available.
+ Details

Name: prgo_DenominatorAbstract

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Numerator: [Abstract]
+ References
No definition available.
+ Details

Name: prgo_NumeratorAbstract

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 28A

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1500-109256

+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This describes the time frame of the terms of the entity's repurchase agreements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(m)(1)(i)(A))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_RepurchaseAgreementsMaturities

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stock repurchase plan authorized.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramAuthorizedAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=prgo_PerrigoCoPLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 45 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Cash Flows From (For) Operating Activities

Net income $ 112.6 $ 96.3

Adjustments to derive cash flows

Depreciation and amortization 175.4 126.6

Share-based Compensation 14.3 8.8

Non-cash restructuring charges 2.2 1.7

Deferred income taxes (14.2) (20.1)

Other non-cash adjustments 3.2 0.3

Subtotal 293.5 213.6

Increase (decrease) in cash due to

Accounts receivable 46.2 57.3

Inventories (57.0) (29.7)

Accounts payable (194.0) (32.5)

Payroll and related taxes (22.8) (34.9)

Accrued customer programs (0.4) 18.1

Accrued liabilities 61.5 0.6

Accrued income taxes 15.2 14.6

Other (6.2) (12.0)

Subtotal (157.5) (18.5)

Net cash from (for) operating activities 136.0 195.1

Cash Flows (For) From Investing Activities

Acquisitions of business, net of cash acquired 405.1 0.0

Additions to property and equipment (38.6) (31.7)

Other investing 5.0 (1.0)

Net cash from (for) investing activities (448.7) (30.7)

Cash Flows (For) From Financing Activities

Repayment of long-term debt (14.3) (39.5)

Borrowings (repayments) of Short-term debt, net 79.0 (2.1)

Issuance of ordinary shares 2.2 2.6

Shares withheld for payment of employees' withholding tax liability (9.0) (7.5)

Cash dividends (18.3) (14.1)

Other Financing 4.1 (0.7)

Net cash from (for) financing activities 43.7 (61.3)

Effect of exchange rate changes on cash (10.1) (11.1)

Net increase (decrease) in cash and cash equivalents (279.1) 92.0

Cash and cash equivalents, beginning of period 785.6 799.5

Cash and cash equivalents, end of period 506.5 891.5

Cash paid/received during the period for:

Interest paid 6.2 5.2

Interest received 0.3 0.2

Income taxes paid 19.8 10.9

Income taxes refunded $ 1.0 $ 0.5

X

- Definition
The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables.
+ References
No definition available.
+ Details

Name: prgo_IncreaseDecreaseInAccruedCustomerPrograms

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other assets used in operating activities less other operating liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets and liabilities, other noncurrent assets and liabilities, or a combination of other current and noncurrent assets and liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).
+ References
No definition available.
+ Details

Name: us-gaap_OtherOperatingActivitiesCashFlowStatement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

+ Details

Name: us-gaap_PaymentsForProceedsFromOtherInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash received during the period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_ProceedsFromIncomeTaxRefunds

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Interest received on loans and other debt instruments during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_ProceedsFromInterestReceived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the additional capital contribution to the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net cash inflow or outflow from other financing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

+ Details

Name: us-gaap_ProceedsFromPaymentsForOtherFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3095-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 9

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3098-108585

+ Details

Name: us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_RestructuringCostsAndAssetImpairmentCharges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R35.htm IDEA: XBRL DOCUMENT v3.3.0.814

Goodwill and Other Intangible Assets - Intangible categories (Details) - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Jun. 27, 2015

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets subject to amortization, Gross $ 9,485.8 $ 9,160.6

Intangible assets subject to amortization, Accumulated Amortization 1,195.6 1,055.0

Intangible assets not subject to amortization 2,368.1 2,263.1

Total other intangible assets 11,853.9 11,423.7

Intangible assets amortization expense 147.6 $ 106.5

Trademarks, trade names and brands

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets not subject to amortization 2,362.5 2,257.3

In Process Research and Development [Member]

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets not subject to amortization 5.6 5.8

Distribution And License Agreements [Member]

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets subject to amortization, Gross 6,064.2 6,029.9

Intangible assets subject to amortization, Accumulated Amortization 582.6 502.3

Developed Product Technology/Formulation and Product Rights [Member]

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets subject to amortization, Gross 1,015.4 1,025.3

Intangible assets subject to amortization, Accumulated Amortization 402.5 383.1

Customer Relationships [Member]

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets subject to amortization, Gross 1,888.2 1,749.9

Intangible assets subject to amortization, Accumulated Amortization 181.5 146.2

Trademarks, trade names and brands

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets subject to amortization, Gross 502.8 340.8

Intangible assets subject to amortization, Accumulated Amortization 16.7 11.5

Noncompete Agreements [Member]

Finite And Indefinite Lived Assets By Major Class [Line Items]

Intangible assets subject to amortization, Gross 15.2 14.7

Intangible assets subject to amortization, Accumulated Amortization $ 12.3 $ 11.9

X

- Definition
Finite and Indefinite-Lived Assets By Major Class [Line Items]
+ References
No definition available.
+ Details

Name: prgo_FiniteAndIndefiniteLivedAssetsByMajorClassLineItems

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_DistributionAndLicenseAgreementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814

Business Acquisitions (Tables)
3 Months Ended

Sep. 26, 2015

Business Acquisition [Line Items]

Fair value of consideration transferred in business acquisition [Table Text Block]
The acquisition was a cash and stock transaction made up of the following consideration (in millions, except per share data):
Perrigo ordinary shares issued

5.4

Perrigo share price at transaction close on March 30, 2015

$
167.64

Total value of Perrigo ordinary shares issued

$
904.9

Cash consideration

2,078.3

Total consideration

$
2,983.2

Schedule of acquisition-related costs [Table Text Block]
The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded in the fiscal year ended June 27, 2015 (in millions):
Line item

June 27,
2015
Administration

$
29.7

Interest expense, net

23.7

Other expense, net

324.0

Loss on extinguishment of debt

9.6

Total acquisition-related costs

$
387.0

Naturwohl, GSK, Scaraway [Member]

Business Acquisition [Line Items]

Business Combination, Separately Recognized Transactions [Table Text Block]
The below table indicates the purchase price allocation for our current period acquisitions (in millions):

Naturwohl*

ScarAway^®*

GSK*
Total purchase consideration
$
150.4

$
27.0

$
223.6

Assets acquired:

Cash and cash equivalents
$
4.6

$
—

$
—

Accounts receivable
3.3

0.9

—

Inventories
1.7

—

—

Prepaid expenses and other current assets
—

0.1

—

Goodwill
63.5

4.9

48.7

Intangible assets:

Trademarks, trade names, and brands
51.8

11.6

132.4

Customer relationships and distribution networks
33.8

9.0

42.5

Non-competition agreements
0.3

0.5

—

Distribution and license agreements
21.4

—

—

Other intangible assets
107.3

21.1

174.9

Total assets
180.4

27.0

223.6

Liabilities assumed:

Accounts payable
2.8

—

—

Accrued liabilities
0.9

—

—

Current net deferred income tax liabilities
0.9

—

—

Non-current net deferred income tax liabilities
25.4

—

—

Total liabilities
30.0

—

—

Net assets acquired
$
150.4

$
27.0

$
223.6

*
Opening balance sheets are preliminary.

Omega, Gelcaps, Lumara [Member]

Business Acquisition [Line Items]

Business Combination, Separately Recognized Transactions [Table Text Block]
ACQUISITIONS

All of the below acquisitions have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date.

Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets and liabilities assumed, as well as asset lives, can materially impact our results of operations. For those acquisitions for which the purchase price allocation is preliminary, we will continue to refine the allocation during the measurement period. As we obtain the information to finalize our purchase accounting assessments, it is reasonably possible that there will be changes in the valuation of assets acquired and liabilities assumed that may have a material impact on our results of operations and financial position.

The effects of all of the acquisitions described below were included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense.

Current Period Acquisitions

Naturwohl Pharma GmbH

On September 15, 2015, we completed our acquisition of 100% of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe. The acquisition builds on our BCH segment's leading OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at €133.5 million ($150.4 million). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired included a trademark with a 15-year useful life, customer relationships with a 15-year useful life, non-compete agreements with a three-year useful life, and a licensing agreement with a three-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, the lost income method for valuing the non-compete agreements, and the with or without approach for the licensing agreement. The with or without approach estimates the fair value of an asset by comparing the value of the business, inclusive of the asset, to the hypothetical value of the same business excluding the asset. The goodwill acquired is not deductible for tax purposes.

ScarAway^®

On August 28, 2015, we acquired ScarAway^®, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for $27.0 million in cash. This acquisition serves as our entry into the branded OTC business in the U.S. Operating results attributable to ScarAway^®are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life, non-compete agreements with a four-year useful life and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.

GlaxoSmithKline Consumer Healthcare

On August 28, 2015, we completed the acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK”). This acquisition further leverages our European market share and expands our product offerings. The assets were purchased through an all-cash transaction valued at €200.0 million ($223.6 million). Operating results attributable to GSK are included in the BCH segment. The intangible assets acquired included trademarks with 25-year useful lives and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes.

Other Product Acquisitions

We also acquired two OTC product portfolios totaling €7.9 million ($8.7 million) during the three months ended September 26, 2015, which are included in the BCH segment.

Purchase Price Allocation of Current Period Acquisitions

The Naturwohl, ScarAway^®, and GSK opening balance sheets are still preliminary and are based on valuation information, estimates, and assumptions available at September 26, 2015. As we finalize the fair value estimates of assets acquired and liabilities assumed, additional purchase price adjustments may be recorded during the measurement period. Tax accounts as well as certain tangible and intangible assets have not yet been finalized.
The below table indicates the purchase price allocation for our current period acquisitions (in millions):

Naturwohl*

ScarAway^®*

GSK*
Total purchase consideration
$
150.4

$
27.0

$
223.6

Assets acquired:

Cash and cash equivalents
$
4.6

$
—

$
—

Accounts receivable
3.3

0.9

—

Inventories
1.7

—

—

Prepaid expenses and other current assets
—

0.1

—

Goodwill
63.5

4.9

48.7

Intangible assets:

Trademarks, trade names, and brands
51.8

11.6

132.4

Customer relationships and distribution networks
33.8

9.0

42.5

Non-competition agreements
0.3

0.5

—

Distribution and license agreements
21.4

—

—

Other intangible assets
107.3

21.1

174.9

Total assets
180.4

27.0

223.6

Liabilities assumed:

Accounts payable
2.8

—

—

Accrued liabilities
0.9

—

—

Current net deferred income tax liabilities
0.9

—

—

Non-current net deferred income tax liabilities
25.4

—

—

Total liabilities
30.0

—

—

Net assets acquired
$
150.4

$
27.0

$
223.6

*
Opening balance sheets are preliminary.

Prior Period Acquisitions

Gelcaps Exportadora de Mexico, S.A. de C.V.

On May 12, 2015, we acquired 100% of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for $36.4 million in cash. The purchase price was adjusted during the three months ended September 26, 2015 to account for a working capital adjustment with the seller. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life and customer relationships with a 20-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $0.6 million was recorded in the opening balance sheet, which was charged to cost of goods sold during the three months ended September 26, 2015. In addition, property, plant and equipment were written up by $0.9 million to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.

Omega Pharma Invest N.V.

On March 30, 2015, we completed our acquisition of Omega, a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company, and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with critical mass in key European countries, establishing commercial infrastructure in the high-barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, enhancing our financial profile, and expanding our international management capabilities.

We purchased 95.77% of the issued and outstanding share capital of Omega (685,348,257 shares) from Alychlo N.V. (“Alychlo”) and Holdco I BE N.V. (“Holdco” and, together with Alychlo, the “Sellers”), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining 30,243,983 shares as treasury shares.

The acquisition was a cash and stock transaction made up of the following consideration (in millions, except per share data):
Perrigo ordinary shares issued

5.4

Perrigo share price at transaction close on March 30, 2015

$
167.64

Total value of Perrigo ordinary shares issued

$
904.9

Cash consideration

2,078.3

Total consideration

$
2,983.2

The cash consideration shown in the above table was financed by a combination of debt and equity. We issued $1.6 billion of debt and 6.8 million ordinary shares, which raised $999.3 million net of issuance costs.

The Sellers agreed to indemnify us for certain potential future losses. The Sellers’ indemnification and other obligations to us under the Share Purchase Agreement are secured up to €248.0 million ($277.0 million). Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a three-year non-compete in Europe, and the Sellers are subject to a two-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto.

The operating results attributable to Omega are included in the BCH segment. We incurred costs in connection with the Omega acquisition related to general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded in the fiscal year ended June 27, 2015 (in millions):
Line item

June 27,
2015
Administration

$
29.7

Interest expense, net

23.7

Other expense, net

324.0

Loss on extinguishment of debt

9.6

Total acquisition-related costs

$
387.0

The $324.0 million loss recorded in Other expense, net, consisted of losses from hedging Omega's euro-denominated purchase price due to changes in the euro-to-U.S. dollar exchange rates. These losses were economically offset at closing in the final settlement of the euro-denominated purchase price.

We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an eight-year useful life, definite-lived brands with a 19-year useful life, a distribution network with a 21-year useful life, and developed product technology with useful lives ranging from four to 13 years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above. We utilized the multi-period excess earnings method for the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method for the developed product technology and definite-lived trade name.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $15.1 million was recorded in the opening balance sheet and was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment were written up $41.5 million to their estimated fair market value based on a valuation method that included both the cost and market approaches during the three months ended June 27, 2015. This step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed on the date of acquisition exceeded par value by $101.9 million, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see Note 8.

Lumara Health, Inc.

On October 31, 2014, we acquired a portfolio of women's healthcare products from Lumara Health, Inc., ("Lumara") a privately-held, Chesterfield, Missouri-based specialty pharmaceutical company, for cash consideration of $83.0 million. The acquisition of this portfolio further expanded our women's healthcare product offerings. Operating results attributable to the acquired Lumara products are included in the Rx segment. The intangible assets acquired consisted of three product formulations with useful lives ranging from eight to 12 years. The assets were valued utilizing the multi-period excess earnings method.

Purchase Price Allocation of Prior Period Acquisitions

The Lumara opening balance sheet is final. The Omega and Gelcaps opening balance sheets are still preliminary and are based on valuation information, estimates, and assumptions available at September 26, 2015.

Since the initial valuation, revisions to the Omega allocation have included: a $98.0 million increase in indefinite-lived brands and an $18.4 million increase in definite-lived intangible assets (trade names, brands, and distribution networks) due to refinements in underlying valuation assumptions; a $7.4 million reduction in inventory due to additional analysis related to the fair value of inventory and obsolescence reserves; a $9.6 million increase in property, plant, and equipment due to the completion of additional tangible asset valuations; and an increase in the net deferred tax liabilities of $31.6 million due to the valuation update. These revisions resulted in an $87.0 million reduction in goodwill. The purchase price allocation is still open for verification of the intangible assets valuation, related deferred taxes, and the resulting effects on the value of goodwill.

The Gelcaps purchase price allocation is open for verification of the intangible assets valuation, tax accounts, and any resulting effects on the value of goodwill.

The below table indicates the purchase price allocation for our prior year acquisitions (in millions):

Gelcaps*

Omega*

Lumara
Total purchase consideration
$
36.4

$
2,983.2

$
83.0

Assets acquired:

Cash and cash equivalents
$
4.6

$
14.7

$
—

Accounts receivable
8.5

264.7

2.9

Inventories
7.2

207.1

1.5

Current net deferred tax assets
0.6

7.6

—

Prepaid expenses and other current assets
2.3

39.2

0.4

Property and equipment
6.0

130.8

0.1

Goodwill
4.6

1,426.1

—

Intangible assets:

Trademarks, trade names and brands
4.4

2,492.6

—

Customer relationships and distribution networks
6.6

1,393.9

—

Formulations
—

—

82.0

Developed product technology
—

32.6

—

Other intangible assets
11.0

3,919.1

82.0

Other non-current assets
0.4

2.4

—

Total assets
45.2

6,011.7

86.9

Liabilities assumed:

Accounts payable
3.4

243.1

—

Short-term debt
—

24.6

—

Accrued liabilities
1.6

44.5

3.9

Payroll and related taxes
—

51.3

—

Accrued customer programs
—

39.8

—

Long-term debt
—

1,471.0

—

Non-current net deferred income tax liabilities
3.7

1,071.7

—

Other non-current liabilities
0.1

82.5

—

Total liabilities
8.8

3,028.5

3.9

Net assets acquired
$
36.4

$
2,983.2

$
83.0

*
Opening balance sheets are preliminary.

X

- Definition
Fair value of consideration transferred in business acquisition; cash and stock. [Table Text Block]
+ References
No definition available.
+ Details

Name: prgo_FairvalueofconsiderationtransferredinbusinessacquisitionTableTextBlock

Namespace Prefix: prgo_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule of acquisition-related costs by income statement line item [Table Text Block]
+ References
No definition available.
+ Details

Name: prgo_ScheduleofacquisitionrelatedcostsTableTextBlock

Namespace Prefix: prgo_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_NaturwohlGSKScarawayMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=prgo_OmegaGelcapsLumaraMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Details) - USD ($)
$ in Millions

Sep. 26, 2015

Jun. 27, 2015

Inventory Disclosure [Abstract]

Finished goods $ 504.7 $ 468.9

Work in process 163.2 158.2

Raw materials 220.1 211.8

Total Inventories $ 888.0 $ 838.9

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(4))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InventoryWorkInProcess

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 49 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Tables)
3 Months Ended

Sep. 26, 2015

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

Major components of inventory at September 26, 2015 and June 27, 2015, were as follows (in millions):

September 26,
2015

June 27,
2015
Finished goods
$
504.7

$
468.9

Work in process
163.2

158.2

Raw materials
220.1

211.8

Total inventories
$
888.0

$
838.9

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 51 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies
3 Months Ended

Sep. 26, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and Change in Accounting Principles [Text Block]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a.     General Information

The Company

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013. We became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo", the "Company", "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries. We are a leading over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high-quality products at affordable prices. From our beginning in 1887 as a packager of generic home remedies, we have grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri^®. We provide “Quality Affordable Healthcare Products^®” across a wide variety of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the fiscal year ended June 27, 2015. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included.

In fiscal year 2015, we announced that our fiscal year-end will begin on January 1 and end on December 31 of each year, starting on January 1, 2016. Fiscal year 2015, which ended on June 27, 2015, will be followed by a transition period from June 28, 2015 to December 31, 2015. We plan to disclose the results of the transition period on a Form 10-KT transition report.

We will continue to close our books on the Saturday closest to end of the quarter, with the last quarter ending on December 31. This practice will only affect the quarterly reporting periods and not the annual reporting periods.

Sales of OTC pharmaceutical products in the Consumer Healthcare ("CHC") segment are typically subject to seasonal demands for cough/cold/flu products from September through March and allergy products from April through September. Our Branded Consumer Healthcare ("BCH") sales are also impacted by seasonality and tend to peak in April through June due to increased demand for seasonal health and wellness products. In addition, our animal health products are subject to seasonal demand for flea and tick products that peaks during the warmer weather months, typically from March through June. Our Prescription Pharmaceuticals ("Rx"), Specialty Sciences, and Other segments' sales are not generally impacted by seasonal conditions. Accordingly, operating results for the three months ended September 26, 2015 are not necessarily indicative of the results that may be expected for a full year.

Principles of Consolidation

The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Accounts Receivable Factoring

As a result of our acquisition of Omega Pharma Invest N.V. ("Omega"), we assumed multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was $159.3 million at September 26, 2015, a $12.3 million decrease since June 27, 2015.

b.     Recent Accounting Standard Pronouncements
Accounting Standard Update

Description

Date of Adoption

Effect on the Financial Statements or Other Significant Matters
Simplifying the Accounting for Measurement-Period Adjustments

The updated guidance eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. The guidance is effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted.

September 26, 2015

Provisional amounts that occur on or after the adoption date will be recognized in the period in which they are determined. The adoption of this accounting guidance did not materially impact the financial statements for the quarter ended September 26, 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6003-108592

+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R3.htm IDEA: XBRL DOCUMENT v3.3.0.814

Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Net income $ 112.6 $ 96.3

Other Comprehensive Income (loss):

Foreign currency translation adjustments (39.8) (63.8)

Change in fair value of derivative financial instruments, net of tax 0.1 (2.1)

Change in fair value of investment securities, net of tax 2.5 0.6

Other comprehensive income (loss), net of tax (37.2) (65.3)

Comprehensive income $ 75.4 $ 31.0

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (c)(3)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

+ Details

Name: us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (c)(3)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

+ Details

Name: us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a-c)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32157-110900

+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 53 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814

Income Taxes
3 Months Ended

Sep. 26, 2015

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]
INCOME TAXES

The effective tax rate was 14.8% and 11.4% for the three months ended September 26, 2015 and September 27, 2014, respectively.

Our tax rate is subject to adjustment over the balance of the prior fiscal year ended due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments to our interpretation of transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes.

The total liability for uncertain tax positions was $399.0 million and $384.3 million as of September 26, 2015 and June 27, 2015, respectively, before considering the federal tax benefit of certain state and local items.

We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $69.0 million and $65.7 million as of September 26, 2015 and June 27, 2015, respectively.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the U.S., Israel, Belgium, France, and the United Kingdom (U.K.).

Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit, and any related litigation, could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, or interest assessments.

We are under audit by the Israel Tax Authority and the Internal Revenue Service ("IRS") for the fiscal year ended June 25, 2011 and June 30, 2012. The IRS audit of the fiscal year ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of $8.0 million, inclusive of interest, in November 2014, the statutory notice of deficiency asserted various additional positions, including transfer pricing, relative to the same fiscal year ended June 27, 2009 and June 26, 2010 audit. The statutory notice asserted an incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the notice of deficiency. In January 2015, we paid this amount, a prerequisite to being able to contest the IRS’s positions in U.S. Federal court, and in June 2015, we filed a request for a refund. As the IRS has denied our request for a refund, we intend to contest the IRS’s asserted positions in U.S. Federal court. The payment was recorded as a deferred charge on the balance sheet given our anticipated action to recover this amount. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods. There are numerous other income tax jurisdictions for which tax returns are not yet settled, none of which are individually significant. At this time, we cannot predict the outcome of any audit or related litigation.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R1.htm IDEA: XBRL DOCUMENT v3.3.0.814

Document and Entity Information Document - shares
3 Months Ended

Sep. 26, 2015

Oct. 30, 2015

Document and Entity Information [Abstract]

Entity Registrant Name PERRIGO CO PLC

Entity Central Index Key 0001585364

Current Fiscal Year End Date --06-25

Entity Filer Category Large Accelerated Filer

Document Type 10-Q

Document Period End Date Sep. 26, 2015

Document Fiscal Year Focus 2016

Document Fiscal Period Focus Q1

Amendment Flag false

Entity Common Stock, Shares Outstanding 146,402,066

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Document and Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: prgo_DocumentAndEntityInformationAbstract

Namespace Prefix: prgo_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814

Commitments and Contingencies
3 Months Ended

Sep. 26, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies [Text Block]
COMMITMENTS AND CONTINGENCIES

In addition to the discussions below, we have pending certain other legal actions and claims incurred in the normal course of business. We record accruals for such contingencies when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. As of September 26, 2015, we have determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. We have accrued for these matters and will continue to monitor each related legal issue and adjust accruals for new information and further development. Other than what is disclosed below, we consider the litigation matters to be immaterial individually and in the aggregate.

Texas Medicaid

In June 2013, we received notices from the Office of the Attorney General for the State of Texas, of civil investigative demands to two of our affiliates, Perrigo Pharmaceuticals Company and Paddock Laboratories, LLC, for information under the Texas Medicaid Fraud Prevention Act relating to the submission of prices to Texas Medicaid in claims for reimbursement for drugs. We have cooperated with requests for information and are in the process of evaluating this and other information. While we do not know the full extent of our potential liability at this time and intend to vigorously defend against any claims, we could be subject to material penalties and damages. We initially established a contingency loss accrual of $15.0 million to cover potential settlement or other outcomes. Due to changes in circumstances, during the three months ended March 28, 2015, we accrued an additional $9.0 million. In addition, we recorded a receivable of $7.0 million representing the amount we expect to collect from the previous owners of Paddock Laboratories, LLC. We cannot predict whether we will obtain a settlement on terms we deem acceptable, or whether a settlement or potential liability for these claims will be materially higher than the amount recorded.

Eltroxin

During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by Perrigo Israel Agencies Ltd. The respondents include Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel.
One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.
Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd.
On June 16, 2015, Perrigo submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. Other than requiring Perrigo to file its statement of defense to the underlying proceedings, the underlying proceedings have been stayed pending a decision on the motion to appeal.
At this stage, we cannot reasonably predict the outcome or the liability, if any, associated with these claims.

Tysabri^® Product Liability Lawsuits

Perrigo Company plc and collaborator Biogen Idec are co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy, a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri^®. Perrigo Company plc and Biogen Idec will each be responsible for 50% of losses and expenses arising out of any Tysabri^® product liability claims. While these lawsuits will be vigorously defended, management cannot predict how these cases will be resolved. Adverse results in one or more of these lawsuits could result in substantial judgments against us.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R4.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions

Sep. 26, 2015

Jun. 27, 2015

Assets

Cash and cash equivalents $ 506.5 $ 785.6

Investment securities 16.5 12.7

Accounts receivable, net, current 1,232.2 1,282.1

Inventories 888.0 838.9

Current deferred income taxes 69.0 122.3

Prepaid expenses and other current assets 168.6 141.3

Total current assets 2,880.8 3,182.9

Property and equipment, net 924.1 932.4

Goodwill and other indefinite-lived intangible assets 7,355.2 7,235.0

Other intangible assets, net 8,290.2 8,105.6

Non-current deferred income taxes 27.8 39.6

Other non-current assets 225.0 225.1

Total non-current assets 16,822.3 16,537.7

Total Assets 19,703.1 19,720.6

Liabilities and Shareholders' Equity

Accounts payable 541.2 747.5

Short-term debt 86.9 6.4

Payroll and related taxes 112.2 133.9

Accrued customer programs 367.1 368.1

Accrued liabilities 308.8 246.4

Accrued income taxes 82.3 52.6

Current deferred income taxes 104.5 80.6

Current portion of long-term debt 58.2 58.2

Total current liabilities 1,661.2 1,693.7

Long-term debt, less current portion 5,229.9 5,246.9

Non-current deferred income taxes 1,705.1 1,745.1

Other non-current liabilities 374.9 372.1

Total non-current liabilities 7,309.9 7,364.1

Total liabilities 8,971.1 9,057.8

Commitments and contingencies disclosure [Abstract]

Preferred shares, $0.0001 par value, 10 million shares authorized 0.0 0.0

Common shares, €0.0001 par value, 10 billion shares authorized 8,632.8 8,621.9

Accumulated other comprehensive income 65.2 102.4

Retained earnings 2,034.0 1,938.3

Total controlling interest 10,732.0 10,662.6

Noncontrolling interest 0.0 0.2

Total shareholders' equity 10,732.0 10,662.8

Total liabilities and shareholders' equity $ 19,703.1 $ 19,720.6

Supplemental Disclosures of Balance Sheet Information

Preferred shares, issued and outstanding 0.0 0.0

Ordinary shares, issued and outstanding 146.4 146.3

Perrigo Co PLC [Member]

Liabilities and Shareholders' Equity

Long-term debt, less current portion $ 5,229.9 $ 5,246.8

Commitments and contingencies disclosure [Abstract]

Accumulated other comprehensive income $ 65.2

X

- Definition
Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable.
+ References
No definition available.
+ Details

Name: prgo_AccruedCustomerPrograms

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements.
+ References
No definition available.
+ Details

Name: prgo_GoodwillAndIndefiniteLivedIntangibles

Namespace Prefix: prgo_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 15

-Subparagraph b(1)

-Article 7

+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.10-17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51813488&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26626-111562

+ Details

Name: us-gaap_AvailableForSaleSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_BalanceSheetRelatedDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, netted by jurisdiction and classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31928-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

+ Details

Name: us-gaap_DeferredTaxAssetsNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, netted by jurisdiction and classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

+ Details

Name: us-gaap_DeferredTaxLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, netted by jurisdiction and classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 22, 23, 24, 25, 26, 27

-Article 5

+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 27

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 7

+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.13)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),16(a)(1))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 13

-Subparagraph 2, 3

-Article 9

+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=prgo_PerrigoCoPLCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R12.htm IDEA: XBRL DOCUMENT v3.3.0.814

Investments (Notes)
3 Months Ended

Sep. 26, 2015

Investments [Abstract]

Cost and Equity Method Investments Disclosure [Text Block]
INVESTMENTS

Available for Sale Securities

Our available for sale securities are reported in Investment securities. Unrealized investment gains (losses) on available for sale securities were as follows (in millions):

September 26, 2015

June 27, 2015
Equity securities, at cost less impairments
$
17.1

$
17.1

Gross unrealized gains
10.6

5.7

Gross unrealized losses
(11.2
)

(10.1
)
Estimated fair value of equity securities
$
16.5

$
12.7

The factors affecting the assessment of impairments include both general financial market conditions and factors specific to a particular company. The equity securities in a gross unrealized loss position at September 26, 2015 were in that position for less than 12 months. We have evaluated the near-term prospects of the equity securities in relation to the severity and duration of the unrealized impairments, and based on that evaluation, we have the ability and intent to hold the investments until a recovery of fair value.

Cost Method Investments

Our cost method investments totaled $6.9 million and $6.8 million at September 26, 2015 and June 27, 2015, respectively, and are included in Other non-current assets.

Equity Method Investments

Our equity method investments totaled $48.5 million and $48.9 million at September 26, 2015 and June 27, 2015, respectively, and are included in Other non-current assets. We recorded net losses of $4.1 million and $3.1 million during the three months ended September 26, 2015 and September 27, 2014, respectively, for our proportionate share of the equity method investment earnings or losses. The losses were recorded in Other expense, net.

X

- Definition
The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses).
+ References
No definition available.
+ Details

Name: us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 58 R11.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair value measurements (Note)
3 Months Ended

Sep. 26, 2015

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]
FAIR VALUE MEASUREMENTS

Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable.

Level 1:
Quoted prices for identical instruments in active markets.

Level 2:
Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.

Level 3:
Valuations derived from valuation techniques in which one or more significant inputs are not observable.

The following tables summarize the valuation of our financial instruments carried at fair value by the above pricing categories at September 26, 2015 and June 27, 2015 (in millions):

September 26, 2015

Level 1

Level 2

Level 3

Total
Assets:

Investment securities
$
16.5

$
—

$
—

$
16.5

Foreign currency forward contracts
—

4.8

—

4.8

Funds associated with Israeli post-employment benefits
—

16.5

—

16.5

Total assets
$
16.5

$
21.3

$
—

$
37.8

Liabilities:

Foreign currency forward contracts
—

5.9

—

5.9

Total liabilities
$
—

$
5.9

$
—

$
5.9

June 27, 2015

Level 1

Level 2

Level 3

Total
Assets:

Investment securities
$
12.7

$
—

$
—

$
12.7

Foreign currency forward contracts
—

12.4

—

12.4

Funds associated with Israeli post-employment benefits
—

17.3

—

17.3

Total assets
$
12.7

$
29.7

$
—

$
42.4

Liabilities:

Foreign currency forward contracts
—

4.6

—

4.6

Total liabilities
$
—

$
4.6

$
—

$
4.6

There were no transfers between Levels 1, 2, and 3 during the three months ended September 26, 2015. Our policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period. See Note 6 for information on our investment securities. See Note 7 for a discussion of derivatives.

Israeli post-employment benefits represent amounts we have deposited in funds managed by financial institutions designated by management to cover post-employment benefits for its Israeli employees as required by Israeli law. The funds are recorded in Other non-current assets and values are determined using prices for recently traded financial instruments with similar underlying terms, as well as directly or indirectly observable inputs, such as interest rates and yield curves, that are observable at commonly quoted intervals.

As of September 26, 2015 and June 27, 2015, our fixed rate long-term debt consisted of public bonds, retail bonds, and private placement notes. The fair value of the public bonds was determined by quoted market prices (Level 1). As of September 26, 2015, the public bonds had a carrying value of $3.9 billion and a fair value of $3.8 billion. As of June 27, 2015, the public bonds had a carrying value and a fair value of $3.9 billion. The fair value of the retail bonds and private placement notes was determined by discounting the future cash flows of the financial instruments to their present value, using interest rates offered for borrowings of a similar nature and remaining maturities (Level 2). As of September 26, 2015 and June 27, 2015, the retail bonds and private placement notes had a carrying value of $822.7 million and $820.9 million, respectively, and a fair value of $890.9 million and $902.4 million, respectively.

The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814

Goodwill and Other Intangible Assets (Tables)
3 Months Ended

Sep. 26, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]
Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
Reporting Segments:

Balance at June 27, 2015

Business Acquisitions

Purchase Accounting Adjustments

Currency Translation Adjustment

Balance at September 26, 2015
CHC

$
1,897.5

$
4.9

$
(0.2
)

$
(3.8
)

$
1,898.4

BCH

1,551.9

112.2

(87.0
)

0.4

1,577.5

Rx

1,233.6

—

—

(8.1
)

1,225.5

Specialty Sciences

200.7

—

—

—

200.7

Other

88.2

—

—

(3.2
)

85.0

Total goodwill

$
4,971.9

$
117.1

$
(87.2
)

$
(14.7
)

$
4,987.1

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]
Other intangible assets and related accumulated amortization consisted of the following (in millions):

September 26, 2015

June 27, 2015

Gross

Accumulated Amortization

Gross

Accumulated Amortization
Definite-lived intangibles:

Distribution and license agreements
$
6,064.2

$
582.6

$
6,029.9

$
502.3

Developed product technology/formulation and product rights
1,015.4

402.5

1,025.3

383.1

Customer relationships and distribution networks
1,888.2

181.5

1,749.9

146.2

Trademarks, trade names, and brands
502.8

16.7

340.8

11.5

Non-compete agreements
15.2

12.3

14.7

11.9

Total definite-lived intangibles
$
9,485.8

$
1,195.6

$
9,160.6

$
1,055.0

Indefinite-lived intangibles:

Trademarks, trade names, and brands
$
2,362.5

$
—

$
2,257.3

$
—

In-process research and development
5.6

—

5.8

—

Total indefinite-lived intangibles
2,368.1

—

2,263.1

—

Total other intangible assets
$
11,853.9

$
1,195.6

$
11,423.7

$
1,055.0

X

- Definition
Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]
+ References
No definition available.
+ Details

Name: prgo_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: prgo_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 60 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Information
3 Months Ended

Sep. 26, 2015

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]
SEGMENT INFORMATION

Our reporting segments are as follows:

•
CHC is focused primarily on the global sale of OTC store brand products including cough, cold, and allergy products, gastrointestinal products, analgesics, nicotine-replacement therapy ("NRT"), Vitamins, Minerals and Supplements ("VMS"), animal health products, infant formula and foods, and diagnostic products.

•
BCH develops, manufactures, markets and distributes some of Europe's most well-known OTC brands in the natural health and VMS, cough, cold and allergy, NRT, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.

•
Rx develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and U.K. markets.

•
Specialty Sciences is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri^®).

We also have an "Other" segment comprised of our active pharmaceutical ingredient ("API") business, which develops, manufactures, and markets active API used worldwide by both generic and branded pharmaceutical companies.

The below tables show select financial measures by reporting segment (in millions):

Three Months Ended

Balance at September 26, 2015

September 26, 2015

Net Sales

Operating Income (Loss)

Amortization of Intangibles

Total Assets
CHC
$
675.2

$
117.3

$
19.4

$
4,211.2

BCH
302.2

4.4

36.3

6,728.0

Rx
260.3

91.0

18.6

2,597.6

Specialty Sciences
84.5

9.0

72.8

5,920.8

Other
22.5

6.2

0.5

245.5

Unallocated expenses
—

(39.3
)

—

—

Total
$
1,344.7

$
188.6

$
147.6

$
19,703.1

Three Months Ended

Balance at
June 27,
2015

September 27, 2014

Net Sales

Operating Income (Loss)

Amortization of Intangibles

Total Assets
CHC
$
640.3

$
74.8

$
16.2

$
4,381.6

BCH
—

—

—

6,441.1

Rx
194.5

64.7

17.0

2,667.9

Specialty Sciences
91.9

14.9

72.8

5,979.0

Other
24.8

7.1

0.5

251.0

Unallocated expenses
—

(24.3
)

—

—

Total
$
951.5

$
137.2

$
106.5

$
19,720.6

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814

Earnings Per Share
3 Months Ended

Sep. 26, 2015

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]
EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):

Three Months Ended

September 26,
2015

September 27,
2014
Numerator:

Net income
$
112.6

$
96.3

Denominator:

Weighted average shares outstanding for basic EPS
146.3

133.9

Dilutive effect of share-based awards
0.6

0.5

Weighted average shares outstanding for diluted EPS
146.9

134.4

Anti-dilutive share-based awards excluded from computation of diluted EPS
0.1

0.1

Shareholders' Equity

On and prior to December 18, 2013, our common stock consisted of common stock of Perrigo Company, a Michigan Corporation, and since December 19, 2013, our common stock has consisted of ordinary shares of Perrigo Company plc, incorporated under the laws of Ireland.

Prior to June 6, 2013, our common stock traded on the NASDAQ Global Select Market under the symbol PRGO. Since June 6, 2013, our ordinary shares have traded on the New York Stock Exchange under the symbol PRGO. In association with the acquisition of Agis Industries (1983) Ltd., our ordinary shares have been trading on the Tel Aviv Stock Exchange since March 16, 2005.

We issued 154 thousand and 186 thousand shares related to the exercise and vesting of share-based compensation during the three months ended September 26, 2015 and September 27, 2014, respectively.

As of September 26, 2015, we did not have an ordinary share repurchase program. On October 22, 2015, we announced a $2.0 billion share repurchase plan over three years, including $500.0 million expected to be repurchased during the fourth quarter of calendar year 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities (Note)
3 Months Ended

Sep. 26, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of September 26, 2015 and June 27, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of Other Comprehensive Income ("OCI"), net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.

Interest Rate Swaps and Treasury Locks

Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. All of our interest rate swaps qualify for hedge accounting treatment.

Foreign Currency Derivatives

We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of 15 months. The total notional amount for these contracts was $562.3 million and $452.3 million as of September 26, 2015 and June 27, 2015, respectively.

Effects of Derivatives on the Financial Statements

The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements at September 26, 2015 and June 27, 2015. All amounts exclude income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:

Asset Derivatives

Balance Sheet Location

Fair Value

September 26, 2015

June 27, 2015
Designated derivatives:

Foreign currency forward contracts
Other current assets

$
2.3

$
3.3

Total designated derivatives

$
2.3

$
3.3

Non-designated derivatives:

Foreign currency forward contracts
Other current assets

$
2.5

$
9.1

Total non-designated derivatives

$
2.5

$
9.1

Liability Derivatives

Balance Sheet Location

Fair Value

September 26, 2015

June 27, 2015
Designated derivatives:

Foreign currency forward contracts
Accrued liabilities

$
2.5

$
2.0

Total designated derivatives

$
2.5

$
2.0

Non-designated derivatives:

Foreign currency forward contracts
Accrued liabilities

$
3.4

$
2.6

Total non-designated derivatives

$
3.4

$
2.6

The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:

Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)

Three Months Ended
Designated Cash Flow Hedges

September 26, 2015

September 27, 2014
Interest rate swap agreements

—

2.7

Foreign currency forward contracts

(0.5
)

(5.2
)

$
(0.5
)

$
(2.5
)

The gains (losses) reclassified from Accumulated Other Comprehensive Income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:
Designated Cash Flow Hedges

Income Statement Location

Amount of Gain/(Loss) Reclassified from AOCI to Income
(Effective Portion)

Three Months Ended

September 26, 2015

September 27, 2014
Interest rate swap agreements

Interest expense, net

(0.4
)

(0.9
)
Foreign currency forward contracts

Net sales

(0.1
)

0.6

Cost of sales

0.2

0.4

Other expense, net

(0.1
)

(0.8
)

$
(0.4
)

$
(0.7
)

The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a$1.8 million loss.

The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
Non-Designated Derivatives

Income Statement Location

Amount of Gain/(Loss) Recognized in Income

Three Months Ended

September 26, 2015

September 27, 2014
Foreign currency forward contracts

Other expense, net

$
(8.9
)

$
(1.8
)

Interest expense, net

0.1

(1.5
)
Total

$
(8.8
)

$
(3.3
)

Derivatives, Policy [Policy Text Block]

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of September 26, 2015 and June 27, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of Other Comprehensive Income ("OCI"), net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4D

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4H

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4E

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 25

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for its derivative instruments and hedging activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41675-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

+ Details

Name: us-gaap_DerivativesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 63 R14.htm IDEA: XBRL DOCUMENT v3.3.0.814

Indebtedness (note)
3 Months Ended

Sep. 26, 2015

Aggregate Indebtedness [Abstract]

Indebtedness [Text Block]
INDEBTEDNESS

Total borrowings outstanding at September 26, 2015 and June 27, 2015 are summarized as follows (in millions):

September 26,
2015

June 27,
2015
Short-term debt

$
86.9

$
6.4

Term loans

*
2014 Term loan due December 5, 2019
517.7

530.5

Public bonds

Coupon
Due

1.300%
November 8, 2016
⁽³⁾

500.0

500.0

*
4.500%
May 23, 2017
⁽²⁾

201.5

201.0

*
5.125%
December 12, 2017
⁽²⁾

335.8

335.0

2.300%
November 8, 2018
⁽³⁾

600.0

600.0

*
5.000%
May 23, 2019
⁽²⁾

134.3

134.1

3.500%
December 15, 2021
⁽¹⁾

500.0

500.0

*
5.105%
July 19, 2023
⁽²⁾

151.1

150.8

4.000%
November 15, 2023
⁽³⁾

800.0

800.0

3.900%
December 15, 2024
⁽¹⁾

700.0

700.0

5.300%
November 15, 2043
⁽³⁾

400.0

400.0

4.900%
December 15, 2044
⁽¹⁾

400.0

400.0

Total public bonds

4,722.7

4,720.9

Other financing
6.3

6.6

Unamortized premium (discount), net
80.4

87.5

Deferred financing fees
(39.0
)

(40.5
)
Total borrowings outstanding
5,375.0

5,311.4

Less short-term debt and current portion of long-term debt
(145.1
)

(64.6
)
Total long-term debt less current portion
$
5,229.9

$
5,246.8

⁽¹⁾
Public bonds issued on December 2, 2014, discussed below collectively as the "2014 Bonds."
⁽²⁾
Debt assumed from Omega.
⁽³⁾
Discussed below collectively as the "2013 Bonds."
*
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.

We were in compliance with all covenants under our various debt agreements as of September 26, 2015 and June 27, 2015.

Our term loan and revolving credit facility each have an event of default for changes of control that would be triggered upon a 35% change of control. Also, if there is a change of control under our $3.9 billion of public senior notes (the 2014 Bonds and 2013 Bonds), and they are downgraded below investment grade by both Moody's Investor Services, Inc. and Standard & Poor's Rating Service, we would be obligated to offer to repurchase all of the 2014 Bonds and 2013 Bonds at 101% of par.

Omega Financing

Debt Issuance

On December 2, 2014, Perrigo Finance plc, our 100% owned finance subsidiary ("Perrigo Finance"), issued $500.0 million in aggregate principal amount of 3.50% senior notes due 2021 (the "2021 Notes”), $700.0 million in aggregate principal amount of 3.90% senior notes due 2024 (the “2024 Notes”), and $400.0 million in aggregate principal amount of 4.90% senior notes due 2044 (the “2044 Notes” and, together with the 2021 Notes and the 2024 Notes, the “2014 Bonds”). Interest on the 2014 Bonds is payable semiannually in arrears in June and December of each year, beginning in June 2015. The 2014 Bonds are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Bonds are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo Company plc, and no other subsidiary of Perrigo Company plc guarantees the 2014 Bonds. There are no restrictions under the 2014 Bonds on our ability to obtain funds from our subsidiaries. Perrigo Finance received net proceeds of approximately $1.6 billion from issuance of the 2014 Bonds after fees and market discount. Perrigo Finance may redeem the 2014 Bonds in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture.

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, with the ability to draw an additional €300.0 million ($368.6 million) tranche, maturing December 5, 2019, and a $600.0 million revolving credit agreement, which stepped up to $1.0 billion upon the closing of the Omega acquisition (the "2014 Revolver") (together, the "2014 Credit Agreements"). On the same date, Perrigo Company plc entered into a $300.0 million term loan tranche maturing December 18, 2015, which we repaid on June 14, 2015. There were no borrowings outstanding under the 2014 Revolver as of September 26, 2015. Subsequent to September 26, 2015, we allowed the undrawn €300.0 million term loan tranche to expire.

Assumed Debt and Repayment

In connection with the Omega acquisition, we assumed $20.0 million in aggregate principal amount of 6.19% senior notes due 2016 ("2016 Notes"), €135.0 million ($147.0 million) in aggregate principal amount of 5.1045% senior notes due 2023 ("2023 Notes"), €300.0 million ($326.7 million) in aggregate principal amount of 5.125% retail bonds due 2017, €180.0 million ($196.0 million) in aggregate principal amount of 4.500% retail bonds due 2017, €120.0 million ($130.7 million) in aggregate principal amount of 5.000% retail bonds due 2019 (collectively, the "Retail Bonds"), a revolving credit facility with €500.0 million ($544.5 million) outstanding, and certain overdraft facilities totaling €51.4 million ($56.0 million). The fair value of the 2023 Notes and Retail Bonds exceeded par value by €93.6 million ($101.9 million) on the date of the acquisition. As a result, a fair value adjustment was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. The adjustment does not affect cash interest payments.

On April 8, 2015, we repaid the €500.0 million ($539.1 million) outstanding under the assumed Omega revolving credit facility and terminated the facility. On May 29, 2015, we repaid the $20.0 million outstanding on the 2016 Notes.

Omega regularly utilizes overdraft facilities to meet its short-term liquidity needs and its balances fluctuate on a day-to-day basis. While the assumed overdraft facilities balance noted above was repaid as of June 27, 2015, additional borrowings were made as of September 26, 2015 and make up the majority of the short-term debt balance in the above table.

Elan Financing

Debt Issuance

On November 8, 2013, Perrigo Company issued $500.0 million aggregate principal amount of its 1.300% senior notes due 2016 (the "2016 Notes"), $600.0 million aggregate principal amount of its 2.300% senior notes due 2018 (the "2018 Notes"), $800.0 million aggregate principal amount of its 4.000% senior notes due 2023 (the "2023 Notes") and $400.0 million aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 2016 Notes, the 2018 Notes and the 2023 Notes, the "2013 Bonds") in a private placement with registration rights. Interest on the 2013 Bonds is payable semiannually in arrears in May and November of each year, beginning in May 2014. The 2013 Bonds are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Bonds are the Company's unsecured and unsubordinated obligations, ranking equally in right of payment to all of Perrigo Company's existing and future unsecured and unsubordinated indebtedness. Perrigo Company received net proceeds of $2.3 billion from the issuance of the 2013 Bonds after fees and market discount. The 2013 Bonds are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Bonds in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Bonds were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our 2013 credit agreements until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors.

On September 2, 2014, we offered to exchange our private placement senior notes with public bonds. The offer was open until October 1, 2014, at which time substantially all of the private placement notes had been exchanged for bonds registered with the Securities and Exchange Commission. As a result of the changes in the guarantor structure noted above, we are no longer required to present guarantor financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AggregateIndebtednessAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 64 R16.htm IDEA: XBRL DOCUMENT v3.3.0.814

Accumulated Other Comprehensive Income
3 Months Ended

Sep. 26, 2015

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Comprehensive Income (Loss) Note [Text Block]
ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in our AOCI balances, net of tax, for the three months ended September 26, 2015 were as follows (in millions):

Foreign currency translation adjustments

Fair value of derivative financial instruments, net of tax

Fair value of investment securities, net of tax

Post-retirement and pension liability adjustments, net of tax

Total AOCI
Balance at June 27, 2015
$
130.9

$
(16.3
)

$
(3.0
)

$
(9.2
)

$
102.4

OCI before reclassifications
(39.8
)

(0.3
)

2.5

—

(37.6
)
Amounts reclassified from AOCI
—

0.4

—

—

0.4

Other comprehensive income
(39.8
)

0.1

2.5

—

(37.2
)
Balance at September 26, 2015
$
91.1

$
(16.2
)

$
(0.5
)

$
(9.2
)

$
65.2

X

- References
No definition available.
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Reclassification Adjustments

-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

Name: us-gaap_ComprehensiveIncomeNoteTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 65 R34.htm IDEA: XBRL DOCUMENT v3.3.0.814

Goodwill and Other Intangible Assets - Goodwill (Details)
$ in Millions
3 Months Ended

Sep. 26, 2015

USD ($)

Goodwill [Roll Forward]

Beginning balance $ 4,971.9

Business Acquisitions 117.1

Purchase Accounting Adjustments (87.2)

Currency translation adjustment (14.7)

Ending balance 4,987.1

CHC [Member]

Goodwill [Roll Forward]

Beginning balance 1,897.5

Business Acquisitions 4.9

Purchase Accounting Adjustments (0.2)

Currency translation adjustment (3.8)

Ending balance 1,898.4

BCH [Member]

Goodwill [Roll Forward]

Beginning balance 1,551.9

Business Acquisitions 112.2

Purchase Accounting Adjustments (87.0)

Currency translation adjustment 0.4

Ending balance 1,577.5

Rx [Member]

Goodwill [Roll Forward]

Beginning balance 1,233.6

Business Acquisitions 0.0

Purchase Accounting Adjustments 0.0

Currency translation adjustment (8.1)

Ending balance 1,225.5

Specialty Sciences [Member]

Goodwill [Roll Forward]

Beginning balance 200.7

Business Acquisitions 0.0

Purchase Accounting Adjustments 0.0

Currency translation adjustment 0.0

Ending balance 200.7

Other [Member]

Goodwill [Roll Forward]

Beginning balance 88.2

Business Acquisitions 0.0

Purchase Accounting Adjustments 0.0

Currency translation adjustment (3.2)

Ending balance $ 85.0

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillAcquiredDuringPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e961-128460

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillPurchaseAccountingAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) from foreign currency translation adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillTranslationAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerHealthcareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_BrandedCHCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_RxPharmaceuticalsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_SpecialtySciencesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_OtherMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R21.htm IDEA: XBRL DOCUMENT v3.3.0.814

Summary of Significant Accounting Policies and Change in Accounting Principles (Policies)
3 Months Ended

Sep. 26, 2015

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Annual Report on Form 10-K for the fiscal year ended June 27, 2015. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included.

In fiscal year 2015, we announced that our fiscal year-end will begin on January 1 and end on December 31 of each year, starting on January 1, 2016. Fiscal year 2015, which ended on June 27, 2015, will be followed by a transition period from June 28, 2015 to December 31, 2015. We plan to disclose the results of the transition period on a Form 10-KT transition report.

We will continue to close our books on the Saturday closest to end of the quarter, with the last quarter ending on December 31. This practice will only affect the quarterly reporting periods and not the annual reporting periods.

Sales of OTC pharmaceutical products in the Consumer Healthcare ("CHC") segment are typically subject to seasonal demands for cough/cold/flu products from September through March and allergy products from April through September. Our Branded Consumer Healthcare ("BCH") sales are also impacted by seasonality and tend to peak in April through June due to increased demand for seasonal health and wellness products. In addition, our animal health products are subject to seasonal demand for flea and tick products that peaks during the warmer weather months, typically from March through June. Our Prescription Pharmaceuticals ("Rx"), Specialty Sciences, and Other segments' sales are not generally impacted by seasonal conditions. Accordingly, operating results for the three months ended September 26, 2015 are not necessarily indicative of the results that may be expected for a full year.

Consolidation, Policy [Policy Text Block]
Principles of Consolidation

The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Transfers and Servicing of Financial Assets, Transfers of Financial Assets, Sales, Policy [Policy Text Block]
Accounts Receivable Factoring

As a result of our acquisition of Omega Pharma Invest N.V. ("Omega"), we assumed multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was $159.3 million at September 26, 2015, a $12.3 million decrease since June 27, 2015.

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
Recent Accounting Standard Pronouncements
Accounting Standard Update

Description

Date of Adoption

Effect on the Financial Statements or Other Significant Matters
Simplifying the Accounting for Measurement-Period Adjustments

The updated guidance eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. The guidance is effective for public business entities for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early adoption is permitted.

September 26, 2015

Provisional amounts that occur on or after the adoption date will be recognized in the period in which they are determined. The adoption of this accounting guidance did not materially impact the financial statements for the quarter ended September 26, 2015.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02)

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02, 03

-Article 3A

+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for recognizing whether a transfer of a financial asset qualifies for sale treatment, and its initial and subsequent accounting for a sale transaction. If an entity has securitized financial assets during any period presented and accounts for that transfer as a sale, for each major asset type (for example, mortgage loans, credit card receivables, and automobile loans), the entity generally discloses its accounting policies for initially and subsequently measuring any interests that it obtains and sells, or those it continues to hold in the transaction, including the methodology (for example, quoted market prices) and significant assumptions used to value such interests, and the gains and losses resulting from the sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 860

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51814546&loc=d3e107314-111719

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 860

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7519067&loc=SL6226446-111709

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_TransfersAndServicingOfFinancialAssetsTransfersOfFinancialAssetsSalesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 67 R26.htm IDEA: XBRL DOCUMENT v3.3.0.814

Investments (Tables)
3 Months Ended

Sep. 26, 2015

Investments [Abstract]

Unrealized Gain (Loss) on Investments [Table Text Block]
Unrealized investment gains (losses) on available for sale securities were as follows (in millions):

September 26, 2015

June 27, 2015
Equity securities, at cost less impairments
$
17.1

$
17.1

Gross unrealized gains
10.6

5.7

Gross unrealized losses
(11.2
)

(10.1
)
Estimated fair value of equity securities
$
16.5

$
12.7

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of unrealized gains and losses on investments.
+ References
No definition available.
+ Details

Name: us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 68 R49.htm IDEA: XBRL DOCUMENT v3.3.0.814

Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended

Sep. 26, 2015

Sep. 27, 2014

Jun. 27, 2015

Segment Reporting Information [Line Items]

Net sales $ 1,344.7 $ 951.5

Operating Income (Loss) 188.6 137.2

Intangible assets amortization expense 147.6 106.5

Total Assets 19,703.1 $ 19,720.6

CHC [Member]

Segment Reporting Information [Line Items]

Net sales 675.2 640.3

Operating Income (Loss) 117.3 74.8

Intangible assets amortization expense 19.4 16.2

Total Assets 4,211.2 4,381.6

BCH [Member]

Segment Reporting Information [Line Items]

Net sales 302.2 0.0

Operating Income (Loss) 4.4 0.0

Intangible assets amortization expense 36.3 0.0

Total Assets 6,728.0 6,441.1

Rx [Member]

Segment Reporting Information [Line Items]

Net sales 260.3 194.5

Operating Income (Loss) 91.0 64.7

Intangible assets amortization expense 18.6 17.0

Total Assets 2,597.6 2,667.9

Specialty Sciences [Member]

Segment Reporting Information [Line Items]

Net sales 84.5 91.9

Operating Income (Loss) 9.0 14.9

Intangible assets amortization expense 72.8 72.8

Total Assets 5,920.8 5,979.0

Other Segments [Member]

Segment Reporting Information [Line Items]

Net sales 22.5 24.8

Operating Income (Loss) 6.2 7.1

Intangible assets amortization expense 0.5 0.5

Total Assets 245.5 251.0

Unallocated expenses

Segment Reporting Information [Line Items]

Net sales 0.0

Operating Income (Loss) (39.3) (24.3)

Intangible assets amortization expense 0.0 $ 0.0

Total Assets $ 0.0 $ 0.0

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerHealthcareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_BrandedCHCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_RxPharmaceuticalsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=prgo_SpecialtySciencesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 69 R41.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities - balance sheet location (Details) - USD ($)
$ in Millions

Sep. 26, 2015

Jun. 27, 2015

Designated as Hedging Instrument [Member]

Derivatives, Fair Value [Line Items]

Derivative Asset, Fair Value, Net $ 2.3 $ 3.3

Derivative Liability, Fair Value, Amount Not Offset Against Collateral 2.5 2.0

Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Foreign Exchange Forward [Member]

Derivatives, Fair Value [Line Items]

Derivative Asset, Fair Value, Net 2.3 3.3

Designated as Hedging Instrument [Member] | Accrued Liabilities [Member] | Foreign Exchange Forward [Member]

Derivatives, Fair Value [Line Items]

Derivative Liability, Fair Value, Amount Not Offset Against Collateral 2.5 2.0

Not Designated as Hedging Instrument [Member]

Derivatives, Fair Value [Line Items]

Derivative Liability, Fair Value, Amount Not Offset Against Collateral 3.4 2.6

Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]

Derivatives, Fair Value [Line Items]

Derivative Asset, Fair Value, Net 2.5 9.1

Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Foreign Exchange Forward [Member]

Derivatives, Fair Value [Line Items]

Derivative Asset, Fair Value, Net 2.5 9.1

Not Designated as Hedging Instrument [Member] | Accrued Liabilities [Member] | Foreign Exchange Forward [Member]

Derivatives, Fair Value [Line Items]

Derivative Liability, Fair Value, Amount Not Offset Against Collateral $ 3.4 $ 2.6

X

- Definition
Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226006-175313

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 8

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41678-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 8

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41678-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226006-175313

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 20

-Section 55

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313

+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativesFairValueLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814

Consolidated Balance Sheets (Parenthetical)
shares in Millions, $ in Millions

Sep. 26, 2015

€ / shares

Sep. 26, 2015

USD ($)

$ / shares

shares

Jun. 27, 2015

€ / shares

Jun. 27, 2015

USD ($)

$ / shares

shares

Shareholders' Equity

Preferred shares, par value | $ / shares $ 0.0001 $ 0.0001

Preferred shares, authorized 10.0 10.0

Ordinary shares, par value | € / shares € 0.001 € 0.001

Ordinary shares, authorized 10,000.0 10,000.0

Preferred shares outstanding 0.0 0.0

Ordinary shares, outstanding 146.4 146.3

Allowance for Doubtful Accounts Receivable | $ $ 2.1 $ 2.4

Commitments and Contingencies | $ $ 0.0 $ 0.0

X

- Definition
For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5074-111524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 71 R10.htm IDEA: XBRL DOCUMENT v3.3.0.814

Inventories (Notes)
3 Months Ended

Sep. 26, 2015

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]
INVENTORIES

Major components of inventory at September 26, 2015 and June 27, 2015, were as follows (in millions):

September 26,
2015

June 27,
2015
Finished goods
$
504.7

$
468.9

Work in process
163.2

158.2

Raw materials
220.1

211.8

Total inventories
$
888.0

$
838.9

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 72 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814

Derivative Instruments and Hedging Activities (Tables)
3 Months Ended

Sep. 26, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:

Asset Derivatives

Balance Sheet Location

Fair Value

September 26, 2015

June 27, 2015
Designated derivatives:

Foreign currency forward contracts
Other current assets

$
2.3

$
3.3

Total designated derivatives

$
2.3

$
3.3

Non-designated derivatives:

Foreign currency forward contracts
Other current assets

$
2.5

$
9.1

Total non-designated derivatives

$
2.5

$
9.1

Liability Derivatives

Balance Sheet Location

Fair Value

September 26, 2015

June 27, 2015
Designated derivatives:

Foreign currency forward contracts
Accrued liabilities

$
2.5

$
2.0

Total designated derivatives

$
2.5

$
2.0

Non-designated derivatives:

Foreign currency forward contracts
Accrued liabilities

$
3.4

$
2.6

Total non-designated derivatives

$
3.4

$
2.6

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]
The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:

Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)

Three Months Ended
Designated Cash Flow Hedges

September 26, 2015

September 27, 2014
Interest rate swap agreements

—

2.7

Foreign currency forward contracts

(0.5
)

(5.2
)

$
(0.5
)

$
(2.5
)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]
The gains (losses) reclassified from Accumulated Other Comprehensive Income ("AOCI") into earnings for the effective portion of our designated cash flow hedges were as follows:
Designated Cash Flow Hedges

Income Statement Location

Amount of Gain/(Loss) Reclassified from AOCI to Income
(Effective Portion)

Three Months Ended

September 26, 2015

September 27, 2014
Interest rate swap agreements

Interest expense, net

(0.4
)

(0.9
)
Foreign currency forward contracts

Net sales

(0.1
)

0.6

Cost of sales

0.2

0.4

Other expense, net

(0.1
)

(0.8
)

$
(0.4
)

$
(0.7
)

Schedule of non-designated derivatives
The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
Non-Designated Derivatives

Income Statement Location

Amount of Gain/(Loss) Recognized in Income

Three Months Ended

September 26, 2015

September 27, 2014
Foreign currency forward contracts

Other expense, net

$
(8.9
)

$
(1.8
)

Interest expense, net

0.1

(1.5
)
Total

$
(8.8
)

$
(3.3
)

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).
+ References
No definition available.
+ Details

Name: us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for other derivative instruments not designated as hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

+ Details

Name: us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.0.814 html 288 264 1 true 98 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Document Sheet http://www.perrigo.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document Cover 1 false false R2.htm 1001000 - Statement - Consolidated Statements of Income Sheet http://www.perrigo.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income Statements 2 false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 1004000 - Statement - Consolidated Balance Sheets Sheet http://www.perrigo.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 1004501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.perrigo.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 2102100 - Disclosure - Business Acquisitions (Notes) Notes http://www.perrigo.com/role/BusinessAcquisitionsNotes Business Acquisitions (Notes) Notes 8 false false R9.htm 2103100 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 9 false false R10.htm 2104100 - Disclosure - Inventories (Notes) Notes http://www.perrigo.com/role/InventoriesNotes Inventories (Notes) Notes 10 false false R11.htm 2105100 - Disclosure - Fair value measurements (Note) Sheet http://www.perrigo.com/role/FairValueMeasurementsNote Fair value measurements (Note) Notes 11 false false R12.htm 2106100 - Disclosure - Investments (Notes) Notes http://www.perrigo.com/role/InvestmentsNotes Investments (Notes) Notes 12 false false R13.htm 2107100 - Disclosure - Derivative Instruments and Hedging Activities (Note) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNote Derivative Instruments and Hedging Activities (Note) Notes 13 false false R14.htm 2108100 - Disclosure - Indebtedness (note) Sheet http://www.perrigo.com/role/IndebtednessNote Indebtedness (note) Notes 14 false false R15.htm 2109100 - Disclosure - Earnings Per Share Sheet http://www.perrigo.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2110100 - Schedule - Accumulated Other Comprehensive Income Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Uncategorized 16 false false R17.htm 2111100 - Disclosure - Income Taxes Sheet http://www.perrigo.com/role/IncomeTaxes Income Taxes Uncategorized 17 false false R18.htm 2112100 - Disclosure - Commitments and Contingencies Sheet http://www.perrigo.com/role/CommitmentsAndContingencies Commitments and Contingencies Uncategorized 18 false false R19.htm 2113100 - Disclosure - Segment Information Sheet http://www.perrigo.com/role/SegmentInformation Segment Information Uncategorized 19 false false R20.htm 2115100 - Disclosure - Subsequent events (Notes) Notes http://www.perrigo.com/role/SubsequentEventsNotes Subsequent events (Notes) Uncategorized 20 false false R21.htm 2201201 - Disclosure - Summary of Significant Accounting Policies and Change in Accounting Principles (Policies) Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAndChangeInAccountingPrinciplesPolicies Summary of Significant Accounting Policies and Change in Accounting Principles (Policies) Uncategorized 21 false false R22.htm 2302301 - Disclosure - Business Acquisitions (Tables) Sheet http://www.perrigo.com/role/BusinessAcquisitionsTables Business Acquisitions (Tables) Uncategorized 22 false false R23.htm 2303301 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Uncategorized 23 false false R24.htm 2304301 - Disclosure - Inventories (Tables) Sheet http://www.perrigo.com/role/InventoriesTables Inventories (Tables) Uncategorized 24 false false R25.htm 2305301 - Disclosure - Fair value measurements (Tables) Sheet http://www.perrigo.com/role/FairValueMeasurementsTables Fair value measurements (Tables) Uncategorized 25 false false R26.htm 2306301 - Disclosure - Investments (Tables) Sheet http://www.perrigo.com/role/InvestmentsTables Investments (Tables) Uncategorized 26 false false R27.htm 2307301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Uncategorized 27 false false R28.htm 2308301 - Disclosure - Indebtedness (Tables) Sheet http://www.perrigo.com/role/IndebtednessTables Indebtedness (Tables) Uncategorized 28 false false R29.htm 2309301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.perrigo.com/role/EarningsPerShareTables Earnings Per Share (Tables) Uncategorized 29 false false R30.htm 2310301 - Schedule - Accumulated Other Comprehensive Income (Tables) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Uncategorized 30 false false R31.htm 2313301 - Disclosure - Segment Information (Tables) Sheet http://www.perrigo.com/role/SegmentInformationTables Segment Information (Tables) Uncategorized 31 false false R32.htm 2401402 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation Summary of Significant Accounting Policies and Basis of Presentation (Details) Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAndBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndBasisOfPresentationDetails Summary of Significant Accounting Policies and Basis of Presentation Summary of Significant Accounting Policies and Basis of Presentation (Details) Uncategorized 32 false false R33.htm 2402402 - Disclosure - Business Acquisitions (Details) Sheet http://www.perrigo.com/role/BusinessAcquisitionsDetails Business Acquisitions (Details) Uncategorized 33 false false R34.htm 2403402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails Goodwill and Other Intangible Assets - Goodwill (Details) Uncategorized 34 false false R35.htm 2403403 - Disclosure - Goodwill and Other Intangible Assets - Intangible categories (Details) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsIntangibleCategoriesDetails Goodwill and Other Intangible Assets - Intangible categories (Details) Uncategorized 35 false false R36.htm 2404402 - Disclosure - Inventories (Details) Sheet http://www.perrigo.com/role/InventoriesDetails Inventories (Details) Uncategorized 36 false false R37.htm 2405402 - Disclosure - Fair value measurements - assets and liabilities on a recurring basis (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsAssetsAndLiabilitiesOnRecurringBasisDetails Fair value measurements - assets and liabilities on a recurring basis (Details) Uncategorized 37 false false R38.htm 2405404 - Disclosure - Fair Value Measurements Fair value measurements - items not carried at fair value (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsFairValueMeasurementsItemsNotCarriedAtFairValueDetails Fair Value Measurements Fair value measurements - items not carried at fair value (Details) Uncategorized 38 false false R39.htm 2406402 - Disclosure - Investments (Details) Sheet http://www.perrigo.com/role/InvestmentsDetails Investments (Details) Uncategorized 39 false false R40.htm 2407402 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesTextLinksDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) Uncategorized 40 false false R41.htm 2407403 - Disclosure - Derivative Instruments and Hedging Activities - balance sheet location (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails Derivative Instruments and Hedging Activities - balance sheet location (Details) Uncategorized 41 false false R42.htm 2407404 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesOtherComprehensiveIncomeMovementDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) Uncategorized 42 false false R43.htm 2407406 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) Uncategorized 43 false false R44.htm 2408402 - Disclosure - Indebtedness (Debt arrangements) (details) Sheet http://www.perrigo.com/role/IndebtednessDebtArrangementsDetails Indebtedness (Debt arrangements) (details) Uncategorized 44 false false R45.htm 2409402 - Disclosure - Earnings Per Share (Details) Sheet http://www.perrigo.com/role/EarningsPerShareDetails Earnings Per Share (Details) Uncategorized 45 false false R46.htm 2410402 - Schedule - Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Details) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeAccumulatedOtherComprehensiveIncomeDetails Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Details) Uncategorized 46 false false R47.htm 2411401 - Disclosure - Income Taxes (Details) Sheet http://www.perrigo.com/role/IncomeTaxesDetails Income Taxes (Details) Uncategorized 47 false false R48.htm 2412401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.perrigo.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Uncategorized 48 false false R49.htm 2413402 - Disclosure - Segment Information (Details) Sheet http://www.perrigo.com/role/SegmentInformationDetails Segment Information (Details) Uncategorized 49 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 5, 6 are contained in other reports, so were removed by flow through suppression. prgo-20150926.xml prgo-20150926_cal.xml prgo-20150926_def.xml prgo-20150926_lab.xml prgo-20150926_pre.xml prgo-20150926.xsd true true XML 74 R38.htm IDEA: XBRL DOCUMENT v3.3.0.814

Fair Value Measurements Fair value measurements - items not carried at fair value (Details) - USD ($)
$ in Millions

Sep. 26, 2015

Jun. 27, 2015

Nov. 08, 2013

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]

Senior Notes $ 4,722.7 $ 4,720.9 $ 2,300.0

Debt Instrument, Fair Value Disclosure 890.9 902.4

Fair Value, Inputs, Level 1 [Member]

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]

Senior Notes 3,900.0 3,900.0

Debt Instrument, Fair Value Disclosure $ 3,811.5 $ 3,850.7

X

- Definition
Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13476-108611

+ Details

Name: us-gaap_DebtInstrumentFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R20.htm IDEA: XBRL DOCUMENT v3.3.0.814

Subsequent events (Notes)
3 Months Ended

Sep. 26, 2015

Subsequent Events [Abstract]

Subsequent Events [Text Block]
SUBSEQUENT EVENTS

On October 22, 2015, we announced that we intend to undertake certain initiatives designed to increase operational efficiency and improve our return on invested capital by globalizing our supply chain through global shared service arrangements, streamlining our organizational structure, and disposing of certain assets.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Investments (Details) - USD ($) $ in Millions	3 Months Ended
Investments (Details) - USD ($) $ in Millions	Sep. 26, 2015	Sep. 27, 2014	Jun. 27, 2015
Schedule of Equity Method Investments [Line Items]
Unrealized loss on equity method investments	$ (4.1)
Loss from Equity Method Investments		$ (3.1)
Unrealized Gain (Loss) on Investments [Abstract]
Equity securities, at cost less impairments	17.1		$ 17.1
Gross unrealized gains	10.6		5.7
Gross unrealized losses	(11.2)		(10.1)
Estimated fair value of equity securities	16.5		12.7
Other Noncurrent Assets [Member]
Schedule of Equity Method Investments [Line Items]
Cost Method Investments	6.9		6.8
Equity Method Investments	$ 48.5		$ 48.9

Commitments and Contingencies (Details) - Texas Medicaid [Member] - USD ($) $ in Millions	Sep. 26, 2015	Mar. 28, 2015
Loss Contingencies [Line Items]
Loss Contingency Accrual	$ 15.0	$ 9.0
Loss Contingency, Receivable		$ 7.0

Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 26, 2015	Sep. 27, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Balance at June 27, 2015	$ 102.4
OCI before reclassifications (net of tax)	(37.6)
Amounts reclassified from AOCI (net of tax)	0.4
Other comprehensive income (loss), net of tax	(37.2)	$ (65.3)
Balance as of September 26, 2015	65.2
Accumulated Translation Adjustment [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Balance at June 27, 2015	130.9
OCI before reclassifications (net of tax)	(39.8)
Amounts reclassified from AOCI (net of tax)	0.0
Other comprehensive income (loss), net of tax	(39.8)
Balance as of September 26, 2015	91.1
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Balance at June 27, 2015	(16.3)
OCI before reclassifications (net of tax)	(0.3)
Amounts reclassified from AOCI (net of tax)	0.4
Other comprehensive income (loss), net of tax	0.1
Balance as of September 26, 2015	(16.2)
Accumulated Net Unrealized Investment Gain (Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Balance at June 27, 2015	(3.0)
OCI before reclassifications (net of tax)	2.5
Amounts reclassified from AOCI (net of tax)	0.0
Other comprehensive income (loss), net of tax	2.5
Balance as of September 26, 2015	(0.5)
Accumulated Defined Benefit Plans Adjustment [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Balance at June 27, 2015	(9.2)
OCI before reclassifications (net of tax)	0.0
Amounts reclassified from AOCI (net of tax)	0.0
Other comprehensive income (loss), net of tax	0.0
Balance as of September 26, 2015	$ (9.2)

Fair value measurements - assets and liabilities on a recurring basis (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 26, 2015	Jun. 27, 2015	Nov. 08, 2013
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount	$ 0	$ 0
Senior Notes	4,722,700,000	4,720,900,000	$ 2,300,000,000
Long-term Debt	822,700,000	820,900,000
Debt Instrument, Fair Value Disclosure	890,900,000	902,400,000
Assets:
Investment securities	16,500,000	12,700,000
Foreign currency forward contracts	4,800,000	12,400,000
Funds associated with Israeli post employment benefits	16,500,000	17,300,000
Total assets	37,800,000	42,400,000
Liabilities:
Foreign currency forward contracts	5,900,000	4,600,000
Total liabilities	5,900,000	4,600,000
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Senior Notes	3,900,000,000	3,900,000,000
Debt Instrument, Fair Value Disclosure	3,811,500,000	3,850,700,000
Assets:
Investment securities	16,500,000	12,700,000
Foreign currency forward contracts	0	0
Funds associated with Israeli post employment benefits	0	0
Total assets	16,500,000	12,700,000
Liabilities:
Foreign currency forward contracts	0	0
Total liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Assets:
Investment securities	0	0
Foreign currency forward contracts	4,800,000	12,400,000
Funds associated with Israeli post employment benefits	16,500,000	17,300,000
Total assets	21,300,000	29,700,000
Liabilities:
Foreign currency forward contracts	5,900,000	4,600,000
Total liabilities	5,900,000	4,600,000
Fair Value, Inputs, Level 3 [Member]
Assets:
Investment securities	0	0
Foreign currency forward contracts	0	0
Funds associated with Israeli post employment benefits	0	0
Total assets	0	0
Liabilities:
Foreign currency forward contracts	0	0
Total liabilities	$ 0	$ 0

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Sep. 26, 2015	Sep. 27, 2014	Jun. 27, 2015
Income Taxes [Line Items]
Effective tax rate on income from continuing operations	14.80%	11.40%
Unrecognized Tax Benefits, Including Income Tax Penalties And Interest Accrued	$ 399.0		$ 384.3
Unrecognized tax benefits liability, interest and penalties accrued	$ 69.0		65.7
Income Tax Examination, Penalties and Interest Expense			8.0
Incremental tax obligation			$ 68.9

Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) - Not Designated as Hedging Instrument [Member] - USD ($) $ in Millions	3 Months Ended
	Sep. 26, 2015	Sep. 27, 2014
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ (8.8)	$ (3.3)
Foreign Exchange Forward [Member] \| Other Nonoperating Income (Expense) [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	(8.9)	(1.8)
Foreign Exchange Forward [Member] \| Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss) on Derivative, Net	$ 0.1	$ (1.5)

Summary of Significant Accounting Policies and Basis of Presentation Summary of Significant Accounting Policies and Basis of Presentation (Details) $ in Millions	3 Months Ended
	Sep. 26, 2015 USD ($)
Summary of Significant Accounting Policies [Line Items]
Balance of non recourse receivables sold	$ 159.3
non recourse receivable activity	$ 12.3
Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Financial asset servicing fees paid	0.14%
Maximum [Member]
Summary of Significant Accounting Policies [Line Items]
Financial asset servicing fees paid	0.15%

Earnings Per Share (Details) - USD ($) shares in Thousands, $ in Millions		3 Months Ended
	Oct. 22, 2015	Sep. 26, 2015	Sep. 27, 2014
Numerator:
Net income		$ 112.6	$ 96.3
Denominator:
Basic		146,300	133,900
Dilutive effect of share-based awards		600	500
Weighted average shares outstanding for diluted EPS		146,900	134,400
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		100	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		154	186
Subsequent Event [Member]
Denominator:
Stock Repurchase Program, Authorized Amount	$ 500.0
Repurchase Agreements, Maturities	P3Y
Subsequent Event [Member] \| Perrigo Co PLC [Member]
Denominator:
Stock Repurchase Program, Authorized Amount	$ 2,000.0

Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Sep. 26, 2015	Sep. 27, 2014
Cash Flows From (For) Operating Activities
Net income	$ 112.6	$ 96.3
Adjustments to derive cash flows
Depreciation and amortization	175.4	126.6
Share-based Compensation	14.3	8.8
Non-cash restructuring charges	2.2	1.7
Deferred income taxes	(14.2)	(20.1)
Other non-cash adjustments	3.2	0.3
Subtotal	293.5	213.6
Increase (decrease) in cash due to
Accounts receivable	46.2	57.3
Inventories	(57.0)	(29.7)
Accounts payable	(194.0)	(32.5)
Payroll and related taxes	(22.8)	(34.9)
Accrued customer programs	(0.4)	18.1
Accrued liabilities	61.5	0.6
Accrued income taxes	15.2	14.6
Other	(6.2)	(12.0)
Subtotal	(157.5)	(18.5)
Net cash from (for) operating activities	136.0	195.1
Cash Flows (For) From Investing Activities
Acquisitions of business, net of cash acquired	405.1	0.0
Additions to property and equipment	(38.6)	(31.7)
Other investing	5.0	(1.0)
Net cash from (for) investing activities	(448.7)	(30.7)
Cash Flows (For) From Financing Activities
Repayment of long-term debt	(14.3)	(39.5)
Borrowings (repayments) of Short-term debt, net	79.0	(2.1)
Issuance of ordinary shares	2.2	2.6
Shares withheld for payment of employees' withholding tax liability	(9.0)	(7.5)
Cash dividends	(18.3)	(14.1)
Other Financing	4.1	(0.7)
Net cash from (for) financing activities	43.7	(61.3)
Effect of exchange rate changes on cash	(10.1)	(11.1)
Net increase (decrease) in cash and cash equivalents	(279.1)	92.0
Cash and cash equivalents, beginning of period	785.6	799.5
Cash and cash equivalents, end of period	506.5	891.5
Cash paid/received during the period for:
Interest paid	6.2	5.2
Interest received	0.3	0.2
Income taxes paid	19.8	10.9
Income taxes refunded	$ 1.0	$ 0.5

Inventories (Details) - USD ($) $ in Millions	Sep. 26, 2015	Jun. 27, 2015
Inventory Disclosure [Abstract]
Finished goods	$ 504.7	$ 468.9
Work in process	163.2	158.2
Raw materials	220.1	211.8
Total Inventories	$ 888.0	$ 838.9

Income Taxes	3 Months Ended
Income Taxes	Sep. 26, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	INCOME TAXES The effective tax rate was 14.8% and 11.4% for the three months ended September 26, 2015 and September 27, 2014, respectively. Our tax rate is subject to adjustment over the balance of the prior fiscal year ended due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments to our interpretation of transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes. The total liability for uncertain tax positions was $399.0 million and $384.3 million as of September 26, 2015 and June 27, 2015, respectively, before considering the federal tax benefit of certain state and local items. We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $69.0 million and $65.7 million as of September 26, 2015 and June 27, 2015, respectively. We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the U.S., Israel, Belgium, France, and the United Kingdom (U.K.). Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit, and any related litigation, could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, or interest assessments. We are under audit by the Israel Tax Authority and the Internal Revenue Service ("IRS") for the fiscal year ended June 25, 2011 and June 30, 2012. The IRS audit of the fiscal year ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of $8.0 million, inclusive of interest, in November 2014, the statutory notice of deficiency asserted various additional positions, including transfer pricing, relative to the same fiscal year ended June 27, 2009 and June 26, 2010 audit. The statutory notice asserted an incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the notice of deficiency. In January 2015, we paid this amount, a prerequisite to being able to contest the IRS’s positions in U.S. Federal court, and in June 2015, we filed a request for a refund. As the IRS has denied our request for a refund, we intend to contest the IRS’s asserted positions in U.S. Federal court. The payment was recorded as a deferred charge on the balance sheet given our anticipated action to recover this amount. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods. There are numerous other income tax jurisdictions for which tax returns are not yet settled, none of which are individually significant. At this time, we cannot predict the outcome of any audit or related litigation.

Document and Entity Information Document - shares	3 Months Ended
Document and Entity Information Document - shares	Sep. 26, 2015	Oct. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	PERRIGO CO PLC
Entity Central Index Key	0001585364
Current Fiscal Year End Date	--06-25
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 26, 2015
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		146,402,066

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Sep. 26, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies [Text Block]	COMMITMENTS AND CONTINGENCIES In addition to the discussions below, we have pending certain other legal actions and claims incurred in the normal course of business. We record accruals for such contingencies when it is probable that a liability will be incurred and the amount of the loss can be reasonably estimated. As of September 26, 2015, we have determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. We have accrued for these matters and will continue to monitor each related legal issue and adjust accruals for new information and further development. Other than what is disclosed below, we consider the litigation matters to be immaterial individually and in the aggregate. Texas Medicaid In June 2013, we received notices from the Office of the Attorney General for the State of Texas, of civil investigative demands to two of our affiliates, Perrigo Pharmaceuticals Company and Paddock Laboratories, LLC, for information under the Texas Medicaid Fraud Prevention Act relating to the submission of prices to Texas Medicaid in claims for reimbursement for drugs. We have cooperated with requests for information and are in the process of evaluating this and other information. While we do not know the full extent of our potential liability at this time and intend to vigorously defend against any claims, we could be subject to material penalties and damages. We initially established a contingency loss accrual of $15.0 million to cover potential settlement or other outcomes. Due to changes in circumstances, during the three months ended March 28, 2015, we accrued an additional $9.0 million. In addition, we recorded a receivable of $7.0 million representing the amount we expect to collect from the previous owners of Paddock Laboratories, LLC. We cannot predict whether we will obtain a settlement on terms we deem acceptable, or whether a settlement or potential liability for these claims will be materially higher than the amount recorded. Eltroxin During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by Perrigo Israel Agencies Ltd. The respondents include Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel. One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation. Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd. On June 16, 2015, Perrigo submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. Other than requiring Perrigo to file its statement of defense to the underlying proceedings, the underlying proceedings have been stayed pending a decision on the motion to appeal. At this stage, we cannot reasonably predict the outcome or the liability, if any, associated with these claims. Tysabri^® Product Liability Lawsuits Perrigo Company plc and collaborator Biogen Idec are co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy, a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri^®. Perrigo Company plc and Biogen Idec will each be responsible for 50% of losses and expenses arising out of any Tysabri^® product liability claims. While these lawsuits will be vigorously defended, management cannot predict how these cases will be resolved. Adverse results in one or more of these lawsuits could result in substantial judgments against us.

Consolidated Balance Sheets - USD ($) shares in Millions, $ in Millions	Sep. 26, 2015	Jun. 27, 2015
Assets
Cash and cash equivalents	$ 506.5	$ 785.6
Investment securities	16.5	12.7
Accounts receivable, net, current	1,232.2	1,282.1
Inventories	888.0	838.9
Current deferred income taxes	69.0	122.3
Prepaid expenses and other current assets	168.6	141.3
Total current assets	2,880.8	3,182.9
Property and equipment, net	924.1	932.4
Goodwill and other indefinite-lived intangible assets	7,355.2	7,235.0
Other intangible assets, net	8,290.2	8,105.6
Non-current deferred income taxes	27.8	39.6
Other non-current assets	225.0	225.1
Total non-current assets	16,822.3	16,537.7
Total Assets	19,703.1	19,720.6
Liabilities and Shareholders' Equity
Accounts payable	541.2	747.5
Short-term debt	86.9	6.4
Payroll and related taxes	112.2	133.9
Accrued customer programs	367.1	368.1
Accrued liabilities	308.8	246.4
Accrued income taxes	82.3	52.6
Current deferred income taxes	104.5	80.6
Current portion of long-term debt	58.2	58.2
Total current liabilities	1,661.2	1,693.7
Long-term debt, less current portion	5,229.9	5,246.9
Non-current deferred income taxes	1,705.1	1,745.1
Other non-current liabilities	374.9	372.1
Total non-current liabilities	7,309.9	7,364.1
Total liabilities	8,971.1	9,057.8
Commitments and contingencies disclosure [Abstract]
Preferred shares, $0.0001 par value, 10 million shares authorized	0.0	0.0
Common shares, €0.0001 par value, 10 billion shares authorized	8,632.8	8,621.9
Accumulated other comprehensive income	65.2	102.4
Retained earnings	2,034.0	1,938.3
Total controlling interest	10,732.0	10,662.6
Noncontrolling interest	0.0	0.2
Total shareholders' equity	10,732.0	10,662.8
Total liabilities and shareholders' equity	$ 19,703.1	$ 19,720.6
Supplemental Disclosures of Balance Sheet Information
Preferred shares, issued and outstanding	0.0	0.0
Ordinary shares, issued and outstanding	146.4	146.3
Perrigo Co PLC [Member]
Liabilities and Shareholders' Equity
Long-term debt, less current portion	$ 5,229.9	$ 5,246.8
Commitments and contingencies disclosure [Abstract]
Accumulated other comprehensive income	$ 65.2

Goodwill and Other Intangible Assets - Goodwill (Details) $ in Millions	3 Months Ended
	Sep. 26, 2015 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 4,971.9
Business Acquisitions	117.1
Purchase Accounting Adjustments	(87.2)
Currency translation adjustment	(14.7)
Ending balance	4,987.1
CHC [Member]
Goodwill [Roll Forward]
Beginning balance	1,897.5
Business Acquisitions	4.9
Purchase Accounting Adjustments	(0.2)
Currency translation adjustment	(3.8)
Ending balance	1,898.4
BCH [Member]
Goodwill [Roll Forward]
Beginning balance	1,551.9
Business Acquisitions	112.2
Purchase Accounting Adjustments	(87.0)
Currency translation adjustment	0.4
Ending balance	1,577.5
Rx [Member]
Goodwill [Roll Forward]
Beginning balance	1,233.6
Business Acquisitions	0.0
Purchase Accounting Adjustments	0.0
Currency translation adjustment	(8.1)
Ending balance	1,225.5
Specialty Sciences [Member]
Goodwill [Roll Forward]
Beginning balance	200.7
Business Acquisitions	0.0
Purchase Accounting Adjustments	0.0
Currency translation adjustment	0.0
Ending balance	200.7
Other [Member]
Goodwill [Roll Forward]
Beginning balance	88.2
Business Acquisitions	0.0
Purchase Accounting Adjustments	0.0
Currency translation adjustment	(3.2)
Ending balance	$ 85.0

Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
Segment Information (Details) - USD ($) $ in Millions	Sep. 26, 2015	Sep. 27, 2014	Jun. 27, 2015
Segment Reporting Information [Line Items]
Net sales	$ 1,344.7	$ 951.5
Operating Income (Loss)	188.6	137.2
Intangible assets amortization expense	147.6	106.5
Total Assets	19,703.1		$ 19,720.6
CHC [Member]
Segment Reporting Information [Line Items]
Net sales	675.2	640.3
Operating Income (Loss)	117.3	74.8
Intangible assets amortization expense	19.4	16.2
Total Assets	4,211.2		4,381.6
BCH [Member]
Segment Reporting Information [Line Items]
Net sales	302.2	0.0
Operating Income (Loss)	4.4	0.0
Intangible assets amortization expense	36.3	0.0
Total Assets	6,728.0		6,441.1
Rx [Member]
Segment Reporting Information [Line Items]
Net sales	260.3	194.5
Operating Income (Loss)	91.0	64.7
Intangible assets amortization expense	18.6	17.0
Total Assets	2,597.6		2,667.9
Specialty Sciences [Member]
Segment Reporting Information [Line Items]
Net sales	84.5	91.9
Operating Income (Loss)	9.0	14.9
Intangible assets amortization expense	72.8	72.8
Total Assets	5,920.8		5,979.0
Other Segments [Member]
Segment Reporting Information [Line Items]
Net sales	22.5	24.8
Operating Income (Loss)	6.2	7.1
Intangible assets amortization expense	0.5	0.5
Total Assets	245.5		251.0
Unallocated expenses
Segment Reporting Information [Line Items]
Net sales	0.0
Operating Income (Loss)	(39.3)	(24.3)
Intangible assets amortization expense	0.0	$ 0.0
Total Assets	$ 0.0		$ 0.0

Derivative Instruments and Hedging Activities - balance sheet location (Details) - USD ($) $ in Millions	Sep. 26, 2015	Jun. 27, 2015
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Net	$ 2.3	$ 3.3
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	2.5	2.0
Designated as Hedging Instrument [Member] \| Other Current Assets [Member] \| Foreign Exchange Forward [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Net	2.3	3.3
Designated as Hedging Instrument [Member] \| Accrued Liabilities [Member] \| Foreign Exchange Forward [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	2.5	2.0
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	3.4	2.6
Not Designated as Hedging Instrument [Member] \| Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Net	2.5	9.1
Not Designated as Hedging Instrument [Member] \| Other Current Assets [Member] \| Foreign Exchange Forward [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Net	2.5	9.1
Not Designated as Hedging Instrument [Member] \| Accrued Liabilities [Member] \| Foreign Exchange Forward [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Amount Not Offset Against Collateral	$ 3.4	$ 2.6

Consolidated Balance Sheets (Parenthetical) shares in Millions, $ in Millions	Sep. 26, 2015 € / shares	Sep. 26, 2015 USD ($) $ / shares shares	Jun. 27, 2015 € / shares	Jun. 27, 2015 USD ($) $ / shares shares
Shareholders' Equity
Preferred shares, par value \| $ / shares		$ 0.0001		$ 0.0001
Preferred shares, authorized		10.0		10.0
Ordinary shares, par value \| € / shares	€ 0.001		€ 0.001
Ordinary shares, authorized		10,000.0		10,000.0
Preferred shares outstanding		0.0		0.0
Ordinary shares, outstanding		146.4		146.3
Allowance for Doubtful Accounts Receivable \| $		$ 2.1		$ 2.4
Commitments and Contingencies \| $		$ 0.0		$ 0.0

Fair Value Measurements Fair value measurements - items not carried at fair value (Details) - USD ($) $ in Millions	Sep. 26, 2015	Jun. 27, 2015	Nov. 08, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Senior Notes	$ 4,722.7	$ 4,720.9	$ 2,300.0
Debt Instrument, Fair Value Disclosure	890.9	902.4
Fair Value, Inputs, Level 1 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Senior Notes	3,900.0	3,900.0
Debt Instrument, Fair Value Disclosure	$ 3,811.5	$ 3,850.7

Subsequent events (Notes)	3 Months Ended
Subsequent events (Notes)	Sep. 26, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	SUBSEQUENT EVENTS On October 22, 2015, we announced that we intend to undertake certain initiatives designed to increase operational efficiency and improve our return on invested capital by globalizing our supply chain through global shared service arrangements, streamlining our organizational structure, and disposing of certain assets.